data_4cio_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 4cio _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 51.9 ttp . . . . . 0 C--O 1.233 0.197 0 N-CA-C 112.043 0.386 . . . . 1.9 112.043 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.448 ' HB3' ' HG3' ' A' ' 86' ' ' ARG . 8.9 m-85 -91.76 -2.34 56.99 Favored 'General case' 0 C--N 1.331 -0.212 0 O-C-N 122.226 -0.296 . . . . 1.76 111.63 -176.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.579 ' O ' ' HA ' ' A' ' 82' ' ' THR . 41.1 p -110.68 -3.49 15.82 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.877 -0.329 . . . . 1.23 111.447 -178.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -85.64 103.24 14.28 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.97 -0.559 . . . . 3.2 110.207 -176.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 98.7 mt -105.57 141.71 20.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 C-N-CA 123.108 0.563 . . . . 1.46 111.577 -173.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.4 ' HD1' ' CE1' ' A' ' 80' ' ' PHE . 58.9 t80 -95.79 132.41 41.06 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.645 -0.707 . . . . 0.81 109.505 174.007 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.644 HG11 HD12 ' A' ' 42' ' ' LEU . 3.6 t -120.96 141.92 39.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 121.082 0.468 . . . . 1.61 110.314 -178.313 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.593 ' HA3' ' HB2' ' A' ' 106' ' ' ASN . . . -141.95 159.52 26.98 Favored Glycine 0 C--O 1.219 -0.807 0 CA-C-N 115.72 -0.673 . . . . 1.39 112.735 -167.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.77 37.38 93.38 Favored Glycine 0 CA--C 1.522 0.503 0 C-N-CA 121.374 -0.441 . . . . 0.71 113.817 172.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.644 HD12 HG11 ' A' ' 39' ' ' VAL . 8.2 mp -87.54 134.0 36.93 Favored Pre-proline 0 C--N 1.326 -0.418 0 O-C-N 122.694 -0.298 . . . . 1.89 110.626 178.332 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.638 ' HD2' ' OG1' ' A' ' 46' ' ' THR . 51.5 Cg_exo -53.33 155.89 11.7 Favored 'Trans proline' 0 N--CA 1.463 -0.282 0 C-N-CA 122.995 2.463 . . . . 0.82 112.101 175.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -69.09 1.87 3.22 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.129 0.49 . . . . 1.46 110.963 -179.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . 0.43 ' HD2' ' OD2' ' A' ' 101' ' ' ASP . 19.5 t60 -106.88 -16.46 14.46 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.747 -0.66 . . . . 2.65 110.627 178.483 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.638 ' OG1' ' HD2' ' A' ' 43' ' ' PRO . 61.2 m -71.77 138.54 48.49 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.257 -0.428 . . . . 1.31 111.467 -175.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 16.9 p -130.96 -178.35 4.78 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-O 120.967 0.413 . . . . 0.75 111.391 -176.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -62.74 -33.52 75.32 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.969 -0.56 . . . . 0.49 110.756 -176.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -71.39 -33.93 69.94 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.286 -0.635 . . . . 3.26 109.286 -179.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.626 HG22 HG21 ' A' ' 46' ' ' THR . 81.2 m -61.24 -45.29 95.16 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.57 -0.741 . . . . 1.25 110.686 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.485 HD22 HG13 ' A' ' 39' ' ' VAL . 54.0 mt -67.57 -35.33 78.82 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.928 -0.578 . . . . 1.53 111.089 178.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 57.7 t-80 -61.89 -54.02 47.78 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.25 -0.648 . . . . 0.77 109.25 176.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -58.66 -37.4 75.89 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.826 -0.624 . . . . 1.52 112.005 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -76.87 -37.59 55.24 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 120.789 0.328 . . . . 1.6 111.714 -178.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.411 ' CE1' HD23 ' A' ' 51' ' ' LEU . 18.4 m-85 -85.22 -25.23 27.45 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 113.402 0.89 . . . . 0.68 113.402 -174.161 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.635 ' N ' HD12 ' A' ' 61' ' ' ILE . 10.8 pt-20 -64.52 -18.14 64.55 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.642 0.734 . . . . 1.57 109.984 179.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -55.45 -27.66 49.54 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.542 -1.208 . . . . 2.79 111.755 170.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -96.06 -21.28 18.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.546 -0.297 . . . . 0.79 110.802 -178.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 151.25 -159.74 28.35 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.565 -0.826 . . . . 0.75 112.419 177.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -65.9 121.94 16.21 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.028 0.442 . . . . 1.02 111.671 -178.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.635 HD12 ' N ' ' A' ' 56' ' ' GLU . 12.5 mt -101.41 130.74 50.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 109.235 -0.654 . . . . 1.13 109.235 176.023 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -85.32 -53.37 5.27 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 121.181 -0.208 . . . . 2.07 111.33 176.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -140.28 129.59 23.85 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.711 -0.222 . . . . 2.48 111.223 -175.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -121.6 116.92 25.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.186 0.517 . . . . 1.18 111.056 174.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.4 HG21 ' HB2' ' A' ' 80' ' ' PHE . 30.3 m -128.64 145.43 35.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.454 -0.794 . . . . 1.97 112.123 -179.474 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 91.3 t -116.76 133.73 62.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.525 -0.761 . . . . 1.12 110.734 174.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 36.8 mm -76.92 152.5 5.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.715 -0.675 . . . . 1.44 109.524 177.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 39.5 p . . . . . 0 N--CA 1.444 -0.773 0 N-CA-C 105.407 -2.072 . . . . 1.83 105.407 -174.21 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 6.3 m . . . . . 0 CA--C 1.534 0.354 0 CA-C-O 120.732 0.301 . . . . 2.07 110.792 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 73.7 mtp180 -58.51 -29.55 66.37 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.769 -0.65 . . . . 3.07 111.191 179.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 93.37 30.37 9.28 Favored Glycine 0 N--CA 1.439 -1.109 0 C-N-CA 120.506 -0.854 . . . . 0.75 112.18 -177.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -131.49 141.83 49.84 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 107.921 -1.14 . . . . 1.61 107.921 175.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -141.72 -171.75 13.04 Favored Glycine 0 N--CA 1.439 -1.142 0 C-N-CA 120.089 -1.053 . . . . 0.59 111.782 -174.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.4 ' CE1' ' HD1' ' A' ' 38' ' ' PHE . 55.4 m-85 -154.91 124.6 6.52 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.582 -0.896 . . . . 0.84 108.582 -177.491 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 53.8 t -119.58 124.14 72.37 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 CA-C-N 115.742 -0.663 . . . . 1.21 110.133 -177.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.579 ' HA ' ' O ' ' A' ' 35' ' ' THR . 17.3 m -109.41 116.33 31.62 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 107.948 -1.13 . . . . 1.09 107.948 175.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 92.5 mmm -87.72 162.69 16.92 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.098 -0.705 . . . . 1.02 109.098 -175.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 44.8 tttm -85.04 -10.47 56.9 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 120.873 0.368 . . . . 2.47 110.997 -175.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -149.5 147.78 28.62 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-N 116.377 -0.374 . . . . 1.68 110.562 175.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.452 ' O ' ' HB1' ' A' ' 89' ' ' ALA . 1.3 tmt_? -67.49 -22.72 65.45 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 112.255 0.465 . . . . 4.24 112.255 -176.318 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.05 -47.27 77.95 Favored 'General case' 0 N--CA 1.464 0.239 0 O-C-N 121.519 -0.738 . . . . 1.33 111.285 178.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 19.1 m -65.92 -31.13 71.88 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.605 0.717 . . . . 1.34 109.754 175.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.452 ' HB1' ' O ' ' A' ' 86' ' ' ARG . . . -59.32 -48.97 79.62 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.123 -1.398 . . . . 1.16 109.818 174.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -55.87 -51.68 66.71 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.203 -0.453 . . . . 2.11 111.654 174.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.481 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 23.7 mmt180 -57.78 -45.39 86.07 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.315 -0.402 . . . . 4.35 111.198 -178.026 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -58.66 -48.12 82.14 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.09 -0.505 . . . . 1.21 111.147 176.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 49.2 t -75.46 -2.97 31.25 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 111.945 0.35 . . . . 1.16 111.945 -176.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.481 ' HB2' ' O ' ' A' ' 91' ' ' ARG . 4.5 mmmm -59.95 -48.74 80.45 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 121.044 -0.262 . . . . 4.58 111.463 176.354 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.441 ' HA ' ' HD3' ' A' ' 96' ' ' PRO . 32.5 t0 -106.39 107.57 60.21 Favored Pre-proline 0 C--N 1.328 -0.365 0 N-CA-C 109.931 -0.396 . . . . 2.24 109.931 179.482 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.465 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 6.9 Cg_exo -74.48 -10.32 22.03 Favored 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 123.082 2.521 . . . . 2.38 113.51 -176.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.7 ' HA ' ' O ' ' A' ' 105' ' ' ALA . 2.0 m120 -142.81 68.57 19.02 Favored Pre-proline 0 N--CA 1.464 0.254 0 N-CA-C 112.824 0.676 . . . . 3.61 112.824 -178.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -81.29 154.46 18.85 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.803 2.336 . . . . 1.54 110.818 172.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 42.6 mm -85.63 91.95 3.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 120.418 -0.513 . . . . 2.08 110.478 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 52.3 mt -89.95 107.77 18.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.702 0.763 . . . . 1.55 112.681 178.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.43 ' OD2' ' HD2' ' A' ' 45' ' ' HIS . 32.2 t70 66.13 43.59 2.83 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 113.901 -1.5 . . . . 1.52 110.438 167.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 88.99 -7.63 81.74 Favored Glycine 0 CA--C 1.518 0.267 0 CA-C-N 115.056 -0.975 . . . . 1.73 114.551 177.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.494 ' HB2' ' HG3' ' A' ' 43' ' ' PRO . 14.7 tpt180 -126.66 141.79 51.74 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 117.992 0.896 . . . . 4.66 110.709 178.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -64.62 131.57 47.34 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.088 -0.708 . . . . 3.14 109.088 172.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.7 ' O ' ' HA ' ' A' ' 97' ' ' ASN . . . -118.64 153.54 34.15 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.821 -0.627 . . . . 1.37 110.087 -169.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.593 ' HB2' ' HA3' ' A' ' 40' ' ' GLY . 6.6 m-20 -96.68 140.15 31.71 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.069 0.461 . . . . 2.18 110.281 178.162 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.465 ' O ' ' HA ' ' A' ' 96' ' ' PRO . 70.6 t -146.08 113.75 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.029 -0.987 . . . . 1.46 110.626 -174.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -159.3 165.06 34.24 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.097 -0.705 . . . . 3.22 109.097 174.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.502 ' HB3' ' CD1' ' A' ' 111' ' ' TYR . 2.0 mm? -71.96 129.31 38.25 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.254 -0.647 . . . . 1.87 109.254 176.479 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -57.84 -31.57 66.78 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.575 0.583 . . . . 1.3 112.575 -173.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.502 ' CD1' ' HB3' ' A' ' 109' ' ' LEU . 2.5 p90 . . . . . 0 N--CA 1.465 0.32 0 CA-C-O 120.758 0.314 . . . . 1.71 111.299 -176.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' MET . . . . . 0.578 ' HE1' ' CE2' ' A' ' 34' ' ' PHE . 44.2 ttp . . . . . 0 N--CA 1.454 -0.248 0 N-CA-C 112.252 0.464 . . . . 1.9 112.252 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.578 ' CE2' ' HE1' ' A' ' 33' ' ' MET . 70.0 m-85 -81.12 -44.88 17.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 118.65 0.659 . . . . 1.76 111.123 -174.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.463 ' HB ' ' O ' ' A' ' 83' ' ' MET . 56.8 p -56.04 -17.94 8.24 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 114.376 1.25 . . . . 1.23 114.376 -175.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.713 ' HG2' ' HB1' ' A' ' 110' ' ' ALA . 29.2 ttpt -81.33 114.77 20.33 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.29 0.567 . . . . 3.2 111.68 -173.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 89.0 mt -105.62 134.18 47.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.364 -0.835 . . . . 1.46 111.112 -179.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -94.28 111.15 22.87 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.027 -0.731 . . . . 0.81 109.027 175.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.6 t -100.75 139.8 21.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.278 0.561 . . . . 1.61 110.24 -179.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.494 ' O ' ' HB3' ' A' ' 105' ' ' ALA . . . -139.99 135.92 7.44 Favored Glycine 0 N--CA 1.448 -0.523 0 CA-C-N 115.212 -0.904 . . . . 1.39 112.798 -170.55 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 86.34 32.37 16.77 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.762 -0.732 . . . . 0.71 113.049 176.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.681 HD12 HD22 ' A' ' 51' ' ' LEU . 2.8 mm? -74.21 117.3 60.55 Favored Pre-proline 0 C--N 1.328 -0.338 0 N-CA-C 109.736 -0.468 . . . . 1.89 109.736 177.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.565 ' HG2' ' HB3' ' A' ' 101' ' ' ASP . 81.8 Cg_exo -51.0 159.36 2.55 Favored 'Trans proline' 0 CA--C 1.527 0.129 0 C-N-CA 122.913 2.409 . . . . 0.82 112.664 178.303 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -69.94 -4.95 22.93 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 116.284 -0.416 . . . . 1.46 111.776 -171.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . 0.66 ' HB3' ' OD2' ' A' ' 101' ' ' ASP . 70.7 t60 -101.41 -6.04 24.54 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 120.964 0.411 . . . . 2.65 110.533 175.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.442 HG22 HD13 ' A' ' 42' ' ' LEU . 95.0 m -75.38 118.81 18.67 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.05 0.453 . . . . 1.31 111.406 -178.016 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 11.7 p -108.62 -178.75 3.68 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-N 115.924 -0.58 . . . . 0.75 110.824 177.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -64.64 -35.93 82.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.296 0.569 . . . . 0.49 110.443 -176.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.562 ' O ' ' HG2' ' A' ' 53' ' ' GLU . 20.2 ptmt -65.93 -37.44 86.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.582 -0.736 . . . . 3.26 110.592 179.37 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 49.9 m -59.49 -45.58 91.26 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.958 -0.564 . . . . 1.25 110.403 178.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.681 HD22 HD12 ' A' ' 42' ' ' LEU . 39.5 mt -66.55 -32.95 74.63 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.736 -0.666 . . . . 1.53 111.22 177.185 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.44 ' HA ' HD13 ' A' ' 61' ' ' ILE . 55.2 t-80 -65.27 -55.07 20.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.867 0.365 . . . . 0.77 110.269 177.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.562 ' HG2' ' O ' ' A' ' 49' ' ' LYS . 9.0 mm-40 -57.93 -43.41 86.28 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.143 0.496 . . . . 1.52 112.211 -179.293 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -74.8 -35.0 62.49 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.108 -0.496 . . . . 1.6 112.148 -174.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.705 ' HB2' HD12 ' A' ' 61' ' ' ILE . 7.5 m-85 -87.12 -25.17 24.26 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 113.493 0.923 . . . . 0.68 113.493 -172.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -67.97 -16.39 64.04 Favored 'General case' 0 CA--C 1.522 -0.098 0 CA-C-O 121.544 0.688 . . . . 1.57 109.557 179.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 28.5 mm-40 -56.59 -16.32 5.93 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.054 -0.976 . . . . 2.79 112.459 169.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -99.51 -18.32 17.46 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.847 0.356 . . . . 0.79 110.7 178.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 161.73 -112.96 0.54 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.482 -0.866 . . . . 0.75 112.998 176.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.572 ' HB3' ' HB3' ' A' ' 84' ' ' LYS . 7.9 m-20 -114.27 126.41 54.99 Favored 'General case' 0 C--N 1.329 -0.322 0 O-C-N 122.654 -0.321 . . . . 1.02 110.74 -179.026 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.705 HD12 ' HB2' ' A' ' 55' ' ' PHE . 32.4 mt -99.82 126.71 53.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 C-N-CA 120.903 -0.319 . . . . 1.13 110.57 173.18 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -83.61 -47.58 11.11 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.828 -0.624 . . . . 2.07 109.928 176.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -156.57 130.27 8.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.73 -0.668 . . . . 2.48 110.743 179.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -115.36 116.36 28.13 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.931 -0.396 . . . . 1.18 109.931 175.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.2 m -133.22 115.67 23.85 Favored 'Isoleucine or valine' 0 C--O 1.24 0.553 0 CA-C-O 121.772 0.796 . . . . 1.97 112.808 -176.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 94.0 t -72.56 126.08 32.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 114.881 -1.054 . . . . 1.12 109.137 173.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 31.1 mm -74.08 95.35 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.542 0 CA-C-O 121.336 0.588 . . . . 1.44 110.268 -178.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 29.9 p . . . . . 0 N--CA 1.436 -1.129 0 CA-C-N 115.403 -0.817 . . . . 1.83 111.222 -176.737 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.477 ' O ' ' HB2' ' A' ' 76' ' ' ARG . 11.7 p . . . . . 0 C--O 1.225 -0.21 0 N-CA-C 111.895 0.331 . . . . 2.07 111.895 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.477 ' HB2' ' O ' ' A' ' 75' ' ' SER . 81.1 mtt180 76.63 -25.17 0.21 Allowed 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.371 0.669 . . . . 3.07 111.43 -179.588 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.4 ' H ' ' C ' ' A' ' 75' ' ' SER . . . 85.17 10.46 78.01 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.652 -0.785 . . . . 0.75 113.221 173.384 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -121.95 154.21 37.47 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.18 -1.044 . . . . 1.61 108.18 177.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -165.93 143.43 8.4 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 119.525 -1.322 . . . . 0.59 113.418 178.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -101.24 124.63 47.25 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 122.184 0.992 . . . . 0.84 112.26 174.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 58.0 t -104.27 130.55 54.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 113.966 -1.47 . . . . 1.21 108.144 170.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 4.7 m -115.08 122.35 45.88 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 107.794 -1.187 . . . . 1.09 107.794 178.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.463 ' O ' ' HB ' ' A' ' 35' ' ' THR . 88.3 mmm -86.61 160.78 18.8 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.528 -0.545 . . . . 1.02 109.528 -174.094 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.572 ' HB3' ' HB3' ' A' ' 60' ' ' ASP . 31.3 ttmt -84.04 -19.03 35.11 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.235 0.54 . . . . 2.47 109.667 -177.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -141.45 144.09 34.22 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 115.554 -0.748 . . . . 1.68 111.153 -178.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.528 ' O ' ' HG2' ' A' ' 90' ' ' GLU . 0.6 OUTLIER -66.1 -29.93 70.34 Favored 'General case' 0 C--O 1.222 -0.382 0 N-CA-C 113.743 1.016 . . . . 4.24 113.743 -177.718 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -67.73 -35.65 79.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 119.361 0.982 . . . . 1.33 110.89 178.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 11.7 m -64.66 -35.11 79.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 122.06 0.933 . . . . 1.34 109.35 173.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -66.02 -45.71 80.51 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 113.685 -1.598 . . . . 1.16 110.468 177.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.528 ' HG2' ' O ' ' A' ' 86' ' ' ARG . 10.7 mm-40 -54.53 -51.54 64.85 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.779 -0.646 . . . . 2.11 112.65 178.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.513 ' O ' ' HB3' ' A' ' 94' ' ' LYS . 57.0 mtp180 -65.91 -39.02 90.18 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 111.736 0.273 . . . . 4.35 111.736 -178.356 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.82 -42.93 99.93 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.388 -0.369 . . . . 1.21 111.305 179.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . 0.558 ' HB2' ' HG ' ' A' ' 109' ' ' LEU . 44.8 t -71.93 -17.18 62.1 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.047 0.451 . . . . 1.16 110.763 175.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.513 ' HB3' ' O ' ' A' ' 91' ' ' ARG . 4.5 tppp? -74.46 -47.88 30.75 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.286 -0.415 . . . . 4.58 111.166 177.547 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -101.62 100.55 14.49 Favored Pre-proline 0 N--CA 1.463 0.218 0 N-CA-C 108.975 -0.75 . . . . 2.24 108.975 178.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -88.78 -16.29 2.42 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 123.009 2.472 . . . . 2.38 115.508 -165.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.426 ' HA ' ' O ' ' A' ' 105' ' ' ALA . 3.8 p30 -120.07 83.0 30.27 Favored Pre-proline 0 C--N 1.326 -0.423 0 N-CA-C 113.622 0.971 . . . . 3.61 113.622 -174.096 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -84.65 128.59 3.98 Favored 'Trans proline' 0 C--O 1.24 0.604 0 C-N-CA 123.657 2.905 . . . . 1.54 112.256 170.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 35.3 mm -70.2 91.76 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 121.199 0.523 . . . . 2.08 110.288 173.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 69.0 mt -99.13 134.1 39.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.923 -0.58 . . . . 1.55 111.277 -178.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.66 ' OD2' ' HB3' ' A' ' 45' ' ' HIS . 18.0 t70 41.56 30.88 0.16 Allowed 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.778 1.029 . . . . 1.52 113.778 -178.037 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 88.48 16.85 58.1 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 120.49 -0.862 . . . . 1.73 113.366 176.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.497 ' HB3' ' HG3' ' A' ' 43' ' ' PRO . 28.0 tpt180 -140.54 139.31 35.01 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.323 -0.621 . . . . 4.66 109.323 176.026 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -82.09 105.38 13.14 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 119.966 -0.694 . . . . 3.14 110.107 -178.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.494 ' HB3' ' O ' ' A' ' 40' ' ' GLY . . . -85.46 166.34 16.43 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 113.874 1.064 . . . . 1.37 113.874 177.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 22.7 t30 -108.86 119.34 39.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.388 -1.278 . . . . 2.18 110.187 -178.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 93.8 t -114.2 140.72 33.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.006 -0.543 . . . . 1.46 110.874 179.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -160.64 170.15 21.42 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.715 -0.846 . . . . 3.22 108.715 178.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.558 ' HG ' ' HB2' ' A' ' 93' ' ' CYS . 5.8 mt -79.67 127.35 32.08 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.361 -0.536 . . . . 1.87 110.737 178.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.713 ' HB1' ' HG2' ' A' ' 36' ' ' LYS . . . -69.26 -24.65 64.01 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.263 -0.881 . . . . 1.3 112.351 -174.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.551 ' CD1' ' HB3' ' A' ' 109' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.466 0.364 0 CA-C-O 120.849 0.357 . . . . 1.71 111.8 -173.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 48.6 ttp . . . . . 0 N--CA 1.454 -0.231 0 N-CA-C 111.27 0.1 . . . . 1.9 111.27 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.52 ' HA ' HD12 ' A' ' 109' ' ' LEU . 25.1 m-85 -107.12 -24.16 12.04 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-O 120.801 0.334 . . . . 1.76 110.992 -178.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.72 ' O ' ' HA ' ' A' ' 82' ' ' THR . 27.1 p -81.4 11.75 4.21 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.289 -0.414 . . . . 1.23 110.958 -174.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.445 ' O ' HD11 ' A' ' 109' ' ' LEU . 5.8 ttpm? -122.43 102.84 8.33 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.074 -0.512 . . . . 3.2 110.247 -173.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 5.0 mp -109.21 136.53 44.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.959 -0.564 . . . . 1.46 110.602 -176.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -95.13 120.51 35.48 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.987 -0.551 . . . . 0.81 109.589 176.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.61 HG13 HD12 ' A' ' 42' ' ' LEU . 96.8 t -132.84 99.08 3.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 118.775 -0.631 . . . . 1.61 110.851 -177.256 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.564 ' HA2' ' CD1' ' A' ' 42' ' ' LEU . . . -132.15 166.49 23.23 Favored Glycine 0 C--O 1.217 -0.913 0 C-N-CA 115.324 -3.322 . . . . 1.39 113.845 162.006 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 128.69 -2.93 6.51 Favored Glycine 0 N--CA 1.445 -0.762 0 N-CA-C 108.706 -1.758 . . . . 0.71 108.706 -168.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.684 ' HB3' ' HB ' ' A' ' 46' ' ' THR . 4.5 mp -62.1 142.13 95.61 Favored Pre-proline 0 N--CA 1.449 -0.486 0 CA-C-N 113.601 -1.3 . . . . 1.89 109.806 179.667 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.57 ' HD2' ' OG1' ' A' ' 46' ' ' THR . 52.5 Cg_exo -54.28 159.78 7.54 Favored 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.669 2.246 . . . . 0.82 111.581 172.386 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -71.55 -1.78 14.64 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.161 -0.472 . . . . 1.46 111.459 -174.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 72.4 t60 -104.08 -11.99 17.02 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.127 0.489 . . . . 2.65 109.944 176.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.684 ' HB ' ' HB3' ' A' ' 42' ' ' LEU . 5.4 m -79.06 129.94 34.99 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 115.921 -0.581 . . . . 1.31 109.868 -178.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 7.4 p -132.76 -177.58 4.55 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.534 -0.303 . . . . 0.75 111.566 -169.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.498 ' OD2' ' HA ' ' A' ' 65' ' ' VAL . 1.2 m-20 -57.01 -31.9 65.58 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.536 0.684 . . . . 0.49 110.043 -177.632 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.723 ' O ' ' HG2' ' A' ' 53' ' ' GLU . 55.2 pttt -74.1 -35.45 64.18 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.908 -1.042 . . . . 3.26 109.638 -178.017 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.651 HG22 HG21 ' A' ' 46' ' ' THR . 6.6 m -67.17 -43.98 80.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.735 0.302 . . . . 1.25 110.756 179.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.668 HD22 HD23 ' A' ' 42' ' ' LEU . 35.8 mt -61.46 -42.97 99.59 Favored 'General case' 0 CA--C 1.512 -0.493 0 N-CA-C 109.631 -0.507 . . . . 1.53 109.631 176.305 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.51 ' HA ' HD13 ' A' ' 61' ' ' ILE . 45.8 t-80 -53.3 -52.74 58.12 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.246 -0.888 . . . . 0.77 110.514 175.681 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.723 ' HG2' ' O ' ' A' ' 49' ' ' LYS . 8.5 mm-40 -59.49 -47.62 84.8 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.3 -0.409 . . . . 1.52 111.756 -176.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.531 ' O ' ' HB2' ' A' ' 57' ' ' GLN . 56.3 t80 -77.73 -36.53 50.75 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.289 0.478 . . . . 1.6 112.289 -170.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.734 ' HB2' HD12 ' A' ' 61' ' ' ILE . 42.9 m-85 -84.62 -30.03 25.27 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 113.224 0.824 . . . . 0.68 113.224 -173.197 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.688 ' HA ' ' O ' ' A' ' 59' ' ' GLY . 12.9 pt-20 -68.58 -11.38 59.91 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.677 0.751 . . . . 1.57 110.009 179.254 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.531 ' HB2' ' O ' ' A' ' 54' ' ' TYR . 27.6 mt-30 -59.35 -23.0 62.16 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.55 -1.204 . . . . 2.79 111.826 170.243 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -94.23 -21.45 19.04 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.217 0.532 . . . . 0.79 110.005 177.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.688 ' O ' ' HA ' ' A' ' 56' ' ' GLU . . . 159.14 -177.7 35.59 Favored Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 115.049 -0.978 . . . . 0.75 110.982 179.334 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -61.77 122.94 16.6 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 117.042 0.421 . . . . 1.02 110.577 -175.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.734 HD12 ' HB2' ' A' ' 55' ' ' PHE . 45.9 mt -86.99 125.03 40.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 O-C-N 122.351 -0.218 . . . . 1.13 110.468 171.506 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -75.64 -43.82 45.79 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.681 0.277 . . . . 2.07 111.607 178.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -152.12 132.55 13.78 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.326 -0.397 . . . . 2.48 111.251 -175.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -125.8 134.81 51.58 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.241 0.543 . . . . 1.18 111.145 178.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.556 ' CG2' ' HB2' ' A' ' 80' ' ' PHE . 31.2 m -144.76 148.43 18.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.225 -0.898 . . . . 1.97 112.485 -177.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 42.4 t -119.3 138.92 48.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.241 -0.89 . . . . 1.12 110.027 171.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.523 HG12 ' HA2' ' A' ' 79' ' ' GLY . 26.2 mm -91.91 153.71 3.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 114.898 -1.046 . . . . 1.44 110.441 -173.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 18.8 p . . . . . 0 N--CA 1.445 -0.705 0 N-CA-C 105.228 -2.138 . . . . 1.83 105.228 -170.57 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 14.9 m . . . . . 0 N--CA 1.453 -0.281 0 CA-C-O 120.791 0.329 . . . . 2.07 110.403 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 26.7 mtm180 -69.58 -5.94 27.79 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.866 -0.606 . . . . 3.07 112.066 -175.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 77.98 9.63 86.8 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 119.88 -1.152 . . . . 0.75 111.082 -177.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.557 ' HD1' ' HA3' ' A' ' 40' ' ' GLY . 20.7 m-85 -117.34 154.05 31.95 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 110.035 -0.357 . . . . 1.61 110.035 -172.475 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.523 ' HA2' HG12 ' A' ' 67' ' ' ILE . . . -157.95 -167.3 18.69 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.388 -0.91 . . . . 0.59 113.145 173.065 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.556 ' HB2' ' CG2' ' A' ' 65' ' ' VAL . 49.7 m-85 -139.5 141.2 37.35 Favored 'General case' 0 CA--C 1.513 -0.469 0 C-N-CA 123.462 0.705 . . . . 0.84 109.496 178.527 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 54.6 t -127.33 111.85 26.54 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 CA-C-O 121.308 0.575 . . . . 1.21 109.931 175.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.72 ' HA ' ' O ' ' A' ' 35' ' ' THR . 29.3 m -109.19 112.43 24.59 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.467 -0.788 . . . . 1.09 109.351 176.416 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.647 ' SD ' HG12 ' A' ' 61' ' ' ILE . 59.8 mmm -87.44 175.34 8.01 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 121.227 0.537 . . . . 1.02 111.639 -172.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.4 ' HB2' ' HE3' ' A' ' 84' ' ' LYS . 37.9 ttmt -82.7 -31.91 28.31 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.189 -0.914 . . . . 2.47 110.826 -179.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -129.83 147.8 51.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.927 0.394 . . . . 1.68 110.446 178.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.566 ' H ' ' HD2' ' A' ' 86' ' ' ARG . 0.7 OUTLIER -73.44 -19.74 60.89 Favored 'General case' 0 C--O 1.218 -0.566 0 CA-C-N 115.812 -0.631 . . . . 4.24 112.105 -174.639 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.418 ' O ' ' HG3' ' A' ' 91' ' ' ARG . . . -67.04 -50.57 61.55 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 118.436 0.562 . . . . 1.33 111.201 176.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.442 ' HA ' ' HD2' ' A' ' 91' ' ' ARG . 14.4 m -63.96 -33.5 75.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.887 0.851 . . . . 1.34 109.36 175.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.494 ' CB ' ' HA ' ' A' ' 35' ' ' THR . . . -58.23 -47.5 83.34 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 113.683 -1.599 . . . . 1.16 110.011 173.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -60.69 -43.99 97.08 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.203 -0.453 . . . . 2.11 111.237 173.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.551 ' O ' ' HB3' ' A' ' 94' ' ' LYS . 99.4 mtt180 -57.59 -42.59 83.47 Favored 'General case' 0 C--O 1.225 -0.227 0 CA-C-O 120.888 0.375 . . . . 4.35 111.466 176.527 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.39 -36.67 83.05 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 111.874 0.324 . . . . 1.21 111.874 173.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 35.7 t -78.71 -7.55 57.84 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.207 0.527 . . . . 1.16 111.259 177.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.551 ' HB3' ' O ' ' A' ' 91' ' ' ARG . 16.1 tppt? -58.42 -48.36 80.92 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.628 -0.715 . . . . 4.58 111.613 -177.562 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -110.35 121.81 40.4 Favored Pre-proline 0 C--N 1.325 -0.495 0 C-N-CA 120.744 -0.383 . . . . 2.24 109.988 176.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -84.66 -1.76 9.65 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 122.902 2.402 . . . . 2.38 114.287 -173.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.57 ' HB2' ' HD3' ' A' ' 104' ' ' LYS . 6.0 p30 -152.61 68.4 6.96 Favored Pre-proline 0 CA--C 1.534 0.333 0 CA-C-O 121.392 0.615 . . . . 3.61 111.691 178.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -80.98 166.97 18.57 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 123.456 2.771 . . . . 1.54 111.686 179.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 47.2 mm -100.81 137.82 27.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 108.578 -0.897 . . . . 2.08 108.578 178.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 54.7 mt -144.77 111.8 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 109.323 -0.621 . . . . 1.55 109.323 -174.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.557 ' O ' ' HG2' ' A' ' 43' ' ' PRO . 16.8 t0 61.87 47.99 5.66 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 121.488 0.661 . . . . 1.52 111.019 173.387 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 82.74 -5.76 73.25 Favored Glycine 0 CA--C 1.529 0.924 0 N-CA-C 116.29 1.276 . . . . 1.73 116.29 178.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.431 ' CB ' ' HG3' ' A' ' 43' ' ' PRO . 23.8 ttt180 -137.93 150.97 47.51 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 118.933 1.367 . . . . 4.66 111.106 -177.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.57 ' HD3' ' HB2' ' A' ' 97' ' ' ASN . 24.3 ttmm -78.88 139.8 38.24 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.46 -0.336 . . . . 3.14 110.37 178.52 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -111.59 154.17 25.23 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.947 -0.57 . . . . 1.37 111.138 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.465 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 46.6 t-20 -95.47 127.86 41.86 Favored 'General case' 0 C--O 1.252 1.224 0 N-CA-C 108.597 -0.89 . . . . 2.18 108.597 173.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.606 HG23 HG11 ' A' ' 39' ' ' VAL . 88.0 t -142.37 129.4 19.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 113.838 -1.528 . . . . 1.46 110.45 -161.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -167.84 158.56 10.89 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.454 -0.572 . . . . 3.22 109.454 178.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.52 HD12 ' HA ' ' A' ' 34' ' ' PHE . 0.2 OUTLIER -57.92 131.94 51.9 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 107.827 -1.175 . . . . 1.87 107.827 173.061 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.96 -30.93 68.42 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.514 -0.475 . . . . 1.3 110.784 -162.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 4.0 p90 . . . . . 0 CA--C 1.534 0.347 0 CA-C-N 115.881 -0.6 . . . . 1.71 111.42 -172.785 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' MET . . . . . 0.511 ' HE3' ' CE2' ' A' ' 34' ' ' PHE . 7.4 ttt . . . . . 0 N--CA 1.455 -0.215 0 CA-C-O 120.419 0.152 . . . . 1.9 111.085 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.556 ' HA ' HD12 ' A' ' 109' ' ' LEU . 40.7 m-85 -103.66 -24.23 13.39 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 111.859 0.318 . . . . 1.76 111.859 -178.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.543 ' O ' ' HA ' ' A' ' 82' ' ' THR . 57.7 p -78.91 -10.9 59.95 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.362 -0.535 . . . . 1.23 110.446 -174.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 47.1 tttm -88.23 106.43 18.19 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 115.367 -0.833 . . . . 3.2 109.104 179.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 95.3 mt -104.6 134.89 44.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 116.051 -0.522 . . . . 1.46 110.442 -179.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.624 ' CB ' ' HA ' ' A' ' 110' ' ' ALA . 82.5 t80 -99.02 121.31 40.8 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.397 -0.594 . . . . 0.81 109.397 179.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.637 HG11 HD12 ' A' ' 42' ' ' LEU . 3.9 t -106.63 140.19 25.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.137 0.494 . . . . 1.61 110.477 -174.425 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -140.76 152.68 23.23 Favored Glycine 0 N--CA 1.452 -0.275 0 CA-C-N 115.29 -0.868 . . . . 1.39 113.423 -167.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.08 40.66 95.17 Favored Glycine 0 C--O 1.228 -0.263 0 C-N-CA 121.635 -0.317 . . . . 0.71 113.298 172.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.637 HD12 HG11 ' A' ' 39' ' ' VAL . 7.1 mp -82.38 134.71 47.97 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-O 120.861 0.363 . . . . 1.89 110.86 179.111 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.572 ' HG3' ' HG3' ' A' ' 103' ' ' ARG . 50.6 Cg_exo -52.91 153.4 15.3 Favored 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.709 2.273 . . . . 0.82 111.379 172.292 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.559 ' HA ' ' HB3' ' A' ' 75' ' ' SER . 20.6 m-85 -67.49 -7.38 25.15 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 113.292 0.849 . . . . 1.46 113.292 -170.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -111.98 2.51 16.94 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 120.409 -0.516 . . . . 2.65 111.168 176.38 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.601 HG21 HG22 ' A' ' 50' ' ' THR . 38.4 m -74.39 134.59 42.42 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.284 -0.416 . . . . 1.31 110.405 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 10.4 p -136.35 -176.85 4.47 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-O 121.507 0.67 . . . . 0.75 112.053 -171.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -60.46 -36.26 77.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.825 -1.08 . . . . 0.49 110.76 -173.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.532 ' O ' ' HG2' ' A' ' 53' ' ' GLU . 9.2 ptmm? -65.15 -36.99 85.98 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.461 -0.79 . . . . 3.26 110.855 178.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.601 HG22 HG21 ' A' ' 46' ' ' THR . 88.0 m -62.07 -45.95 91.27 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.085 0.469 . . . . 1.25 110.922 179.104 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.528 HD22 HG13 ' A' ' 39' ' ' VAL . 98.2 mt -68.33 -34.71 76.59 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.77 -0.65 . . . . 1.53 110.687 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.456 ' O ' ' HG2' ' A' ' 56' ' ' GLU . 55.6 t-80 -59.69 -53.82 53.51 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.111 0.481 . . . . 0.77 109.966 178.225 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.532 ' HG2' ' O ' ' A' ' 49' ' ' LYS . 11.8 mm-40 -57.72 -44.03 85.69 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.618 -0.719 . . . . 1.52 112.628 -179.401 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.621 ' O ' ' HB2' ' A' ' 57' ' ' GLN . 67.8 t80 -76.48 -34.43 58.66 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.821 0.674 . . . . 1.6 112.821 -174.585 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -84.69 -30.5 24.76 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 113.898 1.073 . . . . 0.68 113.898 -171.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.456 ' HG2' ' O ' ' A' ' 52' ' ' HIS . 15.0 pt-20 -71.5 -12.04 61.18 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.842 0.83 . . . . 1.57 110.003 177.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.621 ' HB2' ' O ' ' A' ' 54' ' ' TYR . 27.6 mm-40 -56.03 -24.84 41.78 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.037 -0.983 . . . . 2.79 111.539 166.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -106.64 6.93 30.32 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 111.74 0.274 . . . . 0.79 111.74 -177.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 146.48 -137.86 7.05 Favored Glycine 0 C--O 1.224 -0.529 0 C-N-CA 120.486 -0.864 . . . . 0.75 112.794 -176.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -114.04 127.14 55.81 Favored 'General case' 0 C--N 1.327 -0.372 0 O-C-N 122.661 -0.317 . . . . 1.02 110.874 -178.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.423 HG13 ' HB3' ' A' ' 56' ' ' GLU . 8.7 mt -94.24 126.9 46.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 110.116 -0.328 . . . . 1.13 110.116 176.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -83.59 -48.72 9.92 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.581 -0.448 . . . . 2.07 110.372 174.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -141.56 126.71 18.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.261 -0.427 . . . . 2.48 111.112 -176.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -123.23 123.75 41.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.059 0.457 . . . . 1.18 110.555 174.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 29.6 m -139.09 143.74 30.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.0 -1.0 . . . . 1.97 112.141 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 70.4 t -115.08 139.54 40.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 108.761 -0.829 . . . . 1.12 108.761 170.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 44.2 mm -91.1 95.06 5.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 N-CA-C 109.439 -0.578 . . . . 1.44 109.439 -179.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.485 HG23 ' HA ' ' A' ' 75' ' ' SER . 9.1 p . . . . . 0 C--N 1.317 -0.813 0 CA-C-N 116.047 -0.524 . . . . 1.83 110.985 177.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.559 ' HB3' ' HA ' ' A' ' 44' ' ' TYR . 12.3 t . . . . . 0 N--CA 1.452 -0.335 0 CA-C-O 121.023 0.44 . . . . 2.07 110.274 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 10.8 mtp180 -59.23 -11.76 4.41 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.505 -0.77 . . . . 3.07 111.363 174.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 92.59 14.77 54.92 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.812 -0.709 . . . . 0.75 113.113 175.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -128.41 141.0 51.54 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.422 -0.584 . . . . 1.61 109.422 -178.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -138.65 -178.28 16.12 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.435 -0.888 . . . . 0.59 111.865 179.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -152.03 130.08 11.85 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.386 -0.598 . . . . 0.84 109.386 -177.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 63.7 t -128.22 119.59 51.15 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 CA-C-N 115.813 -0.63 . . . . 1.21 109.936 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.543 ' HA ' ' O ' ' A' ' 35' ' ' THR . 34.8 m -109.45 114.23 27.71 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.183 -1.043 . . . . 1.09 108.183 177.379 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 87.8 mmm -87.94 168.71 12.63 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 122.078 -0.389 . . . . 1.02 110.012 -174.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -83.05 -16.34 47.43 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.272 -0.422 . . . . 2.47 111.05 -176.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -147.97 148.69 31.03 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 120.813 0.339 . . . . 1.68 110.607 -179.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -71.32 -20.84 62.14 Favored 'General case' 0 C--O 1.224 -0.246 0 N-CA-C 112.502 0.556 . . . . 4.24 112.502 -174.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -71.61 -45.75 61.19 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 118.556 0.616 . . . . 1.33 111.346 -179.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 19.4 m -63.37 -35.59 80.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.94 0.876 . . . . 1.34 109.489 173.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.481 ' HB2' ' O ' ' A' ' 34' ' ' PHE . . . -58.79 -46.9 86.49 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 113.503 -1.681 . . . . 1.16 109.824 174.645 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -57.37 -50.03 74.27 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.543 -0.753 . . . . 2.11 112.276 174.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.535 ' O ' ' HB3' ' A' ' 94' ' ' LYS . 79.3 mtp180 -57.06 -46.0 82.8 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.817 0.341 . . . . 4.35 111.457 -179.186 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -60.06 -40.34 89.14 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.154 -0.476 . . . . 1.21 111.858 176.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 49.7 t -71.89 -17.1 62.13 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.294 0.569 . . . . 1.16 110.449 177.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.535 ' HB3' ' O ' ' A' ' 91' ' ' ARG . 21.2 tptp -78.65 7.08 7.41 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.415 0.686 . . . . 4.58 110.821 179.253 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -142.13 76.98 18.56 Favored Pre-proline 0 C--N 1.323 -0.565 0 O-C-N 121.616 -0.678 . . . . 2.24 110.011 -176.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -73.43 156.11 50.32 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 123.095 2.53 . . . . 2.38 111.945 -178.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.608 ' HA ' ' O ' ' A' ' 105' ' ' ALA . 1.9 p-10 34.35 64.14 1.73 Allowed Pre-proline 0 N--CA 1.471 0.615 0 O-C-N 124.166 0.916 . . . . 3.61 113.073 -171.449 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -82.21 167.43 15.78 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 123.063 2.509 . . . . 1.54 111.714 178.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 49.6 mm -89.53 130.74 38.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 116.281 -0.418 . . . . 2.08 110.097 178.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 56.5 mt -146.57 139.67 20.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.801 -0.636 . . . . 1.55 109.326 -175.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 42.7 t0 44.93 42.47 6.26 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 113.134 0.79 . . . . 1.52 113.134 177.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 70.45 17.98 74.97 Favored Glycine 0 CA--C 1.524 0.626 0 C-N-CA 121.128 -0.558 . . . . 1.73 113.619 177.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.572 ' HG3' ' HG3' ' A' ' 43' ' ' PRO . 30.6 mmt180 -143.23 162.38 35.79 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.372 -0.603 . . . . 4.66 109.372 -179.487 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -80.64 134.52 35.89 Favored 'General case' 0 C--N 1.317 -0.845 0 C-N-CA 120.108 -0.637 . . . . 3.14 109.757 171.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.608 ' O ' ' HA ' ' A' ' 97' ' ' ASN . . . -121.67 165.11 16.26 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 107.738 -1.208 . . . . 1.37 107.738 -177.21 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 44.4 t30 -116.38 110.57 18.85 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 120.344 -0.542 . . . . 2.18 110.375 177.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 88.5 t -116.38 139.9 41.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 120.981 0.42 . . . . 1.46 111.611 176.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -162.98 173.75 13.22 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 107.929 -1.137 . . . . 3.22 107.929 175.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.556 HD12 ' HA ' ' A' ' 34' ' ' PHE . 0.2 OUTLIER -62.77 146.56 52.18 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.74 -0.837 . . . . 1.87 108.74 175.904 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.624 ' HA ' ' CB ' ' A' ' 38' ' ' PHE . . . -68.47 -40.61 80.95 Favored 'General case' 0 CA--C 1.512 -0.484 0 C-N-CA 120.634 -0.427 . . . . 1.3 111.305 -169.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 9.7 p90 . . . . . 0 C--N 1.323 -0.554 0 CA-C-N 116.186 -0.461 . . . . 1.71 111.04 -173.376 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 46.7 ttp . . . . . 0 C--O 1.227 -0.1 0 N-CA-C 108.326 -0.99 . . . . 1.9 108.326 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.468 ' HB3' ' HB2' ' A' ' 86' ' ' ARG . 20.4 m-85 123.79 -176.12 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 127.339 2.256 . . . . 1.76 106.918 -173.431 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.518 ' HA ' ' HB3' ' A' ' 89' ' ' ALA . 34.6 p 61.22 -40.79 0.12 Allowed 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 114.384 1.253 . . . . 1.23 114.384 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -80.07 112.56 17.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.286 0.565 . . . . 3.2 110.511 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.52 ' CG2' HG11 ' A' ' 107' ' ' VAL . 82.8 mt -106.84 131.24 57.26 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 CA-C-N 115.514 -0.766 . . . . 1.46 110.842 -178.306 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -86.87 120.12 27.82 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.117 -0.697 . . . . 0.81 109.117 177.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.632 HG11 HD12 ' A' ' 42' ' ' LEU . 5.3 t -112.21 139.91 34.48 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-O 121.514 0.673 . . . . 1.61 111.15 -175.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -144.76 157.01 27.14 Favored Glycine 0 C--O 1.225 -0.421 0 CA-C-N 114.757 -1.111 . . . . 1.39 113.422 -171.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 71.05 34.97 64.63 Favored Glycine 0 C--O 1.227 -0.296 0 C-N-CA 121.31 -0.472 . . . . 0.71 113.549 172.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.632 HD12 HG11 ' A' ' 39' ' ' VAL . 6.8 mp -83.5 134.17 45.68 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-O 120.744 0.307 . . . . 1.89 111.228 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.601 ' HG3' ' CG ' ' A' ' 103' ' ' ARG . 52.8 Cg_exo -52.05 158.26 5.17 Favored 'Trans proline' 0 N--CA 1.461 -0.394 0 C-N-CA 122.92 2.413 . . . . 0.82 111.792 173.057 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -72.53 3.83 4.51 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.933 0.397 . . . . 1.46 111.207 -178.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 80.3 t60 -112.07 -8.92 14.01 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.057 -0.519 . . . . 2.65 110.943 178.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.561 ' CG2' HD21 ' A' ' 42' ' ' LEU . 12.5 m -77.6 125.88 30.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.994 0.426 . . . . 1.31 111.805 -176.356 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 6.5 p -121.08 -178.32 3.73 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.903 -0.59 . . . . 0.75 111.243 -176.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -59.19 -34.81 72.58 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 115.841 -0.618 . . . . 0.49 109.863 -176.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.578 ' HG3' ' N ' ' A' ' 50' ' ' THR . 12.3 pttp -62.13 -39.5 92.76 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.322 -0.854 . . . . 3.26 110.133 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.578 ' N ' ' HG3' ' A' ' 49' ' ' LYS . 15.1 m -68.27 -41.08 81.6 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 116.381 -0.372 . . . . 1.25 110.518 -176.105 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.504 HD22 HG13 ' A' ' 39' ' ' VAL . 65.7 mt -63.66 -35.96 82.26 Favored 'General case' 0 C--O 1.222 -0.355 0 C-N-CA 120.434 -0.506 . . . . 1.53 110.207 174.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 59.2 t-80 -67.28 -51.12 56.66 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.475 -0.49 . . . . 0.77 110.089 179.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.503 ' HG3' ' O ' ' A' ' 49' ' ' LYS . 42.4 mt-10 -55.88 -43.76 77.5 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.729 0.299 . . . . 1.52 111.574 -179.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.506 ' O ' ' HB2' ' A' ' 57' ' ' GLN . 4.7 t80 -75.79 -35.13 60.17 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.353 -0.385 . . . . 1.6 111.609 -176.124 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.443 ' HD1' ' O ' ' A' ' 51' ' ' LEU . 45.9 m-85 -86.82 -28.24 23.05 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 114.126 1.158 . . . . 0.68 114.126 -172.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.687 ' N ' HD12 ' A' ' 61' ' ' ILE . 15.0 pt-20 -70.54 -15.93 62.83 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 122.395 1.093 . . . . 1.57 109.236 -178.639 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.506 ' HB2' ' O ' ' A' ' 54' ' ' TYR . 23.9 mt-30 -53.72 -27.78 30.23 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 113.481 -1.69 . . . . 2.79 112.174 168.438 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -100.17 -13.67 18.84 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.156 -0.475 . . . . 0.79 110.387 -177.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.503 ' O ' ' HA ' ' A' ' 56' ' ' GLU . . . 144.57 -155.54 26.41 Favored Glycine 0 N--CA 1.448 -0.505 0 CA-C-N 115.658 -0.701 . . . . 0.75 112.115 175.09 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -64.32 123.34 18.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.109 0.481 . . . . 1.02 112.29 -179.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.687 HD12 ' N ' ' A' ' 56' ' ' GLU . 10.0 mt -101.61 123.92 55.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 108.208 -1.034 . . . . 1.13 108.208 172.293 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -79.74 -44.08 21.4 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.308 0.575 . . . . 2.07 110.406 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -148.65 130.52 15.19 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.658 -0.701 . . . . 2.48 110.675 -179.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -117.45 115.83 25.96 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.067 -0.515 . . . . 1.18 110.086 174.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.1 p -137.11 135.31 47.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.446 -0.797 . . . . 1.97 112.065 -177.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 89.8 t -98.91 132.81 43.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.498 -0.774 . . . . 1.12 109.033 172.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.567 ' H ' ' HA2' ' A' ' 79' ' ' GLY . 36.6 mm -74.87 84.36 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.826 0.822 . . . . 1.44 109.479 177.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.643 ' HA ' ' O ' ' A' ' 75' ' ' SER . 16.7 p . . . . . 0 N--CA 1.435 -1.222 0 CA-C-N 114.419 -1.264 . . . . 1.83 110.734 -177.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.643 ' O ' ' HA ' ' A' ' 68' ' ' THR . 58.3 p . . . . . 0 N--CA 1.469 0.514 0 N-CA-C 112.332 0.493 . . . . 2.07 112.332 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.562 ' HG3' ' O ' ' A' ' 75' ' ' SER . 46.0 mtt180 129.54 -50.31 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 126.964 2.106 . . . . 3.07 110.137 -167.549 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 104.67 16.62 17.01 Favored Glycine 0 N--CA 1.454 -0.157 0 C-N-CA 120.675 -0.774 . . . . 0.75 113.43 177.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -129.69 152.94 48.64 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.424 -0.954 . . . . 1.61 108.424 177.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.567 ' HA2' ' H ' ' A' ' 67' ' ' ILE . . . -157.08 -166.31 16.43 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 119.854 -1.165 . . . . 0.59 112.509 177.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -159.57 125.01 4.16 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 123.563 0.745 . . . . 0.84 109.216 -177.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 69.9 t -117.95 118.79 59.44 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 N-CA-C 109.669 -0.493 . . . . 1.21 109.669 177.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 17.8 m -110.16 109.48 20.0 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 108.03 -1.1 . . . . 1.09 108.03 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.478 ' HA ' ' HA ' ' A' ' 61' ' ' ILE . 44.1 mtp -88.25 166.56 14.25 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 110.138 -0.319 . . . . 1.02 110.138 -173.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.5 ' HZ3' ' HB2' ' A' ' 84' ' ' LYS . 4.3 ttmp? -74.28 -43.21 57.81 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.929 -0.308 . . . . 2.47 111.376 -174.147 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -128.56 151.01 49.94 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-O 121.784 0.802 . . . . 1.68 111.225 179.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.468 ' HB2' ' HB3' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -65.72 -23.06 66.67 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 114.421 -1.263 . . . . 4.24 112.646 -172.153 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.25 -46.65 76.39 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 118.768 0.713 . . . . 1.33 111.155 -179.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 18.2 m -64.86 -38.23 90.28 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.683 0.754 . . . . 1.34 109.766 176.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.518 ' HB3' ' HA ' ' A' ' 35' ' ' THR . . . -58.41 -47.41 83.99 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 113.544 -1.662 . . . . 1.16 109.691 176.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.595 ' O ' ' HG2' ' A' ' 94' ' ' LYS . 6.3 mm-40 -56.04 -50.88 69.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.12 -0.945 . . . . 2.11 112.006 175.104 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 43.9 mtm180 -57.89 -43.66 86.25 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.518 0.199 . . . . 4.35 111.165 -178.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -56.88 -37.1 70.89 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.934 -0.575 . . . . 1.21 111.711 177.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 48.0 t -86.77 -13.41 45.27 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 112.677 0.621 . . . . 1.16 112.677 -178.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.595 ' HG2' ' O ' ' A' ' 90' ' ' GLU . 72.5 mmtt -65.77 -43.75 87.91 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 120.888 0.375 . . . . 4.58 110.751 -177.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -114.49 92.99 30.45 Favored Pre-proline 0 C--N 1.326 -0.441 0 N-CA-C 109.646 -0.501 . . . . 2.24 109.646 176.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -81.09 -166.7 0.43 Allowed 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 122.735 2.29 . . . . 2.38 112.649 -176.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.708 ' HA ' ' O ' ' A' ' 105' ' ' ALA . 22.7 m120 38.95 63.42 4.28 Favored Pre-proline 0 N--CA 1.467 0.396 0 N-CA-C 113.512 0.93 . . . . 3.61 113.512 -173.372 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . 0.45 ' HD3' ' N ' ' A' ' 97' ' ' ASN . 2.5 Cg_endo -81.54 143.44 13.59 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.775 2.317 . . . . 1.54 110.82 174.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 38.6 mm -81.22 90.25 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.301 0.572 . . . . 2.08 109.827 178.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 31.1 mt -90.88 106.78 17.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 121.462 0.649 . . . . 1.55 111.199 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.437 ' HB2' HG22 ' A' ' 50' ' ' THR . 35.6 t70 66.1 46.62 2.08 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 113.889 -1.505 . . . . 1.52 110.147 166.051 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 91.23 -7.1 81.02 Favored Glycine 0 N--CA 1.451 -0.34 0 CA-C-N 114.94 -1.027 . . . . 1.73 114.821 175.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.601 ' CG ' ' HG3' ' A' ' 43' ' ' PRO . 20.9 mmt180 -133.77 148.93 51.42 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 118.614 1.207 . . . . 4.66 111.642 177.299 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -67.23 138.8 57.2 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.371 -0.831 . . . . 3.14 109.927 174.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.708 ' O ' ' HA ' ' A' ' 97' ' ' ASN . . . -124.57 150.87 45.44 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.042 -0.526 . . . . 1.37 109.856 -172.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -101.69 110.32 22.29 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 109.609 -0.515 . . . . 2.18 109.609 177.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.52 HG11 ' CG2' ' A' ' 37' ' ' ILE . 44.8 t -109.73 133.32 55.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.701 -0.681 . . . . 1.46 111.057 174.198 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -158.65 163.45 36.89 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.856 -0.794 . . . . 3.22 108.856 175.036 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.521 ' HB3' ' CD1' ' A' ' 111' ' ' TYR . 1.7 mm? -76.68 125.56 29.47 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.994 0.426 . . . . 1.87 110.709 -178.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.63 -25.83 65.93 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 113.314 0.857 . . . . 1.3 113.314 -174.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.521 ' CD1' ' HB3' ' A' ' 109' ' ' LEU . 2.6 p90 . . . . . 0 N--CA 1.468 0.429 0 CA-C-O 120.966 0.412 . . . . 1.71 111.295 -174.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 50.7 ttp . . . . . 0 CA--C 1.53 0.209 0 N-CA-C 112.461 0.541 . . . . 1.9 112.461 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.485 ' O ' HD12 ' A' ' 109' ' ' LEU . 39.4 m-85 -96.25 -11.73 25.58 Favored 'General case' 0 C--O 1.224 -0.256 0 O-C-N 121.911 -0.493 . . . . 1.76 111.253 -177.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.524 ' O ' ' HA ' ' A' ' 82' ' ' THR . 39.3 p -105.28 4.49 31.09 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 111.989 0.366 . . . . 1.23 111.989 -173.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -92.83 102.5 14.88 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.322 -0.399 . . . . 3.2 110.046 -178.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.422 HG21 ' O ' ' A' ' 108' ' ' ASN . 4.0 mp -103.42 135.33 41.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.76 0.314 . . . . 1.46 110.674 -177.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.626 ' HD2' HD22 ' A' ' 108' ' ' ASN . 51.5 t80 -94.78 109.38 21.35 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.412 -0.588 . . . . 0.81 109.412 175.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.601 HG12 HD12 ' A' ' 51' ' ' LEU . 5.5 t -97.89 142.94 13.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-N 115.469 -0.787 . . . . 1.61 110.634 -176.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -143.27 161.01 27.66 Favored Glycine 0 N--CA 1.447 -0.624 0 CA-C-N 114.538 -1.21 . . . . 1.39 111.717 -171.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 71.18 21.62 78.47 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.892 -0.671 . . . . 0.71 113.259 175.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.667 HD13 HD11 ' A' ' 51' ' ' LEU . 2.9 mm? -67.02 119.3 63.17 Favored Pre-proline 0 C--O 1.223 -0.319 0 N-CA-C 109.094 -0.706 . . . . 1.89 109.094 175.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.658 ' CG ' ' HB3' ' A' ' 101' ' ' ASP . 11.9 Cg_endo -56.3 158.87 14.17 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.372 2.048 . . . . 0.82 111.232 175.341 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -71.98 2.46 5.62 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.896 0.379 . . . . 1.46 111.649 -171.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 18.1 t-160 -95.7 -16.88 21.7 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.059 -0.519 . . . . 2.65 110.136 174.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.471 HG22 HD11 ' A' ' 42' ' ' LEU . 67.9 m -79.4 116.75 19.82 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.445 0.641 . . . . 1.31 112.278 -174.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 42.1 p -99.81 -177.64 3.62 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.31 -0.859 . . . . 0.75 110.19 172.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.5 ' HA ' HG21 ' A' ' 66' ' ' VAL . 4.6 m-20 -61.25 -35.1 76.34 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.453 0.644 . . . . 0.49 110.105 -178.091 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.757 ' HZ1' ' HB3' ' A' ' 49' ' ' LYS . 0.6 OUTLIER -74.52 -38.23 62.85 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.317 -0.856 . . . . 3.26 110.595 -178.56 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.41 ' HB ' HG21 ' A' ' 46' ' ' THR . 17.0 m -62.4 -43.17 99.45 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.267 0.556 . . . . 1.25 110.051 177.482 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.667 HD11 HD13 ' A' ' 42' ' ' LEU . 22.1 tp -66.15 -37.58 86.02 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 115.547 -0.751 . . . . 1.53 109.796 177.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 48.7 t-80 -58.44 -53.1 62.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.617 -0.719 . . . . 0.77 110.841 175.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.648 ' HG2' ' O ' ' A' ' 49' ' ' LYS . 21.3 mm-40 -58.14 -42.33 85.61 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.128 -0.487 . . . . 1.52 111.529 -177.451 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.456 ' O ' ' HB2' ' A' ' 57' ' ' GLN . 6.2 t80 -74.76 -33.61 62.35 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.16 -0.473 . . . . 1.6 111.762 -174.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.644 ' CB ' HD12 ' A' ' 61' ' ' ILE . 4.9 m-85 -86.2 -26.09 25.27 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 114.043 1.127 . . . . 0.68 114.043 -176.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.432 ' HA ' ' O ' ' A' ' 59' ' ' GLY . 7.9 pt-20 -72.78 -11.78 60.75 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 122.109 0.957 . . . . 1.57 109.553 179.5 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.456 ' HB2' ' O ' ' A' ' 54' ' ' TYR . 13.4 mm100 -55.69 -19.33 10.45 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.505 -1.225 . . . . 2.79 111.602 166.521 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -105.9 10.87 32.31 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.618 0.247 . . . . 0.79 110.786 -178.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.432 ' O ' ' HA ' ' A' ' 56' ' ' GLU . . . 125.61 -171.09 17.49 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.79 -0.719 . . . . 0.75 112.664 -177.03 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.51 123.05 18.63 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.799 0.666 . . . . 1.02 112.799 -179.142 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.644 HD12 ' CB ' ' A' ' 55' ' ' PHE . 10.1 mt -93.52 122.81 45.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.168 -0.924 . . . . 1.13 108.767 169.517 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -78.05 -41.47 35.43 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.234 0.54 . . . . 2.07 110.078 177.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -162.56 131.05 4.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.695 -0.684 . . . . 2.48 110.756 -177.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -117.17 116.49 27.39 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.785 0.326 . . . . 1.18 110.192 177.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.2 m -126.9 112.42 28.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.663 0.744 . . . . 1.97 111.819 -178.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.5 HG21 ' HA ' ' A' ' 48' ' ' ASP . 70.1 t -79.25 131.52 34.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.547 -0.751 . . . . 1.12 109.591 179.017 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.563 ' H ' ' HA2' ' A' ' 79' ' ' GLY . 28.8 mm -71.48 140.67 17.84 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.697 0 N-CA-C 107.473 -1.306 . . . . 1.44 107.473 175.329 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.876 ' HA ' ' O ' ' A' ' 75' ' ' SER . 15.2 p . . . . . 0 N--CA 1.441 -0.918 0 N-CA-C 107.343 -1.355 . . . . 1.83 107.343 -159.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.876 ' O ' ' HA ' ' A' ' 68' ' ' THR . 5.3 p . . . . . 0 C--O 1.216 -0.692 0 CA-C-O 118.659 -0.686 . . . . 2.07 112.709 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.466 ' HB2' ' O ' ' A' ' 75' ' ' SER . 74.4 mtt180 112.23 -19.06 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 125.27 1.428 . . . . 3.07 111.729 -170.188 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 81.78 12.62 81.18 Favored Glycine 0 CA--C 1.526 0.719 0 C-N-CA 120.049 -1.072 . . . . 0.75 113.762 174.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -128.47 160.37 32.51 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.862 -0.792 . . . . 1.61 108.862 -177.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.563 ' HA2' ' H ' ' A' ' 67' ' ' ILE . . . 178.57 145.12 5.93 Favored Glycine 0 C--O 1.222 -0.651 0 C-N-CA 119.424 -1.37 . . . . 0.59 113.648 175.429 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.415 ' HD2' HD13 ' A' ' 67' ' ' ILE . 96.4 m-85 -98.67 137.62 37.03 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 122.188 0.994 . . . . 0.84 112.495 175.43 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 65.0 t -119.91 134.03 64.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 114.234 -1.348 . . . . 1.21 109.526 176.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.524 ' HA ' ' O ' ' A' ' 35' ' ' THR . 27.0 m -114.83 123.95 50.51 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 108.596 -0.891 . . . . 1.09 108.596 175.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.411 ' SD ' HG12 ' A' ' 61' ' ' ILE . 82.2 mmm -88.68 164.3 15.38 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.937 -0.764 . . . . 1.02 108.937 -178.475 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.579 ' HZ3' ' HB2' ' A' ' 84' ' ' LYS . 4.3 ttmp? -82.66 -18.27 41.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.173 0.511 . . . . 2.47 110.454 -176.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -143.03 146.91 34.29 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.158 -0.474 . . . . 1.68 109.85 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.562 ' O ' ' HG3' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -64.96 -25.17 67.76 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.051 0.389 . . . . 4.24 112.051 -178.821 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.519 ' O ' ' HG2' ' A' ' 91' ' ' ARG . . . -64.45 -44.98 89.39 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 121.621 -0.674 . . . . 1.33 111.743 178.344 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 18.3 m -66.92 -32.18 73.26 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.938 0.875 . . . . 1.34 109.665 176.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -59.76 -47.03 87.33 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 113.652 -1.613 . . . . 1.16 109.596 175.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.562 ' HG3' ' O ' ' A' ' 86' ' ' ARG . 45.6 mt-10 -56.05 -50.84 69.83 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.751 -0.659 . . . . 2.11 111.385 174.231 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.519 ' HG2' ' O ' ' A' ' 87' ' ' ALA . 2.0 mmt180 -57.88 -44.87 86.95 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.672 0.272 . . . . 4.35 111.337 -177.318 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -55.79 -41.38 74.01 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.889 -0.596 . . . . 1.21 111.157 176.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 44.1 t -70.44 -20.14 62.92 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.598 -0.274 . . . . 1.16 111.676 178.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -76.61 7.28 4.72 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 112.412 0.523 . . . . 4.58 112.412 -178.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -144.01 93.09 6.13 Favored Pre-proline 0 C--N 1.322 -0.613 0 N-CA-C 108.633 -0.877 . . . . 2.24 108.633 -178.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -74.66 -28.87 9.45 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.499 2.133 . . . . 2.38 113.742 -172.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.533 ' HA ' ' O ' ' A' ' 105' ' ' ALA . 10.5 m120 -130.99 79.02 72.35 Favored Pre-proline 0 C--N 1.33 -0.25 0 N-CA-C 112.133 0.42 . . . . 3.61 112.133 -175.62 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -81.57 141.32 12.34 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.755 2.304 . . . . 1.54 111.875 174.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 42.0 mm -83.32 90.07 2.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.139 0.495 . . . . 2.08 110.865 177.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 53.8 mt -92.96 135.31 28.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.601 -0.727 . . . . 1.55 111.148 175.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.658 ' HB3' ' CG ' ' A' ' 43' ' ' PRO . 38.8 t70 43.21 35.86 0.91 Allowed 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 115.733 -0.667 . . . . 1.52 112.477 -174.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 73.49 18.74 79.51 Favored Glycine 0 CA--C 1.519 0.306 0 C-N-CA 120.8 -0.714 . . . . 1.73 113.03 178.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 5.4 tpt180 -129.77 139.78 51.21 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.722 -0.844 . . . . 4.66 108.722 178.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 6.6 ttpm? -71.37 140.23 50.1 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.795 0.331 . . . . 3.14 110.171 179.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.533 ' O ' ' HA ' ' A' ' 97' ' ' ASN . . . -123.66 166.07 16.14 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.512 -0.313 . . . . 1.37 110.804 -171.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -111.65 146.54 37.26 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.038 -0.528 . . . . 2.18 110.34 -178.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 73.2 t -145.46 135.69 18.73 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 115.719 -0.673 . . . . 1.46 110.95 -173.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.626 HD22 ' HD2' ' A' ' 38' ' ' PHE . 9.3 p30 -167.17 161.87 14.82 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 109.6 -0.518 . . . . 3.22 109.6 173.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.485 HD12 ' O ' ' A' ' 34' ' ' PHE . 1.6 mm? -77.22 120.31 22.09 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.263 -0.643 . . . . 1.87 109.263 173.259 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -56.19 -36.23 68.16 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.545 0.572 . . . . 1.3 112.545 -172.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 5.6 p90 . . . . . 0 C--N 1.327 -0.408 0 C-N-CA 120.854 -0.338 . . . . 1.71 111.537 -174.967 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' MET . . . . . 0.424 ' HE1' ' HB3' ' A' ' 33' ' ' MET . 13.8 tmm? . . . . . 0 CA--C 1.531 0.239 0 N-CA-C 111.851 0.315 . . . . 1.9 111.851 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.541 ' O ' HD12 ' A' ' 109' ' ' LEU . 18.2 m-85 -92.96 -13.43 28.81 Favored 'General case' 0 C--O 1.225 -0.201 0 O-C-N 122.013 -0.429 . . . . 1.76 111.482 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.522 ' HB ' ' O ' ' A' ' 83' ' ' MET . 31.7 p -94.38 -6.09 44.97 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.998 0.428 . . . . 1.23 111.102 -174.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.442 ' O ' HD11 ' A' ' 109' ' ' LEU . 13.8 tptm -84.67 103.7 14.01 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.789 -0.641 . . . . 3.2 110.357 -177.092 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.614 HD12 ' HA ' ' A' ' 89' ' ' ALA . 28.7 mt -98.78 139.03 21.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 121.339 0.59 . . . . 1.46 112.486 -174.226 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.42 ' HD1' ' CE2' ' A' ' 80' ' ' PHE . 68.8 t80 -105.59 111.76 24.58 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.31 -0.859 . . . . 0.81 108.976 174.538 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.3 t -99.29 139.34 21.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.068 0.461 . . . . 1.61 110.042 -178.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -140.53 138.11 8.76 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.268 -0.968 . . . . 1.39 113.396 -170.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 84.9 31.15 24.32 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 121.486 -0.388 . . . . 0.71 112.498 176.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.732 HD13 HD22 ' A' ' 51' ' ' LEU . 3.3 mm? -67.24 129.15 93.86 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-O 120.564 0.221 . . . . 1.89 110.809 178.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.523 ' HG2' ' HB3' ' A' ' 101' ' ' ASP . 65.5 Cg_exo -54.97 159.73 9.0 Favored 'Trans proline' 0 CA--C 1.529 0.271 0 C-N-CA 123.448 2.765 . . . . 0.82 112.923 172.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.651 ' HA ' ' HB2' ' A' ' 75' ' ' SER . 6.8 m-30 -69.18 -9.67 54.04 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.738 -0.664 . . . . 1.46 112.486 -174.146 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 44.5 t60 -104.23 -1.18 27.47 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.054 0.454 . . . . 2.65 110.368 178.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.545 HG23 HD11 ' A' ' 42' ' ' LEU . 85.3 m -73.3 116.4 13.8 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.639 0.733 . . . . 1.31 111.362 -177.631 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 6.1 p -110.74 -178.91 3.6 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.631 -1.168 . . . . 0.75 110.503 176.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -62.36 -35.94 80.71 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.334 0.588 . . . . 0.49 110.284 -175.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.663 ' O ' ' HG2' ' A' ' 53' ' ' GLU . 43.0 pttt -65.13 -35.13 80.14 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.336 -0.847 . . . . 3.26 110.821 179.498 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 6.4 m -67.51 -44.8 77.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.551 -0.295 . . . . 1.25 111.049 -178.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.732 HD22 HD13 ' A' ' 42' ' ' LEU . 22.1 mt -64.99 -33.99 77.36 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-O 120.855 0.36 . . . . 1.53 110.296 175.177 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.452 ' HA ' HD11 ' A' ' 61' ' ' ILE . 49.3 t-80 -64.95 -54.47 30.14 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 116.017 -0.538 . . . . 0.77 110.453 -179.214 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.663 ' HG2' ' O ' ' A' ' 49' ' ' LYS . 13.6 mm-40 -56.41 -51.1 69.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.252 -0.431 . . . . 1.52 111.777 -179.123 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.535 ' O ' ' HB2' ' A' ' 57' ' ' GLN . 2.1 t80 -70.44 -33.31 71.17 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 112.765 0.654 . . . . 1.6 112.765 -173.077 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.75 ' HB2' HD13 ' A' ' 61' ' ' ILE . 11.3 m-85 -85.44 -35.29 21.35 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 114.436 1.273 . . . . 0.68 114.436 -172.05 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.621 ' HB3' HG13 ' A' ' 61' ' ' ILE . 13.5 pt-20 -77.99 -6.56 54.87 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 119.747 1.158 . . . . 1.57 110.189 179.113 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.535 ' HB2' ' O ' ' A' ' 54' ' ' TYR . 11.7 mm100 -57.41 -9.83 1.19 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.454 -0.794 . . . . 2.79 112.028 162.369 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -104.3 -21.95 13.43 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.234 -0.439 . . . . 0.79 109.99 177.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.498 ' HA3' ' OG ' ' A' ' 88' ' ' SER . . . 169.91 -116.28 0.64 Allowed Glycine 0 C--O 1.226 -0.398 0 CA-C-N 115.856 -0.611 . . . . 0.75 112.061 -179.486 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -115.36 128.1 55.85 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.942 0.371 . . . . 1.02 110.617 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.75 HD13 ' HB2' ' A' ' 55' ' ' PHE . 25.5 mt -97.13 124.27 49.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 109.776 -0.454 . . . . 1.13 109.776 170.236 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -88.8 -32.02 18.06 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.161 0.505 . . . . 2.07 110.257 178.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -161.06 126.67 3.77 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.965 -0.561 . . . . 2.48 110.483 179.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -117.53 124.66 49.25 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.834 0.35 . . . . 1.18 110.209 171.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.3 p -141.4 112.63 3.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 121.956 0.884 . . . . 1.97 111.991 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.538 HG23 HD13 ' A' ' 51' ' ' LEU . 23.0 t -79.37 129.06 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 CA-C-N 115.079 -0.964 . . . . 1.12 108.77 177.218 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.54 ' H ' ' HA2' ' A' ' 79' ' ' GLY . 44.5 mm -73.7 85.39 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 CA-C-O 121.699 0.761 . . . . 1.44 109.714 -178.515 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.617 HG23 ' HA ' ' A' ' 75' ' ' SER . 23.9 p . . . . . 0 C--N 1.31 -1.149 0 CA-C-N 114.652 -1.158 . . . . 1.83 110.438 178.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.651 ' HB2' ' HA ' ' A' ' 44' ' ' TYR . 15.5 m . . . . . 0 N--CA 1.464 0.253 0 N-CA-C 113.699 1.0 . . . . 2.07 113.699 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.496 ' HD2' ' O ' ' A' ' 67' ' ' ILE . 14.4 mtt180 -56.08 -25.59 46.1 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 114.249 -1.341 . . . . 3.07 111.903 177.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.459 ' HA2' ' O ' ' A' ' 42' ' ' LEU . . . 102.48 3.94 49.94 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.645 -0.788 . . . . 0.75 111.633 -174.361 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 -114.84 146.99 40.47 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.663 -0.495 . . . . 1.61 109.663 177.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.54 ' HA2' ' H ' ' A' ' 67' ' ' ILE . . . -170.08 140.85 6.25 Favored Glycine 0 C--O 1.224 -0.512 0 C-N-CA 120.525 -0.845 . . . . 0.59 112.091 171.305 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.42 ' CE2' ' HD1' ' A' ' 38' ' ' PHE . 59.4 m-85 -103.84 144.94 30.83 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 122.26 1.029 . . . . 0.84 113.279 175.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 55.7 t -123.65 130.52 74.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 113.739 -1.573 . . . . 1.21 109.216 176.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 19.2 m -110.59 106.23 15.43 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 107.827 -1.175 . . . . 1.09 107.827 177.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.522 ' O ' ' HB ' ' A' ' 35' ' ' THR . 51.4 mtp -89.35 157.82 18.03 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 120.38 -0.528 . . . . 1.02 109.74 -175.121 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 23.1 tttm -84.01 -11.06 57.37 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.469 -0.332 . . . . 2.47 111.746 -171.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -147.81 147.55 29.95 Favored 'General case' 0 C--O 1.245 0.864 0 CA-C-O 121.585 0.707 . . . . 1.68 111.857 175.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 15.7 ptt180 -65.13 -28.05 69.15 Favored 'General case' 0 C--O 1.212 -0.908 0 CA-C-N 114.974 -1.012 . . . . 4.24 113.471 -174.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.403 ' O ' ' HG3' ' A' ' 91' ' ' ARG . . . -65.46 -50.46 65.29 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 119.554 1.07 . . . . 1.33 111.629 -175.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.498 ' OG ' ' HA3' ' A' ' 59' ' ' GLY . 14.6 m -63.2 -39.69 95.35 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.474 0.654 . . . . 1.34 110.231 177.092 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.614 ' HA ' HD12 ' A' ' 37' ' ' ILE . . . -59.37 -50.37 74.23 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 114.529 -1.214 . . . . 1.16 110.49 178.172 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.679 ' O ' ' HG2' ' A' ' 94' ' ' LYS . 4.4 mm-40 -56.41 -50.73 70.79 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.034 -0.985 . . . . 2.11 112.258 176.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.403 ' HG3' ' O ' ' A' ' 87' ' ' ALA . 99.1 mtt180 -58.93 -45.86 89.38 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 111.914 0.339 . . . . 4.35 111.914 -177.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -56.13 -35.15 66.8 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.006 0.431 . . . . 1.21 111.099 177.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 36.8 t -76.47 -26.79 55.73 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.326 -0.397 . . . . 1.16 112.0 176.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.679 ' HG2' ' O ' ' A' ' 90' ' ' GLU . 32.5 mmtm -72.97 -44.27 61.29 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 120.71 0.29 . . . . 4.58 111.155 -175.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -112.12 89.45 11.96 Favored Pre-proline 0 C--N 1.324 -0.508 0 N-CA-C 109.502 -0.555 . . . . 2.24 109.502 174.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.566 ' HB3' ' O ' ' A' ' 107' ' ' VAL . 73.5 Cg_endo -87.73 77.96 1.66 Allowed 'Trans proline' 0 N--CA 1.447 -1.221 0 C-N-CA 122.661 2.241 . . . . 2.38 111.909 -176.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 30.7 m-80 -154.66 39.98 0.13 Allowed Pre-proline 0 CA--C 1.54 0.573 0 CA-C-N 116.1 -0.5 . . . . 3.61 112.312 -175.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . 0.701 ' HD2' ' O ' ' A' ' 105' ' ' ALA . 67.9 Cg_endo -72.36 121.4 7.44 Favored 'Trans proline' 0 C--N 1.352 0.762 0 CA-C-N 120.543 1.23 . . . . 1.54 112.646 -176.316 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 47.4 mm -71.85 91.49 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.966 0.889 . . . . 2.08 110.547 173.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 72.7 mt -106.89 131.98 55.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 114.717 -1.129 . . . . 1.55 110.309 -179.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.523 ' HB3' ' HG2' ' A' ' 43' ' ' PRO . 25.9 t70 45.07 30.0 0.55 Allowed 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 113.337 0.866 . . . . 1.52 113.337 178.248 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 86.88 21.66 49.33 Favored Glycine 0 CA--C 1.521 0.437 0 C-N-CA 120.497 -0.858 . . . . 1.73 113.034 177.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.511 ' HB2' ' HG3' ' A' ' 43' ' ' PRO . 83.0 mmt-85 -138.81 151.74 47.29 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.116 -0.698 . . . . 4.66 109.116 177.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -95.99 106.15 18.27 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 119.298 -0.961 . . . . 3.14 109.284 172.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.701 ' O ' ' HD2' ' A' ' 98' ' ' PRO . . . -86.37 167.27 14.89 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.482 0.658 . . . . 1.37 112.432 174.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -114.15 128.92 56.59 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.02 -0.991 . . . . 2.18 110.147 -177.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.566 ' O ' ' HB3' ' A' ' 96' ' ' PRO . 57.5 t -119.61 147.99 22.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.418 -0.355 . . . . 1.46 110.542 -175.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -160.53 172.97 16.24 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.579 0.228 . . . . 3.22 110.593 177.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.541 HD12 ' O ' ' A' ' 34' ' ' PHE . 0.6 OUTLIER -79.68 130.19 35.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.617 0.246 . . . . 1.87 110.408 179.401 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.52 -33.67 76.45 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.716 0.636 . . . . 1.3 112.716 -174.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.403 ' HD1' HD13 ' A' ' 109' ' ' LEU . 7.1 p90 . . . . . 0 C--N 1.33 -0.254 0 CA-C-O 120.781 0.324 . . . . 1.71 111.737 -173.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 59.9 ttp . . . . . 0 N--CA 1.454 -0.227 0 N-CA-C 111.648 0.24 . . . . 1.9 111.648 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.524 ' HA ' HD12 ' A' ' 109' ' ' LEU . 50.2 m-85 -103.47 -21.06 13.84 Favored 'General case' 0 C--O 1.226 -0.17 0 O-C-N 122.043 -0.41 . . . . 1.76 110.79 -177.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.752 ' O ' ' HA ' ' A' ' 82' ' ' THR . 28.7 p -84.8 14.21 5.01 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.303 0.573 . . . . 1.23 110.631 -175.072 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.425 ' O ' HD11 ' A' ' 109' ' ' LEU . 6.9 ttpt -121.21 102.45 8.31 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.355 -0.839 . . . . 3.2 109.227 -173.093 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.474 HG23 HG21 ' A' ' 39' ' ' VAL . 5.3 mp -109.42 126.85 66.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 116.119 -0.491 . . . . 1.46 111.042 -175.294 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.47 ' HD1' ' CZ ' ' A' ' 80' ' ' PHE . 80.3 t80 -85.76 115.83 23.65 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.487 -0.56 . . . . 0.81 109.487 175.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.638 HG11 HG23 ' A' ' 107' ' ' VAL . 91.6 t -133.05 97.32 2.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-O 118.405 -0.807 . . . . 1.61 110.282 -179.25 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.563 ' HA2' HD11 ' A' ' 42' ' ' LEU . . . -117.61 -156.24 10.34 Favored Glycine 0 C--O 1.215 -1.081 0 C-N-CA 115.838 -3.077 . . . . 1.39 113.721 162.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 88.67 12.0 65.09 Favored Glycine 0 N--CA 1.45 -0.4 0 N-CA-C 110.032 -1.227 . . . . 0.71 110.032 -171.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.563 HD11 ' HA2' ' A' ' 40' ' ' GLY . 7.7 mp -75.54 137.95 70.82 Favored Pre-proline 0 N--CA 1.447 -0.591 0 CA-C-N 114.626 -0.787 . . . . 1.89 110.716 -177.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.505 ' HD2' ' OG1' ' A' ' 46' ' ' THR . 42.5 Cg_exo -55.33 159.89 9.65 Favored 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 123.029 2.486 . . . . 0.82 111.678 173.304 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 44.1 m-85 -65.1 -22.16 66.91 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.165 0.431 . . . . 1.46 112.165 -175.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 23.0 t60 -86.09 -25.49 25.8 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 120.917 0.389 . . . . 2.65 110.44 178.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.684 HG22 HG22 ' A' ' 50' ' ' THR . 19.1 m -66.91 130.08 41.98 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.704 -0.68 . . . . 1.31 110.302 -176.421 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 9.0 p -137.33 -176.65 4.47 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.033 -0.53 . . . . 0.75 111.871 -170.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -55.72 -35.4 66.07 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.559 -0.746 . . . . 0.49 110.126 -176.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.664 ' O ' ' HG2' ' A' ' 53' ' ' GLU . 9.5 ptpp? -66.54 -36.85 83.68 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.045 -0.98 . . . . 3.26 109.85 -177.053 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.684 HG22 HG22 ' A' ' 46' ' ' THR . 53.9 m -63.63 -45.56 89.72 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.797 -0.638 . . . . 1.25 110.89 179.055 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 63.1 mt -67.85 -39.16 83.86 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.75 -0.659 . . . . 1.53 111.237 -179.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 56.1 t-80 -55.31 -51.3 67.16 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.209 -0.451 . . . . 0.77 109.972 175.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.664 ' HG2' ' O ' ' A' ' 49' ' ' LYS . 10.9 mm-40 -64.9 -47.88 76.2 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.832 -0.622 . . . . 1.52 112.489 -176.454 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.419 ' O ' ' HB2' ' A' ' 57' ' ' GLN . 66.1 t80 -77.35 -36.85 53.41 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 121.054 0.454 . . . . 1.6 111.701 -170.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.567 ' CB ' HD12 ' A' ' 61' ' ' ILE . 14.3 m-85 -84.01 -25.81 29.64 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.655 0.613 . . . . 0.68 112.655 -174.528 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.633 ' HA ' ' O ' ' A' ' 59' ' ' GLY . 6.1 pt-20 -70.77 -9.72 57.98 Favored 'General case' 0 N--CA 1.461 0.101 0 CA-C-O 121.487 0.66 . . . . 1.57 109.872 178.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.419 ' HB2' ' O ' ' A' ' 54' ' ' TYR . 27.4 mm-40 -60.39 -25.84 66.2 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.091 -0.959 . . . . 2.79 110.967 170.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -88.08 -28.74 21.13 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.31 0.576 . . . . 0.79 110.036 178.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.633 ' O ' ' HA ' ' A' ' 56' ' ' GLU . . . 170.36 178.5 41.23 Favored Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 110.771 -0.932 . . . . 0.75 110.771 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -63.72 130.19 43.22 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 117.35 0.575 . . . . 1.02 109.65 -178.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.567 HD12 ' CB ' ' A' ' 55' ' ' PHE . 60.6 mt -97.72 125.74 50.82 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 110.376 -0.231 . . . . 1.13 110.376 177.528 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -66.56 -42.04 87.7 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 121.111 0.481 . . . . 2.07 110.721 177.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -161.97 142.28 10.3 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 115.457 -0.792 . . . . 2.48 111.061 -178.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -120.08 122.94 42.17 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.692 -0.685 . . . . 1.18 109.717 174.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.6 p -136.7 122.64 28.39 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-N 114.995 -1.002 . . . . 1.97 112.566 -174.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 54.6 t -101.43 134.14 42.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.697 -0.683 . . . . 1.12 109.423 173.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.474 ' O ' ' HB2' ' A' ' 76' ' ' ARG . 50.7 mm -86.08 100.43 9.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 121.192 0.52 . . . . 1.44 110.271 -174.012 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 20.2 p . . . . . 0 C--N 1.318 -0.775 0 CA-C-N 115.633 -0.712 . . . . 1.83 110.109 174.645 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 13.7 m . . . . . 0 N--CA 1.457 -0.115 0 CA-C-O 120.903 0.382 . . . . 2.07 111.331 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.474 ' HB2' ' O ' ' A' ' 67' ' ' ILE . 44.1 mtt180 -63.4 -18.99 64.29 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.912 -0.585 . . . . 3.07 111.313 175.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 79.73 24.44 60.28 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.81 -0.709 . . . . 0.75 113.389 173.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.463 ' HA ' ' CA ' ' A' ' 40' ' ' GLY . 14.0 m-85 -128.14 149.46 50.41 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 107.851 -1.166 . . . . 1.61 107.851 176.373 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -145.35 -173.55 16.72 Favored Glycine 0 N--CA 1.441 -0.99 0 C-N-CA 119.753 -1.213 . . . . 0.59 112.845 176.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.47 ' CZ ' ' HD1' ' A' ' 38' ' ' PHE . 59.1 m-85 -144.59 125.98 14.86 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 108.375 -0.972 . . . . 0.84 108.375 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 30.9 t -108.15 110.93 33.76 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 N-CA-C 109.464 -0.569 . . . . 1.21 109.464 177.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.752 ' HA ' ' O ' ' A' ' 35' ' ' THR . 28.4 m -105.52 103.72 13.3 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.47 -0.937 . . . . 1.09 108.47 177.459 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.434 ' HA ' ' HA ' ' A' ' 61' ' ' ILE . 48.6 mtp -89.16 173.8 8.22 Favored 'General case' 0 N--CA 1.448 -0.546 0 O-C-N 121.795 -0.565 . . . . 1.02 111.301 -170.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 23.2 tptt -69.52 -41.59 75.82 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.053 -0.522 . . . . 2.47 110.502 -175.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -131.99 153.71 50.07 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 121.087 0.47 . . . . 1.68 111.598 -178.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.453 ' HA ' ' HB1' ' A' ' 89' ' ' ALA . 0.0 OUTLIER -73.01 -20.76 60.94 Favored 'General case' 0 C--O 1.221 -0.399 0 CA-C-N 115.414 -0.812 . . . . 4.24 112.681 -172.762 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.64 -49.97 68.93 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 118.336 0.516 . . . . 1.33 111.403 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 15.3 m -70.45 -33.99 71.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.543 0.687 . . . . 1.34 109.739 177.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.506 ' CB ' ' HA ' ' A' ' 35' ' ' THR . . . -56.85 -45.6 82.32 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-N 114.472 -1.24 . . . . 1.16 109.658 174.656 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.603 ' O ' ' HG2' ' A' ' 94' ' ' LYS . 2.4 mm-40 -55.67 -45.59 77.69 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.618 -0.719 . . . . 2.11 110.78 173.021 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 8.3 mmm180 -57.86 -42.09 83.77 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.715 0.293 . . . . 4.35 111.007 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -58.03 -36.52 72.84 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.75 -0.659 . . . . 1.21 111.631 176.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 37.2 t -84.16 -22.95 30.81 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 112.016 0.376 . . . . 1.16 112.016 179.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.603 ' HG2' ' O ' ' A' ' 90' ' ' GLU . 67.8 mmtt -56.33 -48.32 76.98 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 112.742 0.645 . . . . 4.58 112.742 -175.346 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.446 ' HA ' ' HD3' ' A' ' 96' ' ' PRO . 28.9 t0 -104.91 101.47 29.7 Favored Pre-proline 0 C--N 1.325 -0.462 0 C-N-CA 120.673 -0.411 . . . . 2.24 110.507 -178.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 95' ' ' ASP . 5.7 Cg_exo -80.08 172.74 13.52 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 123.211 2.607 . . . . 2.38 112.936 -175.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.472 ' N ' ' HD3' ' A' ' 98' ' ' PRO . 4.2 p30 31.91 62.45 1.24 Allowed Pre-proline 0 N--CA 1.473 0.707 0 CA-C-N 115.092 -0.958 . . . . 3.61 113.489 -172.431 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . 0.472 ' HD3' ' N ' ' A' ' 97' ' ' ASN . 2.0 Cg_endo -81.15 167.32 17.91 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 123.356 2.704 . . . . 1.54 111.28 176.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 51.0 mm -99.07 135.56 33.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 108.072 -1.084 . . . . 2.08 108.072 178.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 71.6 mt -144.91 108.6 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 N-CA-C 109.453 -0.573 . . . . 1.55 109.453 -172.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 19.1 t0 60.2 52.67 4.85 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.782 0.801 . . . . 1.52 111.003 176.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 77.34 -6.99 40.83 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 115.653 1.021 . . . . 1.73 115.653 177.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.482 ' CG ' ' HG3' ' A' ' 43' ' ' PRO . 27.2 mmt180 -131.62 150.49 52.13 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 118.919 1.36 . . . . 4.66 111.106 -179.282 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -77.19 130.95 37.96 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.892 -0.594 . . . . 3.14 110.913 178.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -107.14 146.93 30.69 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.662 -0.699 . . . . 1.37 110.945 -175.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 39.3 m-20 -96.28 129.37 43.62 Favored 'General case' 0 C--O 1.251 1.163 0 CA-C-O 121.725 0.774 . . . . 2.18 110.011 173.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.638 HG23 HG11 ' A' ' 39' ' ' VAL . 73.3 t -142.26 131.28 22.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 112.942 -1.936 . . . . 1.46 110.462 -161.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 8.4 m-20 -166.6 158.58 13.42 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 123.709 0.63 . . . . 3.22 109.467 175.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.524 HD12 ' HA ' ' A' ' 34' ' ' PHE . 0.2 OUTLIER -58.16 150.16 22.06 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.19 -1.041 . . . . 1.87 108.19 172.35 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.448 ' H ' HD11 ' A' ' 109' ' ' LEU . . . -69.51 -34.12 73.82 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.18 0.514 . . . . 1.3 110.311 -168.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 16.6 p90 . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 115.583 -0.735 . . . . 1.71 110.678 -176.368 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 55.5 ttp . . . . . 0 C--O 1.227 -0.092 0 N-CA-C 111.983 0.364 . . . . 1.9 111.983 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -96.36 -6.21 38.15 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.771 -0.371 . . . . 1.76 111.793 -177.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.674 ' O ' ' HA ' ' A' ' 82' ' ' THR . 34.2 p -102.78 -5.05 24.08 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.746 0.307 . . . . 1.23 111.371 -176.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.575 ' HG3' ' HB2' ' A' ' 110' ' ' ALA . 18.4 tptm -92.67 101.49 13.9 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.274 0.559 . . . . 3.2 110.461 -175.297 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 32.8 mt -107.85 132.92 54.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.724 -0.671 . . . . 1.46 110.449 -177.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.567 ' HD1' ' CE1' ' A' ' 80' ' ' PHE . 88.4 t80 -99.84 116.09 31.11 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.033 -0.728 . . . . 0.81 109.033 173.454 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.554 HG11 HG21 ' A' ' 107' ' ' VAL . 95.7 t -132.31 106.22 10.55 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.886 0 CA-C-O 118.803 -0.618 . . . . 1.61 110.067 -178.202 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.896 ' HA3' ' HD1' ' A' ' 78' ' ' TYR . . . -122.82 -154.74 9.14 Favored Glycine 0 N--CA 1.44 -1.073 0 C-N-CA 115.979 -3.01 . . . . 1.39 113.267 159.322 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 85.62 8.02 80.93 Favored Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 110.265 -1.134 . . . . 0.71 110.265 -174.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.72 ' HB3' ' HB ' ' A' ' 46' ' ' THR . 5.7 mp -69.55 135.57 88.37 Favored Pre-proline 0 N--CA 1.45 -0.448 0 CA-C-N 114.989 -0.605 . . . . 1.89 109.899 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 1.015 ' HG2' ' HB3' ' A' ' 101' ' ' ASP . 53.8 Cg_exo -49.88 158.85 1.89 Allowed 'Trans proline' 0 N--CA 1.463 -0.291 0 C-N-CA 123.146 2.564 . . . . 0.82 112.128 174.419 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -66.72 -9.61 38.22 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 113.439 0.903 . . . . 1.46 113.439 -171.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 1.7 p80 -111.71 0.76 16.4 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.124 -0.631 . . . . 2.65 110.77 176.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.72 ' HB ' ' HB3' ' A' ' 42' ' ' LEU . 5.8 m -79.53 118.52 21.46 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.504 -0.554 . . . . 1.31 109.504 176.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 6.2 p -123.93 -177.95 3.91 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.116 -0.493 . . . . 0.75 112.303 -168.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -54.19 -30.84 51.07 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.628 -0.715 . . . . 0.49 110.79 -178.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.536 ' O ' ' HG2' ' A' ' 53' ' ' GLU . 23.2 pttm -74.92 -34.3 62.11 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.653 -0.703 . . . . 3.26 109.842 -178.114 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.572 HG22 HG21 ' A' ' 46' ' ' THR . 6.1 m -67.12 -45.18 77.95 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 116.535 -0.302 . . . . 1.25 110.514 -178.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.606 HD22 HD23 ' A' ' 42' ' ' LEU . 39.2 mt -62.07 -46.95 86.83 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-O 120.994 0.426 . . . . 1.53 109.974 175.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.515 ' HA ' ' CD1' ' A' ' 61' ' ' ILE . 55.1 t-80 -55.95 -51.28 68.24 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 115.687 -0.688 . . . . 0.77 110.574 179.388 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.536 ' HG2' ' O ' ' A' ' 49' ' ' LYS . 21.5 mm-40 -65.25 -36.54 84.45 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 112.311 0.486 . . . . 1.52 112.311 -176.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.709 ' O ' ' HB2' ' A' ' 57' ' ' GLN . 25.7 t80 -77.79 -34.87 52.04 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 118.128 0.422 . . . . 1.6 111.594 -178.383 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.474 ' CD2' HG12 ' A' ' 81' ' ' VAL . 25.9 m-85 -84.91 -28.88 25.63 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 112.892 0.701 . . . . 0.68 112.892 -175.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.583 ' HA ' ' O ' ' A' ' 59' ' ' GLY . 34.4 mm-40 -57.36 -24.72 57.04 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-O 122.563 1.173 . . . . 1.57 109.413 174.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.709 ' HB2' ' O ' ' A' ' 54' ' ' TYR . 69.1 mt-30 -60.27 -31.68 70.46 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 112.971 -1.922 . . . . 2.79 112.27 176.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.442 ' HD2' ' HA ' ' A' ' 55' ' ' PHE . 86.5 m-85 -89.12 -27.21 20.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.329 0.585 . . . . 0.79 109.463 177.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.583 ' O ' ' HA ' ' A' ' 56' ' ' GLU . . . 162.47 -172.28 38.51 Favored Glycine 0 N--CA 1.443 -0.864 0 CA-C-N 115.006 -0.997 . . . . 0.75 111.697 177.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -64.73 126.26 27.37 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.707 0.289 . . . . 1.02 110.801 -177.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.515 ' CD1' ' HA ' ' A' ' 52' ' ' HIS . 8.2 mt -99.98 124.31 53.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.101 -0.703 . . . . 1.13 109.101 177.295 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -78.97 -41.94 28.0 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.009 0.433 . . . . 2.07 111.608 179.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.55 ' HB3' ' HB ' ' A' ' 82' ' ' THR . 8.7 tp10 -139.89 126.6 20.55 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.974 -0.557 . . . . 2.48 111.013 -172.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -127.89 125.84 40.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.679 0.752 . . . . 1.18 110.883 174.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.492 ' CG1' ' HB2' ' A' ' 80' ' ' PHE . 7.1 p -145.62 136.17 18.92 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 CA-C-N 114.546 -1.206 . . . . 1.97 113.057 -178.098 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 75.2 t -102.18 124.9 56.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.296 -0.865 . . . . 1.12 108.855 167.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.533 HG12 ' HA2' ' A' ' 79' ' ' GLY . 35.2 mm -81.1 103.05 7.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.785 -0.643 . . . . 1.44 110.672 -174.444 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 17.0 p . . . . . 0 C--N 1.316 -0.856 0 CA-C-N 115.326 -0.852 . . . . 1.83 110.638 176.772 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 35.2 t . . . . . 0 N--CA 1.453 -0.285 0 CA-C-O 121.291 0.567 . . . . 2.07 110.479 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.414 ' HB2' ' O ' ' A' ' 67' ' ' ILE . 64.3 mtt180 -61.48 -11.74 11.99 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.503 -0.772 . . . . 3.07 111.52 173.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 78.5 11.14 85.59 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.97 -0.633 . . . . 0.75 112.714 176.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.896 ' HD1' ' HA3' ' A' ' 40' ' ' GLY . 29.9 m-85 -114.78 161.66 17.9 Favored 'General case' 0 CA--C 1.504 -0.821 0 N-CA-C 109.807 -0.442 . . . . 1.61 109.807 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.533 ' HA2' HG12 ' A' ' 67' ' ' ILE . . . -161.67 -166.92 21.33 Favored Glycine 0 N--CA 1.438 -1.185 0 C-N-CA 119.855 -1.164 . . . . 0.59 112.432 168.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.567 ' CE1' ' HD1' ' A' ' 38' ' ' PHE . 62.9 m-85 -135.95 132.98 37.12 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.018 -0.734 . . . . 0.84 109.018 179.124 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.474 HG12 ' CD2' ' A' ' 55' ' ' PHE . 41.1 t -119.94 109.96 27.61 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-O 121.392 0.615 . . . . 1.21 110.012 175.334 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.674 ' HA ' ' O ' ' A' ' 35' ' ' THR . 11.2 m -107.96 112.01 24.38 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 107.663 -1.236 . . . . 1.09 107.663 174.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.426 ' HA ' ' HA ' ' A' ' 61' ' ' ILE . 55.6 mtp -90.23 166.99 13.04 Favored 'General case' 0 N--CA 1.447 -0.586 0 O-C-N 121.412 -0.805 . . . . 1.02 109.162 -173.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -79.44 -17.27 54.61 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.816 0.341 . . . . 2.47 110.945 -173.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -145.01 146.75 32.04 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.281 -0.418 . . . . 1.68 110.235 -179.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.726 ' HD3' ' H ' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -72.77 -22.11 60.9 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.91 0.707 . . . . 4.24 112.91 -174.096 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.426 ' O ' ' HG3' ' A' ' 91' ' ' ARG . . . -72.16 -37.45 69.36 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.054 0.454 . . . . 1.33 111.07 -178.002 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.528 ' OG ' ' HA3' ' A' ' 59' ' ' GLY . 21.1 m -72.64 -37.94 67.85 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.712 0.768 . . . . 1.34 109.666 174.439 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.78 -41.96 83.14 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.061 -1.427 . . . . 1.16 109.333 175.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -54.69 -48.53 72.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.042 -0.981 . . . . 2.11 111.507 171.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.49 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 96.7 mtt180 -59.98 -38.84 83.73 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.258 -0.428 . . . . 4.35 110.951 -179.4 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -59.12 -46.37 88.51 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.028 -0.533 . . . . 1.21 111.658 174.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 51.7 t -76.58 -8.76 57.86 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 111.707 0.262 . . . . 1.16 111.707 -178.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.49 ' HB2' ' O ' ' A' ' 91' ' ' ARG . 39.7 mmtm -58.03 -41.63 83.61 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.661 -0.245 . . . . 4.58 110.951 177.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -103.44 104.67 42.86 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 109.56 -0.533 . . . . 2.24 109.56 174.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.564 ' O ' ' HB2' ' A' ' 97' ' ' ASN . 39.8 Cg_endo -84.94 102.6 0.81 Allowed 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 122.631 2.221 . . . . 2.38 113.427 -174.11 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.564 ' HB2' ' O ' ' A' ' 96' ' ' PRO . 10.8 m120 89.03 54.66 0.03 OUTLIER Pre-proline 0 N--CA 1.476 0.862 0 CA-C-N 114.39 -1.277 . . . . 3.61 110.266 174.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . 0.542 ' O ' HG13 ' A' ' 100' ' ' ILE . 90.1 Cg_endo -82.75 116.85 2.58 Favored 'Trans proline' 0 N--CA 1.45 -1.037 0 C-N-CA 121.49 1.46 . . . . 1.54 112.767 -177.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.987 ' HA ' ' HA ' ' A' ' 104' ' ' LYS . 1.2 mt -25.47 131.39 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.49 -0.777 . . . . 2.08 112.866 151.364 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.542 HG13 ' O ' ' A' ' 98' ' ' PRO . 61.0 mt -148.46 126.99 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 N-CA-C 106.151 -1.796 . . . . 1.55 106.151 -178.599 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 1.015 ' HB3' ' HG2' ' A' ' 43' ' ' PRO . 10.3 t0 65.06 41.18 4.72 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 122.245 1.021 . . . . 1.52 109.164 -178.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 70.27 -8.14 4.13 Favored Glycine 0 CA--C 1.529 0.921 0 CA-C-N 114.708 -1.133 . . . . 1.73 115.529 -179.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.653 ' CG ' ' HG3' ' A' ' 43' ' ' PRO . 34.8 mmt180 -117.5 134.27 55.04 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 119.317 1.559 . . . . 4.66 110.629 178.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.987 ' HA ' ' HA ' ' A' ' 99' ' ' ILE . 4.7 ttpm? -63.98 128.46 35.9 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 121.382 -0.127 . . . . 3.14 111.267 -177.437 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -100.16 152.52 20.16 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 120.956 0.408 . . . . 1.37 111.109 -177.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.542 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 9.0 t30 -102.2 124.69 48.23 Favored 'General case' 0 C--O 1.243 0.726 0 CA-C-N 116.179 -0.464 . . . . 2.18 109.905 177.27 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.554 HG21 HG11 ' A' ' 39' ' ' VAL . 94.7 t -139.37 128.44 28.92 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.125 0 O-C-N 124.842 1.339 . . . . 1.46 110.505 -164.296 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 33.5 p30 -160.25 157.36 28.02 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.388 -0.369 . . . . 3.22 110.011 171.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.568 ' HB3' ' CD1' ' A' ' 111' ' ' TYR . 3.5 mm? -67.01 101.11 0.81 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.202 0.525 . . . . 1.87 110.901 175.154 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.575 ' HB2' ' HG3' ' A' ' 36' ' ' LYS . . . -46.97 -24.11 0.56 Allowed 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 115.518 1.673 . . . . 1.3 115.518 -174.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.568 ' CD1' ' HB3' ' A' ' 109' ' ' LEU . 14.9 p90 . . . . . 0 N--CA 1.468 0.435 0 CA-C-N 118.163 0.438 . . . . 1.71 111.515 -175.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' MET . . . . . 0.545 ' HE1' ' CE2' ' A' ' 34' ' ' PHE . 50.8 ttp . . . . . 0 N--CA 1.454 -0.227 0 CA-C-O 120.624 0.25 . . . . 1.9 111.438 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.545 ' CE2' ' HE1' ' A' ' 33' ' ' MET . 29.3 m-85 -98.77 6.54 46.84 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 111.705 0.261 . . . . 1.76 111.705 -178.382 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.752 ' O ' ' HA ' ' A' ' 82' ' ' THR . 43.1 p -114.51 17.08 17.54 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.264 0.554 . . . . 1.23 109.922 177.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.822 ' HG3' ' HB2' ' A' ' 110' ' ' ALA . 0.1 OUTLIER -113.85 103.43 11.18 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.14 -0.937 . . . . 3.2 110.354 -176.737 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.5 mp -110.26 131.32 61.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.904 -0.589 . . . . 1.46 111.036 -176.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.505 ' O ' ' HA ' ' A' ' 107' ' ' VAL . 69.4 t80 -91.3 113.09 25.26 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.264 -0.88 . . . . 0.81 109.002 176.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.592 ' HA ' ' O ' ' A' ' 106' ' ' ASN . 84.7 t -132.93 102.59 5.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 118.194 -0.907 . . . . 1.61 110.273 -176.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.59 ' HA2' ' CD1' ' A' ' 42' ' ' LEU . . . -122.83 -154.84 9.17 Favored Glycine 0 C--O 1.221 -0.705 0 C-N-CA 115.937 -3.03 . . . . 1.39 113.629 163.119 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 84.07 4.32 88.47 Favored Glycine 0 N--CA 1.452 -0.299 0 N-CA-C 111.098 -0.801 . . . . 0.71 111.098 -175.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.802 ' HB3' ' HB ' ' A' ' 46' ' ' THR . 5.4 mp -64.96 137.51 97.18 Favored Pre-proline 0 N--CA 1.453 -0.282 0 CA-C-N 115.409 -0.395 . . . . 1.89 110.38 -178.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.571 ' HG2' ' HB3' ' A' ' 101' ' ' ASP . 52.7 Cg_exo -51.73 159.75 3.29 Favored 'Trans proline' 0 N--CA 1.463 -0.305 0 C-N-CA 123.198 2.599 . . . . 0.82 111.955 173.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -66.43 -12.43 57.1 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 112.401 0.519 . . . . 1.46 112.401 -175.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 46.3 t60 -92.0 -24.92 19.06 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.15 0.5 . . . . 2.65 109.986 174.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.802 ' HB ' ' HB3' ' A' ' 42' ' ' LEU . 4.4 m -72.71 118.32 15.49 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.876 -0.602 . . . . 1.31 109.849 -176.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 6.0 p -134.46 -175.64 3.94 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.617 -0.719 . . . . 0.75 111.176 -168.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -49.93 -34.87 21.88 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.424 0.631 . . . . 0.49 110.594 -177.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.697 ' O ' ' HG2' ' A' ' 53' ' ' GLU . 8.5 ptpp? -67.65 -43.88 79.25 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 114.893 -1.049 . . . . 3.26 109.887 -178.089 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.607 HG22 HG21 ' A' ' 46' ' ' THR . 6.7 m -66.34 -40.51 89.91 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.629 -0.259 . . . . 1.25 111.24 -176.085 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.587 HD22 HD23 ' A' ' 42' ' ' LEU . 22.8 mt -61.78 -46.86 87.73 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 109.882 -0.414 . . . . 1.53 109.882 175.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.529 ' HA ' HD13 ' A' ' 61' ' ' ILE . 45.9 t-80 -52.69 -51.55 59.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.417 -0.811 . . . . 0.77 110.218 174.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.697 ' HG2' ' O ' ' A' ' 49' ' ' LYS . 23.4 mm-40 -59.48 -48.18 82.65 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.106 -0.497 . . . . 1.52 112.316 -176.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.451 ' O ' ' HB2' ' A' ' 57' ' ' GLN . 47.4 t80 -76.53 -41.44 46.7 Favored 'General case' 0 C--O 1.227 -0.109 0 CA-C-O 121.051 0.453 . . . . 1.6 111.495 -171.384 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.727 ' HB2' HD12 ' A' ' 61' ' ' ILE . 45.8 m-85 -84.16 -30.38 25.9 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 113.063 0.764 . . . . 0.68 113.063 -170.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.599 ' HA ' ' O ' ' A' ' 59' ' ' GLY . 16.6 pt-20 -67.45 -14.58 63.06 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 122.109 0.957 . . . . 1.57 110.113 -178.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.451 ' HB2' ' O ' ' A' ' 54' ' ' TYR . 13.6 mm100 -57.11 -26.3 60.23 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.082 -1.417 . . . . 2.79 112.063 172.167 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -93.12 -25.2 17.99 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.223 0.535 . . . . 0.79 110.055 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.599 ' O ' ' HA ' ' A' ' 56' ' ' GLU . . . 170.96 174.66 38.97 Favored Glycine 0 N--CA 1.447 -0.606 0 N-CA-C 110.386 -1.086 . . . . 0.75 110.386 -179.22 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 61.1 m-20 -67.9 125.14 25.36 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 117.492 0.646 . . . . 1.02 110.819 -173.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.727 HD12 ' HB2' ' A' ' 55' ' ' PHE . 29.8 mt -89.04 118.63 34.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.335 -0.393 . . . . 1.13 110.309 178.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.434 ' HB2' ' HG3' ' A' ' 84' ' ' LYS . 24.9 tt0 -75.7 -33.0 60.32 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.145 0.424 . . . . 2.07 112.145 -179.269 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -157.15 133.3 9.64 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.651 -0.42 . . . . 2.48 111.531 -178.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -125.3 130.08 51.28 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.643 -0.708 . . . . 1.18 110.928 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 20.6 t -135.54 136.19 50.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 114.527 -1.215 . . . . 1.97 111.927 -177.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 56.0 t -118.58 117.72 55.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 108.703 -0.851 . . . . 1.12 108.703 162.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 35.3 mm -77.06 111.81 14.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 115.293 -0.867 . . . . 1.44 111.111 -171.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 21.4 p . . . . . 0 C--N 1.319 -0.736 0 CA-C-N 115.551 -0.75 . . . . 1.83 110.911 176.042 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 17.0 m . . . . . 0 N--CA 1.462 0.164 0 N-CA-C 112.806 0.669 . . . . 2.07 112.806 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.427 ' HB3' ' CD2' ' A' ' 78' ' ' TYR . 21.7 mtp180 -61.19 -25.09 66.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.003 -0.999 . . . . 3.07 111.964 177.324 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 80.58 23.51 60.21 Favored Glycine 0 C--O 1.225 -0.467 0 C-N-CA 120.491 -0.861 . . . . 0.75 112.52 179.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.427 ' CD2' ' HB3' ' A' ' 76' ' ' ARG . 21.7 m-85 -120.07 138.91 53.26 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.113 -1.069 . . . . 1.61 108.113 176.571 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -141.88 -177.77 17.34 Favored Glycine 0 N--CA 1.441 -0.972 0 C-N-CA 119.076 -1.535 . . . . 0.59 113.508 178.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.451 ' CE1' ' HD1' ' A' ' 38' ' ' PHE . 61.3 m-85 -138.65 125.93 21.6 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 123.179 0.592 . . . . 0.84 109.445 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.448 HG21 HD11 ' A' ' 51' ' ' LEU . 42.8 t -113.33 114.51 47.09 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-O 121.03 0.443 . . . . 1.21 110.57 178.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.752 ' HA ' ' O ' ' A' ' 35' ' ' THR . 8.4 m -106.36 125.23 50.73 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.025 -1.102 . . . . 1.09 108.025 171.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 81.3 mtp -110.76 166.49 10.98 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 107.987 -1.116 . . . . 1.02 107.987 -172.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.434 ' HG3' ' HB2' ' A' ' 62' ' ' GLU . 3.4 mttm -83.53 -8.72 59.29 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 112.704 0.631 . . . . 2.47 112.704 -172.575 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.425 ' OD1' ' HD2' ' A' ' 86' ' ' ARG . 9.6 t70 -145.36 146.52 31.62 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 109.908 -0.404 . . . . 1.68 109.908 174.632 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.425 ' HD2' ' OD1' ' A' ' 85' ' ' ASP . 0.8 OUTLIER -73.84 -23.26 59.61 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 111.592 0.219 . . . . 4.24 111.592 -176.524 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -63.04 -50.3 71.19 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.03 0.443 . . . . 1.33 110.42 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 13.2 m -67.57 -35.89 79.88 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.953 -0.567 . . . . 1.34 109.933 176.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.415 ' HB1' ' HA ' ' A' ' 86' ' ' ARG . . . -57.15 -45.83 83.27 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 114.789 -1.096 . . . . 1.16 110.651 176.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -56.5 -42.49 78.43 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.198 -0.455 . . . . 2.11 111.521 172.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.726 ' O ' ' HG3' ' A' ' 94' ' ' LYS . 12.9 mmt180 -68.11 -31.81 71.66 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.969 -0.56 . . . . 4.35 110.83 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -61.39 -38.33 86.67 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.603 -0.271 . . . . 1.21 111.651 171.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 37.0 t -86.58 -20.08 28.45 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 112.961 0.726 . . . . 1.16 112.961 -173.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.726 ' HG3' ' O ' ' A' ' 91' ' ' ARG . 0.0 OUTLIER -51.54 -19.44 1.47 Allowed 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 112.959 0.726 . . . . 4.58 112.959 177.337 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.691 ' N ' ' HD3' ' A' ' 94' ' ' LYS . 24.5 t0 -112.03 103.96 55.66 Favored Pre-proline 0 C--N 1.325 -0.491 0 N-CA-C 108.788 -0.819 . . . . 2.24 108.788 168.427 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 95' ' ' ASP . 3.6 Cg_exo -80.42 -13.32 12.3 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 123.241 2.628 . . . . 2.38 113.503 -172.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 52.7 m-80 -148.75 53.55 1.44 Allowed Pre-proline 0 C--O 1.236 0.38 0 O-C-N 122.383 -0.198 . . . . 3.61 111.278 -176.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . 0.533 ' O ' HG13 ' A' ' 100' ' ' ILE . 72.4 Cg_endo -82.81 113.14 2.17 Favored 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 120.739 0.959 . . . . 1.54 113.13 -175.298 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.428 HD11 ' CA ' ' A' ' 104' ' ' LYS . 12.7 mm -24.14 124.85 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-N 116.033 -0.53 . . . . 2.08 111.979 149.098 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.533 HG13 ' O ' ' A' ' 98' ' ' PRO . 75.2 mt -145.14 119.68 3.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 105.961 -1.866 . . . . 1.55 105.961 179.2 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.571 ' HB3' ' HG2' ' A' ' 43' ' ' PRO . 27.5 t0 55.21 50.64 14.69 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 122.637 1.208 . . . . 1.52 109.783 -174.443 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 71.42 -8.17 5.66 Favored Glycine 0 CA--C 1.53 1.006 0 N-CA-C 117.22 1.648 . . . . 1.73 117.22 176.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.488 ' HB2' ' HG3' ' A' ' 43' ' ' PRO . 2.0 mmm180 -116.22 142.07 47.31 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 120.59 2.195 . . . . 4.66 111.83 176.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.428 ' CA ' HD11 ' A' ' 99' ' ' ILE . 41.1 ttmt -64.64 124.08 20.96 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.896 -0.593 . . . . 3.14 110.57 176.432 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -102.0 162.17 13.12 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.431 -0.349 . . . . 1.37 110.5 178.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.592 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 39.7 t-20 -114.78 127.79 55.93 Favored 'General case' 0 C--O 1.248 0.986 0 N-CA-C 109.48 -0.563 . . . . 2.18 109.48 179.338 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.552 HG21 HG23 ' A' ' 39' ' ' VAL . 88.3 t -138.85 123.19 20.66 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 O-C-N 125.056 1.473 . . . . 1.46 111.065 -163.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -156.62 151.97 26.59 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.324 -0.621 . . . . 3.22 109.324 175.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.515 ' HB3' ' CE1' ' A' ' 111' ' ' TYR . 1.3 mm? -57.37 96.28 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.063 0.459 . . . . 1.87 111.238 176.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.822 ' HB2' ' HG3' ' A' ' 36' ' ' LYS . . . -45.19 -33.16 2.16 Favored 'General case' 0 C--O 1.224 -0.245 0 N-CA-C 115.654 1.724 . . . . 1.3 115.654 -176.378 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.515 ' CE1' ' HB3' ' A' ' 109' ' ' LEU . 9.1 p90 . . . . . 0 N--CA 1.473 0.705 0 N-CA-C 112.662 0.615 . . . . 1.71 112.662 -169.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 49.3 ttp . . . . . 0 CA--C 1.531 0.236 0 CA-C-O 121.38 0.61 . . . . 1.9 110.418 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.457 ' C ' ' H ' ' A' ' 36' ' ' LYS . 21.4 m-85 -52.68 -71.62 0.07 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.716 -1.129 . . . . 1.76 111.575 176.492 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.612 ' HB ' ' O ' ' A' ' 83' ' ' MET . 34.5 p -53.26 18.17 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 116.542 2.053 . . . . 1.23 116.542 178.339 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.457 ' H ' ' C ' ' A' ' 34' ' ' PHE . 41.8 tptt -116.32 113.16 22.57 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 119.52 1.055 . . . . 3.2 111.205 -178.268 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 84.8 mt -103.06 131.15 52.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-N 115.147 -0.933 . . . . 1.46 110.681 -179.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.501 ' HB2' ' HA ' ' A' ' 110' ' ' ALA . 70.2 t80 -91.92 119.74 31.96 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 109.102 -0.703 . . . . 0.81 109.102 175.336 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.585 HG13 HD12 ' A' ' 42' ' ' LEU . 3.9 t -102.31 135.32 39.89 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 N-CA-C 108.315 -0.995 . . . . 1.61 108.315 -179.351 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -141.72 153.79 24.38 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.291 -0.957 . . . . 1.39 112.093 -169.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 70.21 34.96 69.86 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.705 -0.76 . . . . 0.71 112.518 176.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.634 HD21 ' CG2' ' A' ' 46' ' ' THR . 7.2 mp -75.08 142.93 76.54 Favored Pre-proline 0 C--N 1.328 -0.35 0 N-CA-C 109.88 -0.415 . . . . 1.89 109.88 178.058 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.461 ' HG3' ' HB3' ' A' ' 103' ' ' ARG . 28.0 Cg_endo -68.63 158.61 57.03 Favored 'Trans proline' 0 N--CA 1.451 -1.016 0 C-N-CA 121.862 1.708 . . . . 0.82 110.736 173.659 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.518 ' HD1' ' OG ' ' A' ' 75' ' ' SER . 59.7 m-85 -64.96 0.15 1.33 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.771 0.656 . . . . 1.46 112.771 -173.256 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 84.3 t60 -110.37 -6.44 14.98 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.695 0.283 . . . . 2.65 111.441 -178.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.634 ' CG2' HD21 ' A' ' 42' ' ' LEU . 25.7 m -77.75 137.88 38.71 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.611 -0.436 . . . . 1.31 111.094 -179.544 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 10.4 p -131.73 -177.58 4.49 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.777 -0.647 . . . . 0.75 109.961 -179.005 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.402 ' OD2' ' HA ' ' A' ' 65' ' ' VAL . 1.8 m-20 -61.5 -49.4 76.92 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 122.165 0.983 . . . . 0.49 108.871 -175.503 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.719 ' O ' ' HG2' ' A' ' 53' ' ' GLU . 22.9 pttm -53.1 -33.78 53.73 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 113.229 -1.805 . . . . 3.26 111.13 175.333 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.477 ' HB ' HG21 ' A' ' 46' ' ' THR . 5.0 m -68.11 -44.6 75.8 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.028 0.442 . . . . 1.25 110.193 178.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.513 HD22 HG12 ' A' ' 39' ' ' VAL . 33.3 mt -62.97 -44.48 95.93 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-N 115.985 -0.552 . . . . 1.53 110.48 176.492 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.646 ' O ' ' HB2' ' A' ' 56' ' ' GLU . 45.2 t-80 -56.29 -37.24 69.61 Favored 'General case' 0 C--O 1.216 -0.679 0 CA-C-N 116.096 -0.502 . . . . 0.77 110.641 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.719 ' HG2' ' O ' ' A' ' 49' ' ' LYS . 25.8 mm-40 -74.15 -40.44 62.59 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.311 -0.404 . . . . 1.52 111.781 -174.695 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.499 ' O ' ' HB2' ' A' ' 57' ' ' GLN . 2.9 t80 -77.66 -33.7 53.33 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.782 0.801 . . . . 1.6 110.293 -177.215 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.662 ' HB2' HD12 ' A' ' 61' ' ' ILE . 40.4 m-85 -85.89 -25.82 25.95 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.013 -0.994 . . . . 0.68 111.423 -174.642 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.646 ' HB2' ' O ' ' A' ' 52' ' ' HIS . 3.2 tp10 -62.09 -4.4 1.67 Allowed 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 122.266 1.031 . . . . 1.57 110.428 174.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.523 ' H ' ' C ' ' A' ' 55' ' ' PHE . 82.5 mt-30 -88.51 -30.7 19.15 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 114.251 -1.34 . . . . 2.79 110.431 -177.248 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.596 ' CG ' ' HA ' ' A' ' 92' ' ' ALA . 68.4 m-85 -90.75 -8.91 48.49 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.997 -1.001 . . . . 0.79 110.662 -175.276 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 142.83 174.33 15.12 Favored Glycine 0 N--CA 1.441 -1.015 0 N-CA-C 111.139 -0.785 . . . . 0.75 111.139 -179.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.655 ' HB3' ' HD2' ' A' ' 84' ' ' LYS . 3.0 m-20 -49.23 121.82 5.33 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.319 0.581 . . . . 1.02 111.798 176.314 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.662 HD12 ' HB2' ' A' ' 55' ' ' PHE . 85.0 mt -91.59 144.7 8.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 107.059 -1.46 . . . . 1.13 107.059 171.609 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -94.71 -45.09 7.5 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 119.054 0.843 . . . . 2.07 108.872 179.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -154.01 123.91 6.79 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.358 -0.837 . . . . 2.48 109.866 176.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -112.47 127.9 56.18 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.789 0.328 . . . . 1.18 110.741 175.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.402 ' HA ' ' OD2' ' A' ' 48' ' ' ASP . 8.1 p -144.52 137.75 22.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.636 -0.711 . . . . 1.97 111.74 -175.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.532 HG13 HG21 ' A' ' 68' ' ' THR . 54.6 t -104.62 117.31 50.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 108.681 -0.859 . . . . 1.12 108.681 172.153 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.616 ' O ' ' HD3' ' A' ' 76' ' ' ARG . 47.7 mm -76.88 72.38 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 122.084 0.945 . . . . 1.44 111.235 -173.348 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.541 HG23 ' HA ' ' A' ' 75' ' ' SER . 38.5 p . . . . . 0 N--CA 1.433 -1.315 0 CA-C-N 114.627 -1.17 . . . . 1.83 109.757 164.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.541 ' HA ' HG23 ' A' ' 68' ' ' THR . 5.6 p . . . . . 0 CA--C 1.52 -0.197 0 CA-C-O 122.255 1.026 . . . . 2.07 112.218 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.616 ' HD3' ' O ' ' A' ' 67' ' ' ILE . 41.1 mtp180 -87.3 1.35 53.49 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 113.937 -1.483 . . . . 3.07 111.064 -168.736 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 69.64 14.58 70.0 Favored Glycine 0 N--CA 1.447 -0.626 0 CA-C-N 115.785 -0.643 . . . . 0.75 113.084 177.078 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.479 ' O ' HG11 ' A' ' 66' ' ' VAL . 13.8 m-85 -118.68 156.1 29.87 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 116.879 0.339 . . . . 1.61 110.979 -177.185 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -148.2 179.16 25.28 Favored Glycine 0 N--CA 1.444 -0.808 0 CA-C-N 115.967 -0.56 . . . . 0.59 111.792 173.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.429 ' CE1' ' HD1' ' A' ' 38' ' ' PHE . 41.3 m-85 -156.04 123.71 5.56 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 123.604 0.762 . . . . 0.84 109.488 -179.444 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 70.4 t -120.95 127.04 75.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-O 120.811 0.339 . . . . 1.21 110.433 -178.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 13.4 m -104.06 114.85 29.38 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.883 -0.784 . . . . 1.09 108.883 177.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.612 ' O ' ' HB ' ' A' ' 35' ' ' THR . 93.0 mmm -90.68 133.1 35.39 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 120.9 -0.32 . . . . 1.02 110.719 -178.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.655 ' HD2' ' HB3' ' A' ' 60' ' ' ASP . 46.9 mttm -51.04 -6.24 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 114.614 1.339 . . . . 2.47 114.614 174.136 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -160.46 155.49 24.49 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.774 -0.454 . . . . 1.68 109.774 174.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.554 ' HD3' ' H ' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -75.41 -33.02 60.93 Favored 'General case' 0 C--O 1.224 -0.242 0 N-CA-C 108.279 -1.008 . . . . 4.24 108.279 179.49 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -47.71 -48.63 29.38 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.391 -1.277 . . . . 1.33 110.126 168.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 19.7 m -69.33 -27.97 65.83 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.166 -0.47 . . . . 1.34 111.326 179.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -70.19 -50.13 43.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.451 . . . . 1.16 110.482 177.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -55.49 -32.48 62.87 Favored 'General case' 0 C--O 1.222 -0.384 0 CA-C-N 116.101 -0.499 . . . . 2.11 110.732 172.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.574 ' O ' ' HG3' ' A' ' 94' ' ' LYS . 13.4 mtp180 -70.33 -51.42 30.23 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.859 -1.064 . . . . 4.35 110.723 179.522 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . 0.596 ' HA ' ' CG ' ' A' ' 58' ' ' PHE . . . -56.06 -46.72 78.85 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 113.992 1.108 . . . . 1.21 113.992 171.626 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 48.9 t -74.57 -42.47 58.69 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 120.974 -0.291 . . . . 1.16 111.531 -172.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.574 ' HG3' ' O ' ' A' ' 91' ' ' ARG . 1.2 pptp? -49.57 -9.77 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 113.105 0.78 . . . . 4.58 113.105 173.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -101.8 90.92 2.07 Favored Pre-proline 0 CA--C 1.534 0.343 0 N-CA-C 108.589 -0.893 . . . . 2.24 108.589 162.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.481 ' HD3' ' O ' ' A' ' 94' ' ' LYS . 2.9 Cg_exo -76.18 111.97 3.38 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.979 2.453 . . . . 2.38 113.016 -170.653 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.425 ' HB2' ' O ' ' A' ' 96' ' ' PRO . 92.7 m-20 79.23 69.65 0.17 Allowed Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 114.527 -1.215 . . . . 3.61 110.111 175.349 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . 0.422 ' HB2' ' CE1' ' A' ' 54' ' ' TYR . 72.7 Cg_endo -76.23 146.42 28.39 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.534 2.156 . . . . 1.54 111.065 178.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.552 HG23 ' C ' ' A' ' 102' ' ' GLY . 14.6 mm -88.33 92.41 3.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 O-C-N 122.155 -0.341 . . . . 2.08 110.24 -172.7 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.635 ' C ' ' H ' ' A' ' 102' ' ' GLY . 15.9 mt -92.05 151.24 3.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-O 121.548 0.69 . . . . 1.55 112.279 -174.307 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.594 ' H ' HG23 ' A' ' 100' ' ' ILE . 25.3 t0 35.02 17.83 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 CA-C-N 114.489 -1.232 . . . . 1.52 112.872 -152.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.635 ' H ' ' C ' ' A' ' 100' ' ' ILE . . . 89.48 19.82 47.43 Favored Glycine 0 CA--C 1.529 0.929 0 CA-C-N 115.757 -0.656 . . . . 1.73 111.674 178.722 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.461 ' HB3' ' HG3' ' A' ' 43' ' ' PRO . 31.9 tpt180 -127.82 135.73 50.48 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.747 0.819 . . . . 4.66 108.989 174.033 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.406 ' HA ' ' HA ' ' A' ' 99' ' ' ILE . 33.9 ttpt -58.0 114.92 2.56 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.461 0.541 . . . . 3.14 112.461 -174.327 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -99.67 164.66 11.96 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.186 -0.915 . . . . 1.37 110.225 177.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 37.8 t30 -107.93 131.7 54.26 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.454 -0.339 . . . . 2.18 110.154 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 41.1 t -122.38 129.12 75.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.32 0.581 . . . . 1.46 112.003 -179.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -150.01 158.08 43.8 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.084 -0.962 . . . . 3.22 108.405 175.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.669 HD22 ' CE1' ' A' ' 111' ' ' TYR . 1.0 OUTLIER -73.24 124.67 26.11 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 121.594 -0.691 . . . . 1.87 111.461 -177.029 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.501 ' HA ' ' HB2' ' A' ' 38' ' ' PHE . . . -47.23 -47.3 24.61 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.375 -1.284 . . . . 1.3 113.026 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.669 ' CE1' HD22 ' A' ' 109' ' ' LEU . 0.8 OUTLIER . . . . . 0 C--N 1.33 -0.251 0 CA-C-O 121.571 0.701 . . . . 1.71 110.055 -178.257 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' MET . . . . . 0.413 ' HE1' ' HB3' ' A' ' 33' ' ' MET . 12.5 tmm? . . . . . 0 CA--C 1.532 0.278 0 CA-C-O 120.621 0.248 . . . . 1.9 110.963 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -98.1 -46.43 5.87 Favored 'General case' 0 CA--C 1.527 0.077 0 O-C-N 122.225 -0.297 . . . . 1.76 111.312 177.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.569 ' O ' ' HA ' ' A' ' 82' ' ' THR . 63.3 p -68.78 1.63 3.16 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 113.755 1.021 . . . . 1.23 113.755 -176.162 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 58.0 tttt -97.99 107.9 20.49 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.995 0.426 . . . . 3.2 110.117 -175.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.435 HD12 ' HA ' ' A' ' 89' ' ' ALA . 47.1 mt -109.38 136.3 45.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.781 -0.645 . . . . 1.46 111.148 -175.382 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -101.25 118.41 36.93 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.878 -0.601 . . . . 0.81 109.698 174.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.628 HG11 HG23 ' A' ' 107' ' ' VAL . 30.3 t -133.75 110.63 14.55 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.848 0 CA-C-O 117.85 -1.071 . . . . 1.61 110.977 -177.182 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.423 ' HA2' ' CD2' ' A' ' 42' ' ' LEU . . . -116.68 -156.76 10.73 Favored Glycine 0 CA--C 1.503 -0.706 1 C-N-CA 112.341 -4.742 . . . . 1.39 114.835 156.049 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.473 ' HA3' ' HA ' ' A' ' 105' ' ' ALA . . . 92.42 5.07 65.58 Favored Glycine 0 N--CA 1.442 -0.903 0 N-CA-C 110.211 -1.156 . . . . 0.71 110.211 -171.466 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.709 HD13 HD22 ' A' ' 51' ' ' LEU . 3.0 mm? -71.99 121.4 84.5 Favored Pre-proline 0 N--CA 1.45 -0.44 0 CA-C-N 115.06 -0.57 . . . . 1.89 109.931 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.776 ' HG3' ' HD3' ' A' ' 103' ' ' ARG . 88.8 Cg_exo -48.21 160.01 0.61 Allowed 'Trans proline' 0 CA--C 1.529 0.274 0 C-N-CA 124.198 3.266 . . . . 0.82 113.968 177.22 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -71.26 -6.94 43.52 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.704 -0.68 . . . . 1.46 112.688 -174.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 7.6 p-80 -112.85 10.29 19.07 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 121.788 -0.57 . . . . 2.65 110.921 171.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.555 HG21 ' HB ' ' A' ' 50' ' ' THR . 52.0 m -79.62 123.75 27.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.099 -0.5 . . . . 1.31 110.438 174.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 60.3 p -105.72 175.2 5.57 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.264 -0.425 . . . . 0.75 110.577 -178.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.502 ' HB3' ' O ' ' A' ' 64' ' ' ALA . 2.9 m-20 -57.44 -30.56 65.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.571 0.701 . . . . 0.49 110.124 176.691 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.672 ' O ' ' HG2' ' A' ' 53' ' ' GLU . 0.5 OUTLIER -78.71 -29.59 45.52 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.422 -0.808 . . . . 3.26 110.828 -179.389 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.555 ' HB ' HG21 ' A' ' 46' ' ' THR . 14.5 m -61.95 -41.98 98.6 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.98 0.419 . . . . 1.25 110.379 176.454 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.709 HD22 HD13 ' A' ' 42' ' ' LEU . 16.0 mt -67.65 -37.16 82.03 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-N 116.189 -0.46 . . . . 1.53 110.334 174.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.437 ' HA ' HD13 ' A' ' 61' ' ' ILE . 60.5 t-80 -57.05 -47.4 81.05 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.723 -0.672 . . . . 0.77 109.848 175.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.672 ' HG2' ' O ' ' A' ' 49' ' ' LYS . 23.6 mm-40 -57.54 -47.25 82.52 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.976 -0.556 . . . . 1.52 111.521 178.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.477 ' O ' ' HB2' ' A' ' 57' ' ' GLN . 20.9 t80 -76.75 -34.83 58.05 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.591 0.589 . . . . 1.6 112.591 -172.172 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.409 ' CE1' HD23 ' A' ' 51' ' ' LEU . 22.5 m-85 -85.03 -25.17 27.83 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 114.391 1.256 . . . . 0.68 114.391 -173.339 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.574 ' N ' HD12 ' A' ' 61' ' ' ILE . 11.0 pt-20 -67.06 -12.52 60.16 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 122.351 1.072 . . . . 1.57 109.722 177.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.685 ' HA ' HE21 ' A' ' 57' ' ' GLN . 0.0 OUTLIER -56.15 -31.31 63.25 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 113.937 -1.483 . . . . 2.79 111.506 169.001 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -96.92 4.87 51.38 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.466 -0.334 . . . . 0.79 111.737 -176.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 142.2 -133.76 5.8 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.548 -0.834 . . . . 0.75 112.516 -176.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -114.29 124.38 51.86 Favored 'General case' 0 C--N 1.322 -0.599 0 O-C-N 122.567 -0.372 . . . . 1.02 110.475 -179.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.574 HD12 ' N ' ' A' ' 56' ' ' GLU . 7.5 mt -93.23 125.87 45.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 109.579 -0.526 . . . . 1.13 109.579 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -78.48 -38.8 40.09 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.019 0.438 . . . . 2.07 110.753 176.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -157.22 136.37 11.87 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.149 -0.478 . . . . 2.48 111.34 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.502 ' O ' ' HB3' ' A' ' 48' ' ' ASP . . . -121.28 123.4 42.1 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 115.781 -0.645 . . . . 1.18 109.396 174.039 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 8.9 p -135.52 135.17 51.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 114.893 -1.048 . . . . 1.97 112.191 -176.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 98.1 t -102.83 131.76 50.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.356 -0.838 . . . . 1.12 109.386 173.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.462 HG12 ' HA2' ' A' ' 79' ' ' GLY . 44.6 mm -83.61 92.28 2.83 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.625 0 CA-C-O 121.478 0.656 . . . . 1.44 109.665 -179.284 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 31.7 p . . . . . 0 N--CA 1.436 -1.137 0 CA-C-N 115.023 -0.99 . . . . 1.83 110.757 -179.6 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.508 ' O ' ' HB2' ' A' ' 76' ' ' ARG . 8.4 m . . . . . 0 N--CA 1.468 0.451 0 N-CA-C 112.879 0.696 . . . . 2.07 112.879 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.508 ' HB2' ' O ' ' A' ' 75' ' ' SER . 96.5 mtt180 74.57 -55.3 0.66 Allowed 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.329 0.652 . . . . 3.07 110.508 -169.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 103.97 19.24 12.07 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.841 -0.695 . . . . 0.75 113.142 175.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -123.85 157.28 34.53 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.215 -1.031 . . . . 1.61 108.215 177.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.462 ' HA2' HG12 ' A' ' 67' ' ' ILE . . . -159.23 -164.66 14.89 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 119.769 -1.205 . . . . 0.59 112.647 175.742 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -151.3 134.83 16.24 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.731 -0.84 . . . . 0.84 108.731 -177.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.402 HG12 ' CD2' ' A' ' 55' ' ' PHE . 53.7 t -122.36 120.07 60.06 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 N-CA-C 109.938 -0.393 . . . . 1.21 109.938 177.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.569 ' HA ' ' O ' ' A' ' 35' ' ' THR . 17.9 m -109.81 115.68 30.28 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 108.51 -0.922 . . . . 1.09 108.51 177.646 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 83.1 mmm -88.79 163.8 15.53 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 108.898 -0.778 . . . . 1.02 108.898 -176.163 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 20.7 ttmm -83.3 -10.94 58.21 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.099 0.476 . . . . 2.47 110.683 -178.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -145.67 146.64 31.38 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 116.232 -0.44 . . . . 1.68 110.616 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 4.3 tmm_? -71.39 -22.81 61.83 Favored 'General case' 0 C--O 1.223 -0.3 0 N-CA-C 112.845 0.683 . . . . 4.24 112.845 -177.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.26 -43.94 89.68 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 118.649 0.659 . . . . 1.33 110.392 177.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 8.7 m -64.55 -39.23 93.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.699 0.761 . . . . 1.34 109.881 175.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.435 ' HA ' HD12 ' A' ' 37' ' ' ILE . . . -59.41 -49.79 76.45 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.028 -1.442 . . . . 1.16 110.609 178.326 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -54.98 -49.16 72.13 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.55 -0.75 . . . . 2.11 111.826 175.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.612 ' O ' ' HB3' ' A' ' 94' ' ' LYS . 2.6 ttm-85 -61.85 -41.02 97.31 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.295 -0.412 . . . . 4.35 110.773 -177.25 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -63.56 -43.84 95.87 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.996 -0.547 . . . . 1.21 111.73 176.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 45.2 t -75.2 -6.9 52.14 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 121.337 0.589 . . . . 1.16 110.659 178.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.612 ' HB3' ' O ' ' A' ' 91' ' ' ARG . 2.9 tppp? -76.96 -37.94 54.26 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.285 -0.87 . . . . 4.58 110.016 177.402 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -108.33 91.58 8.47 Favored Pre-proline 0 C--N 1.326 -0.441 0 N-CA-C 109.358 -0.608 . . . . 2.24 109.358 172.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.558 ' HA ' ' HB ' ' A' ' 107' ' ' VAL . 59.4 Cg_endo -90.17 -6.54 4.62 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 123.1 2.533 . . . . 2.38 114.144 -169.18 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.456 ' N ' ' HD3' ' A' ' 98' ' ' PRO . 3.4 p-10 -132.76 60.86 53.02 Favored Pre-proline 0 C--N 1.328 -0.337 0 N-CA-C 112.306 0.484 . . . . 3.61 112.306 -177.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . 0.456 ' HD3' ' N ' ' A' ' 97' ' ' ASN . 1.8 Cg_endo -81.38 151.73 17.72 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.795 2.33 . . . . 1.54 111.73 -179.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 35.9 mm -95.06 90.37 2.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.287 0.565 . . . . 2.08 110.302 179.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 57.6 mt -90.85 108.34 19.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.841 -0.618 . . . . 1.55 111.847 177.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.679 ' HB3' ' HG2' ' A' ' 43' ' ' PRO . 25.2 t70 65.31 44.17 3.3 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 122.813 1.292 . . . . 1.52 109.3 173.345 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 80.39 -9.03 51.15 Favored Glycine 0 N--CA 1.445 -0.712 0 CA-C-N 114.412 -1.267 . . . . 1.73 113.579 176.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.776 ' HD3' ' HG3' ' A' ' 43' ' ' PRO . 7.4 mpt_? -107.09 131.09 54.5 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 117.74 0.77 . . . . 4.66 111.623 176.524 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 26.3 ttpp -67.18 134.51 51.86 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.366 -0.834 . . . . 3.14 109.032 169.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.473 ' HA ' ' HA3' ' A' ' 41' ' ' GLY . . . -111.25 150.38 29.68 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 116.232 -0.44 . . . . 1.37 109.964 -175.582 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -108.15 106.18 16.26 Favored 'General case' 0 C--O 1.264 1.857 0 CA-C-O 121.556 0.694 . . . . 2.18 110.053 174.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.628 HG23 HG11 ' A' ' 39' ' ' VAL . 47.4 t -101.67 138.53 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 CA-C-N 112.876 -1.965 . . . . 1.46 111.451 174.317 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 32.8 m-80 -151.86 153.02 33.37 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.428 -0.953 . . . . 3.22 108.428 172.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.534 HD11 ' H ' ' A' ' 110' ' ' ALA . 0.2 OUTLIER -63.25 150.3 43.46 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.402 -0.962 . . . . 1.87 108.402 172.876 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.534 ' H ' HD11 ' A' ' 109' ' ' LEU . . . -74.67 -40.28 61.51 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.081 -0.647 . . . . 1.3 110.36 -167.361 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.53 0.206 0 CA-C-N 114.97 -1.014 . . . . 1.71 112.654 -172.221 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' MET . . . . . 0.587 ' HG3' ' H ' ' A' ' 34' ' ' PHE . 22.5 ptm . . . . . 0 CA--C 1.528 0.099 0 N-CA-C 107.695 -1.224 . . . . 1.9 107.695 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.587 ' H ' ' HG3' ' A' ' 33' ' ' MET . 26.0 m-85 -88.17 -179.97 6.26 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 113.712 -1.586 . . . . 1.76 108.62 170.173 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.72 ' HB ' ' O ' ' A' ' 83' ' ' MET . 14.0 p 65.37 -0.46 1.16 Allowed 'General case' 0 N--CA 1.472 0.637 0 O-C-N 124.065 0.853 . . . . 1.23 112.642 174.588 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 33.0 ttpt -121.89 110.21 15.58 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.136 0.494 . . . . 3.2 110.248 -176.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.617 HD12 ' HA ' ' A' ' 89' ' ' ALA . 3.8 mp -96.3 130.02 45.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.972 -0.558 . . . . 1.46 110.575 -179.292 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -85.77 108.29 18.02 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 108.559 -0.904 . . . . 0.81 108.559 172.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.3 t -95.95 137.03 25.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 N-CA-C 108.074 -1.084 . . . . 1.61 108.074 179.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -140.42 138.09 8.78 Favored Glycine 0 N--CA 1.442 -0.94 0 C-N-CA 119.577 -1.297 . . . . 1.39 111.767 -170.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 96.43 16.36 37.53 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.582 -0.818 . . . . 0.71 112.84 177.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.563 HD13 HD22 ' A' ' 51' ' ' LEU . 2.8 mm? -64.94 124.16 85.81 Favored Pre-proline 0 C--O 1.234 0.246 0 N-CA-C 109.304 -0.628 . . . . 1.89 109.304 177.006 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.569 ' HG2' ' HB3' ' A' ' 101' ' ' ASP . 52.9 Cg_exo -50.58 154.38 6.53 Favored 'Trans proline' 0 CA--C 1.529 0.252 0 C-N-CA 122.91 2.407 . . . . 0.82 111.88 173.733 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -65.76 -7.22 14.6 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.847 0.356 . . . . 1.46 111.61 -178.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 76.9 t60 -101.14 -6.43 24.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.188 0.518 . . . . 2.65 110.222 177.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.536 HG22 HD11 ' A' ' 42' ' ' LEU . 77.5 m -78.72 142.42 37.09 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 116.259 -0.428 . . . . 1.31 109.922 177.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 12.1 p -132.14 -178.77 5.05 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.028 0.442 . . . . 0.75 111.161 -175.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.584 ' OD2' ' HA ' ' A' ' 65' ' ' VAL . 2.4 m-20 -67.31 -48.18 68.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.862 0.839 . . . . 0.49 109.06 -176.423 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.583 ' O ' ' HG2' ' A' ' 53' ' ' GLU . 22.8 pttp -52.52 -35.38 53.14 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 113.908 -1.496 . . . . 3.26 111.149 175.38 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 22.9 m -67.2 -45.76 75.9 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.854 0.359 . . . . 1.25 111.279 179.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.563 HD22 HD13 ' A' ' 42' ' ' LEU . 31.1 mt -67.33 -35.67 79.9 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.485 -0.325 . . . . 1.53 110.805 178.602 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.43 ' HA ' ' CD1' ' A' ' 61' ' ' ILE . 63.9 t-80 -57.3 -38.3 73.77 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.644 -0.502 . . . . 0.77 109.644 175.666 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.583 ' HG2' ' O ' ' A' ' 49' ' ' LYS . 82.3 mm-40 -68.18 -39.84 82.42 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.242 -0.89 . . . . 1.52 110.467 -177.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.642 ' O ' ' HB2' ' A' ' 57' ' ' GLN . 2.2 t80 -78.44 -34.33 47.87 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.566 0.698 . . . . 1.6 111.607 -177.282 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.451 ' CE1' HD23 ' A' ' 51' ' ' LEU . 28.7 m-85 -86.4 -25.63 25.19 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 113.086 0.772 . . . . 0.68 113.086 -172.124 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -71.98 -1.53 14.87 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 122.336 1.065 . . . . 1.57 109.619 174.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.642 ' HB2' ' O ' ' A' ' 54' ' ' TYR . 88.9 mt-30 -86.28 -10.6 54.22 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.092 -1.413 . . . . 2.79 109.96 176.223 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.415 ' HD2' ' HA ' ' A' ' 55' ' ' PHE . 78.8 m-85 -109.86 -51.2 2.9 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.395 -0.821 . . . . 0.79 111.118 -178.332 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -163.92 -135.75 1.87 Allowed Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.274 -0.965 . . . . 0.75 112.006 179.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.419 ' HB3' ' HE3' ' A' ' 84' ' ' LYS . 1.0 OUTLIER -98.22 132.88 43.35 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.803 0.335 . . . . 1.02 110.235 -179.902 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.43 ' CD1' ' HA ' ' A' ' 52' ' ' HIS . 66.0 mt -105.83 139.89 25.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 107.87 -1.159 . . . . 1.13 107.87 174.621 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -97.99 -41.21 8.09 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 107.933 -1.136 . . . . 2.07 107.933 177.099 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -165.48 127.03 1.98 Allowed 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 115.458 -0.792 . . . . 2.48 110.267 177.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.417 ' O ' ' HB3' ' A' ' 48' ' ' ASP . . . -106.04 127.27 53.06 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.272 -0.64 . . . . 1.18 109.272 174.533 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.584 ' HA ' ' OD2' ' A' ' 48' ' ' ASP . 5.0 m -138.1 119.63 17.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.472 0.653 . . . . 1.97 112.649 -175.268 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 91.7 t -86.99 122.06 38.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.381 -0.827 . . . . 1.12 109.553 174.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 39.8 mm -71.69 139.34 19.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.34 0.59 . . . . 1.44 112.16 -176.021 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 35.2 p . . . . . 0 N--CA 1.438 -1.049 0 CA-C-N 115.265 -0.88 . . . . 1.83 109.53 176.558 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.8 m . . . . . 0 CA--C 1.531 0.249 0 N-CA-C 112.712 0.634 . . . . 2.07 112.712 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 60.2 mtp180 -98.15 -10.22 24.51 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.947 -0.57 . . . . 3.07 110.92 -175.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 86.89 13.77 66.13 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.596 -0.811 . . . . 0.75 112.462 -178.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -122.85 162.44 22.17 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.59 -0.893 . . . . 1.61 108.59 178.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -173.77 145.19 8.07 Favored Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 120.148 -1.025 . . . . 0.59 112.211 178.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -104.06 142.17 34.93 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.419 0.628 . . . . 0.84 111.258 176.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 49.8 t -117.99 106.02 19.01 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 CA-C-N 115.239 -0.891 . . . . 1.21 109.483 173.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 8.3 m -76.92 117.33 18.41 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.883 -0.598 . . . . 1.09 109.968 174.002 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.72 ' O ' ' HB ' ' A' ' 35' ' ' THR . 28.1 mtp -103.31 134.85 46.02 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.74 -0.467 . . . . 1.02 109.74 179.069 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.419 ' HE3' ' HB3' ' A' ' 60' ' ' ASP . 19.1 ttmt -51.73 -6.14 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 114.87 1.433 . . . . 2.47 114.87 -179.679 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.459 ' C ' HG23 ' A' ' 35' ' ' THR . 7.2 t70 -162.53 156.68 21.21 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 118.871 0.76 . . . . 1.68 111.323 177.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.656 ' N ' HG23 ' A' ' 35' ' ' THR . 2.5 tmm_? -75.02 -34.8 61.94 Favored 'General case' 0 C--O 1.22 -0.48 0 N-CA-C 108.461 -0.94 . . . . 4.24 108.461 -177.279 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -52.71 -42.4 64.82 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.026 -0.988 . . . . 1.33 110.95 172.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 5.5 m -69.55 -31.95 70.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.072 0.463 . . . . 1.34 110.381 176.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.617 ' HA ' HD12 ' A' ' 37' ' ' ILE . . . -67.62 -50.43 58.11 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.599 -0.728 . . . . 1.16 110.819 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.58 ' O ' ' HG2' ' A' ' 94' ' ' LYS . 6.0 mt-10 -57.72 -32.77 67.74 Favored 'General case' 0 C--O 1.224 -0.283 0 CA-C-N 115.832 -0.622 . . . . 2.11 110.537 174.547 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.401 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 13.3 tpp180 -64.15 -51.72 62.48 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.325 -0.852 . . . . 4.35 109.922 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -53.57 -32.1 49.45 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 113.461 0.912 . . . . 1.21 113.461 172.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 46.5 t -80.25 -34.57 36.99 Favored 'General case' 0 C--N 1.328 -0.363 0 O-C-N 121.894 -0.504 . . . . 1.16 110.609 178.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.58 ' HG2' ' O ' ' A' ' 90' ' ' GLU . 12.2 mmmm -48.23 -30.7 4.98 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 114.733 -1.121 . . . . 4.58 111.838 175.168 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -103.18 102.77 30.52 Favored Pre-proline 0 C--N 1.326 -0.438 0 N-CA-C 108.893 -0.78 . . . . 2.24 108.893 167.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -77.15 173.65 14.06 Favored 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 122.608 2.205 . . . . 2.38 113.761 -169.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.495 ' ND2' ' HA ' ' A' ' 106' ' ' ASN . 12.4 m120 -15.98 91.13 0.04 OUTLIER Pre-proline 0 N--CA 1.481 1.092 0 C-N-CA 125.462 1.505 . . . . 3.61 114.126 -174.473 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -82.27 164.85 16.96 Favored 'Trans proline' 0 C--O 1.235 0.346 0 C-N-CA 123.408 2.739 . . . . 1.54 113.202 -179.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 41.1 mm -94.72 109.79 22.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.445 -0.798 . . . . 2.08 110.329 174.126 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 54.9 mt -114.22 115.65 50.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.017 -0.538 . . . . 1.55 110.251 178.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.569 ' HB3' ' HG2' ' A' ' 43' ' ' PRO . 28.0 t70 50.71 54.53 11.04 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 113.071 0.767 . . . . 1.52 113.071 169.281 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 74.75 21.72 78.17 Favored Glycine 0 N--CA 1.454 -0.12 0 C-N-CA 120.375 -0.917 . . . . 1.73 113.121 176.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.434 ' HB2' ' HG3' ' A' ' 43' ' ' PRO . 0.2 OUTLIER -145.66 160.11 42.17 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.9 -0.407 . . . . 4.66 109.9 179.207 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 2.1 ttmp? -101.79 149.23 24.39 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 107.751 -1.203 . . . . 3.14 107.751 169.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -116.85 141.48 48.17 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 120.674 -0.41 . . . . 1.37 110.103 -174.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.495 ' HA ' ' ND2' ' A' ' 97' ' ' ASN . 91.5 m-20 -94.23 123.8 37.85 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.268 -0.641 . . . . 2.18 109.268 175.453 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.551 HG11 HG22 ' A' ' 37' ' ' ILE . 97.9 t -119.72 114.92 45.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.247 -0.888 . . . . 1.46 110.219 179.353 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -156.48 171.32 20.49 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.506 -0.77 . . . . 3.22 110.254 -179.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.522 ' HB3' ' CD1' ' A' ' 111' ' ' TYR . 3.2 mm? -78.38 115.09 17.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.513 0.673 . . . . 1.87 111.415 -176.531 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -43.92 -35.83 2.17 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 113.949 -1.478 . . . . 1.3 113.987 -179.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.522 ' CD1' ' HB3' ' A' ' 109' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.467 0.395 0 O-C-N 121.69 -0.631 . . . . 1.71 112.311 -174.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' MET . . . . . 0.425 ' HE3' ' HB3' ' A' ' 33' ' ' MET . 41.8 ttp . . . . . 0 CA--C 1.533 0.318 0 N-CA-C 111.987 0.366 . . . . 1.9 111.987 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -93.71 23.8 4.51 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.924 0.712 . . . . 1.76 112.924 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.498 ' O ' ' HA ' ' A' ' 82' ' ' THR . 70.5 p -149.49 19.45 0.93 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 118.726 0.693 . . . . 1.23 110.338 -171.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 5.8 ttpm? -121.97 103.88 9.13 Favored 'General case' 0 CA--C 1.509 -0.608 0 C-N-CA 119.925 -0.71 . . . . 3.2 109.733 -167.284 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.539 HG21 HG11 ' A' ' 107' ' ' VAL . 65.2 mt -90.35 111.91 24.08 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 CA-C-N 115.403 -0.817 . . . . 1.46 109.548 179.496 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.638 ' HB2' ' HB3' ' A' ' 110' ' ' ALA . 69.8 t80 -83.36 108.48 16.58 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 107.907 -1.146 . . . . 0.81 107.907 175.27 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.405 ' HB ' HD22 ' A' ' 42' ' ' LEU . 4.1 t -95.85 87.94 1.96 Allowed 'Isoleucine or valine' 0 C--O 1.209 -1.046 0 CA-C-O 122.105 0.955 . . . . 1.61 109.05 -177.048 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -68.3 147.28 47.17 Favored Glycine 0 C--N 1.305 -1.16 0 C-N-CA 119.359 -1.401 . . . . 1.39 112.151 168.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.91 38.58 13.31 Favored Glycine 0 CA--C 1.523 0.546 0 C-N-CA 120.74 -0.743 . . . . 0.71 114.773 170.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.761 HD12 HD22 ' A' ' 51' ' ' LEU . 2.8 mm? -72.49 143.63 85.47 Favored Pre-proline 0 CA--C 1.514 -0.438 0 CA-C-N 117.934 0.867 . . . . 1.89 110.802 172.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.54 ' HG2' ' HB3' ' A' ' 101' ' ' ASP . 75.4 Cg_exo -52.49 145.13 38.44 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 122.401 2.067 . . . . 0.82 110.867 166.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 46.8 m-85 -60.46 -16.26 34.81 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 113.795 1.035 . . . . 1.46 113.795 -171.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 3.0 p-80 -111.2 18.24 19.52 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 119.674 -0.811 . . . . 2.65 111.97 176.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.584 HG21 ' HB ' ' A' ' 50' ' ' THR . 91.7 m -78.22 107.13 10.59 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 118.971 -1.092 . . . . 1.31 110.445 178.229 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 6.6 p -87.02 171.62 10.6 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 113.767 -1.56 . . . . 0.75 113.849 170.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -55.16 -43.29 74.1 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 113.923 -1.49 . . . . 0.49 110.19 -174.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.634 ' O ' ' HG2' ' A' ' 53' ' ' GLU . 60.0 pttt -54.86 -41.84 71.29 Favored 'General case' 0 C--O 1.224 -0.268 0 CA-C-N 115.165 -0.925 . . . . 3.26 110.687 176.431 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.584 ' HB ' HG21 ' A' ' 46' ' ' THR . 11.2 m -61.8 -43.18 99.35 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.494 -0.321 . . . . 1.25 110.823 -176.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.761 HD22 HD12 ' A' ' 42' ' ' LEU . 18.3 mt -69.94 -46.96 64.17 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.736 -0.385 . . . . 1.53 111.318 178.442 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.413 ' HA ' HD13 ' A' ' 61' ' ' ILE . 57.9 t-80 -53.2 -55.52 23.63 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.899 0.381 . . . . 0.77 111.314 176.59 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.634 ' HG2' ' O ' ' A' ' 49' ' ' LYS . 9.6 mm-40 -56.02 -52.81 62.9 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.805 -0.634 . . . . 1.52 111.301 179.641 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -53.05 -49.09 67.04 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 115.385 1.624 . . . . 1.6 115.385 175.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.511 ' CE1' HD23 ' A' ' 51' ' ' LEU . 28.5 m-85 -81.62 -33.45 31.45 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 114.173 1.175 . . . . 0.68 114.173 -165.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.669 ' H ' HD12 ' A' ' 61' ' ' ILE . 9.8 pt-20 -53.53 0.17 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 114.126 1.158 . . . . 1.57 114.126 171.719 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.477 ' H ' ' C ' ' A' ' 55' ' ' PHE . 37.3 mt-30 -67.33 -34.98 78.47 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 116.105 -0.498 . . . . 2.79 110.499 167.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.48 ' HB2' ' HE2' ' A' ' 83' ' ' MET . 83.5 m-85 -68.71 -54.09 18.24 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.146 -0.479 . . . . 0.79 110.714 178.191 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -177.34 -82.06 0.06 OUTLIER Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 119.684 -1.246 . . . . 0.75 111.623 164.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.42 ' HB3' ' CB ' ' A' ' 84' ' ' LYS . 11.8 m-20 -115.36 106.91 14.56 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 111.536 0.199 . . . . 1.02 111.536 -178.075 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.669 HD12 ' H ' ' A' ' 56' ' ' GLU . 3.5 mt -84.07 146.95 6.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.099 -0.704 . . . . 1.13 109.099 166.515 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.624 ' HB2' ' HA ' ' A' ' 84' ' ' LYS . 8.2 tp10 -102.64 -45.49 5.01 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.405 -0.591 . . . . 2.07 109.405 177.349 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -157.49 123.87 4.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.634 -0.712 . . . . 2.48 109.802 179.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -115.7 141.13 48.49 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 120.929 0.395 . . . . 1.18 110.315 172.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.404 HG11 ' HB2' ' A' ' 80' ' ' PHE . 2.4 p -151.57 144.25 16.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.31 -0.859 . . . . 1.97 109.907 -174.629 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 57.5 t -114.3 128.56 71.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 O-C-N 122.3 -0.25 . . . . 1.12 110.558 176.315 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.404 HG21 ' HD3' ' A' ' 76' ' ' ARG . 31.7 mm -72.77 116.48 14.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.407 0.622 . . . . 1.44 110.436 -179.602 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 73.3 p . . . . . 0 C--N 1.314 -0.945 0 CA-C-N 115.247 -0.888 . . . . 1.83 111.399 -175.175 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 44.7 m . . . . . 0 N--CA 1.451 -0.403 0 CA-C-O 121.211 0.529 . . . . 2.07 112.307 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.404 ' HD3' HG21 ' A' ' 67' ' ' ILE . 66.4 mtp180 -48.92 -12.49 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 115.161 -0.927 . . . . 3.07 113.33 171.159 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 92.96 2.99 66.12 Favored Glycine 0 N--CA 1.441 -0.977 0 C-N-CA 120.378 -0.915 . . . . 0.75 112.426 178.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -114.56 136.91 52.51 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.504 -0.924 . . . . 1.61 108.504 178.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -134.55 179.11 17.91 Favored Glycine 0 N--CA 1.435 -1.405 0 C-N-CA 119.574 -1.298 . . . . 0.59 113.788 178.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.404 ' HB2' HG11 ' A' ' 65' ' ' VAL . 50.1 m-85 -144.71 124.04 13.04 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 113.787 -1.207 . . . . 0.84 110.124 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 53.0 t -127.79 106.98 15.69 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 CA-C-N 115.362 -0.835 . . . . 1.21 109.355 175.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.498 ' HA ' ' O ' ' A' ' 35' ' ' THR . 70.5 m -94.86 132.09 40.05 Favored 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 108.759 -0.83 . . . . 1.09 108.759 174.379 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' MET . . . . . 0.48 ' HE2' ' HB2' ' A' ' 58' ' ' PHE . 26.5 mtp -99.96 156.26 17.25 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 109.132 -0.692 . . . . 1.02 109.132 -176.459 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.624 ' HA ' ' HB2' ' A' ' 62' ' ' GLU . 18.1 ttmt -60.22 -49.8 76.19 Favored 'General case' 0 C--N 1.327 -0.379 0 O-C-N 123.421 0.45 . . . . 2.47 110.554 -170.569 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -129.52 148.03 51.38 Favored 'General case' 0 C--O 1.245 0.864 0 CA-C-O 122.121 0.962 . . . . 1.68 111.926 166.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.56 ' O ' ' HG3' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -47.67 -24.61 0.96 Allowed 'General case' 0 C--O 1.214 -0.808 0 CA-C-N 113.708 -1.587 . . . . 4.24 114.096 176.685 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -58.0 -44.76 87.38 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 119.502 1.047 . . . . 1.33 111.483 175.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 49.9 m -71.96 -38.88 69.69 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.577 -0.449 . . . . 1.34 109.863 177.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -56.61 -28.89 61.41 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.916 -0.584 . . . . 1.16 111.789 173.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.56 ' HG3' ' O ' ' A' ' 86' ' ' ARG . 22.1 mt-10 -72.85 -43.97 61.96 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.471 0.653 . . . . 2.11 109.316 -179.686 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.416 ' O ' ' HG3' ' A' ' 94' ' ' LYS . 97.3 mtt180 -55.22 -41.93 72.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.983 -1.008 . . . . 4.35 111.254 176.036 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -69.36 -47.05 65.51 Favored 'General case' 0 C--O 1.219 -0.54 0 C-N-CA 120.971 -0.292 . . . . 1.21 111.533 174.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 48.4 t -48.5 -44.41 35.96 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 113.112 0.782 . . . . 1.16 113.112 177.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.548 ' HE2' ' HB2' ' A' ' 95' ' ' ASP . 0.0 OUTLIER -60.44 -22.89 63.95 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 118.314 0.506 . . . . 4.58 111.661 176.57 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.548 ' HB2' ' HE2' ' A' ' 94' ' ' LYS . 10.3 t70 -99.65 100.72 11.51 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 115.48 -0.782 . . . . 2.24 110.274 -177.529 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.428 ' HD3' ' O ' ' A' ' 94' ' ' LYS . 55.8 Cg_endo -90.72 113.78 0.44 Allowed 'Trans proline' 0 N--CA 1.451 -0.994 0 C-N-CA 123.113 2.542 . . . . 2.38 113.921 -171.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.535 ' HB3' ' HD2' ' A' ' 104' ' ' LYS . 1.0 OUTLIER 70.18 92.42 0.06 OUTLIER Pre-proline 0 N--CA 1.467 0.388 0 CA-C-N 114.495 -1.23 . . . . 3.61 111.464 175.978 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . 0.618 ' O ' ' HA ' ' A' ' 104' ' ' LYS . 73.4 Cg_endo -82.3 168.75 14.71 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 123.843 3.029 . . . . 1.54 113.926 -175.303 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 48.6 mm -102.22 118.07 48.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 CA-C-N 114.1 -1.409 . . . . 2.08 108.737 178.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 70.9 mt -137.65 124.16 27.79 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.233 0 N-CA-C 110.462 -0.199 . . . . 1.55 110.462 -167.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.54 ' HB3' ' HG2' ' A' ' 43' ' ' PRO . 37.9 t70 44.51 48.15 8.38 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-O 121.288 0.566 . . . . 1.52 111.25 -179.219 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 77.0 2.3 77.15 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 115.478 0.951 . . . . 1.73 115.478 179.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 13.0 tpt180 -141.92 130.52 22.66 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 118.487 1.143 . . . . 4.66 112.01 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.618 ' HA ' ' O ' ' A' ' 98' ' ' PRO . 16.8 ttpp -60.1 141.93 55.0 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.388 -0.369 . . . . 3.14 111.527 172.376 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.454 ' O ' ' HD2' ' A' ' 98' ' ' PRO . . . -124.32 167.78 13.88 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 109.035 -0.728 . . . . 1.37 109.035 177.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -97.7 106.93 19.32 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 122.133 0.968 . . . . 2.18 111.838 -178.166 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.539 HG11 HG21 ' A' ' 37' ' ' ILE . 24.6 t -96.48 113.95 32.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 113.517 -1.674 . . . . 1.46 112.104 172.567 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -134.36 144.34 48.17 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 114.497 -1.228 . . . . 3.22 108.882 172.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.479 HD13 ' CD1' ' A' ' 111' ' ' TYR . 0.1 OUTLIER -68.86 93.3 0.54 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.878 0.371 . . . . 1.87 110.384 177.782 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . 0.638 ' HB3' ' HB2' ' A' ' 38' ' ' PHE . . . -36.42 -19.12 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 118.223 2.675 . . . . 1.3 118.223 177.296 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.479 ' CD1' HD13 ' A' ' 109' ' ' LEU . 0.3 OUTLIER . . . . . 0 CA--C 1.545 0.759 0 CA-C-N 121.534 1.97 . . . . 1.71 109.99 175.29 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' MET . . . . . 0.617 ' HE1' ' CE1' ' A' ' 34' ' ' PHE . 43.0 ttp . . . . . 0 C--O 1.197 -1.699 0 N-CA-C 109.497 -0.557 . . . . 1.9 109.497 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . 0.617 ' CE1' ' HE1' ' A' ' 33' ' ' MET . 15.4 m-30 -92.22 42.19 1.09 Allowed 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 115.43 1.641 . . . . 1.76 115.43 175.559 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 16.2 p -147.89 20.06 1.13 Allowed 'General case' 0 N--CA 1.485 1.314 0 CA-C-N 122.219 2.282 . . . . 1.23 110.821 177.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.653 ' HZ2' ' HB3' ' A' ' 80' ' ' PHE . 3.1 tmtm? -129.58 100.85 5.68 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-O 122.351 1.072 . . . . 3.2 110.753 -160.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.409 HD12 ' HA ' ' A' ' 89' ' ' ALA . 43.1 mt -88.48 142.35 13.03 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 O-C-N 121.677 -0.639 . . . . 1.46 111.894 -170.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.441 ' HB3' ' O ' ' A' ' 108' ' ' ASN . 49.3 t80 -102.17 128.12 48.81 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.348 -0.982 . . . . 0.81 108.348 169.39 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.7 t -120.98 89.09 1.35 Allowed 'Isoleucine or valine' 0 C--O 1.217 -0.652 0 C-N-CA 119.995 -0.682 . . . . 1.61 110.128 -176.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -59.14 154.67 28.65 Favored Glycine 0 C--O 1.221 -0.663 0 C-N-CA 118.113 -1.994 . . . . 1.39 114.513 165.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 96.15 39.16 4.35 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 121.105 -0.569 . . . . 0.71 114.189 170.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.55 HD13 HD22 ' A' ' 51' ' ' LEU . 2.9 mm? -93.68 125.24 54.3 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 117.122 0.461 . . . . 1.89 109.96 173.381 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.531 ' HG2' ' HB3' ' A' ' 101' ' ' ASP . 50.0 Cg_exo -49.08 155.88 2.58 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.779 2.319 . . . . 0.82 111.953 171.406 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -69.42 -3.4 14.2 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.433 0.531 . . . . 1.46 112.433 -173.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -110.05 -8.95 14.75 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 120.545 0.212 . . . . 2.65 111.016 179.028 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.534 HG22 HD11 ' A' ' 42' ' ' LEU . 30.0 m -62.69 133.68 55.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.952 0.406 . . . . 1.31 111.156 -173.609 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 12.0 p -107.63 158.38 17.3 Favored 'General case' 0 C--O 1.251 1.183 0 CA-C-O 121.856 0.836 . . . . 0.75 112.06 -177.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.472 ' HA ' HG21 ' A' ' 66' ' ' VAL . 2.6 m-20 -49.99 -30.93 11.5 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 114.323 -1.308 . . . . 0.49 111.122 177.411 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.556 ' O ' ' HG2' ' A' ' 53' ' ' GLU . 60.6 pttt -78.77 -29.26 44.93 Favored 'General case' 0 C--O 1.215 -0.746 0 N-CA-C 108.799 -0.815 . . . . 3.26 108.799 -174.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.573 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 7.0 m -64.91 -41.75 95.31 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 115.764 -0.653 . . . . 1.25 110.068 179.299 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.55 HD22 HD13 ' A' ' 42' ' ' LEU . 18.8 mt -62.05 -46.2 90.18 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 119.361 -0.935 . . . . 1.53 110.083 173.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . 0.516 ' HA ' ' CD1' ' A' ' 61' ' ' ILE . 59.6 t-80 -53.58 -32.39 50.77 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 116.27 -0.423 . . . . 0.77 110.911 172.474 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.573 ' HB2' ' O ' ' A' ' 50' ' ' THR . 45.2 mm-40 -68.05 -40.05 82.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.314 -0.857 . . . . 1.52 109.489 -175.664 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' TYR . . . . . 0.561 ' O ' ' HB2' ' A' ' 57' ' ' GLN . 24.4 t80 -80.75 -40.82 24.55 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.421 -0.809 . . . . 1.6 111.499 -173.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.672 ' C ' ' H ' ' A' ' 57' ' ' GLN . 58.2 m-85 -85.56 -32.03 22.35 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 114.005 1.113 . . . . 0.68 114.005 -166.21 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.652 ' N ' HD12 ' A' ' 61' ' ' ILE . 15.7 pt-20 -63.28 4.13 0.24 Allowed 'General case' 0 N--CA 1.48 1.061 0 CA-C-O 122.168 0.985 . . . . 1.57 111.145 176.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.672 ' H ' ' C ' ' A' ' 55' ' ' PHE . 36.2 mt-30 -92.32 -18.11 23.79 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 113.753 -1.567 . . . . 2.79 110.73 -176.259 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -102.62 -29.43 11.55 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.506 0.67 . . . . 0.79 109.692 177.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.41 ' O ' ' HA ' ' A' ' 56' ' ' GLU . . . 178.46 -174.6 46.81 Favored Glycine 0 N--CA 1.443 -0.861 0 N-CA-C 110.255 -1.138 . . . . 0.75 110.255 -177.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -64.0 137.34 57.95 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 117.388 0.594 . . . . 1.02 110.492 175.409 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.652 HD12 ' N ' ' A' ' 56' ' ' GLU . 7.5 mt -101.91 142.42 16.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 105.692 -1.966 . . . . 1.13 105.692 172.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.47 ' OE1' ' HE3' ' A' ' 84' ' ' LYS . 7.7 tp10 -88.75 -37.13 15.71 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 119.61 1.096 . . . . 2.07 109.155 178.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -166.24 127.44 1.78 Allowed 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.063 -0.517 . . . . 2.48 110.792 177.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -115.01 134.33 55.28 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.1 0.476 . . . . 1.18 110.753 174.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.487 HG11 ' HB2' ' A' ' 80' ' ' PHE . 2.9 p -147.32 136.71 16.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.248 -0.887 . . . . 1.97 111.231 -174.61 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.472 HG21 ' HA ' ' A' ' 48' ' ' ASP . 78.4 t -107.36 131.37 57.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 109.043 -0.725 . . . . 1.12 109.043 176.317 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 49.0 mm -88.23 139.47 17.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-O 121.867 0.841 . . . . 1.44 112.625 -168.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.695 ' O ' ' HD2' ' A' ' 76' ' ' ARG . 34.4 p . . . . . 0 N--CA 1.444 -0.731 0 N-CA-C 105.994 -1.854 . . . . 1.83 105.994 172.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 2.8 m . . . . . 0 N--CA 1.448 -0.538 0 N-CA-C 108.975 -0.75 . . . . 2.07 108.975 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.695 ' HD2' ' O ' ' A' ' 68' ' ' THR . 15.1 mtt180 -72.45 -10.62 60.02 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.188 -0.46 . . . . 3.07 112.042 -172.452 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 73.29 8.71 75.75 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.56 -0.828 . . . . 0.75 112.059 176.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.493 ' CD2' ' HB3' ' A' ' 76' ' ' ARG . 9.9 m-85 -111.18 141.62 44.46 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.44 -0.948 . . . . 1.61 108.44 178.401 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -126.96 164.76 20.43 Favored Glycine 0 N--CA 1.439 -1.157 0 C-N-CA 120.274 -0.965 . . . . 0.59 112.214 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.653 ' HB3' ' HZ2' ' A' ' 36' ' ' LYS . 51.0 m-85 -139.44 123.12 17.46 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.25 0.547 . . . . 0.84 109.621 178.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.501 HG12 ' CD2' ' A' ' 55' ' ' PHE . 54.0 t -125.27 108.14 19.3 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 115.626 -0.715 . . . . 1.21 110.184 -178.483 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.416 ' HA ' ' HA ' ' A' ' 36' ' ' LYS . 18.5 m -92.83 118.03 30.67 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 109.128 -0.693 . . . . 1.09 109.128 178.022 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 80.3 mmm -85.91 -179.95 6.9 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.244 0.545 . . . . 1.02 110.326 178.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.47 ' HE3' ' OE1' ' A' ' 62' ' ' GLU . 6.4 tptm -93.99 -7.38 42.99 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.345 -0.843 . . . . 2.47 109.156 -171.671 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -167.28 154.17 8.48 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 114.672 -1.149 . . . . 1.68 110.12 -162.217 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.507 ' HB2' ' O ' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -76.17 -49.49 17.11 Favored 'General case' 0 C--O 1.223 -0.341 0 N-CA-C 109.764 -0.458 . . . . 4.24 109.764 -174.258 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -51.69 -39.34 58.12 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.511 -0.768 . . . . 1.33 112.22 176.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.622 ' HA ' ' HE ' ' A' ' 91' ' ' ARG . 14.6 m -69.17 -40.54 78.06 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.838 0.351 . . . . 1.34 110.825 176.72 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.409 ' HA ' HD12 ' A' ' 37' ' ' ILE . . . -55.31 -46.08 76.29 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.049 -0.523 . . . . 1.16 110.525 170.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -60.34 -41.27 93.25 Favored 'General case' 0 C--O 1.222 -0.364 0 CA-C-O 121.268 0.556 . . . . 2.11 110.464 174.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.622 ' HE ' ' HA ' ' A' ' 88' ' ' SER . 16.4 mtm180 -56.72 -50.92 70.76 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 114.713 -1.13 . . . . 4.35 111.641 176.728 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -59.96 -27.31 66.7 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 113.837 1.051 . . . . 1.21 113.837 173.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 44.7 t -79.97 -36.1 36.58 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.943 0.878 . . . . 1.16 109.097 179.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.565 ' HB3' ' O ' ' A' ' 91' ' ' ARG . 59.8 tptt -50.4 -18.8 0.69 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 113.675 -1.602 . . . . 4.58 112.511 170.01 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -104.52 89.15 2.51 Favored Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 109.118 -0.697 . . . . 2.24 109.118 166.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' PRO . . . . . 0.564 ' HD3' ' O ' ' A' ' 94' ' ' LYS . 5.6 Cg_exo -73.67 173.77 13.36 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.923 2.415 . . . . 2.38 111.138 -177.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 5.92 67.74 0.05 OUTLIER Pre-proline 0 N--CA 1.479 1.014 0 O-C-N 124.2 0.937 . . . . 3.61 113.417 -160.71 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -69.13 133.39 26.59 Favored 'Trans proline' 0 CA--C 1.511 -0.644 0 C-N-CA 121.723 1.615 . . . . 1.54 108.962 177.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.547 HG23 ' C ' ' A' ' 102' ' ' GLY . 17.2 mm -87.1 95.92 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.893 0 CA-C-N 119.307 0.958 . . . . 2.08 108.671 -172.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.694 HG21 ' H ' ' A' ' 101' ' ' ASP . 11.2 mm -89.54 150.02 3.85 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.422 0 CA-C-O 121.461 0.648 . . . . 1.55 111.734 -170.683 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.694 ' H ' HG21 ' A' ' 100' ' ' ILE . 30.5 t70 36.24 20.65 0.0 OUTLIER 'General case' 0 CA--C 1.559 1.306 0 CA-C-N 113.898 -1.501 . . . . 1.52 111.916 -156.708 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.547 ' C ' HG23 ' A' ' 99' ' ' ILE . . . 89.18 17.31 56.03 Favored Glycine 0 CA--C 1.535 1.31 0 C-N-CA 120.852 -0.69 . . . . 1.73 113.131 -179.546 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.497 ' N ' HG23 ' A' ' 99' ' ' ILE . 39.5 mmt180 -132.38 140.73 48.6 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.548 0.739 . . . . 4.66 110.035 176.18 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -58.58 112.68 1.69 Allowed 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 113.74 1.015 . . . . 3.14 113.74 -171.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -92.34 164.83 13.36 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 114.752 -1.113 . . . . 1.37 112.993 177.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -123.52 113.46 18.75 Favored 'General case' 0 C--O 1.253 1.27 0 CA-C-N 115.098 -0.956 . . . . 2.18 110.245 177.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 51.0 t -98.18 127.77 50.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 114.63 -1.168 . . . . 1.46 111.444 -173.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . 0.441 ' O ' ' HB3' ' A' ' 38' ' ' PHE . 66.5 t30 -157.39 152.75 26.23 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.517 -0.765 . . . . 3.22 109.909 178.532 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.544 HD13 ' HE1' ' A' ' 111' ' ' TYR . 7.7 mt -65.97 125.93 26.98 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 113.539 0.94 . . . . 1.87 113.539 -177.627 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -45.92 -44.49 14.71 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 113.944 -1.48 . . . . 1.3 113.217 172.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.544 ' HE1' HD13 ' A' ' 109' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.473 0.692 0 O-C-N 121.866 -0.521 . . . . 1.71 111.418 -173.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.887 0 N-CA-C 111.872 -0.491 . . . . 13.51 111.872 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -118.39 -76.08 0.58 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.914 0.388 . . . . 11.28 111.067 -177.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 53.2 ttm -81.35 94.17 6.72 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.168 0.509 . . . . 10.15 110.239 -177.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 149.31 -11.65 1.02 Allowed Glycine 0 N--CA 1.445 -0.713 0 CA-C-N 115.651 -0.704 . . . . 6.69 111.831 -177.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 19.6 m -60.17 -45.14 94.09 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 121.267 0.556 . . . . 5.68 110.579 176.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.42 ' HD2' ' OE1' ' A' ' 62' ' ' GLU . 55.4 mtm180 -136.86 146.27 45.38 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.578 -0.737 . . . . 4.34 110.166 178.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -126.35 127.67 45.87 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.959 -0.564 . . . . 3.53 109.648 178.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.439 ' O ' ' HB2' ' A' ' 36' ' ' LYS . 9.9 p -82.56 -22.17 35.02 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.451 -0.341 . . . . 1.98 111.892 -177.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 51.9 ttp -61.84 -45.43 93.85 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.043 0.386 . . . . 1.9 112.043 -176.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.448 ' HB3' ' HG3' ' A' ' 86' ' ' ARG . 8.9 m-85 -91.76 -2.34 56.99 Favored 'General case' 0 C--N 1.331 -0.212 0 O-C-N 122.226 -0.296 . . . . 1.76 111.63 -176.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.579 ' O ' ' HA ' ' A' ' 82' ' ' THR . 41.1 p -110.68 -3.49 15.82 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.877 -0.329 . . . . 1.23 111.447 -178.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.439 ' HB2' ' O ' ' A' ' 32' ' ' THR . 63.2 tttm -85.64 103.24 14.28 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.97 -0.559 . . . . 3.2 110.207 -176.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 98.7 mt -105.57 141.71 20.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 C-N-CA 123.108 0.563 . . . . 1.46 111.577 -173.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.4 ' HD1' ' CE1' ' A' ' 80' ' ' PHE . 58.9 t80 -95.79 132.41 41.06 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.645 -0.707 . . . . 0.81 109.505 174.007 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.644 HG11 HD12 ' A' ' 42' ' ' LEU . 3.6 t -120.96 141.92 39.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 121.082 0.468 . . . . 1.61 110.314 -178.313 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.593 ' HA3' ' HB2' ' A' ' 106' ' ' ASN . . . -141.95 159.52 26.98 Favored Glycine 0 C--O 1.219 -0.807 0 CA-C-N 115.72 -0.673 . . . . 1.39 112.735 -167.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.77 37.38 93.38 Favored Glycine 0 CA--C 1.522 0.503 0 C-N-CA 121.374 -0.441 . . . . 0.71 113.817 172.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.644 HD12 HG11 ' A' ' 39' ' ' VAL . 8.2 mp -87.54 134.0 36.93 Favored Pre-proline 0 C--N 1.326 -0.418 0 O-C-N 122.694 -0.298 . . . . 1.89 110.626 178.332 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.638 ' HD2' ' OG1' ' A' ' 46' ' ' THR . 51.5 Cg_exo -53.33 155.89 11.7 Favored 'Trans proline' 0 N--CA 1.463 -0.282 0 C-N-CA 122.995 2.463 . . . . 0.82 112.101 175.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.523 ' CE2' ' C5 ' ' B' ' 2' ' ' ' G' . 66.9 m-85 -69.09 1.87 3.22 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.129 0.49 . . . . 1.46 110.963 -179.021 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . 0.43 ' HD2' ' OD2' ' A' ' 101' ' ' ASP . 19.5 t60 -106.88 -16.46 14.46 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.747 -0.66 . . . . 2.65 110.627 178.483 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.638 ' OG1' ' HD2' ' A' ' 43' ' ' PRO . 61.2 m -71.77 138.54 48.49 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.257 -0.428 . . . . 1.31 111.467 -175.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 16.9 p -130.96 -178.35 4.78 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-O 120.967 0.413 . . . . 0.75 111.391 -176.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -62.74 -33.52 75.32 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.969 -0.56 . . . . 0.49 110.756 -176.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -71.39 -33.93 69.94 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.286 -0.635 . . . . 3.26 109.286 -179.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.626 HG22 HG21 ' A' ' 46' ' ' THR . 81.2 m -61.24 -45.29 95.16 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.57 -0.741 . . . . 1.25 110.686 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.485 HD22 HG13 ' A' ' 39' ' ' VAL . 54.0 mt -67.57 -35.33 78.82 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.928 -0.578 . . . . 1.53 111.089 178.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 57.7 t-80 -61.89 -54.02 47.78 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.25 -0.648 . . . . 0.77 109.25 176.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -58.66 -37.4 75.89 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.826 -0.624 . . . . 1.52 112.005 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -76.87 -37.59 55.24 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 120.789 0.328 . . . . 1.6 111.714 -178.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.411 ' CE1' HD23 ' A' ' 51' ' ' LEU . 18.4 m-85 -85.22 -25.23 27.45 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 113.402 0.89 . . . . 0.68 113.402 -174.161 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.635 ' N ' HD12 ' A' ' 61' ' ' ILE . 10.8 pt-20 -64.52 -18.14 64.55 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.642 0.734 . . . . 1.57 109.984 179.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -55.45 -27.66 49.54 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.542 -1.208 . . . . 2.79 111.755 170.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -96.06 -21.28 18.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.546 -0.297 . . . . 0.79 110.802 -178.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 151.25 -159.74 28.35 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.565 -0.826 . . . . 0.75 112.419 177.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -65.9 121.94 16.21 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.028 0.442 . . . . 1.02 111.671 -178.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.635 HD12 ' N ' ' A' ' 56' ' ' GLU . 12.5 mt -101.41 130.74 50.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 109.235 -0.654 . . . . 1.13 109.235 176.023 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.42 ' OE1' ' HD2' ' A' ' 30' ' ' ARG . 28.4 tt0 -85.32 -53.37 5.27 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 121.181 -0.208 . . . . 2.07 111.33 176.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -140.28 129.59 23.85 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.711 -0.222 . . . . 2.48 111.223 -175.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -121.6 116.92 25.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.186 0.517 . . . . 1.18 111.056 174.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.426 HG22 ' H21' ' B' ' 6' ' ' ' G' . 30.3 m -128.64 145.43 35.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.454 -0.794 . . . . 1.97 112.123 -179.474 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 91.3 t -116.76 133.73 62.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.525 -0.761 . . . . 1.12 110.734 174.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 36.8 mm -76.92 152.5 5.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.715 -0.675 . . . . 1.44 109.524 177.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 39.5 p -136.14 167.22 21.67 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 105.407 -2.072 . . . . 1.83 105.407 -174.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.494 ' HB3' ' H ' ' A' ' 74' ' ' LYS . 32.3 t70 -62.59 154.04 30.23 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 118.713 0.688 . . . . 2.49 111.888 -171.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.464 ' O ' ' HD2' ' A' ' 70' ' ' ARG . 1.2 tmm_? -80.11 -24.12 40.75 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.805 -0.634 . . . . 6.58 110.476 -173.393 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -108.09 -61.77 1.54 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.43 -0.35 . . . . 4.33 111.259 -177.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 45.6 p -83.09 -21.59 33.65 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.858 0.361 . . . . 3.67 111.239 -177.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 56.74 66.77 1.1 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.75 0.786 . . . . 3.61 111.133 -174.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.494 ' H ' ' HB3' ' A' ' 69' ' ' ASP . 66.8 mttm -111.41 168.33 9.62 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 106.998 -1.482 . . . . 3.78 106.998 172.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 6.3 m -71.1 97.31 1.47 Allowed 'General case' 0 C--N 1.316 -0.857 0 C-N-CA 120.423 -0.511 . . . . 2.07 110.792 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 73.7 mtp180 -58.51 -29.55 66.37 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.769 -0.65 . . . . 3.07 111.191 179.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.54 ' HA3' ' H21' ' B' ' 2' ' ' ' G' . . . 93.37 30.37 9.28 Favored Glycine 0 N--CA 1.439 -1.109 0 C-N-CA 120.506 -0.854 . . . . 0.75 112.18 -177.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -131.49 141.83 49.84 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 107.921 -1.14 . . . . 1.61 107.921 175.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -141.72 -171.75 13.04 Favored Glycine 0 N--CA 1.439 -1.142 0 C-N-CA 120.089 -1.053 . . . . 0.59 111.782 -174.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.4 ' CE1' ' HD1' ' A' ' 38' ' ' PHE . 55.4 m-85 -154.91 124.6 6.52 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.582 -0.896 . . . . 0.84 108.582 -177.491 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 53.8 t -119.58 124.14 72.37 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 CA-C-N 115.742 -0.663 . . . . 1.21 110.133 -177.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.579 ' HA ' ' O ' ' A' ' 35' ' ' THR . 17.3 m -109.41 116.33 31.62 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 107.948 -1.13 . . . . 1.09 107.948 175.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 92.5 mmm -87.72 162.69 16.92 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.098 -0.705 . . . . 1.02 109.098 -175.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 44.8 tttm -85.04 -10.47 56.9 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 120.873 0.368 . . . . 2.47 110.997 -175.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -149.5 147.78 28.62 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-N 116.377 -0.374 . . . . 1.68 110.562 175.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.452 ' O ' ' HB1' ' A' ' 89' ' ' ALA . 1.3 tmt_? -67.49 -22.72 65.45 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 112.255 0.465 . . . . 4.24 112.255 -176.318 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.05 -47.27 77.95 Favored 'General case' 0 N--CA 1.464 0.239 0 O-C-N 121.519 -0.738 . . . . 1.33 111.285 178.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 19.1 m -65.92 -31.13 71.88 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.605 0.717 . . . . 1.34 109.754 175.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.452 ' HB1' ' O ' ' A' ' 86' ' ' ARG . . . -59.32 -48.97 79.62 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.123 -1.398 . . . . 1.16 109.818 174.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -55.87 -51.68 66.71 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.203 -0.453 . . . . 2.11 111.654 174.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.481 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 23.7 mmt180 -57.78 -45.39 86.07 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.315 -0.402 . . . . 4.35 111.198 -178.026 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -58.66 -48.12 82.14 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.09 -0.505 . . . . 1.21 111.147 176.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 49.2 t -75.46 -2.97 31.25 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 111.945 0.35 . . . . 1.16 111.945 -176.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.481 ' HB2' ' O ' ' A' ' 91' ' ' ARG . 4.5 mmmm -59.95 -48.74 80.45 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 121.044 -0.262 . . . . 4.58 111.463 176.354 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.441 ' HA ' ' HD3' ' A' ' 96' ' ' PRO . 32.5 t0 -106.39 107.57 60.21 Favored Pre-proline 0 C--N 1.328 -0.365 0 N-CA-C 109.931 -0.396 . . . . 2.24 109.931 179.482 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.465 ' HA ' ' O ' ' A' ' 107' ' ' VAL . 6.9 Cg_exo -74.48 -10.32 22.03 Favored 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 123.082 2.521 . . . . 2.38 113.51 -176.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.7 ' HA ' ' O ' ' A' ' 105' ' ' ALA . 2.0 m120 -142.81 68.57 19.02 Favored Pre-proline 0 N--CA 1.464 0.254 0 N-CA-C 112.824 0.676 . . . . 3.61 112.824 -178.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -81.29 154.46 18.85 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.803 2.336 . . . . 1.54 110.818 172.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 42.6 mm -85.63 91.95 3.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 120.418 -0.513 . . . . 2.08 110.478 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 52.3 mt -89.95 107.77 18.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.702 0.763 . . . . 1.55 112.681 178.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.43 ' OD2' ' HD2' ' A' ' 45' ' ' HIS . 32.2 t70 66.13 43.59 2.83 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 113.901 -1.5 . . . . 1.52 110.438 167.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 88.99 -7.63 81.74 Favored Glycine 0 CA--C 1.518 0.267 0 CA-C-N 115.056 -0.975 . . . . 1.73 114.551 177.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.494 ' HB2' ' HG3' ' A' ' 43' ' ' PRO . 14.7 tpt180 -126.66 141.79 51.74 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 117.992 0.896 . . . . 4.66 110.709 178.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -64.62 131.57 47.34 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.088 -0.708 . . . . 3.14 109.088 172.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.7 ' O ' ' HA ' ' A' ' 97' ' ' ASN . . . -118.64 153.54 34.15 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.821 -0.627 . . . . 1.37 110.087 -169.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.593 ' HB2' ' HA3' ' A' ' 40' ' ' GLY . 6.6 m-20 -96.68 140.15 31.71 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.069 0.461 . . . . 2.18 110.281 178.162 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.465 ' O ' ' HA ' ' A' ' 96' ' ' PRO . 70.6 t -146.08 113.75 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.029 -0.987 . . . . 1.46 110.626 -174.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -159.3 165.06 34.24 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.097 -0.705 . . . . 3.22 109.097 174.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.502 ' HB3' ' CD1' ' A' ' 111' ' ' TYR . 2.0 mm? -71.96 129.31 38.25 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.254 -0.647 . . . . 1.87 109.254 176.479 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -57.84 -31.57 66.78 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.575 0.583 . . . . 1.3 112.575 -173.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.502 ' CD1' ' HB3' ' A' ' 109' ' ' LEU . 2.5 p90 -75.81 -8.7 57.52 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.758 0.314 . . . . 1.71 111.299 -176.454 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 98.2 mt -81.23 -31.51 33.79 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.112 0.482 . . . . 1.97 110.589 178.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -122.21 34.53 3.8 Favored Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 111.313 -0.715 . . . . 2.24 111.313 -179.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -90.2 133.29 35.0 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.888 -0.412 . . . . 2.66 109.888 -178.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 50.2 mtmt -136.57 74.92 52.0 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.126 0.489 . . . . 4.52 109.912 173.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -91.62 -16.59 1.22 Allowed 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 123.538 2.826 . . . . 5.53 112.551 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 76.9 ttt180 -167.98 168.5 11.99 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 107.83 -1.174 . . . . 9.2 107.83 -176.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.459 ' O ' ' HB2' ' A' ' 119' ' ' ASN . 5.9 t 44.9 86.74 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.546 0 O-C-N 124.151 0.907 . . . . 6.74 111.688 -177.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.459 ' HB2' ' O ' ' A' ' 118' ' ' THR . 49.9 m-80 77.7 80.4 0.08 Allowed 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 114.777 -1.102 . . . . 8.27 110.83 -172.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 42.9 t -109.73 95.06 3.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.922 -0.581 . . . . 9.39 110.534 179.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.429 ' OE1' ' HA ' ' A' ' 121' ' ' GLN . 6.5 tp60 . . . . . 0 C--O 1.245 0.828 0 CA-C-N 115.473 -0.785 . . . . 12.71 109.451 176.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 1' ' ' ' G' . . . . . 0.47 " H4'" " O5'" ' B' ' 2' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.431 -0.582 0 C3'-C2'-C1' 99.888 -1.791 . 0.0 '__' . 5.37 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 2' ' ' ' G' . . . . . 0.54 ' H21' ' HA3' ' A' ' 77' ' ' GLY . . . . . . . . 0 O5'--C5' 1.427 -0.792 0 O4'-C1'-N19 110.533 2.333 . 0.0 OUTLIER . 4.87 . . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 3' ' ' ' U' . . . . . 0.511 " H3'" " O4'" ' B' ' 4' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.424 -0.972 0 C5'-C4'-O4' 107.525 -1.196 . 0.0 OUTLIER . 5.58 . . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 4' ' ' ' G' . . . . . 0.535 " H3'" ' N3 ' ' B' ' 4' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.423 -1.05 0 O4'-C4'-C3' 103.615 -1.346 . 0.0 OUTLIER '7D dist 2a' 2.69 . . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 5' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.428 -0.777 0 C4'-C3'-C2' 103.885 1.185 . 0.0 OUTLIER . 1.93 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 6' ' ' ' G' . . . . . 0.426 ' H21' HG22 ' A' ' 65' ' ' VAL . . . . . . . . 0 O5'--C5' 1.425 -0.963 0 C4'-C3'-C2' 103.746 1.046 . 0.391 0b . 2.38 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.426 -0.868 0 C4'-C3'-C2' 103.575 0.875 . 0.0 OUTLIER . 4.41 . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.696 0 N-CA-C 111.578 -0.609 . . . . 13.51 111.578 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -158.25 13.33 0.19 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.465 0.174 . . . . 11.28 110.677 178.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 55.2 ttp 58.66 85.03 0.1 Allowed 'General case' 0 N--CA 1.462 0.161 0 O-C-N 123.79 0.681 . . . . 10.15 111.091 -173.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -142.57 -116.77 1.21 Allowed Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.795 -0.717 . . . . 6.69 112.139 -179.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 15.3 t 63.6 13.53 7.37 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 122.961 0.504 . . . . 5.68 111.465 -179.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.465 ' HE ' ' CD ' ' A' ' 62' ' ' GLU . 57.3 mtp85 -90.93 172.18 8.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.746 0.308 . . . . 4.34 110.36 -179.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -79.39 105.75 10.92 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 110.116 -0.327 . . . . 3.53 110.116 178.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.404 ' O ' ' HB2' ' A' ' 36' ' ' LYS . 74.3 p -100.05 -4.52 29.73 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.052 -0.522 . . . . 1.98 110.075 176.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' MET . . . . . 0.578 ' HE1' ' CE2' ' A' ' 34' ' ' PHE . 44.2 ttp -56.26 -66.87 0.36 Allowed 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 115.928 -0.578 . . . . 1.9 112.252 179.624 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.578 ' CE2' ' HE1' ' A' ' 33' ' ' MET . 70.0 m-85 -81.12 -44.88 17.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 118.65 0.659 . . . . 1.76 111.123 -174.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.463 ' HB ' ' O ' ' A' ' 83' ' ' MET . 56.8 p -56.04 -17.94 8.24 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 114.376 1.25 . . . . 1.23 114.376 -175.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.713 ' HG2' ' HB1' ' A' ' 110' ' ' ALA . 29.2 ttpt -81.33 114.77 20.33 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.29 0.567 . . . . 3.2 111.68 -173.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 89.0 mt -105.62 134.18 47.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.364 -0.835 . . . . 1.46 111.112 -179.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.703 ' HZ ' " H2'" ' B' ' 4' ' ' ' G' . 89.0 t80 -94.28 111.15 22.87 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.027 -0.731 . . . . 0.81 109.027 175.175 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.6 t -100.75 139.8 21.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.278 0.561 . . . . 1.61 110.24 -179.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.494 ' O ' ' HB3' ' A' ' 105' ' ' ALA . . . -139.99 135.92 7.44 Favored Glycine 0 N--CA 1.448 -0.523 0 CA-C-N 115.212 -0.904 . . . . 1.39 112.798 -170.55 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 86.34 32.37 16.77 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.762 -0.732 . . . . 0.71 113.049 176.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.681 HD12 HD22 ' A' ' 51' ' ' LEU . 2.8 mm? -74.21 117.3 60.55 Favored Pre-proline 0 C--N 1.328 -0.338 0 N-CA-C 109.736 -0.468 . . . . 1.89 109.736 177.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.565 ' HG2' ' HB3' ' A' ' 101' ' ' ASP . 81.8 Cg_exo -51.0 159.36 2.55 Favored 'Trans proline' 0 CA--C 1.527 0.129 0 C-N-CA 122.913 2.409 . . . . 0.82 112.664 178.303 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.515 ' CE2' ' C4 ' ' B' ' 1' ' ' ' G' . 81.4 m-85 -69.94 -4.95 22.93 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 116.284 -0.416 . . . . 1.46 111.776 -171.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . 0.66 ' HB3' ' OD2' ' A' ' 101' ' ' ASP . 70.7 t60 -101.41 -6.04 24.54 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 120.964 0.411 . . . . 2.65 110.533 175.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.442 HG22 HD13 ' A' ' 42' ' ' LEU . 95.0 m -75.38 118.81 18.67 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.05 0.453 . . . . 1.31 111.406 -178.016 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 11.7 p -108.62 -178.75 3.68 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-N 115.924 -0.58 . . . . 0.75 110.824 177.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -64.64 -35.93 82.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.296 0.569 . . . . 0.49 110.443 -176.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.562 ' O ' ' HG2' ' A' ' 53' ' ' GLU . 20.2 ptmt -65.93 -37.44 86.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.582 -0.736 . . . . 3.26 110.592 179.37 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 49.9 m -59.49 -45.58 91.26 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.958 -0.564 . . . . 1.25 110.403 178.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.681 HD22 HD12 ' A' ' 42' ' ' LEU . 39.5 mt -66.55 -32.95 74.63 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.736 -0.666 . . . . 1.53 111.22 177.185 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.44 ' HA ' HD13 ' A' ' 61' ' ' ILE . 55.2 t-80 -65.27 -55.07 20.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.867 0.365 . . . . 0.77 110.269 177.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.562 ' HG2' ' O ' ' A' ' 49' ' ' LYS . 9.0 mm-40 -57.93 -43.41 86.28 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.143 0.496 . . . . 1.52 112.211 -179.293 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -74.8 -35.0 62.49 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.108 -0.496 . . . . 1.6 112.148 -174.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.705 ' HB2' HD12 ' A' ' 61' ' ' ILE . 7.5 m-85 -87.12 -25.17 24.26 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 113.493 0.923 . . . . 0.68 113.493 -172.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -67.97 -16.39 64.04 Favored 'General case' 0 CA--C 1.522 -0.098 0 CA-C-O 121.544 0.688 . . . . 1.57 109.557 179.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 28.5 mm-40 -56.59 -16.32 5.93 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.054 -0.976 . . . . 2.79 112.459 169.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -99.51 -18.32 17.46 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.847 0.356 . . . . 0.79 110.7 178.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 161.73 -112.96 0.54 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.482 -0.866 . . . . 0.75 112.998 176.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.572 ' HB3' ' HB3' ' A' ' 84' ' ' LYS . 7.9 m-20 -114.27 126.41 54.99 Favored 'General case' 0 C--N 1.329 -0.322 0 O-C-N 122.654 -0.321 . . . . 1.02 110.74 -179.026 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.705 HD12 ' HB2' ' A' ' 55' ' ' PHE . 32.4 mt -99.82 126.71 53.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 C-N-CA 120.903 -0.319 . . . . 1.13 110.57 173.18 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.465 ' CD ' ' HE ' ' A' ' 30' ' ' ARG . 28.6 tt0 -83.61 -47.58 11.11 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.828 -0.624 . . . . 2.07 109.928 176.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -156.57 130.27 8.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.73 -0.668 . . . . 2.48 110.743 179.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -115.36 116.36 28.13 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.931 -0.396 . . . . 1.18 109.931 175.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.561 HG22 ' N2 ' ' B' ' 6' ' ' ' G' . 4.2 m -133.22 115.67 23.85 Favored 'Isoleucine or valine' 0 C--O 1.24 0.553 0 CA-C-O 121.772 0.796 . . . . 1.97 112.808 -176.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 94.0 t -72.56 126.08 32.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 114.881 -1.054 . . . . 1.12 109.137 173.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 31.1 mm -74.08 95.35 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.542 0 CA-C-O 121.336 0.588 . . . . 1.44 110.268 -178.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 29.9 p -88.97 155.8 19.28 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-N 115.403 -0.817 . . . . 1.83 111.222 -176.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.708 ' HA ' ' NE ' ' A' ' 76' ' ' ARG . 36.3 t70 -50.76 144.81 7.74 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 113.964 -1.471 . . . . 2.49 113.019 -170.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.406 HH11 ' HD2' ' A' ' 70' ' ' ARG . 7.8 ttp180 -70.94 -22.72 62.19 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.765 -0.652 . . . . 6.58 111.991 -176.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -108.7 -19.51 13.4 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.736 0.303 . . . . 4.33 111.076 -172.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 22.0 p -134.15 -27.6 1.4 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.774 0.321 . . . . 3.67 111.734 -175.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 56.44 65.02 1.52 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.811 -0.631 . . . . 3.61 111.28 -175.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 57.0 mtmt -102.21 -63.72 1.13 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.586 -0.734 . . . . 3.78 112.131 -178.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.477 ' O ' ' HB2' ' A' ' 76' ' ' ARG . 11.7 p -160.44 -69.26 0.07 Allowed 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.732 -0.387 . . . . 2.07 111.895 -176.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.708 ' NE ' ' HA ' ' A' ' 69' ' ' ASP . 81.1 mtt180 76.63 -25.17 0.21 Allowed 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.371 0.669 . . . . 3.07 111.43 -179.588 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.404 ' HA3' ' C6 ' ' B' ' 2' ' ' ' G' . . . 85.17 10.46 78.01 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.652 -0.785 . . . . 0.75 113.221 173.384 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -121.95 154.21 37.47 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.18 -1.044 . . . . 1.61 108.18 177.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -165.93 143.43 8.4 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 119.525 -1.322 . . . . 0.59 113.418 178.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -101.24 124.63 47.25 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 122.184 0.992 . . . . 0.84 112.26 174.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 58.0 t -104.27 130.55 54.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 113.966 -1.47 . . . . 1.21 108.144 170.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 4.7 m -115.08 122.35 45.88 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 107.794 -1.187 . . . . 1.09 107.794 178.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.463 ' O ' ' HB ' ' A' ' 35' ' ' THR . 88.3 mmm -86.61 160.78 18.8 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.528 -0.545 . . . . 1.02 109.528 -174.094 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.572 ' HB3' ' HB3' ' A' ' 60' ' ' ASP . 31.3 ttmt -84.04 -19.03 35.11 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.235 0.54 . . . . 2.47 109.667 -177.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -141.45 144.09 34.22 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 115.554 -0.748 . . . . 1.68 111.153 -178.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.528 ' O ' ' HG2' ' A' ' 90' ' ' GLU . 0.6 OUTLIER -66.1 -29.93 70.34 Favored 'General case' 0 C--O 1.222 -0.382 0 N-CA-C 113.743 1.016 . . . . 4.24 113.743 -177.718 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -67.73 -35.65 79.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 119.361 0.982 . . . . 1.33 110.89 178.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 11.7 m -64.66 -35.11 79.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 122.06 0.933 . . . . 1.34 109.35 173.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -66.02 -45.71 80.51 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 113.685 -1.598 . . . . 1.16 110.468 177.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.528 ' HG2' ' O ' ' A' ' 86' ' ' ARG . 10.7 mm-40 -54.53 -51.54 64.85 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.779 -0.646 . . . . 2.11 112.65 178.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.513 ' O ' ' HB3' ' A' ' 94' ' ' LYS . 57.0 mtp180 -65.91 -39.02 90.18 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 111.736 0.273 . . . . 4.35 111.736 -178.356 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.82 -42.93 99.93 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.388 -0.369 . . . . 1.21 111.305 179.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . 0.558 ' HB2' ' HG ' ' A' ' 109' ' ' LEU . 44.8 t -71.93 -17.18 62.1 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.047 0.451 . . . . 1.16 110.763 175.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.513 ' HB3' ' O ' ' A' ' 91' ' ' ARG . 4.5 tppp? -74.46 -47.88 30.75 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.286 -0.415 . . . . 4.58 111.166 177.547 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -101.62 100.55 14.49 Favored Pre-proline 0 N--CA 1.463 0.218 0 N-CA-C 108.975 -0.75 . . . . 2.24 108.975 178.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -88.78 -16.29 2.42 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 123.009 2.472 . . . . 2.38 115.508 -165.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.426 ' HA ' ' O ' ' A' ' 105' ' ' ALA . 3.8 p30 -120.07 83.0 30.27 Favored Pre-proline 0 C--N 1.326 -0.423 0 N-CA-C 113.622 0.971 . . . . 3.61 113.622 -174.096 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -84.65 128.59 3.98 Favored 'Trans proline' 0 C--O 1.24 0.604 0 C-N-CA 123.657 2.905 . . . . 1.54 112.256 170.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 35.3 mm -70.2 91.76 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 121.199 0.523 . . . . 2.08 110.288 173.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 69.0 mt -99.13 134.1 39.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.923 -0.58 . . . . 1.55 111.277 -178.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.66 ' OD2' ' HB3' ' A' ' 45' ' ' HIS . 18.0 t70 41.56 30.88 0.16 Allowed 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.778 1.029 . . . . 1.52 113.778 -178.037 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 88.48 16.85 58.1 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 120.49 -0.862 . . . . 1.73 113.366 176.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.497 ' HB3' ' HG3' ' A' ' 43' ' ' PRO . 28.0 tpt180 -140.54 139.31 35.01 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.323 -0.621 . . . . 4.66 109.323 176.026 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -82.09 105.38 13.14 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 119.966 -0.694 . . . . 3.14 110.107 -178.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.494 ' HB3' ' O ' ' A' ' 40' ' ' GLY . . . -85.46 166.34 16.43 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 113.874 1.064 . . . . 1.37 113.874 177.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 22.7 t30 -108.86 119.34 39.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.388 -1.278 . . . . 2.18 110.187 -178.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 93.8 t -114.2 140.72 33.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.006 -0.543 . . . . 1.46 110.874 179.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -160.64 170.15 21.42 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.715 -0.846 . . . . 3.22 108.715 178.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.558 ' HG ' ' HB2' ' A' ' 93' ' ' CYS . 5.8 mt -79.67 127.35 32.08 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.361 -0.536 . . . . 1.87 110.737 178.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.713 ' HB1' ' HG2' ' A' ' 36' ' ' LYS . . . -69.26 -24.65 64.01 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.263 -0.881 . . . . 1.3 112.351 -174.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.551 ' CD1' ' HB3' ' A' ' 109' ' ' LEU . 0.1 OUTLIER -67.54 -3.64 9.34 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.849 0.357 . . . . 1.71 111.8 -173.616 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 96.8 mt -75.83 -24.06 55.8 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 116.43 -0.35 . . . . 1.97 110.295 175.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.455 ' O ' ' HG2' ' A' ' 115' ' ' LYS . . . -123.54 -58.13 0.19 Allowed Glycine 0 C--N 1.333 0.381 0 C-N-CA 120.931 -0.652 . . . . 2.24 111.53 173.445 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -50.89 149.37 3.53 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-O 121.634 0.731 . . . . 2.66 111.563 172.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.455 ' HG2' ' O ' ' A' ' 113' ' ' GLY . 26.5 mmtp -137.73 117.94 10.3 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 115.119 -0.946 . . . . 4.52 110.38 -166.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -96.73 32.43 0.15 Allowed 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 123.563 2.842 . . . . 5.53 113.041 -177.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.425 HH11 ' HD3' ' A' ' 117' ' ' ARG . 7.9 ttm180 -151.58 -57.53 0.15 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.957 0.408 . . . . 9.2 111.084 -177.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 12.1 p -90.64 9.79 28.3 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.144 0.497 . . . . 6.74 111.342 -177.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -154.83 164.28 39.05 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 107.736 -1.209 . . . . 8.27 107.736 174.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 39.6 t 59.72 85.91 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.294 0 CA-C-O 121.399 0.619 . . . . 9.39 109.966 -174.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 20.5 mm-40 . . . . . 0 C--O 1.251 1.171 0 CA-C-N 115.732 -0.667 . . . . 12.71 110.195 -174.819 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 1' ' ' ' G' . . . . . 0.515 ' C4 ' ' CE2' ' A' ' 44' ' ' TYR . . . . . . . . 0 O5'--C5' 1.433 -0.43 0 C3'-C2'-C1' 99.15 -2.611 . 0.0 '__' . 5.37 . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 2' ' ' ' G' . . . . . 0.505 ' C5 ' ' CE2' ' A' ' 44' ' ' TYR . . . . . . . . 0 O5'--C5' 1.422 -1.11 0 C3'-C2'-C1' 99.604 -2.107 . 0.0 OUTLIER . 4.87 . . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 3' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.429 -0.656 0 C3'-C2'-C1' 100.107 -1.548 . 0.0 OUTLIER . 5.58 . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 4' ' ' ' G' . . . . . 0.703 " H2'" ' HZ ' ' A' ' 38' ' ' PHE . . . . . . . . 0 O5'--C5' 1.424 -0.971 0 O4'-C1'-C2' 108.26 1.329 . 0.677 0i . 2.69 . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 5' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.431 -0.582 0 C4'-C3'-C2' 103.536 0.836 . 0.0 OUTLIER gamma 1.93 . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 6' ' ' ' G' . . . . . 0.561 ' N2 ' HG22 ' A' ' 65' ' ' VAL . . . . . . . . 0 O5'--C5' 1.426 -0.869 0 C4'-C3'-C2' 104.071 1.371 . 0.0 OUTLIER . 2.38 . . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.427 -0.789 0 C4'-C3'-C2' 104.06 1.36 . 0.0 OUTLIER . 4.41 . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.395 0 N-CA-C 111.578 -0.609 . . . . 13.51 111.578 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -142.47 176.63 8.86 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.633 0.254 . . . . 11.28 110.827 -177.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 4.6 mpp? -94.93 109.21 21.25 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.042 0.449 . . . . 10.15 110.533 -179.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -123.22 56.87 0.66 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.896 -0.668 . . . . 6.69 111.657 179.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 10.3 p -74.7 -64.65 0.99 Allowed 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 112.163 0.431 . . . . 5.68 112.163 -174.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 44.9 mtp180 -122.23 170.25 10.08 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.443 -0.344 . . . . 4.34 110.93 -172.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -78.29 107.0 10.58 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.725 0.774 . . . . 3.53 111.052 -178.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.643 ' HA ' ' OG1' ' A' ' 35' ' ' THR . 33.6 p -105.86 6.73 31.81 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.778 -0.647 . . . . 1.98 111.222 -178.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 48.6 ttp -69.32 -34.38 74.57 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.785 -0.366 . . . . 1.9 111.27 -179.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.52 ' HA ' HD12 ' A' ' 109' ' ' LEU . 25.1 m-85 -107.12 -24.16 12.04 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-O 120.801 0.334 . . . . 1.76 110.992 -178.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.72 ' O ' ' HA ' ' A' ' 82' ' ' THR . 27.1 p -81.4 11.75 4.21 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.289 -0.414 . . . . 1.23 110.958 -174.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.664 ' HD2' ' O6 ' ' B' ' 6' ' ' ' G' . 5.8 ttpm? -122.43 102.84 8.33 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.074 -0.512 . . . . 3.2 110.247 -173.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 5.0 mp -109.21 136.53 44.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.959 -0.564 . . . . 1.46 110.602 -176.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.556 ' HE2' ' C8 ' ' B' ' 4' ' ' ' G' . 85.7 t80 -95.13 120.51 35.48 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.987 -0.551 . . . . 0.81 109.589 176.225 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.61 HG13 HD12 ' A' ' 42' ' ' LEU . 96.8 t -132.84 99.08 3.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 118.775 -0.631 . . . . 1.61 110.851 -177.256 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.564 ' HA2' ' CD1' ' A' ' 42' ' ' LEU . . . -132.15 166.49 23.23 Favored Glycine 0 C--O 1.217 -0.913 0 C-N-CA 115.324 -3.322 . . . . 1.39 113.845 162.006 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 128.69 -2.93 6.51 Favored Glycine 0 N--CA 1.445 -0.762 0 N-CA-C 108.706 -1.758 . . . . 0.71 108.706 -168.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.684 ' HB3' ' HB ' ' A' ' 46' ' ' THR . 4.5 mp -62.1 142.13 95.61 Favored Pre-proline 0 N--CA 1.449 -0.486 0 CA-C-N 113.601 -1.3 . . . . 1.89 109.806 179.667 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.57 ' HD2' ' OG1' ' A' ' 46' ' ' THR . 52.5 Cg_exo -54.28 159.78 7.54 Favored 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.669 2.246 . . . . 0.82 111.581 172.386 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.525 ' CZ ' ' C5 ' ' B' ' 2' ' ' ' G' . 6.8 m-85 -71.55 -1.78 14.64 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.161 -0.472 . . . . 1.46 111.459 -174.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 72.4 t60 -104.08 -11.99 17.02 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.127 0.489 . . . . 2.65 109.944 176.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.684 ' HB ' ' HB3' ' A' ' 42' ' ' LEU . 5.4 m -79.06 129.94 34.99 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 115.921 -0.581 . . . . 1.31 109.868 -178.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 7.4 p -132.76 -177.58 4.55 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.534 -0.303 . . . . 0.75 111.566 -169.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.498 ' OD2' ' HA ' ' A' ' 65' ' ' VAL . 1.2 m-20 -57.01 -31.9 65.58 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.536 0.684 . . . . 0.49 110.043 -177.632 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.723 ' O ' ' HG2' ' A' ' 53' ' ' GLU . 55.2 pttt -74.1 -35.45 64.18 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.908 -1.042 . . . . 3.26 109.638 -178.017 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.651 HG22 HG21 ' A' ' 46' ' ' THR . 6.6 m -67.17 -43.98 80.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.735 0.302 . . . . 1.25 110.756 179.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.668 HD22 HD23 ' A' ' 42' ' ' LEU . 35.8 mt -61.46 -42.97 99.59 Favored 'General case' 0 CA--C 1.512 -0.493 0 N-CA-C 109.631 -0.507 . . . . 1.53 109.631 176.305 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.51 ' HA ' HD13 ' A' ' 61' ' ' ILE . 45.8 t-80 -53.3 -52.74 58.12 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.246 -0.888 . . . . 0.77 110.514 175.681 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.723 ' HG2' ' O ' ' A' ' 49' ' ' LYS . 8.5 mm-40 -59.49 -47.62 84.8 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.3 -0.409 . . . . 1.52 111.756 -176.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.531 ' O ' ' HB2' ' A' ' 57' ' ' GLN . 56.3 t80 -77.73 -36.53 50.75 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.289 0.478 . . . . 1.6 112.289 -170.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.734 ' HB2' HD12 ' A' ' 61' ' ' ILE . 42.9 m-85 -84.62 -30.03 25.27 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 113.224 0.824 . . . . 0.68 113.224 -173.197 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.688 ' HA ' ' O ' ' A' ' 59' ' ' GLY . 12.9 pt-20 -68.58 -11.38 59.91 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.677 0.751 . . . . 1.57 110.009 179.254 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.531 ' HB2' ' O ' ' A' ' 54' ' ' TYR . 27.6 mt-30 -59.35 -23.0 62.16 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.55 -1.204 . . . . 2.79 111.826 170.243 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -94.23 -21.45 19.04 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.217 0.532 . . . . 0.79 110.005 177.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.688 ' O ' ' HA ' ' A' ' 56' ' ' GLU . . . 159.14 -177.7 35.59 Favored Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 115.049 -0.978 . . . . 0.75 110.982 179.334 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -61.77 122.94 16.6 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 117.042 0.421 . . . . 1.02 110.577 -175.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.734 HD12 ' HB2' ' A' ' 55' ' ' PHE . 45.9 mt -86.99 125.03 40.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 O-C-N 122.351 -0.218 . . . . 1.13 110.468 171.506 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -75.64 -43.82 45.79 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.681 0.277 . . . . 2.07 111.607 178.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -152.12 132.55 13.78 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.326 -0.397 . . . . 2.48 111.251 -175.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -125.8 134.81 51.58 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.241 0.543 . . . . 1.18 111.145 178.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.664 HG22 ' H22' ' B' ' 6' ' ' ' G' . 31.2 m -144.76 148.43 18.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.225 -0.898 . . . . 1.97 112.485 -177.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 42.4 t -119.3 138.92 48.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.241 -0.89 . . . . 1.12 110.027 171.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.523 HG12 ' HA2' ' A' ' 79' ' ' GLY . 26.2 mm -91.91 153.71 3.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 114.898 -1.046 . . . . 1.44 110.441 -173.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 18.8 p -147.23 147.66 30.68 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 105.228 -2.138 . . . . 1.83 105.228 -170.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.671 ' HB3' ' H ' ' A' ' 74' ' ' LYS . 7.3 t70 -49.11 138.66 11.77 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 118.665 0.666 . . . . 2.49 111.529 -178.41 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 59.4 ttt180 -57.54 -53.49 57.59 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.158 -0.473 . . . . 6.58 111.574 -178.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -70.63 -62.78 1.26 Allowed 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.217 0.451 . . . . 4.33 112.217 -172.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.42 ' OG1' ' HG3' ' A' ' 74' ' ' LYS . 71.1 p -98.82 -14.79 19.51 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.334 -0.394 . . . . 3.67 111.558 -171.473 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.534 ' HA ' ' O ' ' A' ' 69' ' ' ASP . 40.7 mt-30 57.68 79.81 0.19 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 122.413 1.101 . . . . 3.61 111.655 -172.255 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.671 ' H ' ' HB3' ' A' ' 69' ' ' ASP . 45.2 mtmt -108.72 132.64 53.75 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 106.209 -1.775 . . . . 3.78 106.209 172.369 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 14.9 m -54.75 102.64 0.07 Allowed 'General case' 0 C--N 1.322 -0.613 0 O-C-N 123.318 0.386 . . . . 2.07 110.403 -178.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 26.7 mtm180 -69.58 -5.94 27.79 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.866 -0.606 . . . . 3.07 112.066 -175.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.551 ' HA3' ' C6 ' ' B' ' 2' ' ' ' G' . . . 77.98 9.63 86.8 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 119.88 -1.152 . . . . 0.75 111.082 -177.168 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.557 ' HD1' ' HA3' ' A' ' 40' ' ' GLY . 20.7 m-85 -117.34 154.05 31.95 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 110.035 -0.357 . . . . 1.61 110.035 -172.475 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.523 ' HA2' HG12 ' A' ' 67' ' ' ILE . . . -157.95 -167.3 18.69 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.388 -0.91 . . . . 0.59 113.145 173.065 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.556 ' HB2' ' CG2' ' A' ' 65' ' ' VAL . 49.7 m-85 -139.5 141.2 37.35 Favored 'General case' 0 CA--C 1.513 -0.469 0 C-N-CA 123.462 0.705 . . . . 0.84 109.496 178.527 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 54.6 t -127.33 111.85 26.54 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 CA-C-O 121.308 0.575 . . . . 1.21 109.931 175.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.72 ' HA ' ' O ' ' A' ' 35' ' ' THR . 29.3 m -109.19 112.43 24.59 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.467 -0.788 . . . . 1.09 109.351 176.416 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.647 ' SD ' HG12 ' A' ' 61' ' ' ILE . 59.8 mmm -87.44 175.34 8.01 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 121.227 0.537 . . . . 1.02 111.639 -172.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.4 ' HB2' ' HE3' ' A' ' 84' ' ' LYS . 37.9 ttmt -82.7 -31.91 28.31 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.189 -0.914 . . . . 2.47 110.826 -179.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -129.83 147.8 51.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.927 0.394 . . . . 1.68 110.446 178.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.566 ' H ' ' HD2' ' A' ' 86' ' ' ARG . 0.7 OUTLIER -73.44 -19.74 60.89 Favored 'General case' 0 C--O 1.218 -0.566 0 CA-C-N 115.812 -0.631 . . . . 4.24 112.105 -174.639 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.418 ' O ' ' HG3' ' A' ' 91' ' ' ARG . . . -67.04 -50.57 61.55 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 118.436 0.562 . . . . 1.33 111.201 176.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.442 ' HA ' ' HD2' ' A' ' 91' ' ' ARG . 14.4 m -63.96 -33.5 75.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.887 0.851 . . . . 1.34 109.36 175.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.494 ' CB ' ' HA ' ' A' ' 35' ' ' THR . . . -58.23 -47.5 83.34 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 113.683 -1.599 . . . . 1.16 110.011 173.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -60.69 -43.99 97.08 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.203 -0.453 . . . . 2.11 111.237 173.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.551 ' O ' ' HB3' ' A' ' 94' ' ' LYS . 99.4 mtt180 -57.59 -42.59 83.47 Favored 'General case' 0 C--O 1.225 -0.227 0 CA-C-O 120.888 0.375 . . . . 4.35 111.466 176.527 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.39 -36.67 83.05 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 111.874 0.324 . . . . 1.21 111.874 173.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 35.7 t -78.71 -7.55 57.84 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.207 0.527 . . . . 1.16 111.259 177.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.551 ' HB3' ' O ' ' A' ' 91' ' ' ARG . 16.1 tppt? -58.42 -48.36 80.92 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.628 -0.715 . . . . 4.58 111.613 -177.562 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -110.35 121.81 40.4 Favored Pre-proline 0 C--N 1.325 -0.495 0 C-N-CA 120.744 -0.383 . . . . 2.24 109.988 176.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -84.66 -1.76 9.65 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 122.902 2.402 . . . . 2.38 114.287 -173.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.57 ' HB2' ' HD3' ' A' ' 104' ' ' LYS . 6.0 p30 -152.61 68.4 6.96 Favored Pre-proline 0 CA--C 1.534 0.333 0 CA-C-O 121.392 0.615 . . . . 3.61 111.691 178.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -80.98 166.97 18.57 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 123.456 2.771 . . . . 1.54 111.686 179.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 47.2 mm -100.81 137.82 27.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 108.578 -0.897 . . . . 2.08 108.578 178.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 54.7 mt -144.77 111.8 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 109.323 -0.621 . . . . 1.55 109.323 -174.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.557 ' O ' ' HG2' ' A' ' 43' ' ' PRO . 16.8 t0 61.87 47.99 5.66 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 121.488 0.661 . . . . 1.52 111.019 173.387 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 82.74 -5.76 73.25 Favored Glycine 0 CA--C 1.529 0.924 0 N-CA-C 116.29 1.276 . . . . 1.73 116.29 178.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.431 ' CB ' ' HG3' ' A' ' 43' ' ' PRO . 23.8 ttt180 -137.93 150.97 47.51 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 118.933 1.367 . . . . 4.66 111.106 -177.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.57 ' HD3' ' HB2' ' A' ' 97' ' ' ASN . 24.3 ttmm -78.88 139.8 38.24 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.46 -0.336 . . . . 3.14 110.37 178.52 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -111.59 154.17 25.23 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.947 -0.57 . . . . 1.37 111.138 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.465 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 46.6 t-20 -95.47 127.86 41.86 Favored 'General case' 0 C--O 1.252 1.224 0 N-CA-C 108.597 -0.89 . . . . 2.18 108.597 173.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.606 HG23 HG11 ' A' ' 39' ' ' VAL . 88.0 t -142.37 129.4 19.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 113.838 -1.528 . . . . 1.46 110.45 -161.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -167.84 158.56 10.89 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.454 -0.572 . . . . 3.22 109.454 178.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.52 HD12 ' HA ' ' A' ' 34' ' ' PHE . 0.2 OUTLIER -57.92 131.94 51.9 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 107.827 -1.175 . . . . 1.87 107.827 173.061 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.96 -30.93 68.42 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.514 -0.475 . . . . 1.3 110.784 -162.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 4.0 p90 -70.86 -4.35 23.85 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.881 -0.6 . . . . 1.71 111.42 -172.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 80.4 mt -85.03 1.92 45.52 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.447 -0.342 . . . . 1.97 111.114 177.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -156.08 -1.95 0.11 Allowed Glycine 0 CA--C 1.516 0.125 0 N-CA-C 110.126 -1.189 . . . . 2.24 110.126 -179.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -95.61 158.72 15.33 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.093 -1.053 . . . . 2.66 108.919 178.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.417 ' HA ' ' HD3' ' A' ' 116' ' ' PRO . 99.6 mttt -131.51 146.03 60.17 Favored Pre-proline 0 C--N 1.316 -0.866 0 N-CA-C 109.123 -0.695 . . . . 4.52 109.123 172.199 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 115' ' ' LYS . 31.6 Cg_exo -56.28 -19.68 28.9 Favored 'Trans proline' 0 CA--C 1.512 -0.589 0 C-N-CA 123.954 3.102 . . . . 5.53 112.353 -169.186 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 47.1 ttp180 -148.24 73.01 1.23 Allowed 'General case' 0 N--CA 1.432 -1.341 0 CA-C-N 115.069 -0.968 . . . . 9.2 109.438 175.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 67.5 p 60.49 176.06 0.1 Allowed 'General case' 0 N--CA 1.467 0.388 0 O-C-N 124.679 1.237 . . . . 6.74 113.152 174.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -133.26 110.87 10.4 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.851 -0.613 . . . . 8.27 110.822 -175.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 60.1 t 74.99 -40.98 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-N 115.283 -0.871 . . . . 9.39 111.395 -178.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 25.4 mm-40 . . . . . 0 C--O 1.246 0.883 0 CA-C-O 118.155 -0.926 . . . . 12.71 109.818 176.249 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 1' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.433 -0.41 0 O5'-C5'-C4' 111.786 1.133 . 0.0 '__' . 5.37 . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 2' ' ' ' G' . . . . . 0.551 ' C6 ' ' HA3' ' A' ' 77' ' ' GLY . . . . . . . . 0 O5'--C5' 1.427 -0.808 0 O4'-C1'-N19 109.291 1.091 . 0.0 OUTLIER gamma 4.87 . . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 3' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.427 -0.815 0 C4'-C3'-C2' 104.092 1.392 . 0.0 OUTLIER . 5.58 . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 4' ' ' ' G' . . . . . 0.556 ' C8 ' ' HE2' ' A' ' 38' ' ' PHE . . . . . . . . 0 O5'--C5' 1.426 -0.905 0 O4'-C1'-C2' 108.126 1.233 . 0.0 OUTLIER . 2.69 . . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 5' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.424 -0.995 0 C4'-C3'-C2' 103.893 1.193 . 0.42 1t . 1.93 . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 6' ' ' ' G' . . . . . 0.664 ' O6 ' ' HD2' ' A' ' 36' ' ' LYS . . . . . . . . 0 O5'--C5' 1.427 -0.805 0 C3'-C2'-C1' 100.784 -0.796 . 0.0 OUTLIER . 2.38 . . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.426 -0.889 0 C4'-C3'-C2' 105.529 2.829 . 0.0 OUTLIER delta 4.41 . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.549 0 N-CA-C 112.049 -0.42 . . . . 13.51 112.049 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -151.87 135.39 16.13 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.716 -0.476 . . . . 11.28 109.716 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 24.9 mmt -83.48 -38.13 22.22 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.887 0.375 . . . . 10.15 110.534 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -63.02 135.31 43.36 Favored Glycine 0 N--CA 1.452 -0.279 0 CA-C-N 115.692 -0.686 . . . . 6.69 112.654 -178.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.65 106.58 15.48 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.302 0.573 . . . . 5.68 111.459 -179.089 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 68.0 mtm180 -97.48 -25.68 15.09 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.315 -0.857 . . . . 4.34 109.897 178.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 64.66 80.84 0.22 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 114.997 -1.001 . . . . 3.53 110.075 -175.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.671 ' HA ' ' OG1' ' A' ' 35' ' ' THR . 11.3 p -67.26 -15.25 63.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.973 -1.012 . . . . 1.98 111.972 -173.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' MET . . . . . 0.511 ' HE3' ' CE2' ' A' ' 34' ' ' PHE . 7.4 ttt -57.89 -39.1 77.04 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.462 -0.335 . . . . 1.9 111.085 176.125 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.556 ' HA ' HD12 ' A' ' 109' ' ' LEU . 40.7 m-85 -103.66 -24.23 13.39 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 111.859 0.318 . . . . 1.76 111.859 -178.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.671 ' OG1' ' HA ' ' A' ' 32' ' ' THR . 57.7 p -78.91 -10.9 59.95 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.362 -0.535 . . . . 1.23 110.446 -174.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 47.1 tttm -88.23 106.43 18.19 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 115.367 -0.833 . . . . 3.2 109.104 179.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 95.3 mt -104.6 134.89 44.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 116.051 -0.522 . . . . 1.46 110.442 -179.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.691 ' HE1' " H1'" ' B' ' 5' ' ' ' U' . 82.5 t80 -99.02 121.31 40.8 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.397 -0.594 . . . . 0.81 109.397 179.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.637 HG11 HD12 ' A' ' 42' ' ' LEU . 3.9 t -106.63 140.19 25.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.137 0.494 . . . . 1.61 110.477 -174.425 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -140.76 152.68 23.23 Favored Glycine 0 N--CA 1.452 -0.275 0 CA-C-N 115.29 -0.868 . . . . 1.39 113.423 -167.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.08 40.66 95.17 Favored Glycine 0 C--O 1.228 -0.263 0 C-N-CA 121.635 -0.317 . . . . 0.71 113.298 172.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.637 HD12 HG11 ' A' ' 39' ' ' VAL . 7.1 mp -82.38 134.71 47.97 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-O 120.861 0.363 . . . . 1.89 110.86 179.111 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.572 ' HG3' ' HG3' ' A' ' 103' ' ' ARG . 50.6 Cg_exo -52.91 153.4 15.3 Favored 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.709 2.273 . . . . 0.82 111.379 172.292 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.559 ' HA ' ' HB3' ' A' ' 75' ' ' SER . 20.6 m-85 -67.49 -7.38 25.15 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 113.292 0.849 . . . . 1.46 113.292 -170.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -111.98 2.51 16.94 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 120.409 -0.516 . . . . 2.65 111.168 176.38 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.601 HG21 HG22 ' A' ' 50' ' ' THR . 38.4 m -74.39 134.59 42.42 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.284 -0.416 . . . . 1.31 110.405 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 10.4 p -136.35 -176.85 4.47 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-O 121.507 0.67 . . . . 0.75 112.053 -171.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -60.46 -36.26 77.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.825 -1.08 . . . . 0.49 110.76 -173.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.532 ' O ' ' HG2' ' A' ' 53' ' ' GLU . 9.2 ptmm? -65.15 -36.99 85.98 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.461 -0.79 . . . . 3.26 110.855 178.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.601 HG22 HG21 ' A' ' 46' ' ' THR . 88.0 m -62.07 -45.95 91.27 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.085 0.469 . . . . 1.25 110.922 179.104 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.528 HD22 HG13 ' A' ' 39' ' ' VAL . 98.2 mt -68.33 -34.71 76.59 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.77 -0.65 . . . . 1.53 110.687 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.456 ' O ' ' HG2' ' A' ' 56' ' ' GLU . 55.6 t-80 -59.69 -53.82 53.51 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.111 0.481 . . . . 0.77 109.966 178.225 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.532 ' HG2' ' O ' ' A' ' 49' ' ' LYS . 11.8 mm-40 -57.72 -44.03 85.69 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.618 -0.719 . . . . 1.52 112.628 -179.401 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.621 ' O ' ' HB2' ' A' ' 57' ' ' GLN . 67.8 t80 -76.48 -34.43 58.66 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.821 0.674 . . . . 1.6 112.821 -174.585 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -84.69 -30.5 24.76 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 113.898 1.073 . . . . 0.68 113.898 -171.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.456 ' HG2' ' O ' ' A' ' 52' ' ' HIS . 15.0 pt-20 -71.5 -12.04 61.18 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.842 0.83 . . . . 1.57 110.003 177.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.621 ' HB2' ' O ' ' A' ' 54' ' ' TYR . 27.6 mm-40 -56.03 -24.84 41.78 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.037 -0.983 . . . . 2.79 111.539 166.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -106.64 6.93 30.32 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 111.74 0.274 . . . . 0.79 111.74 -177.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 146.48 -137.86 7.05 Favored Glycine 0 C--O 1.224 -0.529 0 C-N-CA 120.486 -0.864 . . . . 0.75 112.794 -176.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -114.04 127.14 55.81 Favored 'General case' 0 C--N 1.327 -0.372 0 O-C-N 122.661 -0.317 . . . . 1.02 110.874 -178.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.423 HG13 ' HB3' ' A' ' 56' ' ' GLU . 8.7 mt -94.24 126.9 46.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 110.116 -0.328 . . . . 1.13 110.116 176.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -83.59 -48.72 9.92 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.581 -0.448 . . . . 2.07 110.372 174.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -141.56 126.71 18.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.261 -0.427 . . . . 2.48 111.112 -176.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -123.23 123.75 41.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.059 0.457 . . . . 1.18 110.555 174.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.538 HG23 ' H21' ' B' ' 6' ' ' ' G' . 29.6 m -139.09 143.74 30.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.0 -1.0 . . . . 1.97 112.141 -179.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 70.4 t -115.08 139.54 40.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 108.761 -0.829 . . . . 1.12 108.761 170.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 44.2 mm -91.1 95.06 5.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 N-CA-C 109.439 -0.578 . . . . 1.44 109.439 -179.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.485 HG23 ' HA ' ' A' ' 75' ' ' SER . 9.1 p -92.8 158.1 16.06 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.047 -0.524 . . . . 1.83 110.985 177.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.41 ' O ' ' N ' ' A' ' 73' ' ' GLN . 18.6 t70 -57.05 118.24 4.81 Favored 'General case' 0 C--O 1.213 -0.842 0 CA-C-N 115.167 -0.924 . . . . 2.49 110.825 -178.025 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 7.8 ptp180 -56.41 -30.09 62.36 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 113.514 0.931 . . . . 6.58 113.514 -176.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -78.21 -53.55 7.21 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.334 0.494 . . . . 4.33 112.334 -176.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 14.0 p -111.49 -18.07 12.93 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.149 0.499 . . . . 3.67 112.081 -174.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.41 ' N ' ' O ' ' A' ' 69' ' ' ASP . 48.4 mt-30 57.57 81.65 0.14 Allowed 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 123.056 1.408 . . . . 3.61 111.733 -172.321 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.557 ' HB3' ' O6 ' ' B' ' 1' ' ' ' G' . 7.0 mttp -124.08 143.91 50.18 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 112.086 -2.324 . . . . 3.78 105.655 172.447 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.559 ' HB3' ' HA ' ' A' ' 44' ' ' TYR . 12.3 t -66.16 103.96 1.08 Allowed 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 120.337 -0.545 . . . . 2.07 110.274 -175.229 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 10.8 mtp180 -59.23 -11.76 4.41 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.505 -0.77 . . . . 3.07 111.363 174.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 92.59 14.77 54.92 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.812 -0.709 . . . . 0.75 113.113 175.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.436 ' CE1' " H1'" ' B' ' 4' ' ' ' G' . 14.4 m-85 -128.41 141.0 51.54 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.422 -0.584 . . . . 1.61 109.422 -178.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -138.65 -178.28 16.12 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.435 -0.888 . . . . 0.59 111.865 179.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -152.03 130.08 11.85 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.386 -0.598 . . . . 0.84 109.386 -177.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 63.7 t -128.22 119.59 51.15 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 CA-C-N 115.813 -0.63 . . . . 1.21 109.936 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.543 ' HA ' ' O ' ' A' ' 35' ' ' THR . 34.8 m -109.45 114.23 27.71 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.183 -1.043 . . . . 1.09 108.183 177.379 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 87.8 mmm -87.94 168.71 12.63 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 122.078 -0.389 . . . . 1.02 110.012 -174.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -83.05 -16.34 47.43 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.272 -0.422 . . . . 2.47 111.05 -176.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -147.97 148.69 31.03 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 120.813 0.339 . . . . 1.68 110.607 -179.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -71.32 -20.84 62.14 Favored 'General case' 0 C--O 1.224 -0.246 0 N-CA-C 112.502 0.556 . . . . 4.24 112.502 -174.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -71.61 -45.75 61.19 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 118.556 0.616 . . . . 1.33 111.346 -179.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 19.4 m -63.37 -35.59 80.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.94 0.876 . . . . 1.34 109.489 173.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.481 ' HB2' ' O ' ' A' ' 34' ' ' PHE . . . -58.79 -46.9 86.49 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 113.503 -1.681 . . . . 1.16 109.824 174.645 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -57.37 -50.03 74.27 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.543 -0.753 . . . . 2.11 112.276 174.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.535 ' O ' ' HB3' ' A' ' 94' ' ' LYS . 79.3 mtp180 -57.06 -46.0 82.8 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.817 0.341 . . . . 4.35 111.457 -179.186 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -60.06 -40.34 89.14 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.154 -0.476 . . . . 1.21 111.858 176.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 49.7 t -71.89 -17.1 62.13 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.294 0.569 . . . . 1.16 110.449 177.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.535 ' HB3' ' O ' ' A' ' 91' ' ' ARG . 21.2 tptp -78.65 7.08 7.41 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.415 0.686 . . . . 4.58 110.821 179.253 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -142.13 76.98 18.56 Favored Pre-proline 0 C--N 1.323 -0.565 0 O-C-N 121.616 -0.678 . . . . 2.24 110.011 -176.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -73.43 156.11 50.32 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 123.095 2.53 . . . . 2.38 111.945 -178.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.608 ' HA ' ' O ' ' A' ' 105' ' ' ALA . 1.9 p-10 34.35 64.14 1.73 Allowed Pre-proline 0 N--CA 1.471 0.615 0 O-C-N 124.166 0.916 . . . . 3.61 113.073 -171.449 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -82.21 167.43 15.78 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 123.063 2.509 . . . . 1.54 111.714 178.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 49.6 mm -89.53 130.74 38.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 116.281 -0.418 . . . . 2.08 110.097 178.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 56.5 mt -146.57 139.67 20.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.801 -0.636 . . . . 1.55 109.326 -175.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 42.7 t0 44.93 42.47 6.26 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 113.134 0.79 . . . . 1.52 113.134 177.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 70.45 17.98 74.97 Favored Glycine 0 CA--C 1.524 0.626 0 C-N-CA 121.128 -0.558 . . . . 1.73 113.619 177.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.572 ' HG3' ' HG3' ' A' ' 43' ' ' PRO . 30.6 mmt180 -143.23 162.38 35.79 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.372 -0.603 . . . . 4.66 109.372 -179.487 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -80.64 134.52 35.89 Favored 'General case' 0 C--N 1.317 -0.845 0 C-N-CA 120.108 -0.637 . . . . 3.14 109.757 171.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.608 ' O ' ' HA ' ' A' ' 97' ' ' ASN . . . -121.67 165.11 16.26 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 107.738 -1.208 . . . . 1.37 107.738 -177.21 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 44.4 t30 -116.38 110.57 18.85 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 120.344 -0.542 . . . . 2.18 110.375 177.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 88.5 t -116.38 139.9 41.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 120.981 0.42 . . . . 1.46 111.611 176.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.523 ' OD1' HD11 ' A' ' 112' ' ' LEU . 5.7 t-20 -162.98 173.75 13.22 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 107.929 -1.137 . . . . 3.22 107.929 175.215 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.556 HD12 ' HA ' ' A' ' 34' ' ' PHE . 0.2 OUTLIER -62.77 146.56 52.18 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.74 -0.837 . . . . 1.87 108.74 175.904 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.624 ' HA ' ' CB ' ' A' ' 38' ' ' PHE . . . -68.47 -40.61 80.95 Favored 'General case' 0 CA--C 1.512 -0.484 0 C-N-CA 120.634 -0.427 . . . . 1.3 111.305 -169.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 9.7 p90 -67.22 -16.09 64.09 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.186 -0.461 . . . . 1.71 111.04 -173.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.523 HD11 ' OD1' ' A' ' 108' ' ' ASN . 96.2 mt -86.8 -14.66 41.57 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 116.327 -0.397 . . . . 1.97 111.696 176.07 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -100.52 -1.48 55.48 Favored Glycine 0 CA--C 1.507 -0.407 0 C-N-CA 120.833 -0.698 . . . . 2.24 112.086 -177.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.5 ' HB3' ' C5 ' ' B' ' 5' ' ' ' U' . . . -89.06 127.1 35.68 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.619 0.247 . . . . 2.66 111.366 -167.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -133.8 74.46 69.62 Favored Pre-proline 0 C--N 1.323 -0.544 0 N-CA-C 109.502 -0.555 . . . . 4.52 109.502 173.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -87.71 0.01 7.21 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 123.106 2.538 . . . . 5.53 112.284 -176.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 49.3 ttm-85 -179.1 -40.47 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.373 -0.83 . . . . 9.2 109.079 -174.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.423 HG21 HG21 ' A' ' 120' ' ' VAL . 9.5 t -162.18 173.6 14.06 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 114.841 -1.072 . . . . 6.74 108.927 -177.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -107.32 -48.76 3.39 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.841 -0.429 . . . . 8.27 109.841 179.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.423 HG21 HG21 ' A' ' 118' ' ' THR . 95.6 t 71.17 -73.46 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 115.265 -0.879 . . . . 9.39 111.958 177.232 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 . . . . . 0 C--O 1.25 1.119 0 CA-C-O 118.212 -0.899 . . . . 12.71 110.812 -173.586 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 1' ' ' ' G' . . . . . 0.557 ' O6 ' ' HB3' ' A' ' 74' ' ' LYS . . . . . . . . 0 O5'--C5' 1.429 -0.662 0 C3'-C2'-C1' 100.283 -1.352 . 0.0 '__' . 5.37 . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 2' ' ' ' G' . . . . . 0.403 ' H1 ' ' HA ' ' A' ' 43' ' ' PRO . . . . . . . . 0 O5'--C5' 1.427 -0.816 0 C3'-C2'-C1' 99.501 -2.221 . 0.0 OUTLIER . 4.87 . . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 3' ' ' ' U' . . . . . 0.418 HO2' " C4'" ' B' ' 4' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.429 -0.717 0 O4'-C1'-N19 106.861 -1.339 . 0.0 OUTLIER gamma 5.58 . . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 4' ' ' ' G' . . . . . 0.579 " H3'" ' N3 ' ' B' ' 4' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.427 -0.794 0 O4'-C1'-C2' 107.87 1.05 . 0.0 OUTLIER gamma 2.69 . . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 5' ' ' ' U' . . . . . 0.892 " O2'" H5'' ' B' ' 6' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.425 -0.929 0 C3'-C2'-C1' 98.974 -2.807 . 0.0 OUTLIER . 1.93 . . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 6' ' ' ' G' . . . . . 0.892 H5'' " O2'" ' B' ' 5' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.427 -0.802 1 P-O3'-C3' 124.925 4.354 . 0.0 OUTLIER . 2.38 . . . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.423 -1.038 0 C3'-C2'-C1' 104.238 3.042 . 0.0 OUTLIER . 4.41 . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.703 0 N-CA-C 111.906 -0.478 . . . . 13.51 111.906 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . 67.35 177.01 0.24 Allowed 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 123.372 0.669 . . . . 11.28 111.877 179.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 26.6 ptm -160.97 175.43 12.5 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.537 -0.542 . . . . 10.15 109.537 178.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 69.7 -94.32 0.42 Allowed Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.955 -0.64 . . . . 6.69 111.615 -175.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 9.4 t 179.6 -67.11 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.807 -0.812 . . . . 5.68 108.807 177.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 12.4 ttm180 -150.31 -41.26 0.13 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.739 -0.664 . . . . 4.34 110.125 178.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 32.0 t70 74.82 153.56 0.14 Allowed 'General case' 0 N--CA 1.471 0.615 0 O-C-N 124.221 0.951 . . . . 3.53 110.316 -177.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 21.9 p -116.23 33.08 5.73 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 112.527 0.565 . . . . 1.98 112.527 -172.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 46.7 ttp -75.3 69.39 2.12 Favored 'General case' 0 C--N 1.333 -0.127 0 N-CA-C 108.326 -0.99 . . . . 1.9 108.326 167.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.468 ' HB3' ' HB2' ' A' ' 86' ' ' ARG . 20.4 m-85 123.79 -176.12 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 127.339 2.256 . . . . 1.76 106.918 -173.431 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.518 ' HA ' ' HB3' ' A' ' 89' ' ' ALA . 34.6 p 61.22 -40.79 0.12 Allowed 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 114.384 1.253 . . . . 1.23 114.384 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.536 ' HE3' ' O6 ' ' B' ' 6' ' ' ' G' . 85.4 tttt -80.07 112.56 17.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.286 0.565 . . . . 3.2 110.511 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.52 ' CG2' HG11 ' A' ' 107' ' ' VAL . 82.8 mt -106.84 131.24 57.26 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 CA-C-N 115.514 -0.766 . . . . 1.46 110.842 -178.306 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -86.87 120.12 27.82 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.117 -0.697 . . . . 0.81 109.117 177.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.632 HG11 HD12 ' A' ' 42' ' ' LEU . 5.3 t -112.21 139.91 34.48 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-O 121.514 0.673 . . . . 1.61 111.15 -175.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -144.76 157.01 27.14 Favored Glycine 0 C--O 1.225 -0.421 0 CA-C-N 114.757 -1.111 . . . . 1.39 113.422 -171.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 71.05 34.97 64.63 Favored Glycine 0 C--O 1.227 -0.296 0 C-N-CA 121.31 -0.472 . . . . 0.71 113.549 172.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.632 HD12 HG11 ' A' ' 39' ' ' VAL . 6.8 mp -83.5 134.17 45.68 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-O 120.744 0.307 . . . . 1.89 111.228 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.601 ' HG3' ' CG ' ' A' ' 103' ' ' ARG . 52.8 Cg_exo -52.05 158.26 5.17 Favored 'Trans proline' 0 N--CA 1.461 -0.394 0 C-N-CA 122.92 2.413 . . . . 0.82 111.792 173.057 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -72.53 3.83 4.51 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.933 0.397 . . . . 1.46 111.207 -178.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 80.3 t60 -112.07 -8.92 14.01 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.057 -0.519 . . . . 2.65 110.943 178.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.561 ' CG2' HD21 ' A' ' 42' ' ' LEU . 12.5 m -77.6 125.88 30.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.994 0.426 . . . . 1.31 111.805 -176.356 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 6.5 p -121.08 -178.32 3.73 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.903 -0.59 . . . . 0.75 111.243 -176.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -59.19 -34.81 72.58 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 115.841 -0.618 . . . . 0.49 109.863 -176.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.578 ' HG3' ' N ' ' A' ' 50' ' ' THR . 12.3 pttp -62.13 -39.5 92.76 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.322 -0.854 . . . . 3.26 110.133 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.578 ' N ' ' HG3' ' A' ' 49' ' ' LYS . 15.1 m -68.27 -41.08 81.6 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 116.381 -0.372 . . . . 1.25 110.518 -176.105 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.504 HD22 HG13 ' A' ' 39' ' ' VAL . 65.7 mt -63.66 -35.96 82.26 Favored 'General case' 0 C--O 1.222 -0.355 0 C-N-CA 120.434 -0.506 . . . . 1.53 110.207 174.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 59.2 t-80 -67.28 -51.12 56.66 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.475 -0.49 . . . . 0.77 110.089 179.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.503 ' HG3' ' O ' ' A' ' 49' ' ' LYS . 42.4 mt-10 -55.88 -43.76 77.5 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.729 0.299 . . . . 1.52 111.574 -179.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.506 ' O ' ' HB2' ' A' ' 57' ' ' GLN . 4.7 t80 -75.79 -35.13 60.17 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.353 -0.385 . . . . 1.6 111.609 -176.124 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.443 ' HD1' ' O ' ' A' ' 51' ' ' LEU . 45.9 m-85 -86.82 -28.24 23.05 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 114.126 1.158 . . . . 0.68 114.126 -172.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.687 ' N ' HD12 ' A' ' 61' ' ' ILE . 15.0 pt-20 -70.54 -15.93 62.83 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 122.395 1.093 . . . . 1.57 109.236 -178.639 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.506 ' HB2' ' O ' ' A' ' 54' ' ' TYR . 23.9 mt-30 -53.72 -27.78 30.23 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 113.481 -1.69 . . . . 2.79 112.174 168.438 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -100.17 -13.67 18.84 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.156 -0.475 . . . . 0.79 110.387 -177.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.503 ' O ' ' HA ' ' A' ' 56' ' ' GLU . . . 144.57 -155.54 26.41 Favored Glycine 0 N--CA 1.448 -0.505 0 CA-C-N 115.658 -0.701 . . . . 0.75 112.115 175.09 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -64.32 123.34 18.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.109 0.481 . . . . 1.02 112.29 -179.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.687 HD12 ' N ' ' A' ' 56' ' ' GLU . 10.0 mt -101.61 123.92 55.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 108.208 -1.034 . . . . 1.13 108.208 172.293 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -79.74 -44.08 21.4 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.308 0.575 . . . . 2.07 110.406 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -148.65 130.52 15.19 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.658 -0.701 . . . . 2.48 110.675 -179.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -117.45 115.83 25.96 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.067 -0.515 . . . . 1.18 110.086 174.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.405 HG12 ' H21' ' B' ' 6' ' ' ' G' . 9.1 p -137.11 135.31 47.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.446 -0.797 . . . . 1.97 112.065 -177.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 89.8 t -98.91 132.81 43.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.498 -0.774 . . . . 1.12 109.033 172.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.567 ' H ' ' HA2' ' A' ' 79' ' ' GLY . 36.6 mm -74.87 84.36 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.826 0.822 . . . . 1.44 109.479 177.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.758 ' HB ' ' HA ' ' A' ' 73' ' ' GLN . 16.7 p -97.46 177.42 5.53 Favored 'General case' 0 N--CA 1.435 -1.222 0 CA-C-N 114.419 -1.264 . . . . 1.83 110.734 -177.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -85.11 121.57 28.07 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.926 -0.31 . . . . 2.49 110.719 -177.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 3.2 ptm180 -49.37 -17.03 0.22 Allowed 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 114.28 1.215 . . . . 6.58 114.28 -177.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 48.5 m-80 -83.95 -41.3 17.48 Favored 'General case' 0 N--CA 1.462 0.174 0 O-C-N 121.847 -0.533 . . . . 4.33 111.538 -177.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 31.9 p -132.42 -29.28 1.59 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.927 0.394 . . . . 3.67 111.602 -175.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.758 ' HA ' ' HB ' ' A' ' 68' ' ' THR . 27.1 mt-30 61.87 22.86 13.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.461 -0.79 . . . . 3.61 112.068 -178.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -54.61 -45.12 73.63 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 111.895 0.332 . . . . 3.78 111.895 174.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.643 ' O ' ' HA ' ' A' ' 68' ' ' THR . 58.3 p -175.54 -122.87 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 112.332 0.493 . . . . 2.07 112.332 173.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.562 ' HG3' ' O ' ' A' ' 75' ' ' SER . 46.0 mtt180 129.54 -50.31 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 126.964 2.106 . . . . 3.07 110.137 -167.549 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 104.67 16.62 17.01 Favored Glycine 0 N--CA 1.454 -0.157 0 C-N-CA 120.675 -0.774 . . . . 0.75 113.43 177.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -129.69 152.94 48.64 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.424 -0.954 . . . . 1.61 108.424 177.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.567 ' HA2' ' H ' ' A' ' 67' ' ' ILE . . . -157.08 -166.31 16.43 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 119.854 -1.165 . . . . 0.59 112.509 177.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -159.57 125.01 4.16 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 123.563 0.745 . . . . 0.84 109.216 -177.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 69.9 t -117.95 118.79 59.44 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 N-CA-C 109.669 -0.493 . . . . 1.21 109.669 177.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 17.8 m -110.16 109.48 20.0 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 108.03 -1.1 . . . . 1.09 108.03 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.478 ' HA ' ' HA ' ' A' ' 61' ' ' ILE . 44.1 mtp -88.25 166.56 14.25 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 110.138 -0.319 . . . . 1.02 110.138 -173.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.5 ' HZ3' ' HB2' ' A' ' 84' ' ' LYS . 4.3 ttmp? -74.28 -43.21 57.81 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.929 -0.308 . . . . 2.47 111.376 -174.147 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -128.56 151.01 49.94 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-O 121.784 0.802 . . . . 1.68 111.225 179.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.468 ' HB2' ' HB3' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -65.72 -23.06 66.67 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 114.421 -1.263 . . . . 4.24 112.646 -172.153 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.25 -46.65 76.39 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 118.768 0.713 . . . . 1.33 111.155 -179.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 18.2 m -64.86 -38.23 90.28 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.683 0.754 . . . . 1.34 109.766 176.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.518 ' HB3' ' HA ' ' A' ' 35' ' ' THR . . . -58.41 -47.41 83.99 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 113.544 -1.662 . . . . 1.16 109.691 176.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.595 ' O ' ' HG2' ' A' ' 94' ' ' LYS . 6.3 mm-40 -56.04 -50.88 69.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.12 -0.945 . . . . 2.11 112.006 175.104 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 43.9 mtm180 -57.89 -43.66 86.25 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.518 0.199 . . . . 4.35 111.165 -178.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -56.88 -37.1 70.89 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.934 -0.575 . . . . 1.21 111.711 177.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 48.0 t -86.77 -13.41 45.27 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 112.677 0.621 . . . . 1.16 112.677 -178.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.595 ' HG2' ' O ' ' A' ' 90' ' ' GLU . 72.5 mmtt -65.77 -43.75 87.91 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 120.888 0.375 . . . . 4.58 110.751 -177.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -114.49 92.99 30.45 Favored Pre-proline 0 C--N 1.326 -0.441 0 N-CA-C 109.646 -0.501 . . . . 2.24 109.646 176.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -81.09 -166.7 0.43 Allowed 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 122.735 2.29 . . . . 2.38 112.649 -176.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.708 ' HA ' ' O ' ' A' ' 105' ' ' ALA . 22.7 m120 38.95 63.42 4.28 Favored Pre-proline 0 N--CA 1.467 0.396 0 N-CA-C 113.512 0.93 . . . . 3.61 113.512 -173.372 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.45 ' HD3' ' N ' ' A' ' 97' ' ' ASN . 2.5 Cg_endo -81.54 143.44 13.59 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.775 2.317 . . . . 1.54 110.82 174.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 38.6 mm -81.22 90.25 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.301 0.572 . . . . 2.08 109.827 178.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 31.1 mt -90.88 106.78 17.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 121.462 0.649 . . . . 1.55 111.199 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.437 ' HB2' HG22 ' A' ' 50' ' ' THR . 35.6 t70 66.1 46.62 2.08 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 113.889 -1.505 . . . . 1.52 110.147 166.051 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 91.23 -7.1 81.02 Favored Glycine 0 N--CA 1.451 -0.34 0 CA-C-N 114.94 -1.027 . . . . 1.73 114.821 175.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.601 ' CG ' ' HG3' ' A' ' 43' ' ' PRO . 20.9 mmt180 -133.77 148.93 51.42 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 118.614 1.207 . . . . 4.66 111.642 177.299 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -67.23 138.8 57.2 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.371 -0.831 . . . . 3.14 109.927 174.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.708 ' O ' ' HA ' ' A' ' 97' ' ' ASN . . . -124.57 150.87 45.44 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.042 -0.526 . . . . 1.37 109.856 -172.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -101.69 110.32 22.29 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 109.609 -0.515 . . . . 2.18 109.609 177.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.52 HG11 ' CG2' ' A' ' 37' ' ' ILE . 44.8 t -109.73 133.32 55.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.701 -0.681 . . . . 1.46 111.057 174.198 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -158.65 163.45 36.89 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.856 -0.794 . . . . 3.22 108.856 175.036 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.521 ' HB3' ' CD1' ' A' ' 111' ' ' TYR . 1.7 mm? -76.68 125.56 29.47 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.994 0.426 . . . . 1.87 110.709 -178.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.63 -25.83 65.93 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 113.314 0.857 . . . . 1.3 113.314 -174.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.521 ' CD1' ' HB3' ' A' ' 109' ' ' LEU . 2.6 p90 -68.42 -3.4 11.14 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.966 0.412 . . . . 1.71 111.295 -174.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 99.5 mt -73.46 -29.2 62.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.232 -0.44 . . . . 1.97 110.283 175.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -146.47 46.36 0.75 Allowed Glycine 0 C--N 1.333 0.384 0 C-N-CA 120.974 -0.632 . . . . 2.24 111.59 178.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -88.09 126.89 35.35 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.927 -0.136 . . . . 2.66 110.679 -176.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.418 ' HE3' ' HB2' ' A' ' 115' ' ' LYS . 24.5 mtmt -141.84 68.33 23.79 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 120.781 0.324 . . . . 4.52 110.742 177.381 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -89.25 -12.88 3.1 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.774 2.316 . . . . 5.53 111.175 175.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 47.1 ttp180 -175.92 173.38 2.3 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 106.947 -1.501 . . . . 9.2 106.947 -178.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 5.5 p 65.34 20.11 11.77 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.259 0.624 . . . . 6.74 109.991 -176.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -60.5 133.8 56.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.142 -0.935 . . . . 8.27 111.055 -176.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 41.8 t -60.9 -44.93 98.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.662 -0.699 . . . . 9.39 110.231 177.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.45 ' OE1' ' HA ' ' A' ' 121' ' ' GLN . 6.1 tp60 . . . . . 0 C--O 1.247 0.936 0 CA-C-N 115.24 -0.891 . . . . 12.71 110.392 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 1' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.43 -0.63 0 O5'-C5'-C4' 111.544 0.96 . 0.0 '__' . 5.37 . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 2' ' ' ' G' . . . . . 0.404 ' H1 ' ' HA ' ' A' ' 43' ' ' PRO . . . . . . . . 0 O5'--C5' 1.423 -1.091 0 C3'-C2'-C1' 99.281 -2.465 . 0.0 OUTLIER . 4.87 . . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 3' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.426 -0.901 0 C4'-C3'-C2' 104.261 1.561 . 0.0 OUTLIER . 5.58 . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 4' ' ' ' G' . . . . . 0.544 " H3'" ' N3 ' ' B' ' 4' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.428 -0.751 0 O4'-C1'-C2' 107.982 1.13 . 0.0 OUTLIER '7D dist 2a' 2.69 . . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 5' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.426 -0.887 0 C3'-C2'-C1' 100.269 -1.368 . 0.01 1t . 1.93 . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 6' ' ' ' G' . . . . . 0.536 ' O6 ' ' HE3' ' A' ' 36' ' ' LYS . . . . . . . . 0 O5'--C5' 1.428 -0.742 0 C4'-C3'-C2' 104.209 1.509 . 0.0 OUTLIER '7D dist 4b' 2.38 . . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.428 -0.779 0 C1'-O4'-C4' 110.265 0.738 . 0.0 OUTLIER . 4.41 . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.785 0 N-CA-C 112.561 -0.215 . . . . 13.51 112.561 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -75.79 169.92 17.21 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.15 0.5 . . . . 11.28 111.579 -177.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 51.3 ttm -144.83 126.49 15.15 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.735 -0.666 . . . . 10.15 110.165 179.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 81.46 81.71 0.85 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.746 -0.74 . . . . 6.69 112.966 178.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 50.3 m -99.58 -56.11 2.49 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 122.512 -0.405 . . . . 5.68 110.211 174.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 65.17 84.62 0.15 Allowed 'General case' 0 N--CA 1.463 0.213 0 O-C-N 123.74 0.65 . . . . 4.34 110.646 178.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -63.55 113.22 3.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.167 -0.924 . . . . 3.53 110.753 -179.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 18.4 p -78.35 -1.56 33.87 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.862 -0.608 . . . . 1.98 111.785 -175.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 50.7 ttp -58.22 -40.67 82.26 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.461 0.541 . . . . 1.9 112.461 -174.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.485 ' O ' HD12 ' A' ' 109' ' ' LEU . 39.4 m-85 -96.25 -11.73 25.58 Favored 'General case' 0 C--O 1.224 -0.256 0 O-C-N 121.911 -0.493 . . . . 1.76 111.253 -177.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.524 ' O ' ' HA ' ' A' ' 82' ' ' THR . 39.3 p -105.28 4.49 31.09 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 111.989 0.366 . . . . 1.23 111.989 -173.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -92.83 102.5 14.88 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.322 -0.399 . . . . 3.2 110.046 -178.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.422 HG21 ' O ' ' A' ' 108' ' ' ASN . 4.0 mp -103.42 135.33 41.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.76 0.314 . . . . 1.46 110.674 -177.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.626 ' HD2' HD22 ' A' ' 108' ' ' ASN . 51.5 t80 -94.78 109.38 21.35 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.412 -0.588 . . . . 0.81 109.412 175.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.601 HG12 HD12 ' A' ' 51' ' ' LEU . 5.5 t -97.89 142.94 13.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-N 115.469 -0.787 . . . . 1.61 110.634 -176.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -143.27 161.01 27.66 Favored Glycine 0 N--CA 1.447 -0.624 0 CA-C-N 114.538 -1.21 . . . . 1.39 111.717 -171.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 71.18 21.62 78.47 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.892 -0.671 . . . . 0.71 113.259 175.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.667 HD13 HD11 ' A' ' 51' ' ' LEU . 2.9 mm? -67.02 119.3 63.17 Favored Pre-proline 0 C--O 1.223 -0.319 0 N-CA-C 109.094 -0.706 . . . . 1.89 109.094 175.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.658 ' CG ' ' HB3' ' A' ' 101' ' ' ASP . 11.9 Cg_endo -56.3 158.87 14.17 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.372 2.048 . . . . 0.82 111.232 175.341 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.496 ' CZ ' ' C5 ' ' B' ' 2' ' ' ' G' . 76.4 m-85 -71.98 2.46 5.62 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.896 0.379 . . . . 1.46 111.649 -171.028 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 18.1 t-160 -95.7 -16.88 21.7 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.059 -0.519 . . . . 2.65 110.136 174.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.471 HG22 HD11 ' A' ' 42' ' ' LEU . 67.9 m -79.4 116.75 19.82 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.445 0.641 . . . . 1.31 112.278 -174.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 42.1 p -99.81 -177.64 3.62 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.31 -0.859 . . . . 0.75 110.19 172.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.5 ' HA ' HG21 ' A' ' 66' ' ' VAL . 4.6 m-20 -61.25 -35.1 76.34 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.453 0.644 . . . . 0.49 110.105 -178.091 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.757 ' HZ1' ' HB3' ' A' ' 49' ' ' LYS . 0.6 OUTLIER -74.52 -38.23 62.85 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.317 -0.856 . . . . 3.26 110.595 -178.56 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.41 ' HB ' HG21 ' A' ' 46' ' ' THR . 17.0 m -62.4 -43.17 99.45 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.267 0.556 . . . . 1.25 110.051 177.482 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.667 HD11 HD13 ' A' ' 42' ' ' LEU . 22.1 tp -66.15 -37.58 86.02 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 115.547 -0.751 . . . . 1.53 109.796 177.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 48.7 t-80 -58.44 -53.1 62.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.617 -0.719 . . . . 0.77 110.841 175.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.648 ' HG2' ' O ' ' A' ' 49' ' ' LYS . 21.3 mm-40 -58.14 -42.33 85.61 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.128 -0.487 . . . . 1.52 111.529 -177.451 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.456 ' O ' ' HB2' ' A' ' 57' ' ' GLN . 6.2 t80 -74.76 -33.61 62.35 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.16 -0.473 . . . . 1.6 111.762 -174.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.644 ' CB ' HD12 ' A' ' 61' ' ' ILE . 4.9 m-85 -86.2 -26.09 25.27 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 114.043 1.127 . . . . 0.68 114.043 -176.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.432 ' HA ' ' O ' ' A' ' 59' ' ' GLY . 7.9 pt-20 -72.78 -11.78 60.75 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 122.109 0.957 . . . . 1.57 109.553 179.5 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.456 ' HB2' ' O ' ' A' ' 54' ' ' TYR . 13.4 mm100 -55.69 -19.33 10.45 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.505 -1.225 . . . . 2.79 111.602 166.521 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -105.9 10.87 32.31 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.618 0.247 . . . . 0.79 110.786 -178.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.432 ' O ' ' HA ' ' A' ' 56' ' ' GLU . . . 125.61 -171.09 17.49 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.79 -0.719 . . . . 0.75 112.664 -177.03 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.51 123.05 18.63 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.799 0.666 . . . . 1.02 112.799 -179.142 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.644 HD12 ' CB ' ' A' ' 55' ' ' PHE . 10.1 mt -93.52 122.81 45.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.168 -0.924 . . . . 1.13 108.767 169.517 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -78.05 -41.47 35.43 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.234 0.54 . . . . 2.07 110.078 177.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -162.56 131.05 4.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.695 -0.684 . . . . 2.48 110.756 -177.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -117.17 116.49 27.39 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.785 0.326 . . . . 1.18 110.192 177.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.58 HG23 ' H21' ' B' ' 6' ' ' ' G' . 16.2 m -126.9 112.42 28.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.663 0.744 . . . . 1.97 111.819 -178.316 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.5 HG21 ' HA ' ' A' ' 48' ' ' ASP . 70.1 t -79.25 131.52 34.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.547 -0.751 . . . . 1.12 109.591 179.017 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.563 ' H ' ' HA2' ' A' ' 79' ' ' GLY . 28.8 mm -71.48 140.67 17.84 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.697 0 N-CA-C 107.473 -1.306 . . . . 1.44 107.473 175.329 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.876 ' HA ' ' O ' ' A' ' 75' ' ' SER . 15.2 p -159.76 152.62 21.61 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 107.343 -1.355 . . . . 1.83 107.343 -159.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -64.79 125.43 24.78 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.498 -0.481 . . . . 2.49 111.438 -175.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 6.7 ptp180 -49.43 -21.97 1.05 Allowed 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 114.053 1.131 . . . . 6.58 114.053 -177.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -95.6 -38.64 10.31 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 112.713 0.634 . . . . 4.33 112.713 -178.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 32.6 p -120.72 -29.24 4.72 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.669 0.618 . . . . 3.67 112.669 -174.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.742 ' HA ' ' HB ' ' A' ' 68' ' ' THR . 37.7 mt-30 59.12 14.41 3.49 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 113.577 0.955 . . . . 3.61 113.577 178.15 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 51.8 mtmt -42.83 -60.86 1.43 Allowed 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 112.571 0.582 . . . . 3.78 112.571 172.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.876 ' O ' ' HA ' ' A' ' 68' ' ' THR . 5.3 p -163.24 -108.53 0.01 OUTLIER 'General case' 0 C--O 1.216 -0.692 0 CA-C-O 118.659 -0.686 . . . . 2.07 112.709 177.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.606 ' HA ' " O5'" ' B' ' 1' ' ' ' G' . 74.4 mtt180 112.23 -19.06 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 125.27 1.428 . . . . 3.07 111.729 -170.188 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.432 ' HA3' ' C6 ' ' B' ' 2' ' ' ' G' . . . 81.78 12.62 81.18 Favored Glycine 0 CA--C 1.526 0.719 0 C-N-CA 120.049 -1.072 . . . . 0.75 113.762 174.096 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -128.47 160.37 32.51 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.862 -0.792 . . . . 1.61 108.862 -177.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.563 ' HA2' ' H ' ' A' ' 67' ' ' ILE . . . 178.57 145.12 5.93 Favored Glycine 0 C--O 1.222 -0.651 0 C-N-CA 119.424 -1.37 . . . . 0.59 113.648 175.429 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.415 ' HD2' HD13 ' A' ' 67' ' ' ILE . 96.4 m-85 -98.67 137.62 37.03 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 122.188 0.994 . . . . 0.84 112.495 175.43 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 65.0 t -119.91 134.03 64.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 114.234 -1.348 . . . . 1.21 109.526 176.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.524 ' HA ' ' O ' ' A' ' 35' ' ' THR . 27.0 m -114.83 123.95 50.51 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 108.596 -0.891 . . . . 1.09 108.596 175.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.411 ' SD ' HG12 ' A' ' 61' ' ' ILE . 82.2 mmm -88.68 164.3 15.38 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.937 -0.764 . . . . 1.02 108.937 -178.475 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.579 ' HZ3' ' HB2' ' A' ' 84' ' ' LYS . 4.3 ttmp? -82.66 -18.27 41.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.173 0.511 . . . . 2.47 110.454 -176.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -143.03 146.91 34.29 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.158 -0.474 . . . . 1.68 109.85 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.562 ' O ' ' HG3' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -64.96 -25.17 67.76 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.051 0.389 . . . . 4.24 112.051 -178.821 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.519 ' O ' ' HG2' ' A' ' 91' ' ' ARG . . . -64.45 -44.98 89.39 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 121.621 -0.674 . . . . 1.33 111.743 178.344 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 18.3 m -66.92 -32.18 73.26 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.938 0.875 . . . . 1.34 109.665 176.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -59.76 -47.03 87.33 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 113.652 -1.613 . . . . 1.16 109.596 175.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.562 ' HG3' ' O ' ' A' ' 86' ' ' ARG . 45.6 mt-10 -56.05 -50.84 69.83 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.751 -0.659 . . . . 2.11 111.385 174.231 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.519 ' HG2' ' O ' ' A' ' 87' ' ' ALA . 2.0 mmt180 -57.88 -44.87 86.95 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.672 0.272 . . . . 4.35 111.337 -177.318 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -55.79 -41.38 74.01 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.889 -0.596 . . . . 1.21 111.157 176.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 44.1 t -70.44 -20.14 62.92 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.598 -0.274 . . . . 1.16 111.676 178.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -76.61 7.28 4.72 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 112.412 0.523 . . . . 4.58 112.412 -178.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -144.01 93.09 6.13 Favored Pre-proline 0 C--N 1.322 -0.613 0 N-CA-C 108.633 -0.877 . . . . 2.24 108.633 -178.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -74.66 -28.87 9.45 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.499 2.133 . . . . 2.38 113.742 -172.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.533 ' HA ' ' O ' ' A' ' 105' ' ' ALA . 10.5 m120 -130.99 79.02 72.35 Favored Pre-proline 0 C--N 1.33 -0.25 0 N-CA-C 112.133 0.42 . . . . 3.61 112.133 -175.62 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -81.57 141.32 12.34 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.755 2.304 . . . . 1.54 111.875 174.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 42.0 mm -83.32 90.07 2.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.139 0.495 . . . . 2.08 110.865 177.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 53.8 mt -92.96 135.31 28.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.601 -0.727 . . . . 1.55 111.148 175.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.658 ' HB3' ' CG ' ' A' ' 43' ' ' PRO . 38.8 t70 43.21 35.86 0.91 Allowed 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 115.733 -0.667 . . . . 1.52 112.477 -174.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 73.49 18.74 79.51 Favored Glycine 0 CA--C 1.519 0.306 0 C-N-CA 120.8 -0.714 . . . . 1.73 113.03 178.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 5.4 tpt180 -129.77 139.78 51.21 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.722 -0.844 . . . . 4.66 108.722 178.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 6.6 ttpm? -71.37 140.23 50.1 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.795 0.331 . . . . 3.14 110.171 179.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.533 ' O ' ' HA ' ' A' ' 97' ' ' ASN . . . -123.66 166.07 16.14 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.512 -0.313 . . . . 1.37 110.804 -171.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -111.65 146.54 37.26 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.038 -0.528 . . . . 2.18 110.34 -178.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 73.2 t -145.46 135.69 18.73 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 115.719 -0.673 . . . . 1.46 110.95 -173.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.626 HD22 ' HD2' ' A' ' 38' ' ' PHE . 9.3 p30 -167.17 161.87 14.82 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 109.6 -0.518 . . . . 3.22 109.6 173.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.485 HD12 ' O ' ' A' ' 34' ' ' PHE . 1.6 mm? -77.22 120.31 22.09 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.263 -0.643 . . . . 1.87 109.263 173.259 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -56.19 -36.23 68.16 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.545 0.572 . . . . 1.3 112.545 -172.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 5.6 p90 -70.97 -7.31 45.27 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.854 -0.338 . . . . 1.71 111.537 -174.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 97.0 mt -84.59 -23.18 29.73 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.96 0.409 . . . . 1.97 110.458 177.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -127.85 25.94 4.89 Favored Glycine 0 N--CA 1.45 -0.407 0 N-CA-C 110.869 -0.893 . . . . 2.24 110.869 -178.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -89.27 137.02 32.69 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.691 -0.485 . . . . 2.66 109.691 -173.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 35.4 mttm -129.55 78.9 74.76 Favored Pre-proline 0 C--N 1.321 -0.633 0 C-N-CA 120.525 -0.47 . . . . 4.52 109.984 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -89.35 -38.5 0.05 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 122.158 1.905 . . . . 5.53 113.577 -176.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 38.5 ptt180 -131.39 -1.12 3.97 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.853 0.359 . . . . 9.2 111.194 -175.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 8.8 t -144.58 137.96 27.12 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.404 -0.362 . . . . 6.74 110.225 -177.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -150.95 144.75 25.14 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.418 -0.355 . . . . 8.27 110.136 179.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.49 ' O ' ' HB2' ' A' ' 121' ' ' GLN . 26.2 t -91.76 -84.84 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 109.226 -0.657 . . . . 9.39 109.226 177.25 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.49 ' HB2' ' O ' ' A' ' 120' ' ' VAL . 54.8 tt0 . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.364 -0.827 . . . . 12.71 109.209 174.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 1' ' ' ' G' . . . . . 0.606 " O5'" ' HA ' ' A' ' 76' ' ' ARG . . . . . . . . 0 O5'--C5' 1.431 -0.546 0 O5'-C5'-C4' 111.401 0.858 . 0.0 '__' . 5.37 . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 2' ' ' ' G' . . . . . 0.496 ' C5 ' ' CZ ' ' A' ' 44' ' ' TYR . . . . . . . . 0 O5'--C5' 1.423 -1.092 0 C3'-C2'-C1' 99.037 -2.736 . 0.0 OUTLIER . 4.87 . . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 3' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.427 -0.786 0 C3'-C2'-C1' 100.425 -1.195 . 0.0 OUTLIER gamma 5.58 . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 4' ' ' ' G' . . . . . 0.781 " H3'" ' N3 ' ' B' ' 4' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.428 -0.724 0 C1'-O4'-C4' 110.339 0.821 . 0.0 OUTLIER '7D dist 0i' 2.69 . . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 5' ' ' ' U' . . . . . 0.566 ' H6 ' " O5'" ' B' ' 5' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.425 -0.937 0 C3'-C2'-C1' 100.867 -0.704 . 0.157 1b . 1.93 . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 6' ' ' ' G' . . . . . 0.58 ' H21' HG23 ' A' ' 65' ' ' VAL . . . . . . . . 0 O5'--C5' 1.426 -0.846 0 C4'-C3'-C2' 103.591 0.891 . 0.479 0b . 2.38 . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.427 -0.806 0 C3'-C2'-C1' 100.717 -0.87 . 0.0 OUTLIER . 4.41 . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.684 0 N-CA-C 112.196 -0.362 . . . . 13.51 112.196 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -91.5 2.95 56.07 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.083 0.468 . . . . 11.28 110.77 -179.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 24.8 mmt -96.31 134.66 39.16 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.093 -0.503 . . . . 10.15 110.104 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -104.64 150.5 17.2 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.843 -0.694 . . . . 6.69 112.446 -178.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 9.6 m -77.76 -58.08 3.46 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.508 0.194 . . . . 5.68 110.775 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 50.2 mtm180 54.42 92.03 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.361 0 O-C-N 123.839 0.712 . . . . 4.34 112.368 -178.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.439 ' C ' ' HG1' ' A' ' 32' ' ' THR . 6.8 t70 -66.78 -48.94 67.48 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.127 -0.942 . . . . 3.53 111.366 177.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.439 ' HG1' ' C ' ' A' ' 31' ' ' ASP . 58.9 p 57.61 16.37 3.35 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 114.282 1.216 . . . . 1.98 114.282 176.574 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' MET . . . . . 0.424 ' HE1' ' HB3' ' A' ' 33' ' ' MET . 13.8 tmm? -65.4 -40.53 93.54 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 121.875 -0.515 . . . . 1.9 111.851 177.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.541 ' O ' HD12 ' A' ' 109' ' ' LEU . 18.2 m-85 -92.96 -13.43 28.81 Favored 'General case' 0 C--O 1.225 -0.201 0 O-C-N 122.013 -0.429 . . . . 1.76 111.482 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.522 ' HB ' ' O ' ' A' ' 83' ' ' MET . 31.7 p -94.38 -6.09 44.97 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.998 0.428 . . . . 1.23 111.102 -174.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.782 ' HE2' ' O6 ' ' B' ' 6' ' ' ' G' . 13.8 tptm -84.67 103.7 14.01 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.789 -0.641 . . . . 3.2 110.357 -177.092 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.614 HD12 ' HA ' ' A' ' 89' ' ' ALA . 28.7 mt -98.78 139.03 21.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 121.339 0.59 . . . . 1.46 112.486 -174.226 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.42 ' HD1' ' CE2' ' A' ' 80' ' ' PHE . 68.8 t80 -105.59 111.76 24.58 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.31 -0.859 . . . . 0.81 108.976 174.538 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.3 t -99.29 139.34 21.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.068 0.461 . . . . 1.61 110.042 -178.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -140.53 138.11 8.76 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.268 -0.968 . . . . 1.39 113.396 -170.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 84.9 31.15 24.32 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 121.486 -0.388 . . . . 0.71 112.498 176.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.732 HD13 HD22 ' A' ' 51' ' ' LEU . 3.3 mm? -67.24 129.15 93.86 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-O 120.564 0.221 . . . . 1.89 110.809 178.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.695 ' HA ' ' O6 ' ' B' ' 2' ' ' ' G' . 65.5 Cg_exo -54.97 159.73 9.0 Favored 'Trans proline' 0 CA--C 1.529 0.271 0 C-N-CA 123.448 2.765 . . . . 0.82 112.923 172.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.687 ' CE1' ' C5 ' ' B' ' 2' ' ' ' G' . 6.8 m-30 -69.18 -9.67 54.04 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.738 -0.664 . . . . 1.46 112.486 -174.146 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 44.5 t60 -104.23 -1.18 27.47 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.054 0.454 . . . . 2.65 110.368 178.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.545 HG23 HD11 ' A' ' 42' ' ' LEU . 85.3 m -73.3 116.4 13.8 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.639 0.733 . . . . 1.31 111.362 -177.631 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 6.1 p -110.74 -178.91 3.6 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.631 -1.168 . . . . 0.75 110.503 176.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -62.36 -35.94 80.71 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.334 0.588 . . . . 0.49 110.284 -175.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.663 ' O ' ' HG2' ' A' ' 53' ' ' GLU . 43.0 pttt -65.13 -35.13 80.14 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.336 -0.847 . . . . 3.26 110.821 179.498 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 6.4 m -67.51 -44.8 77.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.551 -0.295 . . . . 1.25 111.049 -178.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.732 HD22 HD13 ' A' ' 42' ' ' LEU . 22.1 mt -64.99 -33.99 77.36 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-O 120.855 0.36 . . . . 1.53 110.296 175.177 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.452 ' HA ' HD11 ' A' ' 61' ' ' ILE . 49.3 t-80 -64.95 -54.47 30.14 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 116.017 -0.538 . . . . 0.77 110.453 -179.214 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.663 ' HG2' ' O ' ' A' ' 49' ' ' LYS . 13.6 mm-40 -56.41 -51.1 69.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.252 -0.431 . . . . 1.52 111.777 -179.123 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.535 ' O ' ' HB2' ' A' ' 57' ' ' GLN . 2.1 t80 -70.44 -33.31 71.17 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 112.765 0.654 . . . . 1.6 112.765 -173.077 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.75 ' HB2' HD13 ' A' ' 61' ' ' ILE . 11.3 m-85 -85.44 -35.29 21.35 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 114.436 1.273 . . . . 0.68 114.436 -172.05 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.621 ' HB3' HG13 ' A' ' 61' ' ' ILE . 13.5 pt-20 -77.99 -6.56 54.87 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 119.747 1.158 . . . . 1.57 110.189 179.113 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.535 ' HB2' ' O ' ' A' ' 54' ' ' TYR . 11.7 mm100 -57.41 -9.83 1.19 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.454 -0.794 . . . . 2.79 112.028 162.369 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -104.3 -21.95 13.43 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.234 -0.439 . . . . 0.79 109.99 177.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.498 ' HA3' ' OG ' ' A' ' 88' ' ' SER . . . 169.91 -116.28 0.64 Allowed Glycine 0 C--O 1.226 -0.398 0 CA-C-N 115.856 -0.611 . . . . 0.75 112.061 -179.486 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -115.36 128.1 55.85 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.942 0.371 . . . . 1.02 110.617 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.75 HD13 ' HB2' ' A' ' 55' ' ' PHE . 25.5 mt -97.13 124.27 49.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 109.776 -0.454 . . . . 1.13 109.776 170.236 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -88.8 -32.02 18.06 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.161 0.505 . . . . 2.07 110.257 178.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -161.06 126.67 3.77 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.965 -0.561 . . . . 2.48 110.483 179.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -117.53 124.66 49.25 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.834 0.35 . . . . 1.18 110.209 171.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.3 p -141.4 112.63 3.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 121.956 0.884 . . . . 1.97 111.991 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.538 HG23 HD13 ' A' ' 51' ' ' LEU . 23.0 t -79.37 129.06 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 CA-C-N 115.079 -0.964 . . . . 1.12 108.77 177.218 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.54 ' H ' ' HA2' ' A' ' 79' ' ' GLY . 44.5 mm -73.7 85.39 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 CA-C-O 121.699 0.761 . . . . 1.44 109.714 -178.515 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.617 HG23 ' HA ' ' A' ' 75' ' ' SER . 23.9 p -119.69 -179.12 3.79 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 114.652 -1.158 . . . . 1.83 110.438 178.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 1.016 ' H ' ' HA ' ' A' ' 73' ' ' GLN . 25.6 t70 -96.25 120.4 36.47 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.224 -0.444 . . . . 2.49 110.979 -173.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 6.3 mpt_? -57.89 -4.75 0.34 Allowed 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 113.909 1.078 . . . . 6.58 113.909 -177.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.41 ' HB2' ' OD2' ' A' ' 69' ' ' ASP . 37.4 m-80 -107.87 -40.65 5.2 Favored 'General case' 0 N--CA 1.464 0.272 0 O-C-N 121.82 -0.55 . . . . 4.33 111.577 177.534 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.3 p -132.07 -28.89 1.69 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.118 0.485 . . . . 3.67 111.951 -173.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 1.016 ' HA ' ' H ' ' A' ' 69' ' ' ASP . 28.9 mt-30 62.6 -92.16 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.999 -1.0 . . . . 3.61 111.625 -175.169 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp 55.16 78.26 0.19 Allowed 'General case' 0 C--N 1.333 -0.112 0 N-CA-C 108.114 -1.069 . . . . 3.78 108.114 -175.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.651 ' HB2' ' HA ' ' A' ' 44' ' ' TYR . 15.5 m -35.8 107.82 0.06 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 114.721 -1.127 . . . . 2.07 113.699 -164.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.496 ' HD2' ' O ' ' A' ' 67' ' ' ILE . 14.4 mtt180 -56.08 -25.59 46.1 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 114.249 -1.341 . . . . 3.07 111.903 177.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.459 ' HA2' ' O ' ' A' ' 42' ' ' LEU . . . 102.48 3.94 49.94 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.645 -0.788 . . . . 0.75 111.633 -174.361 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 -114.84 146.99 40.47 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.663 -0.495 . . . . 1.61 109.663 177.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.54 ' HA2' ' H ' ' A' ' 67' ' ' ILE . . . -170.08 140.85 6.25 Favored Glycine 0 C--O 1.224 -0.512 0 C-N-CA 120.525 -0.845 . . . . 0.59 112.091 171.305 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.42 ' CE2' ' HD1' ' A' ' 38' ' ' PHE . 59.4 m-85 -103.84 144.94 30.83 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 122.26 1.029 . . . . 0.84 113.279 175.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 55.7 t -123.65 130.52 74.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 113.739 -1.573 . . . . 1.21 109.216 176.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 19.2 m -110.59 106.23 15.43 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 107.827 -1.175 . . . . 1.09 107.827 177.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.522 ' O ' ' HB ' ' A' ' 35' ' ' THR . 51.4 mtp -89.35 157.82 18.03 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 120.38 -0.528 . . . . 1.02 109.74 -175.121 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 23.1 tttm -84.01 -11.06 57.37 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.469 -0.332 . . . . 2.47 111.746 -171.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -147.81 147.55 29.95 Favored 'General case' 0 C--O 1.245 0.864 0 CA-C-O 121.585 0.707 . . . . 1.68 111.857 175.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 15.7 ptt180 -65.13 -28.05 69.15 Favored 'General case' 0 C--O 1.212 -0.908 0 CA-C-N 114.974 -1.012 . . . . 4.24 113.471 -174.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.403 ' O ' ' HG3' ' A' ' 91' ' ' ARG . . . -65.46 -50.46 65.29 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 119.554 1.07 . . . . 1.33 111.629 -175.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.498 ' OG ' ' HA3' ' A' ' 59' ' ' GLY . 14.6 m -63.2 -39.69 95.35 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.474 0.654 . . . . 1.34 110.231 177.092 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.614 ' HA ' HD12 ' A' ' 37' ' ' ILE . . . -59.37 -50.37 74.23 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 114.529 -1.214 . . . . 1.16 110.49 178.172 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.679 ' O ' ' HG2' ' A' ' 94' ' ' LYS . 4.4 mm-40 -56.41 -50.73 70.79 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.034 -0.985 . . . . 2.11 112.258 176.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.403 ' HG3' ' O ' ' A' ' 87' ' ' ALA . 99.1 mtt180 -58.93 -45.86 89.38 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 111.914 0.339 . . . . 4.35 111.914 -177.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -56.13 -35.15 66.8 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.006 0.431 . . . . 1.21 111.099 177.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 36.8 t -76.47 -26.79 55.73 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.326 -0.397 . . . . 1.16 112.0 176.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.679 ' HG2' ' O ' ' A' ' 90' ' ' GLU . 32.5 mmtm -72.97 -44.27 61.29 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 120.71 0.29 . . . . 4.58 111.155 -175.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -112.12 89.45 11.96 Favored Pre-proline 0 C--N 1.324 -0.508 0 N-CA-C 109.502 -0.555 . . . . 2.24 109.502 174.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.566 ' HB3' ' O ' ' A' ' 107' ' ' VAL . 73.5 Cg_endo -87.73 77.96 1.66 Allowed 'Trans proline' 0 N--CA 1.447 -1.221 0 C-N-CA 122.661 2.241 . . . . 2.38 111.909 -176.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 30.7 m-80 -154.66 39.98 0.13 Allowed Pre-proline 0 CA--C 1.54 0.573 0 CA-C-N 116.1 -0.5 . . . . 3.61 112.312 -175.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.701 ' HD2' ' O ' ' A' ' 105' ' ' ALA . 67.9 Cg_endo -72.36 121.4 7.44 Favored 'Trans proline' 0 C--N 1.352 0.762 0 CA-C-N 120.543 1.23 . . . . 1.54 112.646 -176.316 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 47.4 mm -71.85 91.49 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.966 0.889 . . . . 2.08 110.547 173.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 72.7 mt -106.89 131.98 55.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 114.717 -1.129 . . . . 1.55 110.309 -179.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.523 ' HB3' ' HG2' ' A' ' 43' ' ' PRO . 25.9 t70 45.07 30.0 0.55 Allowed 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 113.337 0.866 . . . . 1.52 113.337 178.248 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 86.88 21.66 49.33 Favored Glycine 0 CA--C 1.521 0.437 0 C-N-CA 120.497 -0.858 . . . . 1.73 113.034 177.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.511 ' HB2' ' HG3' ' A' ' 43' ' ' PRO . 83.0 mmt-85 -138.81 151.74 47.29 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.116 -0.698 . . . . 4.66 109.116 177.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -95.99 106.15 18.27 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 119.298 -0.961 . . . . 3.14 109.284 172.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.701 ' O ' ' HD2' ' A' ' 98' ' ' PRO . . . -86.37 167.27 14.89 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.482 0.658 . . . . 1.37 112.432 174.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -114.15 128.92 56.59 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.02 -0.991 . . . . 2.18 110.147 -177.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.566 ' O ' ' HB3' ' A' ' 96' ' ' PRO . 57.5 t -119.61 147.99 22.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.418 -0.355 . . . . 1.46 110.542 -175.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -160.53 172.97 16.24 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.579 0.228 . . . . 3.22 110.593 177.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.541 HD12 ' O ' ' A' ' 34' ' ' PHE . 0.6 OUTLIER -79.68 130.19 35.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.617 0.246 . . . . 1.87 110.408 179.401 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.52 -33.67 76.45 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.716 0.636 . . . . 1.3 112.716 -174.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.403 ' HD1' HD13 ' A' ' 109' ' ' LEU . 7.1 p90 -68.89 -9.63 52.72 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.781 0.324 . . . . 1.71 111.737 -173.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 84.2 mt -79.83 -12.33 59.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.331 -0.395 . . . . 1.97 110.738 178.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.507 ' HA3' ' C4 ' ' B' ' 5' ' ' ' U' . . . -136.66 30.07 2.71 Favored Glycine 0 N--CA 1.45 -0.389 0 N-CA-C 111.118 -0.793 . . . . 2.24 111.118 177.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -92.68 118.77 31.4 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.188 -0.506 . . . . 2.66 110.124 -176.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -129.54 81.04 70.73 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-O 120.798 0.333 . . . . 4.52 110.318 178.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.418 ' HD2' ' H ' ' A' ' 117' ' ' ARG . 14.9 Cg_endo -91.86 -30.82 0.1 Allowed 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 123.111 2.541 . . . . 5.53 113.255 -176.241 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.418 ' H ' ' HD2' ' A' ' 116' ' ' PRO . 18.0 ptp180 -141.78 19.72 2.16 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.071 0.463 . . . . 9.2 111.13 -175.373 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 6.2 t -156.48 153.23 28.47 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.386 -0.598 . . . . 6.74 109.386 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 47.6 t-20 -158.15 97.09 1.49 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.585 0.231 . . . . 8.27 110.641 -178.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 96.2 t 67.62 107.04 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-N 115.548 -0.751 . . . . 9.39 112.766 173.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 . . . . . 0 C--O 1.252 1.2 0 CA-C-O 118.063 -0.97 . . . . 12.71 109.782 173.693 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 1' ' ' ' G' . . . . . 0.584 ' N2 ' ' N7 ' ' B' ' 2' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.428 -0.738 0 C3'-C2'-C1' 100.56 -1.045 . 0.0 '__' . 5.37 . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 2' ' ' ' G' . . . . . 0.695 ' O6 ' ' HA ' ' A' ' 43' ' ' PRO . . . . . . . . 0 O5'--C5' 1.428 -0.724 0 C3'-C2'-C1' 99.339 -2.401 . 0.0 OUTLIER gamma 4.87 . . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 3' ' ' ' U' . . . . . 0.473 HO2' " C5'" ' B' ' 4' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.427 -0.808 0 C3'-C2'-C1' 100.673 -0.919 . 0.0 OUTLIER . 5.58 . . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 4' ' ' ' G' . . . . . 0.498 " H3'" ' N3 ' ' B' ' 4' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.428 -0.725 0 O4'-C1'-C2' 108.276 1.34 . 0.0 OUTLIER gamma 2.69 . . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 5' ' ' ' U' . . . . . 0.507 ' C4 ' ' HA3' ' A' ' 113' ' ' GLY . . . . . . . . 0 O5'--C5' 1.425 -0.911 0 C3'-C2'-C1' 100.537 -1.07 . 0.0 OUTLIER gamma 1.93 . . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 6' ' ' ' G' . . . . . 0.782 ' O6 ' ' HE2' ' A' ' 36' ' ' LYS . . . . . . . . 0 O5'--C5' 1.427 -0.84 0 C3'-C2'-C1' 100.318 -1.313 . 0.149 0b . 2.38 . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.428 -0.765 0 C4'-C3'-C2' 103.895 1.195 . 0.0 OUTLIER . 4.41 . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.842 0 CA-C-O 120.101 -0.277 . . . . 13.51 112.812 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . 62.0 -160.16 0.31 Allowed 'General case' 0 C--O 1.233 0.207 0 C-N-CA 122.413 0.285 . . . . 11.28 110.461 -177.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 1.7 pmm? -142.26 163.61 32.38 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.771 0.32 . . . . 10.15 110.237 178.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -117.13 163.57 12.55 Favored Glycine 0 N--CA 1.443 -0.845 0 N-CA-C 111.366 -0.694 . . . . 6.69 111.366 176.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 23.2 t -88.49 14.73 9.15 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.989 0.395 . . . . 5.68 110.55 -179.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 35.4 mtp180 -116.25 148.36 40.55 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 110.116 -0.327 . . . . 4.34 110.116 177.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.35 114.81 4.06 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-O 121.25 0.548 . . . . 3.53 110.725 178.4 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.62 ' HA ' ' OG1' ' A' ' 35' ' ' THR . 10.7 p -118.32 15.09 13.93 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.739 -0.664 . . . . 1.98 111.485 -177.15 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 59.9 ttp -70.78 -40.89 72.31 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 120.885 -0.326 . . . . 1.9 111.648 177.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.524 ' HA ' HD12 ' A' ' 109' ' ' LEU . 50.2 m-85 -103.47 -21.06 13.84 Favored 'General case' 0 C--O 1.226 -0.17 0 O-C-N 122.043 -0.41 . . . . 1.76 110.79 -177.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.752 ' O ' ' HA ' ' A' ' 82' ' ' THR . 28.7 p -84.8 14.21 5.01 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.303 0.573 . . . . 1.23 110.631 -175.072 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.469 ' HD2' ' O6 ' ' B' ' 6' ' ' ' G' . 6.9 ttpt -121.21 102.45 8.31 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.355 -0.839 . . . . 3.2 109.227 -173.093 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.474 HG23 HG21 ' A' ' 39' ' ' VAL . 5.3 mp -109.42 126.85 66.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 116.119 -0.491 . . . . 1.46 111.042 -175.294 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.47 ' HD1' ' CZ ' ' A' ' 80' ' ' PHE . 80.3 t80 -85.76 115.83 23.65 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.487 -0.56 . . . . 0.81 109.487 175.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.638 HG11 HG23 ' A' ' 107' ' ' VAL . 91.6 t -133.05 97.32 2.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-O 118.405 -0.807 . . . . 1.61 110.282 -179.25 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.563 ' HA2' HD11 ' A' ' 42' ' ' LEU . . . -117.61 -156.24 10.34 Favored Glycine 0 C--O 1.215 -1.081 0 C-N-CA 115.838 -3.077 . . . . 1.39 113.721 162.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 88.67 12.0 65.09 Favored Glycine 0 N--CA 1.45 -0.4 0 N-CA-C 110.032 -1.227 . . . . 0.71 110.032 -171.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.563 HD11 ' HA2' ' A' ' 40' ' ' GLY . 7.7 mp -75.54 137.95 70.82 Favored Pre-proline 0 N--CA 1.447 -0.591 0 CA-C-N 114.626 -0.787 . . . . 1.89 110.716 -177.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.505 ' HD2' ' OG1' ' A' ' 46' ' ' THR . 42.5 Cg_exo -55.33 159.89 9.65 Favored 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 123.029 2.486 . . . . 0.82 111.678 173.304 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 44.1 m-85 -65.1 -22.16 66.91 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.165 0.431 . . . . 1.46 112.165 -175.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 23.0 t60 -86.09 -25.49 25.8 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 120.917 0.389 . . . . 2.65 110.44 178.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.684 HG22 HG22 ' A' ' 50' ' ' THR . 19.1 m -66.91 130.08 41.98 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.704 -0.68 . . . . 1.31 110.302 -176.421 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 9.0 p -137.33 -176.65 4.47 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.033 -0.53 . . . . 0.75 111.871 -170.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -55.72 -35.4 66.07 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.559 -0.746 . . . . 0.49 110.126 -176.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.664 ' O ' ' HG2' ' A' ' 53' ' ' GLU . 9.5 ptpp? -66.54 -36.85 83.68 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.045 -0.98 . . . . 3.26 109.85 -177.053 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.684 HG22 HG22 ' A' ' 46' ' ' THR . 53.9 m -63.63 -45.56 89.72 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.797 -0.638 . . . . 1.25 110.89 179.055 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 63.1 mt -67.85 -39.16 83.86 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.75 -0.659 . . . . 1.53 111.237 -179.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 56.1 t-80 -55.31 -51.3 67.16 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.209 -0.451 . . . . 0.77 109.972 175.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.664 ' HG2' ' O ' ' A' ' 49' ' ' LYS . 10.9 mm-40 -64.9 -47.88 76.2 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.832 -0.622 . . . . 1.52 112.489 -176.454 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.419 ' O ' ' HB2' ' A' ' 57' ' ' GLN . 66.1 t80 -77.35 -36.85 53.41 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 121.054 0.454 . . . . 1.6 111.701 -170.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.567 ' CB ' HD12 ' A' ' 61' ' ' ILE . 14.3 m-85 -84.01 -25.81 29.64 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.655 0.613 . . . . 0.68 112.655 -174.528 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.633 ' HA ' ' O ' ' A' ' 59' ' ' GLY . 6.1 pt-20 -70.77 -9.72 57.98 Favored 'General case' 0 N--CA 1.461 0.101 0 CA-C-O 121.487 0.66 . . . . 1.57 109.872 178.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.419 ' HB2' ' O ' ' A' ' 54' ' ' TYR . 27.4 mm-40 -60.39 -25.84 66.2 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.091 -0.959 . . . . 2.79 110.967 170.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -88.08 -28.74 21.13 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.31 0.576 . . . . 0.79 110.036 178.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.633 ' O ' ' HA ' ' A' ' 56' ' ' GLU . . . 170.36 178.5 41.23 Favored Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 110.771 -0.932 . . . . 0.75 110.771 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -63.72 130.19 43.22 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 117.35 0.575 . . . . 1.02 109.65 -178.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.567 HD12 ' CB ' ' A' ' 55' ' ' PHE . 60.6 mt -97.72 125.74 50.82 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 110.376 -0.231 . . . . 1.13 110.376 177.528 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -66.56 -42.04 87.7 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 121.111 0.481 . . . . 2.07 110.721 177.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -161.97 142.28 10.3 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 115.457 -0.792 . . . . 2.48 111.061 -178.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -120.08 122.94 42.17 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.692 -0.685 . . . . 1.18 109.717 174.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.645 HG12 ' H21' ' B' ' 6' ' ' ' G' . 3.6 p -136.7 122.64 28.39 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-N 114.995 -1.002 . . . . 1.97 112.566 -174.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 54.6 t -101.43 134.14 42.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.697 -0.683 . . . . 1.12 109.423 173.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.474 ' O ' ' HB2' ' A' ' 76' ' ' ARG . 50.7 mm -86.08 100.43 9.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 121.192 0.52 . . . . 1.44 110.271 -174.012 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 20.2 p -91.68 163.08 14.23 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.633 -0.712 . . . . 1.83 110.109 174.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.647 ' HA ' ' NE ' ' A' ' 76' ' ' ARG . 24.4 t70 -60.31 131.41 50.71 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.271 0.471 . . . . 2.49 112.271 -174.553 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 4.3 tmm_? -54.73 -40.96 69.8 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.973 -0.558 . . . . 6.58 111.067 178.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.435 ' HB2' ' OD2' ' A' ' 69' ' ' ASP . 29.9 m-80 -73.68 -60.33 2.3 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.075 0.398 . . . . 4.33 112.075 -176.382 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.432 ' OG1' ' HG3' ' A' ' 74' ' ' LYS . 22.2 p -115.53 -9.17 12.09 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.304 0.483 . . . . 3.67 112.304 -169.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 63.19 19.81 11.89 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 123.64 0.776 . . . . 3.61 112.894 -178.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.432 ' HG3' ' OG1' ' A' ' 72' ' ' THR . 54.0 mtmt -48.56 137.31 11.93 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 109.303 -0.629 . . . . 3.78 109.303 164.073 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 13.7 m -64.68 96.87 0.19 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.358 -0.383 . . . . 2.07 111.331 -177.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.647 ' NE ' ' HA ' ' A' ' 69' ' ' ASP . 44.1 mtt180 -63.4 -18.99 64.29 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.912 -0.585 . . . . 3.07 111.313 175.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.454 ' HA3' ' H21' ' B' ' 2' ' ' ' G' . . . 79.73 24.44 60.28 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.81 -0.709 . . . . 0.75 113.389 173.16 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.463 ' HA ' ' CA ' ' A' ' 40' ' ' GLY . 14.0 m-85 -128.14 149.46 50.41 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 107.851 -1.166 . . . . 1.61 107.851 176.373 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -145.35 -173.55 16.72 Favored Glycine 0 N--CA 1.441 -0.99 0 C-N-CA 119.753 -1.213 . . . . 0.59 112.845 176.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.47 ' CZ ' ' HD1' ' A' ' 38' ' ' PHE . 59.1 m-85 -144.59 125.98 14.86 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 108.375 -0.972 . . . . 0.84 108.375 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 30.9 t -108.15 110.93 33.76 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 N-CA-C 109.464 -0.569 . . . . 1.21 109.464 177.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.752 ' HA ' ' O ' ' A' ' 35' ' ' THR . 28.4 m -105.52 103.72 13.3 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.47 -0.937 . . . . 1.09 108.47 177.459 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.434 ' HA ' ' HA ' ' A' ' 61' ' ' ILE . 48.6 mtp -89.16 173.8 8.22 Favored 'General case' 0 N--CA 1.448 -0.546 0 O-C-N 121.795 -0.565 . . . . 1.02 111.301 -170.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 23.2 tptt -69.52 -41.59 75.82 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.053 -0.522 . . . . 2.47 110.502 -175.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -131.99 153.71 50.07 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 121.087 0.47 . . . . 1.68 111.598 -178.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.453 ' HA ' ' HB1' ' A' ' 89' ' ' ALA . 0.0 OUTLIER -73.01 -20.76 60.94 Favored 'General case' 0 C--O 1.221 -0.399 0 CA-C-N 115.414 -0.812 . . . . 4.24 112.681 -172.762 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.64 -49.97 68.93 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 118.336 0.516 . . . . 1.33 111.403 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 15.3 m -70.45 -33.99 71.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.543 0.687 . . . . 1.34 109.739 177.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.506 ' CB ' ' HA ' ' A' ' 35' ' ' THR . . . -56.85 -45.6 82.32 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-N 114.472 -1.24 . . . . 1.16 109.658 174.656 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.603 ' O ' ' HG2' ' A' ' 94' ' ' LYS . 2.4 mm-40 -55.67 -45.59 77.69 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.618 -0.719 . . . . 2.11 110.78 173.021 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 8.3 mmm180 -57.86 -42.09 83.77 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.715 0.293 . . . . 4.35 111.007 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -58.03 -36.52 72.84 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.75 -0.659 . . . . 1.21 111.631 176.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 37.2 t -84.16 -22.95 30.81 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 112.016 0.376 . . . . 1.16 112.016 179.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.603 ' HG2' ' O ' ' A' ' 90' ' ' GLU . 67.8 mmtt -56.33 -48.32 76.98 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 112.742 0.645 . . . . 4.58 112.742 -175.346 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.446 ' HA ' ' HD3' ' A' ' 96' ' ' PRO . 28.9 t0 -104.91 101.47 29.7 Favored Pre-proline 0 C--N 1.325 -0.462 0 C-N-CA 120.673 -0.411 . . . . 2.24 110.507 -178.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 95' ' ' ASP . 5.7 Cg_exo -80.08 172.74 13.52 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 123.211 2.607 . . . . 2.38 112.936 -175.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.472 ' N ' ' HD3' ' A' ' 98' ' ' PRO . 4.2 p30 31.91 62.45 1.24 Allowed Pre-proline 0 N--CA 1.473 0.707 0 CA-C-N 115.092 -0.958 . . . . 3.61 113.489 -172.431 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.472 ' HD3' ' N ' ' A' ' 97' ' ' ASN . 2.0 Cg_endo -81.15 167.32 17.91 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 123.356 2.704 . . . . 1.54 111.28 176.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 51.0 mm -99.07 135.56 33.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 108.072 -1.084 . . . . 2.08 108.072 178.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 71.6 mt -144.91 108.6 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 N-CA-C 109.453 -0.573 . . . . 1.55 109.453 -172.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 19.1 t0 60.2 52.67 4.85 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.782 0.801 . . . . 1.52 111.003 176.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 77.34 -6.99 40.83 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 115.653 1.021 . . . . 1.73 115.653 177.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.482 ' CG ' ' HG3' ' A' ' 43' ' ' PRO . 27.2 mmt180 -131.62 150.49 52.13 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 118.919 1.36 . . . . 4.66 111.106 -179.282 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -77.19 130.95 37.96 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.892 -0.594 . . . . 3.14 110.913 178.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -107.14 146.93 30.69 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.662 -0.699 . . . . 1.37 110.945 -175.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 39.3 m-20 -96.28 129.37 43.62 Favored 'General case' 0 C--O 1.251 1.163 0 CA-C-O 121.725 0.774 . . . . 2.18 110.011 173.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.638 HG23 HG11 ' A' ' 39' ' ' VAL . 73.3 t -142.26 131.28 22.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 112.942 -1.936 . . . . 1.46 110.462 -161.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 8.4 m-20 -166.6 158.58 13.42 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 123.709 0.63 . . . . 3.22 109.467 175.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.524 HD12 ' HA ' ' A' ' 34' ' ' PHE . 0.2 OUTLIER -58.16 150.16 22.06 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.19 -1.041 . . . . 1.87 108.19 172.35 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.448 ' H ' HD11 ' A' ' 109' ' ' LEU . . . -69.51 -34.12 73.82 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.18 0.514 . . . . 1.3 110.311 -168.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 16.6 p90 -77.51 -8.68 58.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.583 -0.735 . . . . 1.71 110.678 -176.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 64.5 mt -85.06 -16.51 40.42 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.778 0.323 . . . . 1.97 111.712 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.751 ' HA3' ' C4 ' ' B' ' 5' ' ' ' U' . . . -125.41 13.81 7.37 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.515 -0.85 . . . . 2.24 111.408 -177.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -90.34 147.78 23.26 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.556 -0.535 . . . . 2.66 109.556 -177.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 22.9 mmtp -125.21 81.14 63.82 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-O 121.215 0.531 . . . . 4.52 109.855 174.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -97.18 -57.59 0.01 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 123.751 2.968 . . . . 5.53 113.214 -179.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 34.8 ptt180 -94.9 5.91 50.55 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.934 -0.575 . . . . 9.2 111.624 -173.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.7 t -159.5 139.26 11.59 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.144 -0.687 . . . . 6.74 109.144 176.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -136.68 170.68 15.68 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.864 0.364 . . . . 8.27 111.005 -175.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 42.9 t -106.94 139.27 29.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.146 -0.479 . . . . 9.39 110.616 -176.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 . . . . . 0 C--O 1.248 0.992 0 CA-C-O 118.847 -0.597 . . . . 12.71 110.022 178.047 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 1' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.434 -0.391 0 O5'-C5'-C4' 111.617 1.012 . 0.0 '__' . 5.37 . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 2' ' ' ' G' . . . . . 0.454 ' H21' ' HA3' ' A' ' 77' ' ' GLY . . . . . . . . 0 O5'--C5' 1.427 -0.833 0 C4'-C3'-C2' 103.948 1.248 . 0.0 OUTLIER . 4.87 . . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 3' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.427 -0.789 0 C3'-C2'-C1' 100.199 -1.445 . 0.0 OUTLIER . 5.58 . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 4' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.427 -0.809 0 O4'-C1'-C2' 108.457 1.469 . 0.152 0i . 2.69 . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 5' ' ' ' U' . . . . . 0.751 ' C4 ' ' HA3' ' A' ' 113' ' ' GLY . . . . . . . . 0 O5'--C5' 1.426 -0.859 0 C3'-C2'-C1' 100.514 -1.096 . 0.0 OUTLIER . 1.93 . . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 6' ' ' ' G' . . . . . 0.645 ' H21' HG12 ' A' ' 65' ' ' VAL . . . . . . . . 0 O5'--C5' 1.425 -0.96 0 C4'-C3'-C2' 103.852 1.152 . 0.321 0b . 2.38 . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.427 -0.829 0 C4'-C3'-C2' 104.472 1.772 . 0.0 OUTLIER . 4.41 . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.639 0 N-CA-C 112.337 -0.305 . . . . 13.51 112.337 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.36 -38.15 27.1 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.04 0.448 . . . . 11.28 109.904 179.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 96.0 mmm -111.43 107.42 16.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.93 -0.577 . . . . 10.15 110.453 -179.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -118.09 -105.07 2.26 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.861 -0.685 . . . . 6.69 112.642 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.7 p -135.21 139.04 44.18 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 110.536 -0.172 . . . . 5.68 110.536 -178.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 50.8 mtm180 -94.87 -73.52 0.58 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.832 0.348 . . . . 4.34 111.24 -176.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 68.67 164.17 0.23 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.236 -0.893 . . . . 3.53 111.094 -175.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.46 ' HA ' ' OG1' ' A' ' 35' ' ' THR . 10.8 p -121.86 -28.13 4.53 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.675 0.621 . . . . 1.98 112.675 -177.095 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 55.5 ttp -59.01 -43.66 91.56 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 111.983 0.364 . . . . 1.9 111.983 -173.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -96.36 -6.21 38.15 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.771 -0.371 . . . . 1.76 111.793 -177.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.674 ' O ' ' HA ' ' A' ' 82' ' ' THR . 34.2 p -102.78 -5.05 24.08 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.746 0.307 . . . . 1.23 111.371 -176.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.575 ' HG3' ' HB2' ' A' ' 110' ' ' ALA . 18.4 tptm -92.67 101.49 13.9 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.274 0.559 . . . . 3.2 110.461 -175.297 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 32.8 mt -107.85 132.92 54.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.724 -0.671 . . . . 1.46 110.449 -177.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.567 ' HD1' ' CE1' ' A' ' 80' ' ' PHE . 88.4 t80 -99.84 116.09 31.11 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.033 -0.728 . . . . 0.81 109.033 173.454 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.554 HG11 HG21 ' A' ' 107' ' ' VAL . 95.7 t -132.31 106.22 10.55 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.886 0 CA-C-O 118.803 -0.618 . . . . 1.61 110.067 -178.202 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.896 ' HA3' ' HD1' ' A' ' 78' ' ' TYR . . . -122.82 -154.74 9.14 Favored Glycine 0 N--CA 1.44 -1.073 0 C-N-CA 115.979 -3.01 . . . . 1.39 113.267 159.322 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 85.62 8.02 80.93 Favored Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 110.265 -1.134 . . . . 0.71 110.265 -174.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.72 ' HB3' ' HB ' ' A' ' 46' ' ' THR . 5.7 mp -69.55 135.57 88.37 Favored Pre-proline 0 N--CA 1.45 -0.448 0 CA-C-N 114.989 -0.605 . . . . 1.89 109.899 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 1.015 ' HG2' ' HB3' ' A' ' 101' ' ' ASP . 53.8 Cg_exo -49.88 158.85 1.89 Allowed 'Trans proline' 0 N--CA 1.463 -0.291 0 C-N-CA 123.146 2.564 . . . . 0.82 112.128 174.419 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.421 ' CE2' ' C5 ' ' B' ' 2' ' ' ' G' . 51.7 m-85 -66.72 -9.61 38.22 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 113.439 0.903 . . . . 1.46 113.439 -171.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 1.7 p80 -111.71 0.76 16.4 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.124 -0.631 . . . . 2.65 110.77 176.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.72 ' HB ' ' HB3' ' A' ' 42' ' ' LEU . 5.8 m -79.53 118.52 21.46 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.504 -0.554 . . . . 1.31 109.504 176.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 6.2 p -123.93 -177.95 3.91 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.116 -0.493 . . . . 0.75 112.303 -168.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -54.19 -30.84 51.07 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.628 -0.715 . . . . 0.49 110.79 -178.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.536 ' O ' ' HG2' ' A' ' 53' ' ' GLU . 23.2 pttm -74.92 -34.3 62.11 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.653 -0.703 . . . . 3.26 109.842 -178.114 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.572 HG22 HG21 ' A' ' 46' ' ' THR . 6.1 m -67.12 -45.18 77.95 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 116.535 -0.302 . . . . 1.25 110.514 -178.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.606 HD22 HD23 ' A' ' 42' ' ' LEU . 39.2 mt -62.07 -46.95 86.83 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-O 120.994 0.426 . . . . 1.53 109.974 175.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.515 ' HA ' ' CD1' ' A' ' 61' ' ' ILE . 55.1 t-80 -55.95 -51.28 68.24 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 115.687 -0.688 . . . . 0.77 110.574 179.388 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.536 ' HG2' ' O ' ' A' ' 49' ' ' LYS . 21.5 mm-40 -65.25 -36.54 84.45 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 112.311 0.486 . . . . 1.52 112.311 -176.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.709 ' O ' ' HB2' ' A' ' 57' ' ' GLN . 25.7 t80 -77.79 -34.87 52.04 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 118.128 0.422 . . . . 1.6 111.594 -178.383 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.474 ' CD2' HG12 ' A' ' 81' ' ' VAL . 25.9 m-85 -84.91 -28.88 25.63 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 112.892 0.701 . . . . 0.68 112.892 -175.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.583 ' HA ' ' O ' ' A' ' 59' ' ' GLY . 34.4 mm-40 -57.36 -24.72 57.04 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-O 122.563 1.173 . . . . 1.57 109.413 174.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.709 ' HB2' ' O ' ' A' ' 54' ' ' TYR . 69.1 mt-30 -60.27 -31.68 70.46 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 112.971 -1.922 . . . . 2.79 112.27 176.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.442 ' HD2' ' HA ' ' A' ' 55' ' ' PHE . 86.5 m-85 -89.12 -27.21 20.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.329 0.585 . . . . 0.79 109.463 177.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.583 ' O ' ' HA ' ' A' ' 56' ' ' GLU . . . 162.47 -172.28 38.51 Favored Glycine 0 N--CA 1.443 -0.864 0 CA-C-N 115.006 -0.997 . . . . 0.75 111.697 177.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -64.73 126.26 27.37 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.707 0.289 . . . . 1.02 110.801 -177.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.515 ' CD1' ' HA ' ' A' ' 52' ' ' HIS . 8.2 mt -99.98 124.31 53.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.101 -0.703 . . . . 1.13 109.101 177.295 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -78.97 -41.94 28.0 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.009 0.433 . . . . 2.07 111.608 179.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.55 ' HB3' ' HB ' ' A' ' 82' ' ' THR . 8.7 tp10 -139.89 126.6 20.55 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.974 -0.557 . . . . 2.48 111.013 -172.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -127.89 125.84 40.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.679 0.752 . . . . 1.18 110.883 174.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.635 HG22 ' N2 ' ' B' ' 6' ' ' ' G' . 7.1 p -145.62 136.17 18.92 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 CA-C-N 114.546 -1.206 . . . . 1.97 113.057 -178.098 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 75.2 t -102.18 124.9 56.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.296 -0.865 . . . . 1.12 108.855 167.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.533 HG12 ' HA2' ' A' ' 79' ' ' GLY . 35.2 mm -81.1 103.05 7.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.785 -0.643 . . . . 1.44 110.672 -174.444 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 17.0 p -92.99 172.83 8.06 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.326 -0.852 . . . . 1.83 110.638 176.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.47 ' HA ' ' NE ' ' A' ' 76' ' ' ARG . 30.6 t70 -71.74 126.8 30.63 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.823 -0.626 . . . . 2.49 111.039 -176.461 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.427 ' HG3' ' OD1' ' A' ' 71' ' ' ASN . 33.1 ptt180 -55.9 -32.33 63.64 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 112.813 0.671 . . . . 6.58 112.813 -177.385 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.427 ' OD1' ' HG3' ' A' ' 70' ' ' ARG . 4.4 m-20 -83.94 -54.21 5.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.991 0.424 . . . . 4.33 111.971 -176.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 32.7 p -109.63 -21.94 12.19 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.226 -0.443 . . . . 3.67 111.93 -171.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 63.3 mt-30 57.62 76.39 0.33 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 122.442 1.115 . . . . 3.61 111.418 -171.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 54.0 mttm -108.25 153.01 23.84 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 105.953 -1.869 . . . . 3.78 105.953 171.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 35.2 t -71.55 93.07 1.18 Allowed 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 120.138 -0.625 . . . . 2.07 110.479 -177.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.47 ' NE ' ' HA ' ' A' ' 69' ' ' ASP . 64.3 mtt180 -61.48 -11.74 11.99 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.503 -0.772 . . . . 3.07 111.52 173.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.664 ' HA3' ' H21' ' B' ' 2' ' ' ' G' . . . 78.5 11.14 85.59 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.97 -0.633 . . . . 0.75 112.714 176.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.896 ' HD1' ' HA3' ' A' ' 40' ' ' GLY . 29.9 m-85 -114.78 161.66 17.9 Favored 'General case' 0 CA--C 1.504 -0.821 0 N-CA-C 109.807 -0.442 . . . . 1.61 109.807 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.533 ' HA2' HG12 ' A' ' 67' ' ' ILE . . . -161.67 -166.92 21.33 Favored Glycine 0 N--CA 1.438 -1.185 0 C-N-CA 119.855 -1.164 . . . . 0.59 112.432 168.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.567 ' CE1' ' HD1' ' A' ' 38' ' ' PHE . 62.9 m-85 -135.95 132.98 37.12 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.018 -0.734 . . . . 0.84 109.018 179.124 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.474 HG12 ' CD2' ' A' ' 55' ' ' PHE . 41.1 t -119.94 109.96 27.61 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-O 121.392 0.615 . . . . 1.21 110.012 175.334 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.674 ' HA ' ' O ' ' A' ' 35' ' ' THR . 11.2 m -107.96 112.01 24.38 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 107.663 -1.236 . . . . 1.09 107.663 174.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.426 ' HA ' ' HA ' ' A' ' 61' ' ' ILE . 55.6 mtp -90.23 166.99 13.04 Favored 'General case' 0 N--CA 1.447 -0.586 0 O-C-N 121.412 -0.805 . . . . 1.02 109.162 -173.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -79.44 -17.27 54.61 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.816 0.341 . . . . 2.47 110.945 -173.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -145.01 146.75 32.04 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.281 -0.418 . . . . 1.68 110.235 -179.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.726 ' HD3' ' H ' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -72.77 -22.11 60.9 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.91 0.707 . . . . 4.24 112.91 -174.096 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.426 ' O ' ' HG3' ' A' ' 91' ' ' ARG . . . -72.16 -37.45 69.36 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.054 0.454 . . . . 1.33 111.07 -178.002 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.528 ' OG ' ' HA3' ' A' ' 59' ' ' GLY . 21.1 m -72.64 -37.94 67.85 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.712 0.768 . . . . 1.34 109.666 174.439 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.78 -41.96 83.14 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.061 -1.427 . . . . 1.16 109.333 175.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -54.69 -48.53 72.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.042 -0.981 . . . . 2.11 111.507 171.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.49 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 96.7 mtt180 -59.98 -38.84 83.73 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.258 -0.428 . . . . 4.35 110.951 -179.4 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -59.12 -46.37 88.51 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.028 -0.533 . . . . 1.21 111.658 174.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 51.7 t -76.58 -8.76 57.86 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 111.707 0.262 . . . . 1.16 111.707 -178.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.49 ' HB2' ' O ' ' A' ' 91' ' ' ARG . 39.7 mmtm -58.03 -41.63 83.61 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.661 -0.245 . . . . 4.58 110.951 177.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -103.44 104.67 42.86 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 109.56 -0.533 . . . . 2.24 109.56 174.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.564 ' O ' ' HB2' ' A' ' 97' ' ' ASN . 39.8 Cg_endo -84.94 102.6 0.81 Allowed 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 122.631 2.221 . . . . 2.38 113.427 -174.11 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.564 ' HB2' ' O ' ' A' ' 96' ' ' PRO . 10.8 m120 89.03 54.66 0.03 OUTLIER Pre-proline 0 N--CA 1.476 0.862 0 CA-C-N 114.39 -1.277 . . . . 3.61 110.266 174.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.542 ' O ' HG13 ' A' ' 100' ' ' ILE . 90.1 Cg_endo -82.75 116.85 2.58 Favored 'Trans proline' 0 N--CA 1.45 -1.037 0 C-N-CA 121.49 1.46 . . . . 1.54 112.767 -177.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.987 ' HA ' ' HA ' ' A' ' 104' ' ' LYS . 1.2 mt -25.47 131.39 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.49 -0.777 . . . . 2.08 112.866 151.364 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.542 HG13 ' O ' ' A' ' 98' ' ' PRO . 61.0 mt -148.46 126.99 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 N-CA-C 106.151 -1.796 . . . . 1.55 106.151 -178.599 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 1.015 ' HB3' ' HG2' ' A' ' 43' ' ' PRO . 10.3 t0 65.06 41.18 4.72 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 122.245 1.021 . . . . 1.52 109.164 -178.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 70.27 -8.14 4.13 Favored Glycine 0 CA--C 1.529 0.921 0 CA-C-N 114.708 -1.133 . . . . 1.73 115.529 -179.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.653 ' CG ' ' HG3' ' A' ' 43' ' ' PRO . 34.8 mmt180 -117.5 134.27 55.04 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 119.317 1.559 . . . . 4.66 110.629 178.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.987 ' HA ' ' HA ' ' A' ' 99' ' ' ILE . 4.7 ttpm? -63.98 128.46 35.9 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 121.382 -0.127 . . . . 3.14 111.267 -177.437 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -100.16 152.52 20.16 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 120.956 0.408 . . . . 1.37 111.109 -177.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.542 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 9.0 t30 -102.2 124.69 48.23 Favored 'General case' 0 C--O 1.243 0.726 0 CA-C-N 116.179 -0.464 . . . . 2.18 109.905 177.27 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.554 HG21 HG11 ' A' ' 39' ' ' VAL . 94.7 t -139.37 128.44 28.92 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.125 0 O-C-N 124.842 1.339 . . . . 1.46 110.505 -164.296 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 33.5 p30 -160.25 157.36 28.02 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.388 -0.369 . . . . 3.22 110.011 171.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.568 ' HB3' ' CD1' ' A' ' 111' ' ' TYR . 3.5 mm? -67.01 101.11 0.81 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.202 0.525 . . . . 1.87 110.901 175.154 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.575 ' HB2' ' HG3' ' A' ' 36' ' ' LYS . . . -46.97 -24.11 0.56 Allowed 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 115.518 1.673 . . . . 1.3 115.518 -174.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.568 ' CD1' ' HB3' ' A' ' 109' ' ' LEU . 14.9 p90 -66.21 -9.21 29.93 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 118.163 0.438 . . . . 1.71 111.515 -175.185 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' A' ' 109' ' ' LEU . 91.4 mt -61.88 -47.39 85.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.739 -0.21 . . . . 1.97 111.421 -179.371 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -113.33 28.36 8.73 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.809 -0.71 . . . . 2.24 111.969 178.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -84.46 135.4 34.26 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.616 0.246 . . . . 2.66 111.156 -175.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -134.72 71.85 69.87 Favored Pre-proline 0 C--N 1.324 -0.537 0 N-CA-C 109.294 -0.632 . . . . 4.52 109.294 170.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -81.03 9.94 3.61 Favored 'Trans proline' 0 C--N 1.348 0.5 0 C-N-CA 123.058 2.505 . . . . 5.53 111.766 -178.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 33.2 ttm180 173.76 -39.36 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.272 -1.331 . . . . 9.2 108.387 -177.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 11.8 t -172.6 176.16 3.29 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 114.995 -1.002 . . . . 6.74 109.685 -178.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -178.37 -57.61 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 O-C-N 124.188 0.93 . . . . 8.27 108.788 173.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 34.2 t 55.69 87.43 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-N 115.354 -0.839 . . . . 9.39 111.986 176.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.411 ' O ' ' HG3' ' A' ' 121' ' ' GLN . 3.9 pt20 . . . . . 0 C--O 1.251 1.174 0 CA-C-O 119.078 -0.486 . . . . 12.71 110.431 178.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 1' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.43 -0.62 0 C3'-C2'-C1' 100.448 -1.169 . 0.0 '__' . 5.37 . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 2' ' ' ' G' . . . . . 0.664 ' H21' ' HA3' ' A' ' 77' ' ' GLY . . . . . . . . 0 O5'--C5' 1.427 -0.803 0 C4'-C3'-C2' 103.746 1.046 . 0.0 OUTLIER gamma 4.87 . . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 3' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.429 -0.695 0 P-O3'-C3' 120.709 0.841 . 0.0 OUTLIER gamma 5.58 . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 4' ' ' ' G' . . . . . 0.516 ' C8 ' ' HE2' ' A' ' 38' ' ' PHE . . . . . . . . 0 O5'--C5' 1.425 -0.954 0 O4'-C1'-C2' 108.033 1.166 . 0.0 OUTLIER . 2.69 . . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 5' ' ' ' U' . . . . . 0.464 ' H6 ' " O5'" ' B' ' 5' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.429 -0.692 0 C3'-C2'-C1' 100.499 -1.113 . 0.0 OUTLIER gamma 1.93 . . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 6' ' ' ' G' . . . . . 0.635 ' N2 ' HG22 ' A' ' 65' ' ' VAL . . . . . . . . 0 O5'--C5' 1.428 -0.758 0 C4'-C3'-C2' 104.189 1.489 . 0.0 OUTLIER gamma 2.38 . . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 7' ' ' ' C' . . . . . 0.408 ' OP1' ' C6 ' ' B' ' 7' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.428 -0.762 0 C3'-C2'-C1' 103.293 1.992 . 0.0 OUTLIER . 4.41 . . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.796 0 N-CA-C 112.369 -0.292 . . . . 13.51 112.369 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . 67.89 -78.04 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 123.38 0.672 . . . . 11.28 112.24 178.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 68.2 mtm -88.11 99.83 12.49 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.039 0.447 . . . . 10.15 110.517 -175.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 172.21 113.35 0.3 Allowed Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 120.908 -0.663 . . . . 6.69 112.175 179.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.3 p -80.38 110.64 16.02 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.017 0.437 . . . . 5.68 110.357 175.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 78.9 mtm180 -110.65 132.31 54.3 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.999 -0.546 . . . . 4.34 111.307 -175.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -73.25 85.57 1.42 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.101 -0.5 . . . . 3.53 110.694 174.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.584 ' HA ' ' OG1' ' A' ' 35' ' ' THR . 12.2 p -85.05 -17.91 36.01 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.855 -0.338 . . . . 1.98 111.154 177.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' MET . . . . . 0.545 ' HE1' ' CE2' ' A' ' 34' ' ' PHE . 50.8 ttp -62.13 -44.66 96.15 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.035 -0.529 . . . . 1.9 111.438 -178.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.545 ' CE2' ' HE1' ' A' ' 33' ' ' MET . 29.3 m-85 -98.77 6.54 46.84 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 111.705 0.261 . . . . 1.76 111.705 -178.382 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.752 ' O ' ' HA ' ' A' ' 82' ' ' THR . 43.1 p -114.51 17.08 17.54 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.264 0.554 . . . . 1.23 109.922 177.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.822 ' HG3' ' HB2' ' A' ' 110' ' ' ALA . 0.1 OUTLIER -113.85 103.43 11.18 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.14 -0.937 . . . . 3.2 110.354 -176.737 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.5 mp -110.26 131.32 61.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.904 -0.589 . . . . 1.46 111.036 -176.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.505 ' O ' ' HA ' ' A' ' 107' ' ' VAL . 69.4 t80 -91.3 113.09 25.26 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.264 -0.88 . . . . 0.81 109.002 176.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.592 ' HA ' ' O ' ' A' ' 106' ' ' ASN . 84.7 t -132.93 102.59 5.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 118.194 -0.907 . . . . 1.61 110.273 -176.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.59 ' HA2' ' CD1' ' A' ' 42' ' ' LEU . . . -122.83 -154.84 9.17 Favored Glycine 0 C--O 1.221 -0.705 0 C-N-CA 115.937 -3.03 . . . . 1.39 113.629 163.119 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 84.07 4.32 88.47 Favored Glycine 0 N--CA 1.452 -0.299 0 N-CA-C 111.098 -0.801 . . . . 0.71 111.098 -175.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.802 ' HB3' ' HB ' ' A' ' 46' ' ' THR . 5.4 mp -64.96 137.51 97.18 Favored Pre-proline 0 N--CA 1.453 -0.282 0 CA-C-N 115.409 -0.395 . . . . 1.89 110.38 -178.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.571 ' HG2' ' HB3' ' A' ' 101' ' ' ASP . 52.7 Cg_exo -51.73 159.75 3.29 Favored 'Trans proline' 0 N--CA 1.463 -0.305 0 C-N-CA 123.198 2.599 . . . . 0.82 111.955 173.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.743 ' HH ' HO2' ' B' ' 1' ' ' ' G' . 28.5 m-85 -66.43 -12.43 57.1 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 112.401 0.519 . . . . 1.46 112.401 -175.163 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 46.3 t60 -92.0 -24.92 19.06 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.15 0.5 . . . . 2.65 109.986 174.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.802 ' HB ' ' HB3' ' A' ' 42' ' ' LEU . 4.4 m -72.71 118.32 15.49 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.876 -0.602 . . . . 1.31 109.849 -176.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 6.0 p -134.46 -175.64 3.94 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.617 -0.719 . . . . 0.75 111.176 -168.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -49.93 -34.87 21.88 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.424 0.631 . . . . 0.49 110.594 -177.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.697 ' O ' ' HG2' ' A' ' 53' ' ' GLU . 8.5 ptpp? -67.65 -43.88 79.25 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 114.893 -1.049 . . . . 3.26 109.887 -178.089 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.607 HG22 HG21 ' A' ' 46' ' ' THR . 6.7 m -66.34 -40.51 89.91 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.629 -0.259 . . . . 1.25 111.24 -176.085 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.587 HD22 HD23 ' A' ' 42' ' ' LEU . 22.8 mt -61.78 -46.86 87.73 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 109.882 -0.414 . . . . 1.53 109.882 175.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.529 ' HA ' HD13 ' A' ' 61' ' ' ILE . 45.9 t-80 -52.69 -51.55 59.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.417 -0.811 . . . . 0.77 110.218 174.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.697 ' HG2' ' O ' ' A' ' 49' ' ' LYS . 23.4 mm-40 -59.48 -48.18 82.65 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.106 -0.497 . . . . 1.52 112.316 -176.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.451 ' O ' ' HB2' ' A' ' 57' ' ' GLN . 47.4 t80 -76.53 -41.44 46.7 Favored 'General case' 0 C--O 1.227 -0.109 0 CA-C-O 121.051 0.453 . . . . 1.6 111.495 -171.384 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.727 ' HB2' HD12 ' A' ' 61' ' ' ILE . 45.8 m-85 -84.16 -30.38 25.9 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 113.063 0.764 . . . . 0.68 113.063 -170.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.599 ' HA ' ' O ' ' A' ' 59' ' ' GLY . 16.6 pt-20 -67.45 -14.58 63.06 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 122.109 0.957 . . . . 1.57 110.113 -178.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.451 ' HB2' ' O ' ' A' ' 54' ' ' TYR . 13.6 mm100 -57.11 -26.3 60.23 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.082 -1.417 . . . . 2.79 112.063 172.167 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -93.12 -25.2 17.99 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.223 0.535 . . . . 0.79 110.055 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.599 ' O ' ' HA ' ' A' ' 56' ' ' GLU . . . 170.96 174.66 38.97 Favored Glycine 0 N--CA 1.447 -0.606 0 N-CA-C 110.386 -1.086 . . . . 0.75 110.386 -179.22 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 61.1 m-20 -67.9 125.14 25.36 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 117.492 0.646 . . . . 1.02 110.819 -173.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.727 HD12 ' HB2' ' A' ' 55' ' ' PHE . 29.8 mt -89.04 118.63 34.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.335 -0.393 . . . . 1.13 110.309 178.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.434 ' HB2' ' HG3' ' A' ' 84' ' ' LYS . 24.9 tt0 -75.7 -33.0 60.32 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.145 0.424 . . . . 2.07 112.145 -179.269 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -157.15 133.3 9.64 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.651 -0.42 . . . . 2.48 111.531 -178.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -125.3 130.08 51.28 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.643 -0.708 . . . . 1.18 110.928 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.843 HG23 ' H21' ' B' ' 6' ' ' ' G' . 20.6 t -135.54 136.19 50.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 114.527 -1.215 . . . . 1.97 111.927 -177.328 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 56.0 t -118.58 117.72 55.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 108.703 -0.851 . . . . 1.12 108.703 162.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 35.3 mm -77.06 111.81 14.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 115.293 -0.867 . . . . 1.44 111.111 -171.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 21.4 p -91.83 164.24 13.76 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.551 -0.75 . . . . 1.83 110.911 176.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.478 ' OD2' ' HB2' ' A' ' 71' ' ' ASN . 5.2 t70 -68.89 133.22 47.95 Favored 'General case' 0 C--O 1.217 -0.61 0 CA-C-N 116.151 -0.477 . . . . 2.49 111.59 -175.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.652 ' HD3' ' H ' ' A' ' 70' ' ' ARG . 0.8 OUTLIER -54.13 -41.6 68.57 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.063 -0.517 . . . . 6.58 111.286 179.548 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.478 ' HB2' ' OD2' ' A' ' 69' ' ' ASP . 35.2 m-80 -70.65 -59.63 2.72 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.76 0.652 . . . . 4.33 112.76 -176.218 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.472 ' OG1' ' HE2' ' A' ' 74' ' ' LYS . 41.4 p -115.73 -23.44 8.68 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.36 0.504 . . . . 3.67 112.36 -171.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.435 ' HA ' ' N ' ' A' ' 69' ' ' ASP . 42.2 mt-30 69.58 15.2 8.23 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 123.689 0.796 . . . . 3.61 112.606 -176.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.472 ' HE2' ' OG1' ' A' ' 72' ' ' THR . 46.9 mtmt -54.27 120.01 5.94 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 108.268 -1.012 . . . . 3.78 108.268 165.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 17.0 m -50.17 104.63 0.07 Allowed 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 112.806 0.669 . . . . 2.07 112.806 -168.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.427 ' HB3' ' CD2' ' A' ' 78' ' ' TYR . 21.7 mtp180 -61.19 -25.09 66.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.003 -0.999 . . . . 3.07 111.964 177.324 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.446 ' HA3' ' H21' ' B' ' 2' ' ' ' G' . . . 80.58 23.51 60.21 Favored Glycine 0 C--O 1.225 -0.467 0 C-N-CA 120.491 -0.861 . . . . 0.75 112.52 179.216 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.427 ' CD2' ' HB3' ' A' ' 76' ' ' ARG . 21.7 m-85 -120.07 138.91 53.26 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.113 -1.069 . . . . 1.61 108.113 176.571 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -141.88 -177.77 17.34 Favored Glycine 0 N--CA 1.441 -0.972 0 C-N-CA 119.076 -1.535 . . . . 0.59 113.508 178.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.451 ' CE1' ' HD1' ' A' ' 38' ' ' PHE . 61.3 m-85 -138.65 125.93 21.6 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 123.179 0.592 . . . . 0.84 109.445 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.448 HG21 HD11 ' A' ' 51' ' ' LEU . 42.8 t -113.33 114.51 47.09 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-O 121.03 0.443 . . . . 1.21 110.57 178.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.752 ' HA ' ' O ' ' A' ' 35' ' ' THR . 8.4 m -106.36 125.23 50.73 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.025 -1.102 . . . . 1.09 108.025 171.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 81.3 mtp -110.76 166.49 10.98 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 107.987 -1.116 . . . . 1.02 107.987 -172.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.434 ' HG3' ' HB2' ' A' ' 62' ' ' GLU . 3.4 mttm -83.53 -8.72 59.29 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 112.704 0.631 . . . . 2.47 112.704 -172.575 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.425 ' OD1' ' HD2' ' A' ' 86' ' ' ARG . 9.6 t70 -145.36 146.52 31.62 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 109.908 -0.404 . . . . 1.68 109.908 174.632 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.425 ' HD2' ' OD1' ' A' ' 85' ' ' ASP . 0.8 OUTLIER -73.84 -23.26 59.61 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 111.592 0.219 . . . . 4.24 111.592 -176.524 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -63.04 -50.3 71.19 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.03 0.443 . . . . 1.33 110.42 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 13.2 m -67.57 -35.89 79.88 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.953 -0.567 . . . . 1.34 109.933 176.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.415 ' HB1' ' HA ' ' A' ' 86' ' ' ARG . . . -57.15 -45.83 83.27 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 114.789 -1.096 . . . . 1.16 110.651 176.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -56.5 -42.49 78.43 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.198 -0.455 . . . . 2.11 111.521 172.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.726 ' O ' ' HG3' ' A' ' 94' ' ' LYS . 12.9 mmt180 -68.11 -31.81 71.66 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.969 -0.56 . . . . 4.35 110.83 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -61.39 -38.33 86.67 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.603 -0.271 . . . . 1.21 111.651 171.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 37.0 t -86.58 -20.08 28.45 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 112.961 0.726 . . . . 1.16 112.961 -173.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.726 ' HG3' ' O ' ' A' ' 91' ' ' ARG . 0.0 OUTLIER -51.54 -19.44 1.47 Allowed 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 112.959 0.726 . . . . 4.58 112.959 177.337 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.691 ' N ' ' HD3' ' A' ' 94' ' ' LYS . 24.5 t0 -112.03 103.96 55.66 Favored Pre-proline 0 C--N 1.325 -0.491 0 N-CA-C 108.788 -0.819 . . . . 2.24 108.788 168.427 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 95' ' ' ASP . 3.6 Cg_exo -80.42 -13.32 12.3 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 123.241 2.628 . . . . 2.38 113.503 -172.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 52.7 m-80 -148.75 53.55 1.44 Allowed Pre-proline 0 C--O 1.236 0.38 0 O-C-N 122.383 -0.198 . . . . 3.61 111.278 -176.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.533 ' O ' HG13 ' A' ' 100' ' ' ILE . 72.4 Cg_endo -82.81 113.14 2.17 Favored 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 120.739 0.959 . . . . 1.54 113.13 -175.298 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.428 HD11 ' CA ' ' A' ' 104' ' ' LYS . 12.7 mm -24.14 124.85 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-N 116.033 -0.53 . . . . 2.08 111.979 149.098 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.533 HG13 ' O ' ' A' ' 98' ' ' PRO . 75.2 mt -145.14 119.68 3.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 105.961 -1.866 . . . . 1.55 105.961 179.2 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.571 ' HB3' ' HG2' ' A' ' 43' ' ' PRO . 27.5 t0 55.21 50.64 14.69 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 122.637 1.208 . . . . 1.52 109.783 -174.443 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 71.42 -8.17 5.66 Favored Glycine 0 CA--C 1.53 1.006 0 N-CA-C 117.22 1.648 . . . . 1.73 117.22 176.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.488 ' HB2' ' HG3' ' A' ' 43' ' ' PRO . 2.0 mmm180 -116.22 142.07 47.31 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 120.59 2.195 . . . . 4.66 111.83 176.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.428 ' CA ' HD11 ' A' ' 99' ' ' ILE . 41.1 ttmt -64.64 124.08 20.96 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.896 -0.593 . . . . 3.14 110.57 176.432 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -102.0 162.17 13.12 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.431 -0.349 . . . . 1.37 110.5 178.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.592 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 39.7 t-20 -114.78 127.79 55.93 Favored 'General case' 0 C--O 1.248 0.986 0 N-CA-C 109.48 -0.563 . . . . 2.18 109.48 179.338 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.552 HG21 HG23 ' A' ' 39' ' ' VAL . 88.3 t -138.85 123.19 20.66 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 O-C-N 125.056 1.473 . . . . 1.46 111.065 -163.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -156.62 151.97 26.59 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.324 -0.621 . . . . 3.22 109.324 175.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.515 ' HB3' ' CE1' ' A' ' 111' ' ' TYR . 1.3 mm? -57.37 96.28 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.063 0.459 . . . . 1.87 111.238 176.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.822 ' HB2' ' HG3' ' A' ' 36' ' ' LYS . . . -45.19 -33.16 2.16 Favored 'General case' 0 C--O 1.224 -0.245 0 N-CA-C 115.654 1.724 . . . . 1.3 115.654 -176.378 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.515 ' CE1' ' HB3' ' A' ' 109' ' ' LEU . 9.1 p90 -55.96 -14.82 2.75 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 112.662 0.615 . . . . 1.71 112.662 -169.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 60.3 mt -62.28 -47.28 85.03 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 120.878 0.37 . . . . 1.97 110.444 175.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -102.34 -28.67 6.32 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.959 -0.638 . . . . 2.24 112.524 173.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -76.1 123.45 25.82 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 109.623 -0.51 . . . . 2.66 109.623 179.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -134.67 100.69 12.16 Favored Pre-proline 0 C--N 1.316 -0.866 0 CA-C-N 116.023 -0.535 . . . . 4.52 110.317 -172.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -77.15 15.25 1.19 Allowed 'Trans proline' 0 C--O 1.234 0.291 0 C-N-CA 123.16 2.573 . . . . 5.53 113.198 -176.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 16.6 tpt180 -176.78 -78.75 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.845 -0.616 . . . . 9.2 109.957 178.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 13.9 t -156.19 23.74 0.36 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 122.41 1.1 . . . . 6.74 108.275 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -70.83 104.18 2.83 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.375 -1.284 . . . . 8.27 112.362 -168.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 57.3 t -107.35 -50.2 7.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 107.691 -1.226 . . . . 9.39 107.691 165.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 19.8 tt0 . . . . . 0 C--O 1.245 0.834 0 CA-C-N 114.558 -1.201 . . . . 12.71 108.528 171.756 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 1' ' ' ' G' . . . . . 0.743 HO2' ' HH ' ' A' ' 44' ' ' TYR . . . . . . . . 0 O5'--C5' 1.43 -0.629 0 C4'-C3'-C2' 104.046 1.346 . 0.0 '__' . 5.37 . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 2' ' ' ' G' . . . . . 0.446 ' H21' ' HA3' ' A' ' 77' ' ' GLY . . . . . . . . 0 O5'--C5' 1.424 -0.991 0 C3'-C2'-C1' 99.041 -2.732 . 0.0 OUTLIER . 4.87 . . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 3' ' ' ' U' . . . . . 0.445 ' P ' " O2'" ' B' ' 2' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.426 -0.85 0 O4'-C1'-N19 109.951 1.751 . 0.0 OUTLIER . 5.58 . . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 4' ' ' ' G' . . . . . 0.863 " H3'" ' N3 ' ' B' ' 4' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.427 -0.836 0 P-O3'-C3' 120.978 1.065 . 0.0 OUTLIER . 2.69 . . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 5' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.426 -0.869 0 C4'-C3'-C2' 104.544 1.844 . 0.0 OUTLIER gamma 1.93 . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 6' ' ' ' G' . . . . . 0.843 ' H21' HG23 ' A' ' 65' ' ' VAL . . . . . . . . 0 O5'--C5' 1.425 -0.931 0 C3'-C2'-C1' 100.836 -0.738 . 0.369 4b . 2.38 . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C2'--C1' 1.536 0.759 0 O4'-C1'-C2' 108.031 1.165 . 0.0 OUTLIER . 4.41 . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.762 0 N-CA-C 111.625 -0.59 . . . . 13.51 111.625 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -86.23 132.62 33.96 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.815 0.341 . . . . 11.28 110.58 178.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 44.3 ttm -111.34 134.86 52.62 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.233 -0.439 . . . . 10.15 111.008 -177.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 167.48 155.2 9.04 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.952 -0.642 . . . . 6.69 112.468 177.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 8.6 m -87.37 -5.53 58.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.085 0.469 . . . . 5.68 110.55 177.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 64.2 mtm180 -94.92 139.46 31.29 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.769 -0.65 . . . . 4.34 110.695 -175.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.401 ' OD2' ' HB3' ' A' ' 33' ' ' MET . 29.0 t70 -88.84 108.68 19.65 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 110.116 -0.327 . . . . 3.53 110.116 176.105 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.645 ' O ' ' HB2' ' A' ' 36' ' ' LYS . 18.7 p -90.51 8.34 34.39 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.744 0.307 . . . . 1.98 111.685 -178.412 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' MET . . . . . 0.401 ' HB3' ' OD2' ' A' ' 31' ' ' ASP . 49.3 ttp -73.9 -71.45 0.33 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.38 0.61 . . . . 1.9 110.418 171.385 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.457 ' C ' ' H ' ' A' ' 36' ' ' LYS . 21.4 m-85 -52.68 -71.62 0.07 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.716 -1.129 . . . . 1.76 111.575 176.492 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.612 ' HB ' ' O ' ' A' ' 83' ' ' MET . 34.5 p -53.26 18.17 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 116.542 2.053 . . . . 1.23 116.542 178.339 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.645 ' HB2' ' O ' ' A' ' 32' ' ' THR . 41.8 tptt -116.32 113.16 22.57 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 119.52 1.055 . . . . 3.2 111.205 -178.268 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 84.8 mt -103.06 131.15 52.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-N 115.147 -0.933 . . . . 1.46 110.681 -179.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.501 ' HB2' ' HA ' ' A' ' 110' ' ' ALA . 70.2 t80 -91.92 119.74 31.96 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 109.102 -0.703 . . . . 0.81 109.102 175.336 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.585 HG13 HD12 ' A' ' 42' ' ' LEU . 3.9 t -102.31 135.32 39.89 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 N-CA-C 108.315 -0.995 . . . . 1.61 108.315 -179.351 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -141.72 153.79 24.38 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.291 -0.957 . . . . 1.39 112.093 -169.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 70.21 34.96 69.86 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.705 -0.76 . . . . 0.71 112.518 176.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.634 HD21 ' CG2' ' A' ' 46' ' ' THR . 7.2 mp -75.08 142.93 76.54 Favored Pre-proline 0 C--N 1.328 -0.35 0 N-CA-C 109.88 -0.415 . . . . 1.89 109.88 178.058 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.461 ' HG3' ' HB3' ' A' ' 103' ' ' ARG . 28.0 Cg_endo -68.63 158.61 57.03 Favored 'Trans proline' 0 N--CA 1.451 -1.016 0 C-N-CA 121.862 1.708 . . . . 0.82 110.736 173.659 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.518 ' HD1' ' OG ' ' A' ' 75' ' ' SER . 59.7 m-85 -64.96 0.15 1.33 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.771 0.656 . . . . 1.46 112.771 -173.256 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 84.3 t60 -110.37 -6.44 14.98 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.695 0.283 . . . . 2.65 111.441 -178.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.634 ' CG2' HD21 ' A' ' 42' ' ' LEU . 25.7 m -77.75 137.88 38.71 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.611 -0.436 . . . . 1.31 111.094 -179.544 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 10.4 p -131.73 -177.58 4.49 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.777 -0.647 . . . . 0.75 109.961 -179.005 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.402 ' OD2' ' HA ' ' A' ' 65' ' ' VAL . 1.8 m-20 -61.5 -49.4 76.92 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 122.165 0.983 . . . . 0.49 108.871 -175.503 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.719 ' O ' ' HG2' ' A' ' 53' ' ' GLU . 22.9 pttm -53.1 -33.78 53.73 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 113.229 -1.805 . . . . 3.26 111.13 175.333 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.477 ' HB ' HG21 ' A' ' 46' ' ' THR . 5.0 m -68.11 -44.6 75.8 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.028 0.442 . . . . 1.25 110.193 178.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.513 HD22 HG12 ' A' ' 39' ' ' VAL . 33.3 mt -62.97 -44.48 95.93 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-N 115.985 -0.552 . . . . 1.53 110.48 176.492 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.646 ' O ' ' HB2' ' A' ' 56' ' ' GLU . 45.2 t-80 -56.29 -37.24 69.61 Favored 'General case' 0 C--O 1.216 -0.679 0 CA-C-N 116.096 -0.502 . . . . 0.77 110.641 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.719 ' HG2' ' O ' ' A' ' 49' ' ' LYS . 25.8 mm-40 -74.15 -40.44 62.59 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.311 -0.404 . . . . 1.52 111.781 -174.695 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.499 ' O ' ' HB2' ' A' ' 57' ' ' GLN . 2.9 t80 -77.66 -33.7 53.33 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.782 0.801 . . . . 1.6 110.293 -177.215 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.662 ' HB2' HD12 ' A' ' 61' ' ' ILE . 40.4 m-85 -85.89 -25.82 25.95 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.013 -0.994 . . . . 0.68 111.423 -174.642 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.646 ' HB2' ' O ' ' A' ' 52' ' ' HIS . 3.2 tp10 -62.09 -4.4 1.67 Allowed 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 122.266 1.031 . . . . 1.57 110.428 174.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.523 ' H ' ' C ' ' A' ' 55' ' ' PHE . 82.5 mt-30 -88.51 -30.7 19.15 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 114.251 -1.34 . . . . 2.79 110.431 -177.248 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.596 ' CG ' ' HA ' ' A' ' 92' ' ' ALA . 68.4 m-85 -90.75 -8.91 48.49 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.997 -1.001 . . . . 0.79 110.662 -175.276 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 142.83 174.33 15.12 Favored Glycine 0 N--CA 1.441 -1.015 0 N-CA-C 111.139 -0.785 . . . . 0.75 111.139 -179.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.655 ' HB3' ' HD2' ' A' ' 84' ' ' LYS . 3.0 m-20 -49.23 121.82 5.33 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.319 0.581 . . . . 1.02 111.798 176.314 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.662 HD12 ' HB2' ' A' ' 55' ' ' PHE . 85.0 mt -91.59 144.7 8.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 107.059 -1.46 . . . . 1.13 107.059 171.609 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -94.71 -45.09 7.5 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 119.054 0.843 . . . . 2.07 108.872 179.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -154.01 123.91 6.79 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.358 -0.837 . . . . 2.48 109.866 176.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -112.47 127.9 56.18 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.789 0.328 . . . . 1.18 110.741 175.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.402 ' HA ' ' OD2' ' A' ' 48' ' ' ASP . 8.1 p -144.52 137.75 22.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.636 -0.711 . . . . 1.97 111.74 -175.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.532 HG13 HG21 ' A' ' 68' ' ' THR . 54.6 t -104.62 117.31 50.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 108.681 -0.859 . . . . 1.12 108.681 172.153 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.616 ' O ' ' HD3' ' A' ' 76' ' ' ARG . 47.7 mm -76.88 72.38 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 122.084 0.945 . . . . 1.44 111.235 -173.348 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.541 HG23 ' HA ' ' A' ' 75' ' ' SER . 38.5 p -101.78 160.22 14.66 Favored 'General case' 0 N--CA 1.433 -1.315 0 CA-C-N 114.627 -1.17 . . . . 1.83 109.757 164.33 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.478 ' N ' ' HA ' ' A' ' 73' ' ' GLN . 9.9 t70 -73.26 111.22 8.18 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.371 -0.377 . . . . 2.49 111.006 -176.5 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.429 HH11 ' HD3' ' A' ' 70' ' ' ARG . 2.1 ptp180 -52.09 -10.67 0.13 Allowed 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 114.632 1.345 . . . . 6.58 114.632 -179.273 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -93.07 -42.87 9.17 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 121.634 -0.666 . . . . 4.33 112.172 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 19.6 p -135.17 -24.59 1.42 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.864 0.84 . . . . 3.67 110.143 -175.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.478 ' HA ' ' N ' ' A' ' 69' ' ' ASP . 92.4 mt-30 69.45 -86.0 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 113.589 -1.641 . . . . 3.61 111.479 -173.045 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 32.3 mtmm 63.04 67.31 0.69 Allowed 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 105.317 -2.105 . . . . 3.78 105.317 -171.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.541 ' HA ' HG23 ' A' ' 68' ' ' THR . 5.6 p -42.99 121.99 2.28 Favored 'General case' 0 CA--C 1.52 -0.197 0 O-C-N 124.581 1.176 . . . . 2.07 112.218 -160.643 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.616 ' HD3' ' O ' ' A' ' 67' ' ' ILE . 41.1 mtp180 -87.3 1.35 53.49 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 113.937 -1.483 . . . . 3.07 111.064 -168.736 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 69.64 14.58 70.0 Favored Glycine 0 N--CA 1.447 -0.626 0 CA-C-N 115.785 -0.643 . . . . 0.75 113.084 177.078 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.479 ' O ' HG11 ' A' ' 66' ' ' VAL . 13.8 m-85 -118.68 156.1 29.87 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 116.879 0.339 . . . . 1.61 110.979 -177.185 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -148.2 179.16 25.28 Favored Glycine 0 N--CA 1.444 -0.808 0 CA-C-N 115.967 -0.56 . . . . 0.59 111.792 173.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.429 ' CE1' ' HD1' ' A' ' 38' ' ' PHE . 41.3 m-85 -156.04 123.71 5.56 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 123.604 0.762 . . . . 0.84 109.488 -179.444 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 70.4 t -120.95 127.04 75.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-O 120.811 0.339 . . . . 1.21 110.433 -178.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 13.4 m -104.06 114.85 29.38 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.883 -0.784 . . . . 1.09 108.883 177.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.612 ' O ' ' HB ' ' A' ' 35' ' ' THR . 93.0 mmm -90.68 133.1 35.39 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 120.9 -0.32 . . . . 1.02 110.719 -178.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.655 ' HD2' ' HB3' ' A' ' 60' ' ' ASP . 46.9 mttm -51.04 -6.24 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 114.614 1.339 . . . . 2.47 114.614 174.136 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -160.46 155.49 24.49 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.774 -0.454 . . . . 1.68 109.774 174.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.554 ' HD3' ' H ' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -75.41 -33.02 60.93 Favored 'General case' 0 C--O 1.224 -0.242 0 N-CA-C 108.279 -1.008 . . . . 4.24 108.279 179.49 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -47.71 -48.63 29.38 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.391 -1.277 . . . . 1.33 110.126 168.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 19.7 m -69.33 -27.97 65.83 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.166 -0.47 . . . . 1.34 111.326 179.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -70.19 -50.13 43.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.451 . . . . 1.16 110.482 177.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -55.49 -32.48 62.87 Favored 'General case' 0 C--O 1.222 -0.384 0 CA-C-N 116.101 -0.499 . . . . 2.11 110.732 172.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.574 ' O ' ' HG3' ' A' ' 94' ' ' LYS . 13.4 mtp180 -70.33 -51.42 30.23 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.859 -1.064 . . . . 4.35 110.723 179.522 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . 0.596 ' HA ' ' CG ' ' A' ' 58' ' ' PHE . . . -56.06 -46.72 78.85 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 113.992 1.108 . . . . 1.21 113.992 171.626 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 48.9 t -74.57 -42.47 58.69 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 120.974 -0.291 . . . . 1.16 111.531 -172.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.574 ' HG3' ' O ' ' A' ' 91' ' ' ARG . 1.2 pptp? -49.57 -9.77 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 113.105 0.78 . . . . 4.58 113.105 173.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -101.8 90.92 2.07 Favored Pre-proline 0 CA--C 1.534 0.343 0 N-CA-C 108.589 -0.893 . . . . 2.24 108.589 162.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.481 ' HD3' ' O ' ' A' ' 94' ' ' LYS . 2.9 Cg_exo -76.18 111.97 3.38 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.979 2.453 . . . . 2.38 113.016 -170.653 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.425 ' HB2' ' O ' ' A' ' 96' ' ' PRO . 92.7 m-20 79.23 69.65 0.17 Allowed Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 114.527 -1.215 . . . . 3.61 110.111 175.349 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.422 ' HB2' ' CE1' ' A' ' 54' ' ' TYR . 72.7 Cg_endo -76.23 146.42 28.39 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.534 2.156 . . . . 1.54 111.065 178.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.552 HG23 ' C ' ' A' ' 102' ' ' GLY . 14.6 mm -88.33 92.41 3.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 O-C-N 122.155 -0.341 . . . . 2.08 110.24 -172.7 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.635 ' C ' ' H ' ' A' ' 102' ' ' GLY . 15.9 mt -92.05 151.24 3.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-O 121.548 0.69 . . . . 1.55 112.279 -174.307 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.594 ' H ' HG23 ' A' ' 100' ' ' ILE . 25.3 t0 35.02 17.83 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 CA-C-N 114.489 -1.232 . . . . 1.52 112.872 -152.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.635 ' H ' ' C ' ' A' ' 100' ' ' ILE . . . 89.48 19.82 47.43 Favored Glycine 0 CA--C 1.529 0.929 0 CA-C-N 115.757 -0.656 . . . . 1.73 111.674 178.722 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.461 ' HB3' ' HG3' ' A' ' 43' ' ' PRO . 31.9 tpt180 -127.82 135.73 50.48 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.747 0.819 . . . . 4.66 108.989 174.033 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.406 ' HA ' ' HA ' ' A' ' 99' ' ' ILE . 33.9 ttpt -58.0 114.92 2.56 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.461 0.541 . . . . 3.14 112.461 -174.327 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -99.67 164.66 11.96 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.186 -0.915 . . . . 1.37 110.225 177.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 37.8 t30 -107.93 131.7 54.26 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.454 -0.339 . . . . 2.18 110.154 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 41.1 t -122.38 129.12 75.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.32 0.581 . . . . 1.46 112.003 -179.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -150.01 158.08 43.8 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.084 -0.962 . . . . 3.22 108.405 175.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.669 HD22 ' CE1' ' A' ' 111' ' ' TYR . 1.0 OUTLIER -73.24 124.67 26.11 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 121.594 -0.691 . . . . 1.87 111.461 -177.029 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.501 ' HA ' ' HB2' ' A' ' 38' ' ' PHE . . . -47.23 -47.3 24.61 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.375 -1.284 . . . . 1.3 113.026 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.669 ' CE1' HD22 ' A' ' 109' ' ' LEU . 0.8 OUTLIER -74.55 -21.16 59.65 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.571 0.701 . . . . 1.71 110.055 -178.257 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -83.99 -45.06 13.53 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.035 -0.984 . . . . 1.97 109.607 -173.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.505 ' HA3' ' C4 ' ' B' ' 5' ' ' ' U' . . . -89.28 17.6 50.75 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.601 -0.809 . . . . 2.24 112.246 174.324 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.475 ' O ' ' HE3' ' A' ' 115' ' ' LYS . . . -64.34 162.05 15.66 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-O 120.553 0.216 . . . . 2.66 110.798 176.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.475 ' HE3' ' O ' ' A' ' 114' ' ' ALA . 0.0 OUTLIER 74.4 92.2 0.05 OUTLIER Pre-proline 0 N--CA 1.464 0.247 0 C-N-CA 123.508 0.723 . . . . 4.52 110.648 -179.222 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.629 ' HG3' " H3'" ' B' ' 5' ' ' ' U' . 1.9 Cg_endo -80.54 23.34 0.71 Allowed 'Trans proline' 0 C--O 1.235 0.34 0 C-N-CA 123.555 2.837 . . . . 5.53 111.889 -179.553 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 66.2 ttt180 -134.95 -46.6 0.72 Allowed 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.192 -0.913 . . . . 9.2 110.272 -178.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 2.4 t -134.57 92.41 2.9 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-O 121.739 0.78 . . . . 6.74 110.999 -178.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -108.51 137.7 46.02 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.327 -0.851 . . . . 8.27 108.857 176.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 4.1 t -100.48 14.56 5.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.207 0.527 . . . . 9.39 111.116 -171.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 27.8 mm-40 . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.478 -0.772 . . . . 12.71 110.757 -178.474 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 1' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.431 -0.564 0 C3'-C2'-C1' 100.403 -1.218 . 0.0 '__' . 5.37 . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 2' ' ' ' G' . . . . . 0.472 ' C5 ' ' CE1' ' A' ' 44' ' ' TYR . . . . . . . . 0 O5'--C5' 1.426 -0.877 0 C3'-C2'-C1' 100.092 -1.565 . 0.0 OUTLIER . 4.87 . . . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 3' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.426 -0.855 0 C4'-C3'-C2' 104.069 1.369 . 0.0 OUTLIER . 5.58 . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 4' ' ' ' G' . . . . . 0.685 " H3'" ' N3 ' ' B' ' 4' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.425 -0.955 0 O4'-C1'-C2' 107.948 1.106 . 0.0 OUTLIER . 2.69 . . . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 5' ' ' ' U' . . . . . 0.629 " H3'" ' HG3' ' A' ' 116' ' ' PRO . . . . . . . . 0 O5'--C5' 1.427 -0.812 0 C3'-C2'-C1' 100.28 -1.355 . 0.438 1b . 1.93 . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 6' ' ' ' G' . . . . . 0.878 " O2'" " H5'" ' B' ' 7' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.428 -0.751 0 C4'-C3'-C2' 103.483 0.783 . 0.011 0b . 2.38 . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 7' ' ' ' C' . . . . . 0.878 " H5'" " O2'" ' B' ' 6' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.431 -0.542 0 P-O5'-C5' 123.45 1.593 . 0.0 OUTLIER . 4.41 . . . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.883 0 N-CA-C 112.603 -0.199 . . . . 13.51 112.603 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -90.32 114.31 26.35 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 122.568 -0.372 . . . . 11.28 111.11 -177.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 22.6 mmt 64.17 87.57 0.11 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.305 -0.861 . . . . 10.15 111.557 176.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -82.45 117.75 4.48 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.811 -0.709 . . . . 6.69 111.669 177.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 23.6 m -113.42 127.98 56.3 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.868 0.366 . . . . 5.68 110.713 -177.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.461 ' HG3' HG21 ' A' ' 32' ' ' THR . 17.7 ptp180 -103.68 19.06 20.56 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.208 0.527 . . . . 4.34 110.073 178.312 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 58.81 48.88 10.66 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 114.736 -1.12 . . . . 3.53 111.86 178.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.608 ' O ' ' HB2' ' A' ' 36' ' ' LYS . 9.6 p -65.01 -13.79 58.74 Favored 'General case' 0 C--O 1.221 -0.439 0 CA-C-N 115.761 -0.654 . . . . 1.98 111.009 175.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' MET . . . . . 0.413 ' HE1' ' HB3' ' A' ' 33' ' ' MET . 12.5 tmm? -62.18 -29.27 70.25 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.526 -0.307 . . . . 1.9 110.963 175.322 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -98.1 -46.43 5.87 Favored 'General case' 0 CA--C 1.527 0.077 0 O-C-N 122.225 -0.297 . . . . 1.76 111.312 177.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.601 ' OG1' ' HA ' ' A' ' 32' ' ' THR . 63.3 p -68.78 1.63 3.16 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 113.755 1.021 . . . . 1.23 113.755 -176.162 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.608 ' HB2' ' O ' ' A' ' 32' ' ' THR . 58.0 tttt -97.99 107.9 20.49 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.995 0.426 . . . . 3.2 110.117 -175.477 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.435 HD12 ' HA ' ' A' ' 89' ' ' ALA . 47.1 mt -109.38 136.3 45.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.781 -0.645 . . . . 1.46 111.148 -175.382 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -101.25 118.41 36.93 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.878 -0.601 . . . . 0.81 109.698 174.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.628 HG11 HG23 ' A' ' 107' ' ' VAL . 30.3 t -133.75 110.63 14.55 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.848 0 CA-C-O 117.85 -1.071 . . . . 1.61 110.977 -177.182 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.423 ' HA2' ' CD2' ' A' ' 42' ' ' LEU . . . -116.68 -156.76 10.73 Favored Glycine 0 CA--C 1.503 -0.706 1 C-N-CA 112.341 -4.742 . . . . 1.39 114.835 156.049 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.473 ' HA3' ' HA ' ' A' ' 105' ' ' ALA . . . 92.42 5.07 65.58 Favored Glycine 0 N--CA 1.442 -0.903 0 N-CA-C 110.211 -1.156 . . . . 0.71 110.211 -171.466 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.709 HD13 HD22 ' A' ' 51' ' ' LEU . 3.0 mm? -71.99 121.4 84.5 Favored Pre-proline 0 N--CA 1.45 -0.44 0 CA-C-N 115.06 -0.57 . . . . 1.89 109.931 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.776 ' HG3' ' HD3' ' A' ' 103' ' ' ARG . 88.8 Cg_exo -48.21 160.01 0.61 Allowed 'Trans proline' 0 CA--C 1.529 0.274 0 C-N-CA 124.198 3.266 . . . . 0.82 113.968 177.22 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.479 ' CE2' ' C5 ' ' B' ' 2' ' ' ' G' . 64.2 m-85 -71.26 -6.94 43.52 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.704 -0.68 . . . . 1.46 112.688 -174.105 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 7.6 p-80 -112.85 10.29 19.07 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 121.788 -0.57 . . . . 2.65 110.921 171.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.555 HG21 ' HB ' ' A' ' 50' ' ' THR . 52.0 m -79.62 123.75 27.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.099 -0.5 . . . . 1.31 110.438 174.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 60.3 p -105.72 175.2 5.57 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.264 -0.425 . . . . 0.75 110.577 -178.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.502 ' HB3' ' O ' ' A' ' 64' ' ' ALA . 2.9 m-20 -57.44 -30.56 65.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.571 0.701 . . . . 0.49 110.124 176.691 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.672 ' O ' ' HG2' ' A' ' 53' ' ' GLU . 0.5 OUTLIER -78.71 -29.59 45.52 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.422 -0.808 . . . . 3.26 110.828 -179.389 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.555 ' HB ' HG21 ' A' ' 46' ' ' THR . 14.5 m -61.95 -41.98 98.6 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.98 0.419 . . . . 1.25 110.379 176.454 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.709 HD22 HD13 ' A' ' 42' ' ' LEU . 16.0 mt -67.65 -37.16 82.03 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-N 116.189 -0.46 . . . . 1.53 110.334 174.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.437 ' HA ' HD13 ' A' ' 61' ' ' ILE . 60.5 t-80 -57.05 -47.4 81.05 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.723 -0.672 . . . . 0.77 109.848 175.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.672 ' HG2' ' O ' ' A' ' 49' ' ' LYS . 23.6 mm-40 -57.54 -47.25 82.52 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.976 -0.556 . . . . 1.52 111.521 178.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.477 ' O ' ' HB2' ' A' ' 57' ' ' GLN . 20.9 t80 -76.75 -34.83 58.05 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.591 0.589 . . . . 1.6 112.591 -172.172 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.409 ' CE1' HD23 ' A' ' 51' ' ' LEU . 22.5 m-85 -85.03 -25.17 27.83 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 114.391 1.256 . . . . 0.68 114.391 -173.339 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.574 ' N ' HD12 ' A' ' 61' ' ' ILE . 11.0 pt-20 -67.06 -12.52 60.16 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 122.351 1.072 . . . . 1.57 109.722 177.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.685 ' HA ' HE21 ' A' ' 57' ' ' GLN . 0.0 OUTLIER -56.15 -31.31 63.25 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 113.937 -1.483 . . . . 2.79 111.506 169.001 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -96.92 4.87 51.38 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.466 -0.334 . . . . 0.79 111.737 -176.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 142.2 -133.76 5.8 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.548 -0.834 . . . . 0.75 112.516 -176.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -114.29 124.38 51.86 Favored 'General case' 0 C--N 1.322 -0.599 0 O-C-N 122.567 -0.372 . . . . 1.02 110.475 -179.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.574 HD12 ' N ' ' A' ' 56' ' ' GLU . 7.5 mt -93.23 125.87 45.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 109.579 -0.526 . . . . 1.13 109.579 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.414 ' CD ' HH11 ' A' ' 30' ' ' ARG . 23.1 tt0 -78.48 -38.8 40.09 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.019 0.438 . . . . 2.07 110.753 176.217 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -157.22 136.37 11.87 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.149 -0.478 . . . . 2.48 111.34 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.502 ' O ' ' HB3' ' A' ' 48' ' ' ASP . . . -121.28 123.4 42.1 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 115.781 -0.645 . . . . 1.18 109.396 174.039 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 8.9 p -135.52 135.17 51.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 114.893 -1.048 . . . . 1.97 112.191 -176.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 98.1 t -102.83 131.76 50.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.356 -0.838 . . . . 1.12 109.386 173.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.462 HG12 ' HA2' ' A' ' 79' ' ' GLY . 44.6 mm -83.61 92.28 2.83 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.625 0 CA-C-O 121.478 0.656 . . . . 1.44 109.665 -179.284 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.43 ' HB ' ' HA ' ' A' ' 73' ' ' GLN . 31.7 p -92.44 172.82 8.14 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 115.023 -0.99 . . . . 1.83 110.757 -179.6 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.411 ' HB3' ' H ' ' A' ' 73' ' ' GLN . 29.3 t70 -61.56 124.0 19.44 Favored 'General case' 0 C--O 1.216 -0.709 0 CA-C-N 116.347 -0.388 . . . . 2.49 111.177 -174.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.458 ' HG3' ' OD1' ' A' ' 71' ' ' ASN . 11.3 ptt180 -54.92 -22.71 15.82 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 113.011 0.745 . . . . 6.58 113.011 -177.289 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.458 ' OD1' ' HG3' ' A' ' 70' ' ' ARG . 4.5 m-20 -100.9 -39.21 7.88 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 112.63 0.604 . . . . 4.33 112.63 -179.394 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 40.7 p -112.17 -27.95 8.15 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 112.148 0.425 . . . . 3.67 112.148 -175.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.43 ' HA ' ' HB ' ' A' ' 68' ' ' THR . 27.3 mt-30 63.16 12.91 6.42 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 123.775 0.83 . . . . 3.61 113.0 178.433 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.686 ' HE2' ' HA ' ' A' ' 74' ' ' LYS . 5.0 mmpt? -38.56 -76.32 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 113.565 0.95 . . . . 3.78 113.565 171.305 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.508 ' O ' ' HB2' ' A' ' 76' ' ' ARG . 8.4 m -155.99 -65.65 0.11 Allowed 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 112.879 0.696 . . . . 2.07 112.879 -178.345 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.508 ' HB2' ' O ' ' A' ' 75' ' ' SER . 96.5 mtt180 74.57 -55.3 0.66 Allowed 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.329 0.652 . . . . 3.07 110.508 -169.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.636 ' HA3' ' N2 ' ' B' ' 2' ' ' ' G' . . . 103.97 19.24 12.07 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.841 -0.695 . . . . 0.75 113.142 175.775 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -123.85 157.28 34.53 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.215 -1.031 . . . . 1.61 108.215 177.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.462 ' HA2' HG12 ' A' ' 67' ' ' ILE . . . -159.23 -164.66 14.89 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 119.769 -1.205 . . . . 0.59 112.647 175.742 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -151.3 134.83 16.24 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.731 -0.84 . . . . 0.84 108.731 -177.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.402 HG12 ' CD2' ' A' ' 55' ' ' PHE . 53.7 t -122.36 120.07 60.06 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 N-CA-C 109.938 -0.393 . . . . 1.21 109.938 177.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.569 ' HA ' ' O ' ' A' ' 35' ' ' THR . 17.9 m -109.81 115.68 30.28 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 108.51 -0.922 . . . . 1.09 108.51 177.646 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 83.1 mmm -88.79 163.8 15.53 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 108.898 -0.778 . . . . 1.02 108.898 -176.163 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 20.7 ttmm -83.3 -10.94 58.21 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.099 0.476 . . . . 2.47 110.683 -178.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -145.67 146.64 31.38 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 116.232 -0.44 . . . . 1.68 110.616 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 4.3 tmm_? -71.39 -22.81 61.83 Favored 'General case' 0 C--O 1.223 -0.3 0 N-CA-C 112.845 0.683 . . . . 4.24 112.845 -177.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.26 -43.94 89.68 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 118.649 0.659 . . . . 1.33 110.392 177.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 8.7 m -64.55 -39.23 93.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.699 0.761 . . . . 1.34 109.881 175.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.435 ' HA ' HD12 ' A' ' 37' ' ' ILE . . . -59.41 -49.79 76.45 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.028 -1.442 . . . . 1.16 110.609 178.326 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -54.98 -49.16 72.13 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.55 -0.75 . . . . 2.11 111.826 175.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.612 ' O ' ' HB3' ' A' ' 94' ' ' LYS . 2.6 ttm-85 -61.85 -41.02 97.31 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.295 -0.412 . . . . 4.35 110.773 -177.25 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -63.56 -43.84 95.87 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.996 -0.547 . . . . 1.21 111.73 176.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 45.2 t -75.2 -6.9 52.14 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 121.337 0.589 . . . . 1.16 110.659 178.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.612 ' HB3' ' O ' ' A' ' 91' ' ' ARG . 2.9 tppp? -76.96 -37.94 54.26 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.285 -0.87 . . . . 4.58 110.016 177.402 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -108.33 91.58 8.47 Favored Pre-proline 0 C--N 1.326 -0.441 0 N-CA-C 109.358 -0.608 . . . . 2.24 109.358 172.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.558 ' HA ' ' HB ' ' A' ' 107' ' ' VAL . 59.4 Cg_endo -90.17 -6.54 4.62 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 123.1 2.533 . . . . 2.38 114.144 -169.18 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.456 ' N ' ' HD3' ' A' ' 98' ' ' PRO . 3.4 p-10 -132.76 60.86 53.02 Favored Pre-proline 0 C--N 1.328 -0.337 0 N-CA-C 112.306 0.484 . . . . 3.61 112.306 -177.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.456 ' HD3' ' N ' ' A' ' 97' ' ' ASN . 1.8 Cg_endo -81.38 151.73 17.72 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.795 2.33 . . . . 1.54 111.73 -179.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 35.9 mm -95.06 90.37 2.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.287 0.565 . . . . 2.08 110.302 179.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 57.6 mt -90.85 108.34 19.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.841 -0.618 . . . . 1.55 111.847 177.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.679 ' HB3' ' HG2' ' A' ' 43' ' ' PRO . 25.2 t70 65.31 44.17 3.3 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 122.813 1.292 . . . . 1.52 109.3 173.345 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 80.39 -9.03 51.15 Favored Glycine 0 N--CA 1.445 -0.712 0 CA-C-N 114.412 -1.267 . . . . 1.73 113.579 176.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.776 ' HD3' ' HG3' ' A' ' 43' ' ' PRO . 7.4 mpt_? -107.09 131.09 54.5 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 117.74 0.77 . . . . 4.66 111.623 176.524 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 26.3 ttpp -67.18 134.51 51.86 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.366 -0.834 . . . . 3.14 109.032 169.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.473 ' HA ' ' HA3' ' A' ' 41' ' ' GLY . . . -111.25 150.38 29.68 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 116.232 -0.44 . . . . 1.37 109.964 -175.582 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -108.15 106.18 16.26 Favored 'General case' 0 C--O 1.264 1.857 0 CA-C-O 121.556 0.694 . . . . 2.18 110.053 174.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.628 HG23 HG11 ' A' ' 39' ' ' VAL . 47.4 t -101.67 138.53 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 CA-C-N 112.876 -1.965 . . . . 1.46 111.451 174.317 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.442 ' HB3' HD13 ' A' ' 112' ' ' LEU . 32.8 m-80 -151.86 153.02 33.37 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.428 -0.953 . . . . 3.22 108.428 172.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.534 HD11 ' H ' ' A' ' 110' ' ' ALA . 0.2 OUTLIER -63.25 150.3 43.46 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.402 -0.962 . . . . 1.87 108.402 172.876 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.534 ' H ' HD11 ' A' ' 109' ' ' LEU . . . -74.67 -40.28 61.51 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.081 -0.647 . . . . 1.3 110.36 -167.361 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -68.28 -2.3 8.0 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 114.97 -1.014 . . . . 1.71 112.654 -172.221 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.442 HD13 ' HB3' ' A' ' 108' ' ' ASN . 82.6 mt -66.42 -45.83 78.57 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.612 0.244 . . . . 1.97 110.714 179.045 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -126.67 40.51 1.78 Allowed Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.21 -0.995 . . . . 2.24 111.987 174.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -86.59 113.06 22.17 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.625 -0.509 . . . . 2.66 109.625 -178.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.406 ' HE3' ' HB2' ' A' ' 115' ' ' LYS . 41.0 mtmt -128.57 77.35 77.47 Favored Pre-proline 0 C--N 1.326 -0.442 0 C-N-CA 120.86 -0.336 . . . . 4.52 110.592 -175.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -83.89 -51.78 0.04 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 122.549 2.166 . . . . 5.53 110.553 174.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -157.55 1.97 0.12 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.109 -0.95 . . . . 9.2 108.703 177.399 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.13 96.77 5.18 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 114.792 -1.095 . . . . 6.74 111.1 -171.328 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -94.34 65.35 3.27 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.055 0.455 . . . . 8.27 111.222 -178.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 95.2 t 69.22 117.32 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 N-CA-C 113.64 0.978 . . . . 9.39 113.64 171.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.44 ' O ' ' HG3' ' A' ' 121' ' ' GLN . 6.8 pt20 . . . . . 0 C--O 1.245 0.866 0 CA-C-O 118.546 -0.74 . . . . 12.71 109.605 168.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 1' ' ' ' G' . . . . . 0.549 " H4'" " O5'" ' B' ' 2' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.431 -0.562 0 C3'-C2'-C1' 99.647 -2.059 . 0.0 '__' . 5.37 . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 2' ' ' ' G' . . . . . 0.687 ' O6 ' ' HA ' ' A' ' 43' ' ' PRO . . . . . . . . 0 O5'--C5' 1.427 -0.787 0 C4'-C3'-C2' 103.736 1.036 . 0.0 OUTLIER . 4.87 . . . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 3' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.427 -0.832 0 C3'-C2'-C1' 100.876 -0.694 . 0.0 OUTLIER gamma 5.58 . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 4' ' ' ' G' . . . . . 0.559 " O2'" " H5'" ' B' ' 5' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.427 -0.786 0 O4'-C1'-C2' 108.171 1.265 . 0.0 OUTLIER '7D dist 2a' 2.69 . . . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 5' ' ' ' U' . . . . . 0.559 " H5'" " O2'" ' B' ' 4' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.426 -0.863 0 C4'-C3'-C2' 103.95 1.25 . 0.418 1[ . 1.93 . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 6' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.427 -0.814 0 C4'-C3'-C2' 103.508 0.808 . 0.28 0b . 2.38 . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 7' ' ' ' C' . . . . . 0.665 ' H6 ' " O5'" ' B' ' 7' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.426 -0.855 0 C3'-C2'-C1' 100.52 -1.089 . 0.019 2[ . 4.41 . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.609 0 N-CA-C 112.059 -0.416 . . . . 13.51 112.059 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -115.98 94.92 4.87 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.09 0.471 . . . . 11.28 109.803 178.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 95.6 mmm -99.68 143.52 29.82 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.878 -0.601 . . . . 10.15 110.767 -175.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -137.58 49.63 0.85 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.795 -0.717 . . . . 6.69 112.63 -178.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 18.3 m 58.43 64.08 1.56 Allowed 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 121.014 0.435 . . . . 5.68 111.7 176.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -84.75 91.43 7.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.991 0.424 . . . . 4.34 110.21 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -82.46 109.97 17.16 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 109.173 -0.677 . . . . 3.53 109.173 -178.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.441 ' O ' ' HE2' ' A' ' 36' ' ' LYS . 14.5 p -90.5 53.92 2.58 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 114.094 1.146 . . . . 1.98 114.094 -165.732 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' MET . . . . . 0.587 ' HG3' ' H ' ' A' ' 34' ' ' PHE . 22.5 ptm -73.23 -51.0 19.32 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 107.695 -1.224 . . . . 1.9 107.695 162.586 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.587 ' H ' ' HG3' ' A' ' 33' ' ' MET . 26.0 m-85 -88.17 -179.97 6.26 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 113.712 -1.586 . . . . 1.76 108.62 170.173 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.72 ' HB ' ' O ' ' A' ' 83' ' ' MET . 14.0 p 65.37 -0.46 1.16 Allowed 'General case' 0 N--CA 1.472 0.637 0 O-C-N 124.065 0.853 . . . . 1.23 112.642 174.588 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.589 ' HD2' ' O6 ' ' B' ' 6' ' ' ' G' . 33.0 ttpt -121.89 110.21 15.58 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.136 0.494 . . . . 3.2 110.248 -176.314 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.617 HD12 ' HA ' ' A' ' 89' ' ' ALA . 3.8 mp -96.3 130.02 45.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.972 -0.558 . . . . 1.46 110.575 -179.292 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -85.77 108.29 18.02 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 108.559 -0.904 . . . . 0.81 108.559 172.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.3 t -95.95 137.03 25.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 N-CA-C 108.074 -1.084 . . . . 1.61 108.074 179.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -140.42 138.09 8.78 Favored Glycine 0 N--CA 1.442 -0.94 0 C-N-CA 119.577 -1.297 . . . . 1.39 111.767 -170.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 96.43 16.36 37.53 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.582 -0.818 . . . . 0.71 112.84 177.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.563 HD13 HD22 ' A' ' 51' ' ' LEU . 2.8 mm? -64.94 124.16 85.81 Favored Pre-proline 0 C--O 1.234 0.246 0 N-CA-C 109.304 -0.628 . . . . 1.89 109.304 177.006 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.569 ' HG2' ' HB3' ' A' ' 101' ' ' ASP . 52.9 Cg_exo -50.58 154.38 6.53 Favored 'Trans proline' 0 CA--C 1.529 0.252 0 C-N-CA 122.91 2.407 . . . . 0.82 111.88 173.733 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.641 ' HH ' HO2' ' B' ' 1' ' ' ' G' . 26.0 m-85 -65.76 -7.22 14.6 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.847 0.356 . . . . 1.46 111.61 -178.057 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 76.9 t60 -101.14 -6.43 24.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.188 0.518 . . . . 2.65 110.222 177.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.536 HG22 HD11 ' A' ' 42' ' ' LEU . 77.5 m -78.72 142.42 37.09 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 116.259 -0.428 . . . . 1.31 109.922 177.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 12.1 p -132.14 -178.77 5.05 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.028 0.442 . . . . 0.75 111.161 -175.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.584 ' OD2' ' HA ' ' A' ' 65' ' ' VAL . 2.4 m-20 -67.31 -48.18 68.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.862 0.839 . . . . 0.49 109.06 -176.423 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.583 ' O ' ' HG2' ' A' ' 53' ' ' GLU . 22.8 pttp -52.52 -35.38 53.14 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 113.908 -1.496 . . . . 3.26 111.149 175.38 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 22.9 m -67.2 -45.76 75.9 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.854 0.359 . . . . 1.25 111.279 179.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.563 HD22 HD13 ' A' ' 42' ' ' LEU . 31.1 mt -67.33 -35.67 79.9 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.485 -0.325 . . . . 1.53 110.805 178.602 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.43 ' HA ' ' CD1' ' A' ' 61' ' ' ILE . 63.9 t-80 -57.3 -38.3 73.77 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.644 -0.502 . . . . 0.77 109.644 175.666 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.583 ' HG2' ' O ' ' A' ' 49' ' ' LYS . 82.3 mm-40 -68.18 -39.84 82.42 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.242 -0.89 . . . . 1.52 110.467 -177.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.642 ' O ' ' HB2' ' A' ' 57' ' ' GLN . 2.2 t80 -78.44 -34.33 47.87 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.566 0.698 . . . . 1.6 111.607 -177.282 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.451 ' CE1' HD23 ' A' ' 51' ' ' LEU . 28.7 m-85 -86.4 -25.63 25.19 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 113.086 0.772 . . . . 0.68 113.086 -172.124 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -71.98 -1.53 14.87 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 122.336 1.065 . . . . 1.57 109.619 174.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.642 ' HB2' ' O ' ' A' ' 54' ' ' TYR . 88.9 mt-30 -86.28 -10.6 54.22 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.092 -1.413 . . . . 2.79 109.96 176.223 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.415 ' HD2' ' HA ' ' A' ' 55' ' ' PHE . 78.8 m-85 -109.86 -51.2 2.9 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.395 -0.821 . . . . 0.79 111.118 -178.332 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -163.92 -135.75 1.87 Allowed Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.274 -0.965 . . . . 0.75 112.006 179.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.419 ' HB3' ' HE3' ' A' ' 84' ' ' LYS . 1.0 OUTLIER -98.22 132.88 43.35 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.803 0.335 . . . . 1.02 110.235 -179.902 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.43 ' CD1' ' HA ' ' A' ' 52' ' ' HIS . 66.0 mt -105.83 139.89 25.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 107.87 -1.159 . . . . 1.13 107.87 174.621 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -97.99 -41.21 8.09 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 107.933 -1.136 . . . . 2.07 107.933 177.099 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -165.48 127.03 1.98 Allowed 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 115.458 -0.792 . . . . 2.48 110.267 177.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.417 ' O ' ' HB3' ' A' ' 48' ' ' ASP . . . -106.04 127.27 53.06 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.272 -0.64 . . . . 1.18 109.272 174.533 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.584 ' HA ' ' OD2' ' A' ' 48' ' ' ASP . 5.0 m -138.1 119.63 17.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.472 0.653 . . . . 1.97 112.649 -175.268 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 91.7 t -86.99 122.06 38.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.381 -0.827 . . . . 1.12 109.553 174.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 39.8 mm -71.69 139.34 19.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.34 0.59 . . . . 1.44 112.16 -176.021 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.468 ' HB ' ' C ' ' A' ' 73' ' ' GLN . 35.2 p -106.74 177.55 4.82 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 115.265 -0.88 . . . . 1.83 109.53 176.558 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.595 ' HB3' ' N ' ' A' ' 73' ' ' GLN . 31.4 t70 -70.61 160.39 32.64 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.737 0.779 . . . . 2.49 113.047 -171.467 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -72.27 -53.95 10.98 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.048 -1.433 . . . . 6.58 109.207 177.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 -79.76 -58.98 2.91 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.419 -0.81 . . . . 4.33 112.588 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 61.5 p -92.61 -16.05 26.11 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 112.615 0.598 . . . . 3.67 112.615 -171.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.595 ' N ' ' HB3' ' A' ' 69' ' ' ASP . 47.5 mt-30 57.12 31.99 20.93 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.507 0.67 . . . . 3.61 111.444 -175.056 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -94.6 142.71 27.13 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.24 -0.891 . . . . 3.78 109.054 171.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.8 m -45.8 132.15 8.99 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.712 0.634 . . . . 2.07 112.712 -169.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 60.2 mtp180 -98.15 -10.22 24.51 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.947 -0.57 . . . . 3.07 110.92 -175.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.432 ' HA3' ' N2 ' ' B' ' 2' ' ' ' G' . . . 86.89 13.77 66.13 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.596 -0.811 . . . . 0.75 112.462 -178.515 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -122.85 162.44 22.17 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.59 -0.893 . . . . 1.61 108.59 178.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -173.77 145.19 8.07 Favored Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 120.148 -1.025 . . . . 0.59 112.211 178.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -104.06 142.17 34.93 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.419 0.628 . . . . 0.84 111.258 176.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 49.8 t -117.99 106.02 19.01 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 CA-C-N 115.239 -0.891 . . . . 1.21 109.483 173.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 8.3 m -76.92 117.33 18.41 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.883 -0.598 . . . . 1.09 109.968 174.002 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.72 ' O ' ' HB ' ' A' ' 35' ' ' THR . 28.1 mtp -103.31 134.85 46.02 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.74 -0.467 . . . . 1.02 109.74 179.069 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.419 ' HE3' ' HB3' ' A' ' 60' ' ' ASP . 19.1 ttmt -51.73 -6.14 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 114.87 1.433 . . . . 2.47 114.87 -179.679 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.459 ' C ' HG23 ' A' ' 35' ' ' THR . 7.2 t70 -162.53 156.68 21.21 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 118.871 0.76 . . . . 1.68 111.323 177.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.656 ' N ' HG23 ' A' ' 35' ' ' THR . 2.5 tmm_? -75.02 -34.8 61.94 Favored 'General case' 0 C--O 1.22 -0.48 0 N-CA-C 108.461 -0.94 . . . . 4.24 108.461 -177.279 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -52.71 -42.4 64.82 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.026 -0.988 . . . . 1.33 110.95 172.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 5.5 m -69.55 -31.95 70.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.072 0.463 . . . . 1.34 110.381 176.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.617 ' HA ' HD12 ' A' ' 37' ' ' ILE . . . -67.62 -50.43 58.11 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.599 -0.728 . . . . 1.16 110.819 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.58 ' O ' ' HG2' ' A' ' 94' ' ' LYS . 6.0 mt-10 -57.72 -32.77 67.74 Favored 'General case' 0 C--O 1.224 -0.283 0 CA-C-N 115.832 -0.622 . . . . 2.11 110.537 174.547 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.401 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 13.3 tpp180 -64.15 -51.72 62.48 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.325 -0.852 . . . . 4.35 109.922 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -53.57 -32.1 49.45 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 113.461 0.912 . . . . 1.21 113.461 172.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 46.5 t -80.25 -34.57 36.99 Favored 'General case' 0 C--N 1.328 -0.363 0 O-C-N 121.894 -0.504 . . . . 1.16 110.609 178.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.58 ' HG2' ' O ' ' A' ' 90' ' ' GLU . 12.2 mmmm -48.23 -30.7 4.98 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 114.733 -1.121 . . . . 4.58 111.838 175.168 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -103.18 102.77 30.52 Favored Pre-proline 0 C--N 1.326 -0.438 0 N-CA-C 108.893 -0.78 . . . . 2.24 108.893 167.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -77.15 173.65 14.06 Favored 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 122.608 2.205 . . . . 2.38 113.761 -169.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.495 ' ND2' ' HA ' ' A' ' 106' ' ' ASN . 12.4 m120 -15.98 91.13 0.04 OUTLIER Pre-proline 0 N--CA 1.481 1.092 0 C-N-CA 125.462 1.505 . . . . 3.61 114.126 -174.473 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -82.27 164.85 16.96 Favored 'Trans proline' 0 C--O 1.235 0.346 0 C-N-CA 123.408 2.739 . . . . 1.54 113.202 -179.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 41.1 mm -94.72 109.79 22.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.445 -0.798 . . . . 2.08 110.329 174.126 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 54.9 mt -114.22 115.65 50.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.017 -0.538 . . . . 1.55 110.251 178.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.569 ' HB3' ' HG2' ' A' ' 43' ' ' PRO . 28.0 t70 50.71 54.53 11.04 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 113.071 0.767 . . . . 1.52 113.071 169.281 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 74.75 21.72 78.17 Favored Glycine 0 N--CA 1.454 -0.12 0 C-N-CA 120.375 -0.917 . . . . 1.73 113.121 176.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.434 ' HB2' ' HG3' ' A' ' 43' ' ' PRO . 0.2 OUTLIER -145.66 160.11 42.17 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.9 -0.407 . . . . 4.66 109.9 179.207 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 2.1 ttmp? -101.79 149.23 24.39 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 107.751 -1.203 . . . . 3.14 107.751 169.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -116.85 141.48 48.17 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 120.674 -0.41 . . . . 1.37 110.103 -174.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.495 ' HA ' ' ND2' ' A' ' 97' ' ' ASN . 91.5 m-20 -94.23 123.8 37.85 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.268 -0.641 . . . . 2.18 109.268 175.453 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.551 HG11 HG22 ' A' ' 37' ' ' ILE . 97.9 t -119.72 114.92 45.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.247 -0.888 . . . . 1.46 110.219 179.353 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -156.48 171.32 20.49 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.506 -0.77 . . . . 3.22 110.254 -179.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.522 ' HB3' ' CD1' ' A' ' 111' ' ' TYR . 3.2 mm? -78.38 115.09 17.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.513 0.673 . . . . 1.87 111.415 -176.531 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -43.92 -35.83 2.17 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 113.949 -1.478 . . . . 1.3 113.987 -179.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.522 ' CD1' ' HB3' ' A' ' 109' ' ' LEU . 0.4 OUTLIER -72.97 -10.32 59.68 Favored 'General case' 0 N--CA 1.467 0.395 0 O-C-N 121.69 -0.631 . . . . 1.71 112.311 -174.712 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 96.6 mt -68.11 -38.71 82.58 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.906 0.384 . . . . 1.97 110.636 177.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -104.31 10.44 50.59 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.958 -0.639 . . . . 2.24 111.972 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -90.47 123.31 34.06 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 109.19 -0.67 . . . . 2.66 109.19 -178.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -132.5 94.08 23.43 Favored Pre-proline 0 C--N 1.322 -0.618 0 C-N-CA 120.199 -0.6 . . . . 4.52 111.498 -179.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.495 ' HD2' ' H ' ' A' ' 117' ' ' ARG . 34.3 Cg_endo -93.17 -37.98 0.04 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.092 0 C-N-CA 122.743 2.295 . . . . 5.53 111.559 171.18 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.495 ' H ' ' HD2' ' A' ' 116' ' ' PRO . 25.9 ptt180 -145.71 9.76 1.19 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.554 -0.748 . . . . 9.2 110.038 -178.214 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 5.7 p -101.87 50.79 0.84 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.639 -0.709 . . . . 6.74 110.831 -179.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -90.64 91.18 8.3 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.885 -0.598 . . . . 8.27 111.467 -175.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 56.4 t 69.81 103.55 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 115.334 -0.848 . . . . 9.39 112.825 172.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 . . . . . 0 C--O 1.247 0.956 0 CA-C-O 118.679 -0.677 . . . . 12.71 109.517 172.493 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 1' ' ' ' G' . . . . . 0.641 HO2' ' HH ' ' A' ' 44' ' ' TYR . . . . . . . . 0 O5'--C5' 1.429 -0.714 0 C4'-C3'-C2' 103.827 1.127 . 0.0 '__' . 5.37 . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 2' ' ' ' G' . . . . . 0.432 ' N2 ' ' HA3' ' A' ' 77' ' ' GLY . . . . . . . . 0 O5'--C5' 1.425 -0.948 0 C4'-C3'-C2' 104.072 1.372 . 0.0 OUTLIER . 4.87 . . . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 3' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.425 -0.919 0 C3'-C2'-C1' 100.823 -0.752 . 0.0 OUTLIER . 5.58 . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 4' ' ' ' G' . . . . . 0.542 " H3'" ' N3 ' ' B' ' 4' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.428 -0.727 0 O4'-C1'-C2' 108.248 1.32 . 0.0 OUTLIER . 2.69 . . . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 5' ' ' ' U' . . . . . 0.514 ' H6 ' " O5'" ' B' ' 5' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.426 -0.902 0 C4'-C3'-C2' 104.113 1.413 . 0.091 1b . 1.93 . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 6' ' ' ' G' . . . . . 0.589 ' O6 ' ' HD2' ' A' ' 36' ' ' LYS . . . . . . . . 0 O5'--C5' 1.426 -0.858 0 C3'-C2'-C1' 100.335 -1.294 . 0.776 4b . 2.38 . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.426 -0.885 0 C3'-C2'-C1' 100.78 -0.8 . 0.0 OUTLIER . 4.41 . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.897 0 N-CA-C 112.73 -0.148 . . . . 13.51 112.73 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.61 -36.17 62.94 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.767 0.654 . . . . 11.28 112.767 -173.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 24.3 ptm -131.77 172.88 11.76 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 121.137 -0.225 . . . . 10.15 110.776 -175.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -151.88 -113.79 0.58 Allowed Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.988 -0.625 . . . . 6.69 112.061 -177.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 51.1 m 69.01 103.33 0.06 Allowed 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 123.205 0.602 . . . . 5.68 111.055 -177.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 15.6 mmt180 66.55 178.44 0.22 Allowed 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.582 -0.735 . . . . 4.34 111.481 -178.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -151.47 130.44 12.55 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.813 -0.81 . . . . 3.53 108.813 177.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.575 ' HA ' ' OG1' ' A' ' 35' ' ' THR . 79.3 p -100.22 -26.13 14.03 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.926 0.393 . . . . 1.98 110.46 179.492 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' MET . . . . . 0.425 ' HE3' ' HB3' ' A' ' 33' ' ' MET . 41.8 ttp -43.57 -54.52 4.87 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.808 -0.633 . . . . 1.9 111.987 178.382 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -93.71 23.8 4.51 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.924 0.712 . . . . 1.76 112.924 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.575 ' OG1' ' HA ' ' A' ' 32' ' ' THR . 70.5 p -149.49 19.45 0.93 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 118.726 0.693 . . . . 1.23 110.338 -171.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.434 ' HB2' ' O ' ' A' ' 32' ' ' THR . 5.8 ttpm? -121.97 103.88 9.13 Favored 'General case' 0 CA--C 1.509 -0.608 0 C-N-CA 119.925 -0.71 . . . . 3.2 109.733 -167.284 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.539 HG21 HG11 ' A' ' 107' ' ' VAL . 65.2 mt -90.35 111.91 24.08 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 CA-C-N 115.403 -0.817 . . . . 1.46 109.548 179.496 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.638 ' HB2' ' HB3' ' A' ' 110' ' ' ALA . 69.8 t80 -83.36 108.48 16.58 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 107.907 -1.146 . . . . 0.81 107.907 175.27 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.405 ' HB ' HD22 ' A' ' 42' ' ' LEU . 4.1 t -95.85 87.94 1.96 Allowed 'Isoleucine or valine' 0 C--O 1.209 -1.046 0 CA-C-O 122.105 0.955 . . . . 1.61 109.05 -177.048 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -68.3 147.28 47.17 Favored Glycine 0 C--N 1.305 -1.16 0 C-N-CA 119.359 -1.401 . . . . 1.39 112.151 168.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.524 ' HA2' ' O4 ' ' B' ' 3' ' ' ' U' . . . 81.91 38.58 13.31 Favored Glycine 0 CA--C 1.523 0.546 0 C-N-CA 120.74 -0.743 . . . . 0.71 114.773 170.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.761 HD12 HD22 ' A' ' 51' ' ' LEU . 2.8 mm? -72.49 143.63 85.47 Favored Pre-proline 0 CA--C 1.514 -0.438 0 CA-C-N 117.934 0.867 . . . . 1.89 110.802 172.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.54 ' HG2' ' HB3' ' A' ' 101' ' ' ASP . 75.4 Cg_exo -52.49 145.13 38.44 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 122.401 2.067 . . . . 0.82 110.867 166.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.439 ' CE1' ' C5 ' ' B' ' 2' ' ' ' G' . 46.8 m-85 -60.46 -16.26 34.81 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 113.795 1.035 . . . . 1.46 113.795 -171.527 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 3.0 p-80 -111.2 18.24 19.52 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 119.674 -0.811 . . . . 2.65 111.97 176.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.584 HG21 ' HB ' ' A' ' 50' ' ' THR . 91.7 m -78.22 107.13 10.59 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 118.971 -1.092 . . . . 1.31 110.445 178.229 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 6.6 p -87.02 171.62 10.6 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 113.767 -1.56 . . . . 0.75 113.849 170.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -55.16 -43.29 74.1 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 113.923 -1.49 . . . . 0.49 110.19 -174.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.634 ' O ' ' HG2' ' A' ' 53' ' ' GLU . 60.0 pttt -54.86 -41.84 71.29 Favored 'General case' 0 C--O 1.224 -0.268 0 CA-C-N 115.165 -0.925 . . . . 3.26 110.687 176.431 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.584 ' HB ' HG21 ' A' ' 46' ' ' THR . 11.2 m -61.8 -43.18 99.35 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.494 -0.321 . . . . 1.25 110.823 -176.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.761 HD22 HD12 ' A' ' 42' ' ' LEU . 18.3 mt -69.94 -46.96 64.17 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.736 -0.385 . . . . 1.53 111.318 178.442 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.413 ' HA ' HD13 ' A' ' 61' ' ' ILE . 57.9 t-80 -53.2 -55.52 23.63 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.899 0.381 . . . . 0.77 111.314 176.59 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.634 ' HG2' ' O ' ' A' ' 49' ' ' LYS . 9.6 mm-40 -56.02 -52.81 62.9 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.805 -0.634 . . . . 1.52 111.301 179.641 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -53.05 -49.09 67.04 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 115.385 1.624 . . . . 1.6 115.385 175.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.511 ' CE1' HD23 ' A' ' 51' ' ' LEU . 28.5 m-85 -81.62 -33.45 31.45 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 114.173 1.175 . . . . 0.68 114.173 -165.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.669 ' H ' HD12 ' A' ' 61' ' ' ILE . 9.8 pt-20 -53.53 0.17 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 114.126 1.158 . . . . 1.57 114.126 171.719 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.477 ' H ' ' C ' ' A' ' 55' ' ' PHE . 37.3 mt-30 -67.33 -34.98 78.47 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 116.105 -0.498 . . . . 2.79 110.499 167.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.48 ' HB2' ' HE2' ' A' ' 83' ' ' MET . 83.5 m-85 -68.71 -54.09 18.24 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.146 -0.479 . . . . 0.79 110.714 178.191 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -177.34 -82.06 0.06 OUTLIER Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 119.684 -1.246 . . . . 0.75 111.623 164.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.42 ' HB3' ' CB ' ' A' ' 84' ' ' LYS . 11.8 m-20 -115.36 106.91 14.56 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 111.536 0.199 . . . . 1.02 111.536 -178.075 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.669 HD12 ' H ' ' A' ' 56' ' ' GLU . 3.5 mt -84.07 146.95 6.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.099 -0.704 . . . . 1.13 109.099 166.515 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.624 ' HB2' ' HA ' ' A' ' 84' ' ' LYS . 8.2 tp10 -102.64 -45.49 5.01 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.405 -0.591 . . . . 2.07 109.405 177.349 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -157.49 123.87 4.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.634 -0.712 . . . . 2.48 109.802 179.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -115.7 141.13 48.49 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 120.929 0.395 . . . . 1.18 110.315 172.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.707 HG12 ' N2 ' ' B' ' 6' ' ' ' G' . 2.4 p -151.57 144.25 16.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.31 -0.859 . . . . 1.97 109.907 -174.629 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 57.5 t -114.3 128.56 71.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 O-C-N 122.3 -0.25 . . . . 1.12 110.558 176.315 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.404 HG21 ' HD3' ' A' ' 76' ' ' ARG . 31.7 mm -72.77 116.48 14.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.407 0.622 . . . . 1.44 110.436 -179.602 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.553 ' HB ' ' O ' ' A' ' 73' ' ' GLN . 73.3 p -104.78 149.81 25.32 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.247 -0.888 . . . . 1.83 111.399 -175.175 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.527 ' O ' ' HA ' ' A' ' 73' ' ' GLN . 16.7 t70 -44.96 154.92 0.12 Allowed 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 115.205 -0.907 . . . . 2.49 111.665 175.109 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 32.1 ttm180 -70.41 -47.9 58.64 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.489 -0.323 . . . . 6.58 111.245 -173.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -92.44 -50.37 5.66 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 111.792 0.293 . . . . 4.33 111.792 -171.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 82.4 p -90.8 -26.37 19.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.395 0.617 . . . . 3.67 110.735 -176.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.553 ' O ' ' HB ' ' A' ' 68' ' ' THR . 31.9 mt-30 65.47 21.1 11.81 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 114.741 -1.118 . . . . 3.61 112.933 178.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 50.3 mtmt -64.09 156.22 28.98 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.591 -0.522 . . . . 3.78 109.591 164.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 44.7 m -68.26 103.67 1.65 Allowed 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.211 0.529 . . . . 2.07 112.307 -174.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.626 ' HA ' " O5'" ' B' ' 1' ' ' ' G' . 66.4 mtp180 -48.92 -12.49 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 115.161 -0.927 . . . . 3.07 113.33 171.159 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 92.96 2.99 66.12 Favored Glycine 0 N--CA 1.441 -0.977 0 C-N-CA 120.378 -0.915 . . . . 0.75 112.426 178.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.438 ' CE1' " H1'" ' B' ' 4' ' ' ' G' . 11.2 m-85 -114.56 136.91 52.51 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.504 -0.924 . . . . 1.61 108.504 178.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -134.55 179.11 17.91 Favored Glycine 0 N--CA 1.435 -1.405 0 C-N-CA 119.574 -1.298 . . . . 0.59 113.788 178.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.404 ' HB2' HG11 ' A' ' 65' ' ' VAL . 50.1 m-85 -144.71 124.04 13.04 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 113.787 -1.207 . . . . 0.84 110.124 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 53.0 t -127.79 106.98 15.69 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 CA-C-N 115.362 -0.835 . . . . 1.21 109.355 175.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.498 ' HA ' ' O ' ' A' ' 35' ' ' THR . 70.5 m -94.86 132.09 40.05 Favored 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 108.759 -0.83 . . . . 1.09 108.759 174.379 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' MET . . . . . 0.48 ' HE2' ' HB2' ' A' ' 58' ' ' PHE . 26.5 mtp -99.96 156.26 17.25 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 109.132 -0.692 . . . . 1.02 109.132 -176.459 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.624 ' HA ' ' HB2' ' A' ' 62' ' ' GLU . 18.1 ttmt -60.22 -49.8 76.19 Favored 'General case' 0 C--N 1.327 -0.379 0 O-C-N 123.421 0.45 . . . . 2.47 110.554 -170.569 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -129.52 148.03 51.38 Favored 'General case' 0 C--O 1.245 0.864 0 CA-C-O 122.121 0.962 . . . . 1.68 111.926 166.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.56 ' O ' ' HG3' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -47.67 -24.61 0.96 Allowed 'General case' 0 C--O 1.214 -0.808 0 CA-C-N 113.708 -1.587 . . . . 4.24 114.096 176.685 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -58.0 -44.76 87.38 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 119.502 1.047 . . . . 1.33 111.483 175.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 49.9 m -71.96 -38.88 69.69 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.577 -0.449 . . . . 1.34 109.863 177.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -56.61 -28.89 61.41 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.916 -0.584 . . . . 1.16 111.789 173.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.56 ' HG3' ' O ' ' A' ' 86' ' ' ARG . 22.1 mt-10 -72.85 -43.97 61.96 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.471 0.653 . . . . 2.11 109.316 -179.686 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.416 ' O ' ' HG3' ' A' ' 94' ' ' LYS . 97.3 mtt180 -55.22 -41.93 72.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.983 -1.008 . . . . 4.35 111.254 176.036 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -69.36 -47.05 65.51 Favored 'General case' 0 C--O 1.219 -0.54 0 C-N-CA 120.971 -0.292 . . . . 1.21 111.533 174.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 48.4 t -48.5 -44.41 35.96 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 113.112 0.782 . . . . 1.16 113.112 177.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.548 ' HE2' ' HB2' ' A' ' 95' ' ' ASP . 0.0 OUTLIER -60.44 -22.89 63.95 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 118.314 0.506 . . . . 4.58 111.661 176.57 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.548 ' HB2' ' HE2' ' A' ' 94' ' ' LYS . 10.3 t70 -99.65 100.72 11.51 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 115.48 -0.782 . . . . 2.24 110.274 -177.529 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.428 ' HD3' ' O ' ' A' ' 94' ' ' LYS . 55.8 Cg_endo -90.72 113.78 0.44 Allowed 'Trans proline' 0 N--CA 1.451 -0.994 0 C-N-CA 123.113 2.542 . . . . 2.38 113.921 -171.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.535 ' HB3' ' HD2' ' A' ' 104' ' ' LYS . 1.0 OUTLIER 70.18 92.42 0.06 OUTLIER Pre-proline 0 N--CA 1.467 0.388 0 CA-C-N 114.495 -1.23 . . . . 3.61 111.464 175.978 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.618 ' O ' ' HA ' ' A' ' 104' ' ' LYS . 73.4 Cg_endo -82.3 168.75 14.71 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 123.843 3.029 . . . . 1.54 113.926 -175.303 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 48.6 mm -102.22 118.07 48.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 CA-C-N 114.1 -1.409 . . . . 2.08 108.737 178.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 70.9 mt -137.65 124.16 27.79 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.233 0 N-CA-C 110.462 -0.199 . . . . 1.55 110.462 -167.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.54 ' HB3' ' HG2' ' A' ' 43' ' ' PRO . 37.9 t70 44.51 48.15 8.38 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-O 121.288 0.566 . . . . 1.52 111.25 -179.219 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 77.0 2.3 77.15 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 115.478 0.951 . . . . 1.73 115.478 179.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 13.0 tpt180 -141.92 130.52 22.66 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 118.487 1.143 . . . . 4.66 112.01 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.618 ' HA ' ' O ' ' A' ' 98' ' ' PRO . 16.8 ttpp -60.1 141.93 55.0 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.388 -0.369 . . . . 3.14 111.527 172.376 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.454 ' O ' ' HD2' ' A' ' 98' ' ' PRO . . . -124.32 167.78 13.88 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 109.035 -0.728 . . . . 1.37 109.035 177.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -97.7 106.93 19.32 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 122.133 0.968 . . . . 2.18 111.838 -178.166 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.539 HG11 HG21 ' A' ' 37' ' ' ILE . 24.6 t -96.48 113.95 32.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 113.517 -1.674 . . . . 1.46 112.104 172.567 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -134.36 144.34 48.17 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 114.497 -1.228 . . . . 3.22 108.882 172.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.479 HD13 ' CD1' ' A' ' 111' ' ' TYR . 0.1 OUTLIER -68.86 93.3 0.54 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.878 0.371 . . . . 1.87 110.384 177.782 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . 0.638 ' HB3' ' HB2' ' A' ' 38' ' ' PHE . . . -36.42 -19.12 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 118.223 2.675 . . . . 1.3 118.223 177.296 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.479 ' CD1' HD13 ' A' ' 109' ' ' LEU . 0.3 OUTLIER -71.16 -9.57 58.31 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 121.534 1.97 . . . . 1.71 109.99 175.29 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 60.5 mt -84.98 3.52 38.03 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.687 0.795 . . . . 1.97 110.222 172.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.508 ' HA3' ' N3 ' ' B' ' 5' ' ' ' U' . . . -138.14 -22.87 0.43 Allowed Glycine 0 N--CA 1.453 -0.168 0 CA-C-N 115.133 -0.94 . . . . 2.24 111.458 -172.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.489 ' O ' ' HD3' ' A' ' 116' ' ' PRO . . . -60.81 161.91 7.45 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 123.182 0.593 . . . . 2.66 110.247 172.419 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.431 ' N ' ' HD2' ' A' ' 115' ' ' LYS . 12.6 mptt -114.14 75.64 3.2 Favored Pre-proline 0 C--N 1.324 -0.533 0 N-CA-C 110.05 -0.352 . . . . 4.52 110.05 -179.606 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.489 ' HD3' ' O ' ' A' ' 114' ' ' ALA . 49.1 Cg_endo -90.03 -42.4 0.04 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.572 2.181 . . . . 5.53 112.671 -178.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 28.2 ptt180 -124.87 6.45 8.05 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.082 -0.508 . . . . 9.2 110.239 -176.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 10.2 t -150.49 156.34 41.24 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.71 0.291 . . . . 6.74 111.294 -172.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -134.74 122.25 21.9 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.95 -0.759 . . . . 8.27 108.95 173.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 16.4 t -106.74 -10.08 10.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.22 0.533 . . . . 9.39 111.027 -173.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.238 -0.887 . . . . 12.71 111.243 -171.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 1' ' ' ' G' . . . . . 0.626 " O5'" ' HA ' ' A' ' 76' ' ' ARG . . . . . . . . 0 O5'--C5' 1.431 -0.586 0 C3'-C2'-C1' 99.518 -2.202 . 0.0 '__' . 5.37 . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 2' ' ' ' G' . . . . . 0.451 ' C4 ' ' C4 ' ' B' ' 3' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.429 -0.69 0 C3'-C2'-C1' 99.624 -2.084 . 0.0 OUTLIER gamma 4.87 . . . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 3' ' ' ' U' . . . . . 0.524 ' O4 ' ' HA2' ' A' ' 41' ' ' GLY . . . . . . . . 0 O5'--C5' 1.427 -0.81 0 C3'-C2'-C1' 100.156 -1.493 . 0.0 OUTLIER . 5.58 . . . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 4' ' ' ' G' . . . . . 0.549 HO2' " C5'" ' B' ' 5' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.424 -1.029 0 O4'-C1'-C2' 108.107 1.219 . 0.0 OUTLIER . 2.69 . . . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 5' ' ' ' U' . . . . . 0.549 " C5'" HO2' ' B' ' 4' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.427 -0.843 0 C3'-C2'-C1' 100.367 -1.259 . 0.0 OUTLIER '7D dist 1b' 1.93 . . . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 6' ' ' ' G' . . . . . 0.707 ' N2 ' HG12 ' A' ' 65' ' ' VAL . . . . . . . . 0 O5'--C5' 1.425 -0.913 0 C3'-C2'-C1' 99.566 -2.149 . 0.0 OUTLIER gamma 2.38 . . . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 7' ' ' ' C' . . . . . 0.504 " C5'" HH12 ' A' ' 76' ' ' ARG . . . . . . . . 0 O5'--C5' 1.424 -0.991 0 C4'-C3'-C2' 105.486 2.786 . 0.0 OUTLIER gamma 4.41 . . . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.733 0 N-CA-C 111.8 -0.52 . . . . 13.51 111.8 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.887 ' HB2' ' HA ' ' A' ' 90' ' ' GLU . . . -111.59 136.74 50.38 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.603 0.716 . . . . 11.28 111.195 -178.629 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' MET . . . . . 0.934 ' HB3' ' HA ' ' A' ' 34' ' ' PHE . 37.8 mtt -147.46 -130.38 0.06 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.812 -1.085 . . . . 10.15 108.902 -172.245 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.737 ' HA2' ' O ' ' A' ' 36' ' ' LYS . . . -173.92 -135.32 2.0 Favored Glycine 0 C--O 1.212 -1.278 0 C-N-CA 119.19 -1.481 . . . . 6.69 115.406 -178.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 1.011 ' H ' ' HB3' ' A' ' 36' ' ' LYS . 21.4 t 178.72 104.25 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.462 0.705 . . . . 5.68 111.48 175.379 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.455 ' HG2' ' HG3' ' A' ' 36' ' ' LYS . 0.0 OUTLIER 166.19 -154.04 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.959 1.304 . . . . 4.34 107.582 172.787 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -47.28 -51.75 18.16 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 108.48 -0.933 . . . . 3.53 108.48 168.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.721 ' HB ' ' OG1' ' A' ' 35' ' ' THR . 7.8 p -81.56 94.32 6.87 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 114.96 -1.018 . . . . 1.98 109.879 165.448 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' MET . . . . . 0.617 ' HE1' ' CE1' ' A' ' 34' ' ' PHE . 43.0 ttp -74.14 -50.96 17.09 Favored 'General case' 0 C--O 1.197 -1.699 0 CA-C-N 114.285 -1.325 . . . . 1.9 109.497 -175.424 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . 0.934 ' HA ' ' HB3' ' A' ' 27' ' ' MET . 15.4 m-30 -92.22 42.19 1.09 Allowed 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 115.43 1.641 . . . . 1.76 115.43 175.559 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.721 ' OG1' ' HB ' ' A' ' 32' ' ' THR . 16.2 p -147.89 20.06 1.13 Allowed 'General case' 0 N--CA 1.485 1.314 0 CA-C-N 122.219 2.282 . . . . 1.23 110.821 177.474 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 1.011 ' HB3' ' H ' ' A' ' 29' ' ' SER . 3.1 tmtm? -129.58 100.85 5.68 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-O 122.351 1.072 . . . . 3.2 110.753 -160.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.409 HD12 ' HA ' ' A' ' 89' ' ' ALA . 43.1 mt -88.48 142.35 13.03 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 O-C-N 121.677 -0.639 . . . . 1.46 111.894 -170.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.441 ' HB3' ' O ' ' A' ' 108' ' ' ASN . 49.3 t80 -102.17 128.12 48.81 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.348 -0.982 . . . . 0.81 108.348 169.39 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.7 t -120.98 89.09 1.35 Allowed 'Isoleucine or valine' 0 C--O 1.217 -0.652 0 C-N-CA 119.995 -0.682 . . . . 1.61 110.128 -176.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -59.14 154.67 28.65 Favored Glycine 0 C--O 1.221 -0.663 0 C-N-CA 118.113 -1.994 . . . . 1.39 114.513 165.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 96.15 39.16 4.35 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 121.105 -0.569 . . . . 0.71 114.189 170.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.55 HD13 HD22 ' A' ' 51' ' ' LEU . 2.9 mm? -93.68 125.24 54.3 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 117.122 0.461 . . . . 1.89 109.96 173.381 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.57 ' HA ' ' H1 ' ' B' ' 2' ' ' ' G' . 50.0 Cg_exo -49.08 155.88 2.58 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.779 2.319 . . . . 0.82 111.953 171.406 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -69.42 -3.4 14.2 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.433 0.531 . . . . 1.46 112.433 -173.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -110.05 -8.95 14.75 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 120.545 0.212 . . . . 2.65 111.016 179.028 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.534 HG22 HD11 ' A' ' 42' ' ' LEU . 30.0 m -62.69 133.68 55.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.952 0.406 . . . . 1.31 111.156 -173.609 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 12.0 p -107.63 158.38 17.3 Favored 'General case' 0 C--O 1.251 1.183 0 CA-C-O 121.856 0.836 . . . . 0.75 112.06 -177.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.472 ' HA ' HG21 ' A' ' 66' ' ' VAL . 2.6 m-20 -49.99 -30.93 11.5 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 114.323 -1.308 . . . . 0.49 111.122 177.411 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.556 ' O ' ' HG2' ' A' ' 53' ' ' GLU . 60.6 pttt -78.77 -29.26 44.93 Favored 'General case' 0 C--O 1.215 -0.746 0 N-CA-C 108.799 -0.815 . . . . 3.26 108.799 -174.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.573 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 7.0 m -64.91 -41.75 95.31 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 115.764 -0.653 . . . . 1.25 110.068 179.299 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.55 HD22 HD13 ' A' ' 42' ' ' LEU . 18.8 mt -62.05 -46.2 90.18 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 119.361 -0.935 . . . . 1.53 110.083 173.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . 0.516 ' HA ' ' CD1' ' A' ' 61' ' ' ILE . 59.6 t-80 -53.58 -32.39 50.77 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 116.27 -0.423 . . . . 0.77 110.911 172.474 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.573 ' HB2' ' O ' ' A' ' 50' ' ' THR . 45.2 mm-40 -68.05 -40.05 82.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.314 -0.857 . . . . 1.52 109.489 -175.664 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' TYR . . . . . 0.561 ' O ' ' HB2' ' A' ' 57' ' ' GLN . 24.4 t80 -80.75 -40.82 24.55 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.421 -0.809 . . . . 1.6 111.499 -173.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.672 ' C ' ' H ' ' A' ' 57' ' ' GLN . 58.2 m-85 -85.56 -32.03 22.35 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 114.005 1.113 . . . . 0.68 114.005 -166.21 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.652 ' N ' HD12 ' A' ' 61' ' ' ILE . 15.7 pt-20 -63.28 4.13 0.24 Allowed 'General case' 0 N--CA 1.48 1.061 0 CA-C-O 122.168 0.985 . . . . 1.57 111.145 176.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.672 ' H ' ' C ' ' A' ' 55' ' ' PHE . 36.2 mt-30 -92.32 -18.11 23.79 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 113.753 -1.567 . . . . 2.79 110.73 -176.259 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -102.62 -29.43 11.55 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.506 0.67 . . . . 0.79 109.692 177.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.41 ' O ' ' HA ' ' A' ' 56' ' ' GLU . . . 178.46 -174.6 46.81 Favored Glycine 0 N--CA 1.443 -0.861 0 N-CA-C 110.255 -1.138 . . . . 0.75 110.255 -177.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -64.0 137.34 57.95 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 117.388 0.594 . . . . 1.02 110.492 175.409 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.652 HD12 ' N ' ' A' ' 56' ' ' GLU . 7.5 mt -101.91 142.42 16.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 105.692 -1.966 . . . . 1.13 105.692 172.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.47 ' OE1' ' HE3' ' A' ' 84' ' ' LYS . 7.7 tp10 -88.75 -37.13 15.71 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 119.61 1.096 . . . . 2.07 109.155 178.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -166.24 127.44 1.78 Allowed 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.063 -0.517 . . . . 2.48 110.792 177.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -115.01 134.33 55.28 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.1 0.476 . . . . 1.18 110.753 174.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.595 HG12 ' N2 ' ' B' ' 6' ' ' ' G' . 2.9 p -147.32 136.71 16.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.248 -0.887 . . . . 1.97 111.231 -174.61 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.472 HG21 ' HA ' ' A' ' 48' ' ' ASP . 78.4 t -107.36 131.37 57.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 109.043 -0.725 . . . . 1.12 109.043 176.317 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 49.0 mm -88.23 139.47 17.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-O 121.867 0.841 . . . . 1.44 112.625 -168.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.695 ' O ' ' HD2' ' A' ' 76' ' ' ARG . 34.4 p -118.34 -178.76 3.59 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 105.994 -1.854 . . . . 1.83 105.994 172.196 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.679 ' H ' ' HA ' ' A' ' 73' ' ' GLN . 37.6 t70 -95.47 158.75 15.32 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 105.874 -1.899 . . . . 2.49 105.874 -171.699 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 3.4 tpp180 -77.26 -55.62 5.26 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 120.224 1.375 . . . . 6.58 110.216 -179.443 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -71.25 -55.2 8.57 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 113.115 0.783 . . . . 4.33 113.115 178.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 60.3 p -91.22 -23.58 20.16 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.924 0.392 . . . . 3.67 111.803 -172.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.679 ' HA ' ' H ' ' A' ' 69' ' ' ASP . 50.0 mt-30 59.12 15.21 3.94 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 113.562 0.949 . . . . 3.61 113.562 179.047 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.422 ' HB3' ' N1 ' ' B' ' 1' ' ' ' G' . 67.4 mttm -53.93 145.86 15.5 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 110.099 -0.334 . . . . 3.78 110.099 166.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 2.8 m -59.8 107.82 0.66 Allowed 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.975 -0.75 . . . . 2.07 108.975 173.063 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.695 ' HD2' ' O ' ' A' ' 68' ' ' THR . 15.1 mtt180 -72.45 -10.62 60.02 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.188 -0.46 . . . . 3.07 112.042 -172.452 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 73.29 8.71 75.75 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.56 -0.828 . . . . 0.75 112.059 176.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.493 ' CD2' ' HB3' ' A' ' 76' ' ' ARG . 9.9 m-85 -111.18 141.62 44.46 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.44 -0.948 . . . . 1.61 108.44 178.401 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -126.96 164.76 20.43 Favored Glycine 0 N--CA 1.439 -1.157 0 C-N-CA 120.274 -0.965 . . . . 0.59 112.214 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.653 ' HB3' ' HZ2' ' A' ' 36' ' ' LYS . 51.0 m-85 -139.44 123.12 17.46 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.25 0.547 . . . . 0.84 109.621 178.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.501 HG12 ' CD2' ' A' ' 55' ' ' PHE . 54.0 t -125.27 108.14 19.3 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 115.626 -0.715 . . . . 1.21 110.184 -178.483 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.416 ' HA ' ' HA ' ' A' ' 36' ' ' LYS . 18.5 m -92.83 118.03 30.67 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 109.128 -0.693 . . . . 1.09 109.128 178.022 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 80.3 mmm -85.91 -179.95 6.9 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.244 0.545 . . . . 1.02 110.326 178.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.47 ' HE3' ' OE1' ' A' ' 62' ' ' GLU . 6.4 tptm -93.99 -7.38 42.99 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.345 -0.843 . . . . 2.47 109.156 -171.671 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -167.28 154.17 8.48 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 114.672 -1.149 . . . . 1.68 110.12 -162.217 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.507 ' HB2' ' O ' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -76.17 -49.49 17.11 Favored 'General case' 0 C--O 1.223 -0.341 0 N-CA-C 109.764 -0.458 . . . . 4.24 109.764 -174.258 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -51.69 -39.34 58.12 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.511 -0.768 . . . . 1.33 112.22 176.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.622 ' HA ' ' HE ' ' A' ' 91' ' ' ARG . 14.6 m -69.17 -40.54 78.06 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.838 0.351 . . . . 1.34 110.825 176.72 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.409 ' HA ' HD12 ' A' ' 37' ' ' ILE . . . -55.31 -46.08 76.29 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.049 -0.523 . . . . 1.16 110.525 170.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.887 ' HA ' ' HB2' ' A' ' 26' ' ' ALA . 4.1 mt-10 -60.34 -41.27 93.25 Favored 'General case' 0 C--O 1.222 -0.364 0 CA-C-O 121.268 0.556 . . . . 2.11 110.464 174.463 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.622 ' HE ' ' HA ' ' A' ' 88' ' ' SER . 16.4 mtm180 -56.72 -50.92 70.76 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 114.713 -1.13 . . . . 4.35 111.641 176.728 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -59.96 -27.31 66.7 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 113.837 1.051 . . . . 1.21 113.837 173.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 44.7 t -79.97 -36.1 36.58 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.943 0.878 . . . . 1.16 109.097 179.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.565 ' HB3' ' O ' ' A' ' 91' ' ' ARG . 59.8 tptt -50.4 -18.8 0.69 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 113.675 -1.602 . . . . 4.58 112.511 170.01 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -104.52 89.15 2.51 Favored Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 109.118 -0.697 . . . . 2.24 109.118 166.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.564 ' HD3' ' O ' ' A' ' 94' ' ' LYS . 5.6 Cg_exo -73.67 173.77 13.36 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.923 2.415 . . . . 2.38 111.138 -177.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 5.92 67.74 0.05 OUTLIER Pre-proline 0 N--CA 1.479 1.014 0 O-C-N 124.2 0.937 . . . . 3.61 113.417 -160.71 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -69.13 133.39 26.59 Favored 'Trans proline' 0 CA--C 1.511 -0.644 0 C-N-CA 121.723 1.615 . . . . 1.54 108.962 177.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.547 HG23 ' C ' ' A' ' 102' ' ' GLY . 17.2 mm -87.1 95.92 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.893 0 CA-C-N 119.307 0.958 . . . . 2.08 108.671 -172.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.694 HG21 ' H ' ' A' ' 101' ' ' ASP . 11.2 mm -89.54 150.02 3.85 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.422 0 CA-C-O 121.461 0.648 . . . . 1.55 111.734 -170.683 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.694 ' H ' HG21 ' A' ' 100' ' ' ILE . 30.5 t70 36.24 20.65 0.0 OUTLIER 'General case' 0 CA--C 1.559 1.306 0 CA-C-N 113.898 -1.501 . . . . 1.52 111.916 -156.708 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.547 ' C ' HG23 ' A' ' 99' ' ' ILE . . . 89.18 17.31 56.03 Favored Glycine 0 CA--C 1.535 1.31 0 C-N-CA 120.852 -0.69 . . . . 1.73 113.131 -179.546 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.497 ' N ' HG23 ' A' ' 99' ' ' ILE . 39.5 mmt180 -132.38 140.73 48.6 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.548 0.739 . . . . 4.66 110.035 176.18 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -58.58 112.68 1.69 Allowed 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 113.74 1.015 . . . . 3.14 113.74 -171.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -92.34 164.83 13.36 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 114.752 -1.113 . . . . 1.37 112.993 177.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -123.52 113.46 18.75 Favored 'General case' 0 C--O 1.253 1.27 0 CA-C-N 115.098 -0.956 . . . . 2.18 110.245 177.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 51.0 t -98.18 127.77 50.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 114.63 -1.168 . . . . 1.46 111.444 -173.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . 0.441 ' O ' ' HB3' ' A' ' 38' ' ' PHE . 66.5 t30 -157.39 152.75 26.23 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.517 -0.765 . . . . 3.22 109.909 178.532 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.806 HD22 ' H ' ' A' ' 27' ' ' MET . 7.7 mt -65.97 125.93 26.98 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 113.539 0.94 . . . . 1.87 113.539 -177.627 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -45.92 -44.49 14.71 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 113.944 -1.48 . . . . 1.3 113.217 172.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.722 ' HB3' ' O ' ' A' ' 28' ' ' GLY . 0.1 OUTLIER -75.74 -6.42 50.51 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 121.866 -0.521 . . . . 1.71 111.418 -173.835 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 94.4 mt -86.1 -37.78 18.47 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.949 0.404 . . . . 1.97 110.715 174.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -87.69 -15.59 61.36 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.852 -0.689 . . . . 2.24 112.786 -179.208 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.11 154.61 40.82 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.992 -0.373 . . . . 2.66 109.992 -179.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.463 ' HD3' ' HA ' ' A' ' 119' ' ' ASN . 65.5 mttm -120.14 88.87 42.05 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-O 120.83 0.348 . . . . 4.52 111.158 -175.144 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.403 ' HD2' ' H ' ' A' ' 117' ' ' ARG . 1.2 Cg_endo -86.05 -39.66 0.08 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 122.822 2.348 . . . . 5.53 111.204 175.781 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.403 ' H ' ' HD2' ' A' ' 116' ' ' PRO . 13.6 ptp180 -127.63 -21.7 3.73 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.93 -0.577 . . . . 9.2 111.626 -176.675 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 3.5 t -110.18 99.98 8.96 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.284 0.564 . . . . 6.74 110.633 -177.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.463 ' HA ' ' HD3' ' A' ' 115' ' ' LYS . 24.7 p-10 -99.61 -36.93 9.35 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.75 -0.659 . . . . 8.27 110.75 179.049 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 46.3 t 62.53 82.25 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 115.728 -0.669 . . . . 9.39 110.557 -176.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.428 ' HG2' ' OXT' ' A' ' 121' ' ' GLN . 19.1 pm0 . . . . . 0 C--O 1.247 0.959 0 CA-C-N 115.364 -0.835 . . . . 12.71 110.495 -179.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 1' ' ' ' G' . . . . . 0.422 ' N1 ' ' HB3' ' A' ' 74' ' ' LYS . . . . . . . . 0 O5'--C5' 1.434 -0.396 0 C3'-C2'-C1' 99.737 -1.959 . 0.0 '__' . 5.37 . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 2' ' ' ' G' . . . . . 0.57 ' H1 ' ' HA ' ' A' ' 43' ' ' PRO . . . . . . . . 0 O5'--C5' 1.426 -0.856 0 C3'-C2'-C1' 99.998 -1.669 . 0.0 OUTLIER . 4.87 . . . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 3' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.426 -0.885 0 C4'-C3'-C2' 104.15 1.45 . 0.0 OUTLIER . 5.58 . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 4' ' ' ' G' . . . . . 0.638 " H3'" ' N3 ' ' B' ' 4' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.428 -0.762 0 O4'-C4'-C3' 103.844 -1.183 . 0.0 OUTLIER . 2.69 . . . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 5' ' ' ' U' . . . . . 0.619 " H5'" " O2'" ' B' ' 4' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.425 -0.926 0 C4'-C3'-C2' 104.423 1.723 . 0.495 1b . 1.93 . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 6' ' ' ' G' . . . . . 0.595 ' N2 ' HG12 ' A' ' 65' ' ' VAL . . . . . . . . 0 O5'--C5' 1.424 -1.005 0 C4'-C3'-C2' 103.628 0.928 . 0.0 OUTLIER . 2.38 . . . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.428 -0.729 0 O4'-C1'-C2' 107.996 1.14 . 0.0 OUTLIER . 4.41 . . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 51.9 ttp . . . . . 0 C--O 1.233 0.197 0 N-CA-C 112.043 0.386 . . . . 1.49 112.043 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.474 ' HB3' ' HG3' ' A' ' 86' ' ' ARG . 8.9 m-85 -91.76 -2.34 56.99 Favored 'General case' 0 C--N 1.331 -0.212 0 O-C-N 122.226 -0.296 . . . . 1.5 111.63 -176.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.581 ' O ' ' HA ' ' A' ' 82' ' ' THR . 41.1 p -110.68 -3.49 15.82 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.877 -0.329 . . . . 0.53000000000000003 111.447 -178.845 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -85.64 103.24 14.28 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.97 -0.559 . . . . 2.75 110.207 -176.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 98.7 mt -105.57 141.71 20.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 C-N-CA 123.108 0.563 . . . . 0.84999999999999998 111.577 -173.796 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.401 ' HD1' ' CE1' ' A' ' 80' ' ' PHE . 58.9 t80 -95.79 132.41 41.06 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.645 -0.707 . . . . 0.70999999999999996 109.505 174.007 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.788 HG12 HD11 ' A' ' 42' ' ' LEU . 3.6 t -120.96 141.92 39.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 121.082 0.468 . . . . 0.92000000000000004 110.314 -178.313 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.591 ' HA3' ' HB2' ' A' ' 106' ' ' ASN . . . -141.95 159.52 26.98 Favored Glycine 0 C--O 1.219 -0.807 0 CA-C-N 115.72 -0.673 . . . . 0.83999999999999997 112.735 -167.876 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.77 37.38 93.38 Favored Glycine 0 CA--C 1.522 0.503 0 C-N-CA 121.374 -0.441 . . . . 0.68000000000000005 113.817 172.462 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.788 HD11 HG12 ' A' ' 39' ' ' VAL . 8.2 mp -87.54 134.0 36.93 Favored Pre-proline 0 C--N 1.326 -0.418 0 O-C-N 122.694 -0.298 . . . . 1.28 110.626 178.332 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.622 ' HD2' ' OG1' ' A' ' 46' ' ' THR . 51.5 Cg_exo -53.33 155.89 11.7 Favored 'Trans proline' 0 N--CA 1.463 -0.282 0 C-N-CA 122.995 2.463 . . . . 0.57999999999999996 112.101 175.721 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -69.09 1.87 3.22 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.129 0.49 . . . . 1.05 110.963 -179.021 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 4.2 t-80 -106.88 -16.46 14.46 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.747 -0.66 . . . . 2.0099999999999998 110.627 178.483 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.796 HG23 HG21 ' A' ' 50' ' ' THR . 61.2 m -71.77 138.54 48.49 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.257 -0.428 . . . . 0.71999999999999997 111.467 -175.846 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 16.9 p -130.96 -178.35 4.78 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-O 120.967 0.413 . . . . 0.55000000000000004 111.391 -176.396 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -62.74 -33.52 75.32 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.969 -0.56 . . . . 0.48999999999999999 110.756 -176.53 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -71.39 -33.93 69.94 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.286 -0.635 . . . . 2.7599999999999998 109.286 -179.48 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.796 HG21 HG23 ' A' ' 46' ' ' THR . 81.2 m -61.24 -45.29 95.16 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.57 -0.741 . . . . 0.57999999999999996 110.686 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 54.0 mt -67.57 -35.33 78.82 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.928 -0.578 . . . . 0.84999999999999998 111.089 178.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 57.7 t-80 -61.89 -54.02 47.78 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.25 -0.648 . . . . 0.58999999999999997 109.25 176.659 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -58.66 -37.4 75.89 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.826 -0.624 . . . . 1.52 112.005 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -76.87 -37.59 55.24 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 120.789 0.328 . . . . 1.1200000000000001 111.714 -178.091 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -85.22 -25.23 27.45 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 113.402 0.89 . . . . 0.56000000000000005 113.402 -174.161 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.66 ' N ' HD11 ' A' ' 61' ' ' ILE . 10.8 pt-20 -64.52 -18.14 64.55 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.642 0.734 . . . . 1.5700000000000001 109.984 179.631 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -55.45 -27.66 49.54 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.542 -1.208 . . . . 2.1600000000000001 111.755 170.604 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -96.06 -21.28 18.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.546 -0.297 . . . . 0.70999999999999996 110.802 -178.233 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 151.25 -159.74 28.35 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.565 -0.826 . . . . 0.75 112.419 177.021 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -65.9 121.94 16.21 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.028 0.442 . . . . 1.02 111.671 -178.621 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.66 HD11 ' N ' ' A' ' 56' ' ' GLU . 12.5 mt -101.41 130.74 50.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 109.235 -0.654 . . . . 0.46999999999999997 109.235 176.023 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -85.32 -53.37 5.27 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 121.181 -0.208 . . . . 2.0699999999999998 111.33 176.715 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -140.28 129.59 23.85 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.711 -0.222 . . . . 2.48 111.223 -175.001 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -121.6 116.92 25.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.186 0.517 . . . . 0.44 111.056 174.764 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.416 HG23 ' HB2' ' A' ' 80' ' ' PHE . 30.3 m -128.64 145.43 35.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.454 -0.794 . . . . 1.3799999999999999 112.123 -179.474 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 91.3 t -116.76 133.73 62.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.525 -0.761 . . . . 0.48999999999999999 110.734 174.465 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 36.8 mm -76.92 152.5 5.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.715 -0.675 . . . . 0.71999999999999997 109.524 177.154 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 39.5 p . . . . . 0 N--CA 1.444 -0.773 0 N-CA-C 105.407 -2.072 . . . . 1.52 105.407 -174.21 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 6.3 m . . . . . 0 CA--C 1.534 0.354 0 CA-C-O 120.732 0.301 . . . . 1.8100000000000001 110.792 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 73.7 mtp180 -58.51 -29.55 66.37 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.769 -0.65 . . . . 2.5600000000000001 111.191 179.057 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 93.37 30.37 9.28 Favored Glycine 0 N--CA 1.439 -1.109 0 C-N-CA 120.506 -0.854 . . . . 0.64000000000000001 112.18 -177.444 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -131.49 141.83 49.84 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 107.921 -1.14 . . . . 1.1799999999999999 107.921 175.167 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -141.72 -171.75 13.04 Favored Glycine 0 N--CA 1.439 -1.142 0 C-N-CA 120.089 -1.053 . . . . 0.58999999999999997 111.782 -174.389 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.416 ' HB2' HG23 ' A' ' 65' ' ' VAL . 55.4 m-85 -154.91 124.6 6.52 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.582 -0.896 . . . . 0.63 108.582 -177.491 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.475 HG23 HG21 ' A' ' 39' ' ' VAL . 53.8 t -119.58 124.14 72.37 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 CA-C-N 115.742 -0.663 . . . . 0.40999999999999998 110.133 -177.149 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.581 ' HA ' ' O ' ' A' ' 35' ' ' THR . 17.3 m -109.41 116.33 31.62 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 107.948 -1.13 . . . . 0.46999999999999997 107.948 175.658 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 92.5 mmm -87.72 162.69 16.92 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.098 -0.705 . . . . 0.88 109.098 -175.822 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 44.8 tttm -85.04 -10.47 56.9 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 120.873 0.368 . . . . 1.9199999999999999 110.997 -175.562 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -149.5 147.78 28.62 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-N 116.377 -0.374 . . . . 1.6799999999999999 110.562 175.02 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.483 ' O ' ' HB3' ' A' ' 89' ' ' ALA . 1.3 tmt_? -67.49 -22.72 65.45 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 112.255 0.465 . . . . 3.6600000000000001 112.255 -176.318 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.05 -47.27 77.95 Favored 'General case' 0 N--CA 1.464 0.239 0 O-C-N 121.519 -0.738 . . . . 0.66000000000000003 111.285 178.685 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 19.1 m -65.92 -31.13 71.88 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.605 0.717 . . . . 0.78000000000000003 109.754 175.781 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.483 ' HB3' ' O ' ' A' ' 86' ' ' ARG . . . -59.32 -48.97 79.62 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.123 -1.398 . . . . 0.46000000000000002 109.818 174.863 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -55.87 -51.68 66.71 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.203 -0.453 . . . . 2.1099999999999999 111.654 174.44 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.483 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 23.7 mmt180 -57.78 -45.39 86.07 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.315 -0.402 . . . . 3.8199999999999998 111.198 -178.026 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -58.66 -48.12 82.14 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.09 -0.505 . . . . 0.92000000000000004 111.147 176.175 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 49.2 t -75.46 -2.97 31.25 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 111.945 0.35 . . . . 1.1599999999999999 111.945 -176.809 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.483 ' HB2' ' O ' ' A' ' 91' ' ' ARG . 4.5 mmmm -59.95 -48.74 80.45 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 121.044 -0.262 . . . . 4.2000000000000002 111.463 176.354 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.439 ' HA ' ' HD3' ' A' ' 96' ' ' PRO . 32.5 t0 -106.39 107.57 60.21 Favored Pre-proline 0 C--N 1.328 -0.365 0 N-CA-C 109.931 -0.396 . . . . 2.2400000000000002 109.931 179.482 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 95' ' ' ASP . 6.9 Cg_exo -74.48 -10.32 22.03 Favored 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 123.082 2.521 . . . . 2.3799999999999999 113.51 -176.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.707 ' HA ' ' O ' ' A' ' 105' ' ' ALA . 2.0 m120 -142.81 68.57 19.02 Favored Pre-proline 0 N--CA 1.464 0.254 0 N-CA-C 112.824 0.676 . . . . 3.0299999999999998 112.824 -178.609 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -81.29 154.46 18.85 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.803 2.336 . . . . 1.29 110.818 172.177 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 42.6 mm -85.63 91.95 3.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 120.418 -0.513 . . . . 1.8100000000000001 110.478 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 52.3 mt -89.95 107.77 18.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.702 0.763 . . . . 0.98999999999999999 112.681 178.275 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.407 ' O ' ' HG2' ' A' ' 43' ' ' PRO . 32.2 t70 66.13 43.59 2.83 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 113.901 -1.5 . . . . 1.3700000000000001 110.438 167.362 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 88.99 -7.63 81.74 Favored Glycine 0 CA--C 1.518 0.267 0 CA-C-N 115.056 -0.975 . . . . 1.5600000000000001 114.551 177.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.532 ' HB2' ' HG3' ' A' ' 43' ' ' PRO . 14.7 tpt180 -126.66 141.79 51.74 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 117.992 0.896 . . . . 4.1299999999999999 110.709 178.871 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -64.62 131.57 47.34 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.088 -0.708 . . . . 2.73 109.088 172.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.707 ' O ' ' HA ' ' A' ' 97' ' ' ASN . . . -118.64 153.54 34.15 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.821 -0.627 . . . . 1.04 110.087 -169.566 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.591 ' HB2' ' HA3' ' A' ' 40' ' ' GLY . 6.6 m-20 -96.68 140.15 31.71 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.069 0.461 . . . . 2.04 110.281 178.162 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.436 ' O ' ' HA ' ' A' ' 96' ' ' PRO . 70.6 t -146.08 113.75 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.029 -0.987 . . . . 1.0600000000000001 110.626 -174.762 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.454 HD22 ' HA ' ' A' ' 108' ' ' ASN . 0.8 OUTLIER -159.3 165.06 34.24 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.097 -0.705 . . . . 2.4900000000000002 109.097 174.906 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.511 ' HB3' ' CD1' ' A' ' 111' ' ' TYR . 2.0 mm? -71.96 129.31 38.25 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.254 -0.647 . . . . 1.23 109.254 176.479 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -57.84 -31.57 66.78 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.575 0.583 . . . . 0.91000000000000003 112.575 -173.637 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.511 ' CD1' ' HB3' ' A' ' 109' ' ' LEU . 2.5 p90 . . . . . 0 N--CA 1.465 0.32 0 CA-C-O 120.758 0.314 . . . . 1.3999999999999999 111.299 -176.454 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' MET . . . . . 0.479 ' O ' ' HB3' ' A' ' 111' ' ' TYR . 44.2 ttp . . . . . 0 N--CA 1.454 -0.248 0 N-CA-C 112.252 0.464 . . . . 1.49 112.252 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -81.12 -44.88 17.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 118.65 0.659 . . . . 1.5 111.123 -174.619 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.473 ' HB ' ' O ' ' A' ' 83' ' ' MET . 56.8 p -56.04 -17.94 8.24 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 114.376 1.25 . . . . 0.53000000000000003 114.376 -175.718 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.722 ' HG2' ' HB3' ' A' ' 110' ' ' ALA . 29.2 ttpt -81.33 114.77 20.33 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.29 0.567 . . . . 2.75 111.68 -173.556 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 89.0 mt -105.62 134.18 47.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.364 -0.835 . . . . 0.84999999999999998 111.112 -179.227 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -94.28 111.15 22.87 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.027 -0.731 . . . . 0.70999999999999996 109.027 175.175 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.6 t -100.75 139.8 21.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.278 0.561 . . . . 0.92000000000000004 110.24 -179.563 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.46 ' O ' ' HB1' ' A' ' 105' ' ' ALA . . . -139.99 135.92 7.44 Favored Glycine 0 N--CA 1.448 -0.523 0 CA-C-N 115.212 -0.904 . . . . 0.83999999999999997 112.798 -170.55 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 86.34 32.37 16.77 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.762 -0.732 . . . . 0.68000000000000005 113.049 176.619 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.683 HD11 HD21 ' A' ' 51' ' ' LEU . 2.8 mm? -74.21 117.3 60.55 Favored Pre-proline 0 C--N 1.328 -0.338 0 N-CA-C 109.736 -0.468 . . . . 1.28 109.736 177.849 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.57 ' HG2' ' HB3' ' A' ' 101' ' ' ASP . 81.8 Cg_exo -51.0 159.36 2.55 Favored 'Trans proline' 0 CA--C 1.527 0.129 0 C-N-CA 122.913 2.409 . . . . 0.57999999999999996 112.664 178.303 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -69.94 -4.95 22.93 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 116.284 -0.416 . . . . 1.05 111.776 -171.673 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' HIS . . . . . 0.672 ' HB3' ' OD2' ' A' ' 101' ' ' ASP . 58.0 t-80 -101.41 -6.04 24.54 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 120.964 0.411 . . . . 2.0099999999999998 110.533 175.833 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.488 HG21 HD12 ' A' ' 42' ' ' LEU . 95.0 m -75.38 118.81 18.67 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.05 0.453 . . . . 0.71999999999999997 111.406 -178.016 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 11.7 p -108.62 -178.75 3.68 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-N 115.924 -0.58 . . . . 0.55000000000000004 110.824 177.513 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -64.64 -35.93 82.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.296 0.569 . . . . 0.48999999999999999 110.443 -176.185 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.571 ' O ' ' HG2' ' A' ' 53' ' ' GLU . 20.2 ptmt -65.93 -37.44 86.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.582 -0.736 . . . . 2.7599999999999998 110.592 179.37 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 49.9 m -59.49 -45.58 91.26 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.958 -0.564 . . . . 0.57999999999999996 110.403 178.792 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.683 HD21 HD11 ' A' ' 42' ' ' LEU . 39.5 mt -66.55 -32.95 74.63 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.736 -0.666 . . . . 0.84999999999999998 111.22 177.185 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.432 ' HA ' HD12 ' A' ' 61' ' ' ILE . 55.2 t-80 -65.27 -55.07 20.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.867 0.365 . . . . 0.58999999999999997 110.269 177.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.571 ' HG2' ' O ' ' A' ' 49' ' ' LYS . 9.0 mm-40 -57.93 -43.41 86.28 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.143 0.496 . . . . 1.52 112.211 -179.293 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -74.8 -35.0 62.49 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.108 -0.496 . . . . 1.1200000000000001 112.148 -174.575 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.764 ' HB2' HD11 ' A' ' 61' ' ' ILE . 7.5 m-85 -87.12 -25.17 24.26 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 113.493 0.923 . . . . 0.56000000000000005 113.493 -172.62 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -67.97 -16.39 64.04 Favored 'General case' 0 CA--C 1.522 -0.098 0 CA-C-O 121.544 0.688 . . . . 1.5700000000000001 109.557 179.368 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 28.5 mm-40 -56.59 -16.32 5.93 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.054 -0.976 . . . . 2.1600000000000001 112.459 169.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -99.51 -18.32 17.46 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.847 0.356 . . . . 0.70999999999999996 110.7 178.783 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 161.73 -112.96 0.54 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.482 -0.866 . . . . 0.75 112.998 176.393 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.612 ' HB3' ' HB3' ' A' ' 84' ' ' LYS . 7.9 m-20 -114.27 126.41 54.99 Favored 'General case' 0 C--N 1.329 -0.322 0 O-C-N 122.654 -0.321 . . . . 1.02 110.74 -179.026 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.764 HD11 ' HB2' ' A' ' 55' ' ' PHE . 32.4 mt -99.82 126.71 53.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 C-N-CA 120.903 -0.319 . . . . 0.46999999999999997 110.57 173.18 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -83.61 -47.58 11.11 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.828 -0.624 . . . . 2.0699999999999998 109.928 176.801 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -156.57 130.27 8.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.73 -0.668 . . . . 2.48 110.743 179.398 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -115.36 116.36 28.13 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.931 -0.396 . . . . 0.44 109.931 175.265 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.2 m -133.22 115.67 23.85 Favored 'Isoleucine or valine' 0 C--O 1.24 0.553 0 CA-C-O 121.772 0.796 . . . . 1.3799999999999999 112.808 -176.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 94.0 t -72.56 126.08 32.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 114.881 -1.054 . . . . 0.48999999999999999 109.137 173.228 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.4 ' O ' ' HB2' ' A' ' 76' ' ' ARG . 31.1 mm -74.08 95.35 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.542 0 CA-C-O 121.336 0.588 . . . . 0.71999999999999997 110.268 -178.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 29.9 p . . . . . 0 N--CA 1.436 -1.129 0 CA-C-N 115.403 -0.817 . . . . 1.52 111.222 -176.737 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.479 ' O ' ' HB2' ' A' ' 76' ' ' ARG . 11.7 p . . . . . 0 C--O 1.225 -0.21 0 N-CA-C 111.895 0.331 . . . . 1.8100000000000001 111.895 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.479 ' HB2' ' O ' ' A' ' 75' ' ' SER . 81.1 mtt180 76.63 -25.17 0.21 Allowed 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.371 0.669 . . . . 2.5600000000000001 111.43 -179.588 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 85.17 10.46 78.01 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.652 -0.785 . . . . 0.64000000000000001 113.221 173.384 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -121.95 154.21 37.47 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.18 -1.044 . . . . 1.1799999999999999 108.18 177.724 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -165.93 143.43 8.4 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 119.525 -1.322 . . . . 0.58999999999999997 113.418 178.746 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -101.24 124.63 47.25 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 122.184 0.992 . . . . 0.63 112.26 174.389 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 58.0 t -104.27 130.55 54.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 113.966 -1.47 . . . . 0.40999999999999998 108.144 170.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 4.7 m -115.08 122.35 45.88 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 107.794 -1.187 . . . . 0.46999999999999997 107.794 178.704 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.473 ' O ' ' HB ' ' A' ' 35' ' ' THR . 88.3 mmm -86.61 160.78 18.8 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.528 -0.545 . . . . 0.88 109.528 -174.094 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.612 ' HB3' ' HB3' ' A' ' 60' ' ' ASP . 31.3 ttmt -84.04 -19.03 35.11 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.235 0.54 . . . . 1.9199999999999999 109.667 -177.701 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -141.45 144.09 34.22 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 115.554 -0.748 . . . . 1.6799999999999999 111.153 -178.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.536 ' O ' ' HG2' ' A' ' 90' ' ' GLU . 0.6 OUTLIER -66.1 -29.93 70.34 Favored 'General case' 0 C--O 1.222 -0.382 0 N-CA-C 113.743 1.016 . . . . 3.6600000000000001 113.743 -177.718 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -67.73 -35.65 79.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 119.361 0.982 . . . . 0.66000000000000003 110.89 178.88 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 11.7 m -64.66 -35.11 79.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 122.06 0.933 . . . . 0.78000000000000003 109.35 173.208 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.466 ' HB2' ' HA ' ' A' ' 35' ' ' THR . . . -66.02 -45.71 80.51 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 113.685 -1.598 . . . . 0.46000000000000002 110.468 177.782 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.536 ' HG2' ' O ' ' A' ' 86' ' ' ARG . 10.7 mm-40 -54.53 -51.54 64.85 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.779 -0.646 . . . . 2.1099999999999999 112.65 178.606 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.521 ' O ' ' HB3' ' A' ' 94' ' ' LYS . 57.0 mtp180 -65.91 -39.02 90.18 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 111.736 0.273 . . . . 3.8199999999999998 111.736 -178.356 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.82 -42.93 99.93 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.388 -0.369 . . . . 0.92000000000000004 111.305 179.085 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' CYS . . . . . 0.577 ' HB2' ' HG ' ' A' ' 109' ' ' LEU . 44.8 t -71.93 -17.18 62.1 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.047 0.451 . . . . 1.1599999999999999 110.763 175.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.521 ' HB3' ' O ' ' A' ' 91' ' ' ARG . 4.5 tppp? -74.46 -47.88 30.75 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.286 -0.415 . . . . 4.2000000000000002 111.166 177.547 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -101.62 100.55 14.49 Favored Pre-proline 0 N--CA 1.463 0.218 0 N-CA-C 108.975 -0.75 . . . . 2.2400000000000002 108.975 178.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -88.78 -16.29 2.42 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 123.009 2.472 . . . . 2.3799999999999999 115.508 -165.526 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.438 ' HA ' ' O ' ' A' ' 105' ' ' ALA . 2.4 p-10 -120.07 83.0 30.27 Favored Pre-proline 0 C--N 1.326 -0.423 0 N-CA-C 113.622 0.971 . . . . 3.0299999999999998 113.622 -174.096 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -84.65 128.59 3.98 Favored 'Trans proline' 0 C--O 1.24 0.604 0 C-N-CA 123.657 2.905 . . . . 1.29 112.256 170.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 35.3 mm -70.2 91.76 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 121.199 0.523 . . . . 1.8100000000000001 110.288 173.24 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 69.0 mt -99.13 134.1 39.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.923 -0.58 . . . . 0.98999999999999999 111.277 -178.645 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.672 ' OD2' ' HB3' ' A' ' 45' ' ' HIS . 18.0 t70 41.56 30.88 0.16 Allowed 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.778 1.029 . . . . 1.3700000000000001 113.778 -178.037 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 88.48 16.85 58.1 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 120.49 -0.862 . . . . 1.5600000000000001 113.366 176.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.558 ' HB3' ' HG3' ' A' ' 43' ' ' PRO . 28.0 tpt180 -140.54 139.31 35.01 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.323 -0.621 . . . . 4.1299999999999999 109.323 176.026 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -82.09 105.38 13.14 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 119.966 -0.694 . . . . 2.73 110.107 -178.811 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.46 ' HB1' ' O ' ' A' ' 40' ' ' GLY . . . -85.46 166.34 16.43 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 113.874 1.064 . . . . 1.04 113.874 177.673 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 22.7 t30 -108.86 119.34 39.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.388 -1.278 . . . . 2.04 110.187 -178.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 93.8 t -114.2 140.72 33.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.006 -0.543 . . . . 1.0600000000000001 110.874 179.283 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -160.64 170.15 21.42 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.715 -0.846 . . . . 2.4900000000000002 108.715 178.151 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.577 ' HG ' ' HB2' ' A' ' 93' ' ' CYS . 5.8 mt -79.67 127.35 32.08 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.361 -0.536 . . . . 1.23 110.737 178.887 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.722 ' HB3' ' HG2' ' A' ' 36' ' ' LYS . . . -69.26 -24.65 64.01 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.263 -0.881 . . . . 0.91000000000000003 112.351 -174.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.568 ' CD1' ' HB3' ' A' ' 109' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.466 0.364 0 CA-C-O 120.849 0.357 . . . . 1.3999999999999999 111.8 -173.616 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 48.6 ttp . . . . . 0 N--CA 1.454 -0.231 0 N-CA-C 111.27 0.1 . . . . 1.49 111.27 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.592 ' HA ' HD11 ' A' ' 109' ' ' LEU . 25.1 m-85 -107.12 -24.16 12.04 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-O 120.801 0.334 . . . . 1.5 110.992 -178.381 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.735 ' O ' ' HA ' ' A' ' 82' ' ' THR . 27.1 p -81.4 11.75 4.21 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.289 -0.414 . . . . 0.53000000000000003 110.958 -174.823 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.452 ' O ' HD13 ' A' ' 109' ' ' LEU . 5.8 ttpm? -122.43 102.84 8.33 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.074 -0.512 . . . . 2.75 110.247 -173.753 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 5.0 mp -109.21 136.53 44.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.959 -0.564 . . . . 0.84999999999999998 110.602 -176.572 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -95.13 120.51 35.48 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.987 -0.551 . . . . 0.70999999999999996 109.589 176.225 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.635 HG13 HG22 ' A' ' 107' ' ' VAL . 96.8 t -132.84 99.08 3.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 118.775 -0.631 . . . . 0.92000000000000004 110.851 -177.256 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.572 ' HA2' ' CD1' ' A' ' 42' ' ' LEU . . . -132.15 166.49 23.23 Favored Glycine 0 C--O 1.217 -0.913 0 C-N-CA 115.324 -3.322 . . . . 0.83999999999999997 113.845 162.006 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 128.69 -2.93 6.51 Favored Glycine 0 N--CA 1.445 -0.762 0 N-CA-C 108.706 -1.758 . . . . 0.68000000000000005 108.706 -168.291 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.766 HD21 HD21 ' A' ' 51' ' ' LEU . 4.5 mp -62.1 142.13 95.61 Favored Pre-proline 0 N--CA 1.449 -0.486 0 CA-C-N 113.601 -1.3 . . . . 1.28 109.806 179.667 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.581 ' HG2' ' O ' ' A' ' 101' ' ' ASP . 52.5 Cg_exo -54.28 159.78 7.54 Favored 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.669 2.246 . . . . 0.57999999999999996 111.581 172.386 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -71.55 -1.78 14.64 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.161 -0.472 . . . . 1.05 111.459 -174.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 72.4 t60 -104.08 -11.99 17.02 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.127 0.489 . . . . 2.0099999999999998 109.944 176.598 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.704 ' HB ' ' HB3' ' A' ' 42' ' ' LEU . 5.4 m -79.06 129.94 34.99 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 115.921 -0.581 . . . . 0.71999999999999997 109.868 -178.706 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.421 ' HA ' HG21 ' A' ' 66' ' ' VAL . 7.4 p -132.76 -177.58 4.55 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.534 -0.303 . . . . 0.55000000000000004 111.566 -169.832 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.489 ' OD2' ' HA ' ' A' ' 65' ' ' VAL . 1.2 m-20 -57.01 -31.9 65.58 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.536 0.684 . . . . 0.48999999999999999 110.043 -177.632 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.731 ' O ' ' HG2' ' A' ' 53' ' ' GLU . 55.2 pttt -74.1 -35.45 64.18 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.908 -1.042 . . . . 2.7599999999999998 109.638 -178.017 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.645 HG21 HG23 ' A' ' 46' ' ' THR . 6.6 m -67.17 -43.98 80.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.735 0.302 . . . . 0.57999999999999996 110.756 179.49 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.766 HD21 HD21 ' A' ' 42' ' ' LEU . 35.8 mt -61.46 -42.97 99.59 Favored 'General case' 0 CA--C 1.512 -0.493 0 N-CA-C 109.631 -0.507 . . . . 0.84999999999999998 109.631 176.305 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.54 ' HA ' HD12 ' A' ' 61' ' ' ILE . 45.8 t-80 -53.3 -52.74 58.12 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.246 -0.888 . . . . 0.58999999999999997 110.514 175.681 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.731 ' HG2' ' O ' ' A' ' 49' ' ' LYS . 8.5 mm-40 -59.49 -47.62 84.8 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.3 -0.409 . . . . 1.52 111.756 -176.569 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.523 ' O ' ' HB2' ' A' ' 57' ' ' GLN . 56.3 t80 -77.73 -36.53 50.75 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.289 0.478 . . . . 1.1200000000000001 112.289 -170.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.753 ' HB2' HD11 ' A' ' 61' ' ' ILE . 42.9 m-85 -84.62 -30.03 25.27 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 113.224 0.824 . . . . 0.56000000000000005 113.224 -173.197 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.699 ' HA ' ' O ' ' A' ' 59' ' ' GLY . 12.9 pt-20 -68.58 -11.38 59.91 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.677 0.751 . . . . 1.5700000000000001 110.009 179.254 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.523 ' HB2' ' O ' ' A' ' 54' ' ' TYR . 27.6 mt-30 -59.35 -23.0 62.16 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.55 -1.204 . . . . 2.1600000000000001 111.826 170.243 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -94.23 -21.45 19.04 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.217 0.532 . . . . 0.70999999999999996 110.005 177.698 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.699 ' O ' ' HA ' ' A' ' 56' ' ' GLU . . . 159.14 -177.7 35.59 Favored Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 115.049 -0.978 . . . . 0.75 110.982 179.334 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -61.77 122.94 16.6 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 117.042 0.421 . . . . 1.02 110.577 -175.749 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.753 HD11 ' HB2' ' A' ' 55' ' ' PHE . 45.9 mt -86.99 125.03 40.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 O-C-N 122.351 -0.218 . . . . 0.46999999999999997 110.468 171.506 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -75.64 -43.82 45.79 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.681 0.277 . . . . 2.0699999999999998 111.607 178.345 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -152.12 132.55 13.78 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.326 -0.397 . . . . 2.48 111.251 -175.712 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -125.8 134.81 51.58 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.241 0.543 . . . . 0.44 111.145 178.034 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.567 ' CG2' ' HB2' ' A' ' 80' ' ' PHE . 31.2 m -144.76 148.43 18.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.225 -0.898 . . . . 1.3799999999999999 112.485 -177.841 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.421 HG21 ' HA ' ' A' ' 47' ' ' SER . 42.4 t -119.3 138.92 48.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.241 -0.89 . . . . 0.48999999999999999 110.027 171.844 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.536 HG12 ' HA2' ' A' ' 79' ' ' GLY . 26.2 mm -91.91 153.71 3.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 114.898 -1.046 . . . . 0.71999999999999997 110.441 -173.743 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 18.8 p . . . . . 0 N--CA 1.445 -0.705 0 N-CA-C 105.228 -2.138 . . . . 1.52 105.228 -170.57 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 14.9 m . . . . . 0 N--CA 1.453 -0.281 0 CA-C-O 120.791 0.329 . . . . 1.8100000000000001 110.403 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 26.7 mtm180 -69.58 -5.94 27.79 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.866 -0.606 . . . . 2.5600000000000001 112.066 -175.518 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 77.98 9.63 86.8 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 119.88 -1.152 . . . . 0.64000000000000001 111.082 -177.168 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.568 ' HD1' ' HA3' ' A' ' 40' ' ' GLY . 20.7 m-85 -117.34 154.05 31.95 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 110.035 -0.357 . . . . 1.1799999999999999 110.035 -172.475 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.536 ' HA2' HG12 ' A' ' 67' ' ' ILE . . . -157.95 -167.3 18.69 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.388 -0.91 . . . . 0.58999999999999997 113.145 173.065 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.567 ' HB2' ' CG2' ' A' ' 65' ' ' VAL . 49.7 m-85 -139.5 141.2 37.35 Favored 'General case' 0 CA--C 1.513 -0.469 0 C-N-CA 123.462 0.705 . . . . 0.63 109.496 178.527 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 54.6 t -127.33 111.85 26.54 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 CA-C-O 121.308 0.575 . . . . 0.40999999999999998 109.931 175.422 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.735 ' HA ' ' O ' ' A' ' 35' ' ' THR . 29.3 m -109.19 112.43 24.59 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.467 -0.788 . . . . 0.46999999999999997 109.351 176.416 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.668 ' SD ' HG12 ' A' ' 61' ' ' ILE . 59.8 mmm -87.44 175.34 8.01 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 121.227 0.537 . . . . 0.88 111.639 -172.837 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.402 ' HB2' ' HE3' ' A' ' 84' ' ' LYS . 37.9 ttmt -82.7 -31.91 28.31 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.189 -0.914 . . . . 1.9199999999999999 110.826 -179.624 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -129.83 147.8 51.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.927 0.394 . . . . 1.6799999999999999 110.446 178.382 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.591 ' HD2' ' H ' ' A' ' 86' ' ' ARG . 0.7 OUTLIER -73.44 -19.74 60.89 Favored 'General case' 0 C--O 1.218 -0.566 0 CA-C-N 115.812 -0.631 . . . . 3.6600000000000001 112.105 -174.639 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.416 ' O ' ' HG3' ' A' ' 91' ' ' ARG . . . -67.04 -50.57 61.55 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 118.436 0.562 . . . . 0.66000000000000003 111.201 176.838 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.442 ' HA ' ' HD2' ' A' ' 91' ' ' ARG . 14.4 m -63.96 -33.5 75.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.887 0.851 . . . . 0.78000000000000003 109.36 175.88 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.518 ' HB3' ' HA ' ' A' ' 86' ' ' ARG . . . -58.23 -47.5 83.34 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 113.683 -1.599 . . . . 0.46000000000000002 110.011 173.713 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -60.69 -43.99 97.08 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.203 -0.453 . . . . 2.1099999999999999 111.237 173.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.567 ' O ' ' HB3' ' A' ' 94' ' ' LYS . 99.4 mtt180 -57.59 -42.59 83.47 Favored 'General case' 0 C--O 1.225 -0.227 0 CA-C-O 120.888 0.375 . . . . 3.8199999999999998 111.466 176.527 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.39 -36.67 83.05 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 111.874 0.324 . . . . 0.92000000000000004 111.874 173.56 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 35.7 t -78.71 -7.55 57.84 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.207 0.527 . . . . 1.1599999999999999 111.259 177.295 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.567 ' HB3' ' O ' ' A' ' 91' ' ' ARG . 16.1 tppt? -58.42 -48.36 80.92 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.628 -0.715 . . . . 4.2000000000000002 111.613 -177.562 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -110.35 121.81 40.4 Favored Pre-proline 0 C--N 1.325 -0.495 0 C-N-CA 120.744 -0.383 . . . . 2.2400000000000002 109.988 176.601 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -84.66 -1.76 9.65 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 122.902 2.402 . . . . 2.3799999999999999 114.287 -173.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.578 ' HB2' ' HD3' ' A' ' 104' ' ' LYS . 6.0 p30 -152.61 68.4 6.96 Favored Pre-proline 0 CA--C 1.534 0.333 0 CA-C-O 121.392 0.615 . . . . 3.0299999999999998 111.691 178.816 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -80.98 166.97 18.57 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 123.456 2.771 . . . . 1.29 111.686 179.387 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 47.2 mm -100.81 137.82 27.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 108.578 -0.897 . . . . 1.8100000000000001 108.578 178.743 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 54.7 mt -144.77 111.8 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 109.323 -0.621 . . . . 0.98999999999999999 109.323 -174.418 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.581 ' O ' ' HG2' ' A' ' 43' ' ' PRO . 16.8 t0 61.87 47.99 5.66 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 121.488 0.661 . . . . 1.3700000000000001 111.019 173.387 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 82.74 -5.76 73.25 Favored Glycine 0 CA--C 1.529 0.924 0 N-CA-C 116.29 1.276 . . . . 1.5600000000000001 116.29 178.552 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.439 ' CB ' ' HG3' ' A' ' 43' ' ' PRO . 23.8 ttt180 -137.93 150.97 47.51 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 118.933 1.367 . . . . 4.1299999999999999 111.106 -177.856 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.578 ' HD3' ' HB2' ' A' ' 97' ' ' ASN . 24.3 ttmm -78.88 139.8 38.24 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.46 -0.336 . . . . 2.73 110.37 178.52 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -111.59 154.17 25.23 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.947 -0.57 . . . . 1.04 111.138 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.462 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 46.6 t-20 -95.47 127.86 41.86 Favored 'General case' 0 C--O 1.252 1.224 0 N-CA-C 108.597 -0.89 . . . . 2.04 108.597 173.654 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.635 HG22 HG13 ' A' ' 39' ' ' VAL . 88.0 t -142.37 129.4 19.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 113.838 -1.528 . . . . 1.0600000000000001 110.45 -161.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -167.84 158.56 10.89 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.454 -0.572 . . . . 2.4900000000000002 109.454 178.038 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.592 HD11 ' HA ' ' A' ' 34' ' ' PHE . 0.2 OUTLIER -57.92 131.94 51.9 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 107.827 -1.175 . . . . 1.23 107.827 173.061 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.96 -30.93 68.42 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.514 -0.475 . . . . 0.91000000000000003 110.784 -162.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.443 ' HD1' HD12 ' A' ' 109' ' ' LEU . 4.0 p90 . . . . . 0 CA--C 1.534 0.347 0 CA-C-N 115.881 -0.6 . . . . 1.3999999999999999 111.42 -172.785 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 7.4 ttt . . . . . 0 N--CA 1.455 -0.215 0 CA-C-O 120.419 0.152 . . . . 1.49 111.085 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.601 ' HA ' HD11 ' A' ' 109' ' ' LEU . 40.7 m-85 -103.66 -24.23 13.39 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 111.859 0.318 . . . . 1.5 111.859 -178.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.548 ' O ' ' HA ' ' A' ' 82' ' ' THR . 57.7 p -78.91 -10.9 59.95 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.362 -0.535 . . . . 0.53000000000000003 110.446 -174.746 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 47.1 tttm -88.23 106.43 18.19 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 115.367 -0.833 . . . . 2.75 109.104 179.506 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 95.3 mt -104.6 134.89 44.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 116.051 -0.522 . . . . 0.84999999999999998 110.442 -179.209 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.628 ' CB ' ' HA ' ' A' ' 110' ' ' ALA . 82.5 t80 -99.02 121.31 40.8 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.397 -0.594 . . . . 0.70999999999999996 109.397 179.659 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.756 HG12 HD11 ' A' ' 42' ' ' LEU . 3.9 t -106.63 140.19 25.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.137 0.494 . . . . 0.92000000000000004 110.477 -174.425 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -140.76 152.68 23.23 Favored Glycine 0 N--CA 1.452 -0.275 0 CA-C-N 115.29 -0.868 . . . . 0.83999999999999997 113.423 -167.028 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.08 40.66 95.17 Favored Glycine 0 C--O 1.228 -0.263 0 C-N-CA 121.635 -0.317 . . . . 0.68000000000000005 113.298 172.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.756 HD11 HG12 ' A' ' 39' ' ' VAL . 7.1 mp -82.38 134.71 47.97 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-O 120.861 0.363 . . . . 1.28 110.86 179.111 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.591 ' HG3' ' HG3' ' A' ' 103' ' ' ARG . 50.6 Cg_exo -52.91 153.4 15.3 Favored 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.709 2.273 . . . . 0.57999999999999996 111.379 172.292 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.601 ' HA ' ' HB3' ' A' ' 75' ' ' SER . 20.6 m-85 -67.49 -7.38 25.15 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 113.292 0.849 . . . . 1.05 113.292 -170.821 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -111.98 2.51 16.94 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 120.409 -0.516 . . . . 2.0099999999999998 111.168 176.38 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.693 HG23 HG21 ' A' ' 50' ' ' THR . 38.4 m -74.39 134.59 42.42 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.284 -0.416 . . . . 0.71999999999999997 110.405 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 10.4 p -136.35 -176.85 4.47 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-O 121.507 0.67 . . . . 0.55000000000000004 112.053 -171.084 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -60.46 -36.26 77.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.825 -1.08 . . . . 0.48999999999999999 110.76 -173.17 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.54 ' O ' ' HG2' ' A' ' 53' ' ' GLU . 9.2 ptmm? -65.15 -36.99 85.98 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.461 -0.79 . . . . 2.7599999999999998 110.855 178.693 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.693 HG21 HG23 ' A' ' 46' ' ' THR . 88.0 m -62.07 -45.95 91.27 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.085 0.469 . . . . 0.57999999999999996 110.922 179.104 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.464 HD21 HG11 ' A' ' 39' ' ' VAL . 98.2 mt -68.33 -34.71 76.59 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.77 -0.65 . . . . 0.84999999999999998 110.687 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.452 ' O ' ' HG2' ' A' ' 56' ' ' GLU . 55.6 t-80 -59.69 -53.82 53.51 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.111 0.481 . . . . 0.58999999999999997 109.966 178.225 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.54 ' HG2' ' O ' ' A' ' 49' ' ' LYS . 11.8 mm-40 -57.72 -44.03 85.69 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.618 -0.719 . . . . 1.52 112.628 -179.401 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.61 ' O ' ' HB2' ' A' ' 57' ' ' GLN . 67.8 t80 -76.48 -34.43 58.66 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.821 0.674 . . . . 1.1200000000000001 112.821 -174.585 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -84.69 -30.5 24.76 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 113.898 1.073 . . . . 0.56000000000000005 113.898 -171.738 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.452 ' HG2' ' O ' ' A' ' 52' ' ' HIS . 15.0 pt-20 -71.5 -12.04 61.18 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.842 0.83 . . . . 1.5700000000000001 110.003 177.625 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.61 ' HB2' ' O ' ' A' ' 54' ' ' TYR . 27.6 mm-40 -56.03 -24.84 41.78 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.037 -0.983 . . . . 2.1600000000000001 111.539 166.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -106.64 6.93 30.32 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 111.74 0.274 . . . . 0.70999999999999996 111.74 -177.298 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 146.48 -137.86 7.05 Favored Glycine 0 C--O 1.224 -0.529 0 C-N-CA 120.486 -0.864 . . . . 0.75 112.794 -176.301 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -114.04 127.14 55.81 Favored 'General case' 0 C--N 1.327 -0.372 0 O-C-N 122.661 -0.317 . . . . 1.02 110.874 -178.551 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.422 HG13 ' HB3' ' A' ' 56' ' ' GLU . 8.7 mt -94.24 126.9 46.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 110.116 -0.328 . . . . 0.46999999999999997 110.116 176.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -83.59 -48.72 9.92 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.581 -0.448 . . . . 2.0699999999999998 110.372 174.101 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -141.56 126.71 18.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.261 -0.427 . . . . 2.48 111.112 -176.41 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -123.23 123.75 41.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.059 0.457 . . . . 0.44 110.555 174.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 29.6 m -139.09 143.74 30.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.0 -1.0 . . . . 1.3799999999999999 112.141 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 70.4 t -115.08 139.54 40.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 108.761 -0.829 . . . . 0.48999999999999999 108.761 170.381 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 44.2 mm -91.1 95.06 5.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 N-CA-C 109.439 -0.578 . . . . 0.71999999999999997 109.439 -179.49 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.495 HG22 ' HA ' ' A' ' 75' ' ' SER . 9.1 p . . . . . 0 C--N 1.317 -0.813 0 CA-C-N 116.047 -0.524 . . . . 1.52 110.985 177.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.601 ' HB3' ' HA ' ' A' ' 44' ' ' TYR . 12.3 t . . . . . 0 N--CA 1.452 -0.335 0 CA-C-O 121.023 0.44 . . . . 1.8100000000000001 110.274 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 10.8 mtp180 -59.23 -11.76 4.41 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.505 -0.77 . . . . 2.5600000000000001 111.363 174.363 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 92.59 14.77 54.92 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.812 -0.709 . . . . 0.64000000000000001 113.113 175.053 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -128.41 141.0 51.54 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.422 -0.584 . . . . 1.1799999999999999 109.422 -178.611 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -138.65 -178.28 16.12 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.435 -0.888 . . . . 0.58999999999999997 111.865 179.632 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -152.03 130.08 11.85 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.386 -0.598 . . . . 0.63 109.386 -177.611 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 63.7 t -128.22 119.59 51.15 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 CA-C-N 115.813 -0.63 . . . . 0.40999999999999998 109.936 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.548 ' HA ' ' O ' ' A' ' 35' ' ' THR . 34.8 m -109.45 114.23 27.71 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.183 -1.043 . . . . 0.46999999999999997 108.183 177.379 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 87.8 mmm -87.94 168.71 12.63 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 122.078 -0.389 . . . . 0.88 110.012 -174.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -83.05 -16.34 47.43 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.272 -0.422 . . . . 1.9199999999999999 111.05 -176.629 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -147.97 148.69 31.03 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 120.813 0.339 . . . . 1.6799999999999999 110.607 -179.072 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -71.32 -20.84 62.14 Favored 'General case' 0 C--O 1.224 -0.246 0 N-CA-C 112.502 0.556 . . . . 3.6600000000000001 112.502 -174.612 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -71.61 -45.75 61.19 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 118.556 0.616 . . . . 0.66000000000000003 111.346 -179.226 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 19.4 m -63.37 -35.59 80.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.94 0.876 . . . . 0.78000000000000003 109.489 173.701 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.493 ' HB1' ' O ' ' A' ' 34' ' ' PHE . . . -58.79 -46.9 86.49 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 113.503 -1.681 . . . . 0.46000000000000002 109.824 174.645 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -57.37 -50.03 74.27 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.543 -0.753 . . . . 2.1099999999999999 112.276 174.513 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.539 ' O ' ' HB3' ' A' ' 94' ' ' LYS . 79.3 mtp180 -57.06 -46.0 82.8 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.817 0.341 . . . . 3.8199999999999998 111.457 -179.186 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -60.06 -40.34 89.14 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.154 -0.476 . . . . 0.92000000000000004 111.858 176.686 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 49.7 t -71.89 -17.1 62.13 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.294 0.569 . . . . 1.1599999999999999 110.449 177.141 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.539 ' HB3' ' O ' ' A' ' 91' ' ' ARG . 21.2 tptp -78.65 7.08 7.41 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.415 0.686 . . . . 4.2000000000000002 110.821 179.253 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -142.13 76.98 18.56 Favored Pre-proline 0 C--N 1.323 -0.565 0 O-C-N 121.616 -0.678 . . . . 2.2400000000000002 110.011 -176.744 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -73.43 156.11 50.32 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 123.095 2.53 . . . . 2.3799999999999999 111.945 -178.731 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.613 ' HA ' ' O ' ' A' ' 105' ' ' ALA . 1.9 p-10 34.35 64.14 1.73 Allowed Pre-proline 0 N--CA 1.471 0.615 0 O-C-N 124.166 0.916 . . . . 3.0299999999999998 113.073 -171.449 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.403 ' HB2' ' OH ' ' A' ' 54' ' ' TYR . 92.5 Cg_endo -82.21 167.43 15.78 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 123.063 2.509 . . . . 1.29 111.714 178.554 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 49.6 mm -89.53 130.74 38.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 116.281 -0.418 . . . . 1.8100000000000001 110.097 178.331 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 56.5 mt -146.57 139.67 20.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.801 -0.636 . . . . 0.98999999999999999 109.326 -175.728 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 42.7 t0 44.93 42.47 6.26 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 113.134 0.79 . . . . 1.3700000000000001 113.134 177.249 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 70.45 17.98 74.97 Favored Glycine 0 CA--C 1.524 0.626 0 C-N-CA 121.128 -0.558 . . . . 1.5600000000000001 113.619 177.123 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.591 ' HG3' ' HG3' ' A' ' 43' ' ' PRO . 30.6 mmt180 -143.23 162.38 35.79 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.372 -0.603 . . . . 4.1299999999999999 109.372 -179.487 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -80.64 134.52 35.89 Favored 'General case' 0 C--N 1.317 -0.845 0 C-N-CA 120.108 -0.637 . . . . 2.73 109.757 171.611 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.613 ' O ' ' HA ' ' A' ' 97' ' ' ASN . . . -121.67 165.11 16.26 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 107.738 -1.208 . . . . 1.04 107.738 -177.21 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 44.4 t30 -116.38 110.57 18.85 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 120.344 -0.542 . . . . 2.04 110.375 177.776 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 88.5 t -116.38 139.9 41.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 120.981 0.42 . . . . 1.0600000000000001 111.611 176.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -162.98 173.75 13.22 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 107.929 -1.137 . . . . 2.4900000000000002 107.929 175.215 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.601 HD11 ' HA ' ' A' ' 34' ' ' PHE . 0.2 OUTLIER -62.77 146.56 52.18 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.74 -0.837 . . . . 1.23 108.74 175.904 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.628 ' HA ' ' CB ' ' A' ' 38' ' ' PHE . . . -68.47 -40.61 80.95 Favored 'General case' 0 CA--C 1.512 -0.484 0 C-N-CA 120.634 -0.427 . . . . 0.91000000000000003 111.305 -169.8 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 9.7 p90 . . . . . 0 C--N 1.323 -0.554 0 CA-C-N 116.186 -0.461 . . . . 1.3999999999999999 111.04 -173.376 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 46.7 ttp . . . . . 0 C--O 1.227 -0.1 0 N-CA-C 108.326 -0.99 . . . . 1.49 108.326 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.482 ' HB3' ' HB2' ' A' ' 86' ' ' ARG . 20.4 m-85 123.79 -176.12 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 127.339 2.256 . . . . 1.5 106.918 -173.431 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.515 ' HA ' ' HB2' ' A' ' 89' ' ' ALA . 34.6 p 61.22 -40.79 0.12 Allowed 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 114.384 1.253 . . . . 0.53000000000000003 114.384 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -80.07 112.56 17.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.286 0.565 . . . . 2.75 110.511 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.529 ' CG2' HG13 ' A' ' 107' ' ' VAL . 82.8 mt -106.84 131.24 57.26 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 CA-C-N 115.514 -0.766 . . . . 0.84999999999999998 110.842 -178.306 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -86.87 120.12 27.82 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.117 -0.697 . . . . 0.70999999999999996 109.117 177.726 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.909 HG12 HD11 ' A' ' 42' ' ' LEU . 5.3 t -112.21 139.91 34.48 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-O 121.514 0.673 . . . . 0.92000000000000004 111.15 -175.705 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -144.76 157.01 27.14 Favored Glycine 0 C--O 1.225 -0.421 0 CA-C-N 114.757 -1.111 . . . . 0.83999999999999997 113.422 -171.256 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 71.05 34.97 64.63 Favored Glycine 0 C--O 1.227 -0.296 0 C-N-CA 121.31 -0.472 . . . . 0.68000000000000005 113.549 172.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.909 HD11 HG12 ' A' ' 39' ' ' VAL . 6.8 mp -83.5 134.17 45.68 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-O 120.744 0.307 . . . . 1.28 111.228 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.602 ' HG3' ' CG ' ' A' ' 103' ' ' ARG . 52.8 Cg_exo -52.05 158.26 5.17 Favored 'Trans proline' 0 N--CA 1.461 -0.394 0 C-N-CA 122.92 2.413 . . . . 0.57999999999999996 111.792 173.057 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -72.53 3.83 4.51 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.933 0.397 . . . . 1.05 111.207 -178.225 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 80.3 t60 -112.07 -8.92 14.01 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.057 -0.519 . . . . 2.0099999999999998 110.943 178.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.564 ' CG2' HD23 ' A' ' 42' ' ' LEU . 12.5 m -77.6 125.88 30.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.994 0.426 . . . . 0.71999999999999997 111.805 -176.356 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 6.5 p -121.08 -178.32 3.73 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.903 -0.59 . . . . 0.55000000000000004 111.243 -176.48 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -59.19 -34.81 72.58 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 115.841 -0.618 . . . . 0.48999999999999999 109.863 -176.74 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.588 ' HG3' ' N ' ' A' ' 50' ' ' THR . 12.3 pttp -62.13 -39.5 92.76 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.322 -0.854 . . . . 2.7599999999999998 110.133 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.588 ' N ' ' HG3' ' A' ' 49' ' ' LYS . 15.1 m -68.27 -41.08 81.6 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 116.381 -0.372 . . . . 0.57999999999999996 110.518 -176.105 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.517 HD21 HG11 ' A' ' 39' ' ' VAL . 65.7 mt -63.66 -35.96 82.26 Favored 'General case' 0 C--O 1.222 -0.355 0 C-N-CA 120.434 -0.506 . . . . 0.84999999999999998 110.207 174.759 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 59.2 t-80 -67.28 -51.12 56.66 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.475 -0.49 . . . . 0.58999999999999997 110.089 179.099 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.504 ' HG3' ' O ' ' A' ' 49' ' ' LYS . 42.4 mt-10 -55.88 -43.76 77.5 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.729 0.299 . . . . 1.52 111.574 -179.554 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.503 ' O ' ' HB2' ' A' ' 57' ' ' GLN . 4.7 t80 -75.79 -35.13 60.17 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.353 -0.385 . . . . 1.1200000000000001 111.609 -176.124 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.44 ' HD1' ' O ' ' A' ' 51' ' ' LEU . 45.9 m-85 -86.82 -28.24 23.05 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 114.126 1.158 . . . . 0.56000000000000005 114.126 -172.66 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.706 ' N ' HD11 ' A' ' 61' ' ' ILE . 15.0 pt-20 -70.54 -15.93 62.83 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 122.395 1.093 . . . . 1.5700000000000001 109.236 -178.639 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.503 ' HB2' ' O ' ' A' ' 54' ' ' TYR . 70.1 mt-30 -53.72 -27.78 30.23 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 113.481 -1.69 . . . . 2.1600000000000001 112.174 168.438 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -100.17 -13.67 18.84 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.156 -0.475 . . . . 0.70999999999999996 110.387 -177.572 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.514 ' O ' ' HA ' ' A' ' 56' ' ' GLU . . . 144.57 -155.54 26.41 Favored Glycine 0 N--CA 1.448 -0.505 0 CA-C-N 115.658 -0.701 . . . . 0.75 112.115 175.09 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -64.32 123.34 18.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.109 0.481 . . . . 1.02 112.29 -179.034 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.706 HD11 ' N ' ' A' ' 56' ' ' GLU . 10.0 mt -101.61 123.92 55.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 108.208 -1.034 . . . . 0.46999999999999997 108.208 172.293 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -79.74 -44.08 21.4 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.308 0.575 . . . . 2.0699999999999998 110.406 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -148.65 130.52 15.19 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.658 -0.701 . . . . 2.48 110.675 -179.458 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -117.45 115.83 25.96 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.067 -0.515 . . . . 0.44 110.086 174.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.1 p -137.11 135.31 47.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.446 -0.797 . . . . 1.3799999999999999 112.065 -177.72 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 89.8 t -98.91 132.81 43.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.498 -0.774 . . . . 0.48999999999999999 109.033 172.092 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.624 ' H ' ' HA2' ' A' ' 79' ' ' GLY . 36.6 mm -74.87 84.36 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.826 0.822 . . . . 0.71999999999999997 109.479 177.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.66 ' HA ' ' O ' ' A' ' 75' ' ' SER . 16.7 p . . . . . 0 N--CA 1.435 -1.222 0 CA-C-N 114.419 -1.264 . . . . 1.52 110.734 -177.754 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.66 ' O ' ' HA ' ' A' ' 68' ' ' THR . 58.3 p . . . . . 0 N--CA 1.469 0.514 0 N-CA-C 112.332 0.493 . . . . 1.8100000000000001 112.332 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.554 ' HG3' ' O ' ' A' ' 75' ' ' SER . 46.0 mtt180 129.54 -50.31 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 126.964 2.106 . . . . 2.5600000000000001 110.137 -167.549 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 104.67 16.62 17.01 Favored Glycine 0 N--CA 1.454 -0.157 0 C-N-CA 120.675 -0.774 . . . . 0.64000000000000001 113.43 177.47 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -129.69 152.94 48.64 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.424 -0.954 . . . . 1.1799999999999999 108.424 177.626 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.624 ' HA2' ' H ' ' A' ' 67' ' ' ILE . . . -157.08 -166.31 16.43 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 119.854 -1.165 . . . . 0.58999999999999997 112.509 177.814 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.43 ' HD2' HD11 ' A' ' 67' ' ' ILE . 45.4 m-85 -159.57 125.01 4.16 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 123.563 0.745 . . . . 0.63 109.216 -177.554 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 69.9 t -117.95 118.79 59.44 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 N-CA-C 109.669 -0.493 . . . . 0.40999999999999998 109.669 177.5 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 17.8 m -110.16 109.48 20.0 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 108.03 -1.1 . . . . 0.46999999999999997 108.03 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.464 ' HA ' ' HA ' ' A' ' 61' ' ' ILE . 44.1 mtp -88.25 166.56 14.25 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 110.138 -0.319 . . . . 0.88 110.138 -173.693 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.461 ' HB2' ' HZ2' ' A' ' 84' ' ' LYS . 4.3 ttmp? -74.28 -43.21 57.81 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.929 -0.308 . . . . 1.9199999999999999 111.376 -174.147 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -128.56 151.01 49.94 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-O 121.784 0.802 . . . . 1.6799999999999999 111.225 179.114 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.482 ' HB2' ' HB3' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -65.72 -23.06 66.67 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 114.421 -1.263 . . . . 3.6600000000000001 112.646 -172.153 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.25 -46.65 76.39 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 118.768 0.713 . . . . 0.66000000000000003 111.155 -179.299 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 18.2 m -64.86 -38.23 90.28 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.683 0.754 . . . . 0.78000000000000003 109.766 176.677 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.515 ' HB2' ' HA ' ' A' ' 35' ' ' THR . . . -58.41 -47.41 83.99 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 113.544 -1.662 . . . . 0.46000000000000002 109.691 176.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.59 ' O ' ' HG2' ' A' ' 94' ' ' LYS . 6.3 mm-40 -56.04 -50.88 69.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.12 -0.945 . . . . 2.1099999999999999 112.006 175.104 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 43.9 mtm180 -57.89 -43.66 86.25 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.518 0.199 . . . . 3.8199999999999998 111.165 -178.256 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -56.88 -37.1 70.89 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.934 -0.575 . . . . 0.92000000000000004 111.711 177.492 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 48.0 t -86.77 -13.41 45.27 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 112.677 0.621 . . . . 1.1599999999999999 112.677 -178.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.59 ' HG2' ' O ' ' A' ' 90' ' ' GLU . 72.5 mmtt -65.77 -43.75 87.91 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 120.888 0.375 . . . . 4.2000000000000002 110.751 -177.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -114.49 92.99 30.45 Favored Pre-proline 0 C--N 1.326 -0.441 0 N-CA-C 109.646 -0.501 . . . . 2.2400000000000002 109.646 176.066 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -81.09 -166.7 0.43 Allowed 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 122.735 2.29 . . . . 2.3799999999999999 112.649 -176.073 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.728 ' HA ' ' O ' ' A' ' 105' ' ' ALA . 22.7 m120 38.95 63.42 4.28 Favored Pre-proline 0 N--CA 1.467 0.396 0 N-CA-C 113.512 0.93 . . . . 3.0299999999999998 113.512 -173.372 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.452 ' HD3' ' N ' ' A' ' 97' ' ' ASN . 2.5 Cg_endo -81.54 143.44 13.59 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.775 2.317 . . . . 1.29 110.82 174.862 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 38.6 mm -81.22 90.25 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.301 0.572 . . . . 1.8100000000000001 109.827 178.345 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 31.1 mt -90.88 106.78 17.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 121.462 0.649 . . . . 0.98999999999999999 111.199 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.449 ' HB2' HG21 ' A' ' 50' ' ' THR . 35.6 t70 66.1 46.62 2.08 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 113.889 -1.505 . . . . 1.3700000000000001 110.147 166.051 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 91.23 -7.1 81.02 Favored Glycine 0 N--CA 1.451 -0.34 0 CA-C-N 114.94 -1.027 . . . . 1.5600000000000001 114.821 175.654 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.602 ' CG ' ' HG3' ' A' ' 43' ' ' PRO . 20.9 mmt180 -133.77 148.93 51.42 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 118.614 1.207 . . . . 4.1299999999999999 111.642 177.299 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -67.23 138.8 57.2 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.371 -0.831 . . . . 2.73 109.927 174.02 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.728 ' O ' ' HA ' ' A' ' 97' ' ' ASN . . . -124.57 150.87 45.44 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.042 -0.526 . . . . 1.04 109.856 -172.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -101.69 110.32 22.29 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 109.609 -0.515 . . . . 2.04 109.609 177.822 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.529 HG13 ' CG2' ' A' ' 37' ' ' ILE . 44.8 t -109.73 133.32 55.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.701 -0.681 . . . . 1.0600000000000001 111.057 174.198 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -158.65 163.45 36.89 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.856 -0.794 . . . . 2.4900000000000002 108.856 175.036 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.53 ' HB3' ' CD1' ' A' ' 111' ' ' TYR . 1.7 mm? -76.68 125.56 29.47 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.994 0.426 . . . . 1.23 110.709 -178.463 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.63 -25.83 65.93 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 113.314 0.857 . . . . 0.91000000000000003 113.314 -174.737 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.53 ' CD1' ' HB3' ' A' ' 109' ' ' LEU . 2.6 p90 . . . . . 0 N--CA 1.468 0.429 0 CA-C-O 120.966 0.412 . . . . 1.3999999999999999 111.295 -174.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 50.7 ttp . . . . . 0 CA--C 1.53 0.209 0 N-CA-C 112.461 0.541 . . . . 1.49 112.461 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.486 ' O ' HD11 ' A' ' 109' ' ' LEU . 39.4 m-85 -96.25 -11.73 25.58 Favored 'General case' 0 C--O 1.224 -0.256 0 O-C-N 121.911 -0.493 . . . . 1.5 111.253 -177.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.531 ' O ' ' HA ' ' A' ' 82' ' ' THR . 39.3 p -105.28 4.49 31.09 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 111.989 0.366 . . . . 0.53000000000000003 111.989 -173.845 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -92.83 102.5 14.88 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.322 -0.399 . . . . 2.75 110.046 -178.623 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.414 HG23 ' O ' ' A' ' 108' ' ' ASN . 4.0 mp -103.42 135.33 41.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.76 0.314 . . . . 0.84999999999999998 110.674 -177.748 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -94.78 109.38 21.35 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.412 -0.588 . . . . 0.70999999999999996 109.412 175.693 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.572 HG11 HD11 ' A' ' 51' ' ' LEU . 5.5 t -97.89 142.94 13.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-N 115.469 -0.787 . . . . 0.92000000000000004 110.634 -176.9 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -143.27 161.01 27.66 Favored Glycine 0 N--CA 1.447 -0.624 0 CA-C-N 114.538 -1.21 . . . . 0.83999999999999997 111.717 -171.44 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 71.18 21.62 78.47 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.892 -0.671 . . . . 0.68000000000000005 113.259 175.403 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.608 HD11 HD13 ' A' ' 51' ' ' LEU . 2.9 mm? -67.02 119.3 63.17 Favored Pre-proline 0 C--O 1.223 -0.319 0 N-CA-C 109.094 -0.706 . . . . 1.28 109.094 175.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.672 ' CG ' ' HB3' ' A' ' 101' ' ' ASP . 11.9 Cg_endo -56.3 158.87 14.17 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.372 2.048 . . . . 0.57999999999999996 111.232 175.341 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -71.98 2.46 5.62 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.896 0.379 . . . . 1.05 111.649 -171.028 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 18.1 t-160 -95.7 -16.88 21.7 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.059 -0.519 . . . . 2.0099999999999998 110.136 174.585 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.532 HG21 HD12 ' A' ' 42' ' ' LEU . 67.9 m -79.4 116.75 19.82 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.445 0.641 . . . . 0.71999999999999997 112.278 -174.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 42.1 p -99.81 -177.64 3.62 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.31 -0.859 . . . . 0.55000000000000004 110.19 172.735 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.555 ' HA ' HG23 ' A' ' 66' ' ' VAL . 4.6 m-20 -61.25 -35.1 76.34 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.453 0.644 . . . . 0.48999999999999999 110.105 -178.091 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.654 ' O ' ' HG2' ' A' ' 53' ' ' GLU . 0.6 OUTLIER -74.52 -38.23 62.85 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.317 -0.856 . . . . 2.7599999999999998 110.595 -178.56 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.454 ' HB ' HG23 ' A' ' 46' ' ' THR . 17.0 m -62.4 -43.17 99.45 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.267 0.556 . . . . 0.57999999999999996 110.051 177.482 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.608 HD13 HD11 ' A' ' 42' ' ' LEU . 22.1 tp -66.15 -37.58 86.02 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 115.547 -0.751 . . . . 0.84999999999999998 109.796 177.458 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 48.7 t-80 -58.44 -53.1 62.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.617 -0.719 . . . . 0.58999999999999997 110.841 175.749 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.654 ' HG2' ' O ' ' A' ' 49' ' ' LYS . 21.3 mm-40 -58.14 -42.33 85.61 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.128 -0.487 . . . . 1.52 111.529 -177.451 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.448 ' O ' ' HB2' ' A' ' 57' ' ' GLN . 6.2 t80 -74.76 -33.61 62.35 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.16 -0.473 . . . . 1.1200000000000001 111.762 -174.604 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.658 ' CB ' HD11 ' A' ' 61' ' ' ILE . 4.9 m-85 -86.2 -26.09 25.27 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 114.043 1.127 . . . . 0.56000000000000005 114.043 -176.611 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.447 ' HA ' ' O ' ' A' ' 59' ' ' GLY . 7.9 pt-20 -72.78 -11.78 60.75 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 122.109 0.957 . . . . 1.5700000000000001 109.553 179.5 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.448 ' HB2' ' O ' ' A' ' 54' ' ' TYR . 13.4 mm100 -55.69 -19.33 10.45 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.505 -1.225 . . . . 2.1600000000000001 111.602 166.521 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -105.9 10.87 32.31 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.618 0.247 . . . . 0.70999999999999996 110.786 -178.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.447 ' O ' ' HA ' ' A' ' 56' ' ' GLU . . . 125.61 -171.09 17.49 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.79 -0.719 . . . . 0.75 112.664 -177.03 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.4 ' CB ' ' HB3' ' A' ' 84' ' ' LYS . 0.8 OUTLIER -65.51 123.05 18.63 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.799 0.666 . . . . 1.02 112.799 -179.142 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.658 HD11 ' CB ' ' A' ' 55' ' ' PHE . 10.1 mt -93.52 122.81 45.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.168 -0.924 . . . . 0.46999999999999997 108.767 169.517 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -78.05 -41.47 35.43 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.234 0.54 . . . . 2.0699999999999998 110.078 177.484 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -162.56 131.05 4.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.695 -0.684 . . . . 2.48 110.756 -177.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -117.17 116.49 27.39 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.785 0.326 . . . . 0.44 110.192 177.008 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.2 m -126.9 112.42 28.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.663 0.744 . . . . 1.3799999999999999 111.819 -178.316 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.555 HG23 ' HA ' ' A' ' 48' ' ' ASP . 70.1 t -79.25 131.52 34.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.547 -0.751 . . . . 0.48999999999999999 109.591 179.017 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.609 ' H ' ' HA2' ' A' ' 79' ' ' GLY . 28.8 mm -71.48 140.67 17.84 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.697 0 N-CA-C 107.473 -1.306 . . . . 0.71999999999999997 107.473 175.329 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.88 ' HA ' ' O ' ' A' ' 75' ' ' SER . 15.2 p . . . . . 0 N--CA 1.441 -0.918 0 N-CA-C 107.343 -1.355 . . . . 1.52 107.343 -159.698 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.88 ' O ' ' HA ' ' A' ' 68' ' ' THR . 5.3 p . . . . . 0 C--O 1.216 -0.692 0 CA-C-O 118.659 -0.686 . . . . 1.8100000000000001 112.709 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.457 ' HB2' ' O ' ' A' ' 75' ' ' SER . 74.4 mtt180 112.23 -19.06 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 125.27 1.428 . . . . 2.5600000000000001 111.729 -170.188 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 81.78 12.62 81.18 Favored Glycine 0 CA--C 1.526 0.719 0 C-N-CA 120.049 -1.072 . . . . 0.64000000000000001 113.762 174.096 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -128.47 160.37 32.51 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.862 -0.792 . . . . 1.1799999999999999 108.862 -177.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.609 ' HA2' ' H ' ' A' ' 67' ' ' ILE . . . 178.57 145.12 5.93 Favored Glycine 0 C--O 1.222 -0.651 0 C-N-CA 119.424 -1.37 . . . . 0.58999999999999997 113.648 175.429 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.476 ' HD2' HD11 ' A' ' 67' ' ' ILE . 96.4 m-85 -98.67 137.62 37.03 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 122.188 0.994 . . . . 0.63 112.495 175.43 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 65.0 t -119.91 134.03 64.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 114.234 -1.348 . . . . 0.40999999999999998 109.526 176.279 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.531 ' HA ' ' O ' ' A' ' 35' ' ' THR . 27.0 m -114.83 123.95 50.51 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 108.596 -0.891 . . . . 0.46999999999999997 108.596 175.712 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.424 ' SD ' HG12 ' A' ' 61' ' ' ILE . 82.2 mmm -88.68 164.3 15.38 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.937 -0.764 . . . . 0.88 108.937 -178.475 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.448 ' HB2' ' HZ2' ' A' ' 84' ' ' LYS . 4.3 ttmp? -82.66 -18.27 41.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.173 0.511 . . . . 1.9199999999999999 110.454 -176.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -143.03 146.91 34.29 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.158 -0.474 . . . . 1.6799999999999999 109.85 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.571 ' O ' ' HG3' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -64.96 -25.17 67.76 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.051 0.389 . . . . 3.6600000000000001 112.051 -178.821 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.524 ' O ' ' HG2' ' A' ' 91' ' ' ARG . . . -64.45 -44.98 89.39 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 121.621 -0.674 . . . . 0.66000000000000003 111.743 178.344 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 18.3 m -66.92 -32.18 73.26 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.938 0.875 . . . . 0.78000000000000003 109.665 176.813 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.441 ' HB3' ' O ' ' A' ' 86' ' ' ARG . . . -59.76 -47.03 87.33 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 113.652 -1.613 . . . . 0.46000000000000002 109.596 175.781 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.571 ' HG3' ' O ' ' A' ' 86' ' ' ARG . 45.6 mt-10 -56.05 -50.84 69.83 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.751 -0.659 . . . . 2.1099999999999999 111.385 174.231 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.524 ' HG2' ' O ' ' A' ' 87' ' ' ALA . 2.0 mmt180 -57.88 -44.87 86.95 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.672 0.272 . . . . 3.8199999999999998 111.337 -177.318 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -55.79 -41.38 74.01 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.889 -0.596 . . . . 0.92000000000000004 111.157 176.589 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 44.1 t -70.44 -20.14 62.92 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.598 -0.274 . . . . 1.1599999999999999 111.676 178.723 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -76.61 7.28 4.72 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 112.412 0.523 . . . . 4.2000000000000002 112.412 -178.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -144.01 93.09 6.13 Favored Pre-proline 0 C--N 1.322 -0.613 0 N-CA-C 108.633 -0.877 . . . . 2.2400000000000002 108.633 -178.534 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -74.66 -28.87 9.45 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.499 2.133 . . . . 2.3799999999999999 113.742 -172.151 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.537 ' HA ' ' O ' ' A' ' 105' ' ' ALA . 10.5 m120 -130.99 79.02 72.35 Favored Pre-proline 0 C--N 1.33 -0.25 0 N-CA-C 112.133 0.42 . . . . 3.0299999999999998 112.133 -175.62 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.411 ' HB2' ' CE1' ' A' ' 54' ' ' TYR . 73.1 Cg_endo -81.57 141.32 12.34 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.755 2.304 . . . . 1.29 111.875 174.365 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 42.0 mm -83.32 90.07 2.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.139 0.495 . . . . 1.8100000000000001 110.865 177.492 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 53.8 mt -92.96 135.31 28.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.601 -0.727 . . . . 0.98999999999999999 111.148 175.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.672 ' HB3' ' CG ' ' A' ' 43' ' ' PRO . 38.8 t70 43.21 35.86 0.91 Allowed 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 115.733 -0.667 . . . . 1.3700000000000001 112.477 -174.647 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 73.49 18.74 79.51 Favored Glycine 0 CA--C 1.519 0.306 0 C-N-CA 120.8 -0.714 . . . . 1.5600000000000001 113.03 178.543 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 5.4 tpt180 -129.77 139.78 51.21 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.722 -0.844 . . . . 4.1299999999999999 108.722 178.564 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 6.6 ttpm? -71.37 140.23 50.1 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.795 0.331 . . . . 2.73 110.171 179.311 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.537 ' O ' ' HA ' ' A' ' 97' ' ' ASN . . . -123.66 166.07 16.14 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.512 -0.313 . . . . 1.04 110.804 -171.524 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -111.65 146.54 37.26 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.038 -0.528 . . . . 2.04 110.34 -178.589 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 73.2 t -145.46 135.69 18.73 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 115.719 -0.673 . . . . 1.0600000000000001 110.95 -173.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.414 ' O ' HG23 ' A' ' 37' ' ' ILE . 3.4 p-10 -167.17 161.87 14.82 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 109.6 -0.518 . . . . 2.4900000000000002 109.6 173.797 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.486 HD11 ' O ' ' A' ' 34' ' ' PHE . 1.6 mm? -77.22 120.31 22.09 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.263 -0.643 . . . . 1.23 109.263 173.259 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -56.19 -36.23 68.16 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.545 0.572 . . . . 0.91000000000000003 112.545 -172.069 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 5.6 p90 . . . . . 0 C--N 1.327 -0.408 0 C-N-CA 120.854 -0.338 . . . . 1.3999999999999999 111.537 -174.967 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 13.8 tmm? . . . . . 0 CA--C 1.531 0.239 0 N-CA-C 111.851 0.315 . . . . 1.49 111.851 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.552 ' O ' HD11 ' A' ' 109' ' ' LEU . 18.2 m-85 -92.96 -13.43 28.81 Favored 'General case' 0 C--O 1.225 -0.201 0 O-C-N 122.013 -0.429 . . . . 1.5 111.482 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.52 ' HB ' ' O ' ' A' ' 83' ' ' MET . 31.7 p -94.38 -6.09 44.97 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.998 0.428 . . . . 0.53000000000000003 111.102 -174.857 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.456 ' O ' HD13 ' A' ' 109' ' ' LEU . 13.8 tptm -84.67 103.7 14.01 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.789 -0.641 . . . . 2.75 110.357 -177.092 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.635 HD11 ' HA ' ' A' ' 89' ' ' ALA . 28.7 mt -98.78 139.03 21.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 121.339 0.59 . . . . 0.84999999999999998 112.486 -174.226 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.419 ' HD1' ' CE2' ' A' ' 80' ' ' PHE . 68.8 t80 -105.59 111.76 24.58 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.31 -0.859 . . . . 0.70999999999999996 108.976 174.538 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.42 HG13 HG22 ' A' ' 107' ' ' VAL . 5.3 t -99.29 139.34 21.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.068 0.461 . . . . 0.92000000000000004 110.042 -178.803 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -140.53 138.11 8.76 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.268 -0.968 . . . . 0.83999999999999997 113.396 -170.68 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 84.9 31.15 24.32 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 121.486 -0.388 . . . . 0.68000000000000005 112.498 176.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.69 HD12 HG21 ' A' ' 46' ' ' THR . 3.3 mm? -67.24 129.15 93.86 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-O 120.564 0.221 . . . . 1.28 110.809 178.613 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.546 ' HG3' ' HB2' ' A' ' 103' ' ' ARG . 65.5 Cg_exo -54.97 159.73 9.0 Favored 'Trans proline' 0 CA--C 1.529 0.271 0 C-N-CA 123.448 2.765 . . . . 0.57999999999999996 112.923 172.868 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.689 ' HA ' ' HB2' ' A' ' 75' ' ' SER . 6.8 m-30 -69.18 -9.67 54.04 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.738 -0.664 . . . . 1.05 112.486 -174.146 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' HIS . . . . . 0.414 ' HB3' ' OD2' ' A' ' 101' ' ' ASP . 44.5 t60 -104.23 -1.18 27.47 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.054 0.454 . . . . 2.0099999999999998 110.368 178.771 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.69 HG21 HD12 ' A' ' 42' ' ' LEU . 85.3 m -73.3 116.4 13.8 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.639 0.733 . . . . 0.71999999999999997 111.362 -177.631 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 6.1 p -110.74 -178.91 3.6 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.631 -1.168 . . . . 0.55000000000000004 110.503 176.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -62.36 -35.94 80.71 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.334 0.588 . . . . 0.48999999999999999 110.284 -175.104 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.667 ' O ' ' HG2' ' A' ' 53' ' ' GLU . 43.0 pttt -65.13 -35.13 80.14 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.336 -0.847 . . . . 2.7599999999999998 110.821 179.498 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 6.4 m -67.51 -44.8 77.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.551 -0.295 . . . . 0.57999999999999996 111.049 -178.632 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.675 HD21 HD11 ' A' ' 42' ' ' LEU . 22.1 mt -64.99 -33.99 77.36 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-O 120.855 0.36 . . . . 0.84999999999999998 110.296 175.177 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.449 ' HA ' ' CD1' ' A' ' 61' ' ' ILE . 49.3 t-80 -64.95 -54.47 30.14 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 116.017 -0.538 . . . . 0.58999999999999997 110.453 -179.214 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.667 ' HG2' ' O ' ' A' ' 49' ' ' LYS . 13.6 mm-40 -56.41 -51.1 69.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.252 -0.431 . . . . 1.52 111.777 -179.123 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.536 ' O ' ' HB2' ' A' ' 57' ' ' GLN . 2.1 t80 -70.44 -33.31 71.17 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 112.765 0.654 . . . . 1.1200000000000001 112.765 -173.077 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.88 ' HB2' HD11 ' A' ' 61' ' ' ILE . 11.3 m-85 -85.44 -35.29 21.35 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 114.436 1.273 . . . . 0.56000000000000005 114.436 -172.05 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.626 ' HB3' HG13 ' A' ' 61' ' ' ILE . 13.5 pt-20 -77.99 -6.56 54.87 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 119.747 1.158 . . . . 1.5700000000000001 110.189 179.113 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.536 ' HB2' ' O ' ' A' ' 54' ' ' TYR . 73.3 mm-40 -57.41 -9.83 1.19 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.454 -0.794 . . . . 2.1600000000000001 112.028 162.369 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -104.3 -21.95 13.43 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.234 -0.439 . . . . 0.70999999999999996 109.99 177.205 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.51 ' HA3' ' OG ' ' A' ' 88' ' ' SER . . . 169.91 -116.28 0.64 Allowed Glycine 0 C--O 1.226 -0.398 0 CA-C-N 115.856 -0.611 . . . . 0.75 112.061 -179.486 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -115.36 128.1 55.85 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.942 0.371 . . . . 1.02 110.617 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.88 HD11 ' HB2' ' A' ' 55' ' ' PHE . 25.5 mt -97.13 124.27 49.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 109.776 -0.454 . . . . 0.46999999999999997 109.776 170.236 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -88.8 -32.02 18.06 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.161 0.505 . . . . 2.0699999999999998 110.257 178.423 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -161.06 126.67 3.77 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.965 -0.561 . . . . 2.48 110.483 179.204 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -117.53 124.66 49.25 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.834 0.35 . . . . 0.44 110.209 171.03 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.3 p -141.4 112.63 3.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 121.956 0.884 . . . . 1.3799999999999999 111.991 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.525 HG22 HD12 ' A' ' 51' ' ' LEU . 23.0 t -79.37 129.06 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 CA-C-N 115.079 -0.964 . . . . 0.48999999999999999 108.77 177.218 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.564 ' H ' ' HA2' ' A' ' 79' ' ' GLY . 44.5 mm -73.7 85.39 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 CA-C-O 121.699 0.761 . . . . 0.71999999999999997 109.714 -178.515 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.656 HG22 ' HA ' ' A' ' 75' ' ' SER . 23.9 p . . . . . 0 C--N 1.31 -1.149 0 CA-C-N 114.652 -1.158 . . . . 1.52 110.438 178.478 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.689 ' HB2' ' HA ' ' A' ' 44' ' ' TYR . 15.5 m . . . . . 0 N--CA 1.464 0.253 0 N-CA-C 113.699 1.0 . . . . 1.8100000000000001 113.699 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.507 ' HD2' ' O ' ' A' ' 67' ' ' ILE . 14.4 mtt180 -56.08 -25.59 46.1 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 114.249 -1.341 . . . . 2.5600000000000001 111.903 177.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.476 ' HA2' ' O ' ' A' ' 42' ' ' LEU . . . 102.48 3.94 49.94 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.645 -0.788 . . . . 0.64000000000000001 111.633 -174.361 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 -114.84 146.99 40.47 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.663 -0.495 . . . . 1.1799999999999999 109.663 177.672 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.564 ' HA2' ' H ' ' A' ' 67' ' ' ILE . . . -170.08 140.85 6.25 Favored Glycine 0 C--O 1.224 -0.512 0 C-N-CA 120.525 -0.845 . . . . 0.58999999999999997 112.091 171.305 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.419 ' CE2' ' HD1' ' A' ' 38' ' ' PHE . 59.4 m-85 -103.84 144.94 30.83 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 122.26 1.029 . . . . 0.63 113.279 175.655 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 55.7 t -123.65 130.52 74.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 113.739 -1.573 . . . . 0.40999999999999998 109.216 176.119 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 19.2 m -110.59 106.23 15.43 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 107.827 -1.175 . . . . 0.46999999999999997 107.827 177.706 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.52 ' O ' ' HB ' ' A' ' 35' ' ' THR . 51.4 mtp -89.35 157.82 18.03 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 120.38 -0.528 . . . . 0.88 109.74 -175.121 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 23.1 tttm -84.01 -11.06 57.37 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.469 -0.332 . . . . 1.9199999999999999 111.746 -171.205 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -147.81 147.55 29.95 Favored 'General case' 0 C--O 1.245 0.864 0 CA-C-O 121.585 0.707 . . . . 1.6799999999999999 111.857 175.173 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 15.7 ptt180 -65.13 -28.05 69.15 Favored 'General case' 0 C--O 1.212 -0.908 0 CA-C-N 114.974 -1.012 . . . . 3.6600000000000001 113.471 -174.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.46 -50.46 65.29 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 119.554 1.07 . . . . 0.66000000000000003 111.629 -175.625 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.51 ' OG ' ' HA3' ' A' ' 59' ' ' GLY . 14.6 m -63.2 -39.69 95.35 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.474 0.654 . . . . 0.78000000000000003 110.231 177.092 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.635 ' HA ' HD11 ' A' ' 37' ' ' ILE . . . -59.37 -50.37 74.23 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 114.529 -1.214 . . . . 0.46000000000000002 110.49 178.172 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.688 ' O ' ' HG2' ' A' ' 94' ' ' LYS . 4.4 mm-40 -56.41 -50.73 70.79 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.034 -0.985 . . . . 2.1099999999999999 112.258 176.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -58.93 -45.86 89.38 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 111.914 0.339 . . . . 3.8199999999999998 111.914 -177.815 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -56.13 -35.15 66.8 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.006 0.431 . . . . 0.92000000000000004 111.099 177.006 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 36.8 t -76.47 -26.79 55.73 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.326 -0.397 . . . . 1.1599999999999999 112.0 176.322 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.688 ' HG2' ' O ' ' A' ' 90' ' ' GLU . 32.5 mmtm -72.97 -44.27 61.29 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 120.71 0.29 . . . . 4.2000000000000002 111.155 -175.735 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -112.12 89.45 11.96 Favored Pre-proline 0 C--N 1.324 -0.508 0 N-CA-C 109.502 -0.555 . . . . 2.2400000000000002 109.502 174.449 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.586 ' HB3' ' O ' ' A' ' 107' ' ' VAL . 73.5 Cg_endo -87.73 77.96 1.66 Allowed 'Trans proline' 0 N--CA 1.447 -1.221 0 C-N-CA 122.661 2.241 . . . . 2.3799999999999999 111.909 -176.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 30.7 m-80 -154.66 39.98 0.13 Allowed Pre-proline 0 CA--C 1.54 0.573 0 CA-C-N 116.1 -0.5 . . . . 3.0299999999999998 112.312 -175.659 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.696 ' HD2' ' O ' ' A' ' 105' ' ' ALA . 67.9 Cg_endo -72.36 121.4 7.44 Favored 'Trans proline' 0 C--N 1.352 0.762 0 CA-C-N 120.543 1.23 . . . . 1.29 112.646 -176.316 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 47.4 mm -71.85 91.49 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.966 0.889 . . . . 1.8100000000000001 110.547 173.542 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 72.7 mt -106.89 131.98 55.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 114.717 -1.129 . . . . 0.98999999999999999 110.309 -179.082 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.535 ' HB3' ' HG2' ' A' ' 43' ' ' PRO . 25.9 t70 45.07 30.0 0.55 Allowed 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 113.337 0.866 . . . . 1.3700000000000001 113.337 178.248 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 86.88 21.66 49.33 Favored Glycine 0 CA--C 1.521 0.437 0 C-N-CA 120.497 -0.858 . . . . 1.5600000000000001 113.034 177.63 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.546 ' HB2' ' HG3' ' A' ' 43' ' ' PRO . 83.0 mmt-85 -138.81 151.74 47.29 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.116 -0.698 . . . . 4.1299999999999999 109.116 177.838 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -95.99 106.15 18.27 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 119.298 -0.961 . . . . 2.73 109.284 172.41 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.696 ' O ' ' HD2' ' A' ' 98' ' ' PRO . . . -86.37 167.27 14.89 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.482 0.658 . . . . 1.04 112.432 174.7 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -114.15 128.92 56.59 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.02 -0.991 . . . . 2.04 110.147 -177.808 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.586 ' O ' ' HB3' ' A' ' 96' ' ' PRO . 57.5 t -119.61 147.99 22.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.418 -0.355 . . . . 1.0600000000000001 110.542 -175.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -160.53 172.97 16.24 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.579 0.228 . . . . 2.4900000000000002 110.593 177.227 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.552 HD11 ' O ' ' A' ' 34' ' ' PHE . 0.6 OUTLIER -79.68 130.19 35.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.617 0.246 . . . . 1.23 110.408 179.401 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.52 -33.67 76.45 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.716 0.636 . . . . 0.91000000000000003 112.716 -174.003 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.419 ' HD1' HD12 ' A' ' 109' ' ' LEU . 7.1 p90 . . . . . 0 C--N 1.33 -0.254 0 CA-C-O 120.781 0.324 . . . . 1.3999999999999999 111.737 -173.741 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 59.9 ttp . . . . . 0 N--CA 1.454 -0.227 0 N-CA-C 111.648 0.24 . . . . 1.49 111.648 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.601 ' HA ' HD11 ' A' ' 109' ' ' LEU . 50.2 m-85 -103.47 -21.06 13.84 Favored 'General case' 0 C--O 1.226 -0.17 0 O-C-N 122.043 -0.41 . . . . 1.5 110.79 -177.688 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.757 ' O ' ' HA ' ' A' ' 82' ' ' THR . 28.7 p -84.8 14.21 5.01 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.303 0.573 . . . . 0.53000000000000003 110.631 -175.072 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.459 ' O ' HD13 ' A' ' 109' ' ' LEU . 6.9 ttpt -121.21 102.45 8.31 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.355 -0.839 . . . . 2.75 109.227 -173.093 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.5 HG22 HG23 ' A' ' 39' ' ' VAL . 5.3 mp -109.42 126.85 66.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 116.119 -0.491 . . . . 0.84999999999999998 111.042 -175.294 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.473 ' HD1' ' CZ ' ' A' ' 80' ' ' PHE . 80.3 t80 -85.76 115.83 23.65 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.487 -0.56 . . . . 0.70999999999999996 109.487 175.522 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.708 HG13 HG22 ' A' ' 107' ' ' VAL . 91.6 t -133.05 97.32 2.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-O 118.405 -0.807 . . . . 0.92000000000000004 110.282 -179.25 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.575 ' HA2' HD13 ' A' ' 42' ' ' LEU . . . -117.61 -156.24 10.34 Favored Glycine 0 C--O 1.215 -1.081 0 C-N-CA 115.838 -3.077 . . . . 0.83999999999999997 113.721 162.77 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 88.67 12.0 65.09 Favored Glycine 0 N--CA 1.45 -0.4 0 N-CA-C 110.032 -1.227 . . . . 0.68000000000000005 110.032 -171.635 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.575 HD13 ' HA2' ' A' ' 40' ' ' GLY . 7.7 mp -75.54 137.95 70.82 Favored Pre-proline 0 N--CA 1.447 -0.591 0 CA-C-N 114.626 -0.787 . . . . 1.28 110.716 -177.616 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.493 ' HG3' ' CG ' ' A' ' 103' ' ' ARG . 42.5 Cg_exo -55.33 159.89 9.65 Favored 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 123.029 2.486 . . . . 0.57999999999999996 111.678 173.304 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 44.1 m-85 -65.1 -22.16 66.91 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.165 0.431 . . . . 1.05 112.165 -175.112 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 23.0 t60 -86.09 -25.49 25.8 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 120.917 0.389 . . . . 2.0099999999999998 110.44 178.489 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.729 HG23 HG21 ' A' ' 50' ' ' THR . 19.1 m -66.91 130.08 41.98 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.704 -0.68 . . . . 0.71999999999999997 110.302 -176.421 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 9.0 p -137.33 -176.65 4.47 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.033 -0.53 . . . . 0.55000000000000004 111.871 -170.554 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -55.72 -35.4 66.07 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.559 -0.746 . . . . 0.48999999999999999 110.126 -176.213 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.678 ' O ' ' HG2' ' A' ' 53' ' ' GLU . 9.5 ptpp? -66.54 -36.85 83.68 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.045 -0.98 . . . . 2.7599999999999998 109.85 -177.053 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.729 HG21 HG23 ' A' ' 46' ' ' THR . 53.9 m -63.63 -45.56 89.72 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.797 -0.638 . . . . 0.57999999999999996 110.89 179.055 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.415 HD23 ' HA ' ' A' ' 51' ' ' LEU . 63.1 mt -67.85 -39.16 83.86 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.75 -0.659 . . . . 0.84999999999999998 111.237 -179.047 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 56.1 t-80 -55.31 -51.3 67.16 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.209 -0.451 . . . . 0.58999999999999997 109.972 175.567 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.678 ' HG2' ' O ' ' A' ' 49' ' ' LYS . 10.9 mm-40 -64.9 -47.88 76.2 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.832 -0.622 . . . . 1.52 112.489 -176.454 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.404 ' O ' ' HB2' ' A' ' 57' ' ' GLN . 66.1 t80 -77.35 -36.85 53.41 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 121.054 0.454 . . . . 1.1200000000000001 111.701 -170.839 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.578 ' CB ' HD11 ' A' ' 61' ' ' ILE . 14.3 m-85 -84.01 -25.81 29.64 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.655 0.613 . . . . 0.56000000000000005 112.655 -174.528 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.635 ' HA ' ' O ' ' A' ' 59' ' ' GLY . 6.1 pt-20 -70.77 -9.72 57.98 Favored 'General case' 0 N--CA 1.461 0.101 0 CA-C-O 121.487 0.66 . . . . 1.5700000000000001 109.872 178.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.404 ' HB2' ' O ' ' A' ' 54' ' ' TYR . 27.4 mm-40 -60.39 -25.84 66.2 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.091 -0.959 . . . . 2.1600000000000001 110.967 170.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -88.08 -28.74 21.13 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.31 0.576 . . . . 0.70999999999999996 110.036 178.791 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.635 ' O ' ' HA ' ' A' ' 56' ' ' GLU . . . 170.36 178.5 41.23 Favored Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 110.771 -0.932 . . . . 0.75 110.771 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -63.72 130.19 43.22 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 117.35 0.575 . . . . 1.02 109.65 -178.313 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.578 HD11 ' CB ' ' A' ' 55' ' ' PHE . 60.6 mt -97.72 125.74 50.82 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 110.376 -0.231 . . . . 0.46999999999999997 110.376 177.528 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -66.56 -42.04 87.7 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 121.111 0.481 . . . . 2.0699999999999998 110.721 177.639 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -161.97 142.28 10.3 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 115.457 -0.792 . . . . 2.48 111.061 -178.022 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -120.08 122.94 42.17 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.692 -0.685 . . . . 0.44 109.717 174.835 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.6 p -136.7 122.64 28.39 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-N 114.995 -1.002 . . . . 1.3799999999999999 112.566 -174.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 54.6 t -101.43 134.14 42.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.697 -0.683 . . . . 0.48999999999999999 109.423 173.441 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.482 ' O ' ' HB2' ' A' ' 76' ' ' ARG . 50.7 mm -86.08 100.43 9.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 121.192 0.52 . . . . 0.71999999999999997 110.271 -174.012 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.4 HG22 ' HA ' ' A' ' 75' ' ' SER . 20.2 p . . . . . 0 C--N 1.318 -0.775 0 CA-C-N 115.633 -0.712 . . . . 1.52 110.109 174.645 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.4 ' HA ' HG22 ' A' ' 68' ' ' THR . 13.7 m . . . . . 0 N--CA 1.457 -0.115 0 CA-C-O 120.903 0.382 . . . . 1.8100000000000001 111.331 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.482 ' HB2' ' O ' ' A' ' 67' ' ' ILE . 44.1 mtt180 -63.4 -18.99 64.29 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.912 -0.585 . . . . 2.5600000000000001 111.313 175.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 79.73 24.44 60.28 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.81 -0.709 . . . . 0.64000000000000001 113.389 173.16 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.475 ' HA ' ' CA ' ' A' ' 40' ' ' GLY . 14.0 m-85 -128.14 149.46 50.41 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 107.851 -1.166 . . . . 1.1799999999999999 107.851 176.373 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -145.35 -173.55 16.72 Favored Glycine 0 N--CA 1.441 -0.99 0 C-N-CA 119.753 -1.213 . . . . 0.58999999999999997 112.845 176.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.473 ' CZ ' ' HD1' ' A' ' 38' ' ' PHE . 59.1 m-85 -144.59 125.98 14.86 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 108.375 -0.972 . . . . 0.63 108.375 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 30.9 t -108.15 110.93 33.76 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 N-CA-C 109.464 -0.569 . . . . 0.40999999999999998 109.464 177.015 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.757 ' HA ' ' O ' ' A' ' 35' ' ' THR . 28.4 m -105.52 103.72 13.3 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.47 -0.937 . . . . 0.46999999999999997 108.47 177.459 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.44 ' HA ' ' HA ' ' A' ' 61' ' ' ILE . 48.6 mtp -89.16 173.8 8.22 Favored 'General case' 0 N--CA 1.448 -0.546 0 O-C-N 121.795 -0.565 . . . . 0.88 111.301 -170.371 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 23.2 tptt -69.52 -41.59 75.82 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.053 -0.522 . . . . 1.9199999999999999 110.502 -175.641 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -131.99 153.71 50.07 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 121.087 0.47 . . . . 1.6799999999999999 111.598 -178.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.495 ' H ' ' CD ' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -73.01 -20.76 60.94 Favored 'General case' 0 C--O 1.221 -0.399 0 CA-C-N 115.414 -0.812 . . . . 3.6600000000000001 112.681 -172.762 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.64 -49.97 68.93 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 118.336 0.516 . . . . 0.66000000000000003 111.403 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 15.3 m -70.45 -33.99 71.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.543 0.687 . . . . 0.78000000000000003 109.739 177.478 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.515 ' CB ' ' HA ' ' A' ' 35' ' ' THR . . . -56.85 -45.6 82.32 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-N 114.472 -1.24 . . . . 0.46000000000000002 109.658 174.656 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.602 ' O ' ' HG2' ' A' ' 94' ' ' LYS . 2.4 mm-40 -55.67 -45.59 77.69 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.618 -0.719 . . . . 2.1099999999999999 110.78 173.021 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 8.3 mmm180 -57.86 -42.09 83.77 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.715 0.293 . . . . 3.8199999999999998 111.007 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -58.03 -36.52 72.84 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.75 -0.659 . . . . 0.92000000000000004 111.631 176.56 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 37.2 t -84.16 -22.95 30.81 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 112.016 0.376 . . . . 1.1599999999999999 112.016 179.03 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.602 ' HG2' ' O ' ' A' ' 90' ' ' GLU . 67.8 mmtt -56.33 -48.32 76.98 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 112.742 0.645 . . . . 4.2000000000000002 112.742 -175.346 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.45 ' HA ' ' HD3' ' A' ' 96' ' ' PRO . 28.9 t0 -104.91 101.47 29.7 Favored Pre-proline 0 C--N 1.325 -0.462 0 C-N-CA 120.673 -0.411 . . . . 2.2400000000000002 110.507 -178.438 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 95' ' ' ASP . 5.7 Cg_exo -80.08 172.74 13.52 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 123.211 2.607 . . . . 2.3799999999999999 112.936 -175.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.474 ' N ' ' HD3' ' A' ' 98' ' ' PRO . 4.2 p30 31.91 62.45 1.24 Allowed Pre-proline 0 N--CA 1.473 0.707 0 CA-C-N 115.092 -0.958 . . . . 3.0299999999999998 113.489 -172.431 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.474 ' HD3' ' N ' ' A' ' 97' ' ' ASN . 2.0 Cg_endo -81.15 167.32 17.91 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 123.356 2.704 . . . . 1.29 111.28 176.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 51.0 mm -99.07 135.56 33.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 108.072 -1.084 . . . . 1.8100000000000001 108.072 178.038 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 71.6 mt -144.91 108.6 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 N-CA-C 109.453 -0.573 . . . . 0.98999999999999999 109.453 -172.656 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 19.1 t0 60.2 52.67 4.85 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.782 0.801 . . . . 1.3700000000000001 111.003 176.572 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 77.34 -6.99 40.83 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 115.653 1.021 . . . . 1.5600000000000001 115.653 177.405 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.493 ' CG ' ' HG3' ' A' ' 43' ' ' PRO . 27.2 mmt180 -131.62 150.49 52.13 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 118.919 1.36 . . . . 4.1299999999999999 111.106 -179.282 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -77.19 130.95 37.96 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.892 -0.594 . . . . 2.73 110.913 178.473 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -107.14 146.93 30.69 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.662 -0.699 . . . . 1.04 110.945 -175.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 39.3 m-20 -96.28 129.37 43.62 Favored 'General case' 0 C--O 1.251 1.163 0 CA-C-O 121.725 0.774 . . . . 2.04 110.011 173.103 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.708 HG22 HG13 ' A' ' 39' ' ' VAL . 73.3 t -142.26 131.28 22.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 112.942 -1.936 . . . . 1.0600000000000001 110.462 -161.611 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 8.4 m-20 -166.6 158.58 13.42 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 123.709 0.63 . . . . 2.4900000000000002 109.467 175.525 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.601 HD11 ' HA ' ' A' ' 34' ' ' PHE . 0.2 OUTLIER -58.16 150.16 22.06 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.19 -1.041 . . . . 1.23 108.19 172.35 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.51 -34.12 73.82 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.18 0.514 . . . . 0.91000000000000003 110.311 -168.797 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 16.6 p90 . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 115.583 -0.735 . . . . 1.3999999999999999 110.678 -176.368 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 55.5 ttp . . . . . 0 C--O 1.227 -0.092 0 N-CA-C 111.983 0.364 . . . . 1.49 111.983 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -96.36 -6.21 38.15 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.771 -0.371 . . . . 1.5 111.793 -177.1 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.679 ' O ' ' HA ' ' A' ' 82' ' ' THR . 34.2 p -102.78 -5.05 24.08 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.746 0.307 . . . . 0.53000000000000003 111.371 -176.867 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.612 ' HG3' ' HB3' ' A' ' 110' ' ' ALA . 18.4 tptm -92.67 101.49 13.9 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.274 0.559 . . . . 2.75 110.461 -175.297 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.429 HG22 HG23 ' A' ' 39' ' ' VAL . 32.8 mt -107.85 132.92 54.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.724 -0.671 . . . . 0.84999999999999998 110.449 -177.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.568 ' HD1' ' CE1' ' A' ' 80' ' ' PHE . 88.4 t80 -99.84 116.09 31.11 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.033 -0.728 . . . . 0.70999999999999996 109.033 173.454 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.649 HG22 HG22 ' A' ' 107' ' ' VAL . 95.7 t -132.31 106.22 10.55 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.886 0 CA-C-O 118.803 -0.618 . . . . 0.92000000000000004 110.067 -178.202 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.888 ' HA3' ' HD1' ' A' ' 78' ' ' TYR . . . -122.82 -154.74 9.14 Favored Glycine 0 N--CA 1.44 -1.073 0 C-N-CA 115.979 -3.01 . . . . 0.83999999999999997 113.267 159.322 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 85.62 8.02 80.93 Favored Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 110.265 -1.134 . . . . 0.68000000000000005 110.265 -174.307 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.739 ' HB3' ' HB ' ' A' ' 46' ' ' THR . 5.7 mp -69.55 135.57 88.37 Favored Pre-proline 0 N--CA 1.45 -0.448 0 CA-C-N 114.989 -0.605 . . . . 1.28 109.899 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 1.009 ' HG2' ' HB3' ' A' ' 101' ' ' ASP . 53.8 Cg_exo -49.88 158.85 1.89 Allowed 'Trans proline' 0 N--CA 1.463 -0.291 0 C-N-CA 123.146 2.564 . . . . 0.57999999999999996 112.128 174.419 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -66.72 -9.61 38.22 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 113.439 0.903 . . . . 1.05 113.439 -171.764 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 1.7 p80 -111.71 0.76 16.4 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.124 -0.631 . . . . 2.0099999999999998 110.77 176.425 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.739 ' HB ' ' HB3' ' A' ' 42' ' ' LEU . 5.8 m -79.53 118.52 21.46 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.504 -0.554 . . . . 0.71999999999999997 109.504 176.639 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.432 ' HA ' HG21 ' A' ' 66' ' ' VAL . 6.2 p -123.93 -177.95 3.91 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.116 -0.493 . . . . 0.55000000000000004 112.303 -168.469 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -54.19 -30.84 51.07 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.628 -0.715 . . . . 0.48999999999999999 110.79 -178.242 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.544 ' O ' ' HG2' ' A' ' 53' ' ' GLU . 23.2 pttm -74.92 -34.3 62.11 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.653 -0.703 . . . . 2.7599999999999998 109.842 -178.114 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.601 HG21 HG23 ' A' ' 46' ' ' THR . 6.1 m -67.12 -45.18 77.95 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 116.535 -0.302 . . . . 0.57999999999999996 110.514 -178.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.71 HD21 HD21 ' A' ' 42' ' ' LEU . 39.2 mt -62.07 -46.95 86.83 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-O 120.994 0.426 . . . . 0.84999999999999998 109.974 175.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.534 ' HA ' HD12 ' A' ' 61' ' ' ILE . 55.1 t-80 -55.95 -51.28 68.24 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 115.687 -0.688 . . . . 0.58999999999999997 110.574 179.388 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.544 ' HG2' ' O ' ' A' ' 49' ' ' LYS . 21.5 mm-40 -65.25 -36.54 84.45 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 112.311 0.486 . . . . 1.52 112.311 -176.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.7 ' O ' ' HB2' ' A' ' 57' ' ' GLN . 25.7 t80 -77.79 -34.87 52.04 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 118.128 0.422 . . . . 1.1200000000000001 111.594 -178.383 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.482 ' CD2' HG11 ' A' ' 81' ' ' VAL . 25.9 m-85 -84.91 -28.88 25.63 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 112.892 0.701 . . . . 0.56000000000000005 112.892 -175.636 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.583 ' HA ' ' O ' ' A' ' 59' ' ' GLY . 34.4 mm-40 -57.36 -24.72 57.04 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-O 122.563 1.173 . . . . 1.5700000000000001 109.413 174.872 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.7 ' HB2' ' O ' ' A' ' 54' ' ' TYR . 69.1 mt-30 -60.27 -31.68 70.46 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 112.971 -1.922 . . . . 2.1600000000000001 112.27 176.699 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.451 ' HD2' ' HA ' ' A' ' 55' ' ' PHE . 86.5 m-85 -89.12 -27.21 20.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.329 0.585 . . . . 0.70999999999999996 109.463 177.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.583 ' O ' ' HA ' ' A' ' 56' ' ' GLU . . . 162.47 -172.28 38.51 Favored Glycine 0 N--CA 1.443 -0.864 0 CA-C-N 115.006 -0.997 . . . . 0.75 111.697 177.702 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -64.73 126.26 27.37 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.707 0.289 . . . . 1.02 110.801 -177.676 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.534 HD12 ' HA ' ' A' ' 52' ' ' HIS . 8.2 mt -99.98 124.31 53.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.101 -0.703 . . . . 0.46999999999999997 109.101 177.295 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -78.97 -41.94 28.0 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.009 0.433 . . . . 2.0699999999999998 111.608 179.49 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.574 ' HB3' ' HB ' ' A' ' 82' ' ' THR . 8.7 tp10 -139.89 126.6 20.55 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.974 -0.557 . . . . 2.48 111.013 -172.786 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -127.89 125.84 40.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.679 0.752 . . . . 0.44 110.883 174.826 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.502 ' CG1' ' HB2' ' A' ' 80' ' ' PHE . 7.1 p -145.62 136.17 18.92 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 CA-C-N 114.546 -1.206 . . . . 1.3799999999999999 113.057 -178.098 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.432 HG21 ' HA ' ' A' ' 47' ' ' SER . 75.2 t -102.18 124.9 56.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.296 -0.865 . . . . 0.48999999999999999 108.855 167.251 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.548 HG12 ' HA2' ' A' ' 79' ' ' GLY . 35.2 mm -81.1 103.05 7.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.785 -0.643 . . . . 0.71999999999999997 110.672 -174.444 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 17.0 p . . . . . 0 C--N 1.316 -0.856 0 CA-C-N 115.326 -0.852 . . . . 1.52 110.638 176.772 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 35.2 t . . . . . 0 N--CA 1.453 -0.285 0 CA-C-O 121.291 0.567 . . . . 1.8100000000000001 110.479 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.412 ' HB2' ' O ' ' A' ' 67' ' ' ILE . 64.3 mtt180 -61.48 -11.74 11.99 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.503 -0.772 . . . . 2.5600000000000001 111.52 173.549 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 78.5 11.14 85.59 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.97 -0.633 . . . . 0.64000000000000001 112.714 176.789 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.888 ' HD1' ' HA3' ' A' ' 40' ' ' GLY . 29.9 m-85 -114.78 161.66 17.9 Favored 'General case' 0 CA--C 1.504 -0.821 0 N-CA-C 109.807 -0.442 . . . . 1.1799999999999999 109.807 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.548 ' HA2' HG12 ' A' ' 67' ' ' ILE . . . -161.67 -166.92 21.33 Favored Glycine 0 N--CA 1.438 -1.185 0 C-N-CA 119.855 -1.164 . . . . 0.58999999999999997 112.432 168.807 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.568 ' CE1' ' HD1' ' A' ' 38' ' ' PHE . 62.9 m-85 -135.95 132.98 37.12 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.018 -0.734 . . . . 0.63 109.018 179.124 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.482 HG11 ' CD2' ' A' ' 55' ' ' PHE . 41.1 t -119.94 109.96 27.61 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-O 121.392 0.615 . . . . 0.40999999999999998 110.012 175.334 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.679 ' HA ' ' O ' ' A' ' 35' ' ' THR . 11.2 m -107.96 112.01 24.38 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 107.663 -1.236 . . . . 0.46999999999999997 107.663 174.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.438 ' HA ' ' HA ' ' A' ' 61' ' ' ILE . 55.6 mtp -90.23 166.99 13.04 Favored 'General case' 0 N--CA 1.447 -0.586 0 O-C-N 121.412 -0.805 . . . . 0.88 109.162 -173.594 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -79.44 -17.27 54.61 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.816 0.341 . . . . 1.9199999999999999 110.945 -173.706 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -145.01 146.75 32.04 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.281 -0.418 . . . . 1.6799999999999999 110.235 -179.111 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.828 ' HD3' ' H ' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -72.77 -22.11 60.9 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.91 0.707 . . . . 3.6600000000000001 112.91 -174.096 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.432 ' O ' ' HG3' ' A' ' 91' ' ' ARG . . . -72.16 -37.45 69.36 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.054 0.454 . . . . 0.66000000000000003 111.07 -178.002 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.535 ' OG ' ' HA3' ' A' ' 59' ' ' GLY . 21.1 m -72.64 -37.94 67.85 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.712 0.768 . . . . 0.78000000000000003 109.666 174.439 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.78 -41.96 83.14 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.061 -1.427 . . . . 0.46000000000000002 109.333 175.104 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -54.69 -48.53 72.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.042 -0.981 . . . . 2.1099999999999999 111.507 171.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.49 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 96.7 mtt180 -59.98 -38.84 83.73 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.258 -0.428 . . . . 3.8199999999999998 110.951 -179.4 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -59.12 -46.37 88.51 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.028 -0.533 . . . . 0.92000000000000004 111.658 174.756 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 51.7 t -76.58 -8.76 57.86 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 111.707 0.262 . . . . 1.1599999999999999 111.707 -178.749 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.49 ' HB2' ' O ' ' A' ' 91' ' ' ARG . 39.7 mmtm -58.03 -41.63 83.61 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.661 -0.245 . . . . 4.2000000000000002 110.951 177.611 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -103.44 104.67 42.86 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 109.56 -0.533 . . . . 2.2400000000000002 109.56 174.606 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.564 ' O ' ' HB2' ' A' ' 97' ' ' ASN . 39.8 Cg_endo -84.94 102.6 0.81 Allowed 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 122.631 2.221 . . . . 2.3799999999999999 113.427 -174.11 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.564 ' HB2' ' O ' ' A' ' 96' ' ' PRO . 83.8 m-20 89.03 54.66 0.03 OUTLIER Pre-proline 0 N--CA 1.476 0.862 0 CA-C-N 114.39 -1.277 . . . . 3.0299999999999998 110.266 174.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.551 ' O ' HG13 ' A' ' 100' ' ' ILE . 90.1 Cg_endo -82.75 116.85 2.58 Favored 'Trans proline' 0 N--CA 1.45 -1.037 0 C-N-CA 121.49 1.46 . . . . 1.29 112.767 -177.698 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.98 ' HA ' ' HA ' ' A' ' 104' ' ' LYS . 1.2 mt -25.47 131.39 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.49 -0.777 . . . . 1.8100000000000001 112.866 151.364 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.551 HG13 ' O ' ' A' ' 98' ' ' PRO . 61.0 mt -148.46 126.99 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 N-CA-C 106.151 -1.796 . . . . 0.98999999999999999 106.151 -178.599 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 1.009 ' HB3' ' HG2' ' A' ' 43' ' ' PRO . 10.3 t0 65.06 41.18 4.72 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 122.245 1.021 . . . . 1.3700000000000001 109.164 -178.731 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 70.27 -8.14 4.13 Favored Glycine 0 CA--C 1.529 0.921 0 CA-C-N 114.708 -1.133 . . . . 1.5600000000000001 115.529 -179.231 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.666 ' CG ' ' HG3' ' A' ' 43' ' ' PRO . 34.8 mmt180 -117.5 134.27 55.04 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 119.317 1.559 . . . . 4.1299999999999999 110.629 178.616 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.98 ' HA ' ' HA ' ' A' ' 99' ' ' ILE . 4.7 ttpm? -63.98 128.46 35.9 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 121.382 -0.127 . . . . 2.73 111.267 -177.437 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -100.16 152.52 20.16 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 120.956 0.408 . . . . 1.04 111.109 -177.658 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.524 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 9.0 t30 -102.2 124.69 48.23 Favored 'General case' 0 C--O 1.243 0.726 0 CA-C-N 116.179 -0.464 . . . . 2.04 109.905 177.27 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.649 HG22 HG22 ' A' ' 39' ' ' VAL . 94.7 t -139.37 128.44 28.92 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.125 0 O-C-N 124.842 1.339 . . . . 1.0600000000000001 110.505 -164.296 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 33.5 p30 -160.25 157.36 28.02 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.388 -0.369 . . . . 2.4900000000000002 110.011 171.443 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.581 ' HB3' ' CE1' ' A' ' 111' ' ' TYR . 3.5 mm? -67.01 101.11 0.81 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.202 0.525 . . . . 1.23 110.901 175.154 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.612 ' HB3' ' HG3' ' A' ' 36' ' ' LYS . . . -46.97 -24.11 0.56 Allowed 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 115.518 1.673 . . . . 0.91000000000000003 115.518 -174.842 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.581 ' CE1' ' HB3' ' A' ' 109' ' ' LEU . 14.9 p90 . . . . . 0 N--CA 1.468 0.435 0 CA-C-N 118.163 0.438 . . . . 1.3999999999999999 111.515 -175.185 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 50.8 ttp . . . . . 0 N--CA 1.454 -0.227 0 CA-C-O 120.624 0.25 . . . . 1.49 111.438 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -98.77 6.54 46.84 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 111.705 0.261 . . . . 1.5 111.705 -178.382 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.751 ' O ' ' HA ' ' A' ' 82' ' ' THR . 43.1 p -114.51 17.08 17.54 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.264 0.554 . . . . 0.53000000000000003 109.922 177.668 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.886 ' HG3' ' HB3' ' A' ' 110' ' ' ALA . 0.1 OUTLIER -113.85 103.43 11.18 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.14 -0.937 . . . . 2.75 110.354 -176.737 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.5 mp -110.26 131.32 61.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.904 -0.589 . . . . 0.84999999999999998 111.036 -176.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.514 ' O ' ' HA ' ' A' ' 107' ' ' VAL . 69.4 t80 -91.3 113.09 25.26 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.264 -0.88 . . . . 0.70999999999999996 109.002 176.67 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.637 HG22 HG22 ' A' ' 107' ' ' VAL . 84.7 t -132.93 102.59 5.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 118.194 -0.907 . . . . 0.92000000000000004 110.273 -176.659 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.591 ' HA2' ' CD1' ' A' ' 42' ' ' LEU . . . -122.83 -154.84 9.17 Favored Glycine 0 C--O 1.221 -0.705 0 C-N-CA 115.937 -3.03 . . . . 0.83999999999999997 113.629 163.119 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 84.07 4.32 88.47 Favored Glycine 0 N--CA 1.452 -0.299 0 N-CA-C 111.098 -0.801 . . . . 0.68000000000000005 111.098 -175.445 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.82 ' HB3' ' HB ' ' A' ' 46' ' ' THR . 5.4 mp -64.96 137.51 97.18 Favored Pre-proline 0 N--CA 1.453 -0.282 0 CA-C-N 115.409 -0.395 . . . . 1.28 110.38 -178.775 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.569 ' HG2' ' HB3' ' A' ' 101' ' ' ASP . 52.7 Cg_exo -51.73 159.75 3.29 Favored 'Trans proline' 0 N--CA 1.463 -0.305 0 C-N-CA 123.198 2.599 . . . . 0.57999999999999996 111.955 173.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -66.43 -12.43 57.1 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 112.401 0.519 . . . . 1.05 112.401 -175.163 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 46.3 t60 -92.0 -24.92 19.06 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.15 0.5 . . . . 2.0099999999999998 109.986 174.783 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.82 ' HB ' ' HB3' ' A' ' 42' ' ' LEU . 4.4 m -72.71 118.32 15.49 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.876 -0.602 . . . . 0.71999999999999997 109.849 -176.727 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 6.0 p -134.46 -175.64 3.94 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.617 -0.719 . . . . 0.55000000000000004 111.176 -168.23 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -49.93 -34.87 21.88 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.424 0.631 . . . . 0.48999999999999999 110.594 -177.117 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.701 ' O ' ' HG2' ' A' ' 53' ' ' GLU . 8.5 ptpp? -67.65 -43.88 79.25 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 114.893 -1.049 . . . . 2.7599999999999998 109.887 -178.089 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.606 HG21 HG23 ' A' ' 46' ' ' THR . 6.7 m -66.34 -40.51 89.91 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.629 -0.259 . . . . 0.57999999999999996 111.24 -176.085 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.668 HD21 HD21 ' A' ' 42' ' ' LEU . 22.8 mt -61.78 -46.86 87.73 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 109.882 -0.414 . . . . 0.84999999999999998 109.882 175.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.532 ' HA ' HD12 ' A' ' 61' ' ' ILE . 45.9 t-80 -52.69 -51.55 59.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.417 -0.811 . . . . 0.58999999999999997 110.218 174.517 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.701 ' HG2' ' O ' ' A' ' 49' ' ' LYS . 23.4 mm-40 -59.48 -48.18 82.65 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.106 -0.497 . . . . 1.52 112.316 -176.877 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.435 ' O ' ' HB2' ' A' ' 57' ' ' GLN . 47.4 t80 -76.53 -41.44 46.7 Favored 'General case' 0 C--O 1.227 -0.109 0 CA-C-O 121.051 0.453 . . . . 1.1200000000000001 111.495 -171.384 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.774 ' HB2' HD11 ' A' ' 61' ' ' ILE . 45.8 m-85 -84.16 -30.38 25.9 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 113.063 0.764 . . . . 0.56000000000000005 113.063 -170.777 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.603 ' HA ' ' O ' ' A' ' 59' ' ' GLY . 16.6 pt-20 -67.45 -14.58 63.06 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 122.109 0.957 . . . . 1.5700000000000001 110.113 -178.649 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.435 ' HB2' ' O ' ' A' ' 54' ' ' TYR . 79.1 mm-40 -57.11 -26.3 60.23 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.082 -1.417 . . . . 2.1600000000000001 112.063 172.167 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -93.12 -25.2 17.99 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.223 0.535 . . . . 0.70999999999999996 110.055 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.603 ' O ' ' HA ' ' A' ' 56' ' ' GLU . . . 170.96 174.66 38.97 Favored Glycine 0 N--CA 1.447 -0.606 0 N-CA-C 110.386 -1.086 . . . . 0.75 110.386 -179.22 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 61.1 m-20 -67.9 125.14 25.36 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 117.492 0.646 . . . . 1.02 110.819 -173.517 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.774 HD11 ' HB2' ' A' ' 55' ' ' PHE . 29.8 mt -89.04 118.63 34.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.335 -0.393 . . . . 0.46999999999999997 110.309 178.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.437 ' HB2' ' HG3' ' A' ' 84' ' ' LYS . 24.9 tt0 -75.7 -33.0 60.32 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.145 0.424 . . . . 2.0699999999999998 112.145 -179.269 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -157.15 133.3 9.64 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.651 -0.42 . . . . 2.48 111.531 -178.069 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -125.3 130.08 51.28 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.643 -0.708 . . . . 0.44 110.928 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 20.6 t -135.54 136.19 50.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 114.527 -1.215 . . . . 1.3799999999999999 111.927 -177.328 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 56.0 t -118.58 117.72 55.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 108.703 -0.851 . . . . 0.48999999999999999 108.703 162.846 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 35.3 mm -77.06 111.81 14.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 115.293 -0.867 . . . . 0.71999999999999997 111.111 -171.658 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 21.4 p . . . . . 0 C--N 1.319 -0.736 0 CA-C-N 115.551 -0.75 . . . . 1.52 110.911 176.042 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 17.0 m . . . . . 0 N--CA 1.462 0.164 0 N-CA-C 112.806 0.669 . . . . 1.8100000000000001 112.806 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.446 ' HB3' ' CD2' ' A' ' 78' ' ' TYR . 21.7 mtp180 -61.19 -25.09 66.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.003 -0.999 . . . . 2.5600000000000001 111.964 177.324 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 80.58 23.51 60.21 Favored Glycine 0 C--O 1.225 -0.467 0 C-N-CA 120.491 -0.861 . . . . 0.64000000000000001 112.52 179.216 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.446 ' CD2' ' HB3' ' A' ' 76' ' ' ARG . 21.7 m-85 -120.07 138.91 53.26 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.113 -1.069 . . . . 1.1799999999999999 108.113 176.571 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -141.88 -177.77 17.34 Favored Glycine 0 N--CA 1.441 -0.972 0 C-N-CA 119.076 -1.535 . . . . 0.58999999999999997 113.508 178.232 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.45 ' CE1' ' HD1' ' A' ' 38' ' ' PHE . 61.3 m-85 -138.65 125.93 21.6 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 123.179 0.592 . . . . 0.63 109.445 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.474 HG23 HD13 ' A' ' 51' ' ' LEU . 42.8 t -113.33 114.51 47.09 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-O 121.03 0.443 . . . . 0.40999999999999998 110.57 178.758 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.751 ' HA ' ' O ' ' A' ' 35' ' ' THR . 8.4 m -106.36 125.23 50.73 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.025 -1.102 . . . . 0.46999999999999997 108.025 171.889 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 81.3 mtp -110.76 166.49 10.98 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 107.987 -1.116 . . . . 0.88 107.987 -172.501 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.437 ' HG3' ' HB2' ' A' ' 62' ' ' GLU . 3.4 mttm -83.53 -8.72 59.29 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 112.704 0.631 . . . . 1.9199999999999999 112.704 -172.575 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.441 ' OD1' ' HD2' ' A' ' 86' ' ' ARG . 9.6 t70 -145.36 146.52 31.62 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 109.908 -0.404 . . . . 1.6799999999999999 109.908 174.632 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.441 ' HD2' ' OD1' ' A' ' 85' ' ' ASP . 0.8 OUTLIER -73.84 -23.26 59.61 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 111.592 0.219 . . . . 3.6600000000000001 111.592 -176.524 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -63.04 -50.3 71.19 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.03 0.443 . . . . 0.66000000000000003 110.42 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 13.2 m -67.57 -35.89 79.88 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.953 -0.567 . . . . 0.78000000000000003 109.933 176.488 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.41 ' HB3' ' HA ' ' A' ' 86' ' ' ARG . . . -57.15 -45.83 83.27 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 114.789 -1.096 . . . . 0.46000000000000002 110.651 176.831 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -56.5 -42.49 78.43 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.198 -0.455 . . . . 2.1099999999999999 111.521 172.803 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.738 ' O ' ' HG3' ' A' ' 94' ' ' LYS . 12.9 mmt180 -68.11 -31.81 71.66 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.969 -0.56 . . . . 3.8199999999999998 110.83 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -61.39 -38.33 86.67 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.603 -0.271 . . . . 0.92000000000000004 111.651 171.116 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 37.0 t -86.58 -20.08 28.45 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 112.961 0.726 . . . . 1.1599999999999999 112.961 -173.157 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.738 ' HG3' ' O ' ' A' ' 91' ' ' ARG . 0.0 OUTLIER -51.54 -19.44 1.47 Allowed 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 112.959 0.726 . . . . 4.2000000000000002 112.959 177.337 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.686 ' N ' ' HD3' ' A' ' 94' ' ' LYS . 24.5 t0 -112.03 103.96 55.66 Favored Pre-proline 0 C--N 1.325 -0.491 0 N-CA-C 108.788 -0.819 . . . . 2.2400000000000002 108.788 168.427 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 95' ' ' ASP . 3.6 Cg_exo -80.42 -13.32 12.3 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 123.241 2.628 . . . . 2.3799999999999999 113.503 -172.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 52.7 m-80 -148.75 53.55 1.44 Allowed Pre-proline 0 C--O 1.236 0.38 0 O-C-N 122.383 -0.198 . . . . 3.0299999999999998 111.278 -176.05 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.54 ' O ' HG13 ' A' ' 100' ' ' ILE . 72.4 Cg_endo -82.81 113.14 2.17 Favored 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 120.739 0.959 . . . . 1.29 113.13 -175.298 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.441 HD13 ' CA ' ' A' ' 104' ' ' LYS . 12.7 mm -24.14 124.85 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-N 116.033 -0.53 . . . . 1.8100000000000001 111.979 149.098 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.54 HG13 ' O ' ' A' ' 98' ' ' PRO . 75.2 mt -145.14 119.68 3.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 105.961 -1.866 . . . . 0.98999999999999999 105.961 179.2 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.569 ' HB3' ' HG2' ' A' ' 43' ' ' PRO . 27.5 t0 55.21 50.64 14.69 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 122.637 1.208 . . . . 1.3700000000000001 109.783 -174.443 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 71.42 -8.17 5.66 Favored Glycine 0 CA--C 1.53 1.006 0 N-CA-C 117.22 1.648 . . . . 1.5600000000000001 117.22 176.516 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.497 ' HB2' ' HG3' ' A' ' 43' ' ' PRO . 2.0 mmm180 -116.22 142.07 47.31 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 120.59 2.195 . . . . 4.1299999999999999 111.83 176.683 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.441 ' CA ' HD13 ' A' ' 99' ' ' ILE . 41.1 ttmt -64.64 124.08 20.96 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.896 -0.593 . . . . 2.73 110.57 176.432 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -102.0 162.17 13.12 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.431 -0.349 . . . . 1.04 110.5 178.786 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.587 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 39.7 t-20 -114.78 127.79 55.93 Favored 'General case' 0 C--O 1.248 0.986 0 N-CA-C 109.48 -0.563 . . . . 2.04 109.48 179.338 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.637 HG22 HG22 ' A' ' 39' ' ' VAL . 88.3 t -138.85 123.19 20.66 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 O-C-N 125.056 1.473 . . . . 1.0600000000000001 111.065 -163.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -156.62 151.97 26.59 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.324 -0.621 . . . . 2.4900000000000002 109.324 175.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.524 ' HB3' ' CE1' ' A' ' 111' ' ' TYR . 1.3 mm? -57.37 96.28 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.063 0.459 . . . . 1.23 111.238 176.607 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.886 ' HB3' ' HG3' ' A' ' 36' ' ' LYS . . . -45.19 -33.16 2.16 Favored 'General case' 0 C--O 1.224 -0.245 0 N-CA-C 115.654 1.724 . . . . 0.91000000000000003 115.654 -176.378 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.524 ' CE1' ' HB3' ' A' ' 109' ' ' LEU . 9.1 p90 . . . . . 0 N--CA 1.473 0.705 0 N-CA-C 112.662 0.615 . . . . 1.3999999999999999 112.662 -169.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 49.3 ttp . . . . . 0 CA--C 1.531 0.236 0 CA-C-O 121.38 0.61 . . . . 1.49 110.418 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.409 ' C ' ' H ' ' A' ' 36' ' ' LYS . 21.4 m-85 -52.68 -71.62 0.07 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.716 -1.129 . . . . 1.5 111.575 176.492 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.617 ' HB ' ' O ' ' A' ' 83' ' ' MET . 34.5 p -53.26 18.17 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 116.542 2.053 . . . . 0.53000000000000003 116.542 178.339 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.429 ' HD2' ' HA ' ' A' ' 36' ' ' LYS . 41.8 tptt -116.32 113.16 22.57 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 119.52 1.055 . . . . 2.75 111.205 -178.268 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.426 HD11 ' HA ' ' A' ' 89' ' ' ALA . 84.8 mt -103.06 131.15 52.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-N 115.147 -0.933 . . . . 0.84999999999999998 110.681 -179.378 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.494 ' HB2' ' HA ' ' A' ' 110' ' ' ALA . 70.2 t80 -91.92 119.74 31.96 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 109.102 -0.703 . . . . 0.70999999999999996 109.102 175.336 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.676 HG12 HD11 ' A' ' 42' ' ' LEU . 3.9 t -102.31 135.32 39.89 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 N-CA-C 108.315 -0.995 . . . . 0.92000000000000004 108.315 -179.351 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -141.72 153.79 24.38 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.291 -0.957 . . . . 0.83999999999999997 112.093 -169.376 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 70.21 34.96 69.86 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.705 -0.76 . . . . 0.68000000000000005 112.518 176.393 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.676 HD11 HG12 ' A' ' 39' ' ' VAL . 7.2 mp -75.08 142.93 76.54 Favored Pre-proline 0 C--N 1.328 -0.35 0 N-CA-C 109.88 -0.415 . . . . 1.28 109.88 178.058 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.477 ' HG3' ' HB3' ' A' ' 103' ' ' ARG . 28.0 Cg_endo -68.63 158.61 57.03 Favored 'Trans proline' 0 N--CA 1.451 -1.016 0 C-N-CA 121.862 1.708 . . . . 0.57999999999999996 110.736 173.659 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.517 ' HD1' ' OG ' ' A' ' 75' ' ' SER . 59.7 m-85 -64.96 0.15 1.33 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.771 0.656 . . . . 1.05 112.771 -173.256 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 47.9 t-80 -110.37 -6.44 14.98 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.695 0.283 . . . . 2.0099999999999998 111.441 -178.547 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.647 ' CG2' HD23 ' A' ' 42' ' ' LEU . 25.7 m -77.75 137.88 38.71 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.611 -0.436 . . . . 0.71999999999999997 111.094 -179.544 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 10.4 p -131.73 -177.58 4.49 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.777 -0.647 . . . . 0.55000000000000004 109.961 -179.005 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.404 ' OD2' ' HA ' ' A' ' 65' ' ' VAL . 1.8 m-20 -61.5 -49.4 76.92 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 122.165 0.983 . . . . 0.48999999999999999 108.871 -175.503 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.726 ' O ' ' HG2' ' A' ' 53' ' ' GLU . 22.9 pttm -53.1 -33.78 53.73 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 113.229 -1.805 . . . . 2.7599999999999998 111.13 175.333 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 5.0 m -68.11 -44.6 75.8 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.028 0.442 . . . . 0.57999999999999996 110.193 178.882 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.534 HD21 HG11 ' A' ' 39' ' ' VAL . 33.3 mt -62.97 -44.48 95.93 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-N 115.985 -0.552 . . . . 0.84999999999999998 110.48 176.492 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.662 ' O ' ' HB2' ' A' ' 56' ' ' GLU . 45.2 t-80 -56.29 -37.24 69.61 Favored 'General case' 0 C--O 1.216 -0.679 0 CA-C-N 116.096 -0.502 . . . . 0.58999999999999997 110.641 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.726 ' HG2' ' O ' ' A' ' 49' ' ' LYS . 25.8 mm-40 -74.15 -40.44 62.59 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.311 -0.404 . . . . 1.52 111.781 -174.695 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.485 ' O ' ' HB2' ' A' ' 57' ' ' GLN . 2.9 t80 -77.66 -33.7 53.33 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.782 0.801 . . . . 1.1200000000000001 110.293 -177.215 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.675 ' HB2' HD11 ' A' ' 61' ' ' ILE . 40.4 m-85 -85.89 -25.82 25.95 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.013 -0.994 . . . . 0.56000000000000005 111.423 -174.642 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.662 ' HB2' ' O ' ' A' ' 52' ' ' HIS . 3.2 tp10 -62.09 -4.4 1.67 Allowed 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 122.266 1.031 . . . . 1.5700000000000001 110.428 174.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.485 ' HB2' ' O ' ' A' ' 54' ' ' TYR . 82.5 mt-30 -88.51 -30.7 19.15 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 114.251 -1.34 . . . . 2.1600000000000001 110.431 -177.248 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.583 ' CG ' ' HA ' ' A' ' 92' ' ' ALA . 68.4 m-85 -90.75 -8.91 48.49 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.997 -1.001 . . . . 0.70999999999999996 110.662 -175.276 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 142.83 174.33 15.12 Favored Glycine 0 N--CA 1.441 -1.015 0 N-CA-C 111.139 -0.785 . . . . 0.75 111.139 -179.466 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.682 ' HB3' ' HD2' ' A' ' 84' ' ' LYS . 3.0 m-20 -49.23 121.82 5.33 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.319 0.581 . . . . 1.02 111.798 176.314 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.675 HD11 ' HB2' ' A' ' 55' ' ' PHE . 85.0 mt -91.59 144.7 8.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 107.059 -1.46 . . . . 0.46999999999999997 107.059 171.609 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -94.71 -45.09 7.5 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 119.054 0.843 . . . . 2.0699999999999998 108.872 179.65 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -154.01 123.91 6.79 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.358 -0.837 . . . . 2.48 109.866 176.937 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -112.47 127.9 56.18 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.789 0.328 . . . . 0.44 110.741 175.027 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.404 ' HA ' ' OD2' ' A' ' 48' ' ' ASP . 8.1 p -144.52 137.75 22.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.636 -0.711 . . . . 1.3799999999999999 111.74 -175.844 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.532 HG12 HG23 ' A' ' 68' ' ' THR . 54.6 t -104.62 117.31 50.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 108.681 -0.859 . . . . 0.48999999999999999 108.681 172.153 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.619 ' O ' ' HD3' ' A' ' 76' ' ' ARG . 47.7 mm -76.88 72.38 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 122.084 0.945 . . . . 0.71999999999999997 111.235 -173.348 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.594 HG22 ' HA ' ' A' ' 75' ' ' SER . 38.5 p . . . . . 0 N--CA 1.433 -1.315 0 CA-C-N 114.627 -1.17 . . . . 1.52 109.757 164.33 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.594 ' HA ' HG22 ' A' ' 68' ' ' THR . 5.6 p . . . . . 0 CA--C 1.52 -0.197 0 CA-C-O 122.255 1.026 . . . . 1.8100000000000001 112.218 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.619 ' HD3' ' O ' ' A' ' 67' ' ' ILE . 41.1 mtp180 -87.3 1.35 53.49 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 113.937 -1.483 . . . . 2.5600000000000001 111.064 -168.736 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 69.64 14.58 70.0 Favored Glycine 0 N--CA 1.447 -0.626 0 CA-C-N 115.785 -0.643 . . . . 0.64000000000000001 113.084 177.078 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.485 ' O ' HG13 ' A' ' 66' ' ' VAL . 13.8 m-85 -118.68 156.1 29.87 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 116.879 0.339 . . . . 1.1799999999999999 110.979 -177.185 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -148.2 179.16 25.28 Favored Glycine 0 N--CA 1.444 -0.808 0 CA-C-N 115.967 -0.56 . . . . 0.58999999999999997 111.792 173.228 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.428 ' CE1' ' HD1' ' A' ' 38' ' ' PHE . 41.3 m-85 -156.04 123.71 5.56 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 123.604 0.762 . . . . 0.63 109.488 -179.444 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 70.4 t -120.95 127.04 75.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-O 120.811 0.339 . . . . 0.40999999999999998 110.433 -178.605 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 13.4 m -104.06 114.85 29.38 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.883 -0.784 . . . . 0.46999999999999997 108.883 177.345 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.617 ' O ' ' HB ' ' A' ' 35' ' ' THR . 93.0 mmm -90.68 133.1 35.39 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 120.9 -0.32 . . . . 0.88 110.719 -178.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.682 ' HD2' ' HB3' ' A' ' 60' ' ' ASP . 46.9 mttm -51.04 -6.24 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 114.614 1.339 . . . . 1.9199999999999999 114.614 174.136 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -160.46 155.49 24.49 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.774 -0.454 . . . . 1.6799999999999999 109.774 174.262 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.618 ' HD3' ' H ' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -75.41 -33.02 60.93 Favored 'General case' 0 C--O 1.224 -0.242 0 N-CA-C 108.279 -1.008 . . . . 3.6600000000000001 108.279 179.49 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -47.71 -48.63 29.38 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.391 -1.277 . . . . 0.66000000000000003 110.126 168.404 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 19.7 m -69.33 -27.97 65.83 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.166 -0.47 . . . . 0.78000000000000003 111.326 179.161 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.426 ' HA ' HD11 ' A' ' 37' ' ' ILE . . . -70.19 -50.13 43.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.451 . . . . 0.46000000000000002 110.482 177.822 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -55.49 -32.48 62.87 Favored 'General case' 0 C--O 1.222 -0.384 0 CA-C-N 116.101 -0.499 . . . . 2.1099999999999999 110.732 172.665 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.597 ' O ' ' HG3' ' A' ' 94' ' ' LYS . 13.4 mtp180 -70.33 -51.42 30.23 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.859 -1.064 . . . . 3.8199999999999998 110.723 179.522 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.583 ' HA ' ' CG ' ' A' ' 58' ' ' PHE . . . -56.06 -46.72 78.85 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 113.992 1.108 . . . . 0.92000000000000004 113.992 171.626 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 48.9 t -74.57 -42.47 58.69 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 120.974 -0.291 . . . . 1.1599999999999999 111.531 -172.888 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.597 ' HG3' ' O ' ' A' ' 91' ' ' ARG . 1.2 pptp? -49.57 -9.77 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 113.105 0.78 . . . . 4.2000000000000002 113.105 173.856 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -101.8 90.92 2.07 Favored Pre-proline 0 CA--C 1.534 0.343 0 N-CA-C 108.589 -0.893 . . . . 2.2400000000000002 108.589 162.592 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.481 ' HD3' ' O ' ' A' ' 94' ' ' LYS . 2.9 Cg_exo -76.18 111.97 3.38 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.979 2.453 . . . . 2.3799999999999999 113.016 -170.653 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.421 ' HB2' ' O ' ' A' ' 96' ' ' PRO . 92.7 m-20 79.23 69.65 0.17 Allowed Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 114.527 -1.215 . . . . 3.0299999999999998 110.111 175.349 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.448 ' HB2' ' CE1' ' A' ' 54' ' ' TYR . 72.7 Cg_endo -76.23 146.42 28.39 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.534 2.156 . . . . 1.29 111.065 178.756 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.558 HG22 ' C ' ' A' ' 102' ' ' GLY . 14.6 mm -88.33 92.41 3.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 O-C-N 122.155 -0.341 . . . . 1.8100000000000001 110.24 -172.7 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.488 ' C ' ' H ' ' A' ' 102' ' ' GLY . 15.9 mt -92.05 151.24 3.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-O 121.548 0.69 . . . . 0.98999999999999999 112.279 -174.307 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 25.3 t0 35.02 17.83 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 CA-C-N 114.489 -1.232 . . . . 1.3700000000000001 112.872 -152.803 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.558 ' C ' HG22 ' A' ' 99' ' ' ILE . . . 89.48 19.82 47.43 Favored Glycine 0 CA--C 1.529 0.929 0 CA-C-N 115.757 -0.656 . . . . 1.5600000000000001 111.674 178.722 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.477 ' HB3' ' HG3' ' A' ' 43' ' ' PRO . 31.9 tpt180 -127.82 135.73 50.48 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.747 0.819 . . . . 4.1299999999999999 108.989 174.033 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.421 ' HA ' ' HA ' ' A' ' 99' ' ' ILE . 33.9 ttpt -58.0 114.92 2.56 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.461 0.541 . . . . 2.73 112.461 -174.327 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -99.67 164.66 11.96 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.186 -0.915 . . . . 1.04 110.225 177.148 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 37.8 t30 -107.93 131.7 54.26 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.454 -0.339 . . . . 2.04 110.154 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 41.1 t -122.38 129.12 75.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.32 0.581 . . . . 1.0600000000000001 112.003 -179.219 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -150.01 158.08 43.8 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.084 -0.962 . . . . 2.4900000000000002 108.405 175.161 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.752 HD23 ' CE1' ' A' ' 111' ' ' TYR . 1.0 OUTLIER -73.24 124.67 26.11 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 121.594 -0.691 . . . . 1.23 111.461 -177.029 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.494 ' HA ' ' HB2' ' A' ' 38' ' ' PHE . . . -47.23 -47.3 24.61 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.375 -1.284 . . . . 0.91000000000000003 113.026 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.752 ' CE1' HD23 ' A' ' 109' ' ' LEU . 0.8 OUTLIER . . . . . 0 C--N 1.33 -0.251 0 CA-C-O 121.571 0.701 . . . . 1.3999999999999999 110.055 -178.257 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 12.5 tmm? . . . . . 0 CA--C 1.532 0.278 0 CA-C-O 120.621 0.248 . . . . 1.49 110.963 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -98.1 -46.43 5.87 Favored 'General case' 0 CA--C 1.527 0.077 0 O-C-N 122.225 -0.297 . . . . 1.5 111.312 177.031 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.574 ' O ' ' HA ' ' A' ' 82' ' ' THR . 63.3 p -68.78 1.63 3.16 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 113.755 1.021 . . . . 0.53000000000000003 113.755 -176.162 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.408 ' O ' HD13 ' A' ' 109' ' ' LEU . 58.0 tttt -97.99 107.9 20.49 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.995 0.426 . . . . 2.75 110.117 -175.477 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.459 HD11 ' HA ' ' A' ' 89' ' ' ALA . 47.1 mt -109.38 136.3 45.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.781 -0.645 . . . . 0.84999999999999998 111.148 -175.382 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -101.25 118.41 36.93 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.878 -0.601 . . . . 0.70999999999999996 109.698 174.28 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.816 HG13 HG22 ' A' ' 107' ' ' VAL . 30.3 t -133.75 110.63 14.55 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.848 0 CA-C-O 117.85 -1.071 . . . . 0.92000000000000004 110.977 -177.182 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.42 ' HA2' ' CD2' ' A' ' 42' ' ' LEU . . . -116.68 -156.76 10.73 Favored Glycine 0 CA--C 1.503 -0.706 1 C-N-CA 112.341 -4.742 . . . . 0.83999999999999997 114.835 156.049 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.488 ' HA3' ' HA ' ' A' ' 105' ' ' ALA . . . 92.42 5.07 65.58 Favored Glycine 0 N--CA 1.442 -0.903 0 N-CA-C 110.211 -1.156 . . . . 0.68000000000000005 110.211 -171.466 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.67 HD11 HD21 ' A' ' 51' ' ' LEU . 3.0 mm? -71.99 121.4 84.5 Favored Pre-proline 0 N--CA 1.45 -0.44 0 CA-C-N 115.06 -0.57 . . . . 1.28 109.931 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.79 ' HG3' ' HD3' ' A' ' 103' ' ' ARG . 88.8 Cg_exo -48.21 160.01 0.61 Allowed 'Trans proline' 0 CA--C 1.529 0.274 0 C-N-CA 124.198 3.266 . . . . 0.57999999999999996 113.968 177.22 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -71.26 -6.94 43.52 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.704 -0.68 . . . . 1.05 112.688 -174.105 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 7.6 p-80 -112.85 10.29 19.07 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 121.788 -0.57 . . . . 2.0099999999999998 110.921 171.525 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.594 HG21 HD12 ' A' ' 42' ' ' LEU . 52.0 m -79.62 123.75 27.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.099 -0.5 . . . . 0.71999999999999997 110.438 174.929 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 60.3 p -105.72 175.2 5.57 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.264 -0.425 . . . . 0.55000000000000004 110.577 -178.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.511 ' HB3' ' O ' ' A' ' 64' ' ' ALA . 2.9 m-20 -57.44 -30.56 65.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.571 0.701 . . . . 0.48999999999999999 110.124 176.691 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.679 ' O ' ' HG2' ' A' ' 53' ' ' GLU . 0.5 OUTLIER -78.71 -29.59 45.52 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.422 -0.808 . . . . 2.7599999999999998 110.828 -179.389 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.583 ' HB ' HG23 ' A' ' 46' ' ' THR . 14.5 m -61.95 -41.98 98.6 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.98 0.419 . . . . 0.57999999999999996 110.379 176.454 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.67 HD21 HD11 ' A' ' 42' ' ' LEU . 16.0 mt -67.65 -37.16 82.03 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-N 116.189 -0.46 . . . . 0.84999999999999998 110.334 174.8 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.47 ' HA ' HD12 ' A' ' 61' ' ' ILE . 60.5 t-80 -57.05 -47.4 81.05 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.723 -0.672 . . . . 0.58999999999999997 109.848 175.916 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.679 ' HG2' ' O ' ' A' ' 49' ' ' LYS . 23.6 mm-40 -57.54 -47.25 82.52 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.976 -0.556 . . . . 1.52 111.521 178.867 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.464 ' O ' ' HB2' ' A' ' 57' ' ' GLN . 20.9 t80 -76.75 -34.83 58.05 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.591 0.589 . . . . 1.1200000000000001 112.591 -172.172 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.432 ' CZ ' HG21 ' A' ' 39' ' ' VAL . 22.5 m-85 -85.03 -25.17 27.83 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 114.391 1.256 . . . . 0.56000000000000005 114.391 -173.339 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.587 ' N ' HD11 ' A' ' 61' ' ' ILE . 11.0 pt-20 -67.06 -12.52 60.16 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 122.351 1.072 . . . . 1.5700000000000001 109.722 177.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.464 ' HB2' ' O ' ' A' ' 54' ' ' TYR . 17.8 mm-40 -56.15 -31.31 63.25 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 113.937 -1.483 . . . . 2.1600000000000001 111.506 169.001 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -96.92 4.87 51.38 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.466 -0.334 . . . . 0.70999999999999996 111.737 -176.42 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 142.2 -133.76 5.8 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.548 -0.834 . . . . 0.75 112.516 -176.744 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -114.29 124.38 51.86 Favored 'General case' 0 C--N 1.322 -0.599 0 O-C-N 122.567 -0.372 . . . . 1.02 110.475 -179.016 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.587 HD11 ' N ' ' A' ' 56' ' ' GLU . 7.5 mt -93.23 125.87 45.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 109.579 -0.526 . . . . 0.46999999999999997 109.579 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -78.48 -38.8 40.09 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.019 0.438 . . . . 2.0699999999999998 110.753 176.217 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -157.22 136.37 11.87 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.149 -0.478 . . . . 2.48 111.34 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.511 ' O ' ' HB3' ' A' ' 48' ' ' ASP . . . -121.28 123.4 42.1 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 115.781 -0.645 . . . . 0.44 109.396 174.039 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 8.9 p -135.52 135.17 51.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 114.893 -1.048 . . . . 1.3799999999999999 112.191 -176.53 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 98.1 t -102.83 131.76 50.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.356 -0.838 . . . . 0.48999999999999999 109.386 173.394 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.471 HG12 ' HA2' ' A' ' 79' ' ' GLY . 44.6 mm -83.61 92.28 2.83 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.625 0 CA-C-O 121.478 0.656 . . . . 0.71999999999999997 109.665 -179.284 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.425 HG22 ' HA ' ' A' ' 75' ' ' SER . 31.7 p . . . . . 0 N--CA 1.436 -1.137 0 CA-C-N 115.023 -0.99 . . . . 1.52 110.757 -179.6 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.508 ' O ' ' HB2' ' A' ' 76' ' ' ARG . 8.4 m . . . . . 0 N--CA 1.468 0.451 0 N-CA-C 112.879 0.696 . . . . 1.8100000000000001 112.879 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.508 ' HB2' ' O ' ' A' ' 75' ' ' SER . 96.5 mtt180 74.57 -55.3 0.66 Allowed 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.329 0.652 . . . . 2.5600000000000001 110.508 -169.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 103.97 19.24 12.07 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.841 -0.695 . . . . 0.64000000000000001 113.142 175.775 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -123.85 157.28 34.53 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.215 -1.031 . . . . 1.1799999999999999 108.215 177.292 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.471 ' HA2' HG12 ' A' ' 67' ' ' ILE . . . -159.23 -164.66 14.89 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 119.769 -1.205 . . . . 0.58999999999999997 112.647 175.742 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -151.3 134.83 16.24 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.731 -0.84 . . . . 0.63 108.731 -177.054 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 53.7 t -122.36 120.07 60.06 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 N-CA-C 109.938 -0.393 . . . . 0.40999999999999998 109.938 177.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.574 ' HA ' ' O ' ' A' ' 35' ' ' THR . 17.9 m -109.81 115.68 30.28 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 108.51 -0.922 . . . . 0.46999999999999997 108.51 177.646 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 83.1 mmm -88.79 163.8 15.53 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 108.898 -0.778 . . . . 0.88 108.898 -176.163 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 20.7 ttmm -83.3 -10.94 58.21 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.099 0.476 . . . . 1.9199999999999999 110.683 -178.373 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -145.67 146.64 31.38 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 116.232 -0.44 . . . . 1.6799999999999999 110.616 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 4.3 tmm_? -71.39 -22.81 61.83 Favored 'General case' 0 C--O 1.223 -0.3 0 N-CA-C 112.845 0.683 . . . . 3.6600000000000001 112.845 -177.026 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.26 -43.94 89.68 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 118.649 0.659 . . . . 0.66000000000000003 110.392 177.646 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 8.7 m -64.55 -39.23 93.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.699 0.761 . . . . 0.78000000000000003 109.881 175.553 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.459 ' HA ' HD11 ' A' ' 37' ' ' ILE . . . -59.41 -49.79 76.45 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.028 -1.442 . . . . 0.46000000000000002 110.609 178.326 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -54.98 -49.16 72.13 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.55 -0.75 . . . . 2.1099999999999999 111.826 175.26 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.62 ' O ' ' HB3' ' A' ' 94' ' ' LYS . 2.6 ttm-85 -61.85 -41.02 97.31 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.295 -0.412 . . . . 3.8199999999999998 110.773 -177.25 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -63.56 -43.84 95.87 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.996 -0.547 . . . . 0.92000000000000004 111.73 176.605 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 45.2 t -75.2 -6.9 52.14 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 121.337 0.589 . . . . 1.1599999999999999 110.659 178.232 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.62 ' HB3' ' O ' ' A' ' 91' ' ' ARG . 2.9 tppp? -76.96 -37.94 54.26 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.285 -0.87 . . . . 4.2000000000000002 110.016 177.402 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -108.33 91.58 8.47 Favored Pre-proline 0 C--N 1.326 -0.441 0 N-CA-C 109.358 -0.608 . . . . 2.2400000000000002 109.358 172.639 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.594 ' HA ' ' HB ' ' A' ' 107' ' ' VAL . 59.4 Cg_endo -90.17 -6.54 4.62 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 123.1 2.533 . . . . 2.3799999999999999 114.144 -169.18 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.456 ' N ' ' HD3' ' A' ' 98' ' ' PRO . 3.4 p-10 -132.76 60.86 53.02 Favored Pre-proline 0 C--N 1.328 -0.337 0 N-CA-C 112.306 0.484 . . . . 3.0299999999999998 112.306 -177.819 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.456 ' HD3' ' N ' ' A' ' 97' ' ' ASN . 1.8 Cg_endo -81.38 151.73 17.72 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.795 2.33 . . . . 1.29 111.73 -179.683 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 35.9 mm -95.06 90.37 2.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.287 0.565 . . . . 1.8100000000000001 110.302 179.433 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 57.6 mt -90.85 108.34 19.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.841 -0.618 . . . . 0.98999999999999999 111.847 177.454 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.718 ' HB3' ' HG2' ' A' ' 43' ' ' PRO . 25.2 t70 65.31 44.17 3.3 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 122.813 1.292 . . . . 1.3700000000000001 109.3 173.345 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 80.39 -9.03 51.15 Favored Glycine 0 N--CA 1.445 -0.712 0 CA-C-N 114.412 -1.267 . . . . 1.5600000000000001 113.579 176.463 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.79 ' HD3' ' HG3' ' A' ' 43' ' ' PRO . 7.4 mpt_? -107.09 131.09 54.5 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 117.74 0.77 . . . . 4.1299999999999999 111.623 176.524 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 26.3 ttpp -67.18 134.51 51.86 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.366 -0.834 . . . . 2.73 109.032 169.656 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.488 ' HA ' ' HA3' ' A' ' 41' ' ' GLY . . . -111.25 150.38 29.68 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 116.232 -0.44 . . . . 1.04 109.964 -175.582 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -108.15 106.18 16.26 Favored 'General case' 0 C--O 1.264 1.857 0 CA-C-O 121.556 0.694 . . . . 2.04 110.053 174.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.816 HG22 HG13 ' A' ' 39' ' ' VAL . 47.4 t -101.67 138.53 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 CA-C-N 112.876 -1.965 . . . . 1.0600000000000001 111.451 174.317 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 32.8 m-80 -151.86 153.02 33.37 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.428 -0.953 . . . . 2.4900000000000002 108.428 172.801 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.527 HD13 ' H ' ' A' ' 110' ' ' ALA . 0.2 OUTLIER -63.25 150.3 43.46 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.402 -0.962 . . . . 1.23 108.402 172.876 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.527 ' H ' HD13 ' A' ' 109' ' ' LEU . . . -74.67 -40.28 61.51 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.081 -0.647 . . . . 0.91000000000000003 110.36 -167.361 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.409 ' CE1' ' HB3' ' A' ' 109' ' ' LEU . 0.1 OUTLIER . . . . . 0 CA--C 1.53 0.206 0 CA-C-N 114.97 -1.014 . . . . 1.3999999999999999 112.654 -172.221 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' MET . . . . . 0.605 ' HG3' ' H ' ' A' ' 34' ' ' PHE . 22.5 ptm . . . . . 0 CA--C 1.528 0.099 0 N-CA-C 107.695 -1.224 . . . . 1.49 107.695 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.605 ' H ' ' HG3' ' A' ' 33' ' ' MET . 26.0 m-85 -88.17 -179.97 6.26 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 113.712 -1.586 . . . . 1.5 108.62 170.173 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.73 ' HB ' ' O ' ' A' ' 83' ' ' MET . 14.0 p 65.37 -0.46 1.16 Allowed 'General case' 0 N--CA 1.472 0.637 0 O-C-N 124.065 0.853 . . . . 0.53000000000000003 112.642 174.588 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 33.0 ttpt -121.89 110.21 15.58 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.136 0.494 . . . . 2.75 110.248 -176.314 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.616 HD11 ' HA ' ' A' ' 89' ' ' ALA . 3.8 mp -96.3 130.02 45.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.972 -0.558 . . . . 0.84999999999999998 110.575 -179.292 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -85.77 108.29 18.02 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 108.559 -0.904 . . . . 0.70999999999999996 108.559 172.721 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.3 t -95.95 137.03 25.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 N-CA-C 108.074 -1.084 . . . . 0.92000000000000004 108.074 179.577 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -140.42 138.09 8.78 Favored Glycine 0 N--CA 1.442 -0.94 0 C-N-CA 119.577 -1.297 . . . . 0.83999999999999997 111.767 -170.311 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 96.43 16.36 37.53 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.582 -0.818 . . . . 0.68000000000000005 112.84 177.459 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.553 HD12 HG21 ' A' ' 46' ' ' THR . 2.8 mm? -64.94 124.16 85.81 Favored Pre-proline 0 C--O 1.234 0.246 0 N-CA-C 109.304 -0.628 . . . . 1.28 109.304 177.006 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.578 ' HG2' ' HB3' ' A' ' 101' ' ' ASP . 52.9 Cg_exo -50.58 154.38 6.53 Favored 'Trans proline' 0 CA--C 1.529 0.252 0 C-N-CA 122.91 2.407 . . . . 0.57999999999999996 111.88 173.733 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -65.76 -7.22 14.6 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.847 0.356 . . . . 1.05 111.61 -178.057 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 76.9 t60 -101.14 -6.43 24.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.188 0.518 . . . . 2.0099999999999998 110.222 177.538 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.553 HG21 HD12 ' A' ' 42' ' ' LEU . 77.5 m -78.72 142.42 37.09 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 116.259 -0.428 . . . . 0.71999999999999997 109.922 177.762 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 12.1 p -132.14 -178.77 5.05 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.028 0.442 . . . . 0.55000000000000004 111.161 -175.889 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.587 ' OD2' ' HA ' ' A' ' 65' ' ' VAL . 2.4 m-20 -67.31 -48.18 68.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.862 0.839 . . . . 0.48999999999999999 109.06 -176.423 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.598 ' O ' ' HG2' ' A' ' 53' ' ' GLU . 22.8 pttp -52.52 -35.38 53.14 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 113.908 -1.496 . . . . 2.7599999999999998 111.149 175.38 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.47 HG21 HG23 ' A' ' 46' ' ' THR . 22.9 m -67.2 -45.76 75.9 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.854 0.359 . . . . 0.57999999999999996 111.279 179.299 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.525 HD21 HD11 ' A' ' 42' ' ' LEU . 31.1 mt -67.33 -35.67 79.9 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.485 -0.325 . . . . 0.84999999999999998 110.805 178.602 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.432 ' HA ' ' CD1' ' A' ' 61' ' ' ILE . 63.9 t-80 -57.3 -38.3 73.77 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.644 -0.502 . . . . 0.58999999999999997 109.644 175.666 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.598 ' HG2' ' O ' ' A' ' 49' ' ' LYS . 82.3 mm-40 -68.18 -39.84 82.42 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.242 -0.89 . . . . 1.52 110.467 -177.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.634 ' O ' ' HB2' ' A' ' 57' ' ' GLN . 2.2 t80 -78.44 -34.33 47.87 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.566 0.698 . . . . 1.1200000000000001 111.607 -177.282 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.46 ' HB2' HD11 ' A' ' 61' ' ' ILE . 28.7 m-85 -86.4 -25.63 25.19 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 113.086 0.772 . . . . 0.56000000000000005 113.086 -172.124 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -71.98 -1.53 14.87 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 122.336 1.065 . . . . 1.5700000000000001 109.619 174.102 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.634 ' HB2' ' O ' ' A' ' 54' ' ' TYR . 88.9 mt-30 -86.28 -10.6 54.22 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.092 -1.413 . . . . 2.1600000000000001 109.96 176.223 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.431 ' HD2' ' HA ' ' A' ' 55' ' ' PHE . 78.8 m-85 -109.86 -51.2 2.9 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.395 -0.821 . . . . 0.70999999999999996 111.118 -178.332 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -163.92 -135.75 1.87 Allowed Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.274 -0.965 . . . . 0.75 112.006 179.248 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.428 ' HB3' ' HE3' ' A' ' 84' ' ' LYS . 1.0 OUTLIER -98.22 132.88 43.35 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.803 0.335 . . . . 1.02 110.235 -179.902 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.46 HD11 ' HB2' ' A' ' 55' ' ' PHE . 66.0 mt -105.83 139.89 25.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 107.87 -1.159 . . . . 0.46999999999999997 107.87 174.621 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -97.99 -41.21 8.09 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 107.933 -1.136 . . . . 2.0699999999999998 107.933 177.099 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.402 ' HG2' HG13 ' A' ' 65' ' ' VAL . 43.0 tt0 -165.48 127.03 1.98 Allowed 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 115.458 -0.792 . . . . 2.48 110.267 177.014 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.419 ' O ' ' HB3' ' A' ' 48' ' ' ASP . . . -106.04 127.27 53.06 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.272 -0.64 . . . . 0.44 109.272 174.533 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.587 ' HA ' ' OD2' ' A' ' 48' ' ' ASP . 5.0 m -138.1 119.63 17.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.472 0.653 . . . . 1.3799999999999999 112.649 -175.268 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 91.7 t -86.99 122.06 38.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.381 -0.827 . . . . 0.48999999999999999 109.553 174.921 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 39.8 mm -71.69 139.34 19.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.34 0.59 . . . . 0.71999999999999997 112.16 -176.021 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 35.2 p . . . . . 0 N--CA 1.438 -1.049 0 CA-C-N 115.265 -0.88 . . . . 1.52 109.53 176.558 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.8 m . . . . . 0 CA--C 1.531 0.249 0 N-CA-C 112.712 0.634 . . . . 1.8100000000000001 112.712 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 60.2 mtp180 -98.15 -10.22 24.51 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.947 -0.57 . . . . 2.5600000000000001 110.92 -175.29 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 86.89 13.77 66.13 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.596 -0.811 . . . . 0.64000000000000001 112.462 -178.515 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -122.85 162.44 22.17 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.59 -0.893 . . . . 1.1799999999999999 108.59 178.018 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -173.77 145.19 8.07 Favored Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 120.148 -1.025 . . . . 0.58999999999999997 112.211 178.122 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -104.06 142.17 34.93 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.419 0.628 . . . . 0.63 111.258 176.064 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 49.8 t -117.99 106.02 19.01 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 CA-C-N 115.239 -0.891 . . . . 0.40999999999999998 109.483 173.528 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 8.3 m -76.92 117.33 18.41 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.883 -0.598 . . . . 0.46999999999999997 109.968 174.002 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.73 ' O ' ' HB ' ' A' ' 35' ' ' THR . 28.1 mtp -103.31 134.85 46.02 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.74 -0.467 . . . . 0.88 109.74 179.069 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.428 ' HE3' ' HB3' ' A' ' 60' ' ' ASP . 19.1 ttmt -51.73 -6.14 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 114.87 1.433 . . . . 1.9199999999999999 114.87 -179.679 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.481 ' C ' HG22 ' A' ' 35' ' ' THR . 7.2 t70 -162.53 156.68 21.21 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 118.871 0.76 . . . . 1.6799999999999999 111.323 177.722 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.666 ' N ' HG22 ' A' ' 35' ' ' THR . 2.5 tmm_? -75.02 -34.8 61.94 Favored 'General case' 0 C--O 1.22 -0.48 0 N-CA-C 108.461 -0.94 . . . . 3.6600000000000001 108.461 -177.279 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -52.71 -42.4 64.82 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.026 -0.988 . . . . 0.66000000000000003 110.95 172.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 5.5 m -69.55 -31.95 70.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.072 0.463 . . . . 0.78000000000000003 110.381 176.401 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.616 ' HA ' HD11 ' A' ' 37' ' ' ILE . . . -67.62 -50.43 58.11 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.599 -0.728 . . . . 0.46000000000000002 110.819 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.573 ' O ' ' HG2' ' A' ' 94' ' ' LYS . 6.0 mt-10 -57.72 -32.77 67.74 Favored 'General case' 0 C--O 1.224 -0.283 0 CA-C-N 115.832 -0.622 . . . . 2.1099999999999999 110.537 174.547 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.401 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 13.3 tpp180 -64.15 -51.72 62.48 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.325 -0.852 . . . . 3.8199999999999998 109.922 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -53.57 -32.1 49.45 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 113.461 0.912 . . . . 0.92000000000000004 113.461 172.798 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 46.5 t -80.25 -34.57 36.99 Favored 'General case' 0 C--N 1.328 -0.363 0 O-C-N 121.894 -0.504 . . . . 1.1599999999999999 110.609 178.173 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.573 ' HG2' ' O ' ' A' ' 90' ' ' GLU . 12.2 mmmm -48.23 -30.7 4.98 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 114.733 -1.121 . . . . 4.2000000000000002 111.838 175.168 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -103.18 102.77 30.52 Favored Pre-proline 0 C--N 1.326 -0.438 0 N-CA-C 108.893 -0.78 . . . . 2.2400000000000002 108.893 167.533 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -77.15 173.65 14.06 Favored 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 122.608 2.205 . . . . 2.3799999999999999 113.761 -169.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 20.2 m-80 -15.98 91.13 0.04 OUTLIER Pre-proline 0 N--CA 1.481 1.092 0 C-N-CA 125.462 1.505 . . . . 3.0299999999999998 114.126 -174.473 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -82.27 164.85 16.96 Favored 'Trans proline' 0 C--O 1.235 0.346 0 C-N-CA 123.408 2.739 . . . . 1.29 113.202 -179.112 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 41.1 mm -94.72 109.79 22.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.445 -0.798 . . . . 1.8100000000000001 110.329 174.126 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 54.9 mt -114.22 115.65 50.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.017 -0.538 . . . . 0.98999999999999999 110.251 178.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.578 ' HB3' ' HG2' ' A' ' 43' ' ' PRO . 28.0 t70 50.71 54.53 11.04 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 113.071 0.767 . . . . 1.3700000000000001 113.071 169.281 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 74.75 21.72 78.17 Favored Glycine 0 N--CA 1.454 -0.12 0 C-N-CA 120.375 -0.917 . . . . 1.5600000000000001 113.121 176.871 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.463 ' HB2' ' HG3' ' A' ' 43' ' ' PRO . 0.2 OUTLIER -145.66 160.11 42.17 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.9 -0.407 . . . . 4.1299999999999999 109.9 179.207 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 2.1 ttmp? -101.79 149.23 24.39 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 107.751 -1.203 . . . . 2.73 107.751 169.665 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -116.85 141.48 48.17 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 120.674 -0.41 . . . . 1.04 110.103 -174.353 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -94.23 123.8 37.85 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.268 -0.641 . . . . 2.04 109.268 175.453 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.517 HG13 HG21 ' A' ' 37' ' ' ILE . 97.9 t -119.72 114.92 45.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.247 -0.888 . . . . 1.0600000000000001 110.219 179.353 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -156.48 171.32 20.49 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.506 -0.77 . . . . 2.4900000000000002 110.254 -179.44 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.536 ' HB3' ' CD1' ' A' ' 111' ' ' TYR . 3.2 mm? -78.38 115.09 17.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.513 0.673 . . . . 1.23 111.415 -176.531 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -43.92 -35.83 2.17 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 113.949 -1.478 . . . . 0.91000000000000003 113.987 -179.533 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.536 ' CD1' ' HB3' ' A' ' 109' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.467 0.395 0 O-C-N 121.69 -0.631 . . . . 1.3999999999999999 112.311 -174.712 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 41.8 ttp . . . . . 0 CA--C 1.533 0.318 0 N-CA-C 111.987 0.366 . . . . 1.49 111.987 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -93.71 23.8 4.51 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.924 0.712 . . . . 1.5 112.924 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.509 ' O ' ' HA ' ' A' ' 82' ' ' THR . 70.5 p -149.49 19.45 0.93 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 118.726 0.693 . . . . 0.53000000000000003 110.338 -171.859 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 5.8 ttpm? -121.97 103.88 9.13 Favored 'General case' 0 CA--C 1.509 -0.608 0 C-N-CA 119.925 -0.71 . . . . 2.75 109.733 -167.284 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.574 HG23 HG13 ' A' ' 107' ' ' VAL . 65.2 mt -90.35 111.91 24.08 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 CA-C-N 115.403 -0.817 . . . . 0.84999999999999998 109.548 179.496 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.723 ' HB2' ' HB2' ' A' ' 110' ' ' ALA . 69.8 t80 -83.36 108.48 16.58 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 107.907 -1.146 . . . . 0.70999999999999996 107.907 175.27 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.418 ' HB ' HD21 ' A' ' 42' ' ' LEU . 4.1 t -95.85 87.94 1.96 Allowed 'Isoleucine or valine' 0 C--O 1.209 -1.046 0 CA-C-O 122.105 0.955 . . . . 0.92000000000000004 109.05 -177.048 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -68.3 147.28 47.17 Favored Glycine 0 C--N 1.305 -1.16 0 C-N-CA 119.359 -1.401 . . . . 0.83999999999999997 112.151 168.696 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.91 38.58 13.31 Favored Glycine 0 CA--C 1.523 0.546 0 C-N-CA 120.74 -0.743 . . . . 0.68000000000000005 114.773 170.939 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.815 HD11 HD21 ' A' ' 51' ' ' LEU . 2.8 mm? -72.49 143.63 85.47 Favored Pre-proline 0 CA--C 1.514 -0.438 0 CA-C-N 117.934 0.867 . . . . 1.28 110.802 172.754 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.558 ' HG2' ' HB3' ' A' ' 101' ' ' ASP . 75.4 Cg_exo -52.49 145.13 38.44 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 122.401 2.067 . . . . 0.57999999999999996 110.867 166.848 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 46.8 m-85 -60.46 -16.26 34.81 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 113.795 1.035 . . . . 1.05 113.795 -171.527 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 3.0 p-80 -111.2 18.24 19.52 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 119.674 -0.811 . . . . 2.0099999999999998 111.97 176.854 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.589 HG23 ' HB ' ' A' ' 50' ' ' THR . 91.7 m -78.22 107.13 10.59 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 118.971 -1.092 . . . . 0.71999999999999997 110.445 178.229 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 6.6 p -87.02 171.62 10.6 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 113.767 -1.56 . . . . 0.55000000000000004 113.849 170.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -55.16 -43.29 74.1 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 113.923 -1.49 . . . . 0.48999999999999999 110.19 -174.791 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.639 ' O ' ' HG2' ' A' ' 53' ' ' GLU . 60.0 pttt -54.86 -41.84 71.29 Favored 'General case' 0 C--O 1.224 -0.268 0 CA-C-N 115.165 -0.925 . . . . 2.7599999999999998 110.687 176.431 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.589 ' HB ' HG23 ' A' ' 46' ' ' THR . 11.2 m -61.8 -43.18 99.35 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.494 -0.321 . . . . 0.57999999999999996 110.823 -176.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.815 HD21 HD11 ' A' ' 42' ' ' LEU . 18.3 mt -69.94 -46.96 64.17 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.736 -0.385 . . . . 0.84999999999999998 111.318 178.442 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.446 ' HA ' HD12 ' A' ' 61' ' ' ILE . 57.9 t-80 -53.2 -55.52 23.63 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.899 0.381 . . . . 0.58999999999999997 111.314 176.59 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.639 ' HG2' ' O ' ' A' ' 49' ' ' LYS . 9.6 mm-40 -56.02 -52.81 62.9 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.805 -0.634 . . . . 1.52 111.301 179.641 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -53.05 -49.09 67.04 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 115.385 1.624 . . . . 1.1200000000000001 115.385 175.357 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.512 ' CE1' HD22 ' A' ' 51' ' ' LEU . 28.5 m-85 -81.62 -33.45 31.45 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 114.173 1.175 . . . . 0.56000000000000005 114.173 -165.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.55 ' N ' HD11 ' A' ' 61' ' ' ILE . 9.8 pt-20 -53.53 0.17 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 114.126 1.158 . . . . 1.5700000000000001 114.126 171.719 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.401 ' H ' ' C ' ' A' ' 55' ' ' PHE . 37.3 mt-30 -67.33 -34.98 78.47 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 116.105 -0.498 . . . . 2.1600000000000001 110.499 167.893 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -68.71 -54.09 18.24 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.146 -0.479 . . . . 0.70999999999999996 110.714 178.191 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -177.34 -82.06 0.06 OUTLIER Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 119.684 -1.246 . . . . 0.75 111.623 164.08 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.439 ' HB3' ' CB ' ' A' ' 84' ' ' LYS . 11.8 m-20 -115.36 106.91 14.56 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 111.536 0.199 . . . . 1.02 111.536 -178.075 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.55 HD11 ' N ' ' A' ' 56' ' ' GLU . 3.5 mt -84.07 146.95 6.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.099 -0.704 . . . . 0.46999999999999997 109.099 166.515 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.617 ' HB2' ' HA ' ' A' ' 84' ' ' LYS . 8.2 tp10 -102.64 -45.49 5.01 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.405 -0.591 . . . . 2.0699999999999998 109.405 177.349 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -157.49 123.87 4.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.634 -0.712 . . . . 2.48 109.802 179.556 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -115.7 141.13 48.49 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 120.929 0.395 . . . . 0.44 110.315 172.682 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.438 HG13 ' HB2' ' A' ' 80' ' ' PHE . 2.4 p -151.57 144.25 16.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.31 -0.859 . . . . 1.3799999999999999 109.907 -174.629 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 57.5 t -114.3 128.56 71.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 O-C-N 122.3 -0.25 . . . . 0.48999999999999999 110.558 176.315 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.524 HG22 ' HD3' ' A' ' 76' ' ' ARG . 31.7 mm -72.77 116.48 14.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.407 0.622 . . . . 0.71999999999999997 110.436 -179.602 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 73.3 p . . . . . 0 C--N 1.314 -0.945 0 CA-C-N 115.247 -0.888 . . . . 1.52 111.399 -175.175 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 44.7 m . . . . . 0 N--CA 1.451 -0.403 0 CA-C-O 121.211 0.529 . . . . 1.8100000000000001 112.307 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.524 ' HD3' HG22 ' A' ' 67' ' ' ILE . 66.4 mtp180 -48.92 -12.49 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 115.161 -0.927 . . . . 2.5600000000000001 113.33 171.159 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 92.96 2.99 66.12 Favored Glycine 0 N--CA 1.441 -0.977 0 C-N-CA 120.378 -0.915 . . . . 0.64000000000000001 112.426 178.245 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -114.56 136.91 52.51 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.504 -0.924 . . . . 1.1799999999999999 108.504 178.922 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -134.55 179.11 17.91 Favored Glycine 0 N--CA 1.435 -1.405 0 C-N-CA 119.574 -1.298 . . . . 0.58999999999999997 113.788 178.699 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.438 ' HB2' HG13 ' A' ' 65' ' ' VAL . 50.1 m-85 -144.71 124.04 13.04 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 113.787 -1.207 . . . . 0.63 110.124 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 53.0 t -127.79 106.98 15.69 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 CA-C-N 115.362 -0.835 . . . . 0.40999999999999998 109.355 175.922 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.509 ' HA ' ' O ' ' A' ' 35' ' ' THR . 70.5 m -94.86 132.09 40.05 Favored 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 108.759 -0.83 . . . . 0.46999999999999997 108.759 174.379 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' MET . . . . . 0.425 ' HA ' ' HA ' ' A' ' 61' ' ' ILE . 26.5 mtp -99.96 156.26 17.25 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 109.132 -0.692 . . . . 0.88 109.132 -176.459 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.617 ' HA ' ' HB2' ' A' ' 62' ' ' GLU . 18.1 ttmt -60.22 -49.8 76.19 Favored 'General case' 0 C--N 1.327 -0.379 0 O-C-N 123.421 0.45 . . . . 1.9199999999999999 110.554 -170.569 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -129.52 148.03 51.38 Favored 'General case' 0 C--O 1.245 0.864 0 CA-C-O 122.121 0.962 . . . . 1.6799999999999999 111.926 166.171 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.575 ' O ' ' HG3' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -47.67 -24.61 0.96 Allowed 'General case' 0 C--O 1.214 -0.808 0 CA-C-N 113.708 -1.587 . . . . 3.6600000000000001 114.096 176.685 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -58.0 -44.76 87.38 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 119.502 1.047 . . . . 0.66000000000000003 111.483 175.333 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 49.9 m -71.96 -38.88 69.69 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.577 -0.449 . . . . 0.78000000000000003 109.863 177.205 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.463 ' HB3' ' HA ' ' A' ' 86' ' ' ARG . . . -56.61 -28.89 61.41 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.916 -0.584 . . . . 0.46000000000000002 111.789 173.834 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.575 ' HG3' ' O ' ' A' ' 86' ' ' ARG . 22.1 mt-10 -72.85 -43.97 61.96 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.471 0.653 . . . . 2.1099999999999999 109.316 -179.686 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.434 ' O ' ' HG3' ' A' ' 94' ' ' LYS . 97.3 mtt180 -55.22 -41.93 72.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.983 -1.008 . . . . 3.8199999999999998 111.254 176.036 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -69.36 -47.05 65.51 Favored 'General case' 0 C--O 1.219 -0.54 0 C-N-CA 120.971 -0.292 . . . . 0.92000000000000004 111.533 174.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 48.4 t -48.5 -44.41 35.96 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 113.112 0.782 . . . . 1.1599999999999999 113.112 177.381 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.54 ' HE2' ' HB2' ' A' ' 95' ' ' ASP . 0.0 OUTLIER -60.44 -22.89 63.95 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 118.314 0.506 . . . . 4.2000000000000002 111.661 176.57 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.54 ' HB2' ' HE2' ' A' ' 94' ' ' LYS . 10.3 t70 -99.65 100.72 11.51 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 115.48 -0.782 . . . . 2.2400000000000002 110.274 -177.529 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.425 ' HD3' ' O ' ' A' ' 94' ' ' LYS . 55.8 Cg_endo -90.72 113.78 0.44 Allowed 'Trans proline' 0 N--CA 1.451 -0.994 0 C-N-CA 123.113 2.542 . . . . 2.3799999999999999 113.921 -171.697 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.543 ' HB3' ' HD2' ' A' ' 104' ' ' LYS . 1.0 OUTLIER 70.18 92.42 0.06 OUTLIER Pre-proline 0 N--CA 1.467 0.388 0 CA-C-N 114.495 -1.23 . . . . 3.0299999999999998 111.464 175.978 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 98' ' ' PRO . . . . . 0.626 ' O ' ' HA ' ' A' ' 104' ' ' LYS . 73.4 Cg_endo -82.3 168.75 14.71 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 123.843 3.029 . . . . 1.29 113.926 -175.303 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 48.6 mm -102.22 118.07 48.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 CA-C-N 114.1 -1.409 . . . . 1.8100000000000001 108.737 178.057 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 70.9 mt -137.65 124.16 27.79 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.233 0 N-CA-C 110.462 -0.199 . . . . 0.98999999999999999 110.462 -167.268 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.558 ' HB3' ' HG2' ' A' ' 43' ' ' PRO . 37.9 t70 44.51 48.15 8.38 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-O 121.288 0.566 . . . . 1.3700000000000001 111.25 -179.219 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 77.0 2.3 77.15 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 115.478 0.951 . . . . 1.5600000000000001 115.478 179.682 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 13.0 tpt180 -141.92 130.52 22.66 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 118.487 1.143 . . . . 4.1299999999999999 112.01 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.626 ' HA ' ' O ' ' A' ' 98' ' ' PRO . 16.8 ttpp -60.1 141.93 55.0 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.388 -0.369 . . . . 2.73 111.527 172.376 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.461 ' O ' ' HD2' ' A' ' 98' ' ' PRO . . . -124.32 167.78 13.88 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 109.035 -0.728 . . . . 1.04 109.035 177.822 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -97.7 106.93 19.32 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 122.133 0.968 . . . . 2.04 111.838 -178.166 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.574 HG13 HG23 ' A' ' 37' ' ' ILE . 24.6 t -96.48 113.95 32.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 113.517 -1.674 . . . . 1.0600000000000001 112.104 172.567 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -134.36 144.34 48.17 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 114.497 -1.228 . . . . 2.4900000000000002 108.882 172.278 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.482 HD12 ' CD1' ' A' ' 111' ' ' TYR . 0.1 OUTLIER -68.86 93.3 0.54 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.878 0.371 . . . . 1.23 110.384 177.782 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 110' ' ' ALA . . . . . 0.723 ' HB2' ' HB2' ' A' ' 38' ' ' PHE . . . -36.42 -19.12 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 118.223 2.675 . . . . 0.91000000000000003 118.223 177.296 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.482 ' CD1' HD12 ' A' ' 109' ' ' LEU . 0.3 OUTLIER . . . . . 0 CA--C 1.545 0.759 0 CA-C-N 121.534 1.97 . . . . 1.3999999999999999 109.99 175.29 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 43.0 ttp . . . . . 0 C--O 1.197 -1.699 0 N-CA-C 109.497 -0.557 . . . . 1.49 109.497 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 34' ' ' PHE . . . . . 0.501 ' O ' ' HB2' ' A' ' 86' ' ' ARG . 15.4 m-30 -92.22 42.19 1.09 Allowed 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 115.43 1.641 . . . . 1.5 115.43 175.559 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.404 HG22 ' N ' ' A' ' 86' ' ' ARG . 16.2 p -147.89 20.06 1.13 Allowed 'General case' 0 N--CA 1.485 1.314 0 CA-C-N 122.219 2.282 . . . . 0.53000000000000003 110.821 177.474 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.637 ' HE3' ' HD1' ' A' ' 80' ' ' PHE . 3.1 tmtm? -129.58 100.85 5.68 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-O 122.351 1.072 . . . . 2.75 110.753 -160.84 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 43.1 mt -88.48 142.35 13.03 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 O-C-N 121.677 -0.639 . . . . 0.84999999999999998 111.894 -170.785 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.45 ' HB3' ' O ' ' A' ' 108' ' ' ASN . 49.3 t80 -102.17 128.12 48.81 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.348 -0.982 . . . . 0.70999999999999996 108.348 169.39 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.7 t -120.98 89.09 1.35 Allowed 'Isoleucine or valine' 0 C--O 1.217 -0.652 0 C-N-CA 119.995 -0.682 . . . . 0.92000000000000004 110.128 -176.778 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -59.14 154.67 28.65 Favored Glycine 0 C--O 1.221 -0.663 0 C-N-CA 118.113 -1.994 . . . . 0.83999999999999997 114.513 165.695 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 96.15 39.16 4.35 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 121.105 -0.569 . . . . 0.68000000000000005 114.189 170.417 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.675 HD12 HG21 ' A' ' 46' ' ' THR . 2.9 mm? -93.68 125.24 54.3 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 117.122 0.461 . . . . 1.28 109.96 173.381 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.545 ' HG2' ' HB3' ' A' ' 101' ' ' ASP . 50.0 Cg_exo -49.08 155.88 2.58 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.779 2.319 . . . . 0.57999999999999996 111.953 171.406 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -69.42 -3.4 14.2 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.433 0.531 . . . . 1.05 112.433 -173.029 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -110.05 -8.95 14.75 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 120.545 0.212 . . . . 2.0099999999999998 111.016 179.028 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.675 HG21 HD12 ' A' ' 42' ' ' LEU . 30.0 m -62.69 133.68 55.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.952 0.406 . . . . 0.71999999999999997 111.156 -173.609 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 12.0 p -107.63 158.38 17.3 Favored 'General case' 0 C--O 1.251 1.183 0 CA-C-O 121.856 0.836 . . . . 0.55000000000000004 112.06 -177.648 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.518 ' HA ' HG23 ' A' ' 66' ' ' VAL . 2.6 m-20 -49.99 -30.93 11.5 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 114.323 -1.308 . . . . 0.48999999999999999 111.122 177.411 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.573 ' O ' ' HG2' ' A' ' 53' ' ' GLU . 60.6 pttt -78.77 -29.26 44.93 Favored 'General case' 0 C--O 1.215 -0.746 0 N-CA-C 108.799 -0.815 . . . . 2.7599999999999998 108.799 -174.849 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.576 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 7.0 m -64.91 -41.75 95.31 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 115.764 -0.653 . . . . 0.57999999999999996 110.068 179.299 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.591 HD21 HD11 ' A' ' 42' ' ' LEU . 18.8 mt -62.05 -46.2 90.18 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 119.361 -0.935 . . . . 0.84999999999999998 110.083 173.854 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' HIS . . . . . 0.535 ' HA ' ' CD1' ' A' ' 61' ' ' ILE . 59.6 t-80 -53.58 -32.39 50.77 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 116.27 -0.423 . . . . 0.58999999999999997 110.911 172.474 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.576 ' HB2' ' O ' ' A' ' 50' ' ' THR . 45.2 mm-40 -68.05 -40.05 82.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.314 -0.857 . . . . 1.52 109.489 -175.664 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' TYR . . . . . 0.541 ' O ' ' HB2' ' A' ' 57' ' ' GLN . 24.4 t80 -80.75 -40.82 24.55 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.421 -0.809 . . . . 1.1200000000000001 111.499 -173.741 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.598 ' C ' ' H ' ' A' ' 57' ' ' GLN . 58.2 m-85 -85.56 -32.03 22.35 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 114.005 1.113 . . . . 0.56000000000000005 114.005 -166.21 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.659 ' N ' HD11 ' A' ' 61' ' ' ILE . 15.7 pt-20 -63.28 4.13 0.24 Allowed 'General case' 0 N--CA 1.48 1.061 0 CA-C-O 122.168 0.985 . . . . 1.5700000000000001 111.145 176.805 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.598 ' H ' ' C ' ' A' ' 55' ' ' PHE . 37.5 mt-30 -92.32 -18.11 23.79 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 113.753 -1.567 . . . . 2.1600000000000001 110.73 -176.259 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -102.62 -29.43 11.55 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.506 0.67 . . . . 0.70999999999999996 109.692 177.246 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.413 ' O ' ' HA ' ' A' ' 56' ' ' GLU . . . 178.46 -174.6 46.81 Favored Glycine 0 N--CA 1.443 -0.861 0 N-CA-C 110.255 -1.138 . . . . 0.75 110.255 -177.754 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -64.0 137.34 57.95 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 117.388 0.594 . . . . 1.02 110.492 175.409 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.659 HD11 ' N ' ' A' ' 56' ' ' GLU . 7.5 mt -101.91 142.42 16.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 105.692 -1.966 . . . . 0.46999999999999997 105.692 172.94 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.475 ' OE1' ' HE3' ' A' ' 84' ' ' LYS . 7.7 tp10 -88.75 -37.13 15.71 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 119.61 1.096 . . . . 2.0699999999999998 109.155 178.9 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -166.24 127.44 1.78 Allowed 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.063 -0.517 . . . . 2.48 110.792 177.868 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -115.01 134.33 55.28 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.1 0.476 . . . . 0.44 110.753 174.615 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.523 HG13 ' HB2' ' A' ' 80' ' ' PHE . 2.9 p -147.32 136.71 16.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.248 -0.887 . . . . 1.3799999999999999 111.231 -174.61 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.518 HG23 ' HA ' ' A' ' 48' ' ' ASP . 78.4 t -107.36 131.37 57.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 109.043 -0.725 . . . . 0.48999999999999999 109.043 176.317 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 49.0 mm -88.23 139.47 17.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-O 121.867 0.841 . . . . 0.71999999999999997 112.625 -168.392 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.687 ' O ' ' HD2' ' A' ' 76' ' ' ARG . 34.4 p . . . . . 0 N--CA 1.444 -0.731 0 N-CA-C 105.994 -1.854 . . . . 1.52 105.994 172.196 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 2.8 m . . . . . 0 N--CA 1.448 -0.538 0 N-CA-C 108.975 -0.75 . . . . 1.8100000000000001 108.975 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.687 ' HD2' ' O ' ' A' ' 68' ' ' THR . 15.1 mtt180 -72.45 -10.62 60.02 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.188 -0.46 . . . . 2.5600000000000001 112.042 -172.452 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 73.29 8.71 75.75 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.56 -0.828 . . . . 0.64000000000000001 112.059 176.897 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.509 ' CD2' ' HB3' ' A' ' 76' ' ' ARG . 9.9 m-85 -111.18 141.62 44.46 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.44 -0.948 . . . . 1.1799999999999999 108.44 178.401 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -126.96 164.76 20.43 Favored Glycine 0 N--CA 1.439 -1.157 0 C-N-CA 120.274 -0.965 . . . . 0.58999999999999997 112.214 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.637 ' HD1' ' HE3' ' A' ' 36' ' ' LYS . 51.0 m-85 -139.44 123.12 17.46 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.25 0.547 . . . . 0.63 109.621 178.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.496 HG11 ' CD2' ' A' ' 55' ' ' PHE . 54.0 t -125.27 108.14 19.3 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 115.626 -0.715 . . . . 0.40999999999999998 110.184 -178.483 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.451 ' HA ' ' HA ' ' A' ' 36' ' ' LYS . 18.5 m -92.83 118.03 30.67 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 109.128 -0.693 . . . . 0.46999999999999997 109.128 178.022 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 80.3 mmm -85.91 -179.95 6.9 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.244 0.545 . . . . 0.88 110.326 178.897 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.475 ' HE3' ' OE1' ' A' ' 62' ' ' GLU . 6.4 tptm -93.99 -7.38 42.99 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.345 -0.843 . . . . 1.9199999999999999 109.156 -171.671 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -167.28 154.17 8.48 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 114.672 -1.149 . . . . 1.6799999999999999 110.12 -162.217 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.501 ' HB2' ' O ' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -76.17 -49.49 17.11 Favored 'General case' 0 C--O 1.223 -0.341 0 N-CA-C 109.764 -0.458 . . . . 3.6600000000000001 109.764 -174.258 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -51.69 -39.34 58.12 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.511 -0.768 . . . . 0.66000000000000003 112.22 176.321 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.663 ' HA ' ' HE ' ' A' ' 91' ' ' ARG . 14.6 m -69.17 -40.54 78.06 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.838 0.351 . . . . 0.78000000000000003 110.825 176.72 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -55.31 -46.08 76.29 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.049 -0.523 . . . . 0.46000000000000002 110.525 170.767 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -60.34 -41.27 93.25 Favored 'General case' 0 C--O 1.222 -0.364 0 CA-C-O 121.268 0.556 . . . . 2.1099999999999999 110.464 174.463 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.663 ' HE ' ' HA ' ' A' ' 88' ' ' SER . 16.4 mtm180 -56.72 -50.92 70.76 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 114.713 -1.13 . . . . 3.8199999999999998 111.641 176.728 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -59.96 -27.31 66.7 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 113.837 1.051 . . . . 0.92000000000000004 113.837 173.748 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 44.7 t -79.97 -36.1 36.58 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.943 0.878 . . . . 1.1599999999999999 109.097 179.404 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.576 ' HB3' ' O ' ' A' ' 91' ' ' ARG . 59.8 tptt -50.4 -18.8 0.69 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 113.675 -1.602 . . . . 4.2000000000000002 112.511 170.01 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -104.52 89.15 2.51 Favored Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 109.118 -0.697 . . . . 2.2400000000000002 109.118 166.015 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' PRO . . . . . 0.575 ' HD3' ' O ' ' A' ' 94' ' ' LYS . 5.6 Cg_exo -73.67 173.77 13.36 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.923 2.415 . . . . 2.3799999999999999 111.138 -177.887 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 8.6 p30 5.92 67.74 0.05 OUTLIER Pre-proline 0 N--CA 1.479 1.014 0 O-C-N 124.2 0.937 . . . . 3.0299999999999998 113.417 -160.71 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -69.13 133.39 26.59 Favored 'Trans proline' 0 CA--C 1.511 -0.644 0 C-N-CA 121.723 1.615 . . . . 1.29 108.962 177.725 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.569 HG22 ' C ' ' A' ' 102' ' ' GLY . 17.2 mm -87.1 95.92 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.893 0 CA-C-N 119.307 0.958 . . . . 1.8100000000000001 108.671 -172.92 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.441 ' C ' ' N ' ' A' ' 102' ' ' GLY . 11.2 mm -89.54 150.02 3.85 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.422 0 CA-C-O 121.461 0.648 . . . . 0.98999999999999999 111.734 -170.683 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.545 ' HB3' ' HG2' ' A' ' 43' ' ' PRO . 30.5 t70 36.24 20.65 0.0 OUTLIER 'General case' 0 CA--C 1.559 1.306 0 CA-C-N 113.898 -1.501 . . . . 1.3700000000000001 111.916 -156.708 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.569 ' C ' HG22 ' A' ' 99' ' ' ILE . . . 89.18 17.31 56.03 Favored Glycine 0 CA--C 1.535 1.31 0 C-N-CA 120.852 -0.69 . . . . 1.5600000000000001 113.131 -179.546 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.487 ' N ' HG22 ' A' ' 99' ' ' ILE . 39.5 mmt180 -132.38 140.73 48.6 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.548 0.739 . . . . 4.1299999999999999 110.035 176.18 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -58.58 112.68 1.69 Allowed 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 113.74 1.015 . . . . 2.73 113.74 -171.566 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -92.34 164.83 13.36 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 114.752 -1.113 . . . . 1.04 112.993 177.581 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -123.52 113.46 18.75 Favored 'General case' 0 C--O 1.253 1.27 0 CA-C-N 115.098 -0.956 . . . . 2.04 110.245 177.763 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 51.0 t -98.18 127.77 50.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 114.63 -1.168 . . . . 1.0600000000000001 111.444 -173.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ASN . . . . . 0.45 ' O ' ' HB3' ' A' ' 38' ' ' PHE . 66.5 t30 -157.39 152.75 26.23 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.517 -0.765 . . . . 2.4900000000000002 109.909 178.532 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.596 HD12 ' HE1' ' A' ' 111' ' ' TYR . 7.7 mt -65.97 125.93 26.98 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 113.539 0.94 . . . . 1.23 113.539 -177.627 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -45.92 -44.49 14.71 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 113.944 -1.48 . . . . 0.91000000000000003 113.217 172.521 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.596 ' HE1' HD12 ' A' ' 109' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.473 0.692 0 O-C-N 121.866 -0.521 . . . . 1.3999999999999999 111.418 -173.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.887 0 N-CA-C 111.872 -0.491 . . . . 13.029999999999999 111.872 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -118.39 -76.08 0.58 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.914 0.388 . . . . 11.06 111.067 -177.312 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 53.2 ttm -81.35 94.17 6.72 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.168 0.509 . . . . 9.8499999999999996 110.239 -177.63 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 149.31 -11.65 1.02 Allowed Glycine 0 N--CA 1.445 -0.713 0 CA-C-N 115.651 -0.704 . . . . 6.6900000000000004 111.831 -177.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 19.6 m -60.17 -45.14 94.09 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 121.267 0.556 . . . . 5.5499999999999998 110.579 176.084 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.434 ' HD2' ' OE1' ' A' ' 62' ' ' GLU . 55.4 mtm180 -136.86 146.27 45.38 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.578 -0.737 . . . . 3.8700000000000001 110.166 178.402 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -126.35 127.67 45.87 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.959 -0.564 . . . . 3.5299999999999998 109.648 178.171 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.461 ' O ' ' HB2' ' A' ' 36' ' ' LYS . 9.9 p -82.56 -22.17 35.02 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.451 -0.341 . . . . 1.6899999999999999 111.892 -177.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 51.9 ttp -61.84 -45.43 93.85 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.043 0.386 . . . . 1.49 112.043 -176.286 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.474 ' HB3' ' HG3' ' A' ' 86' ' ' ARG . 8.9 m-85 -91.76 -2.34 56.99 Favored 'General case' 0 C--N 1.331 -0.212 0 O-C-N 122.226 -0.296 . . . . 1.5 111.63 -176.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.581 ' O ' ' HA ' ' A' ' 82' ' ' THR . 41.1 p -110.68 -3.49 15.82 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.877 -0.329 . . . . 0.53000000000000003 111.447 -178.845 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.461 ' HB2' ' O ' ' A' ' 32' ' ' THR . 63.2 tttm -85.64 103.24 14.28 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.97 -0.559 . . . . 2.75 110.207 -176.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 98.7 mt -105.57 141.71 20.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 C-N-CA 123.108 0.563 . . . . 0.84999999999999998 111.577 -173.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.401 ' HD1' ' CE1' ' A' ' 80' ' ' PHE . 58.9 t80 -95.79 132.41 41.06 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.645 -0.707 . . . . 0.70999999999999996 109.505 174.007 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.788 HG12 HD11 ' A' ' 42' ' ' LEU . 3.6 t -120.96 141.92 39.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 121.082 0.468 . . . . 0.92000000000000004 110.314 -178.313 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.591 ' HA3' ' HB2' ' A' ' 106' ' ' ASN . . . -141.95 159.52 26.98 Favored Glycine 0 C--O 1.219 -0.807 0 CA-C-N 115.72 -0.673 . . . . 0.83999999999999997 112.735 -167.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.77 37.38 93.38 Favored Glycine 0 CA--C 1.522 0.503 0 C-N-CA 121.374 -0.441 . . . . 0.68000000000000005 113.817 172.462 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.788 HD11 HG12 ' A' ' 39' ' ' VAL . 8.2 mp -87.54 134.0 36.93 Favored Pre-proline 0 C--N 1.326 -0.418 0 O-C-N 122.694 -0.298 . . . . 1.28 110.626 178.332 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.622 ' HD2' ' OG1' ' A' ' 46' ' ' THR . 51.5 Cg_exo -53.33 155.89 11.7 Favored 'Trans proline' 0 N--CA 1.463 -0.282 0 C-N-CA 122.995 2.463 . . . . 0.57999999999999996 112.101 175.721 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.523 ' CE2' ' C5 ' ' B' ' 2' ' ' ' G' . 66.9 m-85 -69.09 1.87 3.22 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.129 0.49 . . . . 1.05 110.963 -179.021 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 4.2 t-80 -106.88 -16.46 14.46 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.747 -0.66 . . . . 2.0099999999999998 110.627 178.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.796 HG23 HG21 ' A' ' 50' ' ' THR . 61.2 m -71.77 138.54 48.49 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.257 -0.428 . . . . 0.71999999999999997 111.467 -175.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 16.9 p -130.96 -178.35 4.78 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-O 120.967 0.413 . . . . 0.55000000000000004 111.391 -176.396 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -62.74 -33.52 75.32 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.969 -0.56 . . . . 0.48999999999999999 110.756 -176.53 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -71.39 -33.93 69.94 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.286 -0.635 . . . . 2.7599999999999998 109.286 -179.48 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.796 HG21 HG23 ' A' ' 46' ' ' THR . 81.2 m -61.24 -45.29 95.16 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.57 -0.741 . . . . 0.57999999999999996 110.686 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 54.0 mt -67.57 -35.33 78.82 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.928 -0.578 . . . . 0.84999999999999998 111.089 178.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 57.7 t-80 -61.89 -54.02 47.78 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.25 -0.648 . . . . 0.58999999999999997 109.25 176.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -58.66 -37.4 75.89 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.826 -0.624 . . . . 1.52 112.005 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -76.87 -37.59 55.24 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 120.789 0.328 . . . . 1.1200000000000001 111.714 -178.091 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -85.22 -25.23 27.45 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 113.402 0.89 . . . . 0.56000000000000005 113.402 -174.161 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.66 ' N ' HD11 ' A' ' 61' ' ' ILE . 10.8 pt-20 -64.52 -18.14 64.55 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.642 0.734 . . . . 1.5700000000000001 109.984 179.631 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -55.45 -27.66 49.54 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.542 -1.208 . . . . 2.1600000000000001 111.755 170.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -96.06 -21.28 18.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.546 -0.297 . . . . 0.70999999999999996 110.802 -178.233 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 151.25 -159.74 28.35 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.565 -0.826 . . . . 0.75 112.419 177.021 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -65.9 121.94 16.21 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.028 0.442 . . . . 1.02 111.671 -178.621 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.66 HD11 ' N ' ' A' ' 56' ' ' GLU . 12.5 mt -101.41 130.74 50.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 109.235 -0.654 . . . . 0.46999999999999997 109.235 176.023 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.434 ' OE1' ' HD2' ' A' ' 30' ' ' ARG . 28.4 tt0 -85.32 -53.37 5.27 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 121.181 -0.208 . . . . 2.0699999999999998 111.33 176.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -140.28 129.59 23.85 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.711 -0.222 . . . . 2.48 111.223 -175.001 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -121.6 116.92 25.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.186 0.517 . . . . 0.44 111.056 174.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.427 HG21 ' H22' ' B' ' 6' ' ' ' G' . 30.3 m -128.64 145.43 35.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.454 -0.794 . . . . 1.3799999999999999 112.123 -179.474 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 91.3 t -116.76 133.73 62.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.525 -0.761 . . . . 0.48999999999999999 110.734 174.465 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 36.8 mm -76.92 152.5 5.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.715 -0.675 . . . . 0.71999999999999997 109.524 177.154 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 39.5 p -136.14 167.22 21.67 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 105.407 -2.072 . . . . 1.52 105.407 -174.21 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.529 ' HB3' ' H ' ' A' ' 74' ' ' LYS . 32.3 t70 -62.59 154.04 30.23 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 118.713 0.688 . . . . 2.4900000000000002 111.888 -171.512 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.463 ' HD2' ' O ' ' A' ' 70' ' ' ARG . 1.2 tmm_? -80.11 -24.12 40.75 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.805 -0.634 . . . . 6.0499999999999998 110.476 -173.393 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 -108.09 -61.77 1.54 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.43 -0.35 . . . . 4.0499999999999998 111.259 -177.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 45.6 p -83.09 -21.59 33.65 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.858 0.361 . . . . 3.0800000000000001 111.239 -177.213 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 56.74 66.77 1.1 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.75 0.786 . . . . 3.2999999999999998 111.133 -174.452 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.529 ' H ' ' HB3' ' A' ' 69' ' ' ASP . 66.8 mttm -111.41 168.33 9.62 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 106.998 -1.482 . . . . 3.4900000000000002 106.998 172.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 6.3 m -71.1 97.31 1.47 Allowed 'General case' 0 C--N 1.316 -0.857 0 C-N-CA 120.423 -0.511 . . . . 1.8100000000000001 110.792 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 73.7 mtp180 -58.51 -29.55 66.37 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.769 -0.65 . . . . 2.5600000000000001 111.191 179.057 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.558 ' HA3' ' H22' ' B' ' 2' ' ' ' G' . . . 93.37 30.37 9.28 Favored Glycine 0 N--CA 1.439 -1.109 0 C-N-CA 120.506 -0.854 . . . . 0.64000000000000001 112.18 -177.444 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.409 ' CE1' " H1'" ' B' ' 4' ' ' ' G' . 24.5 m-85 -131.49 141.83 49.84 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 107.921 -1.14 . . . . 1.1799999999999999 107.921 175.167 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -141.72 -171.75 13.04 Favored Glycine 0 N--CA 1.439 -1.142 0 C-N-CA 120.089 -1.053 . . . . 0.58999999999999997 111.782 -174.389 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.416 ' HB2' HG23 ' A' ' 65' ' ' VAL . 55.4 m-85 -154.91 124.6 6.52 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.582 -0.896 . . . . 0.63 108.582 -177.491 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.475 HG23 HG21 ' A' ' 39' ' ' VAL . 53.8 t -119.58 124.14 72.37 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 CA-C-N 115.742 -0.663 . . . . 0.40999999999999998 110.133 -177.149 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.581 ' HA ' ' O ' ' A' ' 35' ' ' THR . 17.3 m -109.41 116.33 31.62 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 107.948 -1.13 . . . . 0.46999999999999997 107.948 175.658 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 92.5 mmm -87.72 162.69 16.92 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.098 -0.705 . . . . 0.88 109.098 -175.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 44.8 tttm -85.04 -10.47 56.9 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 120.873 0.368 . . . . 1.9199999999999999 110.997 -175.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -149.5 147.78 28.62 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-N 116.377 -0.374 . . . . 1.6799999999999999 110.562 175.02 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.483 ' O ' ' HB3' ' A' ' 89' ' ' ALA . 1.3 tmt_? -67.49 -22.72 65.45 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 112.255 0.465 . . . . 3.6600000000000001 112.255 -176.318 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.05 -47.27 77.95 Favored 'General case' 0 N--CA 1.464 0.239 0 O-C-N 121.519 -0.738 . . . . 0.66000000000000003 111.285 178.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 19.1 m -65.92 -31.13 71.88 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.605 0.717 . . . . 0.78000000000000003 109.754 175.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.483 ' HB3' ' O ' ' A' ' 86' ' ' ARG . . . -59.32 -48.97 79.62 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.123 -1.398 . . . . 0.46000000000000002 109.818 174.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -55.87 -51.68 66.71 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.203 -0.453 . . . . 2.1099999999999999 111.654 174.44 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.483 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 23.7 mmt180 -57.78 -45.39 86.07 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.315 -0.402 . . . . 3.8199999999999998 111.198 -178.026 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -58.66 -48.12 82.14 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.09 -0.505 . . . . 0.92000000000000004 111.147 176.175 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 49.2 t -75.46 -2.97 31.25 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 111.945 0.35 . . . . 1.1599999999999999 111.945 -176.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.483 ' HB2' ' O ' ' A' ' 91' ' ' ARG . 4.5 mmmm -59.95 -48.74 80.45 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 121.044 -0.262 . . . . 4.2000000000000002 111.463 176.354 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.439 ' HA ' ' HD3' ' A' ' 96' ' ' PRO . 32.5 t0 -106.39 107.57 60.21 Favored Pre-proline 0 C--N 1.328 -0.365 0 N-CA-C 109.931 -0.396 . . . . 2.2400000000000002 109.931 179.482 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 95' ' ' ASP . 6.9 Cg_exo -74.48 -10.32 22.03 Favored 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 123.082 2.521 . . . . 2.3799999999999999 113.51 -176.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.707 ' HA ' ' O ' ' A' ' 105' ' ' ALA . 2.0 m120 -142.81 68.57 19.02 Favored Pre-proline 0 N--CA 1.464 0.254 0 N-CA-C 112.824 0.676 . . . . 3.0299999999999998 112.824 -178.609 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -81.29 154.46 18.85 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.803 2.336 . . . . 1.29 110.818 172.177 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 42.6 mm -85.63 91.95 3.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 120.418 -0.513 . . . . 1.8100000000000001 110.478 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 52.3 mt -89.95 107.77 18.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.702 0.763 . . . . 0.98999999999999999 112.681 178.275 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.407 ' O ' ' HG2' ' A' ' 43' ' ' PRO . 32.2 t70 66.13 43.59 2.83 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 113.901 -1.5 . . . . 1.3700000000000001 110.438 167.362 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 88.99 -7.63 81.74 Favored Glycine 0 CA--C 1.518 0.267 0 CA-C-N 115.056 -0.975 . . . . 1.5600000000000001 114.551 177.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.532 ' HB2' ' HG3' ' A' ' 43' ' ' PRO . 14.7 tpt180 -126.66 141.79 51.74 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 117.992 0.896 . . . . 4.1299999999999999 110.709 178.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -64.62 131.57 47.34 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.088 -0.708 . . . . 2.73 109.088 172.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.707 ' O ' ' HA ' ' A' ' 97' ' ' ASN . . . -118.64 153.54 34.15 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.821 -0.627 . . . . 1.04 110.087 -169.566 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.591 ' HB2' ' HA3' ' A' ' 40' ' ' GLY . 6.6 m-20 -96.68 140.15 31.71 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.069 0.461 . . . . 2.04 110.281 178.162 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.436 ' O ' ' HA ' ' A' ' 96' ' ' PRO . 70.6 t -146.08 113.75 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.029 -0.987 . . . . 1.0600000000000001 110.626 -174.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.454 HD22 ' HA ' ' A' ' 108' ' ' ASN . 0.8 OUTLIER -159.3 165.06 34.24 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.097 -0.705 . . . . 2.4900000000000002 109.097 174.906 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.511 ' HB3' ' CD1' ' A' ' 111' ' ' TYR . 2.0 mm? -71.96 129.31 38.25 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.254 -0.647 . . . . 1.23 109.254 176.479 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -57.84 -31.57 66.78 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.575 0.583 . . . . 0.91000000000000003 112.575 -173.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.511 ' CD1' ' HB3' ' A' ' 109' ' ' LEU . 2.5 p90 -75.81 -8.7 57.52 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.758 0.314 . . . . 1.3999999999999999 111.299 -176.454 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 98.2 mt -81.23 -31.51 33.79 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.112 0.482 . . . . 1.97 110.589 178.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -122.21 34.53 3.8 Favored Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 111.313 -0.715 . . . . 2.1400000000000001 111.313 -179.168 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -90.2 133.29 35.0 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.888 -0.412 . . . . 2.6600000000000001 109.888 -178.235 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 50.2 mtmt -136.57 74.92 52.0 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.126 0.489 . . . . 4.1600000000000001 109.912 173.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -91.62 -16.59 1.22 Allowed 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 123.538 2.826 . . . . 5.5300000000000002 112.551 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 76.9 ttt180 -167.98 168.5 11.99 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 107.83 -1.174 . . . . 8.5999999999999996 107.83 -176.582 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.447 ' O ' ' HB2' ' A' ' 119' ' ' ASN . 5.9 t 44.9 86.74 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.546 0 O-C-N 124.151 0.907 . . . . 6.3700000000000001 111.688 -177.705 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.447 ' HB2' ' O ' ' A' ' 118' ' ' THR . 49.9 m-80 77.7 80.4 0.08 Allowed 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 114.777 -1.102 . . . . 7.8499999999999996 110.83 -172.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 42.9 t -109.73 95.06 3.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.922 -0.581 . . . . 9.3699999999999992 110.534 179.275 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.453 ' HA ' ' OE1' ' A' ' 121' ' ' GLN . 6.5 tp60 . . . . . 0 C--O 1.245 0.828 0 CA-C-N 115.473 -0.785 . . . . 12.279999999999999 109.451 176.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 1' ' ' ' G' . . . . . 0.471 " H4'" " O5'" ' B' ' 2' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.431 -0.582 0 C3'-C2'-C1' 99.888 -1.791 . 0.0 '__' . 4.9400000000000004 . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 2' ' ' ' G' . . . . . 0.558 ' H22' ' HA3' ' A' ' 77' ' ' GLY . . . . . . . . 0 O5'--C5' 1.427 -0.792 0 O4'-C1'-N19 110.533 2.333 . 0.0 OUTLIER . 4.8700000000000001 . . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 3' ' ' ' U' . . . . . 0.527 " H3'" " O4'" ' B' ' 4' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.424 -0.972 0 C5'-C4'-O4' 107.525 -1.196 . 0.0 OUTLIER . 5.0199999999999996 . . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 4' ' ' ' G' . . . . . 0.527 " O4'" " H3'" ' B' ' 3' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.423 -1.05 0 O4'-C4'-C3' 103.615 -1.346 . 0.0 OUTLIER '7D dist 2a' 2.6899999999999999 . . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 5' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.428 -0.777 0 C4'-C3'-C2' 103.885 1.185 . 0.0 OUTLIER . 1.9299999999999999 . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 6' ' ' ' G' . . . . . 0.427 ' H22' HG21 ' A' ' 65' ' ' VAL . . . . . . . . 0 O5'--C5' 1.425 -0.963 0 C4'-C3'-C2' 103.746 1.046 . 0.391 0b . 2.3799999999999999 . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.426 -0.868 0 C4'-C3'-C2' 103.575 0.875 . 0.0 OUTLIER . 4.1900000000000004 . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.696 0 N-CA-C 111.578 -0.609 . . . . 13.029999999999999 111.578 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -158.25 13.33 0.19 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.465 0.174 . . . . 11.06 110.677 178.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 55.2 ttp 58.66 85.03 0.1 Allowed 'General case' 0 N--CA 1.462 0.161 0 O-C-N 123.79 0.681 . . . . 9.8499999999999996 111.091 -173.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -142.57 -116.77 1.21 Allowed Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.795 -0.717 . . . . 6.6900000000000004 112.139 -179.378 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 15.3 t 63.6 13.53 7.37 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 122.961 0.504 . . . . 5.5499999999999998 111.465 -179.251 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.469 ' HE ' ' CD ' ' A' ' 62' ' ' GLU . 57.3 mtp85 -90.93 172.18 8.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.746 0.308 . . . . 3.8700000000000001 110.36 -179.651 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -79.39 105.75 10.92 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 110.116 -0.327 . . . . 3.5299999999999998 110.116 178.478 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.423 ' O ' ' HB2' ' A' ' 36' ' ' LYS . 74.3 p -100.05 -4.52 29.73 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.052 -0.522 . . . . 1.6899999999999999 110.075 176.467 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' MET . . . . . 0.479 ' O ' ' HB3' ' A' ' 111' ' ' TYR . 44.2 ttp -56.26 -66.87 0.36 Allowed 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 115.928 -0.578 . . . . 1.49 112.252 179.624 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -81.12 -44.88 17.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 118.65 0.659 . . . . 1.5 111.123 -174.619 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.473 ' HB ' ' O ' ' A' ' 83' ' ' MET . 56.8 p -56.04 -17.94 8.24 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 114.376 1.25 . . . . 0.53000000000000003 114.376 -175.718 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.722 ' HG2' ' HB3' ' A' ' 110' ' ' ALA . 29.2 ttpt -81.33 114.77 20.33 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.29 0.567 . . . . 2.75 111.68 -173.556 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 89.0 mt -105.62 134.18 47.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.364 -0.835 . . . . 0.84999999999999998 111.112 -179.227 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.694 ' HZ ' " H2'" ' B' ' 4' ' ' ' G' . 89.0 t80 -94.28 111.15 22.87 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.027 -0.731 . . . . 0.70999999999999996 109.027 175.175 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.6 t -100.75 139.8 21.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.278 0.561 . . . . 0.92000000000000004 110.24 -179.563 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.46 ' O ' ' HB1' ' A' ' 105' ' ' ALA . . . -139.99 135.92 7.44 Favored Glycine 0 N--CA 1.448 -0.523 0 CA-C-N 115.212 -0.904 . . . . 0.83999999999999997 112.798 -170.55 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 86.34 32.37 16.77 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.762 -0.732 . . . . 0.68000000000000005 113.049 176.619 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.683 HD11 HD21 ' A' ' 51' ' ' LEU . 2.8 mm? -74.21 117.3 60.55 Favored Pre-proline 0 C--N 1.328 -0.338 0 N-CA-C 109.736 -0.468 . . . . 1.28 109.736 177.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.57 ' HG2' ' HB3' ' A' ' 101' ' ' ASP . 81.8 Cg_exo -51.0 159.36 2.55 Favored 'Trans proline' 0 CA--C 1.527 0.129 0 C-N-CA 122.913 2.409 . . . . 0.57999999999999996 112.664 178.303 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.515 ' CE2' ' C4 ' ' B' ' 1' ' ' ' G' . 81.4 m-85 -69.94 -4.95 22.93 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 116.284 -0.416 . . . . 1.05 111.776 -171.673 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' HIS . . . . . 0.672 ' HB3' ' OD2' ' A' ' 101' ' ' ASP . 58.0 t-80 -101.41 -6.04 24.54 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 120.964 0.411 . . . . 2.0099999999999998 110.533 175.833 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.488 HG21 HD12 ' A' ' 42' ' ' LEU . 95.0 m -75.38 118.81 18.67 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.05 0.453 . . . . 0.71999999999999997 111.406 -178.016 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 11.7 p -108.62 -178.75 3.68 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-N 115.924 -0.58 . . . . 0.55000000000000004 110.824 177.513 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -64.64 -35.93 82.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.296 0.569 . . . . 0.48999999999999999 110.443 -176.185 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.571 ' O ' ' HG2' ' A' ' 53' ' ' GLU . 20.2 ptmt -65.93 -37.44 86.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.582 -0.736 . . . . 2.7599999999999998 110.592 179.37 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 49.9 m -59.49 -45.58 91.26 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.958 -0.564 . . . . 0.57999999999999996 110.403 178.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.683 HD21 HD11 ' A' ' 42' ' ' LEU . 39.5 mt -66.55 -32.95 74.63 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.736 -0.666 . . . . 0.84999999999999998 111.22 177.185 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.432 ' HA ' HD12 ' A' ' 61' ' ' ILE . 55.2 t-80 -65.27 -55.07 20.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.867 0.365 . . . . 0.58999999999999997 110.269 177.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.571 ' HG2' ' O ' ' A' ' 49' ' ' LYS . 9.0 mm-40 -57.93 -43.41 86.28 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.143 0.496 . . . . 1.52 112.211 -179.293 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -74.8 -35.0 62.49 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.108 -0.496 . . . . 1.1200000000000001 112.148 -174.575 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.764 ' HB2' HD11 ' A' ' 61' ' ' ILE . 7.5 m-85 -87.12 -25.17 24.26 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 113.493 0.923 . . . . 0.56000000000000005 113.493 -172.62 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -67.97 -16.39 64.04 Favored 'General case' 0 CA--C 1.522 -0.098 0 CA-C-O 121.544 0.688 . . . . 1.5700000000000001 109.557 179.368 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 28.5 mm-40 -56.59 -16.32 5.93 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.054 -0.976 . . . . 2.1600000000000001 112.459 169.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -99.51 -18.32 17.46 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.847 0.356 . . . . 0.70999999999999996 110.7 178.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 161.73 -112.96 0.54 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.482 -0.866 . . . . 0.75 112.998 176.393 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.612 ' HB3' ' HB3' ' A' ' 84' ' ' LYS . 7.9 m-20 -114.27 126.41 54.99 Favored 'General case' 0 C--N 1.329 -0.322 0 O-C-N 122.654 -0.321 . . . . 1.02 110.74 -179.026 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.764 HD11 ' HB2' ' A' ' 55' ' ' PHE . 32.4 mt -99.82 126.71 53.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 C-N-CA 120.903 -0.319 . . . . 0.46999999999999997 110.57 173.18 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.469 ' CD ' ' HE ' ' A' ' 30' ' ' ARG . 28.6 tt0 -83.61 -47.58 11.11 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.828 -0.624 . . . . 2.0699999999999998 109.928 176.801 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -156.57 130.27 8.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.73 -0.668 . . . . 2.48 110.743 179.398 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -115.36 116.36 28.13 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.931 -0.396 . . . . 0.44 109.931 175.265 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.569 HG21 ' N2 ' ' B' ' 6' ' ' ' G' . 4.2 m -133.22 115.67 23.85 Favored 'Isoleucine or valine' 0 C--O 1.24 0.553 0 CA-C-O 121.772 0.796 . . . . 1.3799999999999999 112.808 -176.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 94.0 t -72.56 126.08 32.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 114.881 -1.054 . . . . 0.48999999999999999 109.137 173.228 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.4 ' O ' ' HB2' ' A' ' 76' ' ' ARG . 31.1 mm -74.08 95.35 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.542 0 CA-C-O 121.336 0.588 . . . . 0.71999999999999997 110.268 -178.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.402 ' HB ' ' HA ' ' A' ' 73' ' ' GLN . 29.9 p -88.97 155.8 19.28 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-N 115.403 -0.817 . . . . 1.52 111.222 -176.737 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.715 ' HA ' ' NE ' ' A' ' 76' ' ' ARG . 36.3 t70 -50.76 144.81 7.74 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 113.964 -1.471 . . . . 2.4900000000000002 113.019 -170.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.418 HH11 ' HD2' ' A' ' 70' ' ' ARG . 7.8 ttp180 -70.94 -22.72 62.19 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.765 -0.652 . . . . 6.0499999999999998 111.991 -176.729 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -108.7 -19.51 13.4 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.736 0.303 . . . . 4.0499999999999998 111.076 -172.276 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 22.0 p -134.15 -27.6 1.4 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.774 0.321 . . . . 3.0800000000000001 111.734 -175.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.402 ' HA ' ' HB ' ' A' ' 68' ' ' THR . 83.1 mt-30 56.44 65.02 1.52 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.811 -0.631 . . . . 3.2999999999999998 111.28 -175.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 57.0 mtmt -102.21 -63.72 1.13 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.586 -0.734 . . . . 3.4900000000000002 112.131 -178.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.479 ' O ' ' HB2' ' A' ' 76' ' ' ARG . 11.7 p -160.44 -69.26 0.07 Allowed 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.732 -0.387 . . . . 1.8100000000000001 111.895 -176.532 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.715 ' NE ' ' HA ' ' A' ' 69' ' ' ASP . 81.1 mtt180 76.63 -25.17 0.21 Allowed 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.371 0.669 . . . . 2.5600000000000001 111.43 -179.588 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.414 ' HA3' ' C6 ' ' B' ' 2' ' ' ' G' . . . 85.17 10.46 78.01 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.652 -0.785 . . . . 0.64000000000000001 113.221 173.384 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -121.95 154.21 37.47 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.18 -1.044 . . . . 1.1799999999999999 108.18 177.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -165.93 143.43 8.4 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 119.525 -1.322 . . . . 0.58999999999999997 113.418 178.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -101.24 124.63 47.25 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 122.184 0.992 . . . . 0.63 112.26 174.389 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 58.0 t -104.27 130.55 54.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 113.966 -1.47 . . . . 0.40999999999999998 108.144 170.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 4.7 m -115.08 122.35 45.88 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 107.794 -1.187 . . . . 0.46999999999999997 107.794 178.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.473 ' O ' ' HB ' ' A' ' 35' ' ' THR . 88.3 mmm -86.61 160.78 18.8 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.528 -0.545 . . . . 0.88 109.528 -174.094 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.612 ' HB3' ' HB3' ' A' ' 60' ' ' ASP . 31.3 ttmt -84.04 -19.03 35.11 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.235 0.54 . . . . 1.9199999999999999 109.667 -177.701 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -141.45 144.09 34.22 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 115.554 -0.748 . . . . 1.6799999999999999 111.153 -178.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.536 ' O ' ' HG2' ' A' ' 90' ' ' GLU . 0.6 OUTLIER -66.1 -29.93 70.34 Favored 'General case' 0 C--O 1.222 -0.382 0 N-CA-C 113.743 1.016 . . . . 3.6600000000000001 113.743 -177.718 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -67.73 -35.65 79.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 119.361 0.982 . . . . 0.66000000000000003 110.89 178.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 11.7 m -64.66 -35.11 79.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 122.06 0.933 . . . . 0.78000000000000003 109.35 173.208 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.466 ' HB2' ' HA ' ' A' ' 35' ' ' THR . . . -66.02 -45.71 80.51 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 113.685 -1.598 . . . . 0.46000000000000002 110.468 177.782 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.536 ' HG2' ' O ' ' A' ' 86' ' ' ARG . 10.7 mm-40 -54.53 -51.54 64.85 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.779 -0.646 . . . . 2.1099999999999999 112.65 178.606 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.521 ' O ' ' HB3' ' A' ' 94' ' ' LYS . 57.0 mtp180 -65.91 -39.02 90.18 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 111.736 0.273 . . . . 3.8199999999999998 111.736 -178.356 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.82 -42.93 99.93 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.388 -0.369 . . . . 0.92000000000000004 111.305 179.085 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' CYS . . . . . 0.577 ' HB2' ' HG ' ' A' ' 109' ' ' LEU . 44.8 t -71.93 -17.18 62.1 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.047 0.451 . . . . 1.1599999999999999 110.763 175.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.521 ' HB3' ' O ' ' A' ' 91' ' ' ARG . 4.5 tppp? -74.46 -47.88 30.75 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.286 -0.415 . . . . 4.2000000000000002 111.166 177.547 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -101.62 100.55 14.49 Favored Pre-proline 0 N--CA 1.463 0.218 0 N-CA-C 108.975 -0.75 . . . . 2.2400000000000002 108.975 178.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -88.78 -16.29 2.42 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 123.009 2.472 . . . . 2.3799999999999999 115.508 -165.526 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.438 ' HA ' ' O ' ' A' ' 105' ' ' ALA . 2.4 p-10 -120.07 83.0 30.27 Favored Pre-proline 0 C--N 1.326 -0.423 0 N-CA-C 113.622 0.971 . . . . 3.0299999999999998 113.622 -174.096 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -84.65 128.59 3.98 Favored 'Trans proline' 0 C--O 1.24 0.604 0 C-N-CA 123.657 2.905 . . . . 1.29 112.256 170.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 35.3 mm -70.2 91.76 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 121.199 0.523 . . . . 1.8100000000000001 110.288 173.24 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 69.0 mt -99.13 134.1 39.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.923 -0.58 . . . . 0.98999999999999999 111.277 -178.645 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.672 ' OD2' ' HB3' ' A' ' 45' ' ' HIS . 18.0 t70 41.56 30.88 0.16 Allowed 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.778 1.029 . . . . 1.3700000000000001 113.778 -178.037 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 88.48 16.85 58.1 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 120.49 -0.862 . . . . 1.5600000000000001 113.366 176.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.558 ' HB3' ' HG3' ' A' ' 43' ' ' PRO . 28.0 tpt180 -140.54 139.31 35.01 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.323 -0.621 . . . . 4.1299999999999999 109.323 176.026 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -82.09 105.38 13.14 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 119.966 -0.694 . . . . 2.73 110.107 -178.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.46 ' HB1' ' O ' ' A' ' 40' ' ' GLY . . . -85.46 166.34 16.43 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 113.874 1.064 . . . . 1.04 113.874 177.673 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 22.7 t30 -108.86 119.34 39.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.388 -1.278 . . . . 2.04 110.187 -178.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 93.8 t -114.2 140.72 33.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.006 -0.543 . . . . 1.0600000000000001 110.874 179.283 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -160.64 170.15 21.42 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.715 -0.846 . . . . 2.4900000000000002 108.715 178.151 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.577 ' HG ' ' HB2' ' A' ' 93' ' ' CYS . 5.8 mt -79.67 127.35 32.08 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.361 -0.536 . . . . 1.23 110.737 178.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.722 ' HB3' ' HG2' ' A' ' 36' ' ' LYS . . . -69.26 -24.65 64.01 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.263 -0.881 . . . . 0.91000000000000003 112.351 -174.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.568 ' CD1' ' HB3' ' A' ' 109' ' ' LEU . 0.1 OUTLIER -67.54 -3.64 9.34 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.849 0.357 . . . . 1.3999999999999999 111.8 -173.616 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 96.8 mt -75.83 -24.06 55.8 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 116.43 -0.35 . . . . 1.97 110.295 175.303 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.466 ' O ' ' HG2' ' A' ' 115' ' ' LYS . . . -123.54 -58.13 0.19 Allowed Glycine 0 C--N 1.333 0.381 0 C-N-CA 120.931 -0.652 . . . . 2.1400000000000001 111.53 173.445 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -50.89 149.37 3.53 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-O 121.634 0.731 . . . . 2.6600000000000001 111.563 172.54 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.466 ' HG2' ' O ' ' A' ' 113' ' ' GLY . 26.5 mmtp -137.73 117.94 10.3 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 115.119 -0.946 . . . . 4.1600000000000001 110.38 -166.496 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 115' ' ' LYS . 94.8 Cg_endo -96.73 32.43 0.15 Allowed 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 123.563 2.842 . . . . 5.5300000000000002 113.041 -177.492 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 7.9 ttm180 -151.58 -57.53 0.15 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.957 0.408 . . . . 8.5999999999999996 111.084 -177.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 12.1 p -90.64 9.79 28.3 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.144 0.497 . . . . 6.3700000000000001 111.342 -177.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -154.83 164.28 39.05 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 107.736 -1.209 . . . . 7.8499999999999996 107.736 174.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 39.6 t 59.72 85.91 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.294 0 CA-C-O 121.399 0.619 . . . . 9.3699999999999992 109.966 -174.105 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 20.5 mm-40 . . . . . 0 C--O 1.251 1.171 0 CA-C-N 115.732 -0.667 . . . . 12.279999999999999 110.195 -174.819 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 1' ' ' ' G' . . . . . 0.515 ' C4 ' ' CE2' ' A' ' 44' ' ' TYR . . . . . . . . 0 O5'--C5' 1.433 -0.43 0 C3'-C2'-C1' 99.15 -2.611 . 0.0 '__' . 4.9400000000000004 . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 2' ' ' ' G' . . . . . 0.505 ' C5 ' ' CE2' ' A' ' 44' ' ' TYR . . . . . . . . 0 O5'--C5' 1.422 -1.11 0 C3'-C2'-C1' 99.604 -2.107 . 0.0 OUTLIER . 4.8700000000000001 . . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 3' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.429 -0.656 0 C3'-C2'-C1' 100.107 -1.548 . 0.0 OUTLIER . 5.0199999999999996 . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 4' ' ' ' G' . . . . . 0.694 " H2'" ' HZ ' ' A' ' 38' ' ' PHE . . . . . . . . 0 O5'--C5' 1.424 -0.971 0 O4'-C1'-C2' 108.26 1.329 . 0.677 0i . 2.6899999999999999 . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 5' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.431 -0.582 0 C4'-C3'-C2' 103.536 0.836 . 0.0 OUTLIER gamma 1.9299999999999999 . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 6' ' ' ' G' . . . . . 0.569 ' N2 ' HG21 ' A' ' 65' ' ' VAL . . . . . . . . 0 O5'--C5' 1.426 -0.869 0 C4'-C3'-C2' 104.071 1.371 . 0.0 OUTLIER . 2.3799999999999999 . . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.427 -0.789 0 C4'-C3'-C2' 104.06 1.36 . 0.0 OUTLIER . 4.1900000000000004 . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.395 0 N-CA-C 111.578 -0.609 . . . . 13.029999999999999 111.578 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -142.47 176.63 8.86 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.633 0.254 . . . . 11.06 110.827 -177.442 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 4.6 mpp? -94.93 109.21 21.25 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.042 0.449 . . . . 9.8499999999999996 110.533 -179.565 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -123.22 56.87 0.66 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.896 -0.668 . . . . 6.6900000000000004 111.657 179.477 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 10.3 p -74.7 -64.65 0.99 Allowed 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 112.163 0.431 . . . . 5.5499999999999998 112.163 -174.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 30' ' ' ARG . 44.9 mtp180 -122.23 170.25 10.08 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.443 -0.344 . . . . 3.8700000000000001 110.93 -172.765 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -78.29 107.0 10.58 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.725 0.774 . . . . 3.5299999999999998 111.052 -178.219 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.649 ' HA ' ' OG1' ' A' ' 35' ' ' THR . 33.6 p -105.86 6.73 31.81 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.778 -0.647 . . . . 1.6899999999999999 111.222 -178.69 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 48.6 ttp -69.32 -34.38 74.57 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.785 -0.366 . . . . 1.49 111.27 -179.061 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.592 ' HA ' HD11 ' A' ' 109' ' ' LEU . 25.1 m-85 -107.12 -24.16 12.04 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-O 120.801 0.334 . . . . 1.5 110.992 -178.381 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.735 ' O ' ' HA ' ' A' ' 82' ' ' THR . 27.1 p -81.4 11.75 4.21 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.289 -0.414 . . . . 0.53000000000000003 110.958 -174.823 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.664 ' HD2' ' O6 ' ' B' ' 6' ' ' ' G' . 5.8 ttpm? -122.43 102.84 8.33 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.074 -0.512 . . . . 2.75 110.247 -173.753 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 5.0 mp -109.21 136.53 44.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.959 -0.564 . . . . 0.84999999999999998 110.602 -176.572 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.555 ' HE2' ' C8 ' ' B' ' 4' ' ' ' G' . 85.7 t80 -95.13 120.51 35.48 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.987 -0.551 . . . . 0.70999999999999996 109.589 176.225 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.635 HG13 HG22 ' A' ' 107' ' ' VAL . 96.8 t -132.84 99.08 3.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 118.775 -0.631 . . . . 0.92000000000000004 110.851 -177.256 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.572 ' HA2' ' CD1' ' A' ' 42' ' ' LEU . . . -132.15 166.49 23.23 Favored Glycine 0 C--O 1.217 -0.913 0 C-N-CA 115.324 -3.322 . . . . 0.83999999999999997 113.845 162.006 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 128.69 -2.93 6.51 Favored Glycine 0 N--CA 1.445 -0.762 0 N-CA-C 108.706 -1.758 . . . . 0.68000000000000005 108.706 -168.291 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.766 HD21 HD21 ' A' ' 51' ' ' LEU . 4.5 mp -62.1 142.13 95.61 Favored Pre-proline 0 N--CA 1.449 -0.486 0 CA-C-N 113.601 -1.3 . . . . 1.28 109.806 179.667 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.581 ' HG2' ' O ' ' A' ' 101' ' ' ASP . 52.5 Cg_exo -54.28 159.78 7.54 Favored 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.669 2.246 . . . . 0.57999999999999996 111.581 172.386 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.525 ' CZ ' ' C5 ' ' B' ' 2' ' ' ' G' . 6.8 m-85 -71.55 -1.78 14.64 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.161 -0.472 . . . . 1.05 111.459 -174.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 72.4 t60 -104.08 -11.99 17.02 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.127 0.489 . . . . 2.0099999999999998 109.944 176.598 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.704 ' HB ' ' HB3' ' A' ' 42' ' ' LEU . 5.4 m -79.06 129.94 34.99 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 115.921 -0.581 . . . . 0.71999999999999997 109.868 -178.706 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.421 ' HA ' HG21 ' A' ' 66' ' ' VAL . 7.4 p -132.76 -177.58 4.55 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.534 -0.303 . . . . 0.55000000000000004 111.566 -169.832 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.489 ' OD2' ' HA ' ' A' ' 65' ' ' VAL . 1.2 m-20 -57.01 -31.9 65.58 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.536 0.684 . . . . 0.48999999999999999 110.043 -177.632 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.731 ' O ' ' HG2' ' A' ' 53' ' ' GLU . 55.2 pttt -74.1 -35.45 64.18 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.908 -1.042 . . . . 2.7599999999999998 109.638 -178.017 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.645 HG21 HG23 ' A' ' 46' ' ' THR . 6.6 m -67.17 -43.98 80.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.735 0.302 . . . . 0.57999999999999996 110.756 179.49 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.766 HD21 HD21 ' A' ' 42' ' ' LEU . 35.8 mt -61.46 -42.97 99.59 Favored 'General case' 0 CA--C 1.512 -0.493 0 N-CA-C 109.631 -0.507 . . . . 0.84999999999999998 109.631 176.305 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.54 ' HA ' HD12 ' A' ' 61' ' ' ILE . 45.8 t-80 -53.3 -52.74 58.12 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.246 -0.888 . . . . 0.58999999999999997 110.514 175.681 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.731 ' HG2' ' O ' ' A' ' 49' ' ' LYS . 8.5 mm-40 -59.49 -47.62 84.8 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.3 -0.409 . . . . 1.52 111.756 -176.569 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.523 ' O ' ' HB2' ' A' ' 57' ' ' GLN . 56.3 t80 -77.73 -36.53 50.75 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.289 0.478 . . . . 1.1200000000000001 112.289 -170.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.753 ' HB2' HD11 ' A' ' 61' ' ' ILE . 42.9 m-85 -84.62 -30.03 25.27 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 113.224 0.824 . . . . 0.56000000000000005 113.224 -173.197 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.699 ' HA ' ' O ' ' A' ' 59' ' ' GLY . 12.9 pt-20 -68.58 -11.38 59.91 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.677 0.751 . . . . 1.5700000000000001 110.009 179.254 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.523 ' HB2' ' O ' ' A' ' 54' ' ' TYR . 27.6 mt-30 -59.35 -23.0 62.16 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.55 -1.204 . . . . 2.1600000000000001 111.826 170.243 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -94.23 -21.45 19.04 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.217 0.532 . . . . 0.70999999999999996 110.005 177.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.699 ' O ' ' HA ' ' A' ' 56' ' ' GLU . . . 159.14 -177.7 35.59 Favored Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 115.049 -0.978 . . . . 0.75 110.982 179.334 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -61.77 122.94 16.6 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 117.042 0.421 . . . . 1.02 110.577 -175.749 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.753 HD11 ' HB2' ' A' ' 55' ' ' PHE . 45.9 mt -86.99 125.03 40.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 O-C-N 122.351 -0.218 . . . . 0.46999999999999997 110.468 171.506 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -75.64 -43.82 45.79 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.681 0.277 . . . . 2.0699999999999998 111.607 178.345 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -152.12 132.55 13.78 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.326 -0.397 . . . . 2.48 111.251 -175.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -125.8 134.81 51.58 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.241 0.543 . . . . 0.44 111.145 178.034 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.672 HG21 ' H21' ' B' ' 6' ' ' ' G' . 31.2 m -144.76 148.43 18.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.225 -0.898 . . . . 1.3799999999999999 112.485 -177.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.421 HG21 ' HA ' ' A' ' 47' ' ' SER . 42.4 t -119.3 138.92 48.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.241 -0.89 . . . . 0.48999999999999999 110.027 171.844 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.536 HG12 ' HA2' ' A' ' 79' ' ' GLY . 26.2 mm -91.91 153.71 3.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 114.898 -1.046 . . . . 0.71999999999999997 110.441 -173.743 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 18.8 p -147.23 147.66 30.68 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 105.228 -2.138 . . . . 1.52 105.228 -170.57 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.738 ' HB3' ' H ' ' A' ' 74' ' ' LYS . 7.3 t70 -49.11 138.66 11.77 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 118.665 0.666 . . . . 2.4900000000000002 111.529 -178.41 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 59.4 ttt180 -57.54 -53.49 57.59 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.158 -0.473 . . . . 6.0499999999999998 111.574 -178.531 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -70.63 -62.78 1.26 Allowed 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.217 0.451 . . . . 4.0499999999999998 112.217 -172.351 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.427 ' OG1' ' HG3' ' A' ' 74' ' ' LYS . 71.1 p -98.82 -14.79 19.51 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.334 -0.394 . . . . 3.0800000000000001 111.558 -171.473 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.539 ' HA ' ' O ' ' A' ' 69' ' ' ASP . 40.7 mt-30 57.68 79.81 0.19 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 122.413 1.101 . . . . 3.2999999999999998 111.655 -172.255 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.738 ' H ' ' HB3' ' A' ' 69' ' ' ASP . 45.2 mtmt -108.72 132.64 53.75 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 106.209 -1.775 . . . . 3.4900000000000002 106.209 172.369 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 14.9 m -54.75 102.64 0.07 Allowed 'General case' 0 C--N 1.322 -0.613 0 O-C-N 123.318 0.386 . . . . 1.8100000000000001 110.403 -178.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 26.7 mtm180 -69.58 -5.94 27.79 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.866 -0.606 . . . . 2.5600000000000001 112.066 -175.518 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.556 ' HA3' ' C6 ' ' B' ' 2' ' ' ' G' . . . 77.98 9.63 86.8 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 119.88 -1.152 . . . . 0.64000000000000001 111.082 -177.168 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.568 ' HD1' ' HA3' ' A' ' 40' ' ' GLY . 20.7 m-85 -117.34 154.05 31.95 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 110.035 -0.357 . . . . 1.1799999999999999 110.035 -172.475 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.536 ' HA2' HG12 ' A' ' 67' ' ' ILE . . . -157.95 -167.3 18.69 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.388 -0.91 . . . . 0.58999999999999997 113.145 173.065 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.567 ' HB2' ' CG2' ' A' ' 65' ' ' VAL . 49.7 m-85 -139.5 141.2 37.35 Favored 'General case' 0 CA--C 1.513 -0.469 0 C-N-CA 123.462 0.705 . . . . 0.63 109.496 178.527 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 54.6 t -127.33 111.85 26.54 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 CA-C-O 121.308 0.575 . . . . 0.40999999999999998 109.931 175.422 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.735 ' HA ' ' O ' ' A' ' 35' ' ' THR . 29.3 m -109.19 112.43 24.59 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.467 -0.788 . . . . 0.46999999999999997 109.351 176.416 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.668 ' SD ' HG12 ' A' ' 61' ' ' ILE . 59.8 mmm -87.44 175.34 8.01 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 121.227 0.537 . . . . 0.88 111.639 -172.837 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.402 ' HB2' ' HE3' ' A' ' 84' ' ' LYS . 37.9 ttmt -82.7 -31.91 28.31 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.189 -0.914 . . . . 1.9199999999999999 110.826 -179.624 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -129.83 147.8 51.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.927 0.394 . . . . 1.6799999999999999 110.446 178.382 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.591 ' HD2' ' H ' ' A' ' 86' ' ' ARG . 0.7 OUTLIER -73.44 -19.74 60.89 Favored 'General case' 0 C--O 1.218 -0.566 0 CA-C-N 115.812 -0.631 . . . . 3.6600000000000001 112.105 -174.639 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.416 ' O ' ' HG3' ' A' ' 91' ' ' ARG . . . -67.04 -50.57 61.55 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 118.436 0.562 . . . . 0.66000000000000003 111.201 176.838 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.442 ' HA ' ' HD2' ' A' ' 91' ' ' ARG . 14.4 m -63.96 -33.5 75.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.887 0.851 . . . . 0.78000000000000003 109.36 175.88 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.518 ' HB3' ' HA ' ' A' ' 86' ' ' ARG . . . -58.23 -47.5 83.34 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 113.683 -1.599 . . . . 0.46000000000000002 110.011 173.713 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -60.69 -43.99 97.08 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.203 -0.453 . . . . 2.1099999999999999 111.237 173.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.567 ' O ' ' HB3' ' A' ' 94' ' ' LYS . 99.4 mtt180 -57.59 -42.59 83.47 Favored 'General case' 0 C--O 1.225 -0.227 0 CA-C-O 120.888 0.375 . . . . 3.8199999999999998 111.466 176.527 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.39 -36.67 83.05 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 111.874 0.324 . . . . 0.92000000000000004 111.874 173.56 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 35.7 t -78.71 -7.55 57.84 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.207 0.527 . . . . 1.1599999999999999 111.259 177.295 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.567 ' HB3' ' O ' ' A' ' 91' ' ' ARG . 16.1 tppt? -58.42 -48.36 80.92 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.628 -0.715 . . . . 4.2000000000000002 111.613 -177.562 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -110.35 121.81 40.4 Favored Pre-proline 0 C--N 1.325 -0.495 0 C-N-CA 120.744 -0.383 . . . . 2.2400000000000002 109.988 176.601 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -84.66 -1.76 9.65 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 122.902 2.402 . . . . 2.3799999999999999 114.287 -173.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.578 ' HB2' ' HD3' ' A' ' 104' ' ' LYS . 6.0 p30 -152.61 68.4 6.96 Favored Pre-proline 0 CA--C 1.534 0.333 0 CA-C-O 121.392 0.615 . . . . 3.0299999999999998 111.691 178.816 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -80.98 166.97 18.57 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 123.456 2.771 . . . . 1.29 111.686 179.387 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 47.2 mm -100.81 137.82 27.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 108.578 -0.897 . . . . 1.8100000000000001 108.578 178.743 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 54.7 mt -144.77 111.8 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 109.323 -0.621 . . . . 0.98999999999999999 109.323 -174.418 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.581 ' O ' ' HG2' ' A' ' 43' ' ' PRO . 16.8 t0 61.87 47.99 5.66 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 121.488 0.661 . . . . 1.3700000000000001 111.019 173.387 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 82.74 -5.76 73.25 Favored Glycine 0 CA--C 1.529 0.924 0 N-CA-C 116.29 1.276 . . . . 1.5600000000000001 116.29 178.552 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.439 ' CB ' ' HG3' ' A' ' 43' ' ' PRO . 23.8 ttt180 -137.93 150.97 47.51 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 118.933 1.367 . . . . 4.1299999999999999 111.106 -177.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.578 ' HD3' ' HB2' ' A' ' 97' ' ' ASN . 24.3 ttmm -78.88 139.8 38.24 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.46 -0.336 . . . . 2.73 110.37 178.52 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -111.59 154.17 25.23 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.947 -0.57 . . . . 1.04 111.138 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.462 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 46.6 t-20 -95.47 127.86 41.86 Favored 'General case' 0 C--O 1.252 1.224 0 N-CA-C 108.597 -0.89 . . . . 2.04 108.597 173.654 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.635 HG22 HG13 ' A' ' 39' ' ' VAL . 88.0 t -142.37 129.4 19.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 113.838 -1.528 . . . . 1.0600000000000001 110.45 -161.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -167.84 158.56 10.89 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.454 -0.572 . . . . 2.4900000000000002 109.454 178.038 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.592 HD11 ' HA ' ' A' ' 34' ' ' PHE . 0.2 OUTLIER -57.92 131.94 51.9 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 107.827 -1.175 . . . . 1.23 107.827 173.061 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.96 -30.93 68.42 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.514 -0.475 . . . . 0.91000000000000003 110.784 -162.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.443 ' HD1' HD12 ' A' ' 109' ' ' LEU . 4.0 p90 -70.86 -4.35 23.85 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.881 -0.6 . . . . 1.3999999999999999 111.42 -172.785 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 80.4 mt -85.03 1.92 45.52 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.447 -0.342 . . . . 1.97 111.114 177.046 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -156.08 -1.95 0.11 Allowed Glycine 0 CA--C 1.516 0.125 0 N-CA-C 110.126 -1.189 . . . . 2.1400000000000001 110.126 -179.269 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -95.61 158.72 15.33 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.093 -1.053 . . . . 2.6600000000000001 108.919 178.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.448 ' HA ' ' HD3' ' A' ' 116' ' ' PRO . 99.6 mttt -131.51 146.03 60.17 Favored Pre-proline 0 C--N 1.316 -0.866 0 N-CA-C 109.123 -0.695 . . . . 4.1600000000000001 109.123 172.199 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 115' ' ' LYS . 31.6 Cg_exo -56.28 -19.68 28.9 Favored 'Trans proline' 0 CA--C 1.512 -0.589 0 C-N-CA 123.954 3.102 . . . . 5.5300000000000002 112.353 -169.186 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 47.1 ttp180 -148.24 73.01 1.23 Allowed 'General case' 0 N--CA 1.432 -1.341 0 CA-C-N 115.069 -0.968 . . . . 8.5999999999999996 109.438 175.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.403 ' O ' ' HB2' ' A' ' 115' ' ' LYS . 67.5 p 60.49 176.06 0.1 Allowed 'General case' 0 N--CA 1.467 0.388 0 O-C-N 124.679 1.237 . . . . 6.3700000000000001 113.152 174.274 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -133.26 110.87 10.4 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.851 -0.613 . . . . 7.8499999999999996 110.822 -175.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 60.1 t 74.99 -40.98 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-N 115.283 -0.871 . . . . 9.3699999999999992 111.395 -178.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 25.4 mm-40 . . . . . 0 C--O 1.246 0.883 0 CA-C-O 118.155 -0.926 . . . . 12.279999999999999 109.818 176.249 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 1' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.433 -0.41 0 O5'-C5'-C4' 111.786 1.133 . 0.0 '__' . 4.9400000000000004 . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 2' ' ' ' G' . . . . . 0.556 ' C6 ' ' HA3' ' A' ' 77' ' ' GLY . . . . . . . . 0 O5'--C5' 1.427 -0.808 0 O4'-C1'-N19 109.291 1.091 . 0.0 OUTLIER gamma 4.8700000000000001 . . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 3' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.427 -0.815 0 C4'-C3'-C2' 104.092 1.392 . 0.0 OUTLIER . 5.0199999999999996 . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 4' ' ' ' G' . . . . . 0.555 ' C8 ' ' HE2' ' A' ' 38' ' ' PHE . . . . . . . . 0 O5'--C5' 1.426 -0.905 0 O4'-C1'-C2' 108.126 1.233 . 0.0 OUTLIER . 2.6899999999999999 . . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 5' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.424 -0.995 0 C4'-C3'-C2' 103.893 1.193 . 0.42 1t . 1.9299999999999999 . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 6' ' ' ' G' . . . . . 0.672 ' H21' HG21 ' A' ' 65' ' ' VAL . . . . . . . . 0 O5'--C5' 1.427 -0.805 0 C3'-C2'-C1' 100.784 -0.796 . 0.0 OUTLIER . 2.3799999999999999 . . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.426 -0.889 0 C4'-C3'-C2' 105.529 2.829 . 0.0 OUTLIER delta 4.1900000000000004 . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.549 0 N-CA-C 112.049 -0.42 . . . . 13.029999999999999 112.049 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -151.87 135.39 16.13 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.716 -0.476 . . . . 11.06 109.716 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 24.9 mmt -83.48 -38.13 22.22 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.887 0.375 . . . . 9.8499999999999996 110.534 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -63.02 135.31 43.36 Favored Glycine 0 N--CA 1.452 -0.279 0 CA-C-N 115.692 -0.686 . . . . 6.6900000000000004 112.654 -178.371 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.65 106.58 15.48 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.302 0.573 . . . . 5.5499999999999998 111.459 -179.089 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 68.0 mtm180 -97.48 -25.68 15.09 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.315 -0.857 . . . . 3.8700000000000001 109.897 178.065 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 64.66 80.84 0.22 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 114.997 -1.001 . . . . 3.5299999999999998 110.075 -175.304 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.684 ' HA ' ' OG1' ' A' ' 35' ' ' THR . 11.3 p -67.26 -15.25 63.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.973 -1.012 . . . . 1.6899999999999999 111.972 -173.854 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 7.4 ttt -57.89 -39.1 77.04 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.462 -0.335 . . . . 1.49 111.085 176.125 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.601 ' HA ' HD11 ' A' ' 109' ' ' LEU . 40.7 m-85 -103.66 -24.23 13.39 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 111.859 0.318 . . . . 1.5 111.859 -178.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.684 ' OG1' ' HA ' ' A' ' 32' ' ' THR . 57.7 p -78.91 -10.9 59.95 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.362 -0.535 . . . . 0.53000000000000003 110.446 -174.746 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 47.1 tttm -88.23 106.43 18.19 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 115.367 -0.833 . . . . 2.75 109.104 179.506 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 95.3 mt -104.6 134.89 44.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 116.051 -0.522 . . . . 0.84999999999999998 110.442 -179.209 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.628 ' CB ' ' HA ' ' A' ' 110' ' ' ALA . 82.5 t80 -99.02 121.31 40.8 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.397 -0.594 . . . . 0.70999999999999996 109.397 179.659 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.756 HG12 HD11 ' A' ' 42' ' ' LEU . 3.9 t -106.63 140.19 25.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.137 0.494 . . . . 0.92000000000000004 110.477 -174.425 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -140.76 152.68 23.23 Favored Glycine 0 N--CA 1.452 -0.275 0 CA-C-N 115.29 -0.868 . . . . 0.83999999999999997 113.423 -167.028 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.08 40.66 95.17 Favored Glycine 0 C--O 1.228 -0.263 0 C-N-CA 121.635 -0.317 . . . . 0.68000000000000005 113.298 172.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.756 HD11 HG12 ' A' ' 39' ' ' VAL . 7.1 mp -82.38 134.71 47.97 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-O 120.861 0.363 . . . . 1.28 110.86 179.111 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.591 ' HG3' ' HG3' ' A' ' 103' ' ' ARG . 50.6 Cg_exo -52.91 153.4 15.3 Favored 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.709 2.273 . . . . 0.57999999999999996 111.379 172.292 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.601 ' HA ' ' HB3' ' A' ' 75' ' ' SER . 20.6 m-85 -67.49 -7.38 25.15 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 113.292 0.849 . . . . 1.05 113.292 -170.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -111.98 2.51 16.94 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 120.409 -0.516 . . . . 2.0099999999999998 111.168 176.38 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.693 HG23 HG21 ' A' ' 50' ' ' THR . 38.4 m -74.39 134.59 42.42 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.284 -0.416 . . . . 0.71999999999999997 110.405 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 10.4 p -136.35 -176.85 4.47 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-O 121.507 0.67 . . . . 0.55000000000000004 112.053 -171.084 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -60.46 -36.26 77.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.825 -1.08 . . . . 0.48999999999999999 110.76 -173.17 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.54 ' O ' ' HG2' ' A' ' 53' ' ' GLU . 9.2 ptmm? -65.15 -36.99 85.98 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.461 -0.79 . . . . 2.7599999999999998 110.855 178.693 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.693 HG21 HG23 ' A' ' 46' ' ' THR . 88.0 m -62.07 -45.95 91.27 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.085 0.469 . . . . 0.57999999999999996 110.922 179.104 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.464 HD21 HG11 ' A' ' 39' ' ' VAL . 98.2 mt -68.33 -34.71 76.59 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.77 -0.65 . . . . 0.84999999999999998 110.687 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.452 ' O ' ' HG2' ' A' ' 56' ' ' GLU . 55.6 t-80 -59.69 -53.82 53.51 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.111 0.481 . . . . 0.58999999999999997 109.966 178.225 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.54 ' HG2' ' O ' ' A' ' 49' ' ' LYS . 11.8 mm-40 -57.72 -44.03 85.69 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.618 -0.719 . . . . 1.52 112.628 -179.401 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.61 ' O ' ' HB2' ' A' ' 57' ' ' GLN . 67.8 t80 -76.48 -34.43 58.66 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.821 0.674 . . . . 1.1200000000000001 112.821 -174.585 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -84.69 -30.5 24.76 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 113.898 1.073 . . . . 0.56000000000000005 113.898 -171.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.452 ' HG2' ' O ' ' A' ' 52' ' ' HIS . 15.0 pt-20 -71.5 -12.04 61.18 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.842 0.83 . . . . 1.5700000000000001 110.003 177.625 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.61 ' HB2' ' O ' ' A' ' 54' ' ' TYR . 27.6 mm-40 -56.03 -24.84 41.78 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.037 -0.983 . . . . 2.1600000000000001 111.539 166.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -106.64 6.93 30.32 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 111.74 0.274 . . . . 0.70999999999999996 111.74 -177.298 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 146.48 -137.86 7.05 Favored Glycine 0 C--O 1.224 -0.529 0 C-N-CA 120.486 -0.864 . . . . 0.75 112.794 -176.301 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -114.04 127.14 55.81 Favored 'General case' 0 C--N 1.327 -0.372 0 O-C-N 122.661 -0.317 . . . . 1.02 110.874 -178.551 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.422 HG13 ' HB3' ' A' ' 56' ' ' GLU . 8.7 mt -94.24 126.9 46.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 110.116 -0.328 . . . . 0.46999999999999997 110.116 176.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -83.59 -48.72 9.92 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.581 -0.448 . . . . 2.0699999999999998 110.372 174.101 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -141.56 126.71 18.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.261 -0.427 . . . . 2.48 111.112 -176.41 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -123.23 123.75 41.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.059 0.457 . . . . 0.44 110.555 174.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.588 HG21 ' N2 ' ' B' ' 6' ' ' ' G' . 29.6 m -139.09 143.74 30.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.0 -1.0 . . . . 1.3799999999999999 112.141 -179.546 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 70.4 t -115.08 139.54 40.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 108.761 -0.829 . . . . 0.48999999999999999 108.761 170.381 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 44.2 mm -91.1 95.06 5.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 N-CA-C 109.439 -0.578 . . . . 0.71999999999999997 109.439 -179.49 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.495 HG22 ' HA ' ' A' ' 75' ' ' SER . 9.1 p -92.8 158.1 16.06 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.047 -0.524 . . . . 1.52 110.985 177.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.485 ' HB3' ' H ' ' A' ' 74' ' ' LYS . 18.6 t70 -57.05 118.24 4.81 Favored 'General case' 0 C--O 1.213 -0.842 0 CA-C-N 115.167 -0.924 . . . . 2.4900000000000002 110.825 -178.025 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 7.8 ptp180 -56.41 -30.09 62.36 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 113.514 0.931 . . . . 6.0499999999999998 113.514 -176.599 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -78.21 -53.55 7.21 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.334 0.494 . . . . 4.0499999999999998 112.334 -176.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 14.0 p -111.49 -18.07 12.93 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.149 0.499 . . . . 3.0800000000000001 112.081 -174.42 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 57.57 81.65 0.14 Allowed 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 123.056 1.408 . . . . 3.2999999999999998 111.733 -172.321 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.568 ' HB3' ' O6 ' ' B' ' 1' ' ' ' G' . 7.0 mttp -124.08 143.91 50.18 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 112.086 -2.324 . . . . 3.4900000000000002 105.655 172.447 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.601 ' HB3' ' HA ' ' A' ' 44' ' ' TYR . 12.3 t -66.16 103.96 1.08 Allowed 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 120.337 -0.545 . . . . 1.8100000000000001 110.274 -175.229 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 10.8 mtp180 -59.23 -11.76 4.41 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.505 -0.77 . . . . 2.5600000000000001 111.363 174.363 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 92.59 14.77 54.92 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.812 -0.709 . . . . 0.64000000000000001 113.113 175.053 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.43 ' CE1' " H1'" ' B' ' 4' ' ' ' G' . 14.4 m-85 -128.41 141.0 51.54 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.422 -0.584 . . . . 1.1799999999999999 109.422 -178.611 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -138.65 -178.28 16.12 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.435 -0.888 . . . . 0.58999999999999997 111.865 179.632 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -152.03 130.08 11.85 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.386 -0.598 . . . . 0.63 109.386 -177.611 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 63.7 t -128.22 119.59 51.15 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 CA-C-N 115.813 -0.63 . . . . 0.40999999999999998 109.936 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.548 ' HA ' ' O ' ' A' ' 35' ' ' THR . 34.8 m -109.45 114.23 27.71 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.183 -1.043 . . . . 0.46999999999999997 108.183 177.379 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 87.8 mmm -87.94 168.71 12.63 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 122.078 -0.389 . . . . 0.88 110.012 -174.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -83.05 -16.34 47.43 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.272 -0.422 . . . . 1.9199999999999999 111.05 -176.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -147.97 148.69 31.03 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 120.813 0.339 . . . . 1.6799999999999999 110.607 -179.072 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -71.32 -20.84 62.14 Favored 'General case' 0 C--O 1.224 -0.246 0 N-CA-C 112.502 0.556 . . . . 3.6600000000000001 112.502 -174.612 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -71.61 -45.75 61.19 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 118.556 0.616 . . . . 0.66000000000000003 111.346 -179.226 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 19.4 m -63.37 -35.59 80.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.94 0.876 . . . . 0.78000000000000003 109.489 173.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.493 ' HB1' ' O ' ' A' ' 34' ' ' PHE . . . -58.79 -46.9 86.49 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 113.503 -1.681 . . . . 0.46000000000000002 109.824 174.645 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -57.37 -50.03 74.27 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.543 -0.753 . . . . 2.1099999999999999 112.276 174.513 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.539 ' O ' ' HB3' ' A' ' 94' ' ' LYS . 79.3 mtp180 -57.06 -46.0 82.8 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.817 0.341 . . . . 3.8199999999999998 111.457 -179.186 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -60.06 -40.34 89.14 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.154 -0.476 . . . . 0.92000000000000004 111.858 176.686 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 49.7 t -71.89 -17.1 62.13 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.294 0.569 . . . . 1.1599999999999999 110.449 177.141 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.539 ' HB3' ' O ' ' A' ' 91' ' ' ARG . 21.2 tptp -78.65 7.08 7.41 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.415 0.686 . . . . 4.2000000000000002 110.821 179.253 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -142.13 76.98 18.56 Favored Pre-proline 0 C--N 1.323 -0.565 0 O-C-N 121.616 -0.678 . . . . 2.2400000000000002 110.011 -176.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -73.43 156.11 50.32 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 123.095 2.53 . . . . 2.3799999999999999 111.945 -178.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.613 ' HA ' ' O ' ' A' ' 105' ' ' ALA . 1.9 p-10 34.35 64.14 1.73 Allowed Pre-proline 0 N--CA 1.471 0.615 0 O-C-N 124.166 0.916 . . . . 3.0299999999999998 113.073 -171.449 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.403 ' HB2' ' OH ' ' A' ' 54' ' ' TYR . 92.5 Cg_endo -82.21 167.43 15.78 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 123.063 2.509 . . . . 1.29 111.714 178.554 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 49.6 mm -89.53 130.74 38.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 116.281 -0.418 . . . . 1.8100000000000001 110.097 178.331 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 56.5 mt -146.57 139.67 20.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.801 -0.636 . . . . 0.98999999999999999 109.326 -175.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 42.7 t0 44.93 42.47 6.26 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 113.134 0.79 . . . . 1.3700000000000001 113.134 177.249 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 70.45 17.98 74.97 Favored Glycine 0 CA--C 1.524 0.626 0 C-N-CA 121.128 -0.558 . . . . 1.5600000000000001 113.619 177.123 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.591 ' HG3' ' HG3' ' A' ' 43' ' ' PRO . 30.6 mmt180 -143.23 162.38 35.79 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.372 -0.603 . . . . 4.1299999999999999 109.372 -179.487 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -80.64 134.52 35.89 Favored 'General case' 0 C--N 1.317 -0.845 0 C-N-CA 120.108 -0.637 . . . . 2.73 109.757 171.611 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.613 ' O ' ' HA ' ' A' ' 97' ' ' ASN . . . -121.67 165.11 16.26 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 107.738 -1.208 . . . . 1.04 107.738 -177.21 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 44.4 t30 -116.38 110.57 18.85 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 120.344 -0.542 . . . . 2.04 110.375 177.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 88.5 t -116.38 139.9 41.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 120.981 0.42 . . . . 1.0600000000000001 111.611 176.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.414 ' OD1' HD12 ' A' ' 112' ' ' LEU . 5.7 t-20 -162.98 173.75 13.22 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 107.929 -1.137 . . . . 2.4900000000000002 107.929 175.215 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.601 HD11 ' HA ' ' A' ' 34' ' ' PHE . 0.2 OUTLIER -62.77 146.56 52.18 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.74 -0.837 . . . . 1.23 108.74 175.904 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.628 ' HA ' ' CB ' ' A' ' 38' ' ' PHE . . . -68.47 -40.61 80.95 Favored 'General case' 0 CA--C 1.512 -0.484 0 C-N-CA 120.634 -0.427 . . . . 0.91000000000000003 111.305 -169.8 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 9.7 p90 -67.22 -16.09 64.09 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.186 -0.461 . . . . 1.3999999999999999 111.04 -173.376 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.414 HD12 ' OD1' ' A' ' 108' ' ' ASN . 96.2 mt -86.8 -14.66 41.57 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 116.327 -0.397 . . . . 1.97 111.696 176.07 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -100.52 -1.48 55.48 Favored Glycine 0 CA--C 1.507 -0.407 0 C-N-CA 120.833 -0.698 . . . . 2.1400000000000001 112.086 -177.424 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.508 ' HB2' ' C5 ' ' B' ' 5' ' ' ' U' . . . -89.06 127.1 35.68 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.619 0.247 . . . . 2.6600000000000001 111.366 -167.687 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -133.8 74.46 69.62 Favored Pre-proline 0 C--N 1.323 -0.544 0 N-CA-C 109.502 -0.555 . . . . 4.1600000000000001 109.502 173.246 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -87.71 0.01 7.21 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 123.106 2.538 . . . . 5.5300000000000002 112.284 -176.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 49.3 ttm-85 -179.1 -40.47 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.373 -0.83 . . . . 8.5999999999999996 109.079 -174.485 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.409 HG23 HG23 ' A' ' 120' ' ' VAL . 9.5 t -162.18 173.6 14.06 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 114.841 -1.072 . . . . 6.3700000000000001 108.927 -177.801 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -107.32 -48.76 3.39 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.841 -0.429 . . . . 7.8499999999999996 109.841 179.418 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.409 HG23 HG23 ' A' ' 118' ' ' THR . 95.6 t 71.17 -73.46 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 115.265 -0.879 . . . . 9.3699999999999992 111.958 177.232 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 . . . . . 0 C--O 1.25 1.119 0 CA-C-O 118.212 -0.899 . . . . 12.279999999999999 110.812 -173.586 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 1' ' ' ' G' . . . . . 0.568 ' O6 ' ' HB3' ' A' ' 74' ' ' LYS . . . . . . . . 0 O5'--C5' 1.429 -0.662 0 C3'-C2'-C1' 100.283 -1.352 . 0.0 '__' . 4.9400000000000004 . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 2' ' ' ' G' . . . . . 0.434 ' H1 ' ' HA ' ' A' ' 43' ' ' PRO . . . . . . . . 0 O5'--C5' 1.427 -0.816 0 C3'-C2'-C1' 99.501 -2.221 . 0.0 OUTLIER . 4.8700000000000001 . . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 3' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.429 -0.717 0 O4'-C1'-N19 106.861 -1.339 . 0.0 OUTLIER gamma 5.0199999999999996 . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 4' ' ' ' G' . . . . . 0.569 ' N3 ' " H3'" ' B' ' 4' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.427 -0.794 0 O4'-C1'-C2' 107.87 1.05 . 0.0 OUTLIER gamma 2.6899999999999999 . . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 5' ' ' ' U' . . . . . 0.894 " O2'" H5'' ' B' ' 6' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.425 -0.929 0 C3'-C2'-C1' 98.974 -2.807 . 0.0 OUTLIER . 1.9299999999999999 . . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 6' ' ' ' G' . . . . . 0.894 H5'' " O2'" ' B' ' 5' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.427 -0.802 1 P-O3'-C3' 124.925 4.354 . 0.0 OUTLIER . 2.3799999999999999 . . . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.423 -1.038 0 C3'-C2'-C1' 104.238 3.042 . 0.0 OUTLIER . 4.1900000000000004 . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.703 0 N-CA-C 111.906 -0.478 . . . . 13.029999999999999 111.906 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . 67.35 177.01 0.24 Allowed 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 123.372 0.669 . . . . 11.06 111.877 179.21 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 26.6 ptm -160.97 175.43 12.5 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.537 -0.542 . . . . 9.8499999999999996 109.537 178.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 69.7 -94.32 0.42 Allowed Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.955 -0.64 . . . . 6.6900000000000004 111.615 -175.664 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 9.4 t 179.6 -67.11 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.807 -0.812 . . . . 5.5499999999999998 108.807 177.104 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 12.4 ttm180 -150.31 -41.26 0.13 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.739 -0.664 . . . . 3.8700000000000001 110.125 178.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 32.0 t70 74.82 153.56 0.14 Allowed 'General case' 0 N--CA 1.471 0.615 0 O-C-N 124.221 0.951 . . . . 3.5299999999999998 110.316 -177.235 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 21.9 p -116.23 33.08 5.73 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 112.527 0.565 . . . . 1.6899999999999999 112.527 -172.551 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 46.7 ttp -75.3 69.39 2.12 Favored 'General case' 0 C--N 1.333 -0.127 0 N-CA-C 108.326 -0.99 . . . . 1.49 108.326 167.06 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.482 ' HB3' ' HB2' ' A' ' 86' ' ' ARG . 20.4 m-85 123.79 -176.12 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 127.339 2.256 . . . . 1.5 106.918 -173.431 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.515 ' HA ' ' HB2' ' A' ' 89' ' ' ALA . 34.6 p 61.22 -40.79 0.12 Allowed 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 114.384 1.253 . . . . 0.53000000000000003 114.384 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.547 ' HE3' ' O6 ' ' B' ' 6' ' ' ' G' . 85.4 tttt -80.07 112.56 17.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.286 0.565 . . . . 2.75 110.511 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.529 ' CG2' HG13 ' A' ' 107' ' ' VAL . 82.8 mt -106.84 131.24 57.26 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 CA-C-N 115.514 -0.766 . . . . 0.84999999999999998 110.842 -178.306 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -86.87 120.12 27.82 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.117 -0.697 . . . . 0.70999999999999996 109.117 177.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.909 HG12 HD11 ' A' ' 42' ' ' LEU . 5.3 t -112.21 139.91 34.48 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-O 121.514 0.673 . . . . 0.92000000000000004 111.15 -175.705 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -144.76 157.01 27.14 Favored Glycine 0 C--O 1.225 -0.421 0 CA-C-N 114.757 -1.111 . . . . 0.83999999999999997 113.422 -171.256 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 71.05 34.97 64.63 Favored Glycine 0 C--O 1.227 -0.296 0 C-N-CA 121.31 -0.472 . . . . 0.68000000000000005 113.549 172.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.909 HD11 HG12 ' A' ' 39' ' ' VAL . 6.8 mp -83.5 134.17 45.68 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-O 120.744 0.307 . . . . 1.28 111.228 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.602 ' HG3' ' CG ' ' A' ' 103' ' ' ARG . 52.8 Cg_exo -52.05 158.26 5.17 Favored 'Trans proline' 0 N--CA 1.461 -0.394 0 C-N-CA 122.92 2.413 . . . . 0.57999999999999996 111.792 173.057 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -72.53 3.83 4.51 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.933 0.397 . . . . 1.05 111.207 -178.225 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 80.3 t60 -112.07 -8.92 14.01 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.057 -0.519 . . . . 2.0099999999999998 110.943 178.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.564 ' CG2' HD23 ' A' ' 42' ' ' LEU . 12.5 m -77.6 125.88 30.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.994 0.426 . . . . 0.71999999999999997 111.805 -176.356 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 6.5 p -121.08 -178.32 3.73 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.903 -0.59 . . . . 0.55000000000000004 111.243 -176.48 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -59.19 -34.81 72.58 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 115.841 -0.618 . . . . 0.48999999999999999 109.863 -176.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.588 ' HG3' ' N ' ' A' ' 50' ' ' THR . 12.3 pttp -62.13 -39.5 92.76 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.322 -0.854 . . . . 2.7599999999999998 110.133 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.588 ' N ' ' HG3' ' A' ' 49' ' ' LYS . 15.1 m -68.27 -41.08 81.6 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 116.381 -0.372 . . . . 0.57999999999999996 110.518 -176.105 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.517 HD21 HG11 ' A' ' 39' ' ' VAL . 65.7 mt -63.66 -35.96 82.26 Favored 'General case' 0 C--O 1.222 -0.355 0 C-N-CA 120.434 -0.506 . . . . 0.84999999999999998 110.207 174.759 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 59.2 t-80 -67.28 -51.12 56.66 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.475 -0.49 . . . . 0.58999999999999997 110.089 179.099 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.504 ' HG3' ' O ' ' A' ' 49' ' ' LYS . 42.4 mt-10 -55.88 -43.76 77.5 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.729 0.299 . . . . 1.52 111.574 -179.554 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.503 ' O ' ' HB2' ' A' ' 57' ' ' GLN . 4.7 t80 -75.79 -35.13 60.17 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.353 -0.385 . . . . 1.1200000000000001 111.609 -176.124 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.44 ' HD1' ' O ' ' A' ' 51' ' ' LEU . 45.9 m-85 -86.82 -28.24 23.05 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 114.126 1.158 . . . . 0.56000000000000005 114.126 -172.66 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.706 ' N ' HD11 ' A' ' 61' ' ' ILE . 15.0 pt-20 -70.54 -15.93 62.83 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 122.395 1.093 . . . . 1.5700000000000001 109.236 -178.639 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.503 ' HB2' ' O ' ' A' ' 54' ' ' TYR . 70.1 mt-30 -53.72 -27.78 30.23 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 113.481 -1.69 . . . . 2.1600000000000001 112.174 168.438 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -100.17 -13.67 18.84 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.156 -0.475 . . . . 0.70999999999999996 110.387 -177.572 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.514 ' O ' ' HA ' ' A' ' 56' ' ' GLU . . . 144.57 -155.54 26.41 Favored Glycine 0 N--CA 1.448 -0.505 0 CA-C-N 115.658 -0.701 . . . . 0.75 112.115 175.09 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -64.32 123.34 18.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.109 0.481 . . . . 1.02 112.29 -179.034 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.706 HD11 ' N ' ' A' ' 56' ' ' GLU . 10.0 mt -101.61 123.92 55.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 108.208 -1.034 . . . . 0.46999999999999997 108.208 172.293 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -79.74 -44.08 21.4 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.308 0.575 . . . . 2.0699999999999998 110.406 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -148.65 130.52 15.19 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.658 -0.701 . . . . 2.48 110.675 -179.458 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -117.45 115.83 25.96 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.067 -0.515 . . . . 0.44 110.086 174.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.1 p -137.11 135.31 47.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.446 -0.797 . . . . 1.3799999999999999 112.065 -177.72 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 89.8 t -98.91 132.81 43.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.498 -0.774 . . . . 0.48999999999999999 109.033 172.092 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.624 ' H ' ' HA2' ' A' ' 79' ' ' GLY . 36.6 mm -74.87 84.36 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.826 0.822 . . . . 0.71999999999999997 109.479 177.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.781 ' HB ' ' HA ' ' A' ' 73' ' ' GLN . 16.7 p -97.46 177.42 5.53 Favored 'General case' 0 N--CA 1.435 -1.222 0 CA-C-N 114.419 -1.264 . . . . 1.52 110.734 -177.754 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -85.11 121.57 28.07 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.926 -0.31 . . . . 2.4900000000000002 110.719 -177.311 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 70' ' ' ARG . 3.2 ptm180 -49.37 -17.03 0.22 Allowed 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 114.28 1.215 . . . . 6.0499999999999998 114.28 -177.31 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 48.5 m-80 -83.95 -41.3 17.48 Favored 'General case' 0 N--CA 1.462 0.174 0 O-C-N 121.847 -0.533 . . . . 4.0499999999999998 111.538 -177.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 31.9 p -132.42 -29.28 1.59 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.927 0.394 . . . . 3.0800000000000001 111.602 -175.329 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.781 ' HA ' ' HB ' ' A' ' 68' ' ' THR . 88.8 mt-30 61.87 22.86 13.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.461 -0.79 . . . . 3.2999999999999998 112.068 -178.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -54.61 -45.12 73.63 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 111.895 0.332 . . . . 3.4900000000000002 111.895 174.191 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.66 ' O ' ' HA ' ' A' ' 68' ' ' THR . 58.3 p -175.54 -122.87 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 112.332 0.493 . . . . 1.8100000000000001 112.332 173.577 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.554 ' HG3' ' O ' ' A' ' 75' ' ' SER . 46.0 mtt180 129.54 -50.31 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 126.964 2.106 . . . . 2.5600000000000001 110.137 -167.549 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 104.67 16.62 17.01 Favored Glycine 0 N--CA 1.454 -0.157 0 C-N-CA 120.675 -0.774 . . . . 0.64000000000000001 113.43 177.47 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -129.69 152.94 48.64 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.424 -0.954 . . . . 1.1799999999999999 108.424 177.626 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.624 ' HA2' ' H ' ' A' ' 67' ' ' ILE . . . -157.08 -166.31 16.43 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 119.854 -1.165 . . . . 0.58999999999999997 112.509 177.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.43 ' HD2' HD11 ' A' ' 67' ' ' ILE . 45.4 m-85 -159.57 125.01 4.16 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 123.563 0.745 . . . . 0.63 109.216 -177.554 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 69.9 t -117.95 118.79 59.44 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 N-CA-C 109.669 -0.493 . . . . 0.40999999999999998 109.669 177.5 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 17.8 m -110.16 109.48 20.0 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 108.03 -1.1 . . . . 0.46999999999999997 108.03 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.464 ' HA ' ' HA ' ' A' ' 61' ' ' ILE . 44.1 mtp -88.25 166.56 14.25 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 110.138 -0.319 . . . . 0.88 110.138 -173.693 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.461 ' HB2' ' HZ2' ' A' ' 84' ' ' LYS . 4.3 ttmp? -74.28 -43.21 57.81 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.929 -0.308 . . . . 1.9199999999999999 111.376 -174.147 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -128.56 151.01 49.94 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-O 121.784 0.802 . . . . 1.6799999999999999 111.225 179.114 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.482 ' HB2' ' HB3' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -65.72 -23.06 66.67 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 114.421 -1.263 . . . . 3.6600000000000001 112.646 -172.153 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.25 -46.65 76.39 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 118.768 0.713 . . . . 0.66000000000000003 111.155 -179.299 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 18.2 m -64.86 -38.23 90.28 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.683 0.754 . . . . 0.78000000000000003 109.766 176.677 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.515 ' HB2' ' HA ' ' A' ' 35' ' ' THR . . . -58.41 -47.41 83.99 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 113.544 -1.662 . . . . 0.46000000000000002 109.691 176.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.59 ' O ' ' HG2' ' A' ' 94' ' ' LYS . 6.3 mm-40 -56.04 -50.88 69.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.12 -0.945 . . . . 2.1099999999999999 112.006 175.104 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 43.9 mtm180 -57.89 -43.66 86.25 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.518 0.199 . . . . 3.8199999999999998 111.165 -178.256 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -56.88 -37.1 70.89 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.934 -0.575 . . . . 0.92000000000000004 111.711 177.492 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 48.0 t -86.77 -13.41 45.27 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 112.677 0.621 . . . . 1.1599999999999999 112.677 -178.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.59 ' HG2' ' O ' ' A' ' 90' ' ' GLU . 72.5 mmtt -65.77 -43.75 87.91 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 120.888 0.375 . . . . 4.2000000000000002 110.751 -177.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -114.49 92.99 30.45 Favored Pre-proline 0 C--N 1.326 -0.441 0 N-CA-C 109.646 -0.501 . . . . 2.2400000000000002 109.646 176.066 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -81.09 -166.7 0.43 Allowed 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 122.735 2.29 . . . . 2.3799999999999999 112.649 -176.073 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.728 ' HA ' ' O ' ' A' ' 105' ' ' ALA . 22.7 m120 38.95 63.42 4.28 Favored Pre-proline 0 N--CA 1.467 0.396 0 N-CA-C 113.512 0.93 . . . . 3.0299999999999998 113.512 -173.372 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.452 ' HD3' ' N ' ' A' ' 97' ' ' ASN . 2.5 Cg_endo -81.54 143.44 13.59 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.775 2.317 . . . . 1.29 110.82 174.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 38.6 mm -81.22 90.25 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.301 0.572 . . . . 1.8100000000000001 109.827 178.345 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 31.1 mt -90.88 106.78 17.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 121.462 0.649 . . . . 0.98999999999999999 111.199 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.449 ' HB2' HG21 ' A' ' 50' ' ' THR . 35.6 t70 66.1 46.62 2.08 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 113.889 -1.505 . . . . 1.3700000000000001 110.147 166.051 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 91.23 -7.1 81.02 Favored Glycine 0 N--CA 1.451 -0.34 0 CA-C-N 114.94 -1.027 . . . . 1.5600000000000001 114.821 175.654 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.602 ' CG ' ' HG3' ' A' ' 43' ' ' PRO . 20.9 mmt180 -133.77 148.93 51.42 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 118.614 1.207 . . . . 4.1299999999999999 111.642 177.299 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -67.23 138.8 57.2 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.371 -0.831 . . . . 2.73 109.927 174.02 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.728 ' O ' ' HA ' ' A' ' 97' ' ' ASN . . . -124.57 150.87 45.44 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.042 -0.526 . . . . 1.04 109.856 -172.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -101.69 110.32 22.29 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 109.609 -0.515 . . . . 2.04 109.609 177.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.529 HG13 ' CG2' ' A' ' 37' ' ' ILE . 44.8 t -109.73 133.32 55.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.701 -0.681 . . . . 1.0600000000000001 111.057 174.198 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -158.65 163.45 36.89 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.856 -0.794 . . . . 2.4900000000000002 108.856 175.036 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.53 ' HB3' ' CD1' ' A' ' 111' ' ' TYR . 1.7 mm? -76.68 125.56 29.47 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.994 0.426 . . . . 1.23 110.709 -178.463 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.63 -25.83 65.93 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 113.314 0.857 . . . . 0.91000000000000003 113.314 -174.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.53 ' CD1' ' HB3' ' A' ' 109' ' ' LEU . 2.6 p90 -68.42 -3.4 11.14 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.966 0.412 . . . . 1.3999999999999999 111.295 -174.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 99.5 mt -73.46 -29.2 62.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.232 -0.44 . . . . 1.97 110.283 175.34 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -146.47 46.36 0.75 Allowed Glycine 0 C--N 1.333 0.384 0 C-N-CA 120.974 -0.632 . . . . 2.1400000000000001 111.59 178.166 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -88.09 126.89 35.35 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.927 -0.136 . . . . 2.6600000000000001 110.679 -176.196 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.413 ' HE3' ' HB2' ' A' ' 115' ' ' LYS . 24.5 mtmt -141.84 68.33 23.79 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 120.781 0.324 . . . . 4.1600000000000001 110.742 177.381 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -89.25 -12.88 3.1 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.774 2.316 . . . . 5.5300000000000002 111.175 175.218 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 47.1 ttp180 -175.92 173.38 2.3 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 106.947 -1.501 . . . . 8.5999999999999996 106.947 -178.72 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 5.5 p 65.34 20.11 11.77 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.259 0.624 . . . . 6.3700000000000001 109.991 -176.592 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -60.5 133.8 56.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.142 -0.935 . . . . 7.8499999999999996 111.055 -176.619 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 41.8 t -60.9 -44.93 98.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.662 -0.699 . . . . 9.3699999999999992 110.231 177.679 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.472 ' HA ' ' OE1' ' A' ' 121' ' ' GLN . 6.1 tp60 . . . . . 0 C--O 1.247 0.936 0 CA-C-N 115.24 -0.891 . . . . 12.279999999999999 110.392 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 1' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.43 -0.63 0 O5'-C5'-C4' 111.544 0.96 . 0.0 '__' . 4.9400000000000004 . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 2' ' ' ' G' . . . . . 0.466 ' H1 ' ' HA ' ' A' ' 43' ' ' PRO . . . . . . . . 0 O5'--C5' 1.423 -1.091 0 C3'-C2'-C1' 99.281 -2.465 . 0.0 OUTLIER . 4.8700000000000001 . . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 3' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.426 -0.901 0 C4'-C3'-C2' 104.261 1.561 . 0.0 OUTLIER . 5.0199999999999996 . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 4' ' ' ' G' . . . . . 0.537 ' N3 ' " H3'" ' B' ' 4' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.428 -0.751 0 O4'-C1'-C2' 107.982 1.13 . 0.0 OUTLIER '7D dist 2a' 2.6899999999999999 . . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 5' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.426 -0.887 0 C3'-C2'-C1' 100.269 -1.368 . 0.01 1t . 1.9299999999999999 . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 6' ' ' ' G' . . . . . 0.547 ' O6 ' ' HE3' ' A' ' 36' ' ' LYS . . . . . . . . 0 O5'--C5' 1.428 -0.742 0 C4'-C3'-C2' 104.209 1.509 . 0.0 OUTLIER '7D dist 4b' 2.3799999999999999 . . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.428 -0.779 0 C1'-O4'-C4' 110.265 0.738 . 0.0 OUTLIER . 4.1900000000000004 . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.785 0 N-CA-C 112.561 -0.215 . . . . 13.029999999999999 112.561 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -75.79 169.92 17.21 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.15 0.5 . . . . 11.06 111.579 -177.329 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 51.3 ttm -144.83 126.49 15.15 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.735 -0.666 . . . . 9.8499999999999996 110.165 179.211 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 81.46 81.71 0.85 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.746 -0.74 . . . . 6.6900000000000004 112.966 178.362 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 50.3 m -99.58 -56.11 2.49 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 122.512 -0.405 . . . . 5.5499999999999998 110.211 174.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 65.17 84.62 0.15 Allowed 'General case' 0 N--CA 1.463 0.213 0 O-C-N 123.74 0.65 . . . . 3.8700000000000001 110.646 178.212 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -63.55 113.22 3.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.167 -0.924 . . . . 3.5299999999999998 110.753 -179.02 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 18.4 p -78.35 -1.56 33.87 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.862 -0.608 . . . . 1.6899999999999999 111.785 -175.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 50.7 ttp -58.22 -40.67 82.26 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.461 0.541 . . . . 1.49 112.461 -174.605 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.486 ' O ' HD11 ' A' ' 109' ' ' LEU . 39.4 m-85 -96.25 -11.73 25.58 Favored 'General case' 0 C--O 1.224 -0.256 0 O-C-N 121.911 -0.493 . . . . 1.5 111.253 -177.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.531 ' O ' ' HA ' ' A' ' 82' ' ' THR . 39.3 p -105.28 4.49 31.09 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 111.989 0.366 . . . . 0.53000000000000003 111.989 -173.845 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -92.83 102.5 14.88 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.322 -0.399 . . . . 2.75 110.046 -178.623 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.414 HG23 ' O ' ' A' ' 108' ' ' ASN . 4.0 mp -103.42 135.33 41.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.76 0.314 . . . . 0.84999999999999998 110.674 -177.748 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.427 ' HE2' ' C8 ' ' B' ' 4' ' ' ' G' . 51.5 t80 -94.78 109.38 21.35 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.412 -0.588 . . . . 0.70999999999999996 109.412 175.693 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.572 HG11 HD11 ' A' ' 51' ' ' LEU . 5.5 t -97.89 142.94 13.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-N 115.469 -0.787 . . . . 0.92000000000000004 110.634 -176.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -143.27 161.01 27.66 Favored Glycine 0 N--CA 1.447 -0.624 0 CA-C-N 114.538 -1.21 . . . . 0.83999999999999997 111.717 -171.44 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 71.18 21.62 78.47 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.892 -0.671 . . . . 0.68000000000000005 113.259 175.403 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.608 HD11 HD13 ' A' ' 51' ' ' LEU . 2.9 mm? -67.02 119.3 63.17 Favored Pre-proline 0 C--O 1.223 -0.319 0 N-CA-C 109.094 -0.706 . . . . 1.28 109.094 175.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.672 ' CG ' ' HB3' ' A' ' 101' ' ' ASP . 11.9 Cg_endo -56.3 158.87 14.17 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.372 2.048 . . . . 0.57999999999999996 111.232 175.341 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.496 ' CZ ' ' C5 ' ' B' ' 2' ' ' ' G' . 76.4 m-85 -71.98 2.46 5.62 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.896 0.379 . . . . 1.05 111.649 -171.028 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 18.1 t-160 -95.7 -16.88 21.7 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.059 -0.519 . . . . 2.0099999999999998 110.136 174.585 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.532 HG21 HD12 ' A' ' 42' ' ' LEU . 67.9 m -79.4 116.75 19.82 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.445 0.641 . . . . 0.71999999999999997 112.278 -174.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 42.1 p -99.81 -177.64 3.62 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.31 -0.859 . . . . 0.55000000000000004 110.19 172.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.555 ' HA ' HG23 ' A' ' 66' ' ' VAL . 4.6 m-20 -61.25 -35.1 76.34 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.453 0.644 . . . . 0.48999999999999999 110.105 -178.091 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.654 ' O ' ' HG2' ' A' ' 53' ' ' GLU . 0.6 OUTLIER -74.52 -38.23 62.85 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.317 -0.856 . . . . 2.7599999999999998 110.595 -178.56 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.454 ' HB ' HG23 ' A' ' 46' ' ' THR . 17.0 m -62.4 -43.17 99.45 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.267 0.556 . . . . 0.57999999999999996 110.051 177.482 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.608 HD13 HD11 ' A' ' 42' ' ' LEU . 22.1 tp -66.15 -37.58 86.02 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 115.547 -0.751 . . . . 0.84999999999999998 109.796 177.458 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 48.7 t-80 -58.44 -53.1 62.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.617 -0.719 . . . . 0.58999999999999997 110.841 175.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.654 ' HG2' ' O ' ' A' ' 49' ' ' LYS . 21.3 mm-40 -58.14 -42.33 85.61 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.128 -0.487 . . . . 1.52 111.529 -177.451 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.448 ' O ' ' HB2' ' A' ' 57' ' ' GLN . 6.2 t80 -74.76 -33.61 62.35 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.16 -0.473 . . . . 1.1200000000000001 111.762 -174.604 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.658 ' CB ' HD11 ' A' ' 61' ' ' ILE . 4.9 m-85 -86.2 -26.09 25.27 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 114.043 1.127 . . . . 0.56000000000000005 114.043 -176.611 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.447 ' HA ' ' O ' ' A' ' 59' ' ' GLY . 7.9 pt-20 -72.78 -11.78 60.75 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 122.109 0.957 . . . . 1.5700000000000001 109.553 179.5 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.448 ' HB2' ' O ' ' A' ' 54' ' ' TYR . 13.4 mm100 -55.69 -19.33 10.45 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.505 -1.225 . . . . 2.1600000000000001 111.602 166.521 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -105.9 10.87 32.31 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.618 0.247 . . . . 0.70999999999999996 110.786 -178.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.447 ' O ' ' HA ' ' A' ' 56' ' ' GLU . . . 125.61 -171.09 17.49 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.79 -0.719 . . . . 0.75 112.664 -177.03 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.4 ' CB ' ' HB3' ' A' ' 84' ' ' LYS . 0.8 OUTLIER -65.51 123.05 18.63 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.799 0.666 . . . . 1.02 112.799 -179.142 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.658 HD11 ' CB ' ' A' ' 55' ' ' PHE . 10.1 mt -93.52 122.81 45.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.168 -0.924 . . . . 0.46999999999999997 108.767 169.517 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -78.05 -41.47 35.43 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.234 0.54 . . . . 2.0699999999999998 110.078 177.484 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -162.56 131.05 4.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.695 -0.684 . . . . 2.48 110.756 -177.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -117.17 116.49 27.39 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.785 0.326 . . . . 0.44 110.192 177.008 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.686 HG21 ' H22' ' B' ' 6' ' ' ' G' . 16.2 m -126.9 112.42 28.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.663 0.744 . . . . 1.3799999999999999 111.819 -178.316 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.555 HG23 ' HA ' ' A' ' 48' ' ' ASP . 70.1 t -79.25 131.52 34.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.547 -0.751 . . . . 0.48999999999999999 109.591 179.017 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.609 ' H ' ' HA2' ' A' ' 79' ' ' GLY . 28.8 mm -71.48 140.67 17.84 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.697 0 N-CA-C 107.473 -1.306 . . . . 0.71999999999999997 107.473 175.329 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.88 ' HA ' ' O ' ' A' ' 75' ' ' SER . 15.2 p -159.76 152.62 21.61 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 107.343 -1.355 . . . . 1.52 107.343 -159.698 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -64.79 125.43 24.78 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.498 -0.481 . . . . 2.4900000000000002 111.438 -175.172 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 6.7 ptp180 -49.43 -21.97 1.05 Allowed 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 114.053 1.131 . . . . 6.0499999999999998 114.053 -177.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -95.6 -38.64 10.31 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 112.713 0.634 . . . . 4.0499999999999998 112.713 -178.368 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 32.6 p -120.72 -29.24 4.72 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.669 0.618 . . . . 3.0800000000000001 112.669 -174.194 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.748 ' HA ' ' HB ' ' A' ' 68' ' ' THR . 37.7 mt-30 59.12 14.41 3.49 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 113.577 0.955 . . . . 3.2999999999999998 113.577 178.15 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 51.8 mtmt -42.83 -60.86 1.43 Allowed 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 112.571 0.582 . . . . 3.4900000000000002 112.571 172.162 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.88 ' O ' ' HA ' ' A' ' 68' ' ' THR . 5.3 p -163.24 -108.53 0.01 OUTLIER 'General case' 0 C--O 1.216 -0.692 0 CA-C-O 118.659 -0.686 . . . . 1.8100000000000001 112.709 177.688 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.655 ' HA ' " O5'" ' B' ' 1' ' ' ' G' . 74.4 mtt180 112.23 -19.06 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 125.27 1.428 . . . . 2.5600000000000001 111.729 -170.188 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.452 ' HA3' ' C6 ' ' B' ' 2' ' ' ' G' . . . 81.78 12.62 81.18 Favored Glycine 0 CA--C 1.526 0.719 0 C-N-CA 120.049 -1.072 . . . . 0.64000000000000001 113.762 174.096 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -128.47 160.37 32.51 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.862 -0.792 . . . . 1.1799999999999999 108.862 -177.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.609 ' HA2' ' H ' ' A' ' 67' ' ' ILE . . . 178.57 145.12 5.93 Favored Glycine 0 C--O 1.222 -0.651 0 C-N-CA 119.424 -1.37 . . . . 0.58999999999999997 113.648 175.429 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.476 ' HD2' HD11 ' A' ' 67' ' ' ILE . 96.4 m-85 -98.67 137.62 37.03 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 122.188 0.994 . . . . 0.63 112.495 175.43 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 65.0 t -119.91 134.03 64.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 114.234 -1.348 . . . . 0.40999999999999998 109.526 176.279 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.531 ' HA ' ' O ' ' A' ' 35' ' ' THR . 27.0 m -114.83 123.95 50.51 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 108.596 -0.891 . . . . 0.46999999999999997 108.596 175.712 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.424 ' SD ' HG12 ' A' ' 61' ' ' ILE . 82.2 mmm -88.68 164.3 15.38 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.937 -0.764 . . . . 0.88 108.937 -178.475 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.448 ' HB2' ' HZ2' ' A' ' 84' ' ' LYS . 4.3 ttmp? -82.66 -18.27 41.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.173 0.511 . . . . 1.9199999999999999 110.454 -176.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -143.03 146.91 34.29 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.158 -0.474 . . . . 1.6799999999999999 109.85 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.571 ' O ' ' HG3' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -64.96 -25.17 67.76 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.051 0.389 . . . . 3.6600000000000001 112.051 -178.821 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.524 ' O ' ' HG2' ' A' ' 91' ' ' ARG . . . -64.45 -44.98 89.39 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 121.621 -0.674 . . . . 0.66000000000000003 111.743 178.344 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 18.3 m -66.92 -32.18 73.26 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.938 0.875 . . . . 0.78000000000000003 109.665 176.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.441 ' HB3' ' O ' ' A' ' 86' ' ' ARG . . . -59.76 -47.03 87.33 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 113.652 -1.613 . . . . 0.46000000000000002 109.596 175.781 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.571 ' HG3' ' O ' ' A' ' 86' ' ' ARG . 45.6 mt-10 -56.05 -50.84 69.83 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.751 -0.659 . . . . 2.1099999999999999 111.385 174.231 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.524 ' HG2' ' O ' ' A' ' 87' ' ' ALA . 2.0 mmt180 -57.88 -44.87 86.95 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.672 0.272 . . . . 3.8199999999999998 111.337 -177.318 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -55.79 -41.38 74.01 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.889 -0.596 . . . . 0.92000000000000004 111.157 176.589 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 44.1 t -70.44 -20.14 62.92 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.598 -0.274 . . . . 1.1599999999999999 111.676 178.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -76.61 7.28 4.72 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 112.412 0.523 . . . . 4.2000000000000002 112.412 -178.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -144.01 93.09 6.13 Favored Pre-proline 0 C--N 1.322 -0.613 0 N-CA-C 108.633 -0.877 . . . . 2.2400000000000002 108.633 -178.534 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -74.66 -28.87 9.45 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.499 2.133 . . . . 2.3799999999999999 113.742 -172.151 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.537 ' HA ' ' O ' ' A' ' 105' ' ' ALA . 10.5 m120 -130.99 79.02 72.35 Favored Pre-proline 0 C--N 1.33 -0.25 0 N-CA-C 112.133 0.42 . . . . 3.0299999999999998 112.133 -175.62 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.411 ' HB2' ' CE1' ' A' ' 54' ' ' TYR . 73.1 Cg_endo -81.57 141.32 12.34 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.755 2.304 . . . . 1.29 111.875 174.365 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 42.0 mm -83.32 90.07 2.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.139 0.495 . . . . 1.8100000000000001 110.865 177.492 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 53.8 mt -92.96 135.31 28.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.601 -0.727 . . . . 0.98999999999999999 111.148 175.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.672 ' HB3' ' CG ' ' A' ' 43' ' ' PRO . 38.8 t70 43.21 35.86 0.91 Allowed 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 115.733 -0.667 . . . . 1.3700000000000001 112.477 -174.647 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 73.49 18.74 79.51 Favored Glycine 0 CA--C 1.519 0.306 0 C-N-CA 120.8 -0.714 . . . . 1.5600000000000001 113.03 178.543 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 5.4 tpt180 -129.77 139.78 51.21 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.722 -0.844 . . . . 4.1299999999999999 108.722 178.564 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 6.6 ttpm? -71.37 140.23 50.1 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.795 0.331 . . . . 2.73 110.171 179.311 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.537 ' O ' ' HA ' ' A' ' 97' ' ' ASN . . . -123.66 166.07 16.14 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.512 -0.313 . . . . 1.04 110.804 -171.524 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -111.65 146.54 37.26 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.038 -0.528 . . . . 2.04 110.34 -178.589 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 73.2 t -145.46 135.69 18.73 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 115.719 -0.673 . . . . 1.0600000000000001 110.95 -173.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.414 ' O ' HG23 ' A' ' 37' ' ' ILE . 3.4 p-10 -167.17 161.87 14.82 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 109.6 -0.518 . . . . 2.4900000000000002 109.6 173.797 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.486 HD11 ' O ' ' A' ' 34' ' ' PHE . 1.6 mm? -77.22 120.31 22.09 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.263 -0.643 . . . . 1.23 109.263 173.259 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -56.19 -36.23 68.16 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.545 0.572 . . . . 0.91000000000000003 112.545 -172.069 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 5.6 p90 -70.97 -7.31 45.27 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.854 -0.338 . . . . 1.3999999999999999 111.537 -174.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 97.0 mt -84.59 -23.18 29.73 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.96 0.409 . . . . 1.97 110.458 177.063 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -127.85 25.94 4.89 Favored Glycine 0 N--CA 1.45 -0.407 0 N-CA-C 110.869 -0.893 . . . . 2.1400000000000001 110.869 -178.661 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -89.27 137.02 32.69 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.691 -0.485 . . . . 2.6600000000000001 109.691 -173.488 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 35.4 mttm -129.55 78.9 74.76 Favored Pre-proline 0 C--N 1.321 -0.633 0 C-N-CA 120.525 -0.47 . . . . 4.1600000000000001 109.984 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -89.35 -38.5 0.05 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 122.158 1.905 . . . . 5.5300000000000002 113.577 -176.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 38.5 ptt180 -131.39 -1.12 3.97 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.853 0.359 . . . . 8.5999999999999996 111.194 -175.248 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 8.8 t -144.58 137.96 27.12 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.404 -0.362 . . . . 6.3700000000000001 110.225 -177.347 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -150.95 144.75 25.14 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.418 -0.355 . . . . 7.8499999999999996 110.136 179.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.496 ' O ' ' HB2' ' A' ' 121' ' ' GLN . 26.2 t -91.76 -84.84 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 109.226 -0.657 . . . . 9.3699999999999992 109.226 177.25 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.496 ' HB2' ' O ' ' A' ' 120' ' ' VAL . 54.8 tt0 . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.364 -0.827 . . . . 12.279999999999999 109.209 174.577 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 1' ' ' ' G' . . . . . 0.655 " O5'" ' HA ' ' A' ' 76' ' ' ARG . . . . . . . . 0 O5'--C5' 1.431 -0.546 0 O5'-C5'-C4' 111.401 0.858 . 0.0 '__' . 4.9400000000000004 . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 2' ' ' ' G' . . . . . 0.496 ' C5 ' ' CZ ' ' A' ' 44' ' ' TYR . . . . . . . . 0 O5'--C5' 1.423 -1.092 0 C3'-C2'-C1' 99.037 -2.736 . 0.0 OUTLIER . 4.8700000000000001 . . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 3' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.427 -0.786 0 C3'-C2'-C1' 100.425 -1.195 . 0.0 OUTLIER gamma 5.0199999999999996 . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 4' ' ' ' G' . . . . . 0.763 ' N3 ' " H3'" ' B' ' 4' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.428 -0.724 0 C1'-O4'-C4' 110.339 0.821 . 0.0 OUTLIER '7D dist 0i' 2.6899999999999999 . . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 5' ' ' ' U' . . . . . 0.556 ' H6 ' " O5'" ' B' ' 5' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.425 -0.937 0 C3'-C2'-C1' 100.867 -0.704 . 0.157 1b . 1.9299999999999999 . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 6' ' ' ' G' . . . . . 0.686 ' H22' HG21 ' A' ' 65' ' ' VAL . . . . . . . . 0 O5'--C5' 1.426 -0.846 0 C4'-C3'-C2' 103.591 0.891 . 0.479 0b . 2.3799999999999999 . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.427 -0.806 0 C3'-C2'-C1' 100.717 -0.87 . 0.0 OUTLIER . 4.1900000000000004 . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.684 0 N-CA-C 112.196 -0.362 . . . . 13.029999999999999 112.196 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -91.5 2.95 56.07 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.083 0.468 . . . . 11.06 110.77 -179.389 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 24.8 mmt -96.31 134.66 39.16 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.093 -0.503 . . . . 9.8499999999999996 110.104 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -104.64 150.5 17.2 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.843 -0.694 . . . . 6.6900000000000004 112.446 -178.114 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 9.6 m -77.76 -58.08 3.46 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.508 0.194 . . . . 5.5499999999999998 110.775 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 50.2 mtm180 54.42 92.03 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.361 0 O-C-N 123.839 0.712 . . . . 3.8700000000000001 112.368 -178.405 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -66.78 -48.94 67.48 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.127 -0.942 . . . . 3.5299999999999998 111.366 177.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.423 ' O ' ' HB2' ' A' ' 36' ' ' LYS . 58.9 p 57.61 16.37 3.35 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 114.282 1.216 . . . . 1.6899999999999999 114.282 176.574 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 13.8 tmm? -65.4 -40.53 93.54 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 121.875 -0.515 . . . . 1.49 111.851 177.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.552 ' O ' HD11 ' A' ' 109' ' ' LEU . 18.2 m-85 -92.96 -13.43 28.81 Favored 'General case' 0 C--O 1.225 -0.201 0 O-C-N 122.013 -0.429 . . . . 1.5 111.482 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.52 ' HB ' ' O ' ' A' ' 83' ' ' MET . 31.7 p -94.38 -6.09 44.97 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.998 0.428 . . . . 0.53000000000000003 111.102 -174.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.797 ' HE2' ' O6 ' ' B' ' 6' ' ' ' G' . 13.8 tptm -84.67 103.7 14.01 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.789 -0.641 . . . . 2.75 110.357 -177.092 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.635 HD11 ' HA ' ' A' ' 89' ' ' ALA . 28.7 mt -98.78 139.03 21.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 121.339 0.59 . . . . 0.84999999999999998 112.486 -174.226 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.419 ' HD1' ' CE2' ' A' ' 80' ' ' PHE . 68.8 t80 -105.59 111.76 24.58 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.31 -0.859 . . . . 0.70999999999999996 108.976 174.538 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.42 HG13 HG22 ' A' ' 107' ' ' VAL . 5.3 t -99.29 139.34 21.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.068 0.461 . . . . 0.92000000000000004 110.042 -178.803 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -140.53 138.11 8.76 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.268 -0.968 . . . . 0.83999999999999997 113.396 -170.68 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 84.9 31.15 24.32 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 121.486 -0.388 . . . . 0.68000000000000005 112.498 176.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.69 HD12 HG21 ' A' ' 46' ' ' THR . 3.3 mm? -67.24 129.15 93.86 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-O 120.564 0.221 . . . . 1.28 110.809 178.613 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.692 ' HA ' ' O6 ' ' B' ' 2' ' ' ' G' . 65.5 Cg_exo -54.97 159.73 9.0 Favored 'Trans proline' 0 CA--C 1.529 0.271 0 C-N-CA 123.448 2.765 . . . . 0.57999999999999996 112.923 172.868 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.689 ' HA ' ' HB2' ' A' ' 75' ' ' SER . 6.8 m-30 -69.18 -9.67 54.04 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.738 -0.664 . . . . 1.05 112.486 -174.146 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' HIS . . . . . 0.414 ' HB3' ' OD2' ' A' ' 101' ' ' ASP . 44.5 t60 -104.23 -1.18 27.47 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.054 0.454 . . . . 2.0099999999999998 110.368 178.771 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.69 HG21 HD12 ' A' ' 42' ' ' LEU . 85.3 m -73.3 116.4 13.8 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.639 0.733 . . . . 0.71999999999999997 111.362 -177.631 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 6.1 p -110.74 -178.91 3.6 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.631 -1.168 . . . . 0.55000000000000004 110.503 176.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -62.36 -35.94 80.71 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.334 0.588 . . . . 0.48999999999999999 110.284 -175.104 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.667 ' O ' ' HG2' ' A' ' 53' ' ' GLU . 43.0 pttt -65.13 -35.13 80.14 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.336 -0.847 . . . . 2.7599999999999998 110.821 179.498 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 6.4 m -67.51 -44.8 77.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.551 -0.295 . . . . 0.57999999999999996 111.049 -178.632 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.675 HD21 HD11 ' A' ' 42' ' ' LEU . 22.1 mt -64.99 -33.99 77.36 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-O 120.855 0.36 . . . . 0.84999999999999998 110.296 175.177 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.449 ' HA ' ' CD1' ' A' ' 61' ' ' ILE . 49.3 t-80 -64.95 -54.47 30.14 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 116.017 -0.538 . . . . 0.58999999999999997 110.453 -179.214 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.667 ' HG2' ' O ' ' A' ' 49' ' ' LYS . 13.6 mm-40 -56.41 -51.1 69.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.252 -0.431 . . . . 1.52 111.777 -179.123 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.536 ' O ' ' HB2' ' A' ' 57' ' ' GLN . 2.1 t80 -70.44 -33.31 71.17 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 112.765 0.654 . . . . 1.1200000000000001 112.765 -173.077 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.88 ' HB2' HD11 ' A' ' 61' ' ' ILE . 11.3 m-85 -85.44 -35.29 21.35 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 114.436 1.273 . . . . 0.56000000000000005 114.436 -172.05 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.626 ' HB3' HG13 ' A' ' 61' ' ' ILE . 13.5 pt-20 -77.99 -6.56 54.87 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 119.747 1.158 . . . . 1.5700000000000001 110.189 179.113 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.536 ' HB2' ' O ' ' A' ' 54' ' ' TYR . 73.3 mm-40 -57.41 -9.83 1.19 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.454 -0.794 . . . . 2.1600000000000001 112.028 162.369 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -104.3 -21.95 13.43 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.234 -0.439 . . . . 0.70999999999999996 109.99 177.205 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.51 ' HA3' ' OG ' ' A' ' 88' ' ' SER . . . 169.91 -116.28 0.64 Allowed Glycine 0 C--O 1.226 -0.398 0 CA-C-N 115.856 -0.611 . . . . 0.75 112.061 -179.486 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -115.36 128.1 55.85 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.942 0.371 . . . . 1.02 110.617 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.88 HD11 ' HB2' ' A' ' 55' ' ' PHE . 25.5 mt -97.13 124.27 49.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 109.776 -0.454 . . . . 0.46999999999999997 109.776 170.236 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -88.8 -32.02 18.06 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.161 0.505 . . . . 2.0699999999999998 110.257 178.423 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -161.06 126.67 3.77 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.965 -0.561 . . . . 2.48 110.483 179.204 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -117.53 124.66 49.25 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.834 0.35 . . . . 0.44 110.209 171.03 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.3 p -141.4 112.63 3.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 121.956 0.884 . . . . 1.3799999999999999 111.991 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.525 HG22 HD12 ' A' ' 51' ' ' LEU . 23.0 t -79.37 129.06 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 CA-C-N 115.079 -0.964 . . . . 0.48999999999999999 108.77 177.218 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.564 ' H ' ' HA2' ' A' ' 79' ' ' GLY . 44.5 mm -73.7 85.39 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 CA-C-O 121.699 0.761 . . . . 0.71999999999999997 109.714 -178.515 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.656 HG22 ' HA ' ' A' ' 75' ' ' SER . 23.9 p -119.69 -179.12 3.79 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 114.652 -1.158 . . . . 1.52 110.438 178.478 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.996 ' H ' ' HA ' ' A' ' 73' ' ' GLN . 25.6 t70 -96.25 120.4 36.47 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.224 -0.444 . . . . 2.4900000000000002 110.979 -173.7 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 6.3 mpt_? -57.89 -4.75 0.34 Allowed 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 113.909 1.078 . . . . 6.0499999999999998 113.909 -177.399 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.415 ' HB2' ' OD2' ' A' ' 69' ' ' ASP . 37.4 m-80 -107.87 -40.65 5.2 Favored 'General case' 0 N--CA 1.464 0.272 0 O-C-N 121.82 -0.55 . . . . 4.0499999999999998 111.577 177.534 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.3 p -132.07 -28.89 1.69 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.118 0.485 . . . . 3.0800000000000001 111.951 -173.632 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.996 ' HA ' ' H ' ' A' ' 69' ' ' ASP . 78.2 mt-30 62.6 -92.16 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.999 -1.0 . . . . 3.2999999999999998 111.625 -175.169 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp 55.16 78.26 0.19 Allowed 'General case' 0 C--N 1.333 -0.112 0 N-CA-C 108.114 -1.069 . . . . 3.4900000000000002 108.114 -175.376 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.689 ' HB2' ' HA ' ' A' ' 44' ' ' TYR . 15.5 m -35.8 107.82 0.06 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 114.721 -1.127 . . . . 1.8100000000000001 113.699 -164.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.507 ' HD2' ' O ' ' A' ' 67' ' ' ILE . 14.4 mtt180 -56.08 -25.59 46.1 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 114.249 -1.341 . . . . 2.5600000000000001 111.903 177.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.476 ' HA2' ' O ' ' A' ' 42' ' ' LEU . . . 102.48 3.94 49.94 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.645 -0.788 . . . . 0.64000000000000001 111.633 -174.361 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 -114.84 146.99 40.47 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.663 -0.495 . . . . 1.1799999999999999 109.663 177.672 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.564 ' HA2' ' H ' ' A' ' 67' ' ' ILE . . . -170.08 140.85 6.25 Favored Glycine 0 C--O 1.224 -0.512 0 C-N-CA 120.525 -0.845 . . . . 0.58999999999999997 112.091 171.305 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.419 ' CE2' ' HD1' ' A' ' 38' ' ' PHE . 59.4 m-85 -103.84 144.94 30.83 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 122.26 1.029 . . . . 0.63 113.279 175.655 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 55.7 t -123.65 130.52 74.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 113.739 -1.573 . . . . 0.40999999999999998 109.216 176.119 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 19.2 m -110.59 106.23 15.43 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 107.827 -1.175 . . . . 0.46999999999999997 107.827 177.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.52 ' O ' ' HB ' ' A' ' 35' ' ' THR . 51.4 mtp -89.35 157.82 18.03 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 120.38 -0.528 . . . . 0.88 109.74 -175.121 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 23.1 tttm -84.01 -11.06 57.37 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.469 -0.332 . . . . 1.9199999999999999 111.746 -171.205 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -147.81 147.55 29.95 Favored 'General case' 0 C--O 1.245 0.864 0 CA-C-O 121.585 0.707 . . . . 1.6799999999999999 111.857 175.173 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 15.7 ptt180 -65.13 -28.05 69.15 Favored 'General case' 0 C--O 1.212 -0.908 0 CA-C-N 114.974 -1.012 . . . . 3.6600000000000001 113.471 -174.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.46 -50.46 65.29 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 119.554 1.07 . . . . 0.66000000000000003 111.629 -175.625 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.51 ' OG ' ' HA3' ' A' ' 59' ' ' GLY . 14.6 m -63.2 -39.69 95.35 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.474 0.654 . . . . 0.78000000000000003 110.231 177.092 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.635 ' HA ' HD11 ' A' ' 37' ' ' ILE . . . -59.37 -50.37 74.23 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 114.529 -1.214 . . . . 0.46000000000000002 110.49 178.172 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.688 ' O ' ' HG2' ' A' ' 94' ' ' LYS . 4.4 mm-40 -56.41 -50.73 70.79 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.034 -0.985 . . . . 2.1099999999999999 112.258 176.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -58.93 -45.86 89.38 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 111.914 0.339 . . . . 3.8199999999999998 111.914 -177.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -56.13 -35.15 66.8 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.006 0.431 . . . . 0.92000000000000004 111.099 177.006 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 36.8 t -76.47 -26.79 55.73 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.326 -0.397 . . . . 1.1599999999999999 112.0 176.322 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.688 ' HG2' ' O ' ' A' ' 90' ' ' GLU . 32.5 mmtm -72.97 -44.27 61.29 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 120.71 0.29 . . . . 4.2000000000000002 111.155 -175.735 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -112.12 89.45 11.96 Favored Pre-proline 0 C--N 1.324 -0.508 0 N-CA-C 109.502 -0.555 . . . . 2.2400000000000002 109.502 174.449 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.586 ' HB3' ' O ' ' A' ' 107' ' ' VAL . 73.5 Cg_endo -87.73 77.96 1.66 Allowed 'Trans proline' 0 N--CA 1.447 -1.221 0 C-N-CA 122.661 2.241 . . . . 2.3799999999999999 111.909 -176.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 30.7 m-80 -154.66 39.98 0.13 Allowed Pre-proline 0 CA--C 1.54 0.573 0 CA-C-N 116.1 -0.5 . . . . 3.0299999999999998 112.312 -175.659 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.696 ' HD2' ' O ' ' A' ' 105' ' ' ALA . 67.9 Cg_endo -72.36 121.4 7.44 Favored 'Trans proline' 0 C--N 1.352 0.762 0 CA-C-N 120.543 1.23 . . . . 1.29 112.646 -176.316 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 47.4 mm -71.85 91.49 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.966 0.889 . . . . 1.8100000000000001 110.547 173.542 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 72.7 mt -106.89 131.98 55.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 114.717 -1.129 . . . . 0.98999999999999999 110.309 -179.082 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.535 ' HB3' ' HG2' ' A' ' 43' ' ' PRO . 25.9 t70 45.07 30.0 0.55 Allowed 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 113.337 0.866 . . . . 1.3700000000000001 113.337 178.248 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 86.88 21.66 49.33 Favored Glycine 0 CA--C 1.521 0.437 0 C-N-CA 120.497 -0.858 . . . . 1.5600000000000001 113.034 177.63 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.546 ' HB2' ' HG3' ' A' ' 43' ' ' PRO . 83.0 mmt-85 -138.81 151.74 47.29 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.116 -0.698 . . . . 4.1299999999999999 109.116 177.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -95.99 106.15 18.27 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 119.298 -0.961 . . . . 2.73 109.284 172.41 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.696 ' O ' ' HD2' ' A' ' 98' ' ' PRO . . . -86.37 167.27 14.89 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.482 0.658 . . . . 1.04 112.432 174.7 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -114.15 128.92 56.59 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.02 -0.991 . . . . 2.04 110.147 -177.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.586 ' O ' ' HB3' ' A' ' 96' ' ' PRO . 57.5 t -119.61 147.99 22.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.418 -0.355 . . . . 1.0600000000000001 110.542 -175.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -160.53 172.97 16.24 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.579 0.228 . . . . 2.4900000000000002 110.593 177.227 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.552 HD11 ' O ' ' A' ' 34' ' ' PHE . 0.6 OUTLIER -79.68 130.19 35.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.617 0.246 . . . . 1.23 110.408 179.401 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.52 -33.67 76.45 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.716 0.636 . . . . 0.91000000000000003 112.716 -174.003 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.419 ' HD1' HD12 ' A' ' 109' ' ' LEU . 7.1 p90 -68.89 -9.63 52.72 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.781 0.324 . . . . 1.3999999999999999 111.737 -173.741 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 84.2 mt -79.83 -12.33 59.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.331 -0.395 . . . . 1.97 110.738 178.743 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.504 ' HA3' ' C4 ' ' B' ' 5' ' ' ' U' . . . -136.66 30.07 2.71 Favored Glycine 0 N--CA 1.45 -0.389 0 N-CA-C 111.118 -0.793 . . . . 2.1400000000000001 111.118 177.689 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -92.68 118.77 31.4 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.188 -0.506 . . . . 2.6600000000000001 110.124 -176.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -129.54 81.04 70.73 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-O 120.798 0.333 . . . . 4.1600000000000001 110.318 178.209 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.401 ' HD2' ' H ' ' A' ' 117' ' ' ARG . 14.9 Cg_endo -91.86 -30.82 0.1 Allowed 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 123.111 2.541 . . . . 5.5300000000000002 113.255 -176.241 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.401 ' H ' ' HD2' ' A' ' 116' ' ' PRO . 18.0 ptp180 -141.78 19.72 2.16 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.071 0.463 . . . . 8.5999999999999996 111.13 -175.373 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 6.2 t -156.48 153.23 28.47 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.386 -0.598 . . . . 6.3700000000000001 109.386 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 47.6 t-20 -158.15 97.09 1.49 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.585 0.231 . . . . 7.8499999999999996 110.641 -178.368 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 96.2 t 67.62 107.04 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-N 115.548 -0.751 . . . . 9.3699999999999992 112.766 173.226 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 . . . . . 0 C--O 1.252 1.2 0 CA-C-O 118.063 -0.97 . . . . 12.279999999999999 109.782 173.693 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 1' ' ' ' G' . . . . . 0.584 ' N2 ' ' N7 ' ' B' ' 2' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.428 -0.738 0 C3'-C2'-C1' 100.56 -1.045 . 0.0 '__' . 4.9400000000000004 . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 2' ' ' ' G' . . . . . 0.692 ' O6 ' ' HA ' ' A' ' 43' ' ' PRO . . . . . . . . 0 O5'--C5' 1.428 -0.724 0 C3'-C2'-C1' 99.339 -2.401 . 0.0 OUTLIER gamma 4.8700000000000001 . . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 3' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.427 -0.808 0 C3'-C2'-C1' 100.673 -0.919 . 0.0 OUTLIER . 5.0199999999999996 . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 4' ' ' ' G' . . . . . 0.48 ' N3 ' " H3'" ' B' ' 4' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.428 -0.725 0 O4'-C1'-C2' 108.276 1.34 . 0.0 OUTLIER gamma 2.6899999999999999 . . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 5' ' ' ' U' . . . . . 0.504 ' C4 ' ' HA3' ' A' ' 113' ' ' GLY . . . . . . . . 0 O5'--C5' 1.425 -0.911 0 C3'-C2'-C1' 100.537 -1.07 . 0.0 OUTLIER gamma 1.9299999999999999 . . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 6' ' ' ' G' . . . . . 0.797 ' O6 ' ' HE2' ' A' ' 36' ' ' LYS . . . . . . . . 0 O5'--C5' 1.427 -0.84 0 C3'-C2'-C1' 100.318 -1.313 . 0.149 0b . 2.3799999999999999 . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.428 -0.765 0 C4'-C3'-C2' 103.895 1.195 . 0.0 OUTLIER . 4.1900000000000004 . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.842 0 CA-C-O 120.101 -0.277 . . . . 13.029999999999999 112.812 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . 62.0 -160.16 0.31 Allowed 'General case' 0 C--O 1.233 0.207 0 C-N-CA 122.413 0.285 . . . . 11.06 110.461 -177.18 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 1.7 pmm? -142.26 163.61 32.38 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.771 0.32 . . . . 9.8499999999999996 110.237 178.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -117.13 163.57 12.55 Favored Glycine 0 N--CA 1.443 -0.845 0 N-CA-C 111.366 -0.694 . . . . 6.6900000000000004 111.366 176.426 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 23.2 t -88.49 14.73 9.15 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.989 0.395 . . . . 5.5499999999999998 110.55 -179.009 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 35.4 mtp180 -116.25 148.36 40.55 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 110.116 -0.327 . . . . 3.8700000000000001 110.116 177.491 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.35 114.81 4.06 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-O 121.25 0.548 . . . . 3.5299999999999998 110.725 178.4 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.635 ' HA ' ' OG1' ' A' ' 35' ' ' THR . 10.7 p -118.32 15.09 13.93 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.739 -0.664 . . . . 1.6899999999999999 111.485 -177.15 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 59.9 ttp -70.78 -40.89 72.31 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 120.885 -0.326 . . . . 1.49 111.648 177.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.601 ' HA ' HD11 ' A' ' 109' ' ' LEU . 50.2 m-85 -103.47 -21.06 13.84 Favored 'General case' 0 C--O 1.226 -0.17 0 O-C-N 122.043 -0.41 . . . . 1.5 110.79 -177.688 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.757 ' O ' ' HA ' ' A' ' 82' ' ' THR . 28.7 p -84.8 14.21 5.01 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.303 0.573 . . . . 0.53000000000000003 110.631 -175.072 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.475 ' HD2' ' O6 ' ' B' ' 6' ' ' ' G' . 6.9 ttpt -121.21 102.45 8.31 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.355 -0.839 . . . . 2.75 109.227 -173.093 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.5 HG22 HG23 ' A' ' 39' ' ' VAL . 5.3 mp -109.42 126.85 66.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 116.119 -0.491 . . . . 0.84999999999999998 111.042 -175.294 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.473 ' HD1' ' CZ ' ' A' ' 80' ' ' PHE . 80.3 t80 -85.76 115.83 23.65 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.487 -0.56 . . . . 0.70999999999999996 109.487 175.522 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.708 HG13 HG22 ' A' ' 107' ' ' VAL . 91.6 t -133.05 97.32 2.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-O 118.405 -0.807 . . . . 0.92000000000000004 110.282 -179.25 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.575 ' HA2' HD13 ' A' ' 42' ' ' LEU . . . -117.61 -156.24 10.34 Favored Glycine 0 C--O 1.215 -1.081 0 C-N-CA 115.838 -3.077 . . . . 0.83999999999999997 113.721 162.77 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 88.67 12.0 65.09 Favored Glycine 0 N--CA 1.45 -0.4 0 N-CA-C 110.032 -1.227 . . . . 0.68000000000000005 110.032 -171.635 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.575 HD13 ' HA2' ' A' ' 40' ' ' GLY . 7.7 mp -75.54 137.95 70.82 Favored Pre-proline 0 N--CA 1.447 -0.591 0 CA-C-N 114.626 -0.787 . . . . 1.28 110.716 -177.616 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.493 ' HG3' ' CG ' ' A' ' 103' ' ' ARG . 42.5 Cg_exo -55.33 159.89 9.65 Favored 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 123.029 2.486 . . . . 0.57999999999999996 111.678 173.304 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 44.1 m-85 -65.1 -22.16 66.91 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.165 0.431 . . . . 1.05 112.165 -175.112 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 23.0 t60 -86.09 -25.49 25.8 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 120.917 0.389 . . . . 2.0099999999999998 110.44 178.489 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.729 HG23 HG21 ' A' ' 50' ' ' THR . 19.1 m -66.91 130.08 41.98 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.704 -0.68 . . . . 0.71999999999999997 110.302 -176.421 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 9.0 p -137.33 -176.65 4.47 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.033 -0.53 . . . . 0.55000000000000004 111.871 -170.554 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -55.72 -35.4 66.07 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.559 -0.746 . . . . 0.48999999999999999 110.126 -176.213 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.678 ' O ' ' HG2' ' A' ' 53' ' ' GLU . 9.5 ptpp? -66.54 -36.85 83.68 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.045 -0.98 . . . . 2.7599999999999998 109.85 -177.053 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.729 HG21 HG23 ' A' ' 46' ' ' THR . 53.9 m -63.63 -45.56 89.72 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.797 -0.638 . . . . 0.57999999999999996 110.89 179.055 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.415 HD23 ' HA ' ' A' ' 51' ' ' LEU . 63.1 mt -67.85 -39.16 83.86 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.75 -0.659 . . . . 0.84999999999999998 111.237 -179.047 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 56.1 t-80 -55.31 -51.3 67.16 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.209 -0.451 . . . . 0.58999999999999997 109.972 175.567 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.678 ' HG2' ' O ' ' A' ' 49' ' ' LYS . 10.9 mm-40 -64.9 -47.88 76.2 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.832 -0.622 . . . . 1.52 112.489 -176.454 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.404 ' O ' ' HB2' ' A' ' 57' ' ' GLN . 66.1 t80 -77.35 -36.85 53.41 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 121.054 0.454 . . . . 1.1200000000000001 111.701 -170.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.578 ' CB ' HD11 ' A' ' 61' ' ' ILE . 14.3 m-85 -84.01 -25.81 29.64 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.655 0.613 . . . . 0.56000000000000005 112.655 -174.528 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.635 ' HA ' ' O ' ' A' ' 59' ' ' GLY . 6.1 pt-20 -70.77 -9.72 57.98 Favored 'General case' 0 N--CA 1.461 0.101 0 CA-C-O 121.487 0.66 . . . . 1.5700000000000001 109.872 178.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.404 ' HB2' ' O ' ' A' ' 54' ' ' TYR . 27.4 mm-40 -60.39 -25.84 66.2 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.091 -0.959 . . . . 2.1600000000000001 110.967 170.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -88.08 -28.74 21.13 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.31 0.576 . . . . 0.70999999999999996 110.036 178.791 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.635 ' O ' ' HA ' ' A' ' 56' ' ' GLU . . . 170.36 178.5 41.23 Favored Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 110.771 -0.932 . . . . 0.75 110.771 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -63.72 130.19 43.22 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 117.35 0.575 . . . . 1.02 109.65 -178.313 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.578 HD11 ' CB ' ' A' ' 55' ' ' PHE . 60.6 mt -97.72 125.74 50.82 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 110.376 -0.231 . . . . 0.46999999999999997 110.376 177.528 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -66.56 -42.04 87.7 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 121.111 0.481 . . . . 2.0699999999999998 110.721 177.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -161.97 142.28 10.3 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 115.457 -0.792 . . . . 2.48 111.061 -178.022 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -120.08 122.94 42.17 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.692 -0.685 . . . . 0.44 109.717 174.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.651 HG11 ' H22' ' B' ' 6' ' ' ' G' . 3.6 p -136.7 122.64 28.39 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-N 114.995 -1.002 . . . . 1.3799999999999999 112.566 -174.866 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 54.6 t -101.43 134.14 42.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.697 -0.683 . . . . 0.48999999999999999 109.423 173.441 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.482 ' O ' ' HB2' ' A' ' 76' ' ' ARG . 50.7 mm -86.08 100.43 9.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 121.192 0.52 . . . . 0.71999999999999997 110.271 -174.012 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.4 HG22 ' HA ' ' A' ' 75' ' ' SER . 20.2 p -91.68 163.08 14.23 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.633 -0.712 . . . . 1.52 110.109 174.645 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.644 ' HA ' ' NE ' ' A' ' 76' ' ' ARG . 24.4 t70 -60.31 131.41 50.71 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.271 0.471 . . . . 2.4900000000000002 112.271 -174.553 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 4.3 tmm_? -54.73 -40.96 69.8 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.973 -0.558 . . . . 6.0499999999999998 111.067 178.626 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.437 ' HB2' ' OD2' ' A' ' 69' ' ' ASP . 29.9 m-80 -73.68 -60.33 2.3 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.075 0.398 . . . . 4.0499999999999998 112.075 -176.382 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.434 ' OG1' ' HG3' ' A' ' 74' ' ' LYS . 22.2 p -115.53 -9.17 12.09 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.304 0.483 . . . . 3.0800000000000001 112.304 -169.846 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 63.19 19.81 11.89 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 123.64 0.776 . . . . 3.2999999999999998 112.894 -178.653 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.434 ' HG3' ' OG1' ' A' ' 72' ' ' THR . 54.0 mtmt -48.56 137.31 11.93 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 109.303 -0.629 . . . . 3.4900000000000002 109.303 164.073 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.4 ' HA ' HG22 ' A' ' 68' ' ' THR . 13.7 m -64.68 96.87 0.19 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.358 -0.383 . . . . 1.8100000000000001 111.331 -177.009 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.644 ' NE ' ' HA ' ' A' ' 69' ' ' ASP . 44.1 mtt180 -63.4 -18.99 64.29 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.912 -0.585 . . . . 2.5600000000000001 111.313 175.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.477 ' HA3' ' H22' ' B' ' 2' ' ' ' G' . . . 79.73 24.44 60.28 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.81 -0.709 . . . . 0.64000000000000001 113.389 173.16 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.475 ' HA ' ' CA ' ' A' ' 40' ' ' GLY . 14.0 m-85 -128.14 149.46 50.41 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 107.851 -1.166 . . . . 1.1799999999999999 107.851 176.373 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -145.35 -173.55 16.72 Favored Glycine 0 N--CA 1.441 -0.99 0 C-N-CA 119.753 -1.213 . . . . 0.58999999999999997 112.845 176.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.473 ' CZ ' ' HD1' ' A' ' 38' ' ' PHE . 59.1 m-85 -144.59 125.98 14.86 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 108.375 -0.972 . . . . 0.63 108.375 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 30.9 t -108.15 110.93 33.76 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 N-CA-C 109.464 -0.569 . . . . 0.40999999999999998 109.464 177.015 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.757 ' HA ' ' O ' ' A' ' 35' ' ' THR . 28.4 m -105.52 103.72 13.3 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.47 -0.937 . . . . 0.46999999999999997 108.47 177.459 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.44 ' HA ' ' HA ' ' A' ' 61' ' ' ILE . 48.6 mtp -89.16 173.8 8.22 Favored 'General case' 0 N--CA 1.448 -0.546 0 O-C-N 121.795 -0.565 . . . . 0.88 111.301 -170.371 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 23.2 tptt -69.52 -41.59 75.82 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.053 -0.522 . . . . 1.9199999999999999 110.502 -175.641 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -131.99 153.71 50.07 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 121.087 0.47 . . . . 1.6799999999999999 111.598 -178.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.495 ' H ' ' CD ' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -73.01 -20.76 60.94 Favored 'General case' 0 C--O 1.221 -0.399 0 CA-C-N 115.414 -0.812 . . . . 3.6600000000000001 112.681 -172.762 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.64 -49.97 68.93 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 118.336 0.516 . . . . 0.66000000000000003 111.403 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 15.3 m -70.45 -33.99 71.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.543 0.687 . . . . 0.78000000000000003 109.739 177.478 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.515 ' CB ' ' HA ' ' A' ' 35' ' ' THR . . . -56.85 -45.6 82.32 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-N 114.472 -1.24 . . . . 0.46000000000000002 109.658 174.656 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.602 ' O ' ' HG2' ' A' ' 94' ' ' LYS . 2.4 mm-40 -55.67 -45.59 77.69 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.618 -0.719 . . . . 2.1099999999999999 110.78 173.021 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 8.3 mmm180 -57.86 -42.09 83.77 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.715 0.293 . . . . 3.8199999999999998 111.007 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -58.03 -36.52 72.84 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.75 -0.659 . . . . 0.92000000000000004 111.631 176.56 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 37.2 t -84.16 -22.95 30.81 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 112.016 0.376 . . . . 1.1599999999999999 112.016 179.03 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.602 ' HG2' ' O ' ' A' ' 90' ' ' GLU . 67.8 mmtt -56.33 -48.32 76.98 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 112.742 0.645 . . . . 4.2000000000000002 112.742 -175.346 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.45 ' HA ' ' HD3' ' A' ' 96' ' ' PRO . 28.9 t0 -104.91 101.47 29.7 Favored Pre-proline 0 C--N 1.325 -0.462 0 C-N-CA 120.673 -0.411 . . . . 2.2400000000000002 110.507 -178.438 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 95' ' ' ASP . 5.7 Cg_exo -80.08 172.74 13.52 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 123.211 2.607 . . . . 2.3799999999999999 112.936 -175.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.474 ' N ' ' HD3' ' A' ' 98' ' ' PRO . 4.2 p30 31.91 62.45 1.24 Allowed Pre-proline 0 N--CA 1.473 0.707 0 CA-C-N 115.092 -0.958 . . . . 3.0299999999999998 113.489 -172.431 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.474 ' HD3' ' N ' ' A' ' 97' ' ' ASN . 2.0 Cg_endo -81.15 167.32 17.91 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 123.356 2.704 . . . . 1.29 111.28 176.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 51.0 mm -99.07 135.56 33.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 108.072 -1.084 . . . . 1.8100000000000001 108.072 178.038 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 71.6 mt -144.91 108.6 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 N-CA-C 109.453 -0.573 . . . . 0.98999999999999999 109.453 -172.656 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 19.1 t0 60.2 52.67 4.85 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.782 0.801 . . . . 1.3700000000000001 111.003 176.572 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 77.34 -6.99 40.83 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 115.653 1.021 . . . . 1.5600000000000001 115.653 177.405 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.493 ' CG ' ' HG3' ' A' ' 43' ' ' PRO . 27.2 mmt180 -131.62 150.49 52.13 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 118.919 1.36 . . . . 4.1299999999999999 111.106 -179.282 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -77.19 130.95 37.96 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.892 -0.594 . . . . 2.73 110.913 178.473 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -107.14 146.93 30.69 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.662 -0.699 . . . . 1.04 110.945 -175.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 39.3 m-20 -96.28 129.37 43.62 Favored 'General case' 0 C--O 1.251 1.163 0 CA-C-O 121.725 0.774 . . . . 2.04 110.011 173.103 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.708 HG22 HG13 ' A' ' 39' ' ' VAL . 73.3 t -142.26 131.28 22.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 112.942 -1.936 . . . . 1.0600000000000001 110.462 -161.611 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 8.4 m-20 -166.6 158.58 13.42 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 123.709 0.63 . . . . 2.4900000000000002 109.467 175.525 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.601 HD11 ' HA ' ' A' ' 34' ' ' PHE . 0.2 OUTLIER -58.16 150.16 22.06 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.19 -1.041 . . . . 1.23 108.19 172.35 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.51 -34.12 73.82 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.18 0.514 . . . . 0.91000000000000003 110.311 -168.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 16.6 p90 -77.51 -8.68 58.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.583 -0.735 . . . . 1.3999999999999999 110.678 -176.368 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 64.5 mt -85.06 -16.51 40.42 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.778 0.323 . . . . 1.97 111.712 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.758 ' HA3' ' C4 ' ' B' ' 5' ' ' ' U' . . . -125.41 13.81 7.37 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.515 -0.85 . . . . 2.1400000000000001 111.408 -177.781 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -90.34 147.78 23.26 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.556 -0.535 . . . . 2.6600000000000001 109.556 -177.483 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 22.9 mmtp -125.21 81.14 63.82 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-O 121.215 0.531 . . . . 4.1600000000000001 109.855 174.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -97.18 -57.59 0.01 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 123.751 2.968 . . . . 5.5300000000000002 113.214 -179.193 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 34.8 ptt180 -94.9 5.91 50.55 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.934 -0.575 . . . . 8.5999999999999996 111.624 -173.042 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.7 t -159.5 139.26 11.59 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.144 -0.687 . . . . 6.3700000000000001 109.144 176.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -136.68 170.68 15.68 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.864 0.364 . . . . 7.8499999999999996 111.005 -175.661 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 42.9 t -106.94 139.27 29.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.146 -0.479 . . . . 9.3699999999999992 110.616 -176.571 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 . . . . . 0 C--O 1.248 0.992 0 CA-C-O 118.847 -0.597 . . . . 12.279999999999999 110.022 178.047 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 1' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.434 -0.391 0 O5'-C5'-C4' 111.617 1.012 . 0.0 '__' . 4.9400000000000004 . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 2' ' ' ' G' . . . . . 0.477 ' H22' ' HA3' ' A' ' 77' ' ' GLY . . . . . . . . 0 O5'--C5' 1.427 -0.833 0 C4'-C3'-C2' 103.948 1.248 . 0.0 OUTLIER . 4.8700000000000001 . . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 3' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.427 -0.789 0 C3'-C2'-C1' 100.199 -1.445 . 0.0 OUTLIER . 5.0199999999999996 . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 4' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.427 -0.809 0 O4'-C1'-C2' 108.457 1.469 . 0.152 0i . 2.6899999999999999 . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 5' ' ' ' U' . . . . . 0.758 ' C4 ' ' HA3' ' A' ' 113' ' ' GLY . . . . . . . . 0 O5'--C5' 1.426 -0.859 0 C3'-C2'-C1' 100.514 -1.096 . 0.0 OUTLIER . 1.9299999999999999 . . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 6' ' ' ' G' . . . . . 0.651 ' H22' HG11 ' A' ' 65' ' ' VAL . . . . . . . . 0 O5'--C5' 1.425 -0.96 0 C4'-C3'-C2' 103.852 1.152 . 0.321 0b . 2.3799999999999999 . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.427 -0.829 0 C4'-C3'-C2' 104.472 1.772 . 0.0 OUTLIER . 4.1900000000000004 . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.639 0 N-CA-C 112.337 -0.305 . . . . 13.029999999999999 112.337 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.36 -38.15 27.1 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.04 0.448 . . . . 11.06 109.904 179.243 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 96.0 mmm -111.43 107.42 16.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.93 -0.577 . . . . 9.8499999999999996 110.453 -179.584 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -118.09 -105.07 2.26 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.861 -0.685 . . . . 6.6900000000000004 112.642 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.7 p -135.21 139.04 44.18 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 110.536 -0.172 . . . . 5.5499999999999998 110.536 -178.389 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 50.8 mtm180 -94.87 -73.52 0.58 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.832 0.348 . . . . 3.8700000000000001 111.24 -176.035 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 68.67 164.17 0.23 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.236 -0.893 . . . . 3.5299999999999998 111.094 -175.317 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.492 ' HA ' ' OG1' ' A' ' 35' ' ' THR . 10.8 p -121.86 -28.13 4.53 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.675 0.621 . . . . 1.6899999999999999 112.675 -177.095 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 55.5 ttp -59.01 -43.66 91.56 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 111.983 0.364 . . . . 1.49 111.983 -173.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -96.36 -6.21 38.15 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.771 -0.371 . . . . 1.5 111.793 -177.1 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.679 ' O ' ' HA ' ' A' ' 82' ' ' THR . 34.2 p -102.78 -5.05 24.08 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.746 0.307 . . . . 0.53000000000000003 111.371 -176.867 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.612 ' HG3' ' HB3' ' A' ' 110' ' ' ALA . 18.4 tptm -92.67 101.49 13.9 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.274 0.559 . . . . 2.75 110.461 -175.297 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.429 HG22 HG23 ' A' ' 39' ' ' VAL . 32.8 mt -107.85 132.92 54.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.724 -0.671 . . . . 0.84999999999999998 110.449 -177.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.568 ' HD1' ' CE1' ' A' ' 80' ' ' PHE . 88.4 t80 -99.84 116.09 31.11 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.033 -0.728 . . . . 0.70999999999999996 109.033 173.454 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.649 HG22 HG22 ' A' ' 107' ' ' VAL . 95.7 t -132.31 106.22 10.55 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.886 0 CA-C-O 118.803 -0.618 . . . . 0.92000000000000004 110.067 -178.202 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.888 ' HA3' ' HD1' ' A' ' 78' ' ' TYR . . . -122.82 -154.74 9.14 Favored Glycine 0 N--CA 1.44 -1.073 0 C-N-CA 115.979 -3.01 . . . . 0.83999999999999997 113.267 159.322 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 85.62 8.02 80.93 Favored Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 110.265 -1.134 . . . . 0.68000000000000005 110.265 -174.307 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.739 ' HB3' ' HB ' ' A' ' 46' ' ' THR . 5.7 mp -69.55 135.57 88.37 Favored Pre-proline 0 N--CA 1.45 -0.448 0 CA-C-N 114.989 -0.605 . . . . 1.28 109.899 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 1.009 ' HG2' ' HB3' ' A' ' 101' ' ' ASP . 53.8 Cg_exo -49.88 158.85 1.89 Allowed 'Trans proline' 0 N--CA 1.463 -0.291 0 C-N-CA 123.146 2.564 . . . . 0.57999999999999996 112.128 174.419 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.421 ' CE2' ' C5 ' ' B' ' 2' ' ' ' G' . 51.7 m-85 -66.72 -9.61 38.22 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 113.439 0.903 . . . . 1.05 113.439 -171.764 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 1.7 p80 -111.71 0.76 16.4 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.124 -0.631 . . . . 2.0099999999999998 110.77 176.425 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.739 ' HB ' ' HB3' ' A' ' 42' ' ' LEU . 5.8 m -79.53 118.52 21.46 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.504 -0.554 . . . . 0.71999999999999997 109.504 176.639 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.432 ' HA ' HG21 ' A' ' 66' ' ' VAL . 6.2 p -123.93 -177.95 3.91 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.116 -0.493 . . . . 0.55000000000000004 112.303 -168.469 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -54.19 -30.84 51.07 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.628 -0.715 . . . . 0.48999999999999999 110.79 -178.242 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.544 ' O ' ' HG2' ' A' ' 53' ' ' GLU . 23.2 pttm -74.92 -34.3 62.11 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.653 -0.703 . . . . 2.7599999999999998 109.842 -178.114 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.601 HG21 HG23 ' A' ' 46' ' ' THR . 6.1 m -67.12 -45.18 77.95 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 116.535 -0.302 . . . . 0.57999999999999996 110.514 -178.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.71 HD21 HD21 ' A' ' 42' ' ' LEU . 39.2 mt -62.07 -46.95 86.83 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-O 120.994 0.426 . . . . 0.84999999999999998 109.974 175.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.534 ' HA ' HD12 ' A' ' 61' ' ' ILE . 55.1 t-80 -55.95 -51.28 68.24 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 115.687 -0.688 . . . . 0.58999999999999997 110.574 179.388 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.544 ' HG2' ' O ' ' A' ' 49' ' ' LYS . 21.5 mm-40 -65.25 -36.54 84.45 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 112.311 0.486 . . . . 1.52 112.311 -176.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.7 ' O ' ' HB2' ' A' ' 57' ' ' GLN . 25.7 t80 -77.79 -34.87 52.04 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 118.128 0.422 . . . . 1.1200000000000001 111.594 -178.383 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.482 ' CD2' HG11 ' A' ' 81' ' ' VAL . 25.9 m-85 -84.91 -28.88 25.63 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 112.892 0.701 . . . . 0.56000000000000005 112.892 -175.636 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.583 ' HA ' ' O ' ' A' ' 59' ' ' GLY . 34.4 mm-40 -57.36 -24.72 57.04 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-O 122.563 1.173 . . . . 1.5700000000000001 109.413 174.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.7 ' HB2' ' O ' ' A' ' 54' ' ' TYR . 69.1 mt-30 -60.27 -31.68 70.46 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 112.971 -1.922 . . . . 2.1600000000000001 112.27 176.699 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.451 ' HD2' ' HA ' ' A' ' 55' ' ' PHE . 86.5 m-85 -89.12 -27.21 20.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.329 0.585 . . . . 0.70999999999999996 109.463 177.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.583 ' O ' ' HA ' ' A' ' 56' ' ' GLU . . . 162.47 -172.28 38.51 Favored Glycine 0 N--CA 1.443 -0.864 0 CA-C-N 115.006 -0.997 . . . . 0.75 111.697 177.702 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -64.73 126.26 27.37 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.707 0.289 . . . . 1.02 110.801 -177.676 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.534 HD12 ' HA ' ' A' ' 52' ' ' HIS . 8.2 mt -99.98 124.31 53.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.101 -0.703 . . . . 0.46999999999999997 109.101 177.295 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -78.97 -41.94 28.0 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.009 0.433 . . . . 2.0699999999999998 111.608 179.49 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.574 ' HB3' ' HB ' ' A' ' 82' ' ' THR . 8.7 tp10 -139.89 126.6 20.55 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.974 -0.557 . . . . 2.48 111.013 -172.786 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -127.89 125.84 40.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.679 0.752 . . . . 0.44 110.883 174.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.649 HG21 ' N2 ' ' B' ' 6' ' ' ' G' . 7.1 p -145.62 136.17 18.92 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 CA-C-N 114.546 -1.206 . . . . 1.3799999999999999 113.057 -178.098 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.432 HG21 ' HA ' ' A' ' 47' ' ' SER . 75.2 t -102.18 124.9 56.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.296 -0.865 . . . . 0.48999999999999999 108.855 167.251 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.548 HG12 ' HA2' ' A' ' 79' ' ' GLY . 35.2 mm -81.1 103.05 7.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.785 -0.643 . . . . 0.71999999999999997 110.672 -174.444 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 17.0 p -92.99 172.83 8.06 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.326 -0.852 . . . . 1.52 110.638 176.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.469 ' HA ' ' NE ' ' A' ' 76' ' ' ARG . 30.6 t70 -71.74 126.8 30.63 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.823 -0.626 . . . . 2.4900000000000002 111.039 -176.461 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.436 ' HG3' ' OD1' ' A' ' 71' ' ' ASN . 33.1 ptt180 -55.9 -32.33 63.64 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 112.813 0.671 . . . . 6.0499999999999998 112.813 -177.385 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.436 ' OD1' ' HG3' ' A' ' 70' ' ' ARG . 4.4 m-20 -83.94 -54.21 5.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.991 0.424 . . . . 4.0499999999999998 111.971 -176.62 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 32.7 p -109.63 -21.94 12.19 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.226 -0.443 . . . . 3.0800000000000001 111.93 -171.608 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 63.3 mt-30 57.62 76.39 0.33 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 122.442 1.115 . . . . 3.2999999999999998 111.418 -171.667 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 54.0 mttm -108.25 153.01 23.84 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 105.953 -1.869 . . . . 3.4900000000000002 105.953 171.254 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 35.2 t -71.55 93.07 1.18 Allowed 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 120.138 -0.625 . . . . 1.8100000000000001 110.479 -177.012 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.469 ' NE ' ' HA ' ' A' ' 69' ' ' ASP . 64.3 mtt180 -61.48 -11.74 11.99 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.503 -0.772 . . . . 2.5600000000000001 111.52 173.549 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.683 ' HA3' ' H22' ' B' ' 2' ' ' ' G' . . . 78.5 11.14 85.59 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.97 -0.633 . . . . 0.64000000000000001 112.714 176.789 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.888 ' HD1' ' HA3' ' A' ' 40' ' ' GLY . 29.9 m-85 -114.78 161.66 17.9 Favored 'General case' 0 CA--C 1.504 -0.821 0 N-CA-C 109.807 -0.442 . . . . 1.1799999999999999 109.807 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.548 ' HA2' HG12 ' A' ' 67' ' ' ILE . . . -161.67 -166.92 21.33 Favored Glycine 0 N--CA 1.438 -1.185 0 C-N-CA 119.855 -1.164 . . . . 0.58999999999999997 112.432 168.807 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.568 ' CE1' ' HD1' ' A' ' 38' ' ' PHE . 62.9 m-85 -135.95 132.98 37.12 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.018 -0.734 . . . . 0.63 109.018 179.124 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.482 HG11 ' CD2' ' A' ' 55' ' ' PHE . 41.1 t -119.94 109.96 27.61 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-O 121.392 0.615 . . . . 0.40999999999999998 110.012 175.334 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.679 ' HA ' ' O ' ' A' ' 35' ' ' THR . 11.2 m -107.96 112.01 24.38 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 107.663 -1.236 . . . . 0.46999999999999997 107.663 174.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.438 ' HA ' ' HA ' ' A' ' 61' ' ' ILE . 55.6 mtp -90.23 166.99 13.04 Favored 'General case' 0 N--CA 1.447 -0.586 0 O-C-N 121.412 -0.805 . . . . 0.88 109.162 -173.594 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -79.44 -17.27 54.61 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.816 0.341 . . . . 1.9199999999999999 110.945 -173.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -145.01 146.75 32.04 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.281 -0.418 . . . . 1.6799999999999999 110.235 -179.111 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.828 ' HD3' ' H ' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -72.77 -22.11 60.9 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.91 0.707 . . . . 3.6600000000000001 112.91 -174.096 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.432 ' O ' ' HG3' ' A' ' 91' ' ' ARG . . . -72.16 -37.45 69.36 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.054 0.454 . . . . 0.66000000000000003 111.07 -178.002 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.535 ' OG ' ' HA3' ' A' ' 59' ' ' GLY . 21.1 m -72.64 -37.94 67.85 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.712 0.768 . . . . 0.78000000000000003 109.666 174.439 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.78 -41.96 83.14 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.061 -1.427 . . . . 0.46000000000000002 109.333 175.104 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -54.69 -48.53 72.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.042 -0.981 . . . . 2.1099999999999999 111.507 171.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.49 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 96.7 mtt180 -59.98 -38.84 83.73 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.258 -0.428 . . . . 3.8199999999999998 110.951 -179.4 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -59.12 -46.37 88.51 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.028 -0.533 . . . . 0.92000000000000004 111.658 174.756 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 51.7 t -76.58 -8.76 57.86 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 111.707 0.262 . . . . 1.1599999999999999 111.707 -178.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.49 ' HB2' ' O ' ' A' ' 91' ' ' ARG . 39.7 mmtm -58.03 -41.63 83.61 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.661 -0.245 . . . . 4.2000000000000002 110.951 177.611 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -103.44 104.67 42.86 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 109.56 -0.533 . . . . 2.2400000000000002 109.56 174.606 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.564 ' O ' ' HB2' ' A' ' 97' ' ' ASN . 39.8 Cg_endo -84.94 102.6 0.81 Allowed 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 122.631 2.221 . . . . 2.3799999999999999 113.427 -174.11 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.564 ' HB2' ' O ' ' A' ' 96' ' ' PRO . 83.8 m-20 89.03 54.66 0.03 OUTLIER Pre-proline 0 N--CA 1.476 0.862 0 CA-C-N 114.39 -1.277 . . . . 3.0299999999999998 110.266 174.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.551 ' O ' HG13 ' A' ' 100' ' ' ILE . 90.1 Cg_endo -82.75 116.85 2.58 Favored 'Trans proline' 0 N--CA 1.45 -1.037 0 C-N-CA 121.49 1.46 . . . . 1.29 112.767 -177.698 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.98 ' HA ' ' HA ' ' A' ' 104' ' ' LYS . 1.2 mt -25.47 131.39 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.49 -0.777 . . . . 1.8100000000000001 112.866 151.364 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.551 HG13 ' O ' ' A' ' 98' ' ' PRO . 61.0 mt -148.46 126.99 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 N-CA-C 106.151 -1.796 . . . . 0.98999999999999999 106.151 -178.599 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 1.009 ' HB3' ' HG2' ' A' ' 43' ' ' PRO . 10.3 t0 65.06 41.18 4.72 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 122.245 1.021 . . . . 1.3700000000000001 109.164 -178.731 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 70.27 -8.14 4.13 Favored Glycine 0 CA--C 1.529 0.921 0 CA-C-N 114.708 -1.133 . . . . 1.5600000000000001 115.529 -179.231 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.666 ' CG ' ' HG3' ' A' ' 43' ' ' PRO . 34.8 mmt180 -117.5 134.27 55.04 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 119.317 1.559 . . . . 4.1299999999999999 110.629 178.616 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.98 ' HA ' ' HA ' ' A' ' 99' ' ' ILE . 4.7 ttpm? -63.98 128.46 35.9 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 121.382 -0.127 . . . . 2.73 111.267 -177.437 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -100.16 152.52 20.16 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 120.956 0.408 . . . . 1.04 111.109 -177.658 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.524 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 9.0 t30 -102.2 124.69 48.23 Favored 'General case' 0 C--O 1.243 0.726 0 CA-C-N 116.179 -0.464 . . . . 2.04 109.905 177.27 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.649 HG22 HG22 ' A' ' 39' ' ' VAL . 94.7 t -139.37 128.44 28.92 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.125 0 O-C-N 124.842 1.339 . . . . 1.0600000000000001 110.505 -164.296 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 33.5 p30 -160.25 157.36 28.02 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.388 -0.369 . . . . 2.4900000000000002 110.011 171.443 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.581 ' HB3' ' CE1' ' A' ' 111' ' ' TYR . 3.5 mm? -67.01 101.11 0.81 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.202 0.525 . . . . 1.23 110.901 175.154 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.612 ' HB3' ' HG3' ' A' ' 36' ' ' LYS . . . -46.97 -24.11 0.56 Allowed 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 115.518 1.673 . . . . 0.91000000000000003 115.518 -174.842 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.581 ' CE1' ' HB3' ' A' ' 109' ' ' LEU . 14.9 p90 -66.21 -9.21 29.93 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 118.163 0.438 . . . . 1.3999999999999999 111.515 -175.185 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.431 ' HG ' ' O ' ' A' ' 109' ' ' LEU . 91.4 mt -61.88 -47.39 85.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.739 -0.21 . . . . 1.97 111.421 -179.371 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -113.33 28.36 8.73 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.809 -0.71 . . . . 2.1400000000000001 111.969 178.255 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -84.46 135.4 34.26 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.616 0.246 . . . . 2.6600000000000001 111.156 -175.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -134.72 71.85 69.87 Favored Pre-proline 0 C--N 1.324 -0.537 0 N-CA-C 109.294 -0.632 . . . . 4.1600000000000001 109.294 170.053 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -81.03 9.94 3.61 Favored 'Trans proline' 0 C--N 1.348 0.5 0 C-N-CA 123.058 2.505 . . . . 5.5300000000000002 111.766 -178.234 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 33.2 ttm180 173.76 -39.36 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.272 -1.331 . . . . 8.5999999999999996 108.387 -177.454 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 11.8 t -172.6 176.16 3.29 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 114.995 -1.002 . . . . 6.3700000000000001 109.685 -178.397 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -178.37 -57.61 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 O-C-N 124.188 0.93 . . . . 7.8499999999999996 108.788 173.632 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 34.2 t 55.69 87.43 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-N 115.354 -0.839 . . . . 9.3699999999999992 111.986 176.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.411 ' O ' ' HG3' ' A' ' 121' ' ' GLN . 11.2 pt20 . . . . . 0 C--O 1.251 1.174 0 CA-C-O 119.078 -0.486 . . . . 12.279999999999999 110.431 178.242 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 1' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.43 -0.62 0 C3'-C2'-C1' 100.448 -1.169 . 0.0 '__' . 4.9400000000000004 . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 2' ' ' ' G' . . . . . 0.683 ' H22' ' HA3' ' A' ' 77' ' ' GLY . . . . . . . . 0 O5'--C5' 1.427 -0.803 0 C4'-C3'-C2' 103.746 1.046 . 0.0 OUTLIER gamma 4.8700000000000001 . . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 3' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.429 -0.695 0 P-O3'-C3' 120.709 0.841 . 0.0 OUTLIER gamma 5.0199999999999996 . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 4' ' ' ' G' . . . . . 0.517 ' C8 ' ' HE2' ' A' ' 38' ' ' PHE . . . . . . . . 0 O5'--C5' 1.425 -0.954 0 O4'-C1'-C2' 108.033 1.166 . 0.0 OUTLIER . 2.6899999999999999 . . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 5' ' ' ' U' . . . . . 0.454 ' H6 ' " O5'" ' B' ' 5' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.429 -0.692 0 C3'-C2'-C1' 100.499 -1.113 . 0.0 OUTLIER gamma 1.9299999999999999 . . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 6' ' ' ' G' . . . . . 0.649 ' N2 ' HG21 ' A' ' 65' ' ' VAL . . . . . . . . 0 O5'--C5' 1.428 -0.758 0 C4'-C3'-C2' 104.189 1.489 . 0.0 OUTLIER gamma 2.3799999999999999 . . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 7' ' ' ' C' . . . . . 0.408 ' C6 ' ' OP1' ' B' ' 7' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.428 -0.762 0 C3'-C2'-C1' 103.293 1.992 . 0.0 OUTLIER . 4.1900000000000004 . . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.796 0 N-CA-C 112.369 -0.292 . . . . 13.029999999999999 112.369 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . 67.89 -78.04 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 123.38 0.672 . . . . 11.06 112.24 178.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 68.2 mtm -88.11 99.83 12.49 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.039 0.447 . . . . 9.8499999999999996 110.517 -175.359 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 172.21 113.35 0.3 Allowed Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 120.908 -0.663 . . . . 6.6900000000000004 112.175 179.505 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.3 p -80.38 110.64 16.02 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.017 0.437 . . . . 5.5499999999999998 110.357 175.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 78.9 mtm180 -110.65 132.31 54.3 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.999 -0.546 . . . . 3.8700000000000001 111.307 -175.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -73.25 85.57 1.42 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.101 -0.5 . . . . 3.5299999999999998 110.694 174.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.584 ' HA ' ' OG1' ' A' ' 35' ' ' THR . 12.2 p -85.05 -17.91 36.01 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.855 -0.338 . . . . 1.6899999999999999 111.154 177.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 50.8 ttp -62.13 -44.66 96.15 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.035 -0.529 . . . . 1.49 111.438 -178.621 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -98.77 6.54 46.84 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 111.705 0.261 . . . . 1.5 111.705 -178.382 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.751 ' O ' ' HA ' ' A' ' 82' ' ' THR . 43.1 p -114.51 17.08 17.54 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.264 0.554 . . . . 0.53000000000000003 109.922 177.668 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.886 ' HG3' ' HB3' ' A' ' 110' ' ' ALA . 0.1 OUTLIER -113.85 103.43 11.18 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.14 -0.937 . . . . 2.75 110.354 -176.737 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.5 mp -110.26 131.32 61.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.904 -0.589 . . . . 0.84999999999999998 111.036 -176.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.514 ' O ' ' HA ' ' A' ' 107' ' ' VAL . 69.4 t80 -91.3 113.09 25.26 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.264 -0.88 . . . . 0.70999999999999996 109.002 176.67 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.637 HG22 HG22 ' A' ' 107' ' ' VAL . 84.7 t -132.93 102.59 5.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 118.194 -0.907 . . . . 0.92000000000000004 110.273 -176.659 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.591 ' HA2' ' CD1' ' A' ' 42' ' ' LEU . . . -122.83 -154.84 9.17 Favored Glycine 0 C--O 1.221 -0.705 0 C-N-CA 115.937 -3.03 . . . . 0.83999999999999997 113.629 163.119 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 84.07 4.32 88.47 Favored Glycine 0 N--CA 1.452 -0.299 0 N-CA-C 111.098 -0.801 . . . . 0.68000000000000005 111.098 -175.445 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.82 ' HB3' ' HB ' ' A' ' 46' ' ' THR . 5.4 mp -64.96 137.51 97.18 Favored Pre-proline 0 N--CA 1.453 -0.282 0 CA-C-N 115.409 -0.395 . . . . 1.28 110.38 -178.775 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.569 ' HG2' ' HB3' ' A' ' 101' ' ' ASP . 52.7 Cg_exo -51.73 159.75 3.29 Favored 'Trans proline' 0 N--CA 1.463 -0.305 0 C-N-CA 123.198 2.599 . . . . 0.57999999999999996 111.955 173.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -66.43 -12.43 57.1 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 112.401 0.519 . . . . 1.05 112.401 -175.163 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 46.3 t60 -92.0 -24.92 19.06 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.15 0.5 . . . . 2.0099999999999998 109.986 174.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.82 ' HB ' ' HB3' ' A' ' 42' ' ' LEU . 4.4 m -72.71 118.32 15.49 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.876 -0.602 . . . . 0.71999999999999997 109.849 -176.727 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 6.0 p -134.46 -175.64 3.94 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.617 -0.719 . . . . 0.55000000000000004 111.176 -168.23 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -49.93 -34.87 21.88 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.424 0.631 . . . . 0.48999999999999999 110.594 -177.117 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.701 ' O ' ' HG2' ' A' ' 53' ' ' GLU . 8.5 ptpp? -67.65 -43.88 79.25 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 114.893 -1.049 . . . . 2.7599999999999998 109.887 -178.089 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.606 HG21 HG23 ' A' ' 46' ' ' THR . 6.7 m -66.34 -40.51 89.91 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.629 -0.259 . . . . 0.57999999999999996 111.24 -176.085 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.668 HD21 HD21 ' A' ' 42' ' ' LEU . 22.8 mt -61.78 -46.86 87.73 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 109.882 -0.414 . . . . 0.84999999999999998 109.882 175.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.532 ' HA ' HD12 ' A' ' 61' ' ' ILE . 45.9 t-80 -52.69 -51.55 59.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.417 -0.811 . . . . 0.58999999999999997 110.218 174.517 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.701 ' HG2' ' O ' ' A' ' 49' ' ' LYS . 23.4 mm-40 -59.48 -48.18 82.65 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.106 -0.497 . . . . 1.52 112.316 -176.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.435 ' O ' ' HB2' ' A' ' 57' ' ' GLN . 47.4 t80 -76.53 -41.44 46.7 Favored 'General case' 0 C--O 1.227 -0.109 0 CA-C-O 121.051 0.453 . . . . 1.1200000000000001 111.495 -171.384 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.774 ' HB2' HD11 ' A' ' 61' ' ' ILE . 45.8 m-85 -84.16 -30.38 25.9 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 113.063 0.764 . . . . 0.56000000000000005 113.063 -170.777 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.603 ' HA ' ' O ' ' A' ' 59' ' ' GLY . 16.6 pt-20 -67.45 -14.58 63.06 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 122.109 0.957 . . . . 1.5700000000000001 110.113 -178.649 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.435 ' HB2' ' O ' ' A' ' 54' ' ' TYR . 79.1 mm-40 -57.11 -26.3 60.23 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.082 -1.417 . . . . 2.1600000000000001 112.063 172.167 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -93.12 -25.2 17.99 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.223 0.535 . . . . 0.70999999999999996 110.055 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.603 ' O ' ' HA ' ' A' ' 56' ' ' GLU . . . 170.96 174.66 38.97 Favored Glycine 0 N--CA 1.447 -0.606 0 N-CA-C 110.386 -1.086 . . . . 0.75 110.386 -179.22 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 61.1 m-20 -67.9 125.14 25.36 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 117.492 0.646 . . . . 1.02 110.819 -173.517 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.774 HD11 ' HB2' ' A' ' 55' ' ' PHE . 29.8 mt -89.04 118.63 34.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.335 -0.393 . . . . 0.46999999999999997 110.309 178.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.437 ' HB2' ' HG3' ' A' ' 84' ' ' LYS . 24.9 tt0 -75.7 -33.0 60.32 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.145 0.424 . . . . 2.0699999999999998 112.145 -179.269 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -157.15 133.3 9.64 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.651 -0.42 . . . . 2.48 111.531 -178.069 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -125.3 130.08 51.28 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.643 -0.708 . . . . 0.44 110.928 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.834 HG21 ' H22' ' B' ' 6' ' ' ' G' . 20.6 t -135.54 136.19 50.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 114.527 -1.215 . . . . 1.3799999999999999 111.927 -177.328 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 56.0 t -118.58 117.72 55.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 108.703 -0.851 . . . . 0.48999999999999999 108.703 162.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 35.3 mm -77.06 111.81 14.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 115.293 -0.867 . . . . 0.71999999999999997 111.111 -171.658 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 21.4 p -91.83 164.24 13.76 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.551 -0.75 . . . . 1.52 110.911 176.042 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.475 ' OD2' ' HB2' ' A' ' 71' ' ' ASN . 5.2 t70 -68.89 133.22 47.95 Favored 'General case' 0 C--O 1.217 -0.61 0 CA-C-N 116.151 -0.477 . . . . 2.4900000000000002 111.59 -175.862 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.67 ' H ' ' HD3' ' A' ' 70' ' ' ARG . 0.8 OUTLIER -54.13 -41.6 68.57 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.063 -0.517 . . . . 6.0499999999999998 111.286 179.548 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.475 ' HB2' ' OD2' ' A' ' 69' ' ' ASP . 35.2 m-80 -70.65 -59.63 2.72 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.76 0.652 . . . . 4.0499999999999998 112.76 -176.218 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.485 ' OG1' ' HE2' ' A' ' 74' ' ' LYS . 41.4 p -115.73 -23.44 8.68 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.36 0.504 . . . . 3.0800000000000001 112.36 -171.717 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.448 ' HA ' ' N ' ' A' ' 69' ' ' ASP . 42.2 mt-30 69.58 15.2 8.23 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 123.689 0.796 . . . . 3.2999999999999998 112.606 -176.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.485 ' HE2' ' OG1' ' A' ' 72' ' ' THR . 46.9 mtmt -54.27 120.01 5.94 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 108.268 -1.012 . . . . 3.4900000000000002 108.268 165.777 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 17.0 m -50.17 104.63 0.07 Allowed 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 112.806 0.669 . . . . 1.8100000000000001 112.806 -168.211 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.446 ' HB3' ' CD2' ' A' ' 78' ' ' TYR . 21.7 mtp180 -61.19 -25.09 66.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.003 -0.999 . . . . 2.5600000000000001 111.964 177.324 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.466 ' HA3' ' H22' ' B' ' 2' ' ' ' G' . . . 80.58 23.51 60.21 Favored Glycine 0 C--O 1.225 -0.467 0 C-N-CA 120.491 -0.861 . . . . 0.64000000000000001 112.52 179.216 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.446 ' CD2' ' HB3' ' A' ' 76' ' ' ARG . 21.7 m-85 -120.07 138.91 53.26 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.113 -1.069 . . . . 1.1799999999999999 108.113 176.571 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -141.88 -177.77 17.34 Favored Glycine 0 N--CA 1.441 -0.972 0 C-N-CA 119.076 -1.535 . . . . 0.58999999999999997 113.508 178.232 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.45 ' CE1' ' HD1' ' A' ' 38' ' ' PHE . 61.3 m-85 -138.65 125.93 21.6 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 123.179 0.592 . . . . 0.63 109.445 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.474 HG23 HD13 ' A' ' 51' ' ' LEU . 42.8 t -113.33 114.51 47.09 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-O 121.03 0.443 . . . . 0.40999999999999998 110.57 178.758 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.751 ' HA ' ' O ' ' A' ' 35' ' ' THR . 8.4 m -106.36 125.23 50.73 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.025 -1.102 . . . . 0.46999999999999997 108.025 171.889 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 81.3 mtp -110.76 166.49 10.98 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 107.987 -1.116 . . . . 0.88 107.987 -172.501 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.437 ' HG3' ' HB2' ' A' ' 62' ' ' GLU . 3.4 mttm -83.53 -8.72 59.29 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 112.704 0.631 . . . . 1.9199999999999999 112.704 -172.575 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.441 ' OD1' ' HD2' ' A' ' 86' ' ' ARG . 9.6 t70 -145.36 146.52 31.62 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 109.908 -0.404 . . . . 1.6799999999999999 109.908 174.632 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.441 ' HD2' ' OD1' ' A' ' 85' ' ' ASP . 0.8 OUTLIER -73.84 -23.26 59.61 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 111.592 0.219 . . . . 3.6600000000000001 111.592 -176.524 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -63.04 -50.3 71.19 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.03 0.443 . . . . 0.66000000000000003 110.42 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 13.2 m -67.57 -35.89 79.88 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.953 -0.567 . . . . 0.78000000000000003 109.933 176.488 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.41 ' HB3' ' HA ' ' A' ' 86' ' ' ARG . . . -57.15 -45.83 83.27 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 114.789 -1.096 . . . . 0.46000000000000002 110.651 176.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -56.5 -42.49 78.43 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.198 -0.455 . . . . 2.1099999999999999 111.521 172.803 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.738 ' O ' ' HG3' ' A' ' 94' ' ' LYS . 12.9 mmt180 -68.11 -31.81 71.66 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.969 -0.56 . . . . 3.8199999999999998 110.83 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -61.39 -38.33 86.67 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.603 -0.271 . . . . 0.92000000000000004 111.651 171.116 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 37.0 t -86.58 -20.08 28.45 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 112.961 0.726 . . . . 1.1599999999999999 112.961 -173.157 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.738 ' HG3' ' O ' ' A' ' 91' ' ' ARG . 0.0 OUTLIER -51.54 -19.44 1.47 Allowed 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 112.959 0.726 . . . . 4.2000000000000002 112.959 177.337 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.686 ' N ' ' HD3' ' A' ' 94' ' ' LYS . 24.5 t0 -112.03 103.96 55.66 Favored Pre-proline 0 C--N 1.325 -0.491 0 N-CA-C 108.788 -0.819 . . . . 2.2400000000000002 108.788 168.427 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 95' ' ' ASP . 3.6 Cg_exo -80.42 -13.32 12.3 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 123.241 2.628 . . . . 2.3799999999999999 113.503 -172.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 52.7 m-80 -148.75 53.55 1.44 Allowed Pre-proline 0 C--O 1.236 0.38 0 O-C-N 122.383 -0.198 . . . . 3.0299999999999998 111.278 -176.05 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.54 ' O ' HG13 ' A' ' 100' ' ' ILE . 72.4 Cg_endo -82.81 113.14 2.17 Favored 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 120.739 0.959 . . . . 1.29 113.13 -175.298 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.441 HD13 ' CA ' ' A' ' 104' ' ' LYS . 12.7 mm -24.14 124.85 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-N 116.033 -0.53 . . . . 1.8100000000000001 111.979 149.098 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.54 HG13 ' O ' ' A' ' 98' ' ' PRO . 75.2 mt -145.14 119.68 3.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 105.961 -1.866 . . . . 0.98999999999999999 105.961 179.2 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.569 ' HB3' ' HG2' ' A' ' 43' ' ' PRO . 27.5 t0 55.21 50.64 14.69 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 122.637 1.208 . . . . 1.3700000000000001 109.783 -174.443 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 71.42 -8.17 5.66 Favored Glycine 0 CA--C 1.53 1.006 0 N-CA-C 117.22 1.648 . . . . 1.5600000000000001 117.22 176.516 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.497 ' HB2' ' HG3' ' A' ' 43' ' ' PRO . 2.0 mmm180 -116.22 142.07 47.31 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 120.59 2.195 . . . . 4.1299999999999999 111.83 176.683 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.441 ' CA ' HD13 ' A' ' 99' ' ' ILE . 41.1 ttmt -64.64 124.08 20.96 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.896 -0.593 . . . . 2.73 110.57 176.432 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -102.0 162.17 13.12 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.431 -0.349 . . . . 1.04 110.5 178.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.587 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 39.7 t-20 -114.78 127.79 55.93 Favored 'General case' 0 C--O 1.248 0.986 0 N-CA-C 109.48 -0.563 . . . . 2.04 109.48 179.338 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.637 HG22 HG22 ' A' ' 39' ' ' VAL . 88.3 t -138.85 123.19 20.66 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 O-C-N 125.056 1.473 . . . . 1.0600000000000001 111.065 -163.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -156.62 151.97 26.59 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.324 -0.621 . . . . 2.4900000000000002 109.324 175.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.524 ' HB3' ' CE1' ' A' ' 111' ' ' TYR . 1.3 mm? -57.37 96.28 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.063 0.459 . . . . 1.23 111.238 176.607 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.886 ' HB3' ' HG3' ' A' ' 36' ' ' LYS . . . -45.19 -33.16 2.16 Favored 'General case' 0 C--O 1.224 -0.245 0 N-CA-C 115.654 1.724 . . . . 0.91000000000000003 115.654 -176.378 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.524 ' CE1' ' HB3' ' A' ' 109' ' ' LEU . 9.1 p90 -55.96 -14.82 2.75 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 112.662 0.615 . . . . 1.3999999999999999 112.662 -169.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 60.3 mt -62.28 -47.28 85.03 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 120.878 0.37 . . . . 1.97 110.444 175.179 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -102.34 -28.67 6.32 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.959 -0.638 . . . . 2.1400000000000001 112.524 173.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -76.1 123.45 25.82 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 109.623 -0.51 . . . . 2.6600000000000001 109.623 179.021 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -134.67 100.69 12.16 Favored Pre-proline 0 C--N 1.316 -0.866 0 CA-C-N 116.023 -0.535 . . . . 4.1600000000000001 110.317 -172.398 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -77.15 15.25 1.19 Allowed 'Trans proline' 0 C--O 1.234 0.291 0 C-N-CA 123.16 2.573 . . . . 5.5300000000000002 113.198 -176.418 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 16.6 tpt180 -176.78 -78.75 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.845 -0.616 . . . . 8.5999999999999996 109.957 178.191 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 13.9 t -156.19 23.74 0.36 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 122.41 1.1 . . . . 6.3700000000000001 108.275 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -70.83 104.18 2.83 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.375 -1.284 . . . . 7.8499999999999996 112.362 -168.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 57.3 t -107.35 -50.2 7.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 107.691 -1.226 . . . . 9.3699999999999992 107.691 165.587 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 19.8 tt0 . . . . . 0 C--O 1.245 0.834 0 CA-C-N 114.558 -1.201 . . . . 12.279999999999999 108.528 171.756 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 1' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.43 -0.629 0 C4'-C3'-C2' 104.046 1.346 . 0.0 '__' . 4.9400000000000004 . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 2' ' ' ' G' . . . . . 0.466 ' H22' ' HA3' ' A' ' 77' ' ' GLY . . . . . . . . 0 O5'--C5' 1.424 -0.991 0 C3'-C2'-C1' 99.041 -2.732 . 0.0 OUTLIER . 4.8700000000000001 . . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 3' ' ' ' U' . . . . . 0.445 ' P ' " O2'" ' B' ' 2' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.426 -0.85 0 O4'-C1'-N19 109.951 1.751 . 0.0 OUTLIER . 5.0199999999999996 . . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 4' ' ' ' G' . . . . . 0.839 ' N3 ' " H3'" ' B' ' 4' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.427 -0.836 0 P-O3'-C3' 120.978 1.065 . 0.0 OUTLIER . 2.6899999999999999 . . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 5' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.426 -0.869 0 C4'-C3'-C2' 104.544 1.844 . 0.0 OUTLIER gamma 1.9299999999999999 . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 6' ' ' ' G' . . . . . 0.834 ' H22' HG21 ' A' ' 65' ' ' VAL . . . . . . . . 0 O5'--C5' 1.425 -0.931 0 C3'-C2'-C1' 100.836 -0.738 . 0.369 4b . 2.3799999999999999 . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C2'--C1' 1.536 0.759 0 O4'-C1'-C2' 108.031 1.165 . 0.0 OUTLIER . 4.1900000000000004 . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.762 0 N-CA-C 111.625 -0.59 . . . . 13.029999999999999 111.625 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -86.23 132.62 33.96 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.815 0.341 . . . . 11.06 110.58 178.343 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 44.3 ttm -111.34 134.86 52.62 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.233 -0.439 . . . . 9.8499999999999996 111.008 -177.44 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 167.48 155.2 9.04 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.952 -0.642 . . . . 6.6900000000000004 112.468 177.548 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 8.6 m -87.37 -5.53 58.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.085 0.469 . . . . 5.5499999999999998 110.55 177.228 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 64.2 mtm180 -94.92 139.46 31.29 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.769 -0.65 . . . . 3.8700000000000001 110.695 -175.265 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.408 ' OD2' ' HB3' ' A' ' 33' ' ' MET . 29.0 t70 -88.84 108.68 19.65 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 110.116 -0.327 . . . . 3.5299999999999998 110.116 176.105 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.663 ' O ' ' HB2' ' A' ' 36' ' ' LYS . 18.7 p -90.51 8.34 34.39 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.744 0.307 . . . . 1.6899999999999999 111.685 -178.412 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' MET . . . . . 0.408 ' HB3' ' OD2' ' A' ' 31' ' ' ASP . 49.3 ttp -73.9 -71.45 0.33 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.38 0.61 . . . . 1.49 110.418 171.385 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.409 ' C ' ' H ' ' A' ' 36' ' ' LYS . 21.4 m-85 -52.68 -71.62 0.07 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.716 -1.129 . . . . 1.5 111.575 176.492 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.617 ' HB ' ' O ' ' A' ' 83' ' ' MET . 34.5 p -53.26 18.17 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 116.542 2.053 . . . . 0.53000000000000003 116.542 178.339 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.663 ' HB2' ' O ' ' A' ' 32' ' ' THR . 41.8 tptt -116.32 113.16 22.57 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 119.52 1.055 . . . . 2.75 111.205 -178.268 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.426 HD11 ' HA ' ' A' ' 89' ' ' ALA . 84.8 mt -103.06 131.15 52.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-N 115.147 -0.933 . . . . 0.84999999999999998 110.681 -179.378 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.494 ' HB2' ' HA ' ' A' ' 110' ' ' ALA . 70.2 t80 -91.92 119.74 31.96 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 109.102 -0.703 . . . . 0.70999999999999996 109.102 175.336 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.676 HG12 HD11 ' A' ' 42' ' ' LEU . 3.9 t -102.31 135.32 39.89 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 N-CA-C 108.315 -0.995 . . . . 0.92000000000000004 108.315 -179.351 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -141.72 153.79 24.38 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.291 -0.957 . . . . 0.83999999999999997 112.093 -169.376 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 70.21 34.96 69.86 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.705 -0.76 . . . . 0.68000000000000005 112.518 176.393 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.676 HD11 HG12 ' A' ' 39' ' ' VAL . 7.2 mp -75.08 142.93 76.54 Favored Pre-proline 0 C--N 1.328 -0.35 0 N-CA-C 109.88 -0.415 . . . . 1.28 109.88 178.058 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.477 ' HG3' ' HB3' ' A' ' 103' ' ' ARG . 28.0 Cg_endo -68.63 158.61 57.03 Favored 'Trans proline' 0 N--CA 1.451 -1.016 0 C-N-CA 121.862 1.708 . . . . 0.57999999999999996 110.736 173.659 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.517 ' HD1' ' OG ' ' A' ' 75' ' ' SER . 59.7 m-85 -64.96 0.15 1.33 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.771 0.656 . . . . 1.05 112.771 -173.256 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 47.9 t-80 -110.37 -6.44 14.98 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.695 0.283 . . . . 2.0099999999999998 111.441 -178.547 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.647 ' CG2' HD23 ' A' ' 42' ' ' LEU . 25.7 m -77.75 137.88 38.71 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.611 -0.436 . . . . 0.71999999999999997 111.094 -179.544 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 10.4 p -131.73 -177.58 4.49 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.777 -0.647 . . . . 0.55000000000000004 109.961 -179.005 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.404 ' OD2' ' HA ' ' A' ' 65' ' ' VAL . 1.8 m-20 -61.5 -49.4 76.92 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 122.165 0.983 . . . . 0.48999999999999999 108.871 -175.503 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.726 ' O ' ' HG2' ' A' ' 53' ' ' GLU . 22.9 pttm -53.1 -33.78 53.73 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 113.229 -1.805 . . . . 2.7599999999999998 111.13 175.333 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 5.0 m -68.11 -44.6 75.8 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.028 0.442 . . . . 0.57999999999999996 110.193 178.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.534 HD21 HG11 ' A' ' 39' ' ' VAL . 33.3 mt -62.97 -44.48 95.93 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-N 115.985 -0.552 . . . . 0.84999999999999998 110.48 176.492 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.662 ' O ' ' HB2' ' A' ' 56' ' ' GLU . 45.2 t-80 -56.29 -37.24 69.61 Favored 'General case' 0 C--O 1.216 -0.679 0 CA-C-N 116.096 -0.502 . . . . 0.58999999999999997 110.641 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.726 ' HG2' ' O ' ' A' ' 49' ' ' LYS . 25.8 mm-40 -74.15 -40.44 62.59 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.311 -0.404 . . . . 1.52 111.781 -174.695 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.485 ' O ' ' HB2' ' A' ' 57' ' ' GLN . 2.9 t80 -77.66 -33.7 53.33 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.782 0.801 . . . . 1.1200000000000001 110.293 -177.215 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.675 ' HB2' HD11 ' A' ' 61' ' ' ILE . 40.4 m-85 -85.89 -25.82 25.95 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.013 -0.994 . . . . 0.56000000000000005 111.423 -174.642 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.662 ' HB2' ' O ' ' A' ' 52' ' ' HIS . 3.2 tp10 -62.09 -4.4 1.67 Allowed 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 122.266 1.031 . . . . 1.5700000000000001 110.428 174.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.485 ' HB2' ' O ' ' A' ' 54' ' ' TYR . 82.5 mt-30 -88.51 -30.7 19.15 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 114.251 -1.34 . . . . 2.1600000000000001 110.431 -177.248 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.583 ' CG ' ' HA ' ' A' ' 92' ' ' ALA . 68.4 m-85 -90.75 -8.91 48.49 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.997 -1.001 . . . . 0.70999999999999996 110.662 -175.276 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 142.83 174.33 15.12 Favored Glycine 0 N--CA 1.441 -1.015 0 N-CA-C 111.139 -0.785 . . . . 0.75 111.139 -179.466 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.682 ' HB3' ' HD2' ' A' ' 84' ' ' LYS . 3.0 m-20 -49.23 121.82 5.33 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.319 0.581 . . . . 1.02 111.798 176.314 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.675 HD11 ' HB2' ' A' ' 55' ' ' PHE . 85.0 mt -91.59 144.7 8.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 107.059 -1.46 . . . . 0.46999999999999997 107.059 171.609 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -94.71 -45.09 7.5 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 119.054 0.843 . . . . 2.0699999999999998 108.872 179.65 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -154.01 123.91 6.79 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.358 -0.837 . . . . 2.48 109.866 176.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -112.47 127.9 56.18 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.789 0.328 . . . . 0.44 110.741 175.027 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.404 ' HA ' ' OD2' ' A' ' 48' ' ' ASP . 8.1 p -144.52 137.75 22.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.636 -0.711 . . . . 1.3799999999999999 111.74 -175.844 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.532 HG12 HG23 ' A' ' 68' ' ' THR . 54.6 t -104.62 117.31 50.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 108.681 -0.859 . . . . 0.48999999999999999 108.681 172.153 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.619 ' O ' ' HD3' ' A' ' 76' ' ' ARG . 47.7 mm -76.88 72.38 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 122.084 0.945 . . . . 0.71999999999999997 111.235 -173.348 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.594 HG22 ' HA ' ' A' ' 75' ' ' SER . 38.5 p -101.78 160.22 14.66 Favored 'General case' 0 N--CA 1.433 -1.315 0 CA-C-N 114.627 -1.17 . . . . 1.52 109.757 164.33 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.486 ' N ' ' HA ' ' A' ' 73' ' ' GLN . 9.9 t70 -73.26 111.22 8.18 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.371 -0.377 . . . . 2.4900000000000002 111.006 -176.5 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.444 HH11 ' HD3' ' A' ' 70' ' ' ARG . 2.1 ptp180 -52.09 -10.67 0.13 Allowed 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 114.632 1.345 . . . . 6.0499999999999998 114.632 -179.273 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -93.07 -42.87 9.17 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 121.634 -0.666 . . . . 4.0499999999999998 112.172 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 19.6 p -135.17 -24.59 1.42 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.864 0.84 . . . . 3.0800000000000001 110.143 -175.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.486 ' HA ' ' N ' ' A' ' 69' ' ' ASP . 92.4 mt-30 69.45 -86.0 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 113.589 -1.641 . . . . 3.2999999999999998 111.479 -173.045 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 32.3 mtmm 63.04 67.31 0.69 Allowed 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 105.317 -2.105 . . . . 3.4900000000000002 105.317 -171.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.594 ' HA ' HG22 ' A' ' 68' ' ' THR . 5.6 p -42.99 121.99 2.28 Favored 'General case' 0 CA--C 1.52 -0.197 0 O-C-N 124.581 1.176 . . . . 1.8100000000000001 112.218 -160.643 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.619 ' HD3' ' O ' ' A' ' 67' ' ' ILE . 41.1 mtp180 -87.3 1.35 53.49 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 113.937 -1.483 . . . . 2.5600000000000001 111.064 -168.736 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 69.64 14.58 70.0 Favored Glycine 0 N--CA 1.447 -0.626 0 CA-C-N 115.785 -0.643 . . . . 0.64000000000000001 113.084 177.078 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.485 ' O ' HG13 ' A' ' 66' ' ' VAL . 13.8 m-85 -118.68 156.1 29.87 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 116.879 0.339 . . . . 1.1799999999999999 110.979 -177.185 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -148.2 179.16 25.28 Favored Glycine 0 N--CA 1.444 -0.808 0 CA-C-N 115.967 -0.56 . . . . 0.58999999999999997 111.792 173.228 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.428 ' CE1' ' HD1' ' A' ' 38' ' ' PHE . 41.3 m-85 -156.04 123.71 5.56 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 123.604 0.762 . . . . 0.63 109.488 -179.444 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 70.4 t -120.95 127.04 75.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-O 120.811 0.339 . . . . 0.40999999999999998 110.433 -178.605 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 13.4 m -104.06 114.85 29.38 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.883 -0.784 . . . . 0.46999999999999997 108.883 177.345 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.617 ' O ' ' HB ' ' A' ' 35' ' ' THR . 93.0 mmm -90.68 133.1 35.39 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 120.9 -0.32 . . . . 0.88 110.719 -178.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.682 ' HD2' ' HB3' ' A' ' 60' ' ' ASP . 46.9 mttm -51.04 -6.24 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 114.614 1.339 . . . . 1.9199999999999999 114.614 174.136 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -160.46 155.49 24.49 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.774 -0.454 . . . . 1.6799999999999999 109.774 174.262 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.618 ' HD3' ' H ' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -75.41 -33.02 60.93 Favored 'General case' 0 C--O 1.224 -0.242 0 N-CA-C 108.279 -1.008 . . . . 3.6600000000000001 108.279 179.49 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -47.71 -48.63 29.38 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.391 -1.277 . . . . 0.66000000000000003 110.126 168.404 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 19.7 m -69.33 -27.97 65.83 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.166 -0.47 . . . . 0.78000000000000003 111.326 179.161 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.426 ' HA ' HD11 ' A' ' 37' ' ' ILE . . . -70.19 -50.13 43.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.451 . . . . 0.46000000000000002 110.482 177.822 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -55.49 -32.48 62.87 Favored 'General case' 0 C--O 1.222 -0.384 0 CA-C-N 116.101 -0.499 . . . . 2.1099999999999999 110.732 172.665 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.597 ' O ' ' HG3' ' A' ' 94' ' ' LYS . 13.4 mtp180 -70.33 -51.42 30.23 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.859 -1.064 . . . . 3.8199999999999998 110.723 179.522 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.583 ' HA ' ' CG ' ' A' ' 58' ' ' PHE . . . -56.06 -46.72 78.85 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 113.992 1.108 . . . . 0.92000000000000004 113.992 171.626 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 48.9 t -74.57 -42.47 58.69 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 120.974 -0.291 . . . . 1.1599999999999999 111.531 -172.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.597 ' HG3' ' O ' ' A' ' 91' ' ' ARG . 1.2 pptp? -49.57 -9.77 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 113.105 0.78 . . . . 4.2000000000000002 113.105 173.856 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -101.8 90.92 2.07 Favored Pre-proline 0 CA--C 1.534 0.343 0 N-CA-C 108.589 -0.893 . . . . 2.2400000000000002 108.589 162.592 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.481 ' HD3' ' O ' ' A' ' 94' ' ' LYS . 2.9 Cg_exo -76.18 111.97 3.38 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.979 2.453 . . . . 2.3799999999999999 113.016 -170.653 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.421 ' HB2' ' O ' ' A' ' 96' ' ' PRO . 92.7 m-20 79.23 69.65 0.17 Allowed Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 114.527 -1.215 . . . . 3.0299999999999998 110.111 175.349 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.448 ' HB2' ' CE1' ' A' ' 54' ' ' TYR . 72.7 Cg_endo -76.23 146.42 28.39 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.534 2.156 . . . . 1.29 111.065 178.756 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.558 HG22 ' C ' ' A' ' 102' ' ' GLY . 14.6 mm -88.33 92.41 3.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 O-C-N 122.155 -0.341 . . . . 1.8100000000000001 110.24 -172.7 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.488 ' C ' ' H ' ' A' ' 102' ' ' GLY . 15.9 mt -92.05 151.24 3.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-O 121.548 0.69 . . . . 0.98999999999999999 112.279 -174.307 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 25.3 t0 35.02 17.83 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 CA-C-N 114.489 -1.232 . . . . 1.3700000000000001 112.872 -152.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.558 ' C ' HG22 ' A' ' 99' ' ' ILE . . . 89.48 19.82 47.43 Favored Glycine 0 CA--C 1.529 0.929 0 CA-C-N 115.757 -0.656 . . . . 1.5600000000000001 111.674 178.722 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.477 ' HB3' ' HG3' ' A' ' 43' ' ' PRO . 31.9 tpt180 -127.82 135.73 50.48 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.747 0.819 . . . . 4.1299999999999999 108.989 174.033 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.421 ' HA ' ' HA ' ' A' ' 99' ' ' ILE . 33.9 ttpt -58.0 114.92 2.56 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.461 0.541 . . . . 2.73 112.461 -174.327 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -99.67 164.66 11.96 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.186 -0.915 . . . . 1.04 110.225 177.148 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 37.8 t30 -107.93 131.7 54.26 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.454 -0.339 . . . . 2.04 110.154 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 41.1 t -122.38 129.12 75.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.32 0.581 . . . . 1.0600000000000001 112.003 -179.219 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -150.01 158.08 43.8 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.084 -0.962 . . . . 2.4900000000000002 108.405 175.161 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.752 HD23 ' CE1' ' A' ' 111' ' ' TYR . 1.0 OUTLIER -73.24 124.67 26.11 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 121.594 -0.691 . . . . 1.23 111.461 -177.029 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.494 ' HA ' ' HB2' ' A' ' 38' ' ' PHE . . . -47.23 -47.3 24.61 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.375 -1.284 . . . . 0.91000000000000003 113.026 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.752 ' CE1' HD23 ' A' ' 109' ' ' LEU . 0.8 OUTLIER -74.55 -21.16 59.65 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.571 0.701 . . . . 1.3999999999999999 110.055 -178.257 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -83.99 -45.06 13.53 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.035 -0.984 . . . . 1.97 109.607 -173.552 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.51 ' HA3' ' C4 ' ' B' ' 5' ' ' ' U' . . . -89.28 17.6 50.75 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.601 -0.809 . . . . 2.1400000000000001 112.246 174.324 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.479 ' O ' ' HE3' ' A' ' 115' ' ' LYS . . . -64.34 162.05 15.66 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-O 120.553 0.216 . . . . 2.6600000000000001 110.798 176.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.479 ' HE3' ' O ' ' A' ' 114' ' ' ALA . 0.0 OUTLIER 74.4 92.2 0.05 OUTLIER Pre-proline 0 N--CA 1.464 0.247 0 C-N-CA 123.508 0.723 . . . . 4.1600000000000001 110.648 -179.222 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.656 ' HG3' " H3'" ' B' ' 5' ' ' ' U' . 1.9 Cg_endo -80.54 23.34 0.71 Allowed 'Trans proline' 0 C--O 1.235 0.34 0 C-N-CA 123.555 2.837 . . . . 5.5300000000000002 111.889 -179.553 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 66.2 ttt180 -134.95 -46.6 0.72 Allowed 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.192 -0.913 . . . . 8.5999999999999996 110.272 -178.506 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 2.4 t -134.57 92.41 2.9 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-O 121.739 0.78 . . . . 6.3700000000000001 110.999 -178.24 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -108.51 137.7 46.02 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.327 -0.851 . . . . 7.8499999999999996 108.857 176.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 4.1 t -100.48 14.56 5.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.207 0.527 . . . . 9.3699999999999992 111.116 -171.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 27.8 mm-40 . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.478 -0.772 . . . . 12.279999999999999 110.757 -178.474 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 1' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.431 -0.564 0 C3'-C2'-C1' 100.403 -1.218 . 0.0 '__' . 4.9400000000000004 . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 2' ' ' ' G' . . . . . 0.472 ' C5 ' ' CE1' ' A' ' 44' ' ' TYR . . . . . . . . 0 O5'--C5' 1.426 -0.877 0 C3'-C2'-C1' 100.092 -1.565 . 0.0 OUTLIER . 4.8700000000000001 . . . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 3' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.426 -0.855 0 C4'-C3'-C2' 104.069 1.369 . 0.0 OUTLIER . 5.0199999999999996 . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 4' ' ' ' G' . . . . . 0.676 ' N3 ' " H3'" ' B' ' 4' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.425 -0.955 0 O4'-C1'-C2' 107.948 1.106 . 0.0 OUTLIER . 2.6899999999999999 . . . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 5' ' ' ' U' . . . . . 0.656 " H3'" ' HG3' ' A' ' 116' ' ' PRO . . . . . . . . 0 O5'--C5' 1.427 -0.812 0 C3'-C2'-C1' 100.28 -1.355 . 0.438 1b . 1.9299999999999999 . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 6' ' ' ' G' . . . . . 0.882 " O2'" " H5'" ' B' ' 7' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.428 -0.751 0 C4'-C3'-C2' 103.483 0.783 . 0.011 0b . 2.3799999999999999 . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 7' ' ' ' C' . . . . . 0.882 " H5'" " O2'" ' B' ' 6' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.431 -0.542 0 P-O5'-C5' 123.45 1.593 . 0.0 OUTLIER . 4.1900000000000004 . . . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.883 0 N-CA-C 112.603 -0.199 . . . . 13.029999999999999 112.603 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -90.32 114.31 26.35 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 122.568 -0.372 . . . . 11.06 111.11 -177.247 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 22.6 mmt 64.17 87.57 0.11 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.305 -0.861 . . . . 9.8499999999999996 111.557 176.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -82.45 117.75 4.48 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.811 -0.709 . . . . 6.6900000000000004 111.669 177.443 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 23.6 m -113.42 127.98 56.3 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.868 0.366 . . . . 5.5499999999999998 110.713 -177.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.486 ' HG3' HG23 ' A' ' 32' ' ' THR . 17.7 ptp180 -103.68 19.06 20.56 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.208 0.527 . . . . 3.8700000000000001 110.073 178.312 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 58.81 48.88 10.66 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 114.736 -1.12 . . . . 3.5299999999999998 111.86 178.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.625 ' O ' ' HB2' ' A' ' 36' ' ' LYS . 9.6 p -65.01 -13.79 58.74 Favored 'General case' 0 C--O 1.221 -0.439 0 CA-C-N 115.761 -0.654 . . . . 1.6899999999999999 111.009 175.765 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 12.5 tmm? -62.18 -29.27 70.25 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.526 -0.307 . . . . 1.49 110.963 175.322 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -98.1 -46.43 5.87 Favored 'General case' 0 CA--C 1.527 0.077 0 O-C-N 122.225 -0.297 . . . . 1.5 111.312 177.031 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.609 ' OG1' ' HA ' ' A' ' 32' ' ' THR . 63.3 p -68.78 1.63 3.16 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 113.755 1.021 . . . . 0.53000000000000003 113.755 -176.162 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.625 ' HB2' ' O ' ' A' ' 32' ' ' THR . 58.0 tttt -97.99 107.9 20.49 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.995 0.426 . . . . 2.75 110.117 -175.477 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.459 HD11 ' HA ' ' A' ' 89' ' ' ALA . 47.1 mt -109.38 136.3 45.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.781 -0.645 . . . . 0.84999999999999998 111.148 -175.382 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -101.25 118.41 36.93 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.878 -0.601 . . . . 0.70999999999999996 109.698 174.28 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.816 HG13 HG22 ' A' ' 107' ' ' VAL . 30.3 t -133.75 110.63 14.55 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.848 0 CA-C-O 117.85 -1.071 . . . . 0.92000000000000004 110.977 -177.182 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.42 ' HA2' ' CD2' ' A' ' 42' ' ' LEU . . . -116.68 -156.76 10.73 Favored Glycine 0 CA--C 1.503 -0.706 1 C-N-CA 112.341 -4.742 . . . . 0.83999999999999997 114.835 156.049 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.488 ' HA3' ' HA ' ' A' ' 105' ' ' ALA . . . 92.42 5.07 65.58 Favored Glycine 0 N--CA 1.442 -0.903 0 N-CA-C 110.211 -1.156 . . . . 0.68000000000000005 110.211 -171.466 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.67 HD11 HD21 ' A' ' 51' ' ' LEU . 3.0 mm? -71.99 121.4 84.5 Favored Pre-proline 0 N--CA 1.45 -0.44 0 CA-C-N 115.06 -0.57 . . . . 1.28 109.931 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.79 ' HG3' ' HD3' ' A' ' 103' ' ' ARG . 88.8 Cg_exo -48.21 160.01 0.61 Allowed 'Trans proline' 0 CA--C 1.529 0.274 0 C-N-CA 124.198 3.266 . . . . 0.57999999999999996 113.968 177.22 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.479 ' CE2' ' C5 ' ' B' ' 2' ' ' ' G' . 64.2 m-85 -71.26 -6.94 43.52 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.704 -0.68 . . . . 1.05 112.688 -174.105 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 7.6 p-80 -112.85 10.29 19.07 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 121.788 -0.57 . . . . 2.0099999999999998 110.921 171.525 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.594 HG21 HD12 ' A' ' 42' ' ' LEU . 52.0 m -79.62 123.75 27.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.099 -0.5 . . . . 0.71999999999999997 110.438 174.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 60.3 p -105.72 175.2 5.57 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.264 -0.425 . . . . 0.55000000000000004 110.577 -178.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.511 ' HB3' ' O ' ' A' ' 64' ' ' ALA . 2.9 m-20 -57.44 -30.56 65.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.571 0.701 . . . . 0.48999999999999999 110.124 176.691 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.679 ' O ' ' HG2' ' A' ' 53' ' ' GLU . 0.5 OUTLIER -78.71 -29.59 45.52 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.422 -0.808 . . . . 2.7599999999999998 110.828 -179.389 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.583 ' HB ' HG23 ' A' ' 46' ' ' THR . 14.5 m -61.95 -41.98 98.6 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.98 0.419 . . . . 0.57999999999999996 110.379 176.454 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.67 HD21 HD11 ' A' ' 42' ' ' LEU . 16.0 mt -67.65 -37.16 82.03 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-N 116.189 -0.46 . . . . 0.84999999999999998 110.334 174.8 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.47 ' HA ' HD12 ' A' ' 61' ' ' ILE . 60.5 t-80 -57.05 -47.4 81.05 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.723 -0.672 . . . . 0.58999999999999997 109.848 175.916 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.679 ' HG2' ' O ' ' A' ' 49' ' ' LYS . 23.6 mm-40 -57.54 -47.25 82.52 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.976 -0.556 . . . . 1.52 111.521 178.867 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.464 ' O ' ' HB2' ' A' ' 57' ' ' GLN . 20.9 t80 -76.75 -34.83 58.05 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.591 0.589 . . . . 1.1200000000000001 112.591 -172.172 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.432 ' CZ ' HG21 ' A' ' 39' ' ' VAL . 22.5 m-85 -85.03 -25.17 27.83 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 114.391 1.256 . . . . 0.56000000000000005 114.391 -173.339 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.587 ' N ' HD11 ' A' ' 61' ' ' ILE . 11.0 pt-20 -67.06 -12.52 60.16 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 122.351 1.072 . . . . 1.5700000000000001 109.722 177.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.464 ' HB2' ' O ' ' A' ' 54' ' ' TYR . 17.8 mm-40 -56.15 -31.31 63.25 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 113.937 -1.483 . . . . 2.1600000000000001 111.506 169.001 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -96.92 4.87 51.38 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.466 -0.334 . . . . 0.70999999999999996 111.737 -176.42 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 142.2 -133.76 5.8 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.548 -0.834 . . . . 0.75 112.516 -176.744 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -114.29 124.38 51.86 Favored 'General case' 0 C--N 1.322 -0.599 0 O-C-N 122.567 -0.372 . . . . 1.02 110.475 -179.016 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.587 HD11 ' N ' ' A' ' 56' ' ' GLU . 7.5 mt -93.23 125.87 45.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 109.579 -0.526 . . . . 0.46999999999999997 109.579 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.414 ' CD ' HH11 ' A' ' 30' ' ' ARG . 23.1 tt0 -78.48 -38.8 40.09 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.019 0.438 . . . . 2.0699999999999998 110.753 176.217 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -157.22 136.37 11.87 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.149 -0.478 . . . . 2.48 111.34 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.511 ' O ' ' HB3' ' A' ' 48' ' ' ASP . . . -121.28 123.4 42.1 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 115.781 -0.645 . . . . 0.44 109.396 174.039 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 8.9 p -135.52 135.17 51.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 114.893 -1.048 . . . . 1.3799999999999999 112.191 -176.53 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 98.1 t -102.83 131.76 50.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.356 -0.838 . . . . 0.48999999999999999 109.386 173.394 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.471 HG12 ' HA2' ' A' ' 79' ' ' GLY . 44.6 mm -83.61 92.28 2.83 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.625 0 CA-C-O 121.478 0.656 . . . . 0.71999999999999997 109.665 -179.284 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.456 ' HB ' ' HA ' ' A' ' 73' ' ' GLN . 31.7 p -92.44 172.82 8.14 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 115.023 -0.99 . . . . 1.52 110.757 -179.6 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.453 ' HB3' ' H ' ' A' ' 73' ' ' GLN . 29.3 t70 -61.56 124.0 19.44 Favored 'General case' 0 C--O 1.216 -0.709 0 CA-C-N 116.347 -0.388 . . . . 2.4900000000000002 111.177 -174.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.476 ' HG3' ' OD1' ' A' ' 71' ' ' ASN . 11.3 ptt180 -54.92 -22.71 15.82 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 113.011 0.745 . . . . 6.0499999999999998 113.011 -177.289 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.476 ' OD1' ' HG3' ' A' ' 70' ' ' ARG . 4.5 m-20 -100.9 -39.21 7.88 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 112.63 0.604 . . . . 4.0499999999999998 112.63 -179.394 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 40.7 p -112.17 -27.95 8.15 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 112.148 0.425 . . . . 3.0800000000000001 112.148 -175.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.456 ' HA ' ' HB ' ' A' ' 68' ' ' THR . 93.9 mt-30 63.16 12.91 6.42 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 123.775 0.83 . . . . 3.2999999999999998 113.0 178.433 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.663 ' HE2' ' HA ' ' A' ' 74' ' ' LYS . 5.0 mmpt? -38.56 -76.32 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 113.565 0.95 . . . . 3.4900000000000002 113.565 171.305 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.508 ' O ' ' HB2' ' A' ' 76' ' ' ARG . 8.4 m -155.99 -65.65 0.11 Allowed 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 112.879 0.696 . . . . 1.8100000000000001 112.879 -178.345 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.508 ' HB2' ' O ' ' A' ' 75' ' ' SER . 96.5 mtt180 74.57 -55.3 0.66 Allowed 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.329 0.652 . . . . 2.5600000000000001 110.508 -169.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.652 ' HA3' ' N2 ' ' B' ' 2' ' ' ' G' . . . 103.97 19.24 12.07 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.841 -0.695 . . . . 0.64000000000000001 113.142 175.775 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -123.85 157.28 34.53 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.215 -1.031 . . . . 1.1799999999999999 108.215 177.292 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.471 ' HA2' HG12 ' A' ' 67' ' ' ILE . . . -159.23 -164.66 14.89 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 119.769 -1.205 . . . . 0.58999999999999997 112.647 175.742 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -151.3 134.83 16.24 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.731 -0.84 . . . . 0.63 108.731 -177.054 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 53.7 t -122.36 120.07 60.06 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 N-CA-C 109.938 -0.393 . . . . 0.40999999999999998 109.938 177.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.574 ' HA ' ' O ' ' A' ' 35' ' ' THR . 17.9 m -109.81 115.68 30.28 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 108.51 -0.922 . . . . 0.46999999999999997 108.51 177.646 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 83.1 mmm -88.79 163.8 15.53 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 108.898 -0.778 . . . . 0.88 108.898 -176.163 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 20.7 ttmm -83.3 -10.94 58.21 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.099 0.476 . . . . 1.9199999999999999 110.683 -178.373 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -145.67 146.64 31.38 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 116.232 -0.44 . . . . 1.6799999999999999 110.616 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 4.3 tmm_? -71.39 -22.81 61.83 Favored 'General case' 0 C--O 1.223 -0.3 0 N-CA-C 112.845 0.683 . . . . 3.6600000000000001 112.845 -177.026 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.26 -43.94 89.68 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 118.649 0.659 . . . . 0.66000000000000003 110.392 177.646 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 8.7 m -64.55 -39.23 93.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.699 0.761 . . . . 0.78000000000000003 109.881 175.553 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.459 ' HA ' HD11 ' A' ' 37' ' ' ILE . . . -59.41 -49.79 76.45 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.028 -1.442 . . . . 0.46000000000000002 110.609 178.326 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -54.98 -49.16 72.13 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.55 -0.75 . . . . 2.1099999999999999 111.826 175.26 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.62 ' O ' ' HB3' ' A' ' 94' ' ' LYS . 2.6 ttm-85 -61.85 -41.02 97.31 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.295 -0.412 . . . . 3.8199999999999998 110.773 -177.25 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -63.56 -43.84 95.87 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.996 -0.547 . . . . 0.92000000000000004 111.73 176.605 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 45.2 t -75.2 -6.9 52.14 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 121.337 0.589 . . . . 1.1599999999999999 110.659 178.232 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.62 ' HB3' ' O ' ' A' ' 91' ' ' ARG . 2.9 tppp? -76.96 -37.94 54.26 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.285 -0.87 . . . . 4.2000000000000002 110.016 177.402 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -108.33 91.58 8.47 Favored Pre-proline 0 C--N 1.326 -0.441 0 N-CA-C 109.358 -0.608 . . . . 2.2400000000000002 109.358 172.639 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.594 ' HA ' ' HB ' ' A' ' 107' ' ' VAL . 59.4 Cg_endo -90.17 -6.54 4.62 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 123.1 2.533 . . . . 2.3799999999999999 114.144 -169.18 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.456 ' N ' ' HD3' ' A' ' 98' ' ' PRO . 3.4 p-10 -132.76 60.86 53.02 Favored Pre-proline 0 C--N 1.328 -0.337 0 N-CA-C 112.306 0.484 . . . . 3.0299999999999998 112.306 -177.819 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.456 ' HD3' ' N ' ' A' ' 97' ' ' ASN . 1.8 Cg_endo -81.38 151.73 17.72 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.795 2.33 . . . . 1.29 111.73 -179.683 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 35.9 mm -95.06 90.37 2.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.287 0.565 . . . . 1.8100000000000001 110.302 179.433 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 57.6 mt -90.85 108.34 19.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.841 -0.618 . . . . 0.98999999999999999 111.847 177.454 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.718 ' HB3' ' HG2' ' A' ' 43' ' ' PRO . 25.2 t70 65.31 44.17 3.3 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 122.813 1.292 . . . . 1.3700000000000001 109.3 173.345 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 80.39 -9.03 51.15 Favored Glycine 0 N--CA 1.445 -0.712 0 CA-C-N 114.412 -1.267 . . . . 1.5600000000000001 113.579 176.463 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.79 ' HD3' ' HG3' ' A' ' 43' ' ' PRO . 7.4 mpt_? -107.09 131.09 54.5 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 117.74 0.77 . . . . 4.1299999999999999 111.623 176.524 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 26.3 ttpp -67.18 134.51 51.86 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.366 -0.834 . . . . 2.73 109.032 169.656 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.488 ' HA ' ' HA3' ' A' ' 41' ' ' GLY . . . -111.25 150.38 29.68 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 116.232 -0.44 . . . . 1.04 109.964 -175.582 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -108.15 106.18 16.26 Favored 'General case' 0 C--O 1.264 1.857 0 CA-C-O 121.556 0.694 . . . . 2.04 110.053 174.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.816 HG22 HG13 ' A' ' 39' ' ' VAL . 47.4 t -101.67 138.53 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 CA-C-N 112.876 -1.965 . . . . 1.0600000000000001 111.451 174.317 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.462 ' HB3' HD12 ' A' ' 112' ' ' LEU . 32.8 m-80 -151.86 153.02 33.37 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.428 -0.953 . . . . 2.4900000000000002 108.428 172.801 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.527 HD13 ' H ' ' A' ' 110' ' ' ALA . 0.2 OUTLIER -63.25 150.3 43.46 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.402 -0.962 . . . . 1.23 108.402 172.876 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.527 ' H ' HD13 ' A' ' 109' ' ' LEU . . . -74.67 -40.28 61.51 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.081 -0.647 . . . . 0.91000000000000003 110.36 -167.361 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.409 ' CE1' ' HB3' ' A' ' 109' ' ' LEU . 0.1 OUTLIER -68.28 -2.3 8.0 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 114.97 -1.014 . . . . 1.3999999999999999 112.654 -172.221 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.462 HD12 ' HB3' ' A' ' 108' ' ' ASN . 82.6 mt -66.42 -45.83 78.57 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.612 0.244 . . . . 1.97 110.714 179.045 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -126.67 40.51 1.78 Allowed Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.21 -0.995 . . . . 2.1400000000000001 111.987 174.45 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -86.59 113.06 22.17 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.625 -0.509 . . . . 2.6600000000000001 109.625 -178.283 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.41 ' HE3' ' HB2' ' A' ' 115' ' ' LYS . 41.0 mtmt -128.57 77.35 77.47 Favored Pre-proline 0 C--N 1.326 -0.442 0 C-N-CA 120.86 -0.336 . . . . 4.1600000000000001 110.592 -175.815 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -83.89 -51.78 0.04 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 122.549 2.166 . . . . 5.5300000000000002 110.553 174.772 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -157.55 1.97 0.12 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.109 -0.95 . . . . 8.5999999999999996 108.703 177.399 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.13 96.77 5.18 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 114.792 -1.095 . . . . 6.3700000000000001 111.1 -171.328 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -94.34 65.35 3.27 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.055 0.455 . . . . 7.8499999999999996 111.222 -178.753 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 95.2 t 69.22 117.32 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 N-CA-C 113.64 0.978 . . . . 9.3699999999999992 113.64 171.682 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.445 ' O ' ' HG3' ' A' ' 121' ' ' GLN . 6.8 pt20 . . . . . 0 C--O 1.245 0.866 0 CA-C-O 118.546 -0.74 . . . . 12.279999999999999 109.605 168.196 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 1' ' ' ' G' . . . . . 0.543 " H4'" " O5'" ' B' ' 2' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.431 -0.562 0 C3'-C2'-C1' 99.647 -2.059 . 0.0 '__' . 4.9400000000000004 . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 2' ' ' ' G' . . . . . 0.681 ' O6 ' ' HA ' ' A' ' 43' ' ' PRO . . . . . . . . 0 O5'--C5' 1.427 -0.787 0 C4'-C3'-C2' 103.736 1.036 . 0.0 OUTLIER . 4.8700000000000001 . . . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 3' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.427 -0.832 0 C3'-C2'-C1' 100.876 -0.694 . 0.0 OUTLIER gamma 5.0199999999999996 . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 4' ' ' ' G' . . . . . 0.561 " O2'" " H5'" ' B' ' 5' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.427 -0.786 0 O4'-C1'-C2' 108.171 1.265 . 0.0 OUTLIER '7D dist 2a' 2.6899999999999999 . . . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 5' ' ' ' U' . . . . . 0.561 " H5'" " O2'" ' B' ' 4' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.426 -0.863 0 C4'-C3'-C2' 103.95 1.25 . 0.418 1[ . 1.9299999999999999 . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 6' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.427 -0.814 0 C4'-C3'-C2' 103.508 0.808 . 0.28 0b . 2.3799999999999999 . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 7' ' ' ' C' . . . . . 0.658 ' H6 ' " O5'" ' B' ' 7' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.426 -0.855 0 C3'-C2'-C1' 100.52 -1.089 . 0.019 2[ . 4.1900000000000004 . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.609 0 N-CA-C 112.059 -0.416 . . . . 13.029999999999999 112.059 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -115.98 94.92 4.87 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.09 0.471 . . . . 11.06 109.803 178.208 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 95.6 mmm -99.68 143.52 29.82 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.878 -0.601 . . . . 9.8499999999999996 110.767 -175.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -137.58 49.63 0.85 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.795 -0.717 . . . . 6.6900000000000004 112.63 -178.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 18.3 m 58.43 64.08 1.56 Allowed 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 121.014 0.435 . . . . 5.5499999999999998 111.7 176.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -84.75 91.43 7.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.991 0.424 . . . . 3.8700000000000001 110.21 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -82.46 109.97 17.16 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 109.173 -0.677 . . . . 3.5299999999999998 109.173 -178.82 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.44 ' O ' ' HE2' ' A' ' 36' ' ' LYS . 14.5 p -90.5 53.92 2.58 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 114.094 1.146 . . . . 1.6899999999999999 114.094 -165.732 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' MET . . . . . 0.605 ' HG3' ' H ' ' A' ' 34' ' ' PHE . 22.5 ptm -73.23 -51.0 19.32 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 107.695 -1.224 . . . . 1.49 107.695 162.586 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.605 ' H ' ' HG3' ' A' ' 33' ' ' MET . 26.0 m-85 -88.17 -179.97 6.26 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 113.712 -1.586 . . . . 1.5 108.62 170.173 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.73 ' HB ' ' O ' ' A' ' 83' ' ' MET . 14.0 p 65.37 -0.46 1.16 Allowed 'General case' 0 N--CA 1.472 0.637 0 O-C-N 124.065 0.853 . . . . 0.53000000000000003 112.642 174.588 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.591 ' HD2' ' O6 ' ' B' ' 6' ' ' ' G' . 33.0 ttpt -121.89 110.21 15.58 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.136 0.494 . . . . 2.75 110.248 -176.314 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.616 HD11 ' HA ' ' A' ' 89' ' ' ALA . 3.8 mp -96.3 130.02 45.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.972 -0.558 . . . . 0.84999999999999998 110.575 -179.292 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -85.77 108.29 18.02 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 108.559 -0.904 . . . . 0.70999999999999996 108.559 172.721 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.3 t -95.95 137.03 25.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 N-CA-C 108.074 -1.084 . . . . 0.92000000000000004 108.074 179.577 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -140.42 138.09 8.78 Favored Glycine 0 N--CA 1.442 -0.94 0 C-N-CA 119.577 -1.297 . . . . 0.83999999999999997 111.767 -170.311 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 96.43 16.36 37.53 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.582 -0.818 . . . . 0.68000000000000005 112.84 177.459 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.553 HD12 HG21 ' A' ' 46' ' ' THR . 2.8 mm? -64.94 124.16 85.81 Favored Pre-proline 0 C--O 1.234 0.246 0 N-CA-C 109.304 -0.628 . . . . 1.28 109.304 177.006 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.578 ' HG2' ' HB3' ' A' ' 101' ' ' ASP . 52.9 Cg_exo -50.58 154.38 6.53 Favored 'Trans proline' 0 CA--C 1.529 0.252 0 C-N-CA 122.91 2.407 . . . . 0.57999999999999996 111.88 173.733 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -65.76 -7.22 14.6 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.847 0.356 . . . . 1.05 111.61 -178.057 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 76.9 t60 -101.14 -6.43 24.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.188 0.518 . . . . 2.0099999999999998 110.222 177.538 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.553 HG21 HD12 ' A' ' 42' ' ' LEU . 77.5 m -78.72 142.42 37.09 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 116.259 -0.428 . . . . 0.71999999999999997 109.922 177.762 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 12.1 p -132.14 -178.77 5.05 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.028 0.442 . . . . 0.55000000000000004 111.161 -175.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.587 ' OD2' ' HA ' ' A' ' 65' ' ' VAL . 2.4 m-20 -67.31 -48.18 68.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.862 0.839 . . . . 0.48999999999999999 109.06 -176.423 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.598 ' O ' ' HG2' ' A' ' 53' ' ' GLU . 22.8 pttp -52.52 -35.38 53.14 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 113.908 -1.496 . . . . 2.7599999999999998 111.149 175.38 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.47 HG21 HG23 ' A' ' 46' ' ' THR . 22.9 m -67.2 -45.76 75.9 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.854 0.359 . . . . 0.57999999999999996 111.279 179.299 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.525 HD21 HD11 ' A' ' 42' ' ' LEU . 31.1 mt -67.33 -35.67 79.9 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.485 -0.325 . . . . 0.84999999999999998 110.805 178.602 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.432 ' HA ' ' CD1' ' A' ' 61' ' ' ILE . 63.9 t-80 -57.3 -38.3 73.77 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.644 -0.502 . . . . 0.58999999999999997 109.644 175.666 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.598 ' HG2' ' O ' ' A' ' 49' ' ' LYS . 82.3 mm-40 -68.18 -39.84 82.42 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.242 -0.89 . . . . 1.52 110.467 -177.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.634 ' O ' ' HB2' ' A' ' 57' ' ' GLN . 2.2 t80 -78.44 -34.33 47.87 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.566 0.698 . . . . 1.1200000000000001 111.607 -177.282 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.46 ' HB2' HD11 ' A' ' 61' ' ' ILE . 28.7 m-85 -86.4 -25.63 25.19 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 113.086 0.772 . . . . 0.56000000000000005 113.086 -172.124 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -71.98 -1.53 14.87 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 122.336 1.065 . . . . 1.5700000000000001 109.619 174.102 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.634 ' HB2' ' O ' ' A' ' 54' ' ' TYR . 88.9 mt-30 -86.28 -10.6 54.22 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.092 -1.413 . . . . 2.1600000000000001 109.96 176.223 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.431 ' HD2' ' HA ' ' A' ' 55' ' ' PHE . 78.8 m-85 -109.86 -51.2 2.9 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.395 -0.821 . . . . 0.70999999999999996 111.118 -178.332 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -163.92 -135.75 1.87 Allowed Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.274 -0.965 . . . . 0.75 112.006 179.248 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.428 ' HB3' ' HE3' ' A' ' 84' ' ' LYS . 1.0 OUTLIER -98.22 132.88 43.35 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.803 0.335 . . . . 1.02 110.235 -179.902 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.46 HD11 ' HB2' ' A' ' 55' ' ' PHE . 66.0 mt -105.83 139.89 25.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 107.87 -1.159 . . . . 0.46999999999999997 107.87 174.621 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -97.99 -41.21 8.09 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 107.933 -1.136 . . . . 2.0699999999999998 107.933 177.099 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.402 ' HG2' HG13 ' A' ' 65' ' ' VAL . 43.0 tt0 -165.48 127.03 1.98 Allowed 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 115.458 -0.792 . . . . 2.48 110.267 177.014 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.419 ' O ' ' HB3' ' A' ' 48' ' ' ASP . . . -106.04 127.27 53.06 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.272 -0.64 . . . . 0.44 109.272 174.533 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.587 ' HA ' ' OD2' ' A' ' 48' ' ' ASP . 5.0 m -138.1 119.63 17.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.472 0.653 . . . . 1.3799999999999999 112.649 -175.268 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 91.7 t -86.99 122.06 38.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.381 -0.827 . . . . 0.48999999999999999 109.553 174.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 39.8 mm -71.69 139.34 19.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.34 0.59 . . . . 0.71999999999999997 112.16 -176.021 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.478 ' HB ' ' C ' ' A' ' 73' ' ' GLN . 35.2 p -106.74 177.55 4.82 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 115.265 -0.88 . . . . 1.52 109.53 176.558 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.602 ' HB3' ' N ' ' A' ' 73' ' ' GLN . 31.4 t70 -70.61 160.39 32.64 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.737 0.779 . . . . 2.4900000000000002 113.047 -171.467 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -72.27 -53.95 10.98 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.048 -1.433 . . . . 6.0499999999999998 109.207 177.143 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 -79.76 -58.98 2.91 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.419 -0.81 . . . . 4.0499999999999998 112.588 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 61.5 p -92.61 -16.05 26.11 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 112.615 0.598 . . . . 3.0800000000000001 112.615 -171.574 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.602 ' N ' ' HB3' ' A' ' 69' ' ' ASP . 47.5 mt-30 57.12 31.99 20.93 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.507 0.67 . . . . 3.2999999999999998 111.444 -175.056 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -94.6 142.71 27.13 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.24 -0.891 . . . . 3.4900000000000002 109.054 171.367 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.8 m -45.8 132.15 8.99 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.712 0.634 . . . . 1.8100000000000001 112.712 -169.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 60.2 mtp180 -98.15 -10.22 24.51 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.947 -0.57 . . . . 2.5600000000000001 110.92 -175.29 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.445 ' HA3' ' N2 ' ' B' ' 2' ' ' ' G' . . . 86.89 13.77 66.13 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.596 -0.811 . . . . 0.64000000000000001 112.462 -178.515 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -122.85 162.44 22.17 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.59 -0.893 . . . . 1.1799999999999999 108.59 178.018 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -173.77 145.19 8.07 Favored Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 120.148 -1.025 . . . . 0.58999999999999997 112.211 178.122 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -104.06 142.17 34.93 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.419 0.628 . . . . 0.63 111.258 176.064 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 49.8 t -117.99 106.02 19.01 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 CA-C-N 115.239 -0.891 . . . . 0.40999999999999998 109.483 173.528 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 8.3 m -76.92 117.33 18.41 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.883 -0.598 . . . . 0.46999999999999997 109.968 174.002 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.73 ' O ' ' HB ' ' A' ' 35' ' ' THR . 28.1 mtp -103.31 134.85 46.02 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.74 -0.467 . . . . 0.88 109.74 179.069 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.428 ' HE3' ' HB3' ' A' ' 60' ' ' ASP . 19.1 ttmt -51.73 -6.14 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 114.87 1.433 . . . . 1.9199999999999999 114.87 -179.679 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.481 ' C ' HG22 ' A' ' 35' ' ' THR . 7.2 t70 -162.53 156.68 21.21 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 118.871 0.76 . . . . 1.6799999999999999 111.323 177.722 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.666 ' N ' HG22 ' A' ' 35' ' ' THR . 2.5 tmm_? -75.02 -34.8 61.94 Favored 'General case' 0 C--O 1.22 -0.48 0 N-CA-C 108.461 -0.94 . . . . 3.6600000000000001 108.461 -177.279 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -52.71 -42.4 64.82 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.026 -0.988 . . . . 0.66000000000000003 110.95 172.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 5.5 m -69.55 -31.95 70.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.072 0.463 . . . . 0.78000000000000003 110.381 176.401 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.616 ' HA ' HD11 ' A' ' 37' ' ' ILE . . . -67.62 -50.43 58.11 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.599 -0.728 . . . . 0.46000000000000002 110.819 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.573 ' O ' ' HG2' ' A' ' 94' ' ' LYS . 6.0 mt-10 -57.72 -32.77 67.74 Favored 'General case' 0 C--O 1.224 -0.283 0 CA-C-N 115.832 -0.622 . . . . 2.1099999999999999 110.537 174.547 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.401 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 13.3 tpp180 -64.15 -51.72 62.48 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.325 -0.852 . . . . 3.8199999999999998 109.922 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -53.57 -32.1 49.45 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 113.461 0.912 . . . . 0.92000000000000004 113.461 172.798 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 46.5 t -80.25 -34.57 36.99 Favored 'General case' 0 C--N 1.328 -0.363 0 O-C-N 121.894 -0.504 . . . . 1.1599999999999999 110.609 178.173 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.573 ' HG2' ' O ' ' A' ' 90' ' ' GLU . 12.2 mmmm -48.23 -30.7 4.98 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 114.733 -1.121 . . . . 4.2000000000000002 111.838 175.168 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -103.18 102.77 30.52 Favored Pre-proline 0 C--N 1.326 -0.438 0 N-CA-C 108.893 -0.78 . . . . 2.2400000000000002 108.893 167.533 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -77.15 173.65 14.06 Favored 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 122.608 2.205 . . . . 2.3799999999999999 113.761 -169.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 20.2 m-80 -15.98 91.13 0.04 OUTLIER Pre-proline 0 N--CA 1.481 1.092 0 C-N-CA 125.462 1.505 . . . . 3.0299999999999998 114.126 -174.473 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -82.27 164.85 16.96 Favored 'Trans proline' 0 C--O 1.235 0.346 0 C-N-CA 123.408 2.739 . . . . 1.29 113.202 -179.112 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 41.1 mm -94.72 109.79 22.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.445 -0.798 . . . . 1.8100000000000001 110.329 174.126 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 54.9 mt -114.22 115.65 50.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.017 -0.538 . . . . 0.98999999999999999 110.251 178.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.578 ' HB3' ' HG2' ' A' ' 43' ' ' PRO . 28.0 t70 50.71 54.53 11.04 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 113.071 0.767 . . . . 1.3700000000000001 113.071 169.281 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 74.75 21.72 78.17 Favored Glycine 0 N--CA 1.454 -0.12 0 C-N-CA 120.375 -0.917 . . . . 1.5600000000000001 113.121 176.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.463 ' HB2' ' HG3' ' A' ' 43' ' ' PRO . 0.2 OUTLIER -145.66 160.11 42.17 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.9 -0.407 . . . . 4.1299999999999999 109.9 179.207 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 2.1 ttmp? -101.79 149.23 24.39 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 107.751 -1.203 . . . . 2.73 107.751 169.665 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -116.85 141.48 48.17 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 120.674 -0.41 . . . . 1.04 110.103 -174.353 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -94.23 123.8 37.85 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.268 -0.641 . . . . 2.04 109.268 175.453 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.517 HG13 HG21 ' A' ' 37' ' ' ILE . 97.9 t -119.72 114.92 45.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.247 -0.888 . . . . 1.0600000000000001 110.219 179.353 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -156.48 171.32 20.49 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.506 -0.77 . . . . 2.4900000000000002 110.254 -179.44 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.536 ' HB3' ' CD1' ' A' ' 111' ' ' TYR . 3.2 mm? -78.38 115.09 17.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.513 0.673 . . . . 1.23 111.415 -176.531 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -43.92 -35.83 2.17 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 113.949 -1.478 . . . . 0.91000000000000003 113.987 -179.533 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.536 ' CD1' ' HB3' ' A' ' 109' ' ' LEU . 0.4 OUTLIER -72.97 -10.32 59.68 Favored 'General case' 0 N--CA 1.467 0.395 0 O-C-N 121.69 -0.631 . . . . 1.3999999999999999 112.311 -174.712 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 96.6 mt -68.11 -38.71 82.58 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.906 0.384 . . . . 1.97 110.636 177.798 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -104.31 10.44 50.59 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.958 -0.639 . . . . 2.1400000000000001 111.972 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -90.47 123.31 34.06 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 109.19 -0.67 . . . . 2.6600000000000001 109.19 -178.656 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -132.5 94.08 23.43 Favored Pre-proline 0 C--N 1.322 -0.618 0 C-N-CA 120.199 -0.6 . . . . 4.1600000000000001 111.498 -179.45 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.468 ' HD2' ' H ' ' A' ' 117' ' ' ARG . 34.3 Cg_endo -93.17 -37.98 0.04 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.092 0 C-N-CA 122.743 2.295 . . . . 5.5300000000000002 111.559 171.18 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.468 ' H ' ' HD2' ' A' ' 116' ' ' PRO . 25.9 ptt180 -145.71 9.76 1.19 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.554 -0.748 . . . . 8.5999999999999996 110.038 -178.214 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 5.7 p -101.87 50.79 0.84 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.639 -0.709 . . . . 6.3700000000000001 110.831 -179.703 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -90.64 91.18 8.3 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.885 -0.598 . . . . 7.8499999999999996 111.467 -175.273 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 56.4 t 69.81 103.55 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 115.334 -0.848 . . . . 9.3699999999999992 112.825 172.511 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 . . . . . 0 C--O 1.247 0.956 0 CA-C-O 118.679 -0.677 . . . . 12.279999999999999 109.517 172.493 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 1' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.429 -0.714 0 C4'-C3'-C2' 103.827 1.127 . 0.0 '__' . 4.9400000000000004 . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 2' ' ' ' G' . . . . . 0.445 ' N2 ' ' HA3' ' A' ' 77' ' ' GLY . . . . . . . . 0 O5'--C5' 1.425 -0.948 0 C4'-C3'-C2' 104.072 1.372 . 0.0 OUTLIER . 4.8700000000000001 . . . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 3' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.425 -0.919 0 C3'-C2'-C1' 100.823 -0.752 . 0.0 OUTLIER . 5.0199999999999996 . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 4' ' ' ' G' . . . . . 0.539 ' N3 ' " H3'" ' B' ' 4' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.428 -0.727 0 O4'-C1'-C2' 108.248 1.32 . 0.0 OUTLIER . 2.6899999999999999 . . . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 5' ' ' ' U' . . . . . 0.507 ' H6 ' " O5'" ' B' ' 5' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.426 -0.902 0 C4'-C3'-C2' 104.113 1.413 . 0.091 1b . 1.9299999999999999 . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 6' ' ' ' G' . . . . . 0.591 ' O6 ' ' HD2' ' A' ' 36' ' ' LYS . . . . . . . . 0 O5'--C5' 1.426 -0.858 0 C3'-C2'-C1' 100.335 -1.294 . 0.776 4b . 2.3799999999999999 . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.426 -0.885 0 C3'-C2'-C1' 100.78 -0.8 . 0.0 OUTLIER . 4.1900000000000004 . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.897 0 N-CA-C 112.73 -0.148 . . . . 13.029999999999999 112.73 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.61 -36.17 62.94 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.767 0.654 . . . . 11.06 112.767 -173.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 24.3 ptm -131.77 172.88 11.76 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 121.137 -0.225 . . . . 9.8499999999999996 110.776 -175.663 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -151.88 -113.79 0.58 Allowed Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.988 -0.625 . . . . 6.6900000000000004 112.061 -177.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 51.1 m 69.01 103.33 0.06 Allowed 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 123.205 0.602 . . . . 5.5499999999999998 111.055 -177.718 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 15.6 mmt180 66.55 178.44 0.22 Allowed 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.582 -0.735 . . . . 3.8700000000000001 111.481 -178.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -151.47 130.44 12.55 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.813 -0.81 . . . . 3.5299999999999998 108.813 177.574 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.578 ' HA ' ' OG1' ' A' ' 35' ' ' THR . 79.3 p -100.22 -26.13 14.03 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.926 0.393 . . . . 1.6899999999999999 110.46 179.492 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 41.8 ttp -43.57 -54.52 4.87 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.808 -0.633 . . . . 1.49 111.987 178.382 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -93.71 23.8 4.51 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.924 0.712 . . . . 1.5 112.924 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.578 ' OG1' ' HA ' ' A' ' 32' ' ' THR . 70.5 p -149.49 19.45 0.93 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 118.726 0.693 . . . . 0.53000000000000003 110.338 -171.859 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.447 ' HB2' ' O ' ' A' ' 32' ' ' THR . 5.8 ttpm? -121.97 103.88 9.13 Favored 'General case' 0 CA--C 1.509 -0.608 0 C-N-CA 119.925 -0.71 . . . . 2.75 109.733 -167.284 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.574 HG23 HG13 ' A' ' 107' ' ' VAL . 65.2 mt -90.35 111.91 24.08 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 CA-C-N 115.403 -0.817 . . . . 0.84999999999999998 109.548 179.496 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.723 ' HB2' ' HB2' ' A' ' 110' ' ' ALA . 69.8 t80 -83.36 108.48 16.58 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 107.907 -1.146 . . . . 0.70999999999999996 107.907 175.27 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.418 ' HB ' HD21 ' A' ' 42' ' ' LEU . 4.1 t -95.85 87.94 1.96 Allowed 'Isoleucine or valine' 0 C--O 1.209 -1.046 0 CA-C-O 122.105 0.955 . . . . 0.92000000000000004 109.05 -177.048 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -68.3 147.28 47.17 Favored Glycine 0 C--N 1.305 -1.16 0 C-N-CA 119.359 -1.401 . . . . 0.83999999999999997 112.151 168.696 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.526 ' HA2' ' O4 ' ' B' ' 3' ' ' ' U' . . . 81.91 38.58 13.31 Favored Glycine 0 CA--C 1.523 0.546 0 C-N-CA 120.74 -0.743 . . . . 0.68000000000000005 114.773 170.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.815 HD11 HD21 ' A' ' 51' ' ' LEU . 2.8 mm? -72.49 143.63 85.47 Favored Pre-proline 0 CA--C 1.514 -0.438 0 CA-C-N 117.934 0.867 . . . . 1.28 110.802 172.754 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.558 ' HG2' ' HB3' ' A' ' 101' ' ' ASP . 75.4 Cg_exo -52.49 145.13 38.44 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 122.401 2.067 . . . . 0.57999999999999996 110.867 166.848 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.439 ' CE1' ' C5 ' ' B' ' 2' ' ' ' G' . 46.8 m-85 -60.46 -16.26 34.81 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 113.795 1.035 . . . . 1.05 113.795 -171.527 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 3.0 p-80 -111.2 18.24 19.52 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 119.674 -0.811 . . . . 2.0099999999999998 111.97 176.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.589 HG23 ' HB ' ' A' ' 50' ' ' THR . 91.7 m -78.22 107.13 10.59 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 118.971 -1.092 . . . . 0.71999999999999997 110.445 178.229 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 6.6 p -87.02 171.62 10.6 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 113.767 -1.56 . . . . 0.55000000000000004 113.849 170.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -55.16 -43.29 74.1 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 113.923 -1.49 . . . . 0.48999999999999999 110.19 -174.791 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.639 ' O ' ' HG2' ' A' ' 53' ' ' GLU . 60.0 pttt -54.86 -41.84 71.29 Favored 'General case' 0 C--O 1.224 -0.268 0 CA-C-N 115.165 -0.925 . . . . 2.7599999999999998 110.687 176.431 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.589 ' HB ' HG23 ' A' ' 46' ' ' THR . 11.2 m -61.8 -43.18 99.35 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.494 -0.321 . . . . 0.57999999999999996 110.823 -176.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.815 HD21 HD11 ' A' ' 42' ' ' LEU . 18.3 mt -69.94 -46.96 64.17 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.736 -0.385 . . . . 0.84999999999999998 111.318 178.442 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.446 ' HA ' HD12 ' A' ' 61' ' ' ILE . 57.9 t-80 -53.2 -55.52 23.63 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.899 0.381 . . . . 0.58999999999999997 111.314 176.59 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.639 ' HG2' ' O ' ' A' ' 49' ' ' LYS . 9.6 mm-40 -56.02 -52.81 62.9 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.805 -0.634 . . . . 1.52 111.301 179.641 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -53.05 -49.09 67.04 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 115.385 1.624 . . . . 1.1200000000000001 115.385 175.357 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.512 ' CE1' HD22 ' A' ' 51' ' ' LEU . 28.5 m-85 -81.62 -33.45 31.45 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 114.173 1.175 . . . . 0.56000000000000005 114.173 -165.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.55 ' N ' HD11 ' A' ' 61' ' ' ILE . 9.8 pt-20 -53.53 0.17 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 114.126 1.158 . . . . 1.5700000000000001 114.126 171.719 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.401 ' H ' ' C ' ' A' ' 55' ' ' PHE . 37.3 mt-30 -67.33 -34.98 78.47 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 116.105 -0.498 . . . . 2.1600000000000001 110.499 167.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -68.71 -54.09 18.24 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.146 -0.479 . . . . 0.70999999999999996 110.714 178.191 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -177.34 -82.06 0.06 OUTLIER Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 119.684 -1.246 . . . . 0.75 111.623 164.08 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.439 ' HB3' ' CB ' ' A' ' 84' ' ' LYS . 11.8 m-20 -115.36 106.91 14.56 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 111.536 0.199 . . . . 1.02 111.536 -178.075 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.55 HD11 ' N ' ' A' ' 56' ' ' GLU . 3.5 mt -84.07 146.95 6.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.099 -0.704 . . . . 0.46999999999999997 109.099 166.515 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.617 ' HB2' ' HA ' ' A' ' 84' ' ' LYS . 8.2 tp10 -102.64 -45.49 5.01 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.405 -0.591 . . . . 2.0699999999999998 109.405 177.349 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -157.49 123.87 4.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.634 -0.712 . . . . 2.48 109.802 179.556 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -115.7 141.13 48.49 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 120.929 0.395 . . . . 0.44 110.315 172.682 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.691 HG11 ' N2 ' ' B' ' 6' ' ' ' G' . 2.4 p -151.57 144.25 16.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.31 -0.859 . . . . 1.3799999999999999 109.907 -174.629 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 57.5 t -114.3 128.56 71.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 O-C-N 122.3 -0.25 . . . . 0.48999999999999999 110.558 176.315 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.524 HG22 ' HD3' ' A' ' 76' ' ' ARG . 31.7 mm -72.77 116.48 14.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.407 0.622 . . . . 0.71999999999999997 110.436 -179.602 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.56 ' HB ' ' O ' ' A' ' 73' ' ' GLN . 73.3 p -104.78 149.81 25.32 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.247 -0.888 . . . . 1.52 111.399 -175.175 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.535 ' O ' ' HA ' ' A' ' 73' ' ' GLN . 16.7 t70 -44.96 154.92 0.12 Allowed 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 115.205 -0.907 . . . . 2.4900000000000002 111.665 175.109 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 32.1 ttm180 -70.41 -47.9 58.64 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.489 -0.323 . . . . 6.0499999999999998 111.245 -173.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -92.44 -50.37 5.66 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 111.792 0.293 . . . . 4.0499999999999998 111.792 -171.41 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 82.4 p -90.8 -26.37 19.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.395 0.617 . . . . 3.0800000000000001 110.735 -176.278 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.56 ' O ' ' HB ' ' A' ' 68' ' ' THR . 31.9 mt-30 65.47 21.1 11.81 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 114.741 -1.118 . . . . 3.2999999999999998 112.933 178.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 50.3 mtmt -64.09 156.22 28.98 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.591 -0.522 . . . . 3.4900000000000002 109.591 164.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 44.7 m -68.26 103.67 1.65 Allowed 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.211 0.529 . . . . 1.8100000000000001 112.307 -174.465 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.635 ' HA ' " O5'" ' B' ' 1' ' ' ' G' . 66.4 mtp180 -48.92 -12.49 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 115.161 -0.927 . . . . 2.5600000000000001 113.33 171.159 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 92.96 2.99 66.12 Favored Glycine 0 N--CA 1.441 -0.977 0 C-N-CA 120.378 -0.915 . . . . 0.64000000000000001 112.426 178.245 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -114.56 136.91 52.51 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.504 -0.924 . . . . 1.1799999999999999 108.504 178.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -134.55 179.11 17.91 Favored Glycine 0 N--CA 1.435 -1.405 0 C-N-CA 119.574 -1.298 . . . . 0.58999999999999997 113.788 178.699 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.438 ' HB2' HG13 ' A' ' 65' ' ' VAL . 50.1 m-85 -144.71 124.04 13.04 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 113.787 -1.207 . . . . 0.63 110.124 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 53.0 t -127.79 106.98 15.69 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 CA-C-N 115.362 -0.835 . . . . 0.40999999999999998 109.355 175.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.509 ' HA ' ' O ' ' A' ' 35' ' ' THR . 70.5 m -94.86 132.09 40.05 Favored 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 108.759 -0.83 . . . . 0.46999999999999997 108.759 174.379 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' MET . . . . . 0.425 ' HA ' ' HA ' ' A' ' 61' ' ' ILE . 26.5 mtp -99.96 156.26 17.25 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 109.132 -0.692 . . . . 0.88 109.132 -176.459 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.617 ' HA ' ' HB2' ' A' ' 62' ' ' GLU . 18.1 ttmt -60.22 -49.8 76.19 Favored 'General case' 0 C--N 1.327 -0.379 0 O-C-N 123.421 0.45 . . . . 1.9199999999999999 110.554 -170.569 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -129.52 148.03 51.38 Favored 'General case' 0 C--O 1.245 0.864 0 CA-C-O 122.121 0.962 . . . . 1.6799999999999999 111.926 166.171 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.575 ' O ' ' HG3' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -47.67 -24.61 0.96 Allowed 'General case' 0 C--O 1.214 -0.808 0 CA-C-N 113.708 -1.587 . . . . 3.6600000000000001 114.096 176.685 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -58.0 -44.76 87.38 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 119.502 1.047 . . . . 0.66000000000000003 111.483 175.333 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 49.9 m -71.96 -38.88 69.69 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.577 -0.449 . . . . 0.78000000000000003 109.863 177.205 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.463 ' HB3' ' HA ' ' A' ' 86' ' ' ARG . . . -56.61 -28.89 61.41 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.916 -0.584 . . . . 0.46000000000000002 111.789 173.834 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.575 ' HG3' ' O ' ' A' ' 86' ' ' ARG . 22.1 mt-10 -72.85 -43.97 61.96 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.471 0.653 . . . . 2.1099999999999999 109.316 -179.686 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.434 ' O ' ' HG3' ' A' ' 94' ' ' LYS . 97.3 mtt180 -55.22 -41.93 72.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.983 -1.008 . . . . 3.8199999999999998 111.254 176.036 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -69.36 -47.05 65.51 Favored 'General case' 0 C--O 1.219 -0.54 0 C-N-CA 120.971 -0.292 . . . . 0.92000000000000004 111.533 174.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 48.4 t -48.5 -44.41 35.96 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 113.112 0.782 . . . . 1.1599999999999999 113.112 177.381 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.54 ' HE2' ' HB2' ' A' ' 95' ' ' ASP . 0.0 OUTLIER -60.44 -22.89 63.95 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 118.314 0.506 . . . . 4.2000000000000002 111.661 176.57 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.54 ' HB2' ' HE2' ' A' ' 94' ' ' LYS . 10.3 t70 -99.65 100.72 11.51 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 115.48 -0.782 . . . . 2.2400000000000002 110.274 -177.529 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.425 ' HD3' ' O ' ' A' ' 94' ' ' LYS . 55.8 Cg_endo -90.72 113.78 0.44 Allowed 'Trans proline' 0 N--CA 1.451 -0.994 0 C-N-CA 123.113 2.542 . . . . 2.3799999999999999 113.921 -171.697 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.543 ' HB3' ' HD2' ' A' ' 104' ' ' LYS . 1.0 OUTLIER 70.18 92.42 0.06 OUTLIER Pre-proline 0 N--CA 1.467 0.388 0 CA-C-N 114.495 -1.23 . . . . 3.0299999999999998 111.464 175.978 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.626 ' O ' ' HA ' ' A' ' 104' ' ' LYS . 73.4 Cg_endo -82.3 168.75 14.71 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 123.843 3.029 . . . . 1.29 113.926 -175.303 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 48.6 mm -102.22 118.07 48.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 CA-C-N 114.1 -1.409 . . . . 1.8100000000000001 108.737 178.057 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 70.9 mt -137.65 124.16 27.79 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.233 0 N-CA-C 110.462 -0.199 . . . . 0.98999999999999999 110.462 -167.268 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.558 ' HB3' ' HG2' ' A' ' 43' ' ' PRO . 37.9 t70 44.51 48.15 8.38 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-O 121.288 0.566 . . . . 1.3700000000000001 111.25 -179.219 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 77.0 2.3 77.15 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 115.478 0.951 . . . . 1.5600000000000001 115.478 179.682 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 13.0 tpt180 -141.92 130.52 22.66 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 118.487 1.143 . . . . 4.1299999999999999 112.01 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.626 ' HA ' ' O ' ' A' ' 98' ' ' PRO . 16.8 ttpp -60.1 141.93 55.0 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.388 -0.369 . . . . 2.73 111.527 172.376 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.461 ' O ' ' HD2' ' A' ' 98' ' ' PRO . . . -124.32 167.78 13.88 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 109.035 -0.728 . . . . 1.04 109.035 177.822 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -97.7 106.93 19.32 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 122.133 0.968 . . . . 2.04 111.838 -178.166 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.574 HG13 HG23 ' A' ' 37' ' ' ILE . 24.6 t -96.48 113.95 32.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 113.517 -1.674 . . . . 1.0600000000000001 112.104 172.567 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -134.36 144.34 48.17 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 114.497 -1.228 . . . . 2.4900000000000002 108.882 172.278 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.482 HD12 ' CD1' ' A' ' 111' ' ' TYR . 0.1 OUTLIER -68.86 93.3 0.54 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.878 0.371 . . . . 1.23 110.384 177.782 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ALA . . . . . 0.723 ' HB2' ' HB2' ' A' ' 38' ' ' PHE . . . -36.42 -19.12 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 118.223 2.675 . . . . 0.91000000000000003 118.223 177.296 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.482 ' CD1' HD12 ' A' ' 109' ' ' LEU . 0.3 OUTLIER -71.16 -9.57 58.31 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 121.534 1.97 . . . . 1.3999999999999999 109.99 175.29 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 60.5 mt -84.98 3.52 38.03 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.687 0.795 . . . . 1.97 110.222 172.254 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.517 ' HA3' ' N3 ' ' B' ' 5' ' ' ' U' . . . -138.14 -22.87 0.43 Allowed Glycine 0 N--CA 1.453 -0.168 0 CA-C-N 115.133 -0.94 . . . . 2.1400000000000001 111.458 -172.85 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.511 ' O ' ' HD3' ' A' ' 116' ' ' PRO . . . -60.81 161.91 7.45 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 123.182 0.593 . . . . 2.6600000000000001 110.247 172.419 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.444 ' HD2' ' N ' ' A' ' 115' ' ' LYS . 12.6 mptt -114.14 75.64 3.2 Favored Pre-proline 0 C--N 1.324 -0.533 0 N-CA-C 110.05 -0.352 . . . . 4.1600000000000001 110.05 -179.606 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.511 ' HD3' ' O ' ' A' ' 114' ' ' ALA . 49.1 Cg_endo -90.03 -42.4 0.04 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.572 2.181 . . . . 5.5300000000000002 112.671 -178.726 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 28.2 ptt180 -124.87 6.45 8.05 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.082 -0.508 . . . . 8.5999999999999996 110.239 -176.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 10.2 t -150.49 156.34 41.24 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.71 0.291 . . . . 6.3700000000000001 111.294 -172.2 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -134.74 122.25 21.9 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.95 -0.759 . . . . 7.8499999999999996 108.95 173.451 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 16.4 t -106.74 -10.08 10.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.22 0.533 . . . . 9.3699999999999992 111.027 -173.592 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.238 -0.887 . . . . 12.279999999999999 111.243 -171.51 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 1' ' ' ' G' . . . . . 0.635 " O5'" ' HA ' ' A' ' 76' ' ' ARG . . . . . . . . 0 O5'--C5' 1.431 -0.586 0 C3'-C2'-C1' 99.518 -2.202 . 0.0 '__' . 4.9400000000000004 . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 2' ' ' ' G' . . . . . 0.451 ' C4 ' ' C4 ' ' B' ' 3' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.429 -0.69 0 C3'-C2'-C1' 99.624 -2.084 . 0.0 OUTLIER gamma 4.8700000000000001 . . . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 3' ' ' ' U' . . . . . 0.526 ' O4 ' ' HA2' ' A' ' 41' ' ' GLY . . . . . . . . 0 O5'--C5' 1.427 -0.81 0 C3'-C2'-C1' 100.156 -1.493 . 0.0 OUTLIER . 5.0199999999999996 . . . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 4' ' ' ' G' . . . . . 0.47 ' N3 ' " H3'" ' B' ' 4' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.424 -1.029 0 O4'-C1'-C2' 108.107 1.219 . 0.0 OUTLIER . 2.6899999999999999 . . . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 5' ' ' ' U' . . . . . 0.517 ' N3 ' ' HA3' ' A' ' 113' ' ' GLY . . . . . . . . 0 O5'--C5' 1.427 -0.843 0 C3'-C2'-C1' 100.367 -1.259 . 0.0 OUTLIER '7D dist 1b' 1.9299999999999999 . . . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 6' ' ' ' G' . . . . . 0.691 ' N2 ' HG11 ' A' ' 65' ' ' VAL . . . . . . . . 0 O5'--C5' 1.425 -0.913 0 C3'-C2'-C1' 99.566 -2.149 . 0.0 OUTLIER gamma 2.3799999999999999 . . . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 7' ' ' ' C' . . . . . 0.519 " C5'" HH12 ' A' ' 76' ' ' ARG . . . . . . . . 0 O5'--C5' 1.424 -0.991 0 C4'-C3'-C2' 105.486 2.786 . 0.0 OUTLIER gamma 4.1900000000000004 . . . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.733 0 N-CA-C 111.8 -0.52 . . . . 13.029999999999999 111.8 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.928 ' HB3' ' HA ' ' A' ' 90' ' ' GLU . . . -111.59 136.74 50.38 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.603 0.716 . . . . 11.06 111.195 -178.629 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' MET . . . . . 0.856 ' HB3' ' HA ' ' A' ' 34' ' ' PHE . 37.8 mtt -147.46 -130.38 0.06 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.812 -1.085 . . . . 9.8499999999999996 108.902 -172.245 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.876 ' HA3' ' H ' ' A' ' 36' ' ' LYS . . . -173.92 -135.32 2.0 Favored Glycine 0 C--O 1.212 -1.278 0 C-N-CA 119.19 -1.481 . . . . 6.6900000000000004 115.406 -178.822 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.97 ' H ' ' HB3' ' A' ' 36' ' ' LYS . 21.4 t 178.72 104.25 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.462 0.705 . . . . 5.5499999999999998 111.48 175.379 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.487 ' HG2' ' HG3' ' A' ' 36' ' ' LYS . 0.0 OUTLIER 166.19 -154.04 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.959 1.304 . . . . 3.8700000000000001 107.582 172.787 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -47.28 -51.75 18.16 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 108.48 -0.933 . . . . 3.5299999999999998 108.48 168.103 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.725 ' HB ' ' OG1' ' A' ' 35' ' ' THR . 7.8 p -81.56 94.32 6.87 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 114.96 -1.018 . . . . 1.6899999999999999 109.879 165.448 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 43.0 ttp -74.14 -50.96 17.09 Favored 'General case' 0 C--O 1.197 -1.699 0 CA-C-N 114.285 -1.325 . . . . 1.49 109.497 -175.424 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' PHE . . . . . 0.856 ' HA ' ' HB3' ' A' ' 27' ' ' MET . 15.4 m-30 -92.22 42.19 1.09 Allowed 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 115.43 1.641 . . . . 1.5 115.43 175.559 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.725 ' OG1' ' HB ' ' A' ' 32' ' ' THR . 16.2 p -147.89 20.06 1.13 Allowed 'General case' 0 N--CA 1.485 1.314 0 CA-C-N 122.219 2.282 . . . . 0.53000000000000003 110.821 177.474 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.97 ' HB3' ' H ' ' A' ' 29' ' ' SER . 3.1 tmtm? -129.58 100.85 5.68 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-O 122.351 1.072 . . . . 2.75 110.753 -160.84 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 43.1 mt -88.48 142.35 13.03 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 O-C-N 121.677 -0.639 . . . . 0.84999999999999998 111.894 -170.785 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.45 ' HB3' ' O ' ' A' ' 108' ' ' ASN . 49.3 t80 -102.17 128.12 48.81 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.348 -0.982 . . . . 0.70999999999999996 108.348 169.39 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.7 t -120.98 89.09 1.35 Allowed 'Isoleucine or valine' 0 C--O 1.217 -0.652 0 C-N-CA 119.995 -0.682 . . . . 0.92000000000000004 110.128 -176.778 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -59.14 154.67 28.65 Favored Glycine 0 C--O 1.221 -0.663 0 C-N-CA 118.113 -1.994 . . . . 0.83999999999999997 114.513 165.695 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 96.15 39.16 4.35 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 121.105 -0.569 . . . . 0.68000000000000005 114.189 170.417 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.675 HD12 HG21 ' A' ' 46' ' ' THR . 2.9 mm? -93.68 125.24 54.3 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 117.122 0.461 . . . . 1.28 109.96 173.381 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.601 ' HA ' ' H1 ' ' B' ' 2' ' ' ' G' . 50.0 Cg_exo -49.08 155.88 2.58 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.779 2.319 . . . . 0.57999999999999996 111.953 171.406 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -69.42 -3.4 14.2 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.433 0.531 . . . . 1.05 112.433 -173.029 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -110.05 -8.95 14.75 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 120.545 0.212 . . . . 2.0099999999999998 111.016 179.028 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.675 HG21 HD12 ' A' ' 42' ' ' LEU . 30.0 m -62.69 133.68 55.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.952 0.406 . . . . 0.71999999999999997 111.156 -173.609 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 12.0 p -107.63 158.38 17.3 Favored 'General case' 0 C--O 1.251 1.183 0 CA-C-O 121.856 0.836 . . . . 0.55000000000000004 112.06 -177.648 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.518 ' HA ' HG23 ' A' ' 66' ' ' VAL . 2.6 m-20 -49.99 -30.93 11.5 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 114.323 -1.308 . . . . 0.48999999999999999 111.122 177.411 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.573 ' O ' ' HG2' ' A' ' 53' ' ' GLU . 60.6 pttt -78.77 -29.26 44.93 Favored 'General case' 0 C--O 1.215 -0.746 0 N-CA-C 108.799 -0.815 . . . . 2.7599999999999998 108.799 -174.849 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.576 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 7.0 m -64.91 -41.75 95.31 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 115.764 -0.653 . . . . 0.57999999999999996 110.068 179.299 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.591 HD21 HD11 ' A' ' 42' ' ' LEU . 18.8 mt -62.05 -46.2 90.18 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 119.361 -0.935 . . . . 0.84999999999999998 110.083 173.854 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' HIS . . . . . 0.535 ' HA ' ' CD1' ' A' ' 61' ' ' ILE . 59.6 t-80 -53.58 -32.39 50.77 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 116.27 -0.423 . . . . 0.58999999999999997 110.911 172.474 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.576 ' HB2' ' O ' ' A' ' 50' ' ' THR . 45.2 mm-40 -68.05 -40.05 82.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.314 -0.857 . . . . 1.52 109.489 -175.664 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' TYR . . . . . 0.541 ' O ' ' HB2' ' A' ' 57' ' ' GLN . 24.4 t80 -80.75 -40.82 24.55 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.421 -0.809 . . . . 1.1200000000000001 111.499 -173.741 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.598 ' C ' ' H ' ' A' ' 57' ' ' GLN . 58.2 m-85 -85.56 -32.03 22.35 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 114.005 1.113 . . . . 0.56000000000000005 114.005 -166.21 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.659 ' N ' HD11 ' A' ' 61' ' ' ILE . 15.7 pt-20 -63.28 4.13 0.24 Allowed 'General case' 0 N--CA 1.48 1.061 0 CA-C-O 122.168 0.985 . . . . 1.5700000000000001 111.145 176.805 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.598 ' H ' ' C ' ' A' ' 55' ' ' PHE . 37.5 mt-30 -92.32 -18.11 23.79 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 113.753 -1.567 . . . . 2.1600000000000001 110.73 -176.259 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -102.62 -29.43 11.55 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.506 0.67 . . . . 0.70999999999999996 109.692 177.246 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.413 ' O ' ' HA ' ' A' ' 56' ' ' GLU . . . 178.46 -174.6 46.81 Favored Glycine 0 N--CA 1.443 -0.861 0 N-CA-C 110.255 -1.138 . . . . 0.75 110.255 -177.754 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -64.0 137.34 57.95 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 117.388 0.594 . . . . 1.02 110.492 175.409 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.659 HD11 ' N ' ' A' ' 56' ' ' GLU . 7.5 mt -101.91 142.42 16.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 105.692 -1.966 . . . . 0.46999999999999997 105.692 172.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.475 ' OE1' ' HE3' ' A' ' 84' ' ' LYS . 7.7 tp10 -88.75 -37.13 15.71 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 119.61 1.096 . . . . 2.0699999999999998 109.155 178.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -166.24 127.44 1.78 Allowed 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.063 -0.517 . . . . 2.48 110.792 177.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -115.01 134.33 55.28 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.1 0.476 . . . . 0.44 110.753 174.615 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.582 HG11 ' N2 ' ' B' ' 6' ' ' ' G' . 2.9 p -147.32 136.71 16.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.248 -0.887 . . . . 1.3799999999999999 111.231 -174.61 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.518 HG23 ' HA ' ' A' ' 48' ' ' ASP . 78.4 t -107.36 131.37 57.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 109.043 -0.725 . . . . 0.48999999999999999 109.043 176.317 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 49.0 mm -88.23 139.47 17.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-O 121.867 0.841 . . . . 0.71999999999999997 112.625 -168.392 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.687 ' O ' ' HD2' ' A' ' 76' ' ' ARG . 34.4 p -118.34 -178.76 3.59 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 105.994 -1.854 . . . . 1.52 105.994 172.196 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.573 ' HB3' ' N ' ' A' ' 73' ' ' GLN . 37.6 t70 -95.47 158.75 15.32 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 105.874 -1.899 . . . . 2.4900000000000002 105.874 -171.699 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 3.4 tpp180 -77.26 -55.62 5.26 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 120.224 1.375 . . . . 6.0499999999999998 110.216 -179.443 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -71.25 -55.2 8.57 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 113.115 0.783 . . . . 4.0499999999999998 113.115 178.117 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 60.3 p -91.22 -23.58 20.16 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.924 0.392 . . . . 3.0800000000000001 111.803 -172.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.573 ' N ' ' HB3' ' A' ' 69' ' ' ASP . 50.0 mt-30 59.12 15.21 3.94 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 113.562 0.949 . . . . 3.2999999999999998 113.562 179.047 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.432 ' HB3' ' N1 ' ' B' ' 1' ' ' ' G' . 67.4 mttm -53.93 145.86 15.5 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 110.099 -0.334 . . . . 3.4900000000000002 110.099 166.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 2.8 m -59.8 107.82 0.66 Allowed 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.975 -0.75 . . . . 1.8100000000000001 108.975 173.063 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.687 ' HD2' ' O ' ' A' ' 68' ' ' THR . 15.1 mtt180 -72.45 -10.62 60.02 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.188 -0.46 . . . . 2.5600000000000001 112.042 -172.452 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 73.29 8.71 75.75 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.56 -0.828 . . . . 0.64000000000000001 112.059 176.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.509 ' CD2' ' HB3' ' A' ' 76' ' ' ARG . 9.9 m-85 -111.18 141.62 44.46 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.44 -0.948 . . . . 1.1799999999999999 108.44 178.401 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -126.96 164.76 20.43 Favored Glycine 0 N--CA 1.439 -1.157 0 C-N-CA 120.274 -0.965 . . . . 0.58999999999999997 112.214 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.637 ' HD1' ' HE3' ' A' ' 36' ' ' LYS . 51.0 m-85 -139.44 123.12 17.46 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.25 0.547 . . . . 0.63 109.621 178.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.496 HG11 ' CD2' ' A' ' 55' ' ' PHE . 54.0 t -125.27 108.14 19.3 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 115.626 -0.715 . . . . 0.40999999999999998 110.184 -178.483 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.451 ' HA ' ' HA ' ' A' ' 36' ' ' LYS . 18.5 m -92.83 118.03 30.67 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 109.128 -0.693 . . . . 0.46999999999999997 109.128 178.022 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 80.3 mmm -85.91 -179.95 6.9 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.244 0.545 . . . . 0.88 110.326 178.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.475 ' HE3' ' OE1' ' A' ' 62' ' ' GLU . 6.4 tptm -93.99 -7.38 42.99 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.345 -0.843 . . . . 1.9199999999999999 109.156 -171.671 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -167.28 154.17 8.48 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 114.672 -1.149 . . . . 1.6799999999999999 110.12 -162.217 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.501 ' HB2' ' O ' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -76.17 -49.49 17.11 Favored 'General case' 0 C--O 1.223 -0.341 0 N-CA-C 109.764 -0.458 . . . . 3.6600000000000001 109.764 -174.258 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -51.69 -39.34 58.12 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.511 -0.768 . . . . 0.66000000000000003 112.22 176.321 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.663 ' HA ' ' HE ' ' A' ' 91' ' ' ARG . 14.6 m -69.17 -40.54 78.06 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.838 0.351 . . . . 0.78000000000000003 110.825 176.72 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -55.31 -46.08 76.29 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.049 -0.523 . . . . 0.46000000000000002 110.525 170.767 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.928 ' HA ' ' HB3' ' A' ' 26' ' ' ALA . 4.1 mt-10 -60.34 -41.27 93.25 Favored 'General case' 0 C--O 1.222 -0.364 0 CA-C-O 121.268 0.556 . . . . 2.1099999999999999 110.464 174.463 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.663 ' HE ' ' HA ' ' A' ' 88' ' ' SER . 16.4 mtm180 -56.72 -50.92 70.76 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 114.713 -1.13 . . . . 3.8199999999999998 111.641 176.728 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -59.96 -27.31 66.7 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 113.837 1.051 . . . . 0.92000000000000004 113.837 173.748 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 44.7 t -79.97 -36.1 36.58 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.943 0.878 . . . . 1.1599999999999999 109.097 179.404 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.576 ' HB3' ' O ' ' A' ' 91' ' ' ARG . 59.8 tptt -50.4 -18.8 0.69 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 113.675 -1.602 . . . . 4.2000000000000002 112.511 170.01 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -104.52 89.15 2.51 Favored Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 109.118 -0.697 . . . . 2.2400000000000002 109.118 166.015 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.575 ' HD3' ' O ' ' A' ' 94' ' ' LYS . 5.6 Cg_exo -73.67 173.77 13.36 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.923 2.415 . . . . 2.3799999999999999 111.138 -177.887 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 8.6 p30 5.92 67.74 0.05 OUTLIER Pre-proline 0 N--CA 1.479 1.014 0 O-C-N 124.2 0.937 . . . . 3.0299999999999998 113.417 -160.71 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -69.13 133.39 26.59 Favored 'Trans proline' 0 CA--C 1.511 -0.644 0 C-N-CA 121.723 1.615 . . . . 1.29 108.962 177.725 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.569 HG22 ' C ' ' A' ' 102' ' ' GLY . 17.2 mm -87.1 95.92 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.893 0 CA-C-N 119.307 0.958 . . . . 1.8100000000000001 108.671 -172.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.441 ' C ' ' N ' ' A' ' 102' ' ' GLY . 11.2 mm -89.54 150.02 3.85 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.422 0 CA-C-O 121.461 0.648 . . . . 0.98999999999999999 111.734 -170.683 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.545 ' HB3' ' HG2' ' A' ' 43' ' ' PRO . 30.5 t70 36.24 20.65 0.0 OUTLIER 'General case' 0 CA--C 1.559 1.306 0 CA-C-N 113.898 -1.501 . . . . 1.3700000000000001 111.916 -156.708 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.569 ' C ' HG22 ' A' ' 99' ' ' ILE . . . 89.18 17.31 56.03 Favored Glycine 0 CA--C 1.535 1.31 0 C-N-CA 120.852 -0.69 . . . . 1.5600000000000001 113.131 -179.546 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.487 ' N ' HG22 ' A' ' 99' ' ' ILE . 39.5 mmt180 -132.38 140.73 48.6 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.548 0.739 . . . . 4.1299999999999999 110.035 176.18 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -58.58 112.68 1.69 Allowed 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 113.74 1.015 . . . . 2.73 113.74 -171.566 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -92.34 164.83 13.36 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 114.752 -1.113 . . . . 1.04 112.993 177.581 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -123.52 113.46 18.75 Favored 'General case' 0 C--O 1.253 1.27 0 CA-C-N 115.098 -0.956 . . . . 2.04 110.245 177.763 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 51.0 t -98.18 127.77 50.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 114.63 -1.168 . . . . 1.0600000000000001 111.444 -173.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ASN . . . . . 0.45 ' O ' ' HB3' ' A' ' 38' ' ' PHE . 66.5 t30 -157.39 152.75 26.23 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.517 -0.765 . . . . 2.4900000000000002 109.909 178.532 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.823 HD13 ' HB2' ' A' ' 27' ' ' MET . 7.7 mt -65.97 125.93 26.98 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 113.539 0.94 . . . . 1.23 113.539 -177.627 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -45.92 -44.49 14.71 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 113.944 -1.48 . . . . 0.91000000000000003 113.217 172.521 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.707 ' HB3' ' O ' ' A' ' 28' ' ' GLY . 0.1 OUTLIER -75.74 -6.42 50.51 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 121.866 -0.521 . . . . 1.3999999999999999 111.418 -173.835 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 94.4 mt -86.1 -37.78 18.47 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.949 0.404 . . . . 1.97 110.715 174.407 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -87.69 -15.59 61.36 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.852 -0.689 . . . . 2.1400000000000001 112.786 -179.208 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.41 ' O ' ' HD3' ' A' ' 116' ' ' PRO . . . -67.11 154.61 40.82 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.992 -0.373 . . . . 2.6600000000000001 109.992 -179.28 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.486 ' HD3' ' HA ' ' A' ' 119' ' ' ASN . 65.5 mttm -120.14 88.87 42.05 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-O 120.83 0.348 . . . . 4.1600000000000001 111.158 -175.144 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.41 ' HD3' ' O ' ' A' ' 114' ' ' ALA . 1.2 Cg_endo -86.05 -39.66 0.08 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 122.822 2.348 . . . . 5.5300000000000002 111.204 175.781 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 13.6 ptp180 -127.63 -21.7 3.73 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.93 -0.577 . . . . 8.5999999999999996 111.626 -176.675 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 3.5 t -110.18 99.98 8.96 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.284 0.564 . . . . 6.3700000000000001 110.633 -177.305 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.486 ' HA ' ' HD3' ' A' ' 115' ' ' LYS . 24.7 p-10 -99.61 -36.93 9.35 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.75 -0.659 . . . . 7.8499999999999996 110.75 179.049 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 46.3 t 62.53 82.25 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 115.728 -0.669 . . . . 9.3699999999999992 110.557 -176.486 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.424 ' HG2' ' OXT' ' A' ' 121' ' ' GLN . 19.1 pm0 . . . . . 0 C--O 1.247 0.959 0 CA-C-N 115.364 -0.835 . . . . 12.279999999999999 110.495 -179.244 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 1' ' ' ' G' . . . . . 0.432 ' N1 ' ' HB3' ' A' ' 74' ' ' LYS . . . . . . . . 0 O5'--C5' 1.434 -0.396 0 C3'-C2'-C1' 99.737 -1.959 . 0.0 '__' . 4.9400000000000004 . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 2' ' ' ' G' . . . . . 0.601 ' H1 ' ' HA ' ' A' ' 43' ' ' PRO . . . . . . . . 0 O5'--C5' 1.426 -0.856 0 C3'-C2'-C1' 99.998 -1.669 . 0.0 OUTLIER . 4.8700000000000001 . . . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 3' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.426 -0.885 0 C4'-C3'-C2' 104.15 1.45 . 0.0 OUTLIER . 5.0199999999999996 . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 4' ' ' ' G' . . . . . 0.618 ' N3 ' " H3'" ' B' ' 4' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.428 -0.762 0 O4'-C4'-C3' 103.844 -1.183 . 0.0 OUTLIER . 2.6899999999999999 . . . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 5' ' ' ' U' . . . . . 0.614 " H5'" " O2'" ' B' ' 4' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.425 -0.926 0 C4'-C3'-C2' 104.423 1.723 . 0.495 1b . 1.9299999999999999 . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 6' ' ' ' G' . . . . . 0.582 ' N2 ' HG11 ' A' ' 65' ' ' VAL . . . . . . . . 0 O5'--C5' 1.424 -1.005 0 C4'-C3'-C2' 103.628 0.928 . 0.0 OUTLIER . 2.3799999999999999 . . . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.428 -0.729 0 O4'-C1'-C2' 107.996 1.14 . 0.0 OUTLIER . 4.1900000000000004 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 51.9 ttp . . . . . 0 C--O 1.233 0.197 0 N-CA-C 112.043 0.386 . . . . 1.49 112.043 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.474 ' HB3' ' HG3' ' A' ' 86' ' ' ARG . 8.9 m-85 -91.76 -2.34 56.99 Favored 'General case' 0 C--N 1.331 -0.212 0 O-C-N 122.226 -0.296 . . . . 1.5 111.63 -176.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.581 ' O ' ' HA ' ' A' ' 82' ' ' THR . 41.1 p -110.68 -3.49 15.82 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.877 -0.329 . . . . 0.53 111.447 -178.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 63.2 tttm -85.64 103.24 14.28 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.97 -0.559 . . . . 2.75 110.207 -176.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 98.7 mt -105.57 141.71 20.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 C-N-CA 123.108 0.563 . . . . 0.85 111.577 -173.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.401 ' HD1' ' CE1' ' A' ' 80' ' ' PHE . 58.9 t80 -95.79 132.41 41.06 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.645 -0.707 . . . . 0.71 109.505 174.007 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.788 HG12 HD11 ' A' ' 42' ' ' LEU . 3.6 t -120.96 141.92 39.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 121.082 0.468 . . . . 0.92 110.314 -178.313 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.591 ' HA3' ' HB2' ' A' ' 106' ' ' ASN . . . -141.95 159.52 26.98 Favored Glycine 0 C--O 1.219 -0.807 0 CA-C-N 115.72 -0.673 . . . . 0.84 112.735 -167.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.77 37.38 93.38 Favored Glycine 0 CA--C 1.522 0.503 0 C-N-CA 121.374 -0.441 . . . . 0.68 113.817 172.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.788 HD11 HG12 ' A' ' 39' ' ' VAL . 8.2 mp -87.54 134.0 36.93 Favored Pre-proline 0 C--N 1.326 -0.418 0 O-C-N 122.694 -0.298 . . . . 1.28 110.626 178.332 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.622 ' HD2' ' OG1' ' A' ' 46' ' ' THR . 51.5 Cg_exo -53.33 155.89 11.7 Favored 'Trans proline' 0 N--CA 1.463 -0.282 0 C-N-CA 122.995 2.463 . . . . 0.58 112.101 175.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -69.09 1.87 3.22 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.129 0.49 . . . . 1.05 110.963 -179.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . 0.423 ' HD2' ' OD2' ' A' ' 101' ' ' ASP . 19.5 t60 -106.88 -16.46 14.46 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.747 -0.66 . . . . 2.01 110.627 178.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.796 HG23 HG21 ' A' ' 50' ' ' THR . 61.2 m -71.77 138.54 48.49 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.257 -0.428 . . . . 0.72 111.467 -175.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 16.9 p -130.96 -178.35 4.78 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-O 120.967 0.413 . . . . 0.55 111.391 -176.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -62.74 -33.52 75.32 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.969 -0.56 . . . . 0.49 110.756 -176.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -71.39 -33.93 69.94 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.286 -0.635 . . . . 2.76 109.286 -179.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.796 HG21 HG23 ' A' ' 46' ' ' THR . 81.2 m -61.24 -45.29 95.16 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.57 -0.741 . . . . 0.58 110.686 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 54.0 mt -67.57 -35.33 78.82 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.928 -0.578 . . . . 0.85 111.089 178.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 57.7 t-80 -61.89 -54.02 47.78 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.25 -0.648 . . . . 0.59 109.25 176.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -58.66 -37.4 75.89 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.826 -0.624 . . . . 1.52 112.005 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -76.87 -37.59 55.24 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 120.789 0.328 . . . . 1.12 111.714 -178.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -85.22 -25.23 27.45 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 113.402 0.89 . . . . 0.56 113.402 -174.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.66 ' N ' HD11 ' A' ' 61' ' ' ILE . 10.8 pt-20 -64.52 -18.14 64.55 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.642 0.734 . . . . 1.57 109.984 179.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -55.45 -27.66 49.54 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.542 -1.208 . . . . 2.16 111.755 170.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -96.06 -21.28 18.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.546 -0.297 . . . . 0.71 110.802 -178.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 151.25 -159.74 28.35 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.565 -0.826 . . . . 0.75 112.419 177.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -65.9 121.94 16.21 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.028 0.442 . . . . 1.02 111.671 -178.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.66 HD11 ' N ' ' A' ' 56' ' ' GLU . 12.5 mt -101.41 130.74 50.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 109.235 -0.654 . . . . 0.47 109.235 176.023 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -85.32 -53.37 5.27 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 121.181 -0.208 . . . . 2.07 111.33 176.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -140.28 129.59 23.85 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.711 -0.222 . . . . 2.48 111.223 -175.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -121.6 116.92 25.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.186 0.517 . . . . 0.44 111.056 174.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.416 HG23 ' HB2' ' A' ' 80' ' ' PHE . 30.3 m -128.64 145.43 35.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.454 -0.794 . . . . 1.38 112.123 -179.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 91.3 t -116.76 133.73 62.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.525 -0.761 . . . . 0.49 110.734 174.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 36.8 mm -76.92 152.5 5.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.715 -0.675 . . . . 0.72 109.524 177.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 39.5 p . . . . . 0 N--CA 1.444 -0.773 0 N-CA-C 105.407 -2.072 . . . . 1.52 105.407 -174.21 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 6.3 m . . . . . 0 CA--C 1.534 0.354 0 CA-C-O 120.732 0.301 . . . . 1.81 110.792 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 73.7 mtp180 -58.51 -29.55 66.37 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.769 -0.65 . . . . 2.56 111.191 179.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 93.37 30.37 9.28 Favored Glycine 0 N--CA 1.439 -1.109 0 C-N-CA 120.506 -0.854 . . . . 0.64 112.18 -177.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -131.49 141.83 49.84 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 107.921 -1.14 . . . . 1.18 107.921 175.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -141.72 -171.75 13.04 Favored Glycine 0 N--CA 1.439 -1.142 0 C-N-CA 120.089 -1.053 . . . . 0.59 111.782 -174.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.416 ' HB2' HG23 ' A' ' 65' ' ' VAL . 55.4 m-85 -154.91 124.6 6.52 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.582 -0.896 . . . . 0.63 108.582 -177.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.475 HG23 HG21 ' A' ' 39' ' ' VAL . 53.8 t -119.58 124.14 72.37 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 CA-C-N 115.742 -0.663 . . . . 0.41 110.133 -177.149 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.581 ' HA ' ' O ' ' A' ' 35' ' ' THR . 17.3 m -109.41 116.33 31.62 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 107.948 -1.13 . . . . 0.47 107.948 175.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 92.5 mmm -87.72 162.69 16.92 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.098 -0.705 . . . . 0.88 109.098 -175.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 44.8 tttm -85.04 -10.47 56.9 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 120.873 0.368 . . . . 1.92 110.997 -175.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -149.5 147.78 28.62 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-N 116.377 -0.374 . . . . 1.68 110.562 175.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.483 ' O ' ' HB3' ' A' ' 89' ' ' ALA . 1.3 tmt_? -67.49 -22.72 65.45 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 112.255 0.465 . . . . 3.66 112.255 -176.318 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.05 -47.27 77.95 Favored 'General case' 0 N--CA 1.464 0.239 0 O-C-N 121.519 -0.738 . . . . 0.66 111.285 178.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 19.1 m -65.92 -31.13 71.88 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.605 0.717 . . . . 0.78 109.754 175.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.483 ' HB3' ' O ' ' A' ' 86' ' ' ARG . . . -59.32 -48.97 79.62 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.123 -1.398 . . . . 0.46 109.818 174.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -55.87 -51.68 66.71 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.203 -0.453 . . . . 2.11 111.654 174.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.483 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 23.7 mmt180 -57.78 -45.39 86.07 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.315 -0.402 . . . . 3.82 111.198 -178.026 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -58.66 -48.12 82.14 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.09 -0.505 . . . . 0.92 111.147 176.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 49.2 t -75.46 -2.97 31.25 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 111.945 0.35 . . . . 1.16 111.945 -176.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.483 ' HB2' ' O ' ' A' ' 91' ' ' ARG . 4.5 mmmm -59.95 -48.74 80.45 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 121.044 -0.262 . . . . 4.2 111.463 176.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.439 ' HA ' ' HD3' ' A' ' 96' ' ' PRO . 32.5 t0 -106.39 107.57 60.21 Favored Pre-proline 0 C--N 1.328 -0.365 0 N-CA-C 109.931 -0.396 . . . . 2.24 109.931 179.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 95' ' ' ASP . 6.9 Cg_exo -74.48 -10.32 22.03 Favored 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 123.082 2.521 . . . . 2.38 113.51 -176.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.707 ' HA ' ' O ' ' A' ' 105' ' ' ALA . 2.0 m120 -142.81 68.57 19.02 Favored Pre-proline 0 N--CA 1.464 0.254 0 N-CA-C 112.824 0.676 . . . . 3.03 112.824 -178.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -81.29 154.46 18.85 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.803 2.336 . . . . 1.29 110.818 172.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 42.6 mm -85.63 91.95 3.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 120.418 -0.513 . . . . 1.81 110.478 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 52.3 mt -89.95 107.77 18.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.702 0.763 . . . . 0.99 112.681 178.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.423 ' OD2' ' HD2' ' A' ' 45' ' ' HIS . 32.2 t70 66.13 43.59 2.83 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 113.901 -1.5 . . . . 1.37 110.438 167.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 88.99 -7.63 81.74 Favored Glycine 0 CA--C 1.518 0.267 0 CA-C-N 115.056 -0.975 . . . . 1.56 114.551 177.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.532 ' HB2' ' HG3' ' A' ' 43' ' ' PRO . 14.7 tpt180 -126.66 141.79 51.74 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 117.992 0.896 . . . . 4.13 110.709 178.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -64.62 131.57 47.34 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.088 -0.708 . . . . 2.73 109.088 172.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.707 ' O ' ' HA ' ' A' ' 97' ' ' ASN . . . -118.64 153.54 34.15 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.821 -0.627 . . . . 1.04 110.087 -169.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.591 ' HB2' ' HA3' ' A' ' 40' ' ' GLY . 6.6 m-20 -96.68 140.15 31.71 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.069 0.461 . . . . 2.04 110.281 178.162 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.436 ' O ' ' HA ' ' A' ' 96' ' ' PRO . 70.6 t -146.08 113.75 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.029 -0.987 . . . . 1.06 110.626 -174.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.454 HD22 ' HA ' ' A' ' 108' ' ' ASN . 0.8 OUTLIER -159.3 165.06 34.24 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.097 -0.705 . . . . 2.49 109.097 174.906 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.511 ' HB3' ' CD1' ' A' ' 111' ' ' TYR . 2.0 mm? -71.96 129.31 38.25 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.254 -0.647 . . . . 1.23 109.254 176.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -57.84 -31.57 66.78 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.575 0.583 . . . . 0.91 112.575 -173.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.511 ' CD1' ' HB3' ' A' ' 109' ' ' LEU . 2.5 p90 . . . . . 0 N--CA 1.465 0.32 0 CA-C-O 120.758 0.314 . . . . 1.4 111.299 -176.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' MET . . . . . 0.479 ' O ' ' HB3' ' A' ' 111' ' ' TYR . 44.2 ttp . . . . . 0 N--CA 1.454 -0.248 0 N-CA-C 112.252 0.464 . . . . 1.49 112.252 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -81.12 -44.88 17.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 118.65 0.659 . . . . 1.5 111.123 -174.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.473 ' HB ' ' O ' ' A' ' 83' ' ' MET . 56.8 p -56.04 -17.94 8.24 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 114.376 1.25 . . . . 0.53 114.376 -175.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.722 ' HG2' ' HB3' ' A' ' 110' ' ' ALA . 29.2 ttpt -81.33 114.77 20.33 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.29 0.567 . . . . 2.75 111.68 -173.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 89.0 mt -105.62 134.18 47.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.364 -0.835 . . . . 0.85 111.112 -179.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.403 ' HD2' HD21 ' A' ' 108' ' ' ASN . 89.0 t80 -94.28 111.15 22.87 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.027 -0.731 . . . . 0.71 109.027 175.175 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.6 t -100.75 139.8 21.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.278 0.561 . . . . 0.92 110.24 -179.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.46 ' O ' ' HB1' ' A' ' 105' ' ' ALA . . . -139.99 135.92 7.44 Favored Glycine 0 N--CA 1.448 -0.523 0 CA-C-N 115.212 -0.904 . . . . 0.84 112.798 -170.55 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 86.34 32.37 16.77 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.762 -0.732 . . . . 0.68 113.049 176.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.683 HD11 HD21 ' A' ' 51' ' ' LEU . 2.8 mm? -74.21 117.3 60.55 Favored Pre-proline 0 C--N 1.328 -0.338 0 N-CA-C 109.736 -0.468 . . . . 1.28 109.736 177.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.57 ' HG2' ' HB3' ' A' ' 101' ' ' ASP . 81.8 Cg_exo -51.0 159.36 2.55 Favored 'Trans proline' 0 CA--C 1.527 0.129 0 C-N-CA 122.913 2.409 . . . . 0.58 112.664 178.303 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -69.94 -4.95 22.93 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 116.284 -0.416 . . . . 1.05 111.776 -171.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . 0.672 ' HB3' ' OD2' ' A' ' 101' ' ' ASP . 70.7 t60 -101.41 -6.04 24.54 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 120.964 0.411 . . . . 2.01 110.533 175.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.488 HG21 HD12 ' A' ' 42' ' ' LEU . 95.0 m -75.38 118.81 18.67 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.05 0.453 . . . . 0.72 111.406 -178.016 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 11.7 p -108.62 -178.75 3.68 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-N 115.924 -0.58 . . . . 0.55 110.824 177.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -64.64 -35.93 82.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.296 0.569 . . . . 0.49 110.443 -176.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.571 ' O ' ' HG2' ' A' ' 53' ' ' GLU . 20.2 ptmt -65.93 -37.44 86.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.582 -0.736 . . . . 2.76 110.592 179.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 49.9 m -59.49 -45.58 91.26 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.958 -0.564 . . . . 0.58 110.403 178.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.683 HD21 HD11 ' A' ' 42' ' ' LEU . 39.5 mt -66.55 -32.95 74.63 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.736 -0.666 . . . . 0.85 111.22 177.185 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.432 ' HA ' HD12 ' A' ' 61' ' ' ILE . 55.2 t-80 -65.27 -55.07 20.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.867 0.365 . . . . 0.59 110.269 177.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.571 ' HG2' ' O ' ' A' ' 49' ' ' LYS . 9.0 mm-40 -57.93 -43.41 86.28 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.143 0.496 . . . . 1.52 112.211 -179.293 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -74.8 -35.0 62.49 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.108 -0.496 . . . . 1.12 112.148 -174.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.764 ' HB2' HD11 ' A' ' 61' ' ' ILE . 7.5 m-85 -87.12 -25.17 24.26 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 113.493 0.923 . . . . 0.56 113.493 -172.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -67.97 -16.39 64.04 Favored 'General case' 0 CA--C 1.522 -0.098 0 CA-C-O 121.544 0.688 . . . . 1.57 109.557 179.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 28.5 mm-40 -56.59 -16.32 5.93 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.054 -0.976 . . . . 2.16 112.459 169.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -99.51 -18.32 17.46 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.847 0.356 . . . . 0.71 110.7 178.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 161.73 -112.96 0.54 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.482 -0.866 . . . . 0.75 112.998 176.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.612 ' HB3' ' HB3' ' A' ' 84' ' ' LYS . 7.9 m-20 -114.27 126.41 54.99 Favored 'General case' 0 C--N 1.329 -0.322 0 O-C-N 122.654 -0.321 . . . . 1.02 110.74 -179.026 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.764 HD11 ' HB2' ' A' ' 55' ' ' PHE . 32.4 mt -99.82 126.71 53.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 C-N-CA 120.903 -0.319 . . . . 0.47 110.57 173.18 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -83.61 -47.58 11.11 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.828 -0.624 . . . . 2.07 109.928 176.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -156.57 130.27 8.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.73 -0.668 . . . . 2.48 110.743 179.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -115.36 116.36 28.13 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.931 -0.396 . . . . 0.44 109.931 175.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.2 m -133.22 115.67 23.85 Favored 'Isoleucine or valine' 0 C--O 1.24 0.553 0 CA-C-O 121.772 0.796 . . . . 1.38 112.808 -176.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 94.0 t -72.56 126.08 32.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 114.881 -1.054 . . . . 0.49 109.137 173.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.4 ' O ' ' HB2' ' A' ' 76' ' ' ARG . 31.1 mm -74.08 95.35 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.542 0 CA-C-O 121.336 0.588 . . . . 0.72 110.268 -178.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 29.9 p . . . . . 0 N--CA 1.436 -1.129 0 CA-C-N 115.403 -0.817 . . . . 1.52 111.222 -176.737 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.479 ' O ' ' HB2' ' A' ' 76' ' ' ARG . 11.7 p . . . . . 0 C--O 1.225 -0.21 0 N-CA-C 111.895 0.331 . . . . 1.81 111.895 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.479 ' HB2' ' O ' ' A' ' 75' ' ' SER . 81.1 mtt180 76.63 -25.17 0.21 Allowed 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.371 0.669 . . . . 2.56 111.43 -179.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 85.17 10.46 78.01 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.652 -0.785 . . . . 0.64 113.221 173.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -121.95 154.21 37.47 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.18 -1.044 . . . . 1.18 108.18 177.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -165.93 143.43 8.4 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 119.525 -1.322 . . . . 0.59 113.418 178.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -101.24 124.63 47.25 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 122.184 0.992 . . . . 0.63 112.26 174.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 58.0 t -104.27 130.55 54.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 113.966 -1.47 . . . . 0.41 108.144 170.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 4.7 m -115.08 122.35 45.88 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 107.794 -1.187 . . . . 0.47 107.794 178.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.473 ' O ' ' HB ' ' A' ' 35' ' ' THR . 88.3 mmm -86.61 160.78 18.8 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.528 -0.545 . . . . 0.88 109.528 -174.094 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.612 ' HB3' ' HB3' ' A' ' 60' ' ' ASP . 31.3 ttmt -84.04 -19.03 35.11 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.235 0.54 . . . . 1.92 109.667 -177.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -141.45 144.09 34.22 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 115.554 -0.748 . . . . 1.68 111.153 -178.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.536 ' O ' ' HG2' ' A' ' 90' ' ' GLU . 0.6 OUTLIER -66.1 -29.93 70.34 Favored 'General case' 0 C--O 1.222 -0.382 0 N-CA-C 113.743 1.016 . . . . 3.66 113.743 -177.718 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -67.73 -35.65 79.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 119.361 0.982 . . . . 0.66 110.89 178.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 11.7 m -64.66 -35.11 79.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 122.06 0.933 . . . . 0.78 109.35 173.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.466 ' HB2' ' HA ' ' A' ' 35' ' ' THR . . . -66.02 -45.71 80.51 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 113.685 -1.598 . . . . 0.46 110.468 177.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.536 ' HG2' ' O ' ' A' ' 86' ' ' ARG . 10.7 mm-40 -54.53 -51.54 64.85 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.779 -0.646 . . . . 2.11 112.65 178.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.521 ' O ' ' HB3' ' A' ' 94' ' ' LYS . 57.0 mtp180 -65.91 -39.02 90.18 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 111.736 0.273 . . . . 3.82 111.736 -178.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.82 -42.93 99.93 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.388 -0.369 . . . . 0.92 111.305 179.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . 0.577 ' HB2' ' HG ' ' A' ' 109' ' ' LEU . 44.8 t -71.93 -17.18 62.1 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.047 0.451 . . . . 1.16 110.763 175.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.521 ' HB3' ' O ' ' A' ' 91' ' ' ARG . 4.5 tppp? -74.46 -47.88 30.75 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.286 -0.415 . . . . 4.2 111.166 177.547 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -101.62 100.55 14.49 Favored Pre-proline 0 N--CA 1.463 0.218 0 N-CA-C 108.975 -0.75 . . . . 2.24 108.975 178.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.42 ' HG2' HD22 ' A' ' 97' ' ' ASN . 95.5 Cg_endo -88.78 -16.29 2.42 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 123.009 2.472 . . . . 2.38 115.508 -165.526 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.438 ' HA ' ' O ' ' A' ' 105' ' ' ALA . 3.8 p30 -120.07 83.0 30.27 Favored Pre-proline 0 C--N 1.326 -0.423 0 N-CA-C 113.622 0.971 . . . . 3.03 113.622 -174.096 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -84.65 128.59 3.98 Favored 'Trans proline' 0 C--O 1.24 0.604 0 C-N-CA 123.657 2.905 . . . . 1.29 112.256 170.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 35.3 mm -70.2 91.76 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 121.199 0.523 . . . . 1.81 110.288 173.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 69.0 mt -99.13 134.1 39.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.923 -0.58 . . . . 0.99 111.277 -178.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.672 ' OD2' ' HB3' ' A' ' 45' ' ' HIS . 18.0 t70 41.56 30.88 0.16 Allowed 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.778 1.029 . . . . 1.37 113.778 -178.037 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 88.48 16.85 58.1 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 120.49 -0.862 . . . . 1.56 113.366 176.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.558 ' HB3' ' HG3' ' A' ' 43' ' ' PRO . 28.0 tpt180 -140.54 139.31 35.01 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.323 -0.621 . . . . 4.13 109.323 176.026 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -82.09 105.38 13.14 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 119.966 -0.694 . . . . 2.73 110.107 -178.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.46 ' HB1' ' O ' ' A' ' 40' ' ' GLY . . . -85.46 166.34 16.43 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 113.874 1.064 . . . . 1.04 113.874 177.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 22.7 t30 -108.86 119.34 39.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.388 -1.278 . . . . 2.04 110.187 -178.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 93.8 t -114.2 140.72 33.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.006 -0.543 . . . . 1.06 110.874 179.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.403 HD21 ' HD2' ' A' ' 38' ' ' PHE . 8.3 p30 -160.64 170.15 21.42 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.715 -0.846 . . . . 2.49 108.715 178.151 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.577 ' HG ' ' HB2' ' A' ' 93' ' ' CYS . 5.8 mt -79.67 127.35 32.08 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.361 -0.536 . . . . 1.23 110.737 178.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.722 ' HB3' ' HG2' ' A' ' 36' ' ' LYS . . . -69.26 -24.65 64.01 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.263 -0.881 . . . . 0.91 112.351 -174.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.568 ' CD1' ' HB3' ' A' ' 109' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.466 0.364 0 CA-C-O 120.849 0.357 . . . . 1.4 111.8 -173.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 48.6 ttp . . . . . 0 N--CA 1.454 -0.231 0 N-CA-C 111.27 0.1 . . . . 1.49 111.27 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.592 ' HA ' HD11 ' A' ' 109' ' ' LEU . 25.1 m-85 -107.12 -24.16 12.04 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-O 120.801 0.334 . . . . 1.5 110.992 -178.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.735 ' O ' ' HA ' ' A' ' 82' ' ' THR . 27.1 p -81.4 11.75 4.21 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.289 -0.414 . . . . 0.53 110.958 -174.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.452 ' O ' HD13 ' A' ' 109' ' ' LEU . 5.8 ttpm? -122.43 102.84 8.33 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.074 -0.512 . . . . 2.75 110.247 -173.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 5.0 mp -109.21 136.53 44.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.959 -0.564 . . . . 0.85 110.602 -176.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -95.13 120.51 35.48 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.987 -0.551 . . . . 0.71 109.589 176.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.635 HG13 HG22 ' A' ' 107' ' ' VAL . 96.8 t -132.84 99.08 3.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 118.775 -0.631 . . . . 0.92 110.851 -177.256 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.572 ' HA2' ' CD1' ' A' ' 42' ' ' LEU . . . -132.15 166.49 23.23 Favored Glycine 0 C--O 1.217 -0.913 0 C-N-CA 115.324 -3.322 . . . . 0.84 113.845 162.006 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 128.69 -2.93 6.51 Favored Glycine 0 N--CA 1.445 -0.762 0 N-CA-C 108.706 -1.758 . . . . 0.68 108.706 -168.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.766 HD21 HD21 ' A' ' 51' ' ' LEU . 4.5 mp -62.1 142.13 95.61 Favored Pre-proline 0 N--CA 1.449 -0.486 0 CA-C-N 113.601 -1.3 . . . . 1.28 109.806 179.667 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.581 ' HG2' ' O ' ' A' ' 101' ' ' ASP . 52.5 Cg_exo -54.28 159.78 7.54 Favored 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.669 2.246 . . . . 0.58 111.581 172.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -71.55 -1.78 14.64 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.161 -0.472 . . . . 1.05 111.459 -174.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 72.4 t60 -104.08 -11.99 17.02 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.127 0.489 . . . . 2.01 109.944 176.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.704 ' HB ' ' HB3' ' A' ' 42' ' ' LEU . 5.4 m -79.06 129.94 34.99 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 115.921 -0.581 . . . . 0.72 109.868 -178.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.421 ' HA ' HG21 ' A' ' 66' ' ' VAL . 7.4 p -132.76 -177.58 4.55 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.534 -0.303 . . . . 0.55 111.566 -169.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.489 ' OD2' ' HA ' ' A' ' 65' ' ' VAL . 1.2 m-20 -57.01 -31.9 65.58 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.536 0.684 . . . . 0.49 110.043 -177.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.731 ' O ' ' HG2' ' A' ' 53' ' ' GLU . 55.2 pttt -74.1 -35.45 64.18 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.908 -1.042 . . . . 2.76 109.638 -178.017 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.645 HG21 HG23 ' A' ' 46' ' ' THR . 6.6 m -67.17 -43.98 80.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.735 0.302 . . . . 0.58 110.756 179.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.766 HD21 HD21 ' A' ' 42' ' ' LEU . 35.8 mt -61.46 -42.97 99.59 Favored 'General case' 0 CA--C 1.512 -0.493 0 N-CA-C 109.631 -0.507 . . . . 0.85 109.631 176.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.54 ' HA ' HD12 ' A' ' 61' ' ' ILE . 45.8 t-80 -53.3 -52.74 58.12 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.246 -0.888 . . . . 0.59 110.514 175.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.731 ' HG2' ' O ' ' A' ' 49' ' ' LYS . 8.5 mm-40 -59.49 -47.62 84.8 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.3 -0.409 . . . . 1.52 111.756 -176.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.523 ' O ' ' HB2' ' A' ' 57' ' ' GLN . 56.3 t80 -77.73 -36.53 50.75 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.289 0.478 . . . . 1.12 112.289 -170.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.753 ' HB2' HD11 ' A' ' 61' ' ' ILE . 42.9 m-85 -84.62 -30.03 25.27 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 113.224 0.824 . . . . 0.56 113.224 -173.197 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.699 ' HA ' ' O ' ' A' ' 59' ' ' GLY . 12.9 pt-20 -68.58 -11.38 59.91 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.677 0.751 . . . . 1.57 110.009 179.254 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.523 ' HB2' ' O ' ' A' ' 54' ' ' TYR . 27.6 mt-30 -59.35 -23.0 62.16 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.55 -1.204 . . . . 2.16 111.826 170.243 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -94.23 -21.45 19.04 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.217 0.532 . . . . 0.71 110.005 177.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.699 ' O ' ' HA ' ' A' ' 56' ' ' GLU . . . 159.14 -177.7 35.59 Favored Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 115.049 -0.978 . . . . 0.75 110.982 179.334 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -61.77 122.94 16.6 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 117.042 0.421 . . . . 1.02 110.577 -175.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.753 HD11 ' HB2' ' A' ' 55' ' ' PHE . 45.9 mt -86.99 125.03 40.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 O-C-N 122.351 -0.218 . . . . 0.47 110.468 171.506 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -75.64 -43.82 45.79 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.681 0.277 . . . . 2.07 111.607 178.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -152.12 132.55 13.78 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.326 -0.397 . . . . 2.48 111.251 -175.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -125.8 134.81 51.58 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.241 0.543 . . . . 0.44 111.145 178.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.567 ' CG2' ' HB2' ' A' ' 80' ' ' PHE . 31.2 m -144.76 148.43 18.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.225 -0.898 . . . . 1.38 112.485 -177.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.421 HG21 ' HA ' ' A' ' 47' ' ' SER . 42.4 t -119.3 138.92 48.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.241 -0.89 . . . . 0.49 110.027 171.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.536 HG12 ' HA2' ' A' ' 79' ' ' GLY . 26.2 mm -91.91 153.71 3.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 114.898 -1.046 . . . . 0.72 110.441 -173.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 18.8 p . . . . . 0 N--CA 1.445 -0.705 0 N-CA-C 105.228 -2.138 . . . . 1.52 105.228 -170.57 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 14.9 m . . . . . 0 N--CA 1.453 -0.281 0 CA-C-O 120.791 0.329 . . . . 1.81 110.403 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 26.7 mtm180 -69.58 -5.94 27.79 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.866 -0.606 . . . . 2.56 112.066 -175.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 77.98 9.63 86.8 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 119.88 -1.152 . . . . 0.64 111.082 -177.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.568 ' HD1' ' HA3' ' A' ' 40' ' ' GLY . 20.7 m-85 -117.34 154.05 31.95 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 110.035 -0.357 . . . . 1.18 110.035 -172.475 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.536 ' HA2' HG12 ' A' ' 67' ' ' ILE . . . -157.95 -167.3 18.69 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.388 -0.91 . . . . 0.59 113.145 173.065 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.567 ' HB2' ' CG2' ' A' ' 65' ' ' VAL . 49.7 m-85 -139.5 141.2 37.35 Favored 'General case' 0 CA--C 1.513 -0.469 0 C-N-CA 123.462 0.705 . . . . 0.63 109.496 178.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 54.6 t -127.33 111.85 26.54 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 CA-C-O 121.308 0.575 . . . . 0.41 109.931 175.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.735 ' HA ' ' O ' ' A' ' 35' ' ' THR . 29.3 m -109.19 112.43 24.59 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.467 -0.788 . . . . 0.47 109.351 176.416 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.668 ' SD ' HG12 ' A' ' 61' ' ' ILE . 59.8 mmm -87.44 175.34 8.01 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 121.227 0.537 . . . . 0.88 111.639 -172.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.402 ' HB2' ' HE3' ' A' ' 84' ' ' LYS . 37.9 ttmt -82.7 -31.91 28.31 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.189 -0.914 . . . . 1.92 110.826 -179.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -129.83 147.8 51.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.927 0.394 . . . . 1.68 110.446 178.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.591 ' H ' ' HD2' ' A' ' 86' ' ' ARG . 0.7 OUTLIER -73.44 -19.74 60.89 Favored 'General case' 0 C--O 1.218 -0.566 0 CA-C-N 115.812 -0.631 . . . . 3.66 112.105 -174.639 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.416 ' O ' ' HG3' ' A' ' 91' ' ' ARG . . . -67.04 -50.57 61.55 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 118.436 0.562 . . . . 0.66 111.201 176.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.442 ' HA ' ' HD2' ' A' ' 91' ' ' ARG . 14.4 m -63.96 -33.5 75.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.887 0.851 . . . . 0.78 109.36 175.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.518 ' HB3' ' HA ' ' A' ' 86' ' ' ARG . . . -58.23 -47.5 83.34 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 113.683 -1.599 . . . . 0.46 110.011 173.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -60.69 -43.99 97.08 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.203 -0.453 . . . . 2.11 111.237 173.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.567 ' O ' ' HB3' ' A' ' 94' ' ' LYS . 99.4 mtt180 -57.59 -42.59 83.47 Favored 'General case' 0 C--O 1.225 -0.227 0 CA-C-O 120.888 0.375 . . . . 3.82 111.466 176.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.39 -36.67 83.05 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 111.874 0.324 . . . . 0.92 111.874 173.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 35.7 t -78.71 -7.55 57.84 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.207 0.527 . . . . 1.16 111.259 177.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.567 ' HB3' ' O ' ' A' ' 91' ' ' ARG . 16.1 tppt? -58.42 -48.36 80.92 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.628 -0.715 . . . . 4.2 111.613 -177.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -110.35 121.81 40.4 Favored Pre-proline 0 C--N 1.325 -0.495 0 C-N-CA 120.744 -0.383 . . . . 2.24 109.988 176.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -84.66 -1.76 9.65 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 122.902 2.402 . . . . 2.38 114.287 -173.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.578 ' HB2' ' HD3' ' A' ' 104' ' ' LYS . 6.0 p30 -152.61 68.4 6.96 Favored Pre-proline 0 CA--C 1.534 0.333 0 CA-C-O 121.392 0.615 . . . . 3.03 111.691 178.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -80.98 166.97 18.57 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 123.456 2.771 . . . . 1.29 111.686 179.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 47.2 mm -100.81 137.82 27.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 108.578 -0.897 . . . . 1.81 108.578 178.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 54.7 mt -144.77 111.8 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 109.323 -0.621 . . . . 0.99 109.323 -174.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.581 ' O ' ' HG2' ' A' ' 43' ' ' PRO . 16.8 t0 61.87 47.99 5.66 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 121.488 0.661 . . . . 1.37 111.019 173.387 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 82.74 -5.76 73.25 Favored Glycine 0 CA--C 1.529 0.924 0 N-CA-C 116.29 1.276 . . . . 1.56 116.29 178.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.439 ' CB ' ' HG3' ' A' ' 43' ' ' PRO . 23.8 ttt180 -137.93 150.97 47.51 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 118.933 1.367 . . . . 4.13 111.106 -177.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.578 ' HD3' ' HB2' ' A' ' 97' ' ' ASN . 24.3 ttmm -78.88 139.8 38.24 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.46 -0.336 . . . . 2.73 110.37 178.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -111.59 154.17 25.23 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.947 -0.57 . . . . 1.04 111.138 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.462 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 46.6 t-20 -95.47 127.86 41.86 Favored 'General case' 0 C--O 1.252 1.224 0 N-CA-C 108.597 -0.89 . . . . 2.04 108.597 173.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.635 HG22 HG13 ' A' ' 39' ' ' VAL . 88.0 t -142.37 129.4 19.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 113.838 -1.528 . . . . 1.06 110.45 -161.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -167.84 158.56 10.89 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.454 -0.572 . . . . 2.49 109.454 178.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.592 HD11 ' HA ' ' A' ' 34' ' ' PHE . 0.2 OUTLIER -57.92 131.94 51.9 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 107.827 -1.175 . . . . 1.23 107.827 173.061 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.96 -30.93 68.42 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.514 -0.475 . . . . 0.91 110.784 -162.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.443 ' HD1' HD12 ' A' ' 109' ' ' LEU . 4.0 p90 . . . . . 0 CA--C 1.534 0.347 0 CA-C-N 115.881 -0.6 . . . . 1.4 111.42 -172.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 7.4 ttt . . . . . 0 N--CA 1.455 -0.215 0 CA-C-O 120.419 0.152 . . . . 1.49 111.085 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.601 ' HA ' HD11 ' A' ' 109' ' ' LEU . 40.7 m-85 -103.66 -24.23 13.39 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 111.859 0.318 . . . . 1.5 111.859 -178.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.548 ' O ' ' HA ' ' A' ' 82' ' ' THR . 57.7 p -78.91 -10.9 59.95 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.362 -0.535 . . . . 0.53 110.446 -174.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 47.1 tttm -88.23 106.43 18.19 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 115.367 -0.833 . . . . 2.75 109.104 179.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 95.3 mt -104.6 134.89 44.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 116.051 -0.522 . . . . 0.85 110.442 -179.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.628 ' CB ' ' HA ' ' A' ' 110' ' ' ALA . 82.5 t80 -99.02 121.31 40.8 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.397 -0.594 . . . . 0.71 109.397 179.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.756 HG12 HD11 ' A' ' 42' ' ' LEU . 3.9 t -106.63 140.19 25.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.137 0.494 . . . . 0.92 110.477 -174.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -140.76 152.68 23.23 Favored Glycine 0 N--CA 1.452 -0.275 0 CA-C-N 115.29 -0.868 . . . . 0.84 113.423 -167.028 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.08 40.66 95.17 Favored Glycine 0 C--O 1.228 -0.263 0 C-N-CA 121.635 -0.317 . . . . 0.68 113.298 172.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.756 HD11 HG12 ' A' ' 39' ' ' VAL . 7.1 mp -82.38 134.71 47.97 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-O 120.861 0.363 . . . . 1.28 110.86 179.111 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.591 ' HG3' ' HG3' ' A' ' 103' ' ' ARG . 50.6 Cg_exo -52.91 153.4 15.3 Favored 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.709 2.273 . . . . 0.58 111.379 172.292 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.601 ' HA ' ' HB3' ' A' ' 75' ' ' SER . 20.6 m-85 -67.49 -7.38 25.15 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 113.292 0.849 . . . . 1.05 113.292 -170.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -111.98 2.51 16.94 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 120.409 -0.516 . . . . 2.01 111.168 176.38 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.693 HG23 HG21 ' A' ' 50' ' ' THR . 38.4 m -74.39 134.59 42.42 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.284 -0.416 . . . . 0.72 110.405 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 10.4 p -136.35 -176.85 4.47 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-O 121.507 0.67 . . . . 0.55 112.053 -171.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -60.46 -36.26 77.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.825 -1.08 . . . . 0.49 110.76 -173.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.54 ' O ' ' HG2' ' A' ' 53' ' ' GLU . 9.2 ptmm? -65.15 -36.99 85.98 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.461 -0.79 . . . . 2.76 110.855 178.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.693 HG21 HG23 ' A' ' 46' ' ' THR . 88.0 m -62.07 -45.95 91.27 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.085 0.469 . . . . 0.58 110.922 179.104 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.464 HD21 HG11 ' A' ' 39' ' ' VAL . 98.2 mt -68.33 -34.71 76.59 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.77 -0.65 . . . . 0.85 110.687 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.452 ' O ' ' HG2' ' A' ' 56' ' ' GLU . 55.6 t-80 -59.69 -53.82 53.51 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.111 0.481 . . . . 0.59 109.966 178.225 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.54 ' HG2' ' O ' ' A' ' 49' ' ' LYS . 11.8 mm-40 -57.72 -44.03 85.69 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.618 -0.719 . . . . 1.52 112.628 -179.401 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.61 ' O ' ' HB2' ' A' ' 57' ' ' GLN . 67.8 t80 -76.48 -34.43 58.66 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.821 0.674 . . . . 1.12 112.821 -174.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -84.69 -30.5 24.76 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 113.898 1.073 . . . . 0.56 113.898 -171.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.452 ' HG2' ' O ' ' A' ' 52' ' ' HIS . 15.0 pt-20 -71.5 -12.04 61.18 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.842 0.83 . . . . 1.57 110.003 177.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.61 ' HB2' ' O ' ' A' ' 54' ' ' TYR . 27.6 mm-40 -56.03 -24.84 41.78 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.037 -0.983 . . . . 2.16 111.539 166.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -106.64 6.93 30.32 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 111.74 0.274 . . . . 0.71 111.74 -177.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 146.48 -137.86 7.05 Favored Glycine 0 C--O 1.224 -0.529 0 C-N-CA 120.486 -0.864 . . . . 0.75 112.794 -176.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -114.04 127.14 55.81 Favored 'General case' 0 C--N 1.327 -0.372 0 O-C-N 122.661 -0.317 . . . . 1.02 110.874 -178.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.422 HG13 ' HB3' ' A' ' 56' ' ' GLU . 8.7 mt -94.24 126.9 46.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 110.116 -0.328 . . . . 0.47 110.116 176.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -83.59 -48.72 9.92 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.581 -0.448 . . . . 2.07 110.372 174.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -141.56 126.71 18.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.261 -0.427 . . . . 2.48 111.112 -176.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -123.23 123.75 41.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.059 0.457 . . . . 0.44 110.555 174.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 29.6 m -139.09 143.74 30.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.0 -1.0 . . . . 1.38 112.141 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 70.4 t -115.08 139.54 40.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 108.761 -0.829 . . . . 0.49 108.761 170.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 44.2 mm -91.1 95.06 5.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 N-CA-C 109.439 -0.578 . . . . 0.72 109.439 -179.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.495 HG22 ' HA ' ' A' ' 75' ' ' SER . 9.1 p . . . . . 0 C--N 1.317 -0.813 0 CA-C-N 116.047 -0.524 . . . . 1.52 110.985 177.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.601 ' HB3' ' HA ' ' A' ' 44' ' ' TYR . 12.3 t . . . . . 0 N--CA 1.452 -0.335 0 CA-C-O 121.023 0.44 . . . . 1.81 110.274 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 10.8 mtp180 -59.23 -11.76 4.41 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.505 -0.77 . . . . 2.56 111.363 174.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 92.59 14.77 54.92 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.812 -0.709 . . . . 0.64 113.113 175.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 14.4 m-85 -128.41 141.0 51.54 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.422 -0.584 . . . . 1.18 109.422 -178.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -138.65 -178.28 16.12 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.435 -0.888 . . . . 0.59 111.865 179.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -152.03 130.08 11.85 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.386 -0.598 . . . . 0.63 109.386 -177.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 63.7 t -128.22 119.59 51.15 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 CA-C-N 115.813 -0.63 . . . . 0.41 109.936 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.548 ' HA ' ' O ' ' A' ' 35' ' ' THR . 34.8 m -109.45 114.23 27.71 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.183 -1.043 . . . . 0.47 108.183 177.379 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 87.8 mmm -87.94 168.71 12.63 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 122.078 -0.389 . . . . 0.88 110.012 -174.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -83.05 -16.34 47.43 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.272 -0.422 . . . . 1.92 111.05 -176.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -147.97 148.69 31.03 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 120.813 0.339 . . . . 1.68 110.607 -179.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -71.32 -20.84 62.14 Favored 'General case' 0 C--O 1.224 -0.246 0 N-CA-C 112.502 0.556 . . . . 3.66 112.502 -174.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -71.61 -45.75 61.19 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 118.556 0.616 . . . . 0.66 111.346 -179.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 19.4 m -63.37 -35.59 80.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.94 0.876 . . . . 0.78 109.489 173.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.493 ' HB1' ' O ' ' A' ' 34' ' ' PHE . . . -58.79 -46.9 86.49 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 113.503 -1.681 . . . . 0.46 109.824 174.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -57.37 -50.03 74.27 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.543 -0.753 . . . . 2.11 112.276 174.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.539 ' O ' ' HB3' ' A' ' 94' ' ' LYS . 79.3 mtp180 -57.06 -46.0 82.8 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.817 0.341 . . . . 3.82 111.457 -179.186 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -60.06 -40.34 89.14 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.154 -0.476 . . . . 0.92 111.858 176.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 49.7 t -71.89 -17.1 62.13 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.294 0.569 . . . . 1.16 110.449 177.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.539 ' HB3' ' O ' ' A' ' 91' ' ' ARG . 21.2 tptp -78.65 7.08 7.41 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.415 0.686 . . . . 4.2 110.821 179.253 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -142.13 76.98 18.56 Favored Pre-proline 0 C--N 1.323 -0.565 0 O-C-N 121.616 -0.678 . . . . 2.24 110.011 -176.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -73.43 156.11 50.32 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 123.095 2.53 . . . . 2.38 111.945 -178.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.613 ' HA ' ' O ' ' A' ' 105' ' ' ALA . 1.9 p-10 34.35 64.14 1.73 Allowed Pre-proline 0 N--CA 1.471 0.615 0 O-C-N 124.166 0.916 . . . . 3.03 113.073 -171.449 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.403 ' HB2' ' OH ' ' A' ' 54' ' ' TYR . 92.5 Cg_endo -82.21 167.43 15.78 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 123.063 2.509 . . . . 1.29 111.714 178.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 49.6 mm -89.53 130.74 38.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 116.281 -0.418 . . . . 1.81 110.097 178.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 56.5 mt -146.57 139.67 20.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.801 -0.636 . . . . 0.99 109.326 -175.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 42.7 t0 44.93 42.47 6.26 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 113.134 0.79 . . . . 1.37 113.134 177.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 70.45 17.98 74.97 Favored Glycine 0 CA--C 1.524 0.626 0 C-N-CA 121.128 -0.558 . . . . 1.56 113.619 177.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.591 ' HG3' ' HG3' ' A' ' 43' ' ' PRO . 30.6 mmt180 -143.23 162.38 35.79 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.372 -0.603 . . . . 4.13 109.372 -179.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -80.64 134.52 35.89 Favored 'General case' 0 C--N 1.317 -0.845 0 C-N-CA 120.108 -0.637 . . . . 2.73 109.757 171.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.613 ' O ' ' HA ' ' A' ' 97' ' ' ASN . . . -121.67 165.11 16.26 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 107.738 -1.208 . . . . 1.04 107.738 -177.21 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 44.4 t30 -116.38 110.57 18.85 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 120.344 -0.542 . . . . 2.04 110.375 177.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 88.5 t -116.38 139.9 41.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 120.981 0.42 . . . . 1.06 111.611 176.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -162.98 173.75 13.22 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 107.929 -1.137 . . . . 2.49 107.929 175.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.601 HD11 ' HA ' ' A' ' 34' ' ' PHE . 0.2 OUTLIER -62.77 146.56 52.18 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.74 -0.837 . . . . 1.23 108.74 175.904 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.628 ' HA ' ' CB ' ' A' ' 38' ' ' PHE . . . -68.47 -40.61 80.95 Favored 'General case' 0 CA--C 1.512 -0.484 0 C-N-CA 120.634 -0.427 . . . . 0.91 111.305 -169.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 9.7 p90 . . . . . 0 C--N 1.323 -0.554 0 CA-C-N 116.186 -0.461 . . . . 1.4 111.04 -173.376 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 46.7 ttp . . . . . 0 C--O 1.227 -0.1 0 N-CA-C 108.326 -0.99 . . . . 1.49 108.326 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.482 ' HB3' ' HB2' ' A' ' 86' ' ' ARG . 20.4 m-85 123.79 -176.12 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 127.339 2.256 . . . . 1.5 106.918 -173.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.515 ' HA ' ' HB2' ' A' ' 89' ' ' ALA . 34.6 p 61.22 -40.79 0.12 Allowed 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 114.384 1.253 . . . . 0.53 114.384 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -80.07 112.56 17.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.286 0.565 . . . . 2.75 110.511 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.529 ' CG2' HG13 ' A' ' 107' ' ' VAL . 82.8 mt -106.84 131.24 57.26 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 CA-C-N 115.514 -0.766 . . . . 0.85 110.842 -178.306 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -86.87 120.12 27.82 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.117 -0.697 . . . . 0.71 109.117 177.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.909 HG12 HD11 ' A' ' 42' ' ' LEU . 5.3 t -112.21 139.91 34.48 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-O 121.514 0.673 . . . . 0.92 111.15 -175.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -144.76 157.01 27.14 Favored Glycine 0 C--O 1.225 -0.421 0 CA-C-N 114.757 -1.111 . . . . 0.84 113.422 -171.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 71.05 34.97 64.63 Favored Glycine 0 C--O 1.227 -0.296 0 C-N-CA 121.31 -0.472 . . . . 0.68 113.549 172.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.909 HD11 HG12 ' A' ' 39' ' ' VAL . 6.8 mp -83.5 134.17 45.68 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-O 120.744 0.307 . . . . 1.28 111.228 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.602 ' HG3' ' CG ' ' A' ' 103' ' ' ARG . 52.8 Cg_exo -52.05 158.26 5.17 Favored 'Trans proline' 0 N--CA 1.461 -0.394 0 C-N-CA 122.92 2.413 . . . . 0.58 111.792 173.057 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -72.53 3.83 4.51 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.933 0.397 . . . . 1.05 111.207 -178.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 80.3 t60 -112.07 -8.92 14.01 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.057 -0.519 . . . . 2.01 110.943 178.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.564 ' CG2' HD23 ' A' ' 42' ' ' LEU . 12.5 m -77.6 125.88 30.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.994 0.426 . . . . 0.72 111.805 -176.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 6.5 p -121.08 -178.32 3.73 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.903 -0.59 . . . . 0.55 111.243 -176.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -59.19 -34.81 72.58 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 115.841 -0.618 . . . . 0.49 109.863 -176.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.588 ' HG3' ' N ' ' A' ' 50' ' ' THR . 12.3 pttp -62.13 -39.5 92.76 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.322 -0.854 . . . . 2.76 110.133 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.588 ' N ' ' HG3' ' A' ' 49' ' ' LYS . 15.1 m -68.27 -41.08 81.6 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 116.381 -0.372 . . . . 0.58 110.518 -176.105 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.517 HD21 HG11 ' A' ' 39' ' ' VAL . 65.7 mt -63.66 -35.96 82.26 Favored 'General case' 0 C--O 1.222 -0.355 0 C-N-CA 120.434 -0.506 . . . . 0.85 110.207 174.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 59.2 t-80 -67.28 -51.12 56.66 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.475 -0.49 . . . . 0.59 110.089 179.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.504 ' HG3' ' O ' ' A' ' 49' ' ' LYS . 42.4 mt-10 -55.88 -43.76 77.5 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.729 0.299 . . . . 1.52 111.574 -179.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.503 ' O ' ' HB2' ' A' ' 57' ' ' GLN . 4.7 t80 -75.79 -35.13 60.17 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.353 -0.385 . . . . 1.12 111.609 -176.124 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.44 ' HD1' ' O ' ' A' ' 51' ' ' LEU . 45.9 m-85 -86.82 -28.24 23.05 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 114.126 1.158 . . . . 0.56 114.126 -172.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.706 ' N ' HD11 ' A' ' 61' ' ' ILE . 15.0 pt-20 -70.54 -15.93 62.83 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 122.395 1.093 . . . . 1.57 109.236 -178.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.503 ' HB2' ' O ' ' A' ' 54' ' ' TYR . 23.9 mt-30 -53.72 -27.78 30.23 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 113.481 -1.69 . . . . 2.16 112.174 168.438 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -100.17 -13.67 18.84 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.156 -0.475 . . . . 0.71 110.387 -177.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.514 ' O ' ' HA ' ' A' ' 56' ' ' GLU . . . 144.57 -155.54 26.41 Favored Glycine 0 N--CA 1.448 -0.505 0 CA-C-N 115.658 -0.701 . . . . 0.75 112.115 175.09 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -64.32 123.34 18.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.109 0.481 . . . . 1.02 112.29 -179.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.706 HD11 ' N ' ' A' ' 56' ' ' GLU . 10.0 mt -101.61 123.92 55.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 108.208 -1.034 . . . . 0.47 108.208 172.293 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -79.74 -44.08 21.4 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.308 0.575 . . . . 2.07 110.406 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -148.65 130.52 15.19 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.658 -0.701 . . . . 2.48 110.675 -179.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -117.45 115.83 25.96 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.067 -0.515 . . . . 0.44 110.086 174.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.1 p -137.11 135.31 47.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.446 -0.797 . . . . 1.38 112.065 -177.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 89.8 t -98.91 132.81 43.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.498 -0.774 . . . . 0.49 109.033 172.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.624 ' H ' ' HA2' ' A' ' 79' ' ' GLY . 36.6 mm -74.87 84.36 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.826 0.822 . . . . 0.72 109.479 177.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.66 ' HA ' ' O ' ' A' ' 75' ' ' SER . 16.7 p . . . . . 0 N--CA 1.435 -1.222 0 CA-C-N 114.419 -1.264 . . . . 1.52 110.734 -177.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.66 ' O ' ' HA ' ' A' ' 68' ' ' THR . 58.3 p . . . . . 0 N--CA 1.469 0.514 0 N-CA-C 112.332 0.493 . . . . 1.81 112.332 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.554 ' HG3' ' O ' ' A' ' 75' ' ' SER . 46.0 mtt180 129.54 -50.31 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 126.964 2.106 . . . . 2.56 110.137 -167.549 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 104.67 16.62 17.01 Favored Glycine 0 N--CA 1.454 -0.157 0 C-N-CA 120.675 -0.774 . . . . 0.64 113.43 177.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -129.69 152.94 48.64 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.424 -0.954 . . . . 1.18 108.424 177.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.624 ' HA2' ' H ' ' A' ' 67' ' ' ILE . . . -157.08 -166.31 16.43 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 119.854 -1.165 . . . . 0.59 112.509 177.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.43 ' HD2' HD11 ' A' ' 67' ' ' ILE . 45.4 m-85 -159.57 125.01 4.16 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 123.563 0.745 . . . . 0.63 109.216 -177.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 69.9 t -117.95 118.79 59.44 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 N-CA-C 109.669 -0.493 . . . . 0.41 109.669 177.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 17.8 m -110.16 109.48 20.0 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 108.03 -1.1 . . . . 0.47 108.03 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.464 ' HA ' ' HA ' ' A' ' 61' ' ' ILE . 44.1 mtp -88.25 166.56 14.25 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 110.138 -0.319 . . . . 0.88 110.138 -173.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.461 ' HZ2' ' HB2' ' A' ' 84' ' ' LYS . 4.3 ttmp? -74.28 -43.21 57.81 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.929 -0.308 . . . . 1.92 111.376 -174.147 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -128.56 151.01 49.94 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-O 121.784 0.802 . . . . 1.68 111.225 179.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.482 ' HB2' ' HB3' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -65.72 -23.06 66.67 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 114.421 -1.263 . . . . 3.66 112.646 -172.153 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.25 -46.65 76.39 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 118.768 0.713 . . . . 0.66 111.155 -179.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 18.2 m -64.86 -38.23 90.28 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.683 0.754 . . . . 0.78 109.766 176.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.515 ' HB2' ' HA ' ' A' ' 35' ' ' THR . . . -58.41 -47.41 83.99 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 113.544 -1.662 . . . . 0.46 109.691 176.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.59 ' O ' ' HG2' ' A' ' 94' ' ' LYS . 6.3 mm-40 -56.04 -50.88 69.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.12 -0.945 . . . . 2.11 112.006 175.104 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 43.9 mtm180 -57.89 -43.66 86.25 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.518 0.199 . . . . 3.82 111.165 -178.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -56.88 -37.1 70.89 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.934 -0.575 . . . . 0.92 111.711 177.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 48.0 t -86.77 -13.41 45.27 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 112.677 0.621 . . . . 1.16 112.677 -178.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.59 ' HG2' ' O ' ' A' ' 90' ' ' GLU . 72.5 mmtt -65.77 -43.75 87.91 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 120.888 0.375 . . . . 4.2 110.751 -177.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -114.49 92.99 30.45 Favored Pre-proline 0 C--N 1.326 -0.441 0 N-CA-C 109.646 -0.501 . . . . 2.24 109.646 176.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -81.09 -166.7 0.43 Allowed 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 122.735 2.29 . . . . 2.38 112.649 -176.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.728 ' HA ' ' O ' ' A' ' 105' ' ' ALA . 22.7 m120 38.95 63.42 4.28 Favored Pre-proline 0 N--CA 1.467 0.396 0 N-CA-C 113.512 0.93 . . . . 3.03 113.512 -173.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.452 ' HD3' ' N ' ' A' ' 97' ' ' ASN . 2.5 Cg_endo -81.54 143.44 13.59 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.775 2.317 . . . . 1.29 110.82 174.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 38.6 mm -81.22 90.25 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.301 0.572 . . . . 1.81 109.827 178.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 31.1 mt -90.88 106.78 17.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 121.462 0.649 . . . . 0.99 111.199 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.449 ' HB2' HG21 ' A' ' 50' ' ' THR . 35.6 t70 66.1 46.62 2.08 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 113.889 -1.505 . . . . 1.37 110.147 166.051 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 91.23 -7.1 81.02 Favored Glycine 0 N--CA 1.451 -0.34 0 CA-C-N 114.94 -1.027 . . . . 1.56 114.821 175.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.602 ' CG ' ' HG3' ' A' ' 43' ' ' PRO . 20.9 mmt180 -133.77 148.93 51.42 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 118.614 1.207 . . . . 4.13 111.642 177.299 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -67.23 138.8 57.2 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.371 -0.831 . . . . 2.73 109.927 174.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.728 ' O ' ' HA ' ' A' ' 97' ' ' ASN . . . -124.57 150.87 45.44 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.042 -0.526 . . . . 1.04 109.856 -172.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -101.69 110.32 22.29 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 109.609 -0.515 . . . . 2.04 109.609 177.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.529 HG13 ' CG2' ' A' ' 37' ' ' ILE . 44.8 t -109.73 133.32 55.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.701 -0.681 . . . . 1.06 111.057 174.198 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -158.65 163.45 36.89 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.856 -0.794 . . . . 2.49 108.856 175.036 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.53 ' HB3' ' CD1' ' A' ' 111' ' ' TYR . 1.7 mm? -76.68 125.56 29.47 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.994 0.426 . . . . 1.23 110.709 -178.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.63 -25.83 65.93 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 113.314 0.857 . . . . 0.91 113.314 -174.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.53 ' CD1' ' HB3' ' A' ' 109' ' ' LEU . 2.6 p90 . . . . . 0 N--CA 1.468 0.429 0 CA-C-O 120.966 0.412 . . . . 1.4 111.295 -174.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 50.7 ttp . . . . . 0 CA--C 1.53 0.209 0 N-CA-C 112.461 0.541 . . . . 1.49 112.461 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.486 ' O ' HD11 ' A' ' 109' ' ' LEU . 39.4 m-85 -96.25 -11.73 25.58 Favored 'General case' 0 C--O 1.224 -0.256 0 O-C-N 121.911 -0.493 . . . . 1.5 111.253 -177.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.531 ' O ' ' HA ' ' A' ' 82' ' ' THR . 39.3 p -105.28 4.49 31.09 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 111.989 0.366 . . . . 0.53 111.989 -173.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -92.83 102.5 14.88 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.322 -0.399 . . . . 2.75 110.046 -178.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.414 HG23 ' O ' ' A' ' 108' ' ' ASN . 4.0 mp -103.42 135.33 41.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.76 0.314 . . . . 0.85 110.674 -177.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.654 ' HD2' HD21 ' A' ' 108' ' ' ASN . 51.5 t80 -94.78 109.38 21.35 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.412 -0.588 . . . . 0.71 109.412 175.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.572 HG11 HD11 ' A' ' 51' ' ' LEU . 5.5 t -97.89 142.94 13.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-N 115.469 -0.787 . . . . 0.92 110.634 -176.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -143.27 161.01 27.66 Favored Glycine 0 N--CA 1.447 -0.624 0 CA-C-N 114.538 -1.21 . . . . 0.84 111.717 -171.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 71.18 21.62 78.47 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.892 -0.671 . . . . 0.68 113.259 175.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.608 HD11 HD13 ' A' ' 51' ' ' LEU . 2.9 mm? -67.02 119.3 63.17 Favored Pre-proline 0 C--O 1.223 -0.319 0 N-CA-C 109.094 -0.706 . . . . 1.28 109.094 175.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.672 ' CG ' ' HB3' ' A' ' 101' ' ' ASP . 11.9 Cg_endo -56.3 158.87 14.17 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.372 2.048 . . . . 0.58 111.232 175.341 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -71.98 2.46 5.62 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.896 0.379 . . . . 1.05 111.649 -171.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 18.1 t-160 -95.7 -16.88 21.7 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.059 -0.519 . . . . 2.01 110.136 174.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.532 HG21 HD12 ' A' ' 42' ' ' LEU . 67.9 m -79.4 116.75 19.82 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.445 0.641 . . . . 0.72 112.278 -174.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 42.1 p -99.81 -177.64 3.62 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.31 -0.859 . . . . 0.55 110.19 172.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.555 ' HA ' HG23 ' A' ' 66' ' ' VAL . 4.6 m-20 -61.25 -35.1 76.34 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.453 0.644 . . . . 0.49 110.105 -178.091 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.654 ' O ' ' HG2' ' A' ' 53' ' ' GLU . 0.6 OUTLIER -74.52 -38.23 62.85 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.317 -0.856 . . . . 2.76 110.595 -178.56 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.454 ' HB ' HG23 ' A' ' 46' ' ' THR . 17.0 m -62.4 -43.17 99.45 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.267 0.556 . . . . 0.58 110.051 177.482 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.608 HD13 HD11 ' A' ' 42' ' ' LEU . 22.1 tp -66.15 -37.58 86.02 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 115.547 -0.751 . . . . 0.85 109.796 177.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 48.7 t-80 -58.44 -53.1 62.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.617 -0.719 . . . . 0.59 110.841 175.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.654 ' HG2' ' O ' ' A' ' 49' ' ' LYS . 21.3 mm-40 -58.14 -42.33 85.61 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.128 -0.487 . . . . 1.52 111.529 -177.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.448 ' O ' ' HB2' ' A' ' 57' ' ' GLN . 6.2 t80 -74.76 -33.61 62.35 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.16 -0.473 . . . . 1.12 111.762 -174.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.658 ' CB ' HD11 ' A' ' 61' ' ' ILE . 4.9 m-85 -86.2 -26.09 25.27 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 114.043 1.127 . . . . 0.56 114.043 -176.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.447 ' HA ' ' O ' ' A' ' 59' ' ' GLY . 7.9 pt-20 -72.78 -11.78 60.75 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 122.109 0.957 . . . . 1.57 109.553 179.5 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.448 ' HB2' ' O ' ' A' ' 54' ' ' TYR . 13.4 mm100 -55.69 -19.33 10.45 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.505 -1.225 . . . . 2.16 111.602 166.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -105.9 10.87 32.31 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.618 0.247 . . . . 0.71 110.786 -178.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.447 ' O ' ' HA ' ' A' ' 56' ' ' GLU . . . 125.61 -171.09 17.49 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.79 -0.719 . . . . 0.75 112.664 -177.03 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.4 ' CB ' ' HB3' ' A' ' 84' ' ' LYS . 0.8 OUTLIER -65.51 123.05 18.63 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.799 0.666 . . . . 1.02 112.799 -179.142 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.658 HD11 ' CB ' ' A' ' 55' ' ' PHE . 10.1 mt -93.52 122.81 45.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.168 -0.924 . . . . 0.47 108.767 169.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -78.05 -41.47 35.43 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.234 0.54 . . . . 2.07 110.078 177.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -162.56 131.05 4.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.695 -0.684 . . . . 2.48 110.756 -177.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -117.17 116.49 27.39 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.785 0.326 . . . . 0.44 110.192 177.008 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.2 m -126.9 112.42 28.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.663 0.744 . . . . 1.38 111.819 -178.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.555 HG23 ' HA ' ' A' ' 48' ' ' ASP . 70.1 t -79.25 131.52 34.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.547 -0.751 . . . . 0.49 109.591 179.017 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.609 ' H ' ' HA2' ' A' ' 79' ' ' GLY . 28.8 mm -71.48 140.67 17.84 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.697 0 N-CA-C 107.473 -1.306 . . . . 0.72 107.473 175.329 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.88 ' HA ' ' O ' ' A' ' 75' ' ' SER . 15.2 p . . . . . 0 N--CA 1.441 -0.918 0 N-CA-C 107.343 -1.355 . . . . 1.52 107.343 -159.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.88 ' O ' ' HA ' ' A' ' 68' ' ' THR . 5.3 p . . . . . 0 C--O 1.216 -0.692 0 CA-C-O 118.659 -0.686 . . . . 1.81 112.709 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.457 ' HB2' ' O ' ' A' ' 75' ' ' SER . 74.4 mtt180 112.23 -19.06 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 125.27 1.428 . . . . 2.56 111.729 -170.188 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 81.78 12.62 81.18 Favored Glycine 0 CA--C 1.526 0.719 0 C-N-CA 120.049 -1.072 . . . . 0.64 113.762 174.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -128.47 160.37 32.51 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.862 -0.792 . . . . 1.18 108.862 -177.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.609 ' HA2' ' H ' ' A' ' 67' ' ' ILE . . . 178.57 145.12 5.93 Favored Glycine 0 C--O 1.222 -0.651 0 C-N-CA 119.424 -1.37 . . . . 0.59 113.648 175.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.476 ' HD2' HD11 ' A' ' 67' ' ' ILE . 96.4 m-85 -98.67 137.62 37.03 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 122.188 0.994 . . . . 0.63 112.495 175.43 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 65.0 t -119.91 134.03 64.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 114.234 -1.348 . . . . 0.41 109.526 176.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.531 ' HA ' ' O ' ' A' ' 35' ' ' THR . 27.0 m -114.83 123.95 50.51 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 108.596 -0.891 . . . . 0.47 108.596 175.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.424 ' SD ' HG12 ' A' ' 61' ' ' ILE . 82.2 mmm -88.68 164.3 15.38 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.937 -0.764 . . . . 0.88 108.937 -178.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.448 ' HZ2' ' HB2' ' A' ' 84' ' ' LYS . 4.3 ttmp? -82.66 -18.27 41.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.173 0.511 . . . . 1.92 110.454 -176.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -143.03 146.91 34.29 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.158 -0.474 . . . . 1.68 109.85 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.571 ' O ' ' HG3' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -64.96 -25.17 67.76 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.051 0.389 . . . . 3.66 112.051 -178.821 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.524 ' O ' ' HG2' ' A' ' 91' ' ' ARG . . . -64.45 -44.98 89.39 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 121.621 -0.674 . . . . 0.66 111.743 178.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 18.3 m -66.92 -32.18 73.26 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.938 0.875 . . . . 0.78 109.665 176.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.441 ' HB3' ' O ' ' A' ' 86' ' ' ARG . . . -59.76 -47.03 87.33 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 113.652 -1.613 . . . . 0.46 109.596 175.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.571 ' HG3' ' O ' ' A' ' 86' ' ' ARG . 45.6 mt-10 -56.05 -50.84 69.83 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.751 -0.659 . . . . 2.11 111.385 174.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.524 ' HG2' ' O ' ' A' ' 87' ' ' ALA . 2.0 mmt180 -57.88 -44.87 86.95 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.672 0.272 . . . . 3.82 111.337 -177.318 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -55.79 -41.38 74.01 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.889 -0.596 . . . . 0.92 111.157 176.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 44.1 t -70.44 -20.14 62.92 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.598 -0.274 . . . . 1.16 111.676 178.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -76.61 7.28 4.72 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 112.412 0.523 . . . . 4.2 112.412 -178.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -144.01 93.09 6.13 Favored Pre-proline 0 C--N 1.322 -0.613 0 N-CA-C 108.633 -0.877 . . . . 2.24 108.633 -178.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -74.66 -28.87 9.45 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.499 2.133 . . . . 2.38 113.742 -172.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.537 ' HA ' ' O ' ' A' ' 105' ' ' ALA . 10.5 m120 -130.99 79.02 72.35 Favored Pre-proline 0 C--N 1.33 -0.25 0 N-CA-C 112.133 0.42 . . . . 3.03 112.133 -175.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.411 ' HB2' ' CE1' ' A' ' 54' ' ' TYR . 73.1 Cg_endo -81.57 141.32 12.34 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.755 2.304 . . . . 1.29 111.875 174.365 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 42.0 mm -83.32 90.07 2.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.139 0.495 . . . . 1.81 110.865 177.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 53.8 mt -92.96 135.31 28.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.601 -0.727 . . . . 0.99 111.148 175.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.672 ' HB3' ' CG ' ' A' ' 43' ' ' PRO . 38.8 t70 43.21 35.86 0.91 Allowed 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 115.733 -0.667 . . . . 1.37 112.477 -174.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 73.49 18.74 79.51 Favored Glycine 0 CA--C 1.519 0.306 0 C-N-CA 120.8 -0.714 . . . . 1.56 113.03 178.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 5.4 tpt180 -129.77 139.78 51.21 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.722 -0.844 . . . . 4.13 108.722 178.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 6.6 ttpm? -71.37 140.23 50.1 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.795 0.331 . . . . 2.73 110.171 179.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.537 ' O ' ' HA ' ' A' ' 97' ' ' ASN . . . -123.66 166.07 16.14 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.512 -0.313 . . . . 1.04 110.804 -171.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -111.65 146.54 37.26 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.038 -0.528 . . . . 2.04 110.34 -178.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 73.2 t -145.46 135.69 18.73 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 115.719 -0.673 . . . . 1.06 110.95 -173.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.654 HD21 ' HD2' ' A' ' 38' ' ' PHE . 9.3 p30 -167.17 161.87 14.82 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 109.6 -0.518 . . . . 2.49 109.6 173.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.486 HD11 ' O ' ' A' ' 34' ' ' PHE . 1.6 mm? -77.22 120.31 22.09 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.263 -0.643 . . . . 1.23 109.263 173.259 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -56.19 -36.23 68.16 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.545 0.572 . . . . 0.91 112.545 -172.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 5.6 p90 . . . . . 0 C--N 1.327 -0.408 0 C-N-CA 120.854 -0.338 . . . . 1.4 111.537 -174.967 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 13.8 tmm? . . . . . 0 CA--C 1.531 0.239 0 N-CA-C 111.851 0.315 . . . . 1.49 111.851 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.552 ' O ' HD11 ' A' ' 109' ' ' LEU . 18.2 m-85 -92.96 -13.43 28.81 Favored 'General case' 0 C--O 1.225 -0.201 0 O-C-N 122.013 -0.429 . . . . 1.5 111.482 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.52 ' HB ' ' O ' ' A' ' 83' ' ' MET . 31.7 p -94.38 -6.09 44.97 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.998 0.428 . . . . 0.53 111.102 -174.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.456 ' O ' HD13 ' A' ' 109' ' ' LEU . 13.8 tptm -84.67 103.7 14.01 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.789 -0.641 . . . . 2.75 110.357 -177.092 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.635 HD11 ' HA ' ' A' ' 89' ' ' ALA . 28.7 mt -98.78 139.03 21.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 121.339 0.59 . . . . 0.85 112.486 -174.226 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.419 ' HD1' ' CE2' ' A' ' 80' ' ' PHE . 68.8 t80 -105.59 111.76 24.58 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.31 -0.859 . . . . 0.71 108.976 174.538 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.42 HG13 HG22 ' A' ' 107' ' ' VAL . 5.3 t -99.29 139.34 21.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.068 0.461 . . . . 0.92 110.042 -178.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -140.53 138.11 8.76 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.268 -0.968 . . . . 0.84 113.396 -170.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 84.9 31.15 24.32 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 121.486 -0.388 . . . . 0.68 112.498 176.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.69 HD12 HG21 ' A' ' 46' ' ' THR . 3.3 mm? -67.24 129.15 93.86 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-O 120.564 0.221 . . . . 1.28 110.809 178.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.546 ' HG3' ' HB2' ' A' ' 103' ' ' ARG . 65.5 Cg_exo -54.97 159.73 9.0 Favored 'Trans proline' 0 CA--C 1.529 0.271 0 C-N-CA 123.448 2.765 . . . . 0.58 112.923 172.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.689 ' HA ' ' HB2' ' A' ' 75' ' ' SER . 6.8 m-30 -69.18 -9.67 54.04 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.738 -0.664 . . . . 1.05 112.486 -174.146 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . 0.414 ' HB3' ' OD2' ' A' ' 101' ' ' ASP . 44.5 t60 -104.23 -1.18 27.47 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.054 0.454 . . . . 2.01 110.368 178.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.69 HG21 HD12 ' A' ' 42' ' ' LEU . 85.3 m -73.3 116.4 13.8 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.639 0.733 . . . . 0.72 111.362 -177.631 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 6.1 p -110.74 -178.91 3.6 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.631 -1.168 . . . . 0.55 110.503 176.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -62.36 -35.94 80.71 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.334 0.588 . . . . 0.49 110.284 -175.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.667 ' O ' ' HG2' ' A' ' 53' ' ' GLU . 43.0 pttt -65.13 -35.13 80.14 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.336 -0.847 . . . . 2.76 110.821 179.498 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 6.4 m -67.51 -44.8 77.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.551 -0.295 . . . . 0.58 111.049 -178.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.675 HD21 HD11 ' A' ' 42' ' ' LEU . 22.1 mt -64.99 -33.99 77.36 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-O 120.855 0.36 . . . . 0.85 110.296 175.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.449 ' HA ' ' CD1' ' A' ' 61' ' ' ILE . 49.3 t-80 -64.95 -54.47 30.14 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 116.017 -0.538 . . . . 0.59 110.453 -179.214 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.667 ' HG2' ' O ' ' A' ' 49' ' ' LYS . 13.6 mm-40 -56.41 -51.1 69.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.252 -0.431 . . . . 1.52 111.777 -179.123 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.536 ' O ' ' HB2' ' A' ' 57' ' ' GLN . 2.1 t80 -70.44 -33.31 71.17 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 112.765 0.654 . . . . 1.12 112.765 -173.077 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.88 ' HB2' HD11 ' A' ' 61' ' ' ILE . 11.3 m-85 -85.44 -35.29 21.35 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 114.436 1.273 . . . . 0.56 114.436 -172.05 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.626 ' HB3' HG13 ' A' ' 61' ' ' ILE . 13.5 pt-20 -77.99 -6.56 54.87 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 119.747 1.158 . . . . 1.57 110.189 179.113 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.536 ' HB2' ' O ' ' A' ' 54' ' ' TYR . 11.7 mm100 -57.41 -9.83 1.19 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.454 -0.794 . . . . 2.16 112.028 162.369 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -104.3 -21.95 13.43 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.234 -0.439 . . . . 0.71 109.99 177.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.51 ' HA3' ' OG ' ' A' ' 88' ' ' SER . . . 169.91 -116.28 0.64 Allowed Glycine 0 C--O 1.226 -0.398 0 CA-C-N 115.856 -0.611 . . . . 0.75 112.061 -179.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -115.36 128.1 55.85 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.942 0.371 . . . . 1.02 110.617 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.88 HD11 ' HB2' ' A' ' 55' ' ' PHE . 25.5 mt -97.13 124.27 49.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 109.776 -0.454 . . . . 0.47 109.776 170.236 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -88.8 -32.02 18.06 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.161 0.505 . . . . 2.07 110.257 178.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -161.06 126.67 3.77 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.965 -0.561 . . . . 2.48 110.483 179.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -117.53 124.66 49.25 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.834 0.35 . . . . 0.44 110.209 171.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.3 p -141.4 112.63 3.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 121.956 0.884 . . . . 1.38 111.991 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.525 HG22 HD12 ' A' ' 51' ' ' LEU . 23.0 t -79.37 129.06 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 CA-C-N 115.079 -0.964 . . . . 0.49 108.77 177.218 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.564 ' H ' ' HA2' ' A' ' 79' ' ' GLY . 44.5 mm -73.7 85.39 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 CA-C-O 121.699 0.761 . . . . 0.72 109.714 -178.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.656 HG22 ' HA ' ' A' ' 75' ' ' SER . 23.9 p . . . . . 0 C--N 1.31 -1.149 0 CA-C-N 114.652 -1.158 . . . . 1.52 110.438 178.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.689 ' HB2' ' HA ' ' A' ' 44' ' ' TYR . 15.5 m . . . . . 0 N--CA 1.464 0.253 0 N-CA-C 113.699 1.0 . . . . 1.81 113.699 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.507 ' HD2' ' O ' ' A' ' 67' ' ' ILE . 14.4 mtt180 -56.08 -25.59 46.1 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 114.249 -1.341 . . . . 2.56 111.903 177.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.476 ' HA2' ' O ' ' A' ' 42' ' ' LEU . . . 102.48 3.94 49.94 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.645 -0.788 . . . . 0.64 111.633 -174.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 -114.84 146.99 40.47 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.663 -0.495 . . . . 1.18 109.663 177.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.564 ' HA2' ' H ' ' A' ' 67' ' ' ILE . . . -170.08 140.85 6.25 Favored Glycine 0 C--O 1.224 -0.512 0 C-N-CA 120.525 -0.845 . . . . 0.59 112.091 171.305 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.419 ' CE2' ' HD1' ' A' ' 38' ' ' PHE . 59.4 m-85 -103.84 144.94 30.83 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 122.26 1.029 . . . . 0.63 113.279 175.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 55.7 t -123.65 130.52 74.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 113.739 -1.573 . . . . 0.41 109.216 176.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 19.2 m -110.59 106.23 15.43 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 107.827 -1.175 . . . . 0.47 107.827 177.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.52 ' O ' ' HB ' ' A' ' 35' ' ' THR . 51.4 mtp -89.35 157.82 18.03 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 120.38 -0.528 . . . . 0.88 109.74 -175.121 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 23.1 tttm -84.01 -11.06 57.37 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.469 -0.332 . . . . 1.92 111.746 -171.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -147.81 147.55 29.95 Favored 'General case' 0 C--O 1.245 0.864 0 CA-C-O 121.585 0.707 . . . . 1.68 111.857 175.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 15.7 ptt180 -65.13 -28.05 69.15 Favored 'General case' 0 C--O 1.212 -0.908 0 CA-C-N 114.974 -1.012 . . . . 3.66 113.471 -174.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.46 -50.46 65.29 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 119.554 1.07 . . . . 0.66 111.629 -175.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.51 ' OG ' ' HA3' ' A' ' 59' ' ' GLY . 14.6 m -63.2 -39.69 95.35 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.474 0.654 . . . . 0.78 110.231 177.092 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.635 ' HA ' HD11 ' A' ' 37' ' ' ILE . . . -59.37 -50.37 74.23 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 114.529 -1.214 . . . . 0.46 110.49 178.172 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.688 ' O ' ' HG2' ' A' ' 94' ' ' LYS . 4.4 mm-40 -56.41 -50.73 70.79 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.034 -0.985 . . . . 2.11 112.258 176.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -58.93 -45.86 89.38 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 111.914 0.339 . . . . 3.82 111.914 -177.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -56.13 -35.15 66.8 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.006 0.431 . . . . 0.92 111.099 177.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 36.8 t -76.47 -26.79 55.73 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.326 -0.397 . . . . 1.16 112.0 176.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.688 ' HG2' ' O ' ' A' ' 90' ' ' GLU . 32.5 mmtm -72.97 -44.27 61.29 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 120.71 0.29 . . . . 4.2 111.155 -175.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -112.12 89.45 11.96 Favored Pre-proline 0 C--N 1.324 -0.508 0 N-CA-C 109.502 -0.555 . . . . 2.24 109.502 174.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.586 ' HB3' ' O ' ' A' ' 107' ' ' VAL . 73.5 Cg_endo -87.73 77.96 1.66 Allowed 'Trans proline' 0 N--CA 1.447 -1.221 0 C-N-CA 122.661 2.241 . . . . 2.38 111.909 -176.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 30.7 m-80 -154.66 39.98 0.13 Allowed Pre-proline 0 CA--C 1.54 0.573 0 CA-C-N 116.1 -0.5 . . . . 3.03 112.312 -175.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.696 ' HD2' ' O ' ' A' ' 105' ' ' ALA . 67.9 Cg_endo -72.36 121.4 7.44 Favored 'Trans proline' 0 C--N 1.352 0.762 0 CA-C-N 120.543 1.23 . . . . 1.29 112.646 -176.316 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 47.4 mm -71.85 91.49 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.966 0.889 . . . . 1.81 110.547 173.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 72.7 mt -106.89 131.98 55.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 114.717 -1.129 . . . . 0.99 110.309 -179.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.535 ' HB3' ' HG2' ' A' ' 43' ' ' PRO . 25.9 t70 45.07 30.0 0.55 Allowed 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 113.337 0.866 . . . . 1.37 113.337 178.248 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 86.88 21.66 49.33 Favored Glycine 0 CA--C 1.521 0.437 0 C-N-CA 120.497 -0.858 . . . . 1.56 113.034 177.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.546 ' HB2' ' HG3' ' A' ' 43' ' ' PRO . 83.0 mmt-85 -138.81 151.74 47.29 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.116 -0.698 . . . . 4.13 109.116 177.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -95.99 106.15 18.27 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 119.298 -0.961 . . . . 2.73 109.284 172.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.696 ' O ' ' HD2' ' A' ' 98' ' ' PRO . . . -86.37 167.27 14.89 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.482 0.658 . . . . 1.04 112.432 174.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -114.15 128.92 56.59 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.02 -0.991 . . . . 2.04 110.147 -177.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.586 ' O ' ' HB3' ' A' ' 96' ' ' PRO . 57.5 t -119.61 147.99 22.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.418 -0.355 . . . . 1.06 110.542 -175.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -160.53 172.97 16.24 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.579 0.228 . . . . 2.49 110.593 177.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.552 HD11 ' O ' ' A' ' 34' ' ' PHE . 0.6 OUTLIER -79.68 130.19 35.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.617 0.246 . . . . 1.23 110.408 179.401 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.52 -33.67 76.45 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.716 0.636 . . . . 0.91 112.716 -174.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.419 ' HD1' HD12 ' A' ' 109' ' ' LEU . 7.1 p90 . . . . . 0 C--N 1.33 -0.254 0 CA-C-O 120.781 0.324 . . . . 1.4 111.737 -173.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 59.9 ttp . . . . . 0 N--CA 1.454 -0.227 0 N-CA-C 111.648 0.24 . . . . 1.49 111.648 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.601 ' HA ' HD11 ' A' ' 109' ' ' LEU . 50.2 m-85 -103.47 -21.06 13.84 Favored 'General case' 0 C--O 1.226 -0.17 0 O-C-N 122.043 -0.41 . . . . 1.5 110.79 -177.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.757 ' O ' ' HA ' ' A' ' 82' ' ' THR . 28.7 p -84.8 14.21 5.01 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.303 0.573 . . . . 0.53 110.631 -175.072 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.459 ' O ' HD13 ' A' ' 109' ' ' LEU . 6.9 ttpt -121.21 102.45 8.31 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.355 -0.839 . . . . 2.75 109.227 -173.093 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.5 HG22 HG23 ' A' ' 39' ' ' VAL . 5.3 mp -109.42 126.85 66.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 116.119 -0.491 . . . . 0.85 111.042 -175.294 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.473 ' HD1' ' CZ ' ' A' ' 80' ' ' PHE . 80.3 t80 -85.76 115.83 23.65 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.487 -0.56 . . . . 0.71 109.487 175.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.708 HG13 HG22 ' A' ' 107' ' ' VAL . 91.6 t -133.05 97.32 2.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-O 118.405 -0.807 . . . . 0.92 110.282 -179.25 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.575 ' HA2' HD13 ' A' ' 42' ' ' LEU . . . -117.61 -156.24 10.34 Favored Glycine 0 C--O 1.215 -1.081 0 C-N-CA 115.838 -3.077 . . . . 0.84 113.721 162.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 88.67 12.0 65.09 Favored Glycine 0 N--CA 1.45 -0.4 0 N-CA-C 110.032 -1.227 . . . . 0.68 110.032 -171.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.575 HD13 ' HA2' ' A' ' 40' ' ' GLY . 7.7 mp -75.54 137.95 70.82 Favored Pre-proline 0 N--CA 1.447 -0.591 0 CA-C-N 114.626 -0.787 . . . . 1.28 110.716 -177.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.493 ' HG3' ' CG ' ' A' ' 103' ' ' ARG . 42.5 Cg_exo -55.33 159.89 9.65 Favored 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 123.029 2.486 . . . . 0.58 111.678 173.304 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 44.1 m-85 -65.1 -22.16 66.91 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.165 0.431 . . . . 1.05 112.165 -175.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 23.0 t60 -86.09 -25.49 25.8 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 120.917 0.389 . . . . 2.01 110.44 178.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.729 HG23 HG21 ' A' ' 50' ' ' THR . 19.1 m -66.91 130.08 41.98 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.704 -0.68 . . . . 0.72 110.302 -176.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 9.0 p -137.33 -176.65 4.47 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.033 -0.53 . . . . 0.55 111.871 -170.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -55.72 -35.4 66.07 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.559 -0.746 . . . . 0.49 110.126 -176.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.678 ' O ' ' HG2' ' A' ' 53' ' ' GLU . 9.5 ptpp? -66.54 -36.85 83.68 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.045 -0.98 . . . . 2.76 109.85 -177.053 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.729 HG21 HG23 ' A' ' 46' ' ' THR . 53.9 m -63.63 -45.56 89.72 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.797 -0.638 . . . . 0.58 110.89 179.055 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.415 HD23 ' HA ' ' A' ' 51' ' ' LEU . 63.1 mt -67.85 -39.16 83.86 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.75 -0.659 . . . . 0.85 111.237 -179.047 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 56.1 t-80 -55.31 -51.3 67.16 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.209 -0.451 . . . . 0.59 109.972 175.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.678 ' HG2' ' O ' ' A' ' 49' ' ' LYS . 10.9 mm-40 -64.9 -47.88 76.2 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.832 -0.622 . . . . 1.52 112.489 -176.454 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.404 ' O ' ' HB2' ' A' ' 57' ' ' GLN . 66.1 t80 -77.35 -36.85 53.41 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 121.054 0.454 . . . . 1.12 111.701 -170.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.578 ' CB ' HD11 ' A' ' 61' ' ' ILE . 14.3 m-85 -84.01 -25.81 29.64 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.655 0.613 . . . . 0.56 112.655 -174.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.635 ' HA ' ' O ' ' A' ' 59' ' ' GLY . 6.1 pt-20 -70.77 -9.72 57.98 Favored 'General case' 0 N--CA 1.461 0.101 0 CA-C-O 121.487 0.66 . . . . 1.57 109.872 178.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.404 ' HB2' ' O ' ' A' ' 54' ' ' TYR . 27.4 mm-40 -60.39 -25.84 66.2 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.091 -0.959 . . . . 2.16 110.967 170.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -88.08 -28.74 21.13 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.31 0.576 . . . . 0.71 110.036 178.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.635 ' O ' ' HA ' ' A' ' 56' ' ' GLU . . . 170.36 178.5 41.23 Favored Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 110.771 -0.932 . . . . 0.75 110.771 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -63.72 130.19 43.22 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 117.35 0.575 . . . . 1.02 109.65 -178.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.578 HD11 ' CB ' ' A' ' 55' ' ' PHE . 60.6 mt -97.72 125.74 50.82 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 110.376 -0.231 . . . . 0.47 110.376 177.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -66.56 -42.04 87.7 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 121.111 0.481 . . . . 2.07 110.721 177.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -161.97 142.28 10.3 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 115.457 -0.792 . . . . 2.48 111.061 -178.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -120.08 122.94 42.17 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.692 -0.685 . . . . 0.44 109.717 174.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.6 p -136.7 122.64 28.39 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-N 114.995 -1.002 . . . . 1.38 112.566 -174.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 54.6 t -101.43 134.14 42.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.697 -0.683 . . . . 0.49 109.423 173.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.482 ' O ' ' HB2' ' A' ' 76' ' ' ARG . 50.7 mm -86.08 100.43 9.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 121.192 0.52 . . . . 0.72 110.271 -174.012 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.4 HG22 ' HA ' ' A' ' 75' ' ' SER . 20.2 p . . . . . 0 C--N 1.318 -0.775 0 CA-C-N 115.633 -0.712 . . . . 1.52 110.109 174.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.4 ' HA ' HG22 ' A' ' 68' ' ' THR . 13.7 m . . . . . 0 N--CA 1.457 -0.115 0 CA-C-O 120.903 0.382 . . . . 1.81 111.331 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.482 ' HB2' ' O ' ' A' ' 67' ' ' ILE . 44.1 mtt180 -63.4 -18.99 64.29 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.912 -0.585 . . . . 2.56 111.313 175.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 79.73 24.44 60.28 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.81 -0.709 . . . . 0.64 113.389 173.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.475 ' HA ' ' CA ' ' A' ' 40' ' ' GLY . 14.0 m-85 -128.14 149.46 50.41 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 107.851 -1.166 . . . . 1.18 107.851 176.373 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -145.35 -173.55 16.72 Favored Glycine 0 N--CA 1.441 -0.99 0 C-N-CA 119.753 -1.213 . . . . 0.59 112.845 176.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.473 ' CZ ' ' HD1' ' A' ' 38' ' ' PHE . 59.1 m-85 -144.59 125.98 14.86 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 108.375 -0.972 . . . . 0.63 108.375 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 30.9 t -108.15 110.93 33.76 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 N-CA-C 109.464 -0.569 . . . . 0.41 109.464 177.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.757 ' HA ' ' O ' ' A' ' 35' ' ' THR . 28.4 m -105.52 103.72 13.3 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.47 -0.937 . . . . 0.47 108.47 177.459 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.44 ' HA ' ' HA ' ' A' ' 61' ' ' ILE . 48.6 mtp -89.16 173.8 8.22 Favored 'General case' 0 N--CA 1.448 -0.546 0 O-C-N 121.795 -0.565 . . . . 0.88 111.301 -170.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 23.2 tptt -69.52 -41.59 75.82 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.053 -0.522 . . . . 1.92 110.502 -175.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -131.99 153.71 50.07 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 121.087 0.47 . . . . 1.68 111.598 -178.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.495 ' CD ' ' H ' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -73.01 -20.76 60.94 Favored 'General case' 0 C--O 1.221 -0.399 0 CA-C-N 115.414 -0.812 . . . . 3.66 112.681 -172.762 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.64 -49.97 68.93 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 118.336 0.516 . . . . 0.66 111.403 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 15.3 m -70.45 -33.99 71.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.543 0.687 . . . . 0.78 109.739 177.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.515 ' CB ' ' HA ' ' A' ' 35' ' ' THR . . . -56.85 -45.6 82.32 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-N 114.472 -1.24 . . . . 0.46 109.658 174.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.602 ' O ' ' HG2' ' A' ' 94' ' ' LYS . 2.4 mm-40 -55.67 -45.59 77.69 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.618 -0.719 . . . . 2.11 110.78 173.021 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 8.3 mmm180 -57.86 -42.09 83.77 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.715 0.293 . . . . 3.82 111.007 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -58.03 -36.52 72.84 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.75 -0.659 . . . . 0.92 111.631 176.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 37.2 t -84.16 -22.95 30.81 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 112.016 0.376 . . . . 1.16 112.016 179.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.602 ' HG2' ' O ' ' A' ' 90' ' ' GLU . 67.8 mmtt -56.33 -48.32 76.98 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 112.742 0.645 . . . . 4.2 112.742 -175.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.45 ' HA ' ' HD3' ' A' ' 96' ' ' PRO . 28.9 t0 -104.91 101.47 29.7 Favored Pre-proline 0 C--N 1.325 -0.462 0 C-N-CA 120.673 -0.411 . . . . 2.24 110.507 -178.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 95' ' ' ASP . 5.7 Cg_exo -80.08 172.74 13.52 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 123.211 2.607 . . . . 2.38 112.936 -175.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.474 ' N ' ' HD3' ' A' ' 98' ' ' PRO . 4.2 p30 31.91 62.45 1.24 Allowed Pre-proline 0 N--CA 1.473 0.707 0 CA-C-N 115.092 -0.958 . . . . 3.03 113.489 -172.431 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.474 ' HD3' ' N ' ' A' ' 97' ' ' ASN . 2.0 Cg_endo -81.15 167.32 17.91 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 123.356 2.704 . . . . 1.29 111.28 176.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 51.0 mm -99.07 135.56 33.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 108.072 -1.084 . . . . 1.81 108.072 178.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 71.6 mt -144.91 108.6 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 N-CA-C 109.453 -0.573 . . . . 0.99 109.453 -172.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 19.1 t0 60.2 52.67 4.85 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.782 0.801 . . . . 1.37 111.003 176.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 77.34 -6.99 40.83 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 115.653 1.021 . . . . 1.56 115.653 177.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.493 ' CG ' ' HG3' ' A' ' 43' ' ' PRO . 27.2 mmt180 -131.62 150.49 52.13 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 118.919 1.36 . . . . 4.13 111.106 -179.282 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -77.19 130.95 37.96 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.892 -0.594 . . . . 2.73 110.913 178.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -107.14 146.93 30.69 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.662 -0.699 . . . . 1.04 110.945 -175.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 39.3 m-20 -96.28 129.37 43.62 Favored 'General case' 0 C--O 1.251 1.163 0 CA-C-O 121.725 0.774 . . . . 2.04 110.011 173.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.708 HG22 HG13 ' A' ' 39' ' ' VAL . 73.3 t -142.26 131.28 22.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 112.942 -1.936 . . . . 1.06 110.462 -161.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 8.4 m-20 -166.6 158.58 13.42 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 123.709 0.63 . . . . 2.49 109.467 175.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.601 HD11 ' HA ' ' A' ' 34' ' ' PHE . 0.2 OUTLIER -58.16 150.16 22.06 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.19 -1.041 . . . . 1.23 108.19 172.35 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.51 -34.12 73.82 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.18 0.514 . . . . 0.91 110.311 -168.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 16.6 p90 . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 115.583 -0.735 . . . . 1.4 110.678 -176.368 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 55.5 ttp . . . . . 0 C--O 1.227 -0.092 0 N-CA-C 111.983 0.364 . . . . 1.49 111.983 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -96.36 -6.21 38.15 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.771 -0.371 . . . . 1.5 111.793 -177.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.679 ' O ' ' HA ' ' A' ' 82' ' ' THR . 34.2 p -102.78 -5.05 24.08 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.746 0.307 . . . . 0.53 111.371 -176.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.612 ' HG3' ' HB3' ' A' ' 110' ' ' ALA . 18.4 tptm -92.67 101.49 13.9 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.274 0.559 . . . . 2.75 110.461 -175.297 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.429 HG22 HG23 ' A' ' 39' ' ' VAL . 32.8 mt -107.85 132.92 54.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.724 -0.671 . . . . 0.85 110.449 -177.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.568 ' HD1' ' CE1' ' A' ' 80' ' ' PHE . 88.4 t80 -99.84 116.09 31.11 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.033 -0.728 . . . . 0.71 109.033 173.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.649 HG22 HG22 ' A' ' 107' ' ' VAL . 95.7 t -132.31 106.22 10.55 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.886 0 CA-C-O 118.803 -0.618 . . . . 0.92 110.067 -178.202 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.888 ' HA3' ' HD1' ' A' ' 78' ' ' TYR . . . -122.82 -154.74 9.14 Favored Glycine 0 N--CA 1.44 -1.073 0 C-N-CA 115.979 -3.01 . . . . 0.84 113.267 159.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 85.62 8.02 80.93 Favored Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 110.265 -1.134 . . . . 0.68 110.265 -174.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.739 ' HB3' ' HB ' ' A' ' 46' ' ' THR . 5.7 mp -69.55 135.57 88.37 Favored Pre-proline 0 N--CA 1.45 -0.448 0 CA-C-N 114.989 -0.605 . . . . 1.28 109.899 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 1.009 ' HG2' ' HB3' ' A' ' 101' ' ' ASP . 53.8 Cg_exo -49.88 158.85 1.89 Allowed 'Trans proline' 0 N--CA 1.463 -0.291 0 C-N-CA 123.146 2.564 . . . . 0.58 112.128 174.419 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 51.7 m-85 -66.72 -9.61 38.22 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 113.439 0.903 . . . . 1.05 113.439 -171.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 1.7 p80 -111.71 0.76 16.4 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.124 -0.631 . . . . 2.01 110.77 176.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.739 ' HB ' ' HB3' ' A' ' 42' ' ' LEU . 5.8 m -79.53 118.52 21.46 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.504 -0.554 . . . . 0.72 109.504 176.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.432 ' HA ' HG21 ' A' ' 66' ' ' VAL . 6.2 p -123.93 -177.95 3.91 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.116 -0.493 . . . . 0.55 112.303 -168.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -54.19 -30.84 51.07 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.628 -0.715 . . . . 0.49 110.79 -178.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.544 ' O ' ' HG2' ' A' ' 53' ' ' GLU . 23.2 pttm -74.92 -34.3 62.11 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.653 -0.703 . . . . 2.76 109.842 -178.114 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.601 HG21 HG23 ' A' ' 46' ' ' THR . 6.1 m -67.12 -45.18 77.95 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 116.535 -0.302 . . . . 0.58 110.514 -178.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.71 HD21 HD21 ' A' ' 42' ' ' LEU . 39.2 mt -62.07 -46.95 86.83 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-O 120.994 0.426 . . . . 0.85 109.974 175.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.534 ' HA ' HD12 ' A' ' 61' ' ' ILE . 55.1 t-80 -55.95 -51.28 68.24 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 115.687 -0.688 . . . . 0.59 110.574 179.388 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.544 ' HG2' ' O ' ' A' ' 49' ' ' LYS . 21.5 mm-40 -65.25 -36.54 84.45 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 112.311 0.486 . . . . 1.52 112.311 -176.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.7 ' O ' ' HB2' ' A' ' 57' ' ' GLN . 25.7 t80 -77.79 -34.87 52.04 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 118.128 0.422 . . . . 1.12 111.594 -178.383 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.482 ' CD2' HG11 ' A' ' 81' ' ' VAL . 25.9 m-85 -84.91 -28.88 25.63 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 112.892 0.701 . . . . 0.56 112.892 -175.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.583 ' HA ' ' O ' ' A' ' 59' ' ' GLY . 34.4 mm-40 -57.36 -24.72 57.04 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-O 122.563 1.173 . . . . 1.57 109.413 174.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.7 ' HB2' ' O ' ' A' ' 54' ' ' TYR . 69.1 mt-30 -60.27 -31.68 70.46 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 112.971 -1.922 . . . . 2.16 112.27 176.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.451 ' HD2' ' HA ' ' A' ' 55' ' ' PHE . 86.5 m-85 -89.12 -27.21 20.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.329 0.585 . . . . 0.71 109.463 177.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.583 ' O ' ' HA ' ' A' ' 56' ' ' GLU . . . 162.47 -172.28 38.51 Favored Glycine 0 N--CA 1.443 -0.864 0 CA-C-N 115.006 -0.997 . . . . 0.75 111.697 177.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -64.73 126.26 27.37 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.707 0.289 . . . . 1.02 110.801 -177.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.534 HD12 ' HA ' ' A' ' 52' ' ' HIS . 8.2 mt -99.98 124.31 53.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.101 -0.703 . . . . 0.47 109.101 177.295 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -78.97 -41.94 28.0 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.009 0.433 . . . . 2.07 111.608 179.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.574 ' HB3' ' HB ' ' A' ' 82' ' ' THR . 8.7 tp10 -139.89 126.6 20.55 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.974 -0.557 . . . . 2.48 111.013 -172.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -127.89 125.84 40.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.679 0.752 . . . . 0.44 110.883 174.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.502 ' CG1' ' HB2' ' A' ' 80' ' ' PHE . 7.1 p -145.62 136.17 18.92 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 CA-C-N 114.546 -1.206 . . . . 1.38 113.057 -178.098 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.432 HG21 ' HA ' ' A' ' 47' ' ' SER . 75.2 t -102.18 124.9 56.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.296 -0.865 . . . . 0.49 108.855 167.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.548 HG12 ' HA2' ' A' ' 79' ' ' GLY . 35.2 mm -81.1 103.05 7.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.785 -0.643 . . . . 0.72 110.672 -174.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 17.0 p . . . . . 0 C--N 1.316 -0.856 0 CA-C-N 115.326 -0.852 . . . . 1.52 110.638 176.772 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 35.2 t . . . . . 0 N--CA 1.453 -0.285 0 CA-C-O 121.291 0.567 . . . . 1.81 110.479 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.412 ' HB2' ' O ' ' A' ' 67' ' ' ILE . 64.3 mtt180 -61.48 -11.74 11.99 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.503 -0.772 . . . . 2.56 111.52 173.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 78.5 11.14 85.59 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.97 -0.633 . . . . 0.64 112.714 176.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.888 ' HD1' ' HA3' ' A' ' 40' ' ' GLY . 29.9 m-85 -114.78 161.66 17.9 Favored 'General case' 0 CA--C 1.504 -0.821 0 N-CA-C 109.807 -0.442 . . . . 1.18 109.807 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.548 ' HA2' HG12 ' A' ' 67' ' ' ILE . . . -161.67 -166.92 21.33 Favored Glycine 0 N--CA 1.438 -1.185 0 C-N-CA 119.855 -1.164 . . . . 0.59 112.432 168.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.568 ' CE1' ' HD1' ' A' ' 38' ' ' PHE . 62.9 m-85 -135.95 132.98 37.12 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.018 -0.734 . . . . 0.63 109.018 179.124 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.482 HG11 ' CD2' ' A' ' 55' ' ' PHE . 41.1 t -119.94 109.96 27.61 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-O 121.392 0.615 . . . . 0.41 110.012 175.334 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.679 ' HA ' ' O ' ' A' ' 35' ' ' THR . 11.2 m -107.96 112.01 24.38 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 107.663 -1.236 . . . . 0.47 107.663 174.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.438 ' HA ' ' HA ' ' A' ' 61' ' ' ILE . 55.6 mtp -90.23 166.99 13.04 Favored 'General case' 0 N--CA 1.447 -0.586 0 O-C-N 121.412 -0.805 . . . . 0.88 109.162 -173.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -79.44 -17.27 54.61 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.816 0.341 . . . . 1.92 110.945 -173.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -145.01 146.75 32.04 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.281 -0.418 . . . . 1.68 110.235 -179.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.828 ' HD3' ' H ' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -72.77 -22.11 60.9 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.91 0.707 . . . . 3.66 112.91 -174.096 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.432 ' O ' ' HG3' ' A' ' 91' ' ' ARG . . . -72.16 -37.45 69.36 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.054 0.454 . . . . 0.66 111.07 -178.002 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.535 ' OG ' ' HA3' ' A' ' 59' ' ' GLY . 21.1 m -72.64 -37.94 67.85 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.712 0.768 . . . . 0.78 109.666 174.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.78 -41.96 83.14 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.061 -1.427 . . . . 0.46 109.333 175.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -54.69 -48.53 72.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.042 -0.981 . . . . 2.11 111.507 171.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.49 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 96.7 mtt180 -59.98 -38.84 83.73 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.258 -0.428 . . . . 3.82 110.951 -179.4 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -59.12 -46.37 88.51 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.028 -0.533 . . . . 0.92 111.658 174.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 51.7 t -76.58 -8.76 57.86 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 111.707 0.262 . . . . 1.16 111.707 -178.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.49 ' HB2' ' O ' ' A' ' 91' ' ' ARG . 39.7 mmtm -58.03 -41.63 83.61 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.661 -0.245 . . . . 4.2 110.951 177.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -103.44 104.67 42.86 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 109.56 -0.533 . . . . 2.24 109.56 174.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.564 ' O ' ' HB2' ' A' ' 97' ' ' ASN . 39.8 Cg_endo -84.94 102.6 0.81 Allowed 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 122.631 2.221 . . . . 2.38 113.427 -174.11 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.565 ' ND2' ' H ' ' A' ' 107' ' ' VAL . 10.8 m120 89.03 54.66 0.03 OUTLIER Pre-proline 0 N--CA 1.476 0.862 0 CA-C-N 114.39 -1.277 . . . . 3.03 110.266 174.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.551 ' O ' HG13 ' A' ' 100' ' ' ILE . 90.1 Cg_endo -82.75 116.85 2.58 Favored 'Trans proline' 0 N--CA 1.45 -1.037 0 C-N-CA 121.49 1.46 . . . . 1.29 112.767 -177.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.98 ' HA ' ' HA ' ' A' ' 104' ' ' LYS . 1.2 mt -25.47 131.39 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.49 -0.777 . . . . 1.81 112.866 151.364 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.551 HG13 ' O ' ' A' ' 98' ' ' PRO . 61.0 mt -148.46 126.99 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 N-CA-C 106.151 -1.796 . . . . 0.99 106.151 -178.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 1.009 ' HB3' ' HG2' ' A' ' 43' ' ' PRO . 10.3 t0 65.06 41.18 4.72 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 122.245 1.021 . . . . 1.37 109.164 -178.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 70.27 -8.14 4.13 Favored Glycine 0 CA--C 1.529 0.921 0 CA-C-N 114.708 -1.133 . . . . 1.56 115.529 -179.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.666 ' CG ' ' HG3' ' A' ' 43' ' ' PRO . 34.8 mmt180 -117.5 134.27 55.04 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 119.317 1.559 . . . . 4.13 110.629 178.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.98 ' HA ' ' HA ' ' A' ' 99' ' ' ILE . 4.7 ttpm? -63.98 128.46 35.9 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 121.382 -0.127 . . . . 2.73 111.267 -177.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -100.16 152.52 20.16 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 120.956 0.408 . . . . 1.04 111.109 -177.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.524 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 9.0 t30 -102.2 124.69 48.23 Favored 'General case' 0 C--O 1.243 0.726 0 CA-C-N 116.179 -0.464 . . . . 2.04 109.905 177.27 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.649 HG22 HG22 ' A' ' 39' ' ' VAL . 94.7 t -139.37 128.44 28.92 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.125 0 O-C-N 124.842 1.339 . . . . 1.06 110.505 -164.296 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 33.5 p30 -160.25 157.36 28.02 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.388 -0.369 . . . . 2.49 110.011 171.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.581 ' HB3' ' CE1' ' A' ' 111' ' ' TYR . 3.5 mm? -67.01 101.11 0.81 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.202 0.525 . . . . 1.23 110.901 175.154 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.612 ' HB3' ' HG3' ' A' ' 36' ' ' LYS . . . -46.97 -24.11 0.56 Allowed 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 115.518 1.673 . . . . 0.91 115.518 -174.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.581 ' CE1' ' HB3' ' A' ' 109' ' ' LEU . 14.9 p90 . . . . . 0 N--CA 1.468 0.435 0 CA-C-N 118.163 0.438 . . . . 1.4 111.515 -175.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 50.8 ttp . . . . . 0 N--CA 1.454 -0.227 0 CA-C-O 120.624 0.25 . . . . 1.49 111.438 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -98.77 6.54 46.84 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 111.705 0.261 . . . . 1.5 111.705 -178.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.751 ' O ' ' HA ' ' A' ' 82' ' ' THR . 43.1 p -114.51 17.08 17.54 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.264 0.554 . . . . 0.53 109.922 177.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.886 ' HG3' ' HB3' ' A' ' 110' ' ' ALA . 0.1 OUTLIER -113.85 103.43 11.18 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.14 -0.937 . . . . 2.75 110.354 -176.737 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.5 mp -110.26 131.32 61.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.904 -0.589 . . . . 0.85 111.036 -176.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.514 ' O ' ' HA ' ' A' ' 107' ' ' VAL . 69.4 t80 -91.3 113.09 25.26 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.264 -0.88 . . . . 0.71 109.002 176.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.637 HG22 HG22 ' A' ' 107' ' ' VAL . 84.7 t -132.93 102.59 5.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 118.194 -0.907 . . . . 0.92 110.273 -176.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.591 ' HA2' ' CD1' ' A' ' 42' ' ' LEU . . . -122.83 -154.84 9.17 Favored Glycine 0 C--O 1.221 -0.705 0 C-N-CA 115.937 -3.03 . . . . 0.84 113.629 163.119 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 84.07 4.32 88.47 Favored Glycine 0 N--CA 1.452 -0.299 0 N-CA-C 111.098 -0.801 . . . . 0.68 111.098 -175.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.82 ' HB3' ' HB ' ' A' ' 46' ' ' THR . 5.4 mp -64.96 137.51 97.18 Favored Pre-proline 0 N--CA 1.453 -0.282 0 CA-C-N 115.409 -0.395 . . . . 1.28 110.38 -178.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.569 ' HG2' ' HB3' ' A' ' 101' ' ' ASP . 52.7 Cg_exo -51.73 159.75 3.29 Favored 'Trans proline' 0 N--CA 1.463 -0.305 0 C-N-CA 123.198 2.599 . . . . 0.58 111.955 173.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -66.43 -12.43 57.1 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 112.401 0.519 . . . . 1.05 112.401 -175.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 46.3 t60 -92.0 -24.92 19.06 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.15 0.5 . . . . 2.01 109.986 174.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.82 ' HB ' ' HB3' ' A' ' 42' ' ' LEU . 4.4 m -72.71 118.32 15.49 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.876 -0.602 . . . . 0.72 109.849 -176.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 6.0 p -134.46 -175.64 3.94 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.617 -0.719 . . . . 0.55 111.176 -168.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -49.93 -34.87 21.88 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.424 0.631 . . . . 0.49 110.594 -177.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.701 ' O ' ' HG2' ' A' ' 53' ' ' GLU . 8.5 ptpp? -67.65 -43.88 79.25 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 114.893 -1.049 . . . . 2.76 109.887 -178.089 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.606 HG21 HG23 ' A' ' 46' ' ' THR . 6.7 m -66.34 -40.51 89.91 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.629 -0.259 . . . . 0.58 111.24 -176.085 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.668 HD21 HD21 ' A' ' 42' ' ' LEU . 22.8 mt -61.78 -46.86 87.73 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 109.882 -0.414 . . . . 0.85 109.882 175.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.532 ' HA ' HD12 ' A' ' 61' ' ' ILE . 45.9 t-80 -52.69 -51.55 59.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.417 -0.811 . . . . 0.59 110.218 174.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.701 ' HG2' ' O ' ' A' ' 49' ' ' LYS . 23.4 mm-40 -59.48 -48.18 82.65 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.106 -0.497 . . . . 1.52 112.316 -176.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.435 ' O ' ' HB2' ' A' ' 57' ' ' GLN . 47.4 t80 -76.53 -41.44 46.7 Favored 'General case' 0 C--O 1.227 -0.109 0 CA-C-O 121.051 0.453 . . . . 1.12 111.495 -171.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.774 ' HB2' HD11 ' A' ' 61' ' ' ILE . 45.8 m-85 -84.16 -30.38 25.9 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 113.063 0.764 . . . . 0.56 113.063 -170.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.603 ' HA ' ' O ' ' A' ' 59' ' ' GLY . 16.6 pt-20 -67.45 -14.58 63.06 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 122.109 0.957 . . . . 1.57 110.113 -178.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.435 ' HB2' ' O ' ' A' ' 54' ' ' TYR . 13.6 mm100 -57.11 -26.3 60.23 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.082 -1.417 . . . . 2.16 112.063 172.167 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -93.12 -25.2 17.99 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.223 0.535 . . . . 0.71 110.055 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.603 ' O ' ' HA ' ' A' ' 56' ' ' GLU . . . 170.96 174.66 38.97 Favored Glycine 0 N--CA 1.447 -0.606 0 N-CA-C 110.386 -1.086 . . . . 0.75 110.386 -179.22 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 61.1 m-20 -67.9 125.14 25.36 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 117.492 0.646 . . . . 1.02 110.819 -173.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.774 HD11 ' HB2' ' A' ' 55' ' ' PHE . 29.8 mt -89.04 118.63 34.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.335 -0.393 . . . . 0.47 110.309 178.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.437 ' HB2' ' HG3' ' A' ' 84' ' ' LYS . 24.9 tt0 -75.7 -33.0 60.32 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.145 0.424 . . . . 2.07 112.145 -179.269 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -157.15 133.3 9.64 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.651 -0.42 . . . . 2.48 111.531 -178.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -125.3 130.08 51.28 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.643 -0.708 . . . . 0.44 110.928 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 20.6 t -135.54 136.19 50.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 114.527 -1.215 . . . . 1.38 111.927 -177.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 56.0 t -118.58 117.72 55.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 108.703 -0.851 . . . . 0.49 108.703 162.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 35.3 mm -77.06 111.81 14.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 115.293 -0.867 . . . . 0.72 111.111 -171.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 21.4 p . . . . . 0 C--N 1.319 -0.736 0 CA-C-N 115.551 -0.75 . . . . 1.52 110.911 176.042 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 17.0 m . . . . . 0 N--CA 1.462 0.164 0 N-CA-C 112.806 0.669 . . . . 1.81 112.806 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.446 ' HB3' ' CD2' ' A' ' 78' ' ' TYR . 21.7 mtp180 -61.19 -25.09 66.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.003 -0.999 . . . . 2.56 111.964 177.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 80.58 23.51 60.21 Favored Glycine 0 C--O 1.225 -0.467 0 C-N-CA 120.491 -0.861 . . . . 0.64 112.52 179.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.446 ' CD2' ' HB3' ' A' ' 76' ' ' ARG . 21.7 m-85 -120.07 138.91 53.26 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.113 -1.069 . . . . 1.18 108.113 176.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -141.88 -177.77 17.34 Favored Glycine 0 N--CA 1.441 -0.972 0 C-N-CA 119.076 -1.535 . . . . 0.59 113.508 178.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.45 ' CE1' ' HD1' ' A' ' 38' ' ' PHE . 61.3 m-85 -138.65 125.93 21.6 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 123.179 0.592 . . . . 0.63 109.445 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.474 HG23 HD13 ' A' ' 51' ' ' LEU . 42.8 t -113.33 114.51 47.09 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-O 121.03 0.443 . . . . 0.41 110.57 178.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.751 ' HA ' ' O ' ' A' ' 35' ' ' THR . 8.4 m -106.36 125.23 50.73 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.025 -1.102 . . . . 0.47 108.025 171.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 81.3 mtp -110.76 166.49 10.98 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 107.987 -1.116 . . . . 0.88 107.987 -172.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.437 ' HG3' ' HB2' ' A' ' 62' ' ' GLU . 3.4 mttm -83.53 -8.72 59.29 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 112.704 0.631 . . . . 1.92 112.704 -172.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.441 ' OD1' ' HD2' ' A' ' 86' ' ' ARG . 9.6 t70 -145.36 146.52 31.62 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 109.908 -0.404 . . . . 1.68 109.908 174.632 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.441 ' HD2' ' OD1' ' A' ' 85' ' ' ASP . 0.8 OUTLIER -73.84 -23.26 59.61 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 111.592 0.219 . . . . 3.66 111.592 -176.524 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -63.04 -50.3 71.19 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.03 0.443 . . . . 0.66 110.42 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 13.2 m -67.57 -35.89 79.88 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.953 -0.567 . . . . 0.78 109.933 176.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.41 ' HB3' ' HA ' ' A' ' 86' ' ' ARG . . . -57.15 -45.83 83.27 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 114.789 -1.096 . . . . 0.46 110.651 176.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -56.5 -42.49 78.43 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.198 -0.455 . . . . 2.11 111.521 172.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.738 ' O ' ' HG3' ' A' ' 94' ' ' LYS . 12.9 mmt180 -68.11 -31.81 71.66 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.969 -0.56 . . . . 3.82 110.83 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -61.39 -38.33 86.67 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.603 -0.271 . . . . 0.92 111.651 171.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 37.0 t -86.58 -20.08 28.45 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 112.961 0.726 . . . . 1.16 112.961 -173.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.738 ' HG3' ' O ' ' A' ' 91' ' ' ARG . 0.0 OUTLIER -51.54 -19.44 1.47 Allowed 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 112.959 0.726 . . . . 4.2 112.959 177.337 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.686 ' N ' ' HD3' ' A' ' 94' ' ' LYS . 24.5 t0 -112.03 103.96 55.66 Favored Pre-proline 0 C--N 1.325 -0.491 0 N-CA-C 108.788 -0.819 . . . . 2.24 108.788 168.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 95' ' ' ASP . 3.6 Cg_exo -80.42 -13.32 12.3 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 123.241 2.628 . . . . 2.38 113.503 -172.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 52.7 m-80 -148.75 53.55 1.44 Allowed Pre-proline 0 C--O 1.236 0.38 0 O-C-N 122.383 -0.198 . . . . 3.03 111.278 -176.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.54 ' O ' HG13 ' A' ' 100' ' ' ILE . 72.4 Cg_endo -82.81 113.14 2.17 Favored 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 120.739 0.959 . . . . 1.29 113.13 -175.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.441 HD13 ' CA ' ' A' ' 104' ' ' LYS . 12.7 mm -24.14 124.85 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-N 116.033 -0.53 . . . . 1.81 111.979 149.098 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.54 HG13 ' O ' ' A' ' 98' ' ' PRO . 75.2 mt -145.14 119.68 3.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 105.961 -1.866 . . . . 0.99 105.961 179.2 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.569 ' HB3' ' HG2' ' A' ' 43' ' ' PRO . 27.5 t0 55.21 50.64 14.69 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 122.637 1.208 . . . . 1.37 109.783 -174.443 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 71.42 -8.17 5.66 Favored Glycine 0 CA--C 1.53 1.006 0 N-CA-C 117.22 1.648 . . . . 1.56 117.22 176.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.497 ' HB2' ' HG3' ' A' ' 43' ' ' PRO . 2.0 mmm180 -116.22 142.07 47.31 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 120.59 2.195 . . . . 4.13 111.83 176.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.441 ' CA ' HD13 ' A' ' 99' ' ' ILE . 41.1 ttmt -64.64 124.08 20.96 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.896 -0.593 . . . . 2.73 110.57 176.432 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -102.0 162.17 13.12 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.431 -0.349 . . . . 1.04 110.5 178.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.587 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 39.7 t-20 -114.78 127.79 55.93 Favored 'General case' 0 C--O 1.248 0.986 0 N-CA-C 109.48 -0.563 . . . . 2.04 109.48 179.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.637 HG22 HG22 ' A' ' 39' ' ' VAL . 88.3 t -138.85 123.19 20.66 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 O-C-N 125.056 1.473 . . . . 1.06 111.065 -163.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -156.62 151.97 26.59 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.324 -0.621 . . . . 2.49 109.324 175.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.524 ' HB3' ' CE1' ' A' ' 111' ' ' TYR . 1.3 mm? -57.37 96.28 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.063 0.459 . . . . 1.23 111.238 176.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.886 ' HB3' ' HG3' ' A' ' 36' ' ' LYS . . . -45.19 -33.16 2.16 Favored 'General case' 0 C--O 1.224 -0.245 0 N-CA-C 115.654 1.724 . . . . 0.91 115.654 -176.378 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.524 ' CE1' ' HB3' ' A' ' 109' ' ' LEU . 9.1 p90 . . . . . 0 N--CA 1.473 0.705 0 N-CA-C 112.662 0.615 . . . . 1.4 112.662 -169.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 49.3 ttp . . . . . 0 CA--C 1.531 0.236 0 CA-C-O 121.38 0.61 . . . . 1.49 110.418 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.409 ' C ' ' H ' ' A' ' 36' ' ' LYS . 21.4 m-85 -52.68 -71.62 0.07 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.716 -1.129 . . . . 1.5 111.575 176.492 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.617 ' HB ' ' O ' ' A' ' 83' ' ' MET . 34.5 p -53.26 18.17 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 116.542 2.053 . . . . 0.53 116.542 178.339 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.429 ' HD2' ' HA ' ' A' ' 36' ' ' LYS . 41.8 tptt -116.32 113.16 22.57 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 119.52 1.055 . . . . 2.75 111.205 -178.268 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.426 HD11 ' HA ' ' A' ' 89' ' ' ALA . 84.8 mt -103.06 131.15 52.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-N 115.147 -0.933 . . . . 0.85 110.681 -179.378 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.494 ' HB2' ' HA ' ' A' ' 110' ' ' ALA . 70.2 t80 -91.92 119.74 31.96 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 109.102 -0.703 . . . . 0.71 109.102 175.336 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.676 HG12 HD11 ' A' ' 42' ' ' LEU . 3.9 t -102.31 135.32 39.89 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 N-CA-C 108.315 -0.995 . . . . 0.92 108.315 -179.351 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -141.72 153.79 24.38 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.291 -0.957 . . . . 0.84 112.093 -169.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 70.21 34.96 69.86 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.705 -0.76 . . . . 0.68 112.518 176.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.676 HD11 HG12 ' A' ' 39' ' ' VAL . 7.2 mp -75.08 142.93 76.54 Favored Pre-proline 0 C--N 1.328 -0.35 0 N-CA-C 109.88 -0.415 . . . . 1.28 109.88 178.058 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.477 ' HG3' ' HB3' ' A' ' 103' ' ' ARG . 28.0 Cg_endo -68.63 158.61 57.03 Favored 'Trans proline' 0 N--CA 1.451 -1.016 0 C-N-CA 121.862 1.708 . . . . 0.58 110.736 173.659 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.517 ' HD1' ' OG ' ' A' ' 75' ' ' SER . 59.7 m-85 -64.96 0.15 1.33 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.771 0.656 . . . . 1.05 112.771 -173.256 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 84.3 t60 -110.37 -6.44 14.98 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.695 0.283 . . . . 2.01 111.441 -178.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.647 ' CG2' HD23 ' A' ' 42' ' ' LEU . 25.7 m -77.75 137.88 38.71 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.611 -0.436 . . . . 0.72 111.094 -179.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 10.4 p -131.73 -177.58 4.49 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.777 -0.647 . . . . 0.55 109.961 -179.005 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.404 ' OD2' ' HA ' ' A' ' 65' ' ' VAL . 1.8 m-20 -61.5 -49.4 76.92 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 122.165 0.983 . . . . 0.49 108.871 -175.503 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.726 ' O ' ' HG2' ' A' ' 53' ' ' GLU . 22.9 pttm -53.1 -33.78 53.73 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 113.229 -1.805 . . . . 2.76 111.13 175.333 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 5.0 m -68.11 -44.6 75.8 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.028 0.442 . . . . 0.58 110.193 178.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.534 HD21 HG11 ' A' ' 39' ' ' VAL . 33.3 mt -62.97 -44.48 95.93 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-N 115.985 -0.552 . . . . 0.85 110.48 176.492 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.662 ' O ' ' HB2' ' A' ' 56' ' ' GLU . 45.2 t-80 -56.29 -37.24 69.61 Favored 'General case' 0 C--O 1.216 -0.679 0 CA-C-N 116.096 -0.502 . . . . 0.59 110.641 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.726 ' HG2' ' O ' ' A' ' 49' ' ' LYS . 25.8 mm-40 -74.15 -40.44 62.59 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.311 -0.404 . . . . 1.52 111.781 -174.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.485 ' O ' ' HB2' ' A' ' 57' ' ' GLN . 2.9 t80 -77.66 -33.7 53.33 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.782 0.801 . . . . 1.12 110.293 -177.215 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.675 ' HB2' HD11 ' A' ' 61' ' ' ILE . 40.4 m-85 -85.89 -25.82 25.95 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.013 -0.994 . . . . 0.56 111.423 -174.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.662 ' HB2' ' O ' ' A' ' 52' ' ' HIS . 3.2 tp10 -62.09 -4.4 1.67 Allowed 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 122.266 1.031 . . . . 1.57 110.428 174.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.485 ' HB2' ' O ' ' A' ' 54' ' ' TYR . 82.5 mt-30 -88.51 -30.7 19.15 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 114.251 -1.34 . . . . 2.16 110.431 -177.248 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.583 ' CG ' ' HA ' ' A' ' 92' ' ' ALA . 68.4 m-85 -90.75 -8.91 48.49 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.997 -1.001 . . . . 0.71 110.662 -175.276 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 142.83 174.33 15.12 Favored Glycine 0 N--CA 1.441 -1.015 0 N-CA-C 111.139 -0.785 . . . . 0.75 111.139 -179.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.682 ' HB3' ' HD2' ' A' ' 84' ' ' LYS . 3.0 m-20 -49.23 121.82 5.33 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.319 0.581 . . . . 1.02 111.798 176.314 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.675 HD11 ' HB2' ' A' ' 55' ' ' PHE . 85.0 mt -91.59 144.7 8.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 107.059 -1.46 . . . . 0.47 107.059 171.609 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -94.71 -45.09 7.5 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 119.054 0.843 . . . . 2.07 108.872 179.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -154.01 123.91 6.79 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.358 -0.837 . . . . 2.48 109.866 176.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -112.47 127.9 56.18 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.789 0.328 . . . . 0.44 110.741 175.027 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.404 ' HA ' ' OD2' ' A' ' 48' ' ' ASP . 8.1 p -144.52 137.75 22.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.636 -0.711 . . . . 1.38 111.74 -175.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.532 HG12 HG23 ' A' ' 68' ' ' THR . 54.6 t -104.62 117.31 50.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 108.681 -0.859 . . . . 0.49 108.681 172.153 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.619 ' O ' ' HD3' ' A' ' 76' ' ' ARG . 47.7 mm -76.88 72.38 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 122.084 0.945 . . . . 0.72 111.235 -173.348 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.594 HG22 ' HA ' ' A' ' 75' ' ' SER . 38.5 p . . . . . 0 N--CA 1.433 -1.315 0 CA-C-N 114.627 -1.17 . . . . 1.52 109.757 164.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.594 ' HA ' HG22 ' A' ' 68' ' ' THR . 5.6 p . . . . . 0 CA--C 1.52 -0.197 0 CA-C-O 122.255 1.026 . . . . 1.81 112.218 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.619 ' HD3' ' O ' ' A' ' 67' ' ' ILE . 41.1 mtp180 -87.3 1.35 53.49 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 113.937 -1.483 . . . . 2.56 111.064 -168.736 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 69.64 14.58 70.0 Favored Glycine 0 N--CA 1.447 -0.626 0 CA-C-N 115.785 -0.643 . . . . 0.64 113.084 177.078 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.485 ' O ' HG13 ' A' ' 66' ' ' VAL . 13.8 m-85 -118.68 156.1 29.87 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 116.879 0.339 . . . . 1.18 110.979 -177.185 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -148.2 179.16 25.28 Favored Glycine 0 N--CA 1.444 -0.808 0 CA-C-N 115.967 -0.56 . . . . 0.59 111.792 173.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.428 ' CE1' ' HD1' ' A' ' 38' ' ' PHE . 41.3 m-85 -156.04 123.71 5.56 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 123.604 0.762 . . . . 0.63 109.488 -179.444 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 70.4 t -120.95 127.04 75.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-O 120.811 0.339 . . . . 0.41 110.433 -178.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 13.4 m -104.06 114.85 29.38 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.883 -0.784 . . . . 0.47 108.883 177.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.617 ' O ' ' HB ' ' A' ' 35' ' ' THR . 93.0 mmm -90.68 133.1 35.39 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 120.9 -0.32 . . . . 0.88 110.719 -178.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.682 ' HD2' ' HB3' ' A' ' 60' ' ' ASP . 46.9 mttm -51.04 -6.24 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 114.614 1.339 . . . . 1.92 114.614 174.136 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -160.46 155.49 24.49 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.774 -0.454 . . . . 1.68 109.774 174.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.618 ' HD3' ' H ' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -75.41 -33.02 60.93 Favored 'General case' 0 C--O 1.224 -0.242 0 N-CA-C 108.279 -1.008 . . . . 3.66 108.279 179.49 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -47.71 -48.63 29.38 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.391 -1.277 . . . . 0.66 110.126 168.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 19.7 m -69.33 -27.97 65.83 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.166 -0.47 . . . . 0.78 111.326 179.161 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.426 ' HA ' HD11 ' A' ' 37' ' ' ILE . . . -70.19 -50.13 43.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.451 . . . . 0.46 110.482 177.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -55.49 -32.48 62.87 Favored 'General case' 0 C--O 1.222 -0.384 0 CA-C-N 116.101 -0.499 . . . . 2.11 110.732 172.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.597 ' O ' ' HG3' ' A' ' 94' ' ' LYS . 13.4 mtp180 -70.33 -51.42 30.23 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.859 -1.064 . . . . 3.82 110.723 179.522 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.583 ' HA ' ' CG ' ' A' ' 58' ' ' PHE . . . -56.06 -46.72 78.85 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 113.992 1.108 . . . . 0.92 113.992 171.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 48.9 t -74.57 -42.47 58.69 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 120.974 -0.291 . . . . 1.16 111.531 -172.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.597 ' HG3' ' O ' ' A' ' 91' ' ' ARG . 1.2 pptp? -49.57 -9.77 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 113.105 0.78 . . . . 4.2 113.105 173.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -101.8 90.92 2.07 Favored Pre-proline 0 CA--C 1.534 0.343 0 N-CA-C 108.589 -0.893 . . . . 2.24 108.589 162.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.481 ' HD3' ' O ' ' A' ' 94' ' ' LYS . 2.9 Cg_exo -76.18 111.97 3.38 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.979 2.453 . . . . 2.38 113.016 -170.653 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.421 ' HB2' ' O ' ' A' ' 96' ' ' PRO . 92.7 m-20 79.23 69.65 0.17 Allowed Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 114.527 -1.215 . . . . 3.03 110.111 175.349 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.448 ' HB2' ' CE1' ' A' ' 54' ' ' TYR . 72.7 Cg_endo -76.23 146.42 28.39 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.534 2.156 . . . . 1.29 111.065 178.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.558 HG22 ' C ' ' A' ' 102' ' ' GLY . 14.6 mm -88.33 92.41 3.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 O-C-N 122.155 -0.341 . . . . 1.81 110.24 -172.7 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.488 ' C ' ' H ' ' A' ' 102' ' ' GLY . 15.9 mt -92.05 151.24 3.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-O 121.548 0.69 . . . . 0.99 112.279 -174.307 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 25.3 t0 35.02 17.83 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 CA-C-N 114.489 -1.232 . . . . 1.37 112.872 -152.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.558 ' C ' HG22 ' A' ' 99' ' ' ILE . . . 89.48 19.82 47.43 Favored Glycine 0 CA--C 1.529 0.929 0 CA-C-N 115.757 -0.656 . . . . 1.56 111.674 178.722 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.477 ' HB3' ' HG3' ' A' ' 43' ' ' PRO . 31.9 tpt180 -127.82 135.73 50.48 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.747 0.819 . . . . 4.13 108.989 174.033 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.421 ' HA ' ' HA ' ' A' ' 99' ' ' ILE . 33.9 ttpt -58.0 114.92 2.56 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.461 0.541 . . . . 2.73 112.461 -174.327 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -99.67 164.66 11.96 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.186 -0.915 . . . . 1.04 110.225 177.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 37.8 t30 -107.93 131.7 54.26 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.454 -0.339 . . . . 2.04 110.154 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 41.1 t -122.38 129.12 75.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.32 0.581 . . . . 1.06 112.003 -179.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -150.01 158.08 43.8 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.084 -0.962 . . . . 2.49 108.405 175.161 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.752 HD23 ' CE1' ' A' ' 111' ' ' TYR . 1.0 OUTLIER -73.24 124.67 26.11 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 121.594 -0.691 . . . . 1.23 111.461 -177.029 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.494 ' HA ' ' HB2' ' A' ' 38' ' ' PHE . . . -47.23 -47.3 24.61 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.375 -1.284 . . . . 0.91 113.026 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.752 ' CE1' HD23 ' A' ' 109' ' ' LEU . 0.8 OUTLIER . . . . . 0 C--N 1.33 -0.251 0 CA-C-O 121.571 0.701 . . . . 1.4 110.055 -178.257 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 12.5 tmm? . . . . . 0 CA--C 1.532 0.278 0 CA-C-O 120.621 0.248 . . . . 1.49 110.963 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -98.1 -46.43 5.87 Favored 'General case' 0 CA--C 1.527 0.077 0 O-C-N 122.225 -0.297 . . . . 1.5 111.312 177.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.574 ' O ' ' HA ' ' A' ' 82' ' ' THR . 63.3 p -68.78 1.63 3.16 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 113.755 1.021 . . . . 0.53 113.755 -176.162 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.408 ' O ' HD13 ' A' ' 109' ' ' LEU . 58.0 tttt -97.99 107.9 20.49 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.995 0.426 . . . . 2.75 110.117 -175.477 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.459 HD11 ' HA ' ' A' ' 89' ' ' ALA . 47.1 mt -109.38 136.3 45.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.781 -0.645 . . . . 0.85 111.148 -175.382 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -101.25 118.41 36.93 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.878 -0.601 . . . . 0.71 109.698 174.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.816 HG13 HG22 ' A' ' 107' ' ' VAL . 30.3 t -133.75 110.63 14.55 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.848 0 CA-C-O 117.85 -1.071 . . . . 0.92 110.977 -177.182 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.42 ' HA2' ' CD2' ' A' ' 42' ' ' LEU . . . -116.68 -156.76 10.73 Favored Glycine 0 CA--C 1.503 -0.706 1 C-N-CA 112.341 -4.742 . . . . 0.84 114.835 156.049 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.488 ' HA3' ' HA ' ' A' ' 105' ' ' ALA . . . 92.42 5.07 65.58 Favored Glycine 0 N--CA 1.442 -0.903 0 N-CA-C 110.211 -1.156 . . . . 0.68 110.211 -171.466 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.67 HD11 HD21 ' A' ' 51' ' ' LEU . 3.0 mm? -71.99 121.4 84.5 Favored Pre-proline 0 N--CA 1.45 -0.44 0 CA-C-N 115.06 -0.57 . . . . 1.28 109.931 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.79 ' HG3' ' HD3' ' A' ' 103' ' ' ARG . 88.8 Cg_exo -48.21 160.01 0.61 Allowed 'Trans proline' 0 CA--C 1.529 0.274 0 C-N-CA 124.198 3.266 . . . . 0.58 113.968 177.22 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -71.26 -6.94 43.52 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.704 -0.68 . . . . 1.05 112.688 -174.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 7.6 p-80 -112.85 10.29 19.07 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 121.788 -0.57 . . . . 2.01 110.921 171.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.594 HG21 HD12 ' A' ' 42' ' ' LEU . 52.0 m -79.62 123.75 27.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.099 -0.5 . . . . 0.72 110.438 174.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 60.3 p -105.72 175.2 5.57 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.264 -0.425 . . . . 0.55 110.577 -178.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.511 ' HB3' ' O ' ' A' ' 64' ' ' ALA . 2.9 m-20 -57.44 -30.56 65.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.571 0.701 . . . . 0.49 110.124 176.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.679 ' O ' ' HG2' ' A' ' 53' ' ' GLU . 0.5 OUTLIER -78.71 -29.59 45.52 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.422 -0.808 . . . . 2.76 110.828 -179.389 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.583 ' HB ' HG23 ' A' ' 46' ' ' THR . 14.5 m -61.95 -41.98 98.6 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.98 0.419 . . . . 0.58 110.379 176.454 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.67 HD21 HD11 ' A' ' 42' ' ' LEU . 16.0 mt -67.65 -37.16 82.03 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-N 116.189 -0.46 . . . . 0.85 110.334 174.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.47 ' HA ' HD12 ' A' ' 61' ' ' ILE . 60.5 t-80 -57.05 -47.4 81.05 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.723 -0.672 . . . . 0.59 109.848 175.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.679 ' HG2' ' O ' ' A' ' 49' ' ' LYS . 23.6 mm-40 -57.54 -47.25 82.52 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.976 -0.556 . . . . 1.52 111.521 178.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.464 ' O ' ' HB2' ' A' ' 57' ' ' GLN . 20.9 t80 -76.75 -34.83 58.05 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.591 0.589 . . . . 1.12 112.591 -172.172 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.432 ' CZ ' HG21 ' A' ' 39' ' ' VAL . 22.5 m-85 -85.03 -25.17 27.83 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 114.391 1.256 . . . . 0.56 114.391 -173.339 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.587 ' N ' HD11 ' A' ' 61' ' ' ILE . 11.0 pt-20 -67.06 -12.52 60.16 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 122.351 1.072 . . . . 1.57 109.722 177.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.689 ' HA ' HE21 ' A' ' 57' ' ' GLN . 0.0 OUTLIER -56.15 -31.31 63.25 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 113.937 -1.483 . . . . 2.16 111.506 169.001 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -96.92 4.87 51.38 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.466 -0.334 . . . . 0.71 111.737 -176.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 142.2 -133.76 5.8 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.548 -0.834 . . . . 0.75 112.516 -176.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -114.29 124.38 51.86 Favored 'General case' 0 C--N 1.322 -0.599 0 O-C-N 122.567 -0.372 . . . . 1.02 110.475 -179.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.587 HD11 ' N ' ' A' ' 56' ' ' GLU . 7.5 mt -93.23 125.87 45.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 109.579 -0.526 . . . . 0.47 109.579 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -78.48 -38.8 40.09 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.019 0.438 . . . . 2.07 110.753 176.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -157.22 136.37 11.87 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.149 -0.478 . . . . 2.48 111.34 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.511 ' O ' ' HB3' ' A' ' 48' ' ' ASP . . . -121.28 123.4 42.1 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 115.781 -0.645 . . . . 0.44 109.396 174.039 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 8.9 p -135.52 135.17 51.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 114.893 -1.048 . . . . 1.38 112.191 -176.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 98.1 t -102.83 131.76 50.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.356 -0.838 . . . . 0.49 109.386 173.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.471 HG12 ' HA2' ' A' ' 79' ' ' GLY . 44.6 mm -83.61 92.28 2.83 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.625 0 CA-C-O 121.478 0.656 . . . . 0.72 109.665 -179.284 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.425 HG22 ' HA ' ' A' ' 75' ' ' SER . 31.7 p . . . . . 0 N--CA 1.436 -1.137 0 CA-C-N 115.023 -0.99 . . . . 1.52 110.757 -179.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.508 ' O ' ' HB2' ' A' ' 76' ' ' ARG . 8.4 m . . . . . 0 N--CA 1.468 0.451 0 N-CA-C 112.879 0.696 . . . . 1.81 112.879 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.508 ' HB2' ' O ' ' A' ' 75' ' ' SER . 96.5 mtt180 74.57 -55.3 0.66 Allowed 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.329 0.652 . . . . 2.56 110.508 -169.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 103.97 19.24 12.07 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.841 -0.695 . . . . 0.64 113.142 175.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -123.85 157.28 34.53 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.215 -1.031 . . . . 1.18 108.215 177.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.471 ' HA2' HG12 ' A' ' 67' ' ' ILE . . . -159.23 -164.66 14.89 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 119.769 -1.205 . . . . 0.59 112.647 175.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -151.3 134.83 16.24 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.731 -0.84 . . . . 0.63 108.731 -177.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 53.7 t -122.36 120.07 60.06 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 N-CA-C 109.938 -0.393 . . . . 0.41 109.938 177.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.574 ' HA ' ' O ' ' A' ' 35' ' ' THR . 17.9 m -109.81 115.68 30.28 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 108.51 -0.922 . . . . 0.47 108.51 177.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 83.1 mmm -88.79 163.8 15.53 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 108.898 -0.778 . . . . 0.88 108.898 -176.163 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 20.7 ttmm -83.3 -10.94 58.21 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.099 0.476 . . . . 1.92 110.683 -178.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -145.67 146.64 31.38 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 116.232 -0.44 . . . . 1.68 110.616 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 4.3 tmm_? -71.39 -22.81 61.83 Favored 'General case' 0 C--O 1.223 -0.3 0 N-CA-C 112.845 0.683 . . . . 3.66 112.845 -177.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.26 -43.94 89.68 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 118.649 0.659 . . . . 0.66 110.392 177.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 8.7 m -64.55 -39.23 93.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.699 0.761 . . . . 0.78 109.881 175.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.459 ' HA ' HD11 ' A' ' 37' ' ' ILE . . . -59.41 -49.79 76.45 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.028 -1.442 . . . . 0.46 110.609 178.326 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -54.98 -49.16 72.13 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.55 -0.75 . . . . 2.11 111.826 175.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.62 ' O ' ' HB3' ' A' ' 94' ' ' LYS . 2.6 ttm-85 -61.85 -41.02 97.31 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.295 -0.412 . . . . 3.82 110.773 -177.25 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -63.56 -43.84 95.87 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.996 -0.547 . . . . 0.92 111.73 176.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 45.2 t -75.2 -6.9 52.14 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 121.337 0.589 . . . . 1.16 110.659 178.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.62 ' HB3' ' O ' ' A' ' 91' ' ' ARG . 2.9 tppp? -76.96 -37.94 54.26 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.285 -0.87 . . . . 4.2 110.016 177.402 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -108.33 91.58 8.47 Favored Pre-proline 0 C--N 1.326 -0.441 0 N-CA-C 109.358 -0.608 . . . . 2.24 109.358 172.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.594 ' HA ' ' HB ' ' A' ' 107' ' ' VAL . 59.4 Cg_endo -90.17 -6.54 4.62 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 123.1 2.533 . . . . 2.38 114.144 -169.18 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.456 ' N ' ' HD3' ' A' ' 98' ' ' PRO . 3.4 p-10 -132.76 60.86 53.02 Favored Pre-proline 0 C--N 1.328 -0.337 0 N-CA-C 112.306 0.484 . . . . 3.03 112.306 -177.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.456 ' HD3' ' N ' ' A' ' 97' ' ' ASN . 1.8 Cg_endo -81.38 151.73 17.72 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.795 2.33 . . . . 1.29 111.73 -179.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 35.9 mm -95.06 90.37 2.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.287 0.565 . . . . 1.81 110.302 179.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 57.6 mt -90.85 108.34 19.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.841 -0.618 . . . . 0.99 111.847 177.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.718 ' HB3' ' HG2' ' A' ' 43' ' ' PRO . 25.2 t70 65.31 44.17 3.3 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 122.813 1.292 . . . . 1.37 109.3 173.345 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 80.39 -9.03 51.15 Favored Glycine 0 N--CA 1.445 -0.712 0 CA-C-N 114.412 -1.267 . . . . 1.56 113.579 176.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.79 ' HD3' ' HG3' ' A' ' 43' ' ' PRO . 7.4 mpt_? -107.09 131.09 54.5 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 117.74 0.77 . . . . 4.13 111.623 176.524 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 26.3 ttpp -67.18 134.51 51.86 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.366 -0.834 . . . . 2.73 109.032 169.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.488 ' HA ' ' HA3' ' A' ' 41' ' ' GLY . . . -111.25 150.38 29.68 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 116.232 -0.44 . . . . 1.04 109.964 -175.582 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -108.15 106.18 16.26 Favored 'General case' 0 C--O 1.264 1.857 0 CA-C-O 121.556 0.694 . . . . 2.04 110.053 174.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.816 HG22 HG13 ' A' ' 39' ' ' VAL . 47.4 t -101.67 138.53 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 CA-C-N 112.876 -1.965 . . . . 1.06 111.451 174.317 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 32.8 m-80 -151.86 153.02 33.37 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.428 -0.953 . . . . 2.49 108.428 172.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.527 HD13 ' H ' ' A' ' 110' ' ' ALA . 0.2 OUTLIER -63.25 150.3 43.46 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.402 -0.962 . . . . 1.23 108.402 172.876 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.527 ' H ' HD13 ' A' ' 109' ' ' LEU . . . -74.67 -40.28 61.51 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.081 -0.647 . . . . 0.91 110.36 -167.361 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.409 ' CE1' ' HB3' ' A' ' 109' ' ' LEU . 0.1 OUTLIER . . . . . 0 CA--C 1.53 0.206 0 CA-C-N 114.97 -1.014 . . . . 1.4 112.654 -172.221 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' MET . . . . . 0.605 ' HG3' ' H ' ' A' ' 34' ' ' PHE . 22.5 ptm . . . . . 0 CA--C 1.528 0.099 0 N-CA-C 107.695 -1.224 . . . . 1.49 107.695 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.605 ' H ' ' HG3' ' A' ' 33' ' ' MET . 26.0 m-85 -88.17 -179.97 6.26 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 113.712 -1.586 . . . . 1.5 108.62 170.173 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.73 ' HB ' ' O ' ' A' ' 83' ' ' MET . 14.0 p 65.37 -0.46 1.16 Allowed 'General case' 0 N--CA 1.472 0.637 0 O-C-N 124.065 0.853 . . . . 0.53 112.642 174.588 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 33.0 ttpt -121.89 110.21 15.58 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.136 0.494 . . . . 2.75 110.248 -176.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.616 HD11 ' HA ' ' A' ' 89' ' ' ALA . 3.8 mp -96.3 130.02 45.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.972 -0.558 . . . . 0.85 110.575 -179.292 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -85.77 108.29 18.02 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 108.559 -0.904 . . . . 0.71 108.559 172.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.3 t -95.95 137.03 25.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 N-CA-C 108.074 -1.084 . . . . 0.92 108.074 179.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -140.42 138.09 8.78 Favored Glycine 0 N--CA 1.442 -0.94 0 C-N-CA 119.577 -1.297 . . . . 0.84 111.767 -170.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 96.43 16.36 37.53 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.582 -0.818 . . . . 0.68 112.84 177.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.553 HD12 HG21 ' A' ' 46' ' ' THR . 2.8 mm? -64.94 124.16 85.81 Favored Pre-proline 0 C--O 1.234 0.246 0 N-CA-C 109.304 -0.628 . . . . 1.28 109.304 177.006 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.578 ' HG2' ' HB3' ' A' ' 101' ' ' ASP . 52.9 Cg_exo -50.58 154.38 6.53 Favored 'Trans proline' 0 CA--C 1.529 0.252 0 C-N-CA 122.91 2.407 . . . . 0.58 111.88 173.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -65.76 -7.22 14.6 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.847 0.356 . . . . 1.05 111.61 -178.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 76.9 t60 -101.14 -6.43 24.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.188 0.518 . . . . 2.01 110.222 177.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.553 HG21 HD12 ' A' ' 42' ' ' LEU . 77.5 m -78.72 142.42 37.09 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 116.259 -0.428 . . . . 0.72 109.922 177.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 12.1 p -132.14 -178.77 5.05 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.028 0.442 . . . . 0.55 111.161 -175.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.587 ' OD2' ' HA ' ' A' ' 65' ' ' VAL . 2.4 m-20 -67.31 -48.18 68.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.862 0.839 . . . . 0.49 109.06 -176.423 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.598 ' O ' ' HG2' ' A' ' 53' ' ' GLU . 22.8 pttp -52.52 -35.38 53.14 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 113.908 -1.496 . . . . 2.76 111.149 175.38 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.47 HG21 HG23 ' A' ' 46' ' ' THR . 22.9 m -67.2 -45.76 75.9 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.854 0.359 . . . . 0.58 111.279 179.299 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.525 HD21 HD11 ' A' ' 42' ' ' LEU . 31.1 mt -67.33 -35.67 79.9 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.485 -0.325 . . . . 0.85 110.805 178.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.432 ' HA ' ' CD1' ' A' ' 61' ' ' ILE . 63.9 t-80 -57.3 -38.3 73.77 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.644 -0.502 . . . . 0.59 109.644 175.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.598 ' HG2' ' O ' ' A' ' 49' ' ' LYS . 82.3 mm-40 -68.18 -39.84 82.42 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.242 -0.89 . . . . 1.52 110.467 -177.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.634 ' O ' ' HB2' ' A' ' 57' ' ' GLN . 2.2 t80 -78.44 -34.33 47.87 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.566 0.698 . . . . 1.12 111.607 -177.282 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.46 ' HB2' HD11 ' A' ' 61' ' ' ILE . 28.7 m-85 -86.4 -25.63 25.19 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 113.086 0.772 . . . . 0.56 113.086 -172.124 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -71.98 -1.53 14.87 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 122.336 1.065 . . . . 1.57 109.619 174.102 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.634 ' HB2' ' O ' ' A' ' 54' ' ' TYR . 88.9 mt-30 -86.28 -10.6 54.22 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.092 -1.413 . . . . 2.16 109.96 176.223 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.431 ' HD2' ' HA ' ' A' ' 55' ' ' PHE . 78.8 m-85 -109.86 -51.2 2.9 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.395 -0.821 . . . . 0.71 111.118 -178.332 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -163.92 -135.75 1.87 Allowed Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.274 -0.965 . . . . 0.75 112.006 179.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.428 ' HB3' ' HE3' ' A' ' 84' ' ' LYS . 1.0 OUTLIER -98.22 132.88 43.35 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.803 0.335 . . . . 1.02 110.235 -179.902 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.46 HD11 ' HB2' ' A' ' 55' ' ' PHE . 66.0 mt -105.83 139.89 25.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 107.87 -1.159 . . . . 0.47 107.87 174.621 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -97.99 -41.21 8.09 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 107.933 -1.136 . . . . 2.07 107.933 177.099 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.402 ' HG2' HG13 ' A' ' 65' ' ' VAL . 43.0 tt0 -165.48 127.03 1.98 Allowed 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 115.458 -0.792 . . . . 2.48 110.267 177.014 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.419 ' O ' ' HB3' ' A' ' 48' ' ' ASP . . . -106.04 127.27 53.06 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.272 -0.64 . . . . 0.44 109.272 174.533 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.587 ' HA ' ' OD2' ' A' ' 48' ' ' ASP . 5.0 m -138.1 119.63 17.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.472 0.653 . . . . 1.38 112.649 -175.268 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 91.7 t -86.99 122.06 38.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.381 -0.827 . . . . 0.49 109.553 174.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 39.8 mm -71.69 139.34 19.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.34 0.59 . . . . 0.72 112.16 -176.021 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 35.2 p . . . . . 0 N--CA 1.438 -1.049 0 CA-C-N 115.265 -0.88 . . . . 1.52 109.53 176.558 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.8 m . . . . . 0 CA--C 1.531 0.249 0 N-CA-C 112.712 0.634 . . . . 1.81 112.712 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 60.2 mtp180 -98.15 -10.22 24.51 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.947 -0.57 . . . . 2.56 110.92 -175.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 86.89 13.77 66.13 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.596 -0.811 . . . . 0.64 112.462 -178.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -122.85 162.44 22.17 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.59 -0.893 . . . . 1.18 108.59 178.018 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -173.77 145.19 8.07 Favored Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 120.148 -1.025 . . . . 0.59 112.211 178.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -104.06 142.17 34.93 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.419 0.628 . . . . 0.63 111.258 176.064 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 49.8 t -117.99 106.02 19.01 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 CA-C-N 115.239 -0.891 . . . . 0.41 109.483 173.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 8.3 m -76.92 117.33 18.41 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.883 -0.598 . . . . 0.47 109.968 174.002 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.73 ' O ' ' HB ' ' A' ' 35' ' ' THR . 28.1 mtp -103.31 134.85 46.02 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.74 -0.467 . . . . 0.88 109.74 179.069 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.428 ' HE3' ' HB3' ' A' ' 60' ' ' ASP . 19.1 ttmt -51.73 -6.14 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 114.87 1.433 . . . . 1.92 114.87 -179.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.481 ' C ' HG22 ' A' ' 35' ' ' THR . 7.2 t70 -162.53 156.68 21.21 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 118.871 0.76 . . . . 1.68 111.323 177.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.666 ' N ' HG22 ' A' ' 35' ' ' THR . 2.5 tmm_? -75.02 -34.8 61.94 Favored 'General case' 0 C--O 1.22 -0.48 0 N-CA-C 108.461 -0.94 . . . . 3.66 108.461 -177.279 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -52.71 -42.4 64.82 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.026 -0.988 . . . . 0.66 110.95 172.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 5.5 m -69.55 -31.95 70.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.072 0.463 . . . . 0.78 110.381 176.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.616 ' HA ' HD11 ' A' ' 37' ' ' ILE . . . -67.62 -50.43 58.11 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.599 -0.728 . . . . 0.46 110.819 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.573 ' O ' ' HG2' ' A' ' 94' ' ' LYS . 6.0 mt-10 -57.72 -32.77 67.74 Favored 'General case' 0 C--O 1.224 -0.283 0 CA-C-N 115.832 -0.622 . . . . 2.11 110.537 174.547 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.401 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 13.3 tpp180 -64.15 -51.72 62.48 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.325 -0.852 . . . . 3.82 109.922 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -53.57 -32.1 49.45 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 113.461 0.912 . . . . 0.92 113.461 172.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 46.5 t -80.25 -34.57 36.99 Favored 'General case' 0 C--N 1.328 -0.363 0 O-C-N 121.894 -0.504 . . . . 1.16 110.609 178.173 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.573 ' HG2' ' O ' ' A' ' 90' ' ' GLU . 12.2 mmmm -48.23 -30.7 4.98 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 114.733 -1.121 . . . . 4.2 111.838 175.168 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -103.18 102.77 30.52 Favored Pre-proline 0 C--N 1.326 -0.438 0 N-CA-C 108.893 -0.78 . . . . 2.24 108.893 167.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -77.15 173.65 14.06 Favored 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 122.608 2.205 . . . . 2.38 113.761 -169.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.51 ' ND2' ' HA ' ' A' ' 106' ' ' ASN . 12.4 m120 -15.98 91.13 0.04 OUTLIER Pre-proline 0 N--CA 1.481 1.092 0 C-N-CA 125.462 1.505 . . . . 3.03 114.126 -174.473 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -82.27 164.85 16.96 Favored 'Trans proline' 0 C--O 1.235 0.346 0 C-N-CA 123.408 2.739 . . . . 1.29 113.202 -179.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 41.1 mm -94.72 109.79 22.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.445 -0.798 . . . . 1.81 110.329 174.126 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 54.9 mt -114.22 115.65 50.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.017 -0.538 . . . . 0.99 110.251 178.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.578 ' HB3' ' HG2' ' A' ' 43' ' ' PRO . 28.0 t70 50.71 54.53 11.04 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 113.071 0.767 . . . . 1.37 113.071 169.281 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 74.75 21.72 78.17 Favored Glycine 0 N--CA 1.454 -0.12 0 C-N-CA 120.375 -0.917 . . . . 1.56 113.121 176.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.463 ' HB2' ' HG3' ' A' ' 43' ' ' PRO . 0.2 OUTLIER -145.66 160.11 42.17 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.9 -0.407 . . . . 4.13 109.9 179.207 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 2.1 ttmp? -101.79 149.23 24.39 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 107.751 -1.203 . . . . 2.73 107.751 169.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -116.85 141.48 48.17 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 120.674 -0.41 . . . . 1.04 110.103 -174.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.51 ' HA ' ' ND2' ' A' ' 97' ' ' ASN . 91.5 m-20 -94.23 123.8 37.85 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.268 -0.641 . . . . 2.04 109.268 175.453 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.517 HG13 HG21 ' A' ' 37' ' ' ILE . 97.9 t -119.72 114.92 45.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.247 -0.888 . . . . 1.06 110.219 179.353 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -156.48 171.32 20.49 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.506 -0.77 . . . . 2.49 110.254 -179.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.536 ' HB3' ' CD1' ' A' ' 111' ' ' TYR . 3.2 mm? -78.38 115.09 17.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.513 0.673 . . . . 1.23 111.415 -176.531 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -43.92 -35.83 2.17 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 113.949 -1.478 . . . . 0.91 113.987 -179.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.536 ' CD1' ' HB3' ' A' ' 109' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.467 0.395 0 O-C-N 121.69 -0.631 . . . . 1.4 112.311 -174.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 41.8 ttp . . . . . 0 CA--C 1.533 0.318 0 N-CA-C 111.987 0.366 . . . . 1.49 111.987 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -93.71 23.8 4.51 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.924 0.712 . . . . 1.5 112.924 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.509 ' O ' ' HA ' ' A' ' 82' ' ' THR . 70.5 p -149.49 19.45 0.93 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 118.726 0.693 . . . . 0.53 110.338 -171.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 5.8 ttpm? -121.97 103.88 9.13 Favored 'General case' 0 CA--C 1.509 -0.608 0 C-N-CA 119.925 -0.71 . . . . 2.75 109.733 -167.284 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.574 HG23 HG13 ' A' ' 107' ' ' VAL . 65.2 mt -90.35 111.91 24.08 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 CA-C-N 115.403 -0.817 . . . . 0.85 109.548 179.496 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.723 ' HB2' ' HB2' ' A' ' 110' ' ' ALA . 69.8 t80 -83.36 108.48 16.58 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 107.907 -1.146 . . . . 0.71 107.907 175.27 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.418 ' HB ' HD21 ' A' ' 42' ' ' LEU . 4.1 t -95.85 87.94 1.96 Allowed 'Isoleucine or valine' 0 C--O 1.209 -1.046 0 CA-C-O 122.105 0.955 . . . . 0.92 109.05 -177.048 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -68.3 147.28 47.17 Favored Glycine 0 C--N 1.305 -1.16 0 C-N-CA 119.359 -1.401 . . . . 0.84 112.151 168.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.91 38.58 13.31 Favored Glycine 0 CA--C 1.523 0.546 0 C-N-CA 120.74 -0.743 . . . . 0.68 114.773 170.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.815 HD11 HD21 ' A' ' 51' ' ' LEU . 2.8 mm? -72.49 143.63 85.47 Favored Pre-proline 0 CA--C 1.514 -0.438 0 CA-C-N 117.934 0.867 . . . . 1.28 110.802 172.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.558 ' HG2' ' HB3' ' A' ' 101' ' ' ASP . 75.4 Cg_exo -52.49 145.13 38.44 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 122.401 2.067 . . . . 0.58 110.867 166.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 46.8 m-85 -60.46 -16.26 34.81 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 113.795 1.035 . . . . 1.05 113.795 -171.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 3.0 p-80 -111.2 18.24 19.52 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 119.674 -0.811 . . . . 2.01 111.97 176.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.589 HG23 ' HB ' ' A' ' 50' ' ' THR . 91.7 m -78.22 107.13 10.59 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 118.971 -1.092 . . . . 0.72 110.445 178.229 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 6.6 p -87.02 171.62 10.6 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 113.767 -1.56 . . . . 0.55 113.849 170.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -55.16 -43.29 74.1 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 113.923 -1.49 . . . . 0.49 110.19 -174.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.639 ' O ' ' HG2' ' A' ' 53' ' ' GLU . 60.0 pttt -54.86 -41.84 71.29 Favored 'General case' 0 C--O 1.224 -0.268 0 CA-C-N 115.165 -0.925 . . . . 2.76 110.687 176.431 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.589 ' HB ' HG23 ' A' ' 46' ' ' THR . 11.2 m -61.8 -43.18 99.35 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.494 -0.321 . . . . 0.58 110.823 -176.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.815 HD21 HD11 ' A' ' 42' ' ' LEU . 18.3 mt -69.94 -46.96 64.17 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.736 -0.385 . . . . 0.85 111.318 178.442 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.446 ' HA ' HD12 ' A' ' 61' ' ' ILE . 57.9 t-80 -53.2 -55.52 23.63 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.899 0.381 . . . . 0.59 111.314 176.59 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.639 ' HG2' ' O ' ' A' ' 49' ' ' LYS . 9.6 mm-40 -56.02 -52.81 62.9 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.805 -0.634 . . . . 1.52 111.301 179.641 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -53.05 -49.09 67.04 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 115.385 1.624 . . . . 1.12 115.385 175.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.512 ' CE1' HD22 ' A' ' 51' ' ' LEU . 28.5 m-85 -81.62 -33.45 31.45 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 114.173 1.175 . . . . 0.56 114.173 -165.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.55 ' N ' HD11 ' A' ' 61' ' ' ILE . 9.8 pt-20 -53.53 0.17 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 114.126 1.158 . . . . 1.57 114.126 171.719 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.401 ' H ' ' C ' ' A' ' 55' ' ' PHE . 37.3 mt-30 -67.33 -34.98 78.47 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 116.105 -0.498 . . . . 2.16 110.499 167.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -68.71 -54.09 18.24 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.146 -0.479 . . . . 0.71 110.714 178.191 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -177.34 -82.06 0.06 OUTLIER Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 119.684 -1.246 . . . . 0.75 111.623 164.08 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.439 ' HB3' ' CB ' ' A' ' 84' ' ' LYS . 11.8 m-20 -115.36 106.91 14.56 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 111.536 0.199 . . . . 1.02 111.536 -178.075 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.55 HD11 ' N ' ' A' ' 56' ' ' GLU . 3.5 mt -84.07 146.95 6.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.099 -0.704 . . . . 0.47 109.099 166.515 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.617 ' HB2' ' HA ' ' A' ' 84' ' ' LYS . 8.2 tp10 -102.64 -45.49 5.01 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.405 -0.591 . . . . 2.07 109.405 177.349 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -157.49 123.87 4.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.634 -0.712 . . . . 2.48 109.802 179.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -115.7 141.13 48.49 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 120.929 0.395 . . . . 0.44 110.315 172.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.438 HG13 ' HB2' ' A' ' 80' ' ' PHE . 2.4 p -151.57 144.25 16.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.31 -0.859 . . . . 1.38 109.907 -174.629 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 57.5 t -114.3 128.56 71.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 O-C-N 122.3 -0.25 . . . . 0.49 110.558 176.315 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.524 HG22 ' HD3' ' A' ' 76' ' ' ARG . 31.7 mm -72.77 116.48 14.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.407 0.622 . . . . 0.72 110.436 -179.602 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 73.3 p . . . . . 0 C--N 1.314 -0.945 0 CA-C-N 115.247 -0.888 . . . . 1.52 111.399 -175.175 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 44.7 m . . . . . 0 N--CA 1.451 -0.403 0 CA-C-O 121.211 0.529 . . . . 1.81 112.307 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.524 ' HD3' HG22 ' A' ' 67' ' ' ILE . 66.4 mtp180 -48.92 -12.49 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 115.161 -0.927 . . . . 2.56 113.33 171.159 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 92.96 2.99 66.12 Favored Glycine 0 N--CA 1.441 -0.977 0 C-N-CA 120.378 -0.915 . . . . 0.64 112.426 178.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -114.56 136.91 52.51 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.504 -0.924 . . . . 1.18 108.504 178.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -134.55 179.11 17.91 Favored Glycine 0 N--CA 1.435 -1.405 0 C-N-CA 119.574 -1.298 . . . . 0.59 113.788 178.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.438 ' HB2' HG13 ' A' ' 65' ' ' VAL . 50.1 m-85 -144.71 124.04 13.04 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 113.787 -1.207 . . . . 0.63 110.124 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 53.0 t -127.79 106.98 15.69 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 CA-C-N 115.362 -0.835 . . . . 0.41 109.355 175.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.509 ' HA ' ' O ' ' A' ' 35' ' ' THR . 70.5 m -94.86 132.09 40.05 Favored 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 108.759 -0.83 . . . . 0.47 108.759 174.379 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . 0.425 ' HA ' ' HA ' ' A' ' 61' ' ' ILE . 26.5 mtp -99.96 156.26 17.25 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 109.132 -0.692 . . . . 0.88 109.132 -176.459 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.617 ' HA ' ' HB2' ' A' ' 62' ' ' GLU . 18.1 ttmt -60.22 -49.8 76.19 Favored 'General case' 0 C--N 1.327 -0.379 0 O-C-N 123.421 0.45 . . . . 1.92 110.554 -170.569 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -129.52 148.03 51.38 Favored 'General case' 0 C--O 1.245 0.864 0 CA-C-O 122.121 0.962 . . . . 1.68 111.926 166.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.575 ' O ' ' HG3' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -47.67 -24.61 0.96 Allowed 'General case' 0 C--O 1.214 -0.808 0 CA-C-N 113.708 -1.587 . . . . 3.66 114.096 176.685 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -58.0 -44.76 87.38 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 119.502 1.047 . . . . 0.66 111.483 175.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 49.9 m -71.96 -38.88 69.69 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.577 -0.449 . . . . 0.78 109.863 177.205 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.463 ' HB3' ' HA ' ' A' ' 86' ' ' ARG . . . -56.61 -28.89 61.41 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.916 -0.584 . . . . 0.46 111.789 173.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.575 ' HG3' ' O ' ' A' ' 86' ' ' ARG . 22.1 mt-10 -72.85 -43.97 61.96 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.471 0.653 . . . . 2.11 109.316 -179.686 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.434 ' O ' ' HG3' ' A' ' 94' ' ' LYS . 97.3 mtt180 -55.22 -41.93 72.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.983 -1.008 . . . . 3.82 111.254 176.036 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -69.36 -47.05 65.51 Favored 'General case' 0 C--O 1.219 -0.54 0 C-N-CA 120.971 -0.292 . . . . 0.92 111.533 174.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 48.4 t -48.5 -44.41 35.96 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 113.112 0.782 . . . . 1.16 113.112 177.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.54 ' HE2' ' HB2' ' A' ' 95' ' ' ASP . 0.0 OUTLIER -60.44 -22.89 63.95 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 118.314 0.506 . . . . 4.2 111.661 176.57 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.54 ' HB2' ' HE2' ' A' ' 94' ' ' LYS . 10.3 t70 -99.65 100.72 11.51 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 115.48 -0.782 . . . . 2.24 110.274 -177.529 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.425 ' HD3' ' O ' ' A' ' 94' ' ' LYS . 55.8 Cg_endo -90.72 113.78 0.44 Allowed 'Trans proline' 0 N--CA 1.451 -0.994 0 C-N-CA 123.113 2.542 . . . . 2.38 113.921 -171.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.543 ' HB3' ' HD2' ' A' ' 104' ' ' LYS . 1.0 OUTLIER 70.18 92.42 0.06 OUTLIER Pre-proline 0 N--CA 1.467 0.388 0 CA-C-N 114.495 -1.23 . . . . 3.03 111.464 175.978 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . 0.626 ' O ' ' HA ' ' A' ' 104' ' ' LYS . 73.4 Cg_endo -82.3 168.75 14.71 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 123.843 3.029 . . . . 1.29 113.926 -175.303 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 48.6 mm -102.22 118.07 48.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 CA-C-N 114.1 -1.409 . . . . 1.81 108.737 178.057 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 70.9 mt -137.65 124.16 27.79 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.233 0 N-CA-C 110.462 -0.199 . . . . 0.99 110.462 -167.268 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.558 ' HB3' ' HG2' ' A' ' 43' ' ' PRO . 37.9 t70 44.51 48.15 8.38 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-O 121.288 0.566 . . . . 1.37 111.25 -179.219 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 77.0 2.3 77.15 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 115.478 0.951 . . . . 1.56 115.478 179.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 13.0 tpt180 -141.92 130.52 22.66 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 118.487 1.143 . . . . 4.13 112.01 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.626 ' HA ' ' O ' ' A' ' 98' ' ' PRO . 16.8 ttpp -60.1 141.93 55.0 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.388 -0.369 . . . . 2.73 111.527 172.376 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.461 ' O ' ' HD2' ' A' ' 98' ' ' PRO . . . -124.32 167.78 13.88 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 109.035 -0.728 . . . . 1.04 109.035 177.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -97.7 106.93 19.32 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 122.133 0.968 . . . . 2.04 111.838 -178.166 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.574 HG13 HG23 ' A' ' 37' ' ' ILE . 24.6 t -96.48 113.95 32.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 113.517 -1.674 . . . . 1.06 112.104 172.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -134.36 144.34 48.17 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 114.497 -1.228 . . . . 2.49 108.882 172.278 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.482 HD12 ' CD1' ' A' ' 111' ' ' TYR . 0.1 OUTLIER -68.86 93.3 0.54 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.878 0.371 . . . . 1.23 110.384 177.782 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . 0.723 ' HB2' ' HB2' ' A' ' 38' ' ' PHE . . . -36.42 -19.12 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 118.223 2.675 . . . . 0.91 118.223 177.296 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.482 ' CD1' HD12 ' A' ' 109' ' ' LEU . 0.3 OUTLIER . . . . . 0 CA--C 1.545 0.759 0 CA-C-N 121.534 1.97 . . . . 1.4 109.99 175.29 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 43.0 ttp . . . . . 0 C--O 1.197 -1.699 0 N-CA-C 109.497 -0.557 . . . . 1.49 109.497 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . 0.501 ' O ' ' HB2' ' A' ' 86' ' ' ARG . 15.4 m-30 -92.22 42.19 1.09 Allowed 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 115.43 1.641 . . . . 1.5 115.43 175.559 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.404 HG22 ' N ' ' A' ' 86' ' ' ARG . 16.2 p -147.89 20.06 1.13 Allowed 'General case' 0 N--CA 1.485 1.314 0 CA-C-N 122.219 2.282 . . . . 0.53 110.821 177.474 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.637 ' HE3' ' HD1' ' A' ' 80' ' ' PHE . 3.1 tmtm? -129.58 100.85 5.68 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-O 122.351 1.072 . . . . 2.75 110.753 -160.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 43.1 mt -88.48 142.35 13.03 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 O-C-N 121.677 -0.639 . . . . 0.85 111.894 -170.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.45 ' HB3' ' O ' ' A' ' 108' ' ' ASN . 49.3 t80 -102.17 128.12 48.81 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.348 -0.982 . . . . 0.71 108.348 169.39 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.7 t -120.98 89.09 1.35 Allowed 'Isoleucine or valine' 0 C--O 1.217 -0.652 0 C-N-CA 119.995 -0.682 . . . . 0.92 110.128 -176.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -59.14 154.67 28.65 Favored Glycine 0 C--O 1.221 -0.663 0 C-N-CA 118.113 -1.994 . . . . 0.84 114.513 165.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 96.15 39.16 4.35 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 121.105 -0.569 . . . . 0.68 114.189 170.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.675 HD12 HG21 ' A' ' 46' ' ' THR . 2.9 mm? -93.68 125.24 54.3 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 117.122 0.461 . . . . 1.28 109.96 173.381 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.545 ' HG2' ' HB3' ' A' ' 101' ' ' ASP . 50.0 Cg_exo -49.08 155.88 2.58 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.779 2.319 . . . . 0.58 111.953 171.406 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -69.42 -3.4 14.2 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.433 0.531 . . . . 1.05 112.433 -173.029 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -110.05 -8.95 14.75 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 120.545 0.212 . . . . 2.01 111.016 179.028 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.675 HG21 HD12 ' A' ' 42' ' ' LEU . 30.0 m -62.69 133.68 55.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.952 0.406 . . . . 0.72 111.156 -173.609 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 12.0 p -107.63 158.38 17.3 Favored 'General case' 0 C--O 1.251 1.183 0 CA-C-O 121.856 0.836 . . . . 0.55 112.06 -177.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.518 ' HA ' HG23 ' A' ' 66' ' ' VAL . 2.6 m-20 -49.99 -30.93 11.5 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 114.323 -1.308 . . . . 0.49 111.122 177.411 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.573 ' O ' ' HG2' ' A' ' 53' ' ' GLU . 60.6 pttt -78.77 -29.26 44.93 Favored 'General case' 0 C--O 1.215 -0.746 0 N-CA-C 108.799 -0.815 . . . . 2.76 108.799 -174.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.576 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 7.0 m -64.91 -41.75 95.31 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 115.764 -0.653 . . . . 0.58 110.068 179.299 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.591 HD21 HD11 ' A' ' 42' ' ' LEU . 18.8 mt -62.05 -46.2 90.18 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 119.361 -0.935 . . . . 0.85 110.083 173.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . 0.535 ' HA ' ' CD1' ' A' ' 61' ' ' ILE . 59.6 t-80 -53.58 -32.39 50.77 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 116.27 -0.423 . . . . 0.59 110.911 172.474 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.576 ' HB2' ' O ' ' A' ' 50' ' ' THR . 45.2 mm-40 -68.05 -40.05 82.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.314 -0.857 . . . . 1.52 109.489 -175.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' TYR . . . . . 0.631 ' HA ' HE21 ' A' ' 57' ' ' GLN . 24.4 t80 -80.75 -40.82 24.55 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.421 -0.809 . . . . 1.12 111.499 -173.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.598 ' C ' ' H ' ' A' ' 57' ' ' GLN . 58.2 m-85 -85.56 -32.03 22.35 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 114.005 1.113 . . . . 0.56 114.005 -166.21 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.659 ' N ' HD11 ' A' ' 61' ' ' ILE . 15.7 pt-20 -63.28 4.13 0.24 Allowed 'General case' 0 N--CA 1.48 1.061 0 CA-C-O 122.168 0.985 . . . . 1.57 111.145 176.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.631 HE21 ' HA ' ' A' ' 54' ' ' TYR . 36.2 mt-30 -92.32 -18.11 23.79 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 113.753 -1.567 . . . . 2.16 110.73 -176.259 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -102.62 -29.43 11.55 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.506 0.67 . . . . 0.71 109.692 177.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.413 ' O ' ' HA ' ' A' ' 56' ' ' GLU . . . 178.46 -174.6 46.81 Favored Glycine 0 N--CA 1.443 -0.861 0 N-CA-C 110.255 -1.138 . . . . 0.75 110.255 -177.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -64.0 137.34 57.95 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 117.388 0.594 . . . . 1.02 110.492 175.409 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.659 HD11 ' N ' ' A' ' 56' ' ' GLU . 7.5 mt -101.91 142.42 16.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 105.692 -1.966 . . . . 0.47 105.692 172.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.475 ' OE1' ' HE3' ' A' ' 84' ' ' LYS . 7.7 tp10 -88.75 -37.13 15.71 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 119.61 1.096 . . . . 2.07 109.155 178.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -166.24 127.44 1.78 Allowed 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.063 -0.517 . . . . 2.48 110.792 177.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -115.01 134.33 55.28 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.1 0.476 . . . . 0.44 110.753 174.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.523 HG13 ' HB2' ' A' ' 80' ' ' PHE . 2.9 p -147.32 136.71 16.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.248 -0.887 . . . . 1.38 111.231 -174.61 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.518 HG23 ' HA ' ' A' ' 48' ' ' ASP . 78.4 t -107.36 131.37 57.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 109.043 -0.725 . . . . 0.49 109.043 176.317 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 49.0 mm -88.23 139.47 17.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-O 121.867 0.841 . . . . 0.72 112.625 -168.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.687 ' O ' ' HD2' ' A' ' 76' ' ' ARG . 34.4 p . . . . . 0 N--CA 1.444 -0.731 0 N-CA-C 105.994 -1.854 . . . . 1.52 105.994 172.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 2.8 m . . . . . 0 N--CA 1.448 -0.538 0 N-CA-C 108.975 -0.75 . . . . 1.81 108.975 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.687 ' HD2' ' O ' ' A' ' 68' ' ' THR . 15.1 mtt180 -72.45 -10.62 60.02 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.188 -0.46 . . . . 2.56 112.042 -172.452 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 73.29 8.71 75.75 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.56 -0.828 . . . . 0.64 112.059 176.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.509 ' CD2' ' HB3' ' A' ' 76' ' ' ARG . 9.9 m-85 -111.18 141.62 44.46 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.44 -0.948 . . . . 1.18 108.44 178.401 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -126.96 164.76 20.43 Favored Glycine 0 N--CA 1.439 -1.157 0 C-N-CA 120.274 -0.965 . . . . 0.59 112.214 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.637 ' HD1' ' HE3' ' A' ' 36' ' ' LYS . 51.0 m-85 -139.44 123.12 17.46 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.25 0.547 . . . . 0.63 109.621 178.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.496 HG11 ' CD2' ' A' ' 55' ' ' PHE . 54.0 t -125.27 108.14 19.3 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 115.626 -0.715 . . . . 0.41 110.184 -178.483 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.451 ' HA ' ' HA ' ' A' ' 36' ' ' LYS . 18.5 m -92.83 118.03 30.67 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 109.128 -0.693 . . . . 0.47 109.128 178.022 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 80.3 mmm -85.91 -179.95 6.9 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.244 0.545 . . . . 0.88 110.326 178.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.475 ' HE3' ' OE1' ' A' ' 62' ' ' GLU . 6.4 tptm -93.99 -7.38 42.99 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.345 -0.843 . . . . 1.92 109.156 -171.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -167.28 154.17 8.48 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 114.672 -1.149 . . . . 1.68 110.12 -162.217 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.501 ' HB2' ' O ' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -76.17 -49.49 17.11 Favored 'General case' 0 C--O 1.223 -0.341 0 N-CA-C 109.764 -0.458 . . . . 3.66 109.764 -174.258 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -51.69 -39.34 58.12 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.511 -0.768 . . . . 0.66 112.22 176.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.663 ' HA ' ' HE ' ' A' ' 91' ' ' ARG . 14.6 m -69.17 -40.54 78.06 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.838 0.351 . . . . 0.78 110.825 176.72 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -55.31 -46.08 76.29 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.049 -0.523 . . . . 0.46 110.525 170.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -60.34 -41.27 93.25 Favored 'General case' 0 C--O 1.222 -0.364 0 CA-C-O 121.268 0.556 . . . . 2.11 110.464 174.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.663 ' HE ' ' HA ' ' A' ' 88' ' ' SER . 16.4 mtm180 -56.72 -50.92 70.76 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 114.713 -1.13 . . . . 3.82 111.641 176.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -59.96 -27.31 66.7 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 113.837 1.051 . . . . 0.92 113.837 173.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 44.7 t -79.97 -36.1 36.58 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.943 0.878 . . . . 1.16 109.097 179.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.576 ' HB3' ' O ' ' A' ' 91' ' ' ARG . 59.8 tptt -50.4 -18.8 0.69 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 113.675 -1.602 . . . . 4.2 112.511 170.01 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -104.52 89.15 2.51 Favored Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 109.118 -0.697 . . . . 2.24 109.118 166.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' PRO . . . . . 0.575 ' HD3' ' O ' ' A' ' 94' ' ' LYS . 5.6 Cg_exo -73.67 173.77 13.36 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.923 2.415 . . . . 2.38 111.138 -177.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 5.92 67.74 0.05 OUTLIER Pre-proline 0 N--CA 1.479 1.014 0 O-C-N 124.2 0.937 . . . . 3.03 113.417 -160.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -69.13 133.39 26.59 Favored 'Trans proline' 0 CA--C 1.511 -0.644 0 C-N-CA 121.723 1.615 . . . . 1.29 108.962 177.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.569 HG22 ' C ' ' A' ' 102' ' ' GLY . 17.2 mm -87.1 95.92 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.893 0 CA-C-N 119.307 0.958 . . . . 1.81 108.671 -172.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.441 ' C ' ' N ' ' A' ' 102' ' ' GLY . 11.2 mm -89.54 150.02 3.85 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.422 0 CA-C-O 121.461 0.648 . . . . 0.99 111.734 -170.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.545 ' HB3' ' HG2' ' A' ' 43' ' ' PRO . 30.5 t70 36.24 20.65 0.0 OUTLIER 'General case' 0 CA--C 1.559 1.306 0 CA-C-N 113.898 -1.501 . . . . 1.37 111.916 -156.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.569 ' C ' HG22 ' A' ' 99' ' ' ILE . . . 89.18 17.31 56.03 Favored Glycine 0 CA--C 1.535 1.31 0 C-N-CA 120.852 -0.69 . . . . 1.56 113.131 -179.546 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.487 ' N ' HG22 ' A' ' 99' ' ' ILE . 39.5 mmt180 -132.38 140.73 48.6 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.548 0.739 . . . . 4.13 110.035 176.18 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -58.58 112.68 1.69 Allowed 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 113.74 1.015 . . . . 2.73 113.74 -171.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -92.34 164.83 13.36 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 114.752 -1.113 . . . . 1.04 112.993 177.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -123.52 113.46 18.75 Favored 'General case' 0 C--O 1.253 1.27 0 CA-C-N 115.098 -0.956 . . . . 2.04 110.245 177.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 51.0 t -98.18 127.77 50.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 114.63 -1.168 . . . . 1.06 111.444 -173.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . 0.45 ' O ' ' HB3' ' A' ' 38' ' ' PHE . 66.5 t30 -157.39 152.75 26.23 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.517 -0.765 . . . . 2.49 109.909 178.532 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.596 HD12 ' HE1' ' A' ' 111' ' ' TYR . 7.7 mt -65.97 125.93 26.98 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 113.539 0.94 . . . . 1.23 113.539 -177.627 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -45.92 -44.49 14.71 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 113.944 -1.48 . . . . 0.91 113.217 172.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.596 ' HE1' HD12 ' A' ' 109' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.473 0.692 0 O-C-N 121.866 -0.521 . . . . 1.4 111.418 -173.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.887 0 N-CA-C 111.872 -0.491 . . . . 13.03 111.872 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -118.39 -76.08 0.58 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.914 0.388 . . . . 11.06 111.067 -177.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 53.2 ttm -81.35 94.17 6.72 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.168 0.509 . . . . 9.85 110.239 -177.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 149.31 -11.65 1.02 Allowed Glycine 0 N--CA 1.445 -0.713 0 CA-C-N 115.651 -0.704 . . . . 6.69 111.831 -177.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 19.6 m -60.17 -45.14 94.09 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 121.267 0.556 . . . . 5.55 110.579 176.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.434 ' HD2' ' OE1' ' A' ' 62' ' ' GLU . 55.4 mtm180 -136.86 146.27 45.38 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.578 -0.737 . . . . 3.87 110.166 178.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -126.35 127.67 45.87 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.959 -0.564 . . . . 3.53 109.648 178.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.461 ' O ' ' HB2' ' A' ' 36' ' ' LYS . 9.9 p -82.56 -22.17 35.02 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.451 -0.341 . . . . 1.69 111.892 -177.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 51.9 ttp -61.84 -45.43 93.85 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 112.043 0.386 . . . . 1.49 112.043 -176.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.474 ' HB3' ' HG3' ' A' ' 86' ' ' ARG . 8.9 m-85 -91.76 -2.34 56.99 Favored 'General case' 0 C--N 1.331 -0.212 0 O-C-N 122.226 -0.296 . . . . 1.5 111.63 -176.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.581 ' O ' ' HA ' ' A' ' 82' ' ' THR . 41.1 p -110.68 -3.49 15.82 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.877 -0.329 . . . . 0.53 111.447 -178.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.461 ' HB2' ' O ' ' A' ' 32' ' ' THR . 63.2 tttm -85.64 103.24 14.28 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.97 -0.559 . . . . 2.75 110.207 -176.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 98.7 mt -105.57 141.71 20.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 C-N-CA 123.108 0.563 . . . . 0.85 111.577 -173.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.401 ' HD1' ' CE1' ' A' ' 80' ' ' PHE . 58.9 t80 -95.79 132.41 41.06 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.645 -0.707 . . . . 0.71 109.505 174.007 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.788 HG12 HD11 ' A' ' 42' ' ' LEU . 3.6 t -120.96 141.92 39.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 121.082 0.468 . . . . 0.92 110.314 -178.313 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.591 ' HA3' ' HB2' ' A' ' 106' ' ' ASN . . . -141.95 159.52 26.98 Favored Glycine 0 C--O 1.219 -0.807 0 CA-C-N 115.72 -0.673 . . . . 0.84 112.735 -167.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.77 37.38 93.38 Favored Glycine 0 CA--C 1.522 0.503 0 C-N-CA 121.374 -0.441 . . . . 0.68 113.817 172.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.788 HD11 HG12 ' A' ' 39' ' ' VAL . 8.2 mp -87.54 134.0 36.93 Favored Pre-proline 0 C--N 1.326 -0.418 0 O-C-N 122.694 -0.298 . . . . 1.28 110.626 178.332 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.622 ' HD2' ' OG1' ' A' ' 46' ' ' THR . 51.5 Cg_exo -53.33 155.89 11.7 Favored 'Trans proline' 0 N--CA 1.463 -0.282 0 C-N-CA 122.995 2.463 . . . . 0.58 112.101 175.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.523 ' CE2' ' C5 ' ' B' ' 2' ' ' ' G' . 66.9 m-85 -69.09 1.87 3.22 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.129 0.49 . . . . 1.05 110.963 -179.021 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . 0.423 ' HD2' ' OD2' ' A' ' 101' ' ' ASP . 19.5 t60 -106.88 -16.46 14.46 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.747 -0.66 . . . . 2.01 110.627 178.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.796 HG23 HG21 ' A' ' 50' ' ' THR . 61.2 m -71.77 138.54 48.49 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.257 -0.428 . . . . 0.72 111.467 -175.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 16.9 p -130.96 -178.35 4.78 Favored 'General case' 0 C--O 1.24 0.561 0 CA-C-O 120.967 0.413 . . . . 0.55 111.391 -176.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -62.74 -33.52 75.32 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.969 -0.56 . . . . 0.49 110.756 -176.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -71.39 -33.93 69.94 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.286 -0.635 . . . . 2.76 109.286 -179.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.796 HG21 HG23 ' A' ' 46' ' ' THR . 81.2 m -61.24 -45.29 95.16 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 115.57 -0.741 . . . . 0.58 110.686 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 54.0 mt -67.57 -35.33 78.82 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.928 -0.578 . . . . 0.85 111.089 178.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 57.7 t-80 -61.89 -54.02 47.78 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.25 -0.648 . . . . 0.59 109.25 176.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -58.66 -37.4 75.89 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.826 -0.624 . . . . 1.52 112.005 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -76.87 -37.59 55.24 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 120.789 0.328 . . . . 1.12 111.714 -178.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -85.22 -25.23 27.45 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 113.402 0.89 . . . . 0.56 113.402 -174.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.66 ' N ' HD11 ' A' ' 61' ' ' ILE . 10.8 pt-20 -64.52 -18.14 64.55 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.642 0.734 . . . . 1.57 109.984 179.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -55.45 -27.66 49.54 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 114.542 -1.208 . . . . 2.16 111.755 170.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -96.06 -21.28 18.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.546 -0.297 . . . . 0.71 110.802 -178.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 151.25 -159.74 28.35 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.565 -0.826 . . . . 0.75 112.419 177.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -65.9 121.94 16.21 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.028 0.442 . . . . 1.02 111.671 -178.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.66 HD11 ' N ' ' A' ' 56' ' ' GLU . 12.5 mt -101.41 130.74 50.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 109.235 -0.654 . . . . 0.47 109.235 176.023 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.434 ' OE1' ' HD2' ' A' ' 30' ' ' ARG . 28.4 tt0 -85.32 -53.37 5.27 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 121.181 -0.208 . . . . 2.07 111.33 176.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -140.28 129.59 23.85 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.711 -0.222 . . . . 2.48 111.223 -175.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -121.6 116.92 25.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.186 0.517 . . . . 0.44 111.056 174.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.427 HG21 ' H22' ' B' ' 6' ' ' ' G' . 30.3 m -128.64 145.43 35.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.454 -0.794 . . . . 1.38 112.123 -179.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 91.3 t -116.76 133.73 62.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.525 -0.761 . . . . 0.49 110.734 174.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 36.8 mm -76.92 152.5 5.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.715 -0.675 . . . . 0.72 109.524 177.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 39.5 p -136.14 167.22 21.67 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 105.407 -2.072 . . . . 1.52 105.407 -174.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.529 ' HB3' ' H ' ' A' ' 74' ' ' LYS . 32.3 t70 -62.59 154.04 30.23 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 118.713 0.688 . . . . 2.49 111.888 -171.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.463 ' O ' ' HD2' ' A' ' 70' ' ' ARG . 1.2 tmm_? -80.11 -24.12 40.75 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.805 -0.634 . . . . 6.05 110.476 -173.393 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -108.09 -61.77 1.54 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.43 -0.35 . . . . 4.05 111.259 -177.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 45.6 p -83.09 -21.59 33.65 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.858 0.361 . . . . 3.08 111.239 -177.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 56.74 66.77 1.1 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.75 0.786 . . . . 3.3 111.133 -174.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.529 ' H ' ' HB3' ' A' ' 69' ' ' ASP . 66.8 mttm -111.41 168.33 9.62 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 106.998 -1.482 . . . . 3.49 106.998 172.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 6.3 m -71.1 97.31 1.47 Allowed 'General case' 0 C--N 1.316 -0.857 0 C-N-CA 120.423 -0.511 . . . . 1.81 110.792 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 73.7 mtp180 -58.51 -29.55 66.37 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 115.769 -0.65 . . . . 2.56 111.191 179.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.558 ' HA3' ' H22' ' B' ' 2' ' ' ' G' . . . 93.37 30.37 9.28 Favored Glycine 0 N--CA 1.439 -1.109 0 C-N-CA 120.506 -0.854 . . . . 0.64 112.18 -177.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.409 ' CE1' " H1'" ' B' ' 4' ' ' ' G' . 24.5 m-85 -131.49 141.83 49.84 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 107.921 -1.14 . . . . 1.18 107.921 175.167 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -141.72 -171.75 13.04 Favored Glycine 0 N--CA 1.439 -1.142 0 C-N-CA 120.089 -1.053 . . . . 0.59 111.782 -174.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.416 ' HB2' HG23 ' A' ' 65' ' ' VAL . 55.4 m-85 -154.91 124.6 6.52 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.582 -0.896 . . . . 0.63 108.582 -177.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.475 HG23 HG21 ' A' ' 39' ' ' VAL . 53.8 t -119.58 124.14 72.37 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 CA-C-N 115.742 -0.663 . . . . 0.41 110.133 -177.149 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.581 ' HA ' ' O ' ' A' ' 35' ' ' THR . 17.3 m -109.41 116.33 31.62 Favored 'General case' 0 C--N 1.311 -1.106 0 N-CA-C 107.948 -1.13 . . . . 0.47 107.948 175.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 92.5 mmm -87.72 162.69 16.92 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.098 -0.705 . . . . 0.88 109.098 -175.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 44.8 tttm -85.04 -10.47 56.9 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 120.873 0.368 . . . . 1.92 110.997 -175.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -149.5 147.78 28.62 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-N 116.377 -0.374 . . . . 1.68 110.562 175.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.483 ' O ' ' HB3' ' A' ' 89' ' ' ALA . 1.3 tmt_? -67.49 -22.72 65.45 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 112.255 0.465 . . . . 3.66 112.255 -176.318 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.05 -47.27 77.95 Favored 'General case' 0 N--CA 1.464 0.239 0 O-C-N 121.519 -0.738 . . . . 0.66 111.285 178.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 19.1 m -65.92 -31.13 71.88 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.605 0.717 . . . . 0.78 109.754 175.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.483 ' HB3' ' O ' ' A' ' 86' ' ' ARG . . . -59.32 -48.97 79.62 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.123 -1.398 . . . . 0.46 109.818 174.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -55.87 -51.68 66.71 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.203 -0.453 . . . . 2.11 111.654 174.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.483 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 23.7 mmt180 -57.78 -45.39 86.07 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.315 -0.402 . . . . 3.82 111.198 -178.026 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -58.66 -48.12 82.14 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.09 -0.505 . . . . 0.92 111.147 176.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 49.2 t -75.46 -2.97 31.25 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 111.945 0.35 . . . . 1.16 111.945 -176.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.483 ' HB2' ' O ' ' A' ' 91' ' ' ARG . 4.5 mmmm -59.95 -48.74 80.45 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 121.044 -0.262 . . . . 4.2 111.463 176.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.439 ' HA ' ' HD3' ' A' ' 96' ' ' PRO . 32.5 t0 -106.39 107.57 60.21 Favored Pre-proline 0 C--N 1.328 -0.365 0 N-CA-C 109.931 -0.396 . . . . 2.24 109.931 179.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 95' ' ' ASP . 6.9 Cg_exo -74.48 -10.32 22.03 Favored 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 123.082 2.521 . . . . 2.38 113.51 -176.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.707 ' HA ' ' O ' ' A' ' 105' ' ' ALA . 2.0 m120 -142.81 68.57 19.02 Favored Pre-proline 0 N--CA 1.464 0.254 0 N-CA-C 112.824 0.676 . . . . 3.03 112.824 -178.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -81.29 154.46 18.85 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.803 2.336 . . . . 1.29 110.818 172.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 42.6 mm -85.63 91.95 3.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 120.418 -0.513 . . . . 1.81 110.478 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 52.3 mt -89.95 107.77 18.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.702 0.763 . . . . 0.99 112.681 178.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.423 ' OD2' ' HD2' ' A' ' 45' ' ' HIS . 32.2 t70 66.13 43.59 2.83 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 113.901 -1.5 . . . . 1.37 110.438 167.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 88.99 -7.63 81.74 Favored Glycine 0 CA--C 1.518 0.267 0 CA-C-N 115.056 -0.975 . . . . 1.56 114.551 177.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.532 ' HB2' ' HG3' ' A' ' 43' ' ' PRO . 14.7 tpt180 -126.66 141.79 51.74 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 117.992 0.896 . . . . 4.13 110.709 178.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -64.62 131.57 47.34 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.088 -0.708 . . . . 2.73 109.088 172.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.707 ' O ' ' HA ' ' A' ' 97' ' ' ASN . . . -118.64 153.54 34.15 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.821 -0.627 . . . . 1.04 110.087 -169.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.591 ' HB2' ' HA3' ' A' ' 40' ' ' GLY . 6.6 m-20 -96.68 140.15 31.71 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.069 0.461 . . . . 2.04 110.281 178.162 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.436 ' O ' ' HA ' ' A' ' 96' ' ' PRO . 70.6 t -146.08 113.75 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.029 -0.987 . . . . 1.06 110.626 -174.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.454 HD22 ' HA ' ' A' ' 108' ' ' ASN . 0.8 OUTLIER -159.3 165.06 34.24 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.097 -0.705 . . . . 2.49 109.097 174.906 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.511 ' HB3' ' CD1' ' A' ' 111' ' ' TYR . 2.0 mm? -71.96 129.31 38.25 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.254 -0.647 . . . . 1.23 109.254 176.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -57.84 -31.57 66.78 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 112.575 0.583 . . . . 0.91 112.575 -173.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.511 ' CD1' ' HB3' ' A' ' 109' ' ' LEU . 2.5 p90 -75.81 -8.7 57.52 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.758 0.314 . . . . 1.4 111.299 -176.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 98.2 mt -81.23 -31.51 33.79 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.112 0.482 . . . . 1.97 110.589 178.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -122.21 34.53 3.8 Favored Glycine 0 N--CA 1.45 -0.422 0 N-CA-C 111.313 -0.715 . . . . 2.14 111.313 -179.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -90.2 133.29 35.0 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.888 -0.412 . . . . 2.66 109.888 -178.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 50.2 mtmt -136.57 74.92 52.0 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.126 0.489 . . . . 4.16 109.912 173.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -91.62 -16.59 1.22 Allowed 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 123.538 2.826 . . . . 5.53 112.551 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 76.9 ttt180 -167.98 168.5 11.99 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 107.83 -1.174 . . . . 8.6 107.83 -176.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.447 ' O ' ' HB2' ' A' ' 119' ' ' ASN . 5.9 t 44.9 86.74 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.546 0 O-C-N 124.151 0.907 . . . . 6.37 111.688 -177.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.447 ' HB2' ' O ' ' A' ' 118' ' ' THR . 49.9 m-80 77.7 80.4 0.08 Allowed 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 114.777 -1.102 . . . . 7.85 110.83 -172.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 42.9 t -109.73 95.06 3.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.922 -0.581 . . . . 9.37 110.534 179.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.453 ' OE1' ' HA ' ' A' ' 121' ' ' GLN . 6.5 tp60 . . . . . 0 C--O 1.245 0.828 0 CA-C-N 115.473 -0.785 . . . . 12.28 109.451 176.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 1' ' ' ' G' . . . . . 0.471 " H4'" " O5'" ' B' ' 2' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.431 -0.582 0 C3'-C2'-C1' 99.888 -1.791 . 0.0 '__' . 4.94 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 2' ' ' ' G' . . . . . 0.558 ' H22' ' HA3' ' A' ' 77' ' ' GLY . . . . . . . . 0 O5'--C5' 1.427 -0.792 0 O4'-C1'-N19 110.533 2.333 . 0.0 OUTLIER . 4.87 . . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 3' ' ' ' U' . . . . . 0.527 " H3'" " O4'" ' B' ' 4' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.424 -0.972 0 C5'-C4'-O4' 107.525 -1.196 . 0.0 OUTLIER . 5.02 . . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 4' ' ' ' G' . . . . . 0.527 " O4'" " H3'" ' B' ' 3' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.423 -1.05 0 O4'-C4'-C3' 103.615 -1.346 . 0.0 OUTLIER '7D dist 2a' 2.69 . . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 5' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.428 -0.777 0 C4'-C3'-C2' 103.885 1.185 . 0.0 OUTLIER . 1.93 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 6' ' ' ' G' . . . . . 0.427 ' H22' HG21 ' A' ' 65' ' ' VAL . . . . . . . . 0 O5'--C5' 1.425 -0.963 0 C4'-C3'-C2' 103.746 1.046 . 0.391 0b . 2.38 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.426 -0.868 0 C4'-C3'-C2' 103.575 0.875 . 0.0 OUTLIER . 4.19 . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.696 0 N-CA-C 111.578 -0.609 . . . . 13.03 111.578 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -158.25 13.33 0.19 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.465 0.174 . . . . 11.06 110.677 178.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 55.2 ttp 58.66 85.03 0.1 Allowed 'General case' 0 N--CA 1.462 0.161 0 O-C-N 123.79 0.681 . . . . 9.85 111.091 -173.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -142.57 -116.77 1.21 Allowed Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.795 -0.717 . . . . 6.69 112.139 -179.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 15.3 t 63.6 13.53 7.37 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 122.961 0.504 . . . . 5.55 111.465 -179.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.469 ' HE ' ' CD ' ' A' ' 62' ' ' GLU . 57.3 mtp85 -90.93 172.18 8.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.746 0.308 . . . . 3.87 110.36 -179.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -79.39 105.75 10.92 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 110.116 -0.327 . . . . 3.53 110.116 178.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.423 ' O ' ' HB2' ' A' ' 36' ' ' LYS . 74.3 p -100.05 -4.52 29.73 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.052 -0.522 . . . . 1.69 110.075 176.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . 0.479 ' O ' ' HB3' ' A' ' 111' ' ' TYR . 44.2 ttp -56.26 -66.87 0.36 Allowed 'General case' 0 N--CA 1.454 -0.248 0 CA-C-N 115.928 -0.578 . . . . 1.49 112.252 179.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -81.12 -44.88 17.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 118.65 0.659 . . . . 1.5 111.123 -174.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.473 ' HB ' ' O ' ' A' ' 83' ' ' MET . 56.8 p -56.04 -17.94 8.24 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 114.376 1.25 . . . . 0.53 114.376 -175.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.722 ' HG2' ' HB3' ' A' ' 110' ' ' ALA . 29.2 ttpt -81.33 114.77 20.33 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.29 0.567 . . . . 2.75 111.68 -173.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 89.0 mt -105.62 134.18 47.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.364 -0.835 . . . . 0.85 111.112 -179.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.694 ' HZ ' " H2'" ' B' ' 4' ' ' ' G' . 89.0 t80 -94.28 111.15 22.87 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.027 -0.731 . . . . 0.71 109.027 175.175 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.6 t -100.75 139.8 21.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.278 0.561 . . . . 0.92 110.24 -179.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.46 ' O ' ' HB1' ' A' ' 105' ' ' ALA . . . -139.99 135.92 7.44 Favored Glycine 0 N--CA 1.448 -0.523 0 CA-C-N 115.212 -0.904 . . . . 0.84 112.798 -170.55 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 86.34 32.37 16.77 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.762 -0.732 . . . . 0.68 113.049 176.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.683 HD11 HD21 ' A' ' 51' ' ' LEU . 2.8 mm? -74.21 117.3 60.55 Favored Pre-proline 0 C--N 1.328 -0.338 0 N-CA-C 109.736 -0.468 . . . . 1.28 109.736 177.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.57 ' HG2' ' HB3' ' A' ' 101' ' ' ASP . 81.8 Cg_exo -51.0 159.36 2.55 Favored 'Trans proline' 0 CA--C 1.527 0.129 0 C-N-CA 122.913 2.409 . . . . 0.58 112.664 178.303 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.515 ' CE2' ' C4 ' ' B' ' 1' ' ' ' G' . 81.4 m-85 -69.94 -4.95 22.93 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 116.284 -0.416 . . . . 1.05 111.776 -171.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . 0.672 ' HB3' ' OD2' ' A' ' 101' ' ' ASP . 70.7 t60 -101.41 -6.04 24.54 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-O 120.964 0.411 . . . . 2.01 110.533 175.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.488 HG21 HD12 ' A' ' 42' ' ' LEU . 95.0 m -75.38 118.81 18.67 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.05 0.453 . . . . 0.72 111.406 -178.016 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 11.7 p -108.62 -178.75 3.68 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-N 115.924 -0.58 . . . . 0.55 110.824 177.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -64.64 -35.93 82.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.296 0.569 . . . . 0.49 110.443 -176.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.571 ' O ' ' HG2' ' A' ' 53' ' ' GLU . 20.2 ptmt -65.93 -37.44 86.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.582 -0.736 . . . . 2.76 110.592 179.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 49.9 m -59.49 -45.58 91.26 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.958 -0.564 . . . . 0.58 110.403 178.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.683 HD21 HD11 ' A' ' 42' ' ' LEU . 39.5 mt -66.55 -32.95 74.63 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.736 -0.666 . . . . 0.85 111.22 177.185 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.432 ' HA ' HD12 ' A' ' 61' ' ' ILE . 55.2 t-80 -65.27 -55.07 20.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.867 0.365 . . . . 0.59 110.269 177.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.571 ' HG2' ' O ' ' A' ' 49' ' ' LYS . 9.0 mm-40 -57.93 -43.41 86.28 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.143 0.496 . . . . 1.52 112.211 -179.293 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -74.8 -35.0 62.49 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.108 -0.496 . . . . 1.12 112.148 -174.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.764 ' HB2' HD11 ' A' ' 61' ' ' ILE . 7.5 m-85 -87.12 -25.17 24.26 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 113.493 0.923 . . . . 0.56 113.493 -172.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -67.97 -16.39 64.04 Favored 'General case' 0 CA--C 1.522 -0.098 0 CA-C-O 121.544 0.688 . . . . 1.57 109.557 179.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 28.5 mm-40 -56.59 -16.32 5.93 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.054 -0.976 . . . . 2.16 112.459 169.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -99.51 -18.32 17.46 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.847 0.356 . . . . 0.71 110.7 178.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 161.73 -112.96 0.54 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.482 -0.866 . . . . 0.75 112.998 176.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.612 ' HB3' ' HB3' ' A' ' 84' ' ' LYS . 7.9 m-20 -114.27 126.41 54.99 Favored 'General case' 0 C--N 1.329 -0.322 0 O-C-N 122.654 -0.321 . . . . 1.02 110.74 -179.026 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.764 HD11 ' HB2' ' A' ' 55' ' ' PHE . 32.4 mt -99.82 126.71 53.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 C-N-CA 120.903 -0.319 . . . . 0.47 110.57 173.18 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.469 ' CD ' ' HE ' ' A' ' 30' ' ' ARG . 28.6 tt0 -83.61 -47.58 11.11 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.828 -0.624 . . . . 2.07 109.928 176.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -156.57 130.27 8.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.73 -0.668 . . . . 2.48 110.743 179.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -115.36 116.36 28.13 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.931 -0.396 . . . . 0.44 109.931 175.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.569 HG21 ' N2 ' ' B' ' 6' ' ' ' G' . 4.2 m -133.22 115.67 23.85 Favored 'Isoleucine or valine' 0 C--O 1.24 0.553 0 CA-C-O 121.772 0.796 . . . . 1.38 112.808 -176.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 94.0 t -72.56 126.08 32.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 114.881 -1.054 . . . . 0.49 109.137 173.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.4 ' O ' ' HB2' ' A' ' 76' ' ' ARG . 31.1 mm -74.08 95.35 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.542 0 CA-C-O 121.336 0.588 . . . . 0.72 110.268 -178.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.402 ' HB ' ' HA ' ' A' ' 73' ' ' GLN . 29.9 p -88.97 155.8 19.28 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-N 115.403 -0.817 . . . . 1.52 111.222 -176.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.715 ' HA ' ' NE ' ' A' ' 76' ' ' ARG . 36.3 t70 -50.76 144.81 7.74 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 113.964 -1.471 . . . . 2.49 113.019 -170.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.418 HH11 ' HD2' ' A' ' 70' ' ' ARG . 7.8 ttp180 -70.94 -22.72 62.19 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.765 -0.652 . . . . 6.05 111.991 -176.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -108.7 -19.51 13.4 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.736 0.303 . . . . 4.05 111.076 -172.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 22.0 p -134.15 -27.6 1.4 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.774 0.321 . . . . 3.08 111.734 -175.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.402 ' HA ' ' HB ' ' A' ' 68' ' ' THR . 83.1 mt-30 56.44 65.02 1.52 Allowed 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.811 -0.631 . . . . 3.3 111.28 -175.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 57.0 mtmt -102.21 -63.72 1.13 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.586 -0.734 . . . . 3.49 112.131 -178.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.479 ' O ' ' HB2' ' A' ' 76' ' ' ARG . 11.7 p -160.44 -69.26 0.07 Allowed 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.732 -0.387 . . . . 1.81 111.895 -176.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.715 ' NE ' ' HA ' ' A' ' 69' ' ' ASP . 81.1 mtt180 76.63 -25.17 0.21 Allowed 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.371 0.669 . . . . 2.56 111.43 -179.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.414 ' HA3' ' C6 ' ' B' ' 2' ' ' ' G' . . . 85.17 10.46 78.01 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.652 -0.785 . . . . 0.64 113.221 173.384 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 14.7 m-85 -121.95 154.21 37.47 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.18 -1.044 . . . . 1.18 108.18 177.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -165.93 143.43 8.4 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 119.525 -1.322 . . . . 0.59 113.418 178.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -101.24 124.63 47.25 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 122.184 0.992 . . . . 0.63 112.26 174.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 58.0 t -104.27 130.55 54.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 113.966 -1.47 . . . . 0.41 108.144 170.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 4.7 m -115.08 122.35 45.88 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 107.794 -1.187 . . . . 0.47 107.794 178.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.473 ' O ' ' HB ' ' A' ' 35' ' ' THR . 88.3 mmm -86.61 160.78 18.8 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.528 -0.545 . . . . 0.88 109.528 -174.094 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.612 ' HB3' ' HB3' ' A' ' 60' ' ' ASP . 31.3 ttmt -84.04 -19.03 35.11 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.235 0.54 . . . . 1.92 109.667 -177.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -141.45 144.09 34.22 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 115.554 -0.748 . . . . 1.68 111.153 -178.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.536 ' O ' ' HG2' ' A' ' 90' ' ' GLU . 0.6 OUTLIER -66.1 -29.93 70.34 Favored 'General case' 0 C--O 1.222 -0.382 0 N-CA-C 113.743 1.016 . . . . 3.66 113.743 -177.718 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -67.73 -35.65 79.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 119.361 0.982 . . . . 0.66 110.89 178.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 11.7 m -64.66 -35.11 79.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 122.06 0.933 . . . . 0.78 109.35 173.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.466 ' HB2' ' HA ' ' A' ' 35' ' ' THR . . . -66.02 -45.71 80.51 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 113.685 -1.598 . . . . 0.46 110.468 177.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.536 ' HG2' ' O ' ' A' ' 86' ' ' ARG . 10.7 mm-40 -54.53 -51.54 64.85 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 115.779 -0.646 . . . . 2.11 112.65 178.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.521 ' O ' ' HB3' ' A' ' 94' ' ' LYS . 57.0 mtp180 -65.91 -39.02 90.18 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 111.736 0.273 . . . . 3.82 111.736 -178.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.82 -42.93 99.93 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.388 -0.369 . . . . 0.92 111.305 179.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . 0.577 ' HB2' ' HG ' ' A' ' 109' ' ' LEU . 44.8 t -71.93 -17.18 62.1 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.047 0.451 . . . . 1.16 110.763 175.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.521 ' HB3' ' O ' ' A' ' 91' ' ' ARG . 4.5 tppp? -74.46 -47.88 30.75 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.286 -0.415 . . . . 4.2 111.166 177.547 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -101.62 100.55 14.49 Favored Pre-proline 0 N--CA 1.463 0.218 0 N-CA-C 108.975 -0.75 . . . . 2.24 108.975 178.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.42 ' HG2' HD22 ' A' ' 97' ' ' ASN . 95.5 Cg_endo -88.78 -16.29 2.42 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 123.009 2.472 . . . . 2.38 115.508 -165.526 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.438 ' HA ' ' O ' ' A' ' 105' ' ' ALA . 3.8 p30 -120.07 83.0 30.27 Favored Pre-proline 0 C--N 1.326 -0.423 0 N-CA-C 113.622 0.971 . . . . 3.03 113.622 -174.096 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -84.65 128.59 3.98 Favored 'Trans proline' 0 C--O 1.24 0.604 0 C-N-CA 123.657 2.905 . . . . 1.29 112.256 170.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 35.3 mm -70.2 91.76 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 121.199 0.523 . . . . 1.81 110.288 173.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 69.0 mt -99.13 134.1 39.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.923 -0.58 . . . . 0.99 111.277 -178.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.672 ' OD2' ' HB3' ' A' ' 45' ' ' HIS . 18.0 t70 41.56 30.88 0.16 Allowed 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.778 1.029 . . . . 1.37 113.778 -178.037 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 88.48 16.85 58.1 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 120.49 -0.862 . . . . 1.56 113.366 176.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.558 ' HB3' ' HG3' ' A' ' 43' ' ' PRO . 28.0 tpt180 -140.54 139.31 35.01 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.323 -0.621 . . . . 4.13 109.323 176.026 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -82.09 105.38 13.14 Favored 'General case' 0 C--N 1.321 -0.665 0 C-N-CA 119.966 -0.694 . . . . 2.73 110.107 -178.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.46 ' HB1' ' O ' ' A' ' 40' ' ' GLY . . . -85.46 166.34 16.43 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 113.874 1.064 . . . . 1.04 113.874 177.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 22.7 t30 -108.86 119.34 39.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.388 -1.278 . . . . 2.04 110.187 -178.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 93.8 t -114.2 140.72 33.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.006 -0.543 . . . . 1.06 110.874 179.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.403 HD21 ' HD2' ' A' ' 38' ' ' PHE . 8.3 p30 -160.64 170.15 21.42 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.715 -0.846 . . . . 2.49 108.715 178.151 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.577 ' HG ' ' HB2' ' A' ' 93' ' ' CYS . 5.8 mt -79.67 127.35 32.08 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 120.361 -0.536 . . . . 1.23 110.737 178.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.722 ' HB3' ' HG2' ' A' ' 36' ' ' LYS . . . -69.26 -24.65 64.01 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.263 -0.881 . . . . 0.91 112.351 -174.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.568 ' CD1' ' HB3' ' A' ' 109' ' ' LEU . 0.1 OUTLIER -67.54 -3.64 9.34 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.849 0.357 . . . . 1.4 111.8 -173.616 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 96.8 mt -75.83 -24.06 55.8 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 116.43 -0.35 . . . . 1.97 110.295 175.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.466 ' O ' ' HG2' ' A' ' 115' ' ' LYS . . . -123.54 -58.13 0.19 Allowed Glycine 0 C--N 1.333 0.381 0 C-N-CA 120.931 -0.652 . . . . 2.14 111.53 173.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -50.89 149.37 3.53 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-O 121.634 0.731 . . . . 2.66 111.563 172.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.466 ' HG2' ' O ' ' A' ' 113' ' ' GLY . 26.5 mmtp -137.73 117.94 10.3 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 115.119 -0.946 . . . . 4.16 110.38 -166.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 115' ' ' LYS . 94.8 Cg_endo -96.73 32.43 0.15 Allowed 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 123.563 2.842 . . . . 5.53 113.041 -177.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 7.9 ttm180 -151.58 -57.53 0.15 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.957 0.408 . . . . 8.6 111.084 -177.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 12.1 p -90.64 9.79 28.3 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.144 0.497 . . . . 6.37 111.342 -177.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -154.83 164.28 39.05 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 107.736 -1.209 . . . . 7.85 107.736 174.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 39.6 t 59.72 85.91 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.294 0 CA-C-O 121.399 0.619 . . . . 9.37 109.966 -174.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 20.5 mm-40 . . . . . 0 C--O 1.251 1.171 0 CA-C-N 115.732 -0.667 . . . . 12.28 110.195 -174.819 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 1' ' ' ' G' . . . . . 0.515 ' C4 ' ' CE2' ' A' ' 44' ' ' TYR . . . . . . . . 0 O5'--C5' 1.433 -0.43 0 C3'-C2'-C1' 99.15 -2.611 . 0.0 '__' . 4.94 . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 2' ' ' ' G' . . . . . 0.505 ' C5 ' ' CE2' ' A' ' 44' ' ' TYR . . . . . . . . 0 O5'--C5' 1.422 -1.11 0 C3'-C2'-C1' 99.604 -2.107 . 0.0 OUTLIER . 4.87 . . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 3' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.429 -0.656 0 C3'-C2'-C1' 100.107 -1.548 . 0.0 OUTLIER . 5.02 . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 4' ' ' ' G' . . . . . 0.694 " H2'" ' HZ ' ' A' ' 38' ' ' PHE . . . . . . . . 0 O5'--C5' 1.424 -0.971 0 O4'-C1'-C2' 108.26 1.329 . 0.677 0i . 2.69 . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 5' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.431 -0.582 0 C4'-C3'-C2' 103.536 0.836 . 0.0 OUTLIER gamma 1.93 . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 6' ' ' ' G' . . . . . 0.569 ' N2 ' HG21 ' A' ' 65' ' ' VAL . . . . . . . . 0 O5'--C5' 1.426 -0.869 0 C4'-C3'-C2' 104.071 1.371 . 0.0 OUTLIER . 2.38 . . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.427 -0.789 0 C4'-C3'-C2' 104.06 1.36 . 0.0 OUTLIER . 4.19 . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.395 0 N-CA-C 111.578 -0.609 . . . . 13.03 111.578 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -142.47 176.63 8.86 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.633 0.254 . . . . 11.06 110.827 -177.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 4.6 mpp? -94.93 109.21 21.25 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.042 0.449 . . . . 9.85 110.533 -179.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -123.22 56.87 0.66 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.896 -0.668 . . . . 6.69 111.657 179.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 10.3 p -74.7 -64.65 0.99 Allowed 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 112.163 0.431 . . . . 5.55 112.163 -174.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 30' ' ' ARG . 44.9 mtp180 -122.23 170.25 10.08 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.443 -0.344 . . . . 3.87 110.93 -172.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -78.29 107.0 10.58 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.725 0.774 . . . . 3.53 111.052 -178.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.649 ' HA ' ' OG1' ' A' ' 35' ' ' THR . 33.6 p -105.86 6.73 31.81 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.778 -0.647 . . . . 1.69 111.222 -178.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 48.6 ttp -69.32 -34.38 74.57 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.785 -0.366 . . . . 1.49 111.27 -179.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.592 ' HA ' HD11 ' A' ' 109' ' ' LEU . 25.1 m-85 -107.12 -24.16 12.04 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-O 120.801 0.334 . . . . 1.5 110.992 -178.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.735 ' O ' ' HA ' ' A' ' 82' ' ' THR . 27.1 p -81.4 11.75 4.21 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.289 -0.414 . . . . 0.53 110.958 -174.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.664 ' HD2' ' O6 ' ' B' ' 6' ' ' ' G' . 5.8 ttpm? -122.43 102.84 8.33 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.074 -0.512 . . . . 2.75 110.247 -173.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 5.0 mp -109.21 136.53 44.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.959 -0.564 . . . . 0.85 110.602 -176.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.555 ' HE2' ' C8 ' ' B' ' 4' ' ' ' G' . 85.7 t80 -95.13 120.51 35.48 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.987 -0.551 . . . . 0.71 109.589 176.225 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.635 HG13 HG22 ' A' ' 107' ' ' VAL . 96.8 t -132.84 99.08 3.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 118.775 -0.631 . . . . 0.92 110.851 -177.256 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.572 ' HA2' ' CD1' ' A' ' 42' ' ' LEU . . . -132.15 166.49 23.23 Favored Glycine 0 C--O 1.217 -0.913 0 C-N-CA 115.324 -3.322 . . . . 0.84 113.845 162.006 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 128.69 -2.93 6.51 Favored Glycine 0 N--CA 1.445 -0.762 0 N-CA-C 108.706 -1.758 . . . . 0.68 108.706 -168.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.766 HD21 HD21 ' A' ' 51' ' ' LEU . 4.5 mp -62.1 142.13 95.61 Favored Pre-proline 0 N--CA 1.449 -0.486 0 CA-C-N 113.601 -1.3 . . . . 1.28 109.806 179.667 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.581 ' HG2' ' O ' ' A' ' 101' ' ' ASP . 52.5 Cg_exo -54.28 159.78 7.54 Favored 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.669 2.246 . . . . 0.58 111.581 172.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.525 ' CZ ' ' C5 ' ' B' ' 2' ' ' ' G' . 6.8 m-85 -71.55 -1.78 14.64 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.161 -0.472 . . . . 1.05 111.459 -174.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 72.4 t60 -104.08 -11.99 17.02 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.127 0.489 . . . . 2.01 109.944 176.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.704 ' HB ' ' HB3' ' A' ' 42' ' ' LEU . 5.4 m -79.06 129.94 34.99 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 115.921 -0.581 . . . . 0.72 109.868 -178.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.421 ' HA ' HG21 ' A' ' 66' ' ' VAL . 7.4 p -132.76 -177.58 4.55 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.534 -0.303 . . . . 0.55 111.566 -169.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.489 ' OD2' ' HA ' ' A' ' 65' ' ' VAL . 1.2 m-20 -57.01 -31.9 65.58 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.536 0.684 . . . . 0.49 110.043 -177.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.731 ' O ' ' HG2' ' A' ' 53' ' ' GLU . 55.2 pttt -74.1 -35.45 64.18 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.908 -1.042 . . . . 2.76 109.638 -178.017 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.645 HG21 HG23 ' A' ' 46' ' ' THR . 6.6 m -67.17 -43.98 80.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.735 0.302 . . . . 0.58 110.756 179.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.766 HD21 HD21 ' A' ' 42' ' ' LEU . 35.8 mt -61.46 -42.97 99.59 Favored 'General case' 0 CA--C 1.512 -0.493 0 N-CA-C 109.631 -0.507 . . . . 0.85 109.631 176.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.54 ' HA ' HD12 ' A' ' 61' ' ' ILE . 45.8 t-80 -53.3 -52.74 58.12 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.246 -0.888 . . . . 0.59 110.514 175.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.731 ' HG2' ' O ' ' A' ' 49' ' ' LYS . 8.5 mm-40 -59.49 -47.62 84.8 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.3 -0.409 . . . . 1.52 111.756 -176.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.523 ' O ' ' HB2' ' A' ' 57' ' ' GLN . 56.3 t80 -77.73 -36.53 50.75 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.289 0.478 . . . . 1.12 112.289 -170.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.753 ' HB2' HD11 ' A' ' 61' ' ' ILE . 42.9 m-85 -84.62 -30.03 25.27 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 113.224 0.824 . . . . 0.56 113.224 -173.197 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.699 ' HA ' ' O ' ' A' ' 59' ' ' GLY . 12.9 pt-20 -68.58 -11.38 59.91 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.677 0.751 . . . . 1.57 110.009 179.254 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.523 ' HB2' ' O ' ' A' ' 54' ' ' TYR . 27.6 mt-30 -59.35 -23.0 62.16 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.55 -1.204 . . . . 2.16 111.826 170.243 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -94.23 -21.45 19.04 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.217 0.532 . . . . 0.71 110.005 177.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.699 ' O ' ' HA ' ' A' ' 56' ' ' GLU . . . 159.14 -177.7 35.59 Favored Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 115.049 -0.978 . . . . 0.75 110.982 179.334 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -61.77 122.94 16.6 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 117.042 0.421 . . . . 1.02 110.577 -175.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.753 HD11 ' HB2' ' A' ' 55' ' ' PHE . 45.9 mt -86.99 125.03 40.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 O-C-N 122.351 -0.218 . . . . 0.47 110.468 171.506 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -75.64 -43.82 45.79 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.681 0.277 . . . . 2.07 111.607 178.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -152.12 132.55 13.78 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.326 -0.397 . . . . 2.48 111.251 -175.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -125.8 134.81 51.58 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.241 0.543 . . . . 0.44 111.145 178.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.672 HG21 ' H21' ' B' ' 6' ' ' ' G' . 31.2 m -144.76 148.43 18.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.225 -0.898 . . . . 1.38 112.485 -177.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.421 HG21 ' HA ' ' A' ' 47' ' ' SER . 42.4 t -119.3 138.92 48.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.241 -0.89 . . . . 0.49 110.027 171.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.536 HG12 ' HA2' ' A' ' 79' ' ' GLY . 26.2 mm -91.91 153.71 3.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 114.898 -1.046 . . . . 0.72 110.441 -173.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 18.8 p -147.23 147.66 30.68 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 105.228 -2.138 . . . . 1.52 105.228 -170.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.738 ' HB3' ' H ' ' A' ' 74' ' ' LYS . 7.3 t70 -49.11 138.66 11.77 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 118.665 0.666 . . . . 2.49 111.529 -178.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 59.4 ttt180 -57.54 -53.49 57.59 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.158 -0.473 . . . . 6.05 111.574 -178.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -70.63 -62.78 1.26 Allowed 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.217 0.451 . . . . 4.05 112.217 -172.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.427 ' OG1' ' HG3' ' A' ' 74' ' ' LYS . 71.1 p -98.82 -14.79 19.51 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.334 -0.394 . . . . 3.08 111.558 -171.473 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.539 ' HA ' ' O ' ' A' ' 69' ' ' ASP . 40.7 mt-30 57.68 79.81 0.19 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 122.413 1.101 . . . . 3.3 111.655 -172.255 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.738 ' H ' ' HB3' ' A' ' 69' ' ' ASP . 45.2 mtmt -108.72 132.64 53.75 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 106.209 -1.775 . . . . 3.49 106.209 172.369 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 14.9 m -54.75 102.64 0.07 Allowed 'General case' 0 C--N 1.322 -0.613 0 O-C-N 123.318 0.386 . . . . 1.81 110.403 -178.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 26.7 mtm180 -69.58 -5.94 27.79 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 115.866 -0.606 . . . . 2.56 112.066 -175.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.556 ' HA3' ' C6 ' ' B' ' 2' ' ' ' G' . . . 77.98 9.63 86.8 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 119.88 -1.152 . . . . 0.64 111.082 -177.168 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.568 ' HD1' ' HA3' ' A' ' 40' ' ' GLY . 20.7 m-85 -117.34 154.05 31.95 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 110.035 -0.357 . . . . 1.18 110.035 -172.475 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.536 ' HA2' HG12 ' A' ' 67' ' ' ILE . . . -157.95 -167.3 18.69 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.388 -0.91 . . . . 0.59 113.145 173.065 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.567 ' HB2' ' CG2' ' A' ' 65' ' ' VAL . 49.7 m-85 -139.5 141.2 37.35 Favored 'General case' 0 CA--C 1.513 -0.469 0 C-N-CA 123.462 0.705 . . . . 0.63 109.496 178.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 54.6 t -127.33 111.85 26.54 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 CA-C-O 121.308 0.575 . . . . 0.41 109.931 175.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.735 ' HA ' ' O ' ' A' ' 35' ' ' THR . 29.3 m -109.19 112.43 24.59 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.467 -0.788 . . . . 0.47 109.351 176.416 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.668 ' SD ' HG12 ' A' ' 61' ' ' ILE . 59.8 mmm -87.44 175.34 8.01 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 121.227 0.537 . . . . 0.88 111.639 -172.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.402 ' HB2' ' HE3' ' A' ' 84' ' ' LYS . 37.9 ttmt -82.7 -31.91 28.31 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.189 -0.914 . . . . 1.92 110.826 -179.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -129.83 147.8 51.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.927 0.394 . . . . 1.68 110.446 178.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.591 ' H ' ' HD2' ' A' ' 86' ' ' ARG . 0.7 OUTLIER -73.44 -19.74 60.89 Favored 'General case' 0 C--O 1.218 -0.566 0 CA-C-N 115.812 -0.631 . . . . 3.66 112.105 -174.639 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.416 ' O ' ' HG3' ' A' ' 91' ' ' ARG . . . -67.04 -50.57 61.55 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 118.436 0.562 . . . . 0.66 111.201 176.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.442 ' HA ' ' HD2' ' A' ' 91' ' ' ARG . 14.4 m -63.96 -33.5 75.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.887 0.851 . . . . 0.78 109.36 175.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.518 ' HB3' ' HA ' ' A' ' 86' ' ' ARG . . . -58.23 -47.5 83.34 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 113.683 -1.599 . . . . 0.46 110.011 173.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -60.69 -43.99 97.08 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.203 -0.453 . . . . 2.11 111.237 173.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.567 ' O ' ' HB3' ' A' ' 94' ' ' LYS . 99.4 mtt180 -57.59 -42.59 83.47 Favored 'General case' 0 C--O 1.225 -0.227 0 CA-C-O 120.888 0.375 . . . . 3.82 111.466 176.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -62.39 -36.67 83.05 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 111.874 0.324 . . . . 0.92 111.874 173.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 35.7 t -78.71 -7.55 57.84 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.207 0.527 . . . . 1.16 111.259 177.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.567 ' HB3' ' O ' ' A' ' 91' ' ' ARG . 16.1 tppt? -58.42 -48.36 80.92 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.628 -0.715 . . . . 4.2 111.613 -177.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -110.35 121.81 40.4 Favored Pre-proline 0 C--N 1.325 -0.495 0 C-N-CA 120.744 -0.383 . . . . 2.24 109.988 176.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -84.66 -1.76 9.65 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 122.902 2.402 . . . . 2.38 114.287 -173.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.578 ' HB2' ' HD3' ' A' ' 104' ' ' LYS . 6.0 p30 -152.61 68.4 6.96 Favored Pre-proline 0 CA--C 1.534 0.333 0 CA-C-O 121.392 0.615 . . . . 3.03 111.691 178.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -80.98 166.97 18.57 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 123.456 2.771 . . . . 1.29 111.686 179.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 47.2 mm -100.81 137.82 27.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 108.578 -0.897 . . . . 1.81 108.578 178.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 54.7 mt -144.77 111.8 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 109.323 -0.621 . . . . 0.99 109.323 -174.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.581 ' O ' ' HG2' ' A' ' 43' ' ' PRO . 16.8 t0 61.87 47.99 5.66 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 121.488 0.661 . . . . 1.37 111.019 173.387 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 82.74 -5.76 73.25 Favored Glycine 0 CA--C 1.529 0.924 0 N-CA-C 116.29 1.276 . . . . 1.56 116.29 178.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.439 ' CB ' ' HG3' ' A' ' 43' ' ' PRO . 23.8 ttt180 -137.93 150.97 47.51 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 118.933 1.367 . . . . 4.13 111.106 -177.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.578 ' HD3' ' HB2' ' A' ' 97' ' ' ASN . 24.3 ttmm -78.88 139.8 38.24 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.46 -0.336 . . . . 2.73 110.37 178.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -111.59 154.17 25.23 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.947 -0.57 . . . . 1.04 111.138 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.462 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 46.6 t-20 -95.47 127.86 41.86 Favored 'General case' 0 C--O 1.252 1.224 0 N-CA-C 108.597 -0.89 . . . . 2.04 108.597 173.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.635 HG22 HG13 ' A' ' 39' ' ' VAL . 88.0 t -142.37 129.4 19.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 113.838 -1.528 . . . . 1.06 110.45 -161.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -167.84 158.56 10.89 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.454 -0.572 . . . . 2.49 109.454 178.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.592 HD11 ' HA ' ' A' ' 34' ' ' PHE . 0.2 OUTLIER -57.92 131.94 51.9 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 107.827 -1.175 . . . . 1.23 107.827 173.061 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.96 -30.93 68.42 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.514 -0.475 . . . . 0.91 110.784 -162.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.443 ' HD1' HD12 ' A' ' 109' ' ' LEU . 4.0 p90 -70.86 -4.35 23.85 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.881 -0.6 . . . . 1.4 111.42 -172.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 80.4 mt -85.03 1.92 45.52 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.447 -0.342 . . . . 1.97 111.114 177.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -156.08 -1.95 0.11 Allowed Glycine 0 CA--C 1.516 0.125 0 N-CA-C 110.126 -1.189 . . . . 2.14 110.126 -179.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -95.61 158.72 15.33 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.093 -1.053 . . . . 2.66 108.919 178.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.448 ' HA ' ' HD3' ' A' ' 116' ' ' PRO . 99.6 mttt -131.51 146.03 60.17 Favored Pre-proline 0 C--N 1.316 -0.866 0 N-CA-C 109.123 -0.695 . . . . 4.16 109.123 172.199 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 115' ' ' LYS . 31.6 Cg_exo -56.28 -19.68 28.9 Favored 'Trans proline' 0 CA--C 1.512 -0.589 0 C-N-CA 123.954 3.102 . . . . 5.53 112.353 -169.186 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 47.1 ttp180 -148.24 73.01 1.23 Allowed 'General case' 0 N--CA 1.432 -1.341 0 CA-C-N 115.069 -0.968 . . . . 8.6 109.438 175.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.403 ' O ' ' HB2' ' A' ' 115' ' ' LYS . 67.5 p 60.49 176.06 0.1 Allowed 'General case' 0 N--CA 1.467 0.388 0 O-C-N 124.679 1.237 . . . . 6.37 113.152 174.274 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -133.26 110.87 10.4 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.851 -0.613 . . . . 7.85 110.822 -175.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 60.1 t 74.99 -40.98 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-N 115.283 -0.871 . . . . 9.37 111.395 -178.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 25.4 mm-40 . . . . . 0 C--O 1.246 0.883 0 CA-C-O 118.155 -0.926 . . . . 12.28 109.818 176.249 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 1' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.433 -0.41 0 O5'-C5'-C4' 111.786 1.133 . 0.0 '__' . 4.94 . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 2' ' ' ' G' . . . . . 0.556 ' C6 ' ' HA3' ' A' ' 77' ' ' GLY . . . . . . . . 0 O5'--C5' 1.427 -0.808 0 O4'-C1'-N19 109.291 1.091 . 0.0 OUTLIER gamma 4.87 . . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 3' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.427 -0.815 0 C4'-C3'-C2' 104.092 1.392 . 0.0 OUTLIER . 5.02 . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 4' ' ' ' G' . . . . . 0.555 ' C8 ' ' HE2' ' A' ' 38' ' ' PHE . . . . . . . . 0 O5'--C5' 1.426 -0.905 0 O4'-C1'-C2' 108.126 1.233 . 0.0 OUTLIER . 2.69 . . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 5' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.424 -0.995 0 C4'-C3'-C2' 103.893 1.193 . 0.42 1t . 1.93 . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 6' ' ' ' G' . . . . . 0.672 ' H21' HG21 ' A' ' 65' ' ' VAL . . . . . . . . 0 O5'--C5' 1.427 -0.805 0 C3'-C2'-C1' 100.784 -0.796 . 0.0 OUTLIER . 2.38 . . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.426 -0.889 0 C4'-C3'-C2' 105.529 2.829 . 0.0 OUTLIER delta 4.19 . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.549 0 N-CA-C 112.049 -0.42 . . . . 13.03 112.049 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -151.87 135.39 16.13 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.716 -0.476 . . . . 11.06 109.716 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 24.9 mmt -83.48 -38.13 22.22 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.887 0.375 . . . . 9.85 110.534 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -63.02 135.31 43.36 Favored Glycine 0 N--CA 1.452 -0.279 0 CA-C-N 115.692 -0.686 . . . . 6.69 112.654 -178.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.65 106.58 15.48 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.302 0.573 . . . . 5.55 111.459 -179.089 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 68.0 mtm180 -97.48 -25.68 15.09 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.315 -0.857 . . . . 3.87 109.897 178.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 64.66 80.84 0.22 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 114.997 -1.001 . . . . 3.53 110.075 -175.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.684 ' HA ' ' OG1' ' A' ' 35' ' ' THR . 11.3 p -67.26 -15.25 63.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 114.973 -1.012 . . . . 1.69 111.972 -173.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 7.4 ttt -57.89 -39.1 77.04 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.462 -0.335 . . . . 1.49 111.085 176.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.601 ' HA ' HD11 ' A' ' 109' ' ' LEU . 40.7 m-85 -103.66 -24.23 13.39 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 111.859 0.318 . . . . 1.5 111.859 -178.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.684 ' OG1' ' HA ' ' A' ' 32' ' ' THR . 57.7 p -78.91 -10.9 59.95 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.362 -0.535 . . . . 0.53 110.446 -174.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 47.1 tttm -88.23 106.43 18.19 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 115.367 -0.833 . . . . 2.75 109.104 179.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 95.3 mt -104.6 134.89 44.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 116.051 -0.522 . . . . 0.85 110.442 -179.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.628 ' CB ' ' HA ' ' A' ' 110' ' ' ALA . 82.5 t80 -99.02 121.31 40.8 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.397 -0.594 . . . . 0.71 109.397 179.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.756 HG12 HD11 ' A' ' 42' ' ' LEU . 3.9 t -106.63 140.19 25.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.137 0.494 . . . . 0.92 110.477 -174.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -140.76 152.68 23.23 Favored Glycine 0 N--CA 1.452 -0.275 0 CA-C-N 115.29 -0.868 . . . . 0.84 113.423 -167.028 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 66.08 40.66 95.17 Favored Glycine 0 C--O 1.228 -0.263 0 C-N-CA 121.635 -0.317 . . . . 0.68 113.298 172.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.756 HD11 HG12 ' A' ' 39' ' ' VAL . 7.1 mp -82.38 134.71 47.97 Favored Pre-proline 0 C--N 1.323 -0.546 0 CA-C-O 120.861 0.363 . . . . 1.28 110.86 179.111 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.591 ' HG3' ' HG3' ' A' ' 103' ' ' ARG . 50.6 Cg_exo -52.91 153.4 15.3 Favored 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.709 2.273 . . . . 0.58 111.379 172.292 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.601 ' HA ' ' HB3' ' A' ' 75' ' ' SER . 20.6 m-85 -67.49 -7.38 25.15 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 113.292 0.849 . . . . 1.05 113.292 -170.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -111.98 2.51 16.94 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 120.409 -0.516 . . . . 2.01 111.168 176.38 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.693 HG23 HG21 ' A' ' 50' ' ' THR . 38.4 m -74.39 134.59 42.42 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.284 -0.416 . . . . 0.72 110.405 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 10.4 p -136.35 -176.85 4.47 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-O 121.507 0.67 . . . . 0.55 112.053 -171.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -60.46 -36.26 77.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 114.825 -1.08 . . . . 0.49 110.76 -173.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.54 ' O ' ' HG2' ' A' ' 53' ' ' GLU . 9.2 ptmm? -65.15 -36.99 85.98 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.461 -0.79 . . . . 2.76 110.855 178.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.693 HG21 HG23 ' A' ' 46' ' ' THR . 88.0 m -62.07 -45.95 91.27 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.085 0.469 . . . . 0.58 110.922 179.104 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.464 HD21 HG11 ' A' ' 39' ' ' VAL . 98.2 mt -68.33 -34.71 76.59 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.77 -0.65 . . . . 0.85 110.687 -179.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.452 ' O ' ' HG2' ' A' ' 56' ' ' GLU . 55.6 t-80 -59.69 -53.82 53.51 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.111 0.481 . . . . 0.59 109.966 178.225 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.54 ' HG2' ' O ' ' A' ' 49' ' ' LYS . 11.8 mm-40 -57.72 -44.03 85.69 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.618 -0.719 . . . . 1.52 112.628 -179.401 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.61 ' O ' ' HB2' ' A' ' 57' ' ' GLN . 67.8 t80 -76.48 -34.43 58.66 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.821 0.674 . . . . 1.12 112.821 -174.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -84.69 -30.5 24.76 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 113.898 1.073 . . . . 0.56 113.898 -171.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.452 ' HG2' ' O ' ' A' ' 52' ' ' HIS . 15.0 pt-20 -71.5 -12.04 61.18 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.842 0.83 . . . . 1.57 110.003 177.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.61 ' HB2' ' O ' ' A' ' 54' ' ' TYR . 27.6 mm-40 -56.03 -24.84 41.78 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.037 -0.983 . . . . 2.16 111.539 166.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -106.64 6.93 30.32 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 111.74 0.274 . . . . 0.71 111.74 -177.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 146.48 -137.86 7.05 Favored Glycine 0 C--O 1.224 -0.529 0 C-N-CA 120.486 -0.864 . . . . 0.75 112.794 -176.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -114.04 127.14 55.81 Favored 'General case' 0 C--N 1.327 -0.372 0 O-C-N 122.661 -0.317 . . . . 1.02 110.874 -178.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.422 HG13 ' HB3' ' A' ' 56' ' ' GLU . 8.7 mt -94.24 126.9 46.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 110.116 -0.328 . . . . 0.47 110.116 176.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -83.59 -48.72 9.92 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.581 -0.448 . . . . 2.07 110.372 174.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -141.56 126.71 18.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.261 -0.427 . . . . 2.48 111.112 -176.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -123.23 123.75 41.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.059 0.457 . . . . 0.44 110.555 174.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.588 HG21 ' N2 ' ' B' ' 6' ' ' ' G' . 29.6 m -139.09 143.74 30.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.0 -1.0 . . . . 1.38 112.141 -179.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 70.4 t -115.08 139.54 40.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 108.761 -0.829 . . . . 0.49 108.761 170.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 44.2 mm -91.1 95.06 5.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 N-CA-C 109.439 -0.578 . . . . 0.72 109.439 -179.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.495 HG22 ' HA ' ' A' ' 75' ' ' SER . 9.1 p -92.8 158.1 16.06 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.047 -0.524 . . . . 1.52 110.985 177.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.485 ' HB3' ' H ' ' A' ' 74' ' ' LYS . 18.6 t70 -57.05 118.24 4.81 Favored 'General case' 0 C--O 1.213 -0.842 0 CA-C-N 115.167 -0.924 . . . . 2.49 110.825 -178.025 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 7.8 ptp180 -56.41 -30.09 62.36 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 113.514 0.931 . . . . 6.05 113.514 -176.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -78.21 -53.55 7.21 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.334 0.494 . . . . 4.05 112.334 -176.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 14.0 p -111.49 -18.07 12.93 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.149 0.499 . . . . 3.08 112.081 -174.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 57.57 81.65 0.14 Allowed 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 123.056 1.408 . . . . 3.3 111.733 -172.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.568 ' HB3' ' O6 ' ' B' ' 1' ' ' ' G' . 7.0 mttp -124.08 143.91 50.18 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 112.086 -2.324 . . . . 3.49 105.655 172.447 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.601 ' HB3' ' HA ' ' A' ' 44' ' ' TYR . 12.3 t -66.16 103.96 1.08 Allowed 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 120.337 -0.545 . . . . 1.81 110.274 -175.229 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 10.8 mtp180 -59.23 -11.76 4.41 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 115.505 -0.77 . . . . 2.56 111.363 174.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 92.59 14.77 54.92 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.812 -0.709 . . . . 0.64 113.113 175.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.43 ' CE1' " H1'" ' B' ' 4' ' ' ' G' . 14.4 m-85 -128.41 141.0 51.54 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.422 -0.584 . . . . 1.18 109.422 -178.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -138.65 -178.28 16.12 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.435 -0.888 . . . . 0.59 111.865 179.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -152.03 130.08 11.85 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.386 -0.598 . . . . 0.63 109.386 -177.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 63.7 t -128.22 119.59 51.15 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 CA-C-N 115.813 -0.63 . . . . 0.41 109.936 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.548 ' HA ' ' O ' ' A' ' 35' ' ' THR . 34.8 m -109.45 114.23 27.71 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.183 -1.043 . . . . 0.47 108.183 177.379 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 87.8 mmm -87.94 168.71 12.63 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 122.078 -0.389 . . . . 0.88 110.012 -174.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -83.05 -16.34 47.43 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.272 -0.422 . . . . 1.92 111.05 -176.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -147.97 148.69 31.03 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 120.813 0.339 . . . . 1.68 110.607 -179.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -71.32 -20.84 62.14 Favored 'General case' 0 C--O 1.224 -0.246 0 N-CA-C 112.502 0.556 . . . . 3.66 112.502 -174.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -71.61 -45.75 61.19 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 118.556 0.616 . . . . 0.66 111.346 -179.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 19.4 m -63.37 -35.59 80.9 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.94 0.876 . . . . 0.78 109.489 173.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.493 ' HB1' ' O ' ' A' ' 34' ' ' PHE . . . -58.79 -46.9 86.49 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 113.503 -1.681 . . . . 0.46 109.824 174.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -57.37 -50.03 74.27 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.543 -0.753 . . . . 2.11 112.276 174.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.539 ' O ' ' HB3' ' A' ' 94' ' ' LYS . 79.3 mtp180 -57.06 -46.0 82.8 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.817 0.341 . . . . 3.82 111.457 -179.186 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -60.06 -40.34 89.14 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.154 -0.476 . . . . 0.92 111.858 176.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 49.7 t -71.89 -17.1 62.13 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.294 0.569 . . . . 1.16 110.449 177.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.539 ' HB3' ' O ' ' A' ' 91' ' ' ARG . 21.2 tptp -78.65 7.08 7.41 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 123.415 0.686 . . . . 4.2 110.821 179.253 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 22.9 t0 -142.13 76.98 18.56 Favored Pre-proline 0 C--N 1.323 -0.565 0 O-C-N 121.616 -0.678 . . . . 2.24 110.011 -176.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -73.43 156.11 50.32 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 123.095 2.53 . . . . 2.38 111.945 -178.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.613 ' HA ' ' O ' ' A' ' 105' ' ' ALA . 1.9 p-10 34.35 64.14 1.73 Allowed Pre-proline 0 N--CA 1.471 0.615 0 O-C-N 124.166 0.916 . . . . 3.03 113.073 -171.449 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.403 ' HB2' ' OH ' ' A' ' 54' ' ' TYR . 92.5 Cg_endo -82.21 167.43 15.78 Favored 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 123.063 2.509 . . . . 1.29 111.714 178.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 49.6 mm -89.53 130.74 38.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 116.281 -0.418 . . . . 1.81 110.097 178.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 56.5 mt -146.57 139.67 20.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.801 -0.636 . . . . 0.99 109.326 -175.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 42.7 t0 44.93 42.47 6.26 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 113.134 0.79 . . . . 1.37 113.134 177.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 70.45 17.98 74.97 Favored Glycine 0 CA--C 1.524 0.626 0 C-N-CA 121.128 -0.558 . . . . 1.56 113.619 177.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.591 ' HG3' ' HG3' ' A' ' 43' ' ' PRO . 30.6 mmt180 -143.23 162.38 35.79 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.372 -0.603 . . . . 4.13 109.372 -179.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -80.64 134.52 35.89 Favored 'General case' 0 C--N 1.317 -0.845 0 C-N-CA 120.108 -0.637 . . . . 2.73 109.757 171.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.613 ' O ' ' HA ' ' A' ' 97' ' ' ASN . . . -121.67 165.11 16.26 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 107.738 -1.208 . . . . 1.04 107.738 -177.21 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 44.4 t30 -116.38 110.57 18.85 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 120.344 -0.542 . . . . 2.04 110.375 177.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 88.5 t -116.38 139.9 41.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 120.981 0.42 . . . . 1.06 111.611 176.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.414 ' OD1' HD12 ' A' ' 112' ' ' LEU . 5.7 t-20 -162.98 173.75 13.22 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 107.929 -1.137 . . . . 2.49 107.929 175.215 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.601 HD11 ' HA ' ' A' ' 34' ' ' PHE . 0.2 OUTLIER -62.77 146.56 52.18 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.74 -0.837 . . . . 1.23 108.74 175.904 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.628 ' HA ' ' CB ' ' A' ' 38' ' ' PHE . . . -68.47 -40.61 80.95 Favored 'General case' 0 CA--C 1.512 -0.484 0 C-N-CA 120.634 -0.427 . . . . 0.91 111.305 -169.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 9.7 p90 -67.22 -16.09 64.09 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.186 -0.461 . . . . 1.4 111.04 -173.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.414 HD12 ' OD1' ' A' ' 108' ' ' ASN . 96.2 mt -86.8 -14.66 41.57 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 116.327 -0.397 . . . . 1.97 111.696 176.07 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -100.52 -1.48 55.48 Favored Glycine 0 CA--C 1.507 -0.407 0 C-N-CA 120.833 -0.698 . . . . 2.14 112.086 -177.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.508 ' HB2' ' C5 ' ' B' ' 5' ' ' ' U' . . . -89.06 127.1 35.68 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.619 0.247 . . . . 2.66 111.366 -167.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -133.8 74.46 69.62 Favored Pre-proline 0 C--N 1.323 -0.544 0 N-CA-C 109.502 -0.555 . . . . 4.16 109.502 173.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -87.71 0.01 7.21 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 123.106 2.538 . . . . 5.53 112.284 -176.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 49.3 ttm-85 -179.1 -40.47 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.373 -0.83 . . . . 8.6 109.079 -174.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.409 HG23 HG23 ' A' ' 120' ' ' VAL . 9.5 t -162.18 173.6 14.06 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 114.841 -1.072 . . . . 6.37 108.927 -177.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -107.32 -48.76 3.39 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.841 -0.429 . . . . 7.85 109.841 179.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.409 HG23 HG23 ' A' ' 118' ' ' THR . 95.6 t 71.17 -73.46 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 115.265 -0.879 . . . . 9.37 111.958 177.232 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 . . . . . 0 C--O 1.25 1.119 0 CA-C-O 118.212 -0.899 . . . . 12.28 110.812 -173.586 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 1' ' ' ' G' . . . . . 0.568 ' O6 ' ' HB3' ' A' ' 74' ' ' LYS . . . . . . . . 0 O5'--C5' 1.429 -0.662 0 C3'-C2'-C1' 100.283 -1.352 . 0.0 '__' . 4.94 . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 2' ' ' ' G' . . . . . 0.434 ' H1 ' ' HA ' ' A' ' 43' ' ' PRO . . . . . . . . 0 O5'--C5' 1.427 -0.816 0 C3'-C2'-C1' 99.501 -2.221 . 0.0 OUTLIER . 4.87 . . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 3' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.429 -0.717 0 O4'-C1'-N19 106.861 -1.339 . 0.0 OUTLIER gamma 5.02 . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 4' ' ' ' G' . . . . . 0.569 " H3'" ' N3 ' ' B' ' 4' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.427 -0.794 0 O4'-C1'-C2' 107.87 1.05 . 0.0 OUTLIER gamma 2.69 . . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 5' ' ' ' U' . . . . . 0.894 " O2'" H5'' ' B' ' 6' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.425 -0.929 0 C3'-C2'-C1' 98.974 -2.807 . 0.0 OUTLIER . 1.93 . . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 6' ' ' ' G' . . . . . 0.894 H5'' " O2'" ' B' ' 5' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.427 -0.802 1 P-O3'-C3' 124.925 4.354 . 0.0 OUTLIER . 2.38 . . . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.423 -1.038 0 C3'-C2'-C1' 104.238 3.042 . 0.0 OUTLIER . 4.19 . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.703 0 N-CA-C 111.906 -0.478 . . . . 13.03 111.906 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . 67.35 177.01 0.24 Allowed 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 123.372 0.669 . . . . 11.06 111.877 179.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 26.6 ptm -160.97 175.43 12.5 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.537 -0.542 . . . . 9.85 109.537 178.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 69.7 -94.32 0.42 Allowed Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.955 -0.64 . . . . 6.69 111.615 -175.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 9.4 t 179.6 -67.11 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.807 -0.812 . . . . 5.55 108.807 177.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 12.4 ttm180 -150.31 -41.26 0.13 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.739 -0.664 . . . . 3.87 110.125 178.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 32.0 t70 74.82 153.56 0.14 Allowed 'General case' 0 N--CA 1.471 0.615 0 O-C-N 124.221 0.951 . . . . 3.53 110.316 -177.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 21.9 p -116.23 33.08 5.73 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 112.527 0.565 . . . . 1.69 112.527 -172.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 46.7 ttp -75.3 69.39 2.12 Favored 'General case' 0 C--N 1.333 -0.127 0 N-CA-C 108.326 -0.99 . . . . 1.49 108.326 167.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.482 ' HB3' ' HB2' ' A' ' 86' ' ' ARG . 20.4 m-85 123.79 -176.12 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 127.339 2.256 . . . . 1.5 106.918 -173.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.515 ' HA ' ' HB2' ' A' ' 89' ' ' ALA . 34.6 p 61.22 -40.79 0.12 Allowed 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 114.384 1.253 . . . . 0.53 114.384 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.547 ' HE3' ' O6 ' ' B' ' 6' ' ' ' G' . 85.4 tttt -80.07 112.56 17.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.286 0.565 . . . . 2.75 110.511 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.529 ' CG2' HG13 ' A' ' 107' ' ' VAL . 82.8 mt -106.84 131.24 57.26 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 CA-C-N 115.514 -0.766 . . . . 0.85 110.842 -178.306 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -86.87 120.12 27.82 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.117 -0.697 . . . . 0.71 109.117 177.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.909 HG12 HD11 ' A' ' 42' ' ' LEU . 5.3 t -112.21 139.91 34.48 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-O 121.514 0.673 . . . . 0.92 111.15 -175.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -144.76 157.01 27.14 Favored Glycine 0 C--O 1.225 -0.421 0 CA-C-N 114.757 -1.111 . . . . 0.84 113.422 -171.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 71.05 34.97 64.63 Favored Glycine 0 C--O 1.227 -0.296 0 C-N-CA 121.31 -0.472 . . . . 0.68 113.549 172.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.909 HD11 HG12 ' A' ' 39' ' ' VAL . 6.8 mp -83.5 134.17 45.68 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-O 120.744 0.307 . . . . 1.28 111.228 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.602 ' HG3' ' CG ' ' A' ' 103' ' ' ARG . 52.8 Cg_exo -52.05 158.26 5.17 Favored 'Trans proline' 0 N--CA 1.461 -0.394 0 C-N-CA 122.92 2.413 . . . . 0.58 111.792 173.057 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 23.2 m-85 -72.53 3.83 4.51 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.933 0.397 . . . . 1.05 111.207 -178.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 80.3 t60 -112.07 -8.92 14.01 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.057 -0.519 . . . . 2.01 110.943 178.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.564 ' CG2' HD23 ' A' ' 42' ' ' LEU . 12.5 m -77.6 125.88 30.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.994 0.426 . . . . 0.72 111.805 -176.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 6.5 p -121.08 -178.32 3.73 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.903 -0.59 . . . . 0.55 111.243 -176.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -59.19 -34.81 72.58 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 115.841 -0.618 . . . . 0.49 109.863 -176.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.588 ' HG3' ' N ' ' A' ' 50' ' ' THR . 12.3 pttp -62.13 -39.5 92.76 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.322 -0.854 . . . . 2.76 110.133 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.588 ' N ' ' HG3' ' A' ' 49' ' ' LYS . 15.1 m -68.27 -41.08 81.6 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 116.381 -0.372 . . . . 0.58 110.518 -176.105 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.517 HD21 HG11 ' A' ' 39' ' ' VAL . 65.7 mt -63.66 -35.96 82.26 Favored 'General case' 0 C--O 1.222 -0.355 0 C-N-CA 120.434 -0.506 . . . . 0.85 110.207 174.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 59.2 t-80 -67.28 -51.12 56.66 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.475 -0.49 . . . . 0.59 110.089 179.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.504 ' HG3' ' O ' ' A' ' 49' ' ' LYS . 42.4 mt-10 -55.88 -43.76 77.5 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 120.729 0.299 . . . . 1.52 111.574 -179.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.503 ' O ' ' HB2' ' A' ' 57' ' ' GLN . 4.7 t80 -75.79 -35.13 60.17 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.353 -0.385 . . . . 1.12 111.609 -176.124 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.44 ' HD1' ' O ' ' A' ' 51' ' ' LEU . 45.9 m-85 -86.82 -28.24 23.05 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 114.126 1.158 . . . . 0.56 114.126 -172.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.706 ' N ' HD11 ' A' ' 61' ' ' ILE . 15.0 pt-20 -70.54 -15.93 62.83 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 122.395 1.093 . . . . 1.57 109.236 -178.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.503 ' HB2' ' O ' ' A' ' 54' ' ' TYR . 23.9 mt-30 -53.72 -27.78 30.23 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 113.481 -1.69 . . . . 2.16 112.174 168.438 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -100.17 -13.67 18.84 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.156 -0.475 . . . . 0.71 110.387 -177.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.514 ' O ' ' HA ' ' A' ' 56' ' ' GLU . . . 144.57 -155.54 26.41 Favored Glycine 0 N--CA 1.448 -0.505 0 CA-C-N 115.658 -0.701 . . . . 0.75 112.115 175.09 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -64.32 123.34 18.89 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.109 0.481 . . . . 1.02 112.29 -179.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.706 HD11 ' N ' ' A' ' 56' ' ' GLU . 10.0 mt -101.61 123.92 55.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 108.208 -1.034 . . . . 0.47 108.208 172.293 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -79.74 -44.08 21.4 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.308 0.575 . . . . 2.07 110.406 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -148.65 130.52 15.19 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.658 -0.701 . . . . 2.48 110.675 -179.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -117.45 115.83 25.96 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.067 -0.515 . . . . 0.44 110.086 174.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.1 p -137.11 135.31 47.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.446 -0.797 . . . . 1.38 112.065 -177.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 89.8 t -98.91 132.81 43.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.498 -0.774 . . . . 0.49 109.033 172.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.624 ' H ' ' HA2' ' A' ' 79' ' ' GLY . 36.6 mm -74.87 84.36 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.826 0.822 . . . . 0.72 109.479 177.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.781 ' HB ' ' HA ' ' A' ' 73' ' ' GLN . 16.7 p -97.46 177.42 5.53 Favored 'General case' 0 N--CA 1.435 -1.222 0 CA-C-N 114.419 -1.264 . . . . 1.52 110.734 -177.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -85.11 121.57 28.07 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.926 -0.31 . . . . 2.49 110.719 -177.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 70' ' ' ARG . 3.2 ptm180 -49.37 -17.03 0.22 Allowed 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 114.28 1.215 . . . . 6.05 114.28 -177.31 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 48.5 m-80 -83.95 -41.3 17.48 Favored 'General case' 0 N--CA 1.462 0.174 0 O-C-N 121.847 -0.533 . . . . 4.05 111.538 -177.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 31.9 p -132.42 -29.28 1.59 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.927 0.394 . . . . 3.08 111.602 -175.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.781 ' HA ' ' HB ' ' A' ' 68' ' ' THR . 27.1 mt-30 61.87 22.86 13.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.461 -0.79 . . . . 3.3 112.068 -178.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -54.61 -45.12 73.63 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 111.895 0.332 . . . . 3.49 111.895 174.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.66 ' O ' ' HA ' ' A' ' 68' ' ' THR . 58.3 p -175.54 -122.87 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 112.332 0.493 . . . . 1.81 112.332 173.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.554 ' HG3' ' O ' ' A' ' 75' ' ' SER . 46.0 mtt180 129.54 -50.31 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 126.964 2.106 . . . . 2.56 110.137 -167.549 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 104.67 16.62 17.01 Favored Glycine 0 N--CA 1.454 -0.157 0 C-N-CA 120.675 -0.774 . . . . 0.64 113.43 177.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -129.69 152.94 48.64 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.424 -0.954 . . . . 1.18 108.424 177.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.624 ' HA2' ' H ' ' A' ' 67' ' ' ILE . . . -157.08 -166.31 16.43 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 119.854 -1.165 . . . . 0.59 112.509 177.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.43 ' HD2' HD11 ' A' ' 67' ' ' ILE . 45.4 m-85 -159.57 125.01 4.16 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 123.563 0.745 . . . . 0.63 109.216 -177.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 69.9 t -117.95 118.79 59.44 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 N-CA-C 109.669 -0.493 . . . . 0.41 109.669 177.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 17.8 m -110.16 109.48 20.0 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 108.03 -1.1 . . . . 0.47 108.03 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.464 ' HA ' ' HA ' ' A' ' 61' ' ' ILE . 44.1 mtp -88.25 166.56 14.25 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 110.138 -0.319 . . . . 0.88 110.138 -173.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.461 ' HZ2' ' HB2' ' A' ' 84' ' ' LYS . 4.3 ttmp? -74.28 -43.21 57.81 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.929 -0.308 . . . . 1.92 111.376 -174.147 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -128.56 151.01 49.94 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-O 121.784 0.802 . . . . 1.68 111.225 179.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.482 ' HB2' ' HB3' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -65.72 -23.06 66.67 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-N 114.421 -1.263 . . . . 3.66 112.646 -172.153 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -66.25 -46.65 76.39 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 118.768 0.713 . . . . 0.66 111.155 -179.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 18.2 m -64.86 -38.23 90.28 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.683 0.754 . . . . 0.78 109.766 176.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.515 ' HB2' ' HA ' ' A' ' 35' ' ' THR . . . -58.41 -47.41 83.99 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 113.544 -1.662 . . . . 0.46 109.691 176.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.59 ' O ' ' HG2' ' A' ' 94' ' ' LYS . 6.3 mm-40 -56.04 -50.88 69.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.12 -0.945 . . . . 2.11 112.006 175.104 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 43.9 mtm180 -57.89 -43.66 86.25 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.518 0.199 . . . . 3.82 111.165 -178.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -56.88 -37.1 70.89 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.934 -0.575 . . . . 0.92 111.711 177.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 48.0 t -86.77 -13.41 45.27 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 112.677 0.621 . . . . 1.16 112.677 -178.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.59 ' HG2' ' O ' ' A' ' 90' ' ' GLU . 72.5 mmtt -65.77 -43.75 87.91 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 120.888 0.375 . . . . 4.2 110.751 -177.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -114.49 92.99 30.45 Favored Pre-proline 0 C--N 1.326 -0.441 0 N-CA-C 109.646 -0.501 . . . . 2.24 109.646 176.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -81.09 -166.7 0.43 Allowed 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 122.735 2.29 . . . . 2.38 112.649 -176.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.728 ' HA ' ' O ' ' A' ' 105' ' ' ALA . 22.7 m120 38.95 63.42 4.28 Favored Pre-proline 0 N--CA 1.467 0.396 0 N-CA-C 113.512 0.93 . . . . 3.03 113.512 -173.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.452 ' HD3' ' N ' ' A' ' 97' ' ' ASN . 2.5 Cg_endo -81.54 143.44 13.59 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.775 2.317 . . . . 1.29 110.82 174.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 38.6 mm -81.22 90.25 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 121.301 0.572 . . . . 1.81 109.827 178.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 31.1 mt -90.88 106.78 17.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 121.462 0.649 . . . . 0.99 111.199 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.449 ' HB2' HG21 ' A' ' 50' ' ' THR . 35.6 t70 66.1 46.62 2.08 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 113.889 -1.505 . . . . 1.37 110.147 166.051 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 91.23 -7.1 81.02 Favored Glycine 0 N--CA 1.451 -0.34 0 CA-C-N 114.94 -1.027 . . . . 1.56 114.821 175.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.602 ' CG ' ' HG3' ' A' ' 43' ' ' PRO . 20.9 mmt180 -133.77 148.93 51.42 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 118.614 1.207 . . . . 4.13 111.642 177.299 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -67.23 138.8 57.2 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.371 -0.831 . . . . 2.73 109.927 174.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.728 ' O ' ' HA ' ' A' ' 97' ' ' ASN . . . -124.57 150.87 45.44 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.042 -0.526 . . . . 1.04 109.856 -172.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -101.69 110.32 22.29 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 109.609 -0.515 . . . . 2.04 109.609 177.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.529 HG13 ' CG2' ' A' ' 37' ' ' ILE . 44.8 t -109.73 133.32 55.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.701 -0.681 . . . . 1.06 111.057 174.198 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -158.65 163.45 36.89 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.856 -0.794 . . . . 2.49 108.856 175.036 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.53 ' HB3' ' CD1' ' A' ' 111' ' ' TYR . 1.7 mm? -76.68 125.56 29.47 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.994 0.426 . . . . 1.23 110.709 -178.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.63 -25.83 65.93 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 113.314 0.857 . . . . 0.91 113.314 -174.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.53 ' CD1' ' HB3' ' A' ' 109' ' ' LEU . 2.6 p90 -68.42 -3.4 11.14 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.966 0.412 . . . . 1.4 111.295 -174.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 99.5 mt -73.46 -29.2 62.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.232 -0.44 . . . . 1.97 110.283 175.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -146.47 46.36 0.75 Allowed Glycine 0 C--N 1.333 0.384 0 C-N-CA 120.974 -0.632 . . . . 2.14 111.59 178.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -88.09 126.89 35.35 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.927 -0.136 . . . . 2.66 110.679 -176.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.413 ' HE3' ' HB2' ' A' ' 115' ' ' LYS . 24.5 mtmt -141.84 68.33 23.79 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 120.781 0.324 . . . . 4.16 110.742 177.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -89.25 -12.88 3.1 Favored 'Trans proline' 0 N--CA 1.457 -0.664 0 C-N-CA 122.774 2.316 . . . . 5.53 111.175 175.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 47.1 ttp180 -175.92 173.38 2.3 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 106.947 -1.501 . . . . 8.6 106.947 -178.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 5.5 p 65.34 20.11 11.77 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.259 0.624 . . . . 6.37 109.991 -176.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -60.5 133.8 56.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.142 -0.935 . . . . 7.85 111.055 -176.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 41.8 t -60.9 -44.93 98.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.662 -0.699 . . . . 9.37 110.231 177.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.472 ' OE1' ' HA ' ' A' ' 121' ' ' GLN . 6.1 tp60 . . . . . 0 C--O 1.247 0.936 0 CA-C-N 115.24 -0.891 . . . . 12.28 110.392 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 1' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.43 -0.63 0 O5'-C5'-C4' 111.544 0.96 . 0.0 '__' . 4.94 . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 2' ' ' ' G' . . . . . 0.466 ' H1 ' ' HA ' ' A' ' 43' ' ' PRO . . . . . . . . 0 O5'--C5' 1.423 -1.091 0 C3'-C2'-C1' 99.281 -2.465 . 0.0 OUTLIER . 4.87 . . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 3' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.426 -0.901 0 C4'-C3'-C2' 104.261 1.561 . 0.0 OUTLIER . 5.02 . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 4' ' ' ' G' . . . . . 0.537 " H3'" ' N3 ' ' B' ' 4' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.428 -0.751 0 O4'-C1'-C2' 107.982 1.13 . 0.0 OUTLIER '7D dist 2a' 2.69 . . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 5' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.426 -0.887 0 C3'-C2'-C1' 100.269 -1.368 . 0.01 1t . 1.93 . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 6' ' ' ' G' . . . . . 0.547 ' O6 ' ' HE3' ' A' ' 36' ' ' LYS . . . . . . . . 0 O5'--C5' 1.428 -0.742 0 C4'-C3'-C2' 104.209 1.509 . 0.0 OUTLIER '7D dist 4b' 2.38 . . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.428 -0.779 0 C1'-O4'-C4' 110.265 0.738 . 0.0 OUTLIER . 4.19 . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.785 0 N-CA-C 112.561 -0.215 . . . . 13.03 112.561 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -75.79 169.92 17.21 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.15 0.5 . . . . 11.06 111.579 -177.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 51.3 ttm -144.83 126.49 15.15 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.735 -0.666 . . . . 9.85 110.165 179.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 81.46 81.71 0.85 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.746 -0.74 . . . . 6.69 112.966 178.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 50.3 m -99.58 -56.11 2.49 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 122.512 -0.405 . . . . 5.55 110.211 174.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 65.17 84.62 0.15 Allowed 'General case' 0 N--CA 1.463 0.213 0 O-C-N 123.74 0.65 . . . . 3.87 110.646 178.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -63.55 113.22 3.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.167 -0.924 . . . . 3.53 110.753 -179.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 18.4 p -78.35 -1.56 33.87 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.862 -0.608 . . . . 1.69 111.785 -175.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 50.7 ttp -58.22 -40.67 82.26 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.461 0.541 . . . . 1.49 112.461 -174.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.486 ' O ' HD11 ' A' ' 109' ' ' LEU . 39.4 m-85 -96.25 -11.73 25.58 Favored 'General case' 0 C--O 1.224 -0.256 0 O-C-N 121.911 -0.493 . . . . 1.5 111.253 -177.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.531 ' O ' ' HA ' ' A' ' 82' ' ' THR . 39.3 p -105.28 4.49 31.09 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 111.989 0.366 . . . . 0.53 111.989 -173.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -92.83 102.5 14.88 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.322 -0.399 . . . . 2.75 110.046 -178.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.414 HG23 ' O ' ' A' ' 108' ' ' ASN . 4.0 mp -103.42 135.33 41.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.76 0.314 . . . . 0.85 110.674 -177.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.654 ' HD2' HD21 ' A' ' 108' ' ' ASN . 51.5 t80 -94.78 109.38 21.35 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.412 -0.588 . . . . 0.71 109.412 175.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.572 HG11 HD11 ' A' ' 51' ' ' LEU . 5.5 t -97.89 142.94 13.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 CA-C-N 115.469 -0.787 . . . . 0.92 110.634 -176.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -143.27 161.01 27.66 Favored Glycine 0 N--CA 1.447 -0.624 0 CA-C-N 114.538 -1.21 . . . . 0.84 111.717 -171.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 71.18 21.62 78.47 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.892 -0.671 . . . . 0.68 113.259 175.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.608 HD11 HD13 ' A' ' 51' ' ' LEU . 2.9 mm? -67.02 119.3 63.17 Favored Pre-proline 0 C--O 1.223 -0.319 0 N-CA-C 109.094 -0.706 . . . . 1.28 109.094 175.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.672 ' CG ' ' HB3' ' A' ' 101' ' ' ASP . 11.9 Cg_endo -56.3 158.87 14.17 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.372 2.048 . . . . 0.58 111.232 175.341 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.496 ' CZ ' ' C5 ' ' B' ' 2' ' ' ' G' . 76.4 m-85 -71.98 2.46 5.62 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.896 0.379 . . . . 1.05 111.649 -171.028 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 18.1 t-160 -95.7 -16.88 21.7 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.059 -0.519 . . . . 2.01 110.136 174.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.532 HG21 HD12 ' A' ' 42' ' ' LEU . 67.9 m -79.4 116.75 19.82 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.445 0.641 . . . . 0.72 112.278 -174.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 42.1 p -99.81 -177.64 3.62 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.31 -0.859 . . . . 0.55 110.19 172.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.555 ' HA ' HG23 ' A' ' 66' ' ' VAL . 4.6 m-20 -61.25 -35.1 76.34 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.453 0.644 . . . . 0.49 110.105 -178.091 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.654 ' O ' ' HG2' ' A' ' 53' ' ' GLU . 0.6 OUTLIER -74.52 -38.23 62.85 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.317 -0.856 . . . . 2.76 110.595 -178.56 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.454 ' HB ' HG23 ' A' ' 46' ' ' THR . 17.0 m -62.4 -43.17 99.45 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.267 0.556 . . . . 0.58 110.051 177.482 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.608 HD13 HD11 ' A' ' 42' ' ' LEU . 22.1 tp -66.15 -37.58 86.02 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 115.547 -0.751 . . . . 0.85 109.796 177.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 48.7 t-80 -58.44 -53.1 62.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.617 -0.719 . . . . 0.59 110.841 175.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.654 ' HG2' ' O ' ' A' ' 49' ' ' LYS . 21.3 mm-40 -58.14 -42.33 85.61 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.128 -0.487 . . . . 1.52 111.529 -177.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.448 ' O ' ' HB2' ' A' ' 57' ' ' GLN . 6.2 t80 -74.76 -33.61 62.35 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.16 -0.473 . . . . 1.12 111.762 -174.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.658 ' CB ' HD11 ' A' ' 61' ' ' ILE . 4.9 m-85 -86.2 -26.09 25.27 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 114.043 1.127 . . . . 0.56 114.043 -176.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.447 ' HA ' ' O ' ' A' ' 59' ' ' GLY . 7.9 pt-20 -72.78 -11.78 60.75 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 122.109 0.957 . . . . 1.57 109.553 179.5 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.448 ' HB2' ' O ' ' A' ' 54' ' ' TYR . 13.4 mm100 -55.69 -19.33 10.45 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.505 -1.225 . . . . 2.16 111.602 166.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -105.9 10.87 32.31 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.618 0.247 . . . . 0.71 110.786 -178.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.447 ' O ' ' HA ' ' A' ' 56' ' ' GLU . . . 125.61 -171.09 17.49 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.79 -0.719 . . . . 0.75 112.664 -177.03 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.4 ' CB ' ' HB3' ' A' ' 84' ' ' LYS . 0.8 OUTLIER -65.51 123.05 18.63 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.799 0.666 . . . . 1.02 112.799 -179.142 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.658 HD11 ' CB ' ' A' ' 55' ' ' PHE . 10.1 mt -93.52 122.81 45.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.168 -0.924 . . . . 0.47 108.767 169.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -78.05 -41.47 35.43 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.234 0.54 . . . . 2.07 110.078 177.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -162.56 131.05 4.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.695 -0.684 . . . . 2.48 110.756 -177.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -117.17 116.49 27.39 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.785 0.326 . . . . 0.44 110.192 177.008 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.686 HG21 ' H22' ' B' ' 6' ' ' ' G' . 16.2 m -126.9 112.42 28.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.663 0.744 . . . . 1.38 111.819 -178.316 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.555 HG23 ' HA ' ' A' ' 48' ' ' ASP . 70.1 t -79.25 131.52 34.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.547 -0.751 . . . . 0.49 109.591 179.017 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.609 ' H ' ' HA2' ' A' ' 79' ' ' GLY . 28.8 mm -71.48 140.67 17.84 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.697 0 N-CA-C 107.473 -1.306 . . . . 0.72 107.473 175.329 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.88 ' HA ' ' O ' ' A' ' 75' ' ' SER . 15.2 p -159.76 152.62 21.61 Favored 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 107.343 -1.355 . . . . 1.52 107.343 -159.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -64.79 125.43 24.78 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.498 -0.481 . . . . 2.49 111.438 -175.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 6.7 ptp180 -49.43 -21.97 1.05 Allowed 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 114.053 1.131 . . . . 6.05 114.053 -177.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -95.6 -38.64 10.31 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 112.713 0.634 . . . . 4.05 112.713 -178.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 32.6 p -120.72 -29.24 4.72 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.669 0.618 . . . . 3.08 112.669 -174.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.748 ' HA ' ' HB ' ' A' ' 68' ' ' THR . 37.7 mt-30 59.12 14.41 3.49 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 113.577 0.955 . . . . 3.3 113.577 178.15 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 51.8 mtmt -42.83 -60.86 1.43 Allowed 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 112.571 0.582 . . . . 3.49 112.571 172.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.88 ' O ' ' HA ' ' A' ' 68' ' ' THR . 5.3 p -163.24 -108.53 0.01 OUTLIER 'General case' 0 C--O 1.216 -0.692 0 CA-C-O 118.659 -0.686 . . . . 1.81 112.709 177.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.655 ' HA ' " O5'" ' B' ' 1' ' ' ' G' . 74.4 mtt180 112.23 -19.06 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 125.27 1.428 . . . . 2.56 111.729 -170.188 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.452 ' HA3' ' C6 ' ' B' ' 2' ' ' ' G' . . . 81.78 12.62 81.18 Favored Glycine 0 CA--C 1.526 0.719 0 C-N-CA 120.049 -1.072 . . . . 0.64 113.762 174.096 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -128.47 160.37 32.51 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.862 -0.792 . . . . 1.18 108.862 -177.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.609 ' HA2' ' H ' ' A' ' 67' ' ' ILE . . . 178.57 145.12 5.93 Favored Glycine 0 C--O 1.222 -0.651 0 C-N-CA 119.424 -1.37 . . . . 0.59 113.648 175.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.476 ' HD2' HD11 ' A' ' 67' ' ' ILE . 96.4 m-85 -98.67 137.62 37.03 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 122.188 0.994 . . . . 0.63 112.495 175.43 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 65.0 t -119.91 134.03 64.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 114.234 -1.348 . . . . 0.41 109.526 176.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.531 ' HA ' ' O ' ' A' ' 35' ' ' THR . 27.0 m -114.83 123.95 50.51 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 108.596 -0.891 . . . . 0.47 108.596 175.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.424 ' SD ' HG12 ' A' ' 61' ' ' ILE . 82.2 mmm -88.68 164.3 15.38 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.937 -0.764 . . . . 0.88 108.937 -178.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.448 ' HZ2' ' HB2' ' A' ' 84' ' ' LYS . 4.3 ttmp? -82.66 -18.27 41.64 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.173 0.511 . . . . 1.92 110.454 -176.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -143.03 146.91 34.29 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.158 -0.474 . . . . 1.68 109.85 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.571 ' O ' ' HG3' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -64.96 -25.17 67.76 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.051 0.389 . . . . 3.66 112.051 -178.821 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.524 ' O ' ' HG2' ' A' ' 91' ' ' ARG . . . -64.45 -44.98 89.39 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 121.621 -0.674 . . . . 0.66 111.743 178.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 18.3 m -66.92 -32.18 73.26 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.938 0.875 . . . . 0.78 109.665 176.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.441 ' HB3' ' O ' ' A' ' 86' ' ' ARG . . . -59.76 -47.03 87.33 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 113.652 -1.613 . . . . 0.46 109.596 175.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.571 ' HG3' ' O ' ' A' ' 86' ' ' ARG . 45.6 mt-10 -56.05 -50.84 69.83 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.751 -0.659 . . . . 2.11 111.385 174.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.524 ' HG2' ' O ' ' A' ' 87' ' ' ALA . 2.0 mmt180 -57.88 -44.87 86.95 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.672 0.272 . . . . 3.82 111.337 -177.318 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -55.79 -41.38 74.01 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.889 -0.596 . . . . 0.92 111.157 176.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 44.1 t -70.44 -20.14 62.92 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.598 -0.274 . . . . 1.16 111.676 178.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -76.61 7.28 4.72 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 112.412 0.523 . . . . 4.2 112.412 -178.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -144.01 93.09 6.13 Favored Pre-proline 0 C--N 1.322 -0.613 0 N-CA-C 108.633 -0.877 . . . . 2.24 108.633 -178.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -74.66 -28.87 9.45 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.499 2.133 . . . . 2.38 113.742 -172.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.537 ' HA ' ' O ' ' A' ' 105' ' ' ALA . 10.5 m120 -130.99 79.02 72.35 Favored Pre-proline 0 C--N 1.33 -0.25 0 N-CA-C 112.133 0.42 . . . . 3.03 112.133 -175.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.411 ' HB2' ' CE1' ' A' ' 54' ' ' TYR . 73.1 Cg_endo -81.57 141.32 12.34 Favored 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.755 2.304 . . . . 1.29 111.875 174.365 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 42.0 mm -83.32 90.07 2.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.139 0.495 . . . . 1.81 110.865 177.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 53.8 mt -92.96 135.31 28.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.601 -0.727 . . . . 0.99 111.148 175.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.672 ' HB3' ' CG ' ' A' ' 43' ' ' PRO . 38.8 t70 43.21 35.86 0.91 Allowed 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 115.733 -0.667 . . . . 1.37 112.477 -174.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 73.49 18.74 79.51 Favored Glycine 0 CA--C 1.519 0.306 0 C-N-CA 120.8 -0.714 . . . . 1.56 113.03 178.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 5.4 tpt180 -129.77 139.78 51.21 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.722 -0.844 . . . . 4.13 108.722 178.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 6.6 ttpm? -71.37 140.23 50.1 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.795 0.331 . . . . 2.73 110.171 179.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.537 ' O ' ' HA ' ' A' ' 97' ' ' ASN . . . -123.66 166.07 16.14 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.512 -0.313 . . . . 1.04 110.804 -171.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -111.65 146.54 37.26 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.038 -0.528 . . . . 2.04 110.34 -178.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 73.2 t -145.46 135.69 18.73 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 115.719 -0.673 . . . . 1.06 110.95 -173.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.654 HD21 ' HD2' ' A' ' 38' ' ' PHE . 9.3 p30 -167.17 161.87 14.82 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 109.6 -0.518 . . . . 2.49 109.6 173.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.486 HD11 ' O ' ' A' ' 34' ' ' PHE . 1.6 mm? -77.22 120.31 22.09 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.263 -0.643 . . . . 1.23 109.263 173.259 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -56.19 -36.23 68.16 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.545 0.572 . . . . 0.91 112.545 -172.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 5.6 p90 -70.97 -7.31 45.27 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.854 -0.338 . . . . 1.4 111.537 -174.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 97.0 mt -84.59 -23.18 29.73 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.96 0.409 . . . . 1.97 110.458 177.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -127.85 25.94 4.89 Favored Glycine 0 N--CA 1.45 -0.407 0 N-CA-C 110.869 -0.893 . . . . 2.14 110.869 -178.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -89.27 137.02 32.69 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.691 -0.485 . . . . 2.66 109.691 -173.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 35.4 mttm -129.55 78.9 74.76 Favored Pre-proline 0 C--N 1.321 -0.633 0 C-N-CA 120.525 -0.47 . . . . 4.16 109.984 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -89.35 -38.5 0.05 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 122.158 1.905 . . . . 5.53 113.577 -176.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 38.5 ptt180 -131.39 -1.12 3.97 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.853 0.359 . . . . 8.6 111.194 -175.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 8.8 t -144.58 137.96 27.12 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.404 -0.362 . . . . 6.37 110.225 -177.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -150.95 144.75 25.14 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.418 -0.355 . . . . 7.85 110.136 179.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.496 ' O ' ' HB2' ' A' ' 121' ' ' GLN . 26.2 t -91.76 -84.84 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 109.226 -0.657 . . . . 9.37 109.226 177.25 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.496 ' HB2' ' O ' ' A' ' 120' ' ' VAL . 54.8 tt0 . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.364 -0.827 . . . . 12.28 109.209 174.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 1' ' ' ' G' . . . . . 0.655 " O5'" ' HA ' ' A' ' 76' ' ' ARG . . . . . . . . 0 O5'--C5' 1.431 -0.546 0 O5'-C5'-C4' 111.401 0.858 . 0.0 '__' . 4.94 . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 2' ' ' ' G' . . . . . 0.496 ' C5 ' ' CZ ' ' A' ' 44' ' ' TYR . . . . . . . . 0 O5'--C5' 1.423 -1.092 0 C3'-C2'-C1' 99.037 -2.736 . 0.0 OUTLIER . 4.87 . . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 3' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.427 -0.786 0 C3'-C2'-C1' 100.425 -1.195 . 0.0 OUTLIER gamma 5.02 . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 4' ' ' ' G' . . . . . 0.763 " H3'" ' N3 ' ' B' ' 4' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.428 -0.724 0 C1'-O4'-C4' 110.339 0.821 . 0.0 OUTLIER '7D dist 0i' 2.69 . . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 5' ' ' ' U' . . . . . 0.556 ' H6 ' " O5'" ' B' ' 5' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.425 -0.937 0 C3'-C2'-C1' 100.867 -0.704 . 0.157 1b . 1.93 . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 6' ' ' ' G' . . . . . 0.686 ' H22' HG21 ' A' ' 65' ' ' VAL . . . . . . . . 0 O5'--C5' 1.426 -0.846 0 C4'-C3'-C2' 103.591 0.891 . 0.479 0b . 2.38 . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.427 -0.806 0 C3'-C2'-C1' 100.717 -0.87 . 0.0 OUTLIER . 4.19 . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.684 0 N-CA-C 112.196 -0.362 . . . . 13.03 112.196 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -91.5 2.95 56.07 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.083 0.468 . . . . 11.06 110.77 -179.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 24.8 mmt -96.31 134.66 39.16 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.093 -0.503 . . . . 9.85 110.104 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -104.64 150.5 17.2 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.843 -0.694 . . . . 6.69 112.446 -178.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 9.6 m -77.76 -58.08 3.46 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.508 0.194 . . . . 5.55 110.775 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 50.2 mtm180 54.42 92.03 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.361 0 O-C-N 123.839 0.712 . . . . 3.87 112.368 -178.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -66.78 -48.94 67.48 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.127 -0.942 . . . . 3.53 111.366 177.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.423 ' O ' ' HB2' ' A' ' 36' ' ' LYS . 58.9 p 57.61 16.37 3.35 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 114.282 1.216 . . . . 1.69 114.282 176.574 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 13.8 tmm? -65.4 -40.53 93.54 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 121.875 -0.515 . . . . 1.49 111.851 177.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.552 ' O ' HD11 ' A' ' 109' ' ' LEU . 18.2 m-85 -92.96 -13.43 28.81 Favored 'General case' 0 C--O 1.225 -0.201 0 O-C-N 122.013 -0.429 . . . . 1.5 111.482 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.52 ' HB ' ' O ' ' A' ' 83' ' ' MET . 31.7 p -94.38 -6.09 44.97 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.998 0.428 . . . . 0.53 111.102 -174.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.797 ' HE2' ' O6 ' ' B' ' 6' ' ' ' G' . 13.8 tptm -84.67 103.7 14.01 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.789 -0.641 . . . . 2.75 110.357 -177.092 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.635 HD11 ' HA ' ' A' ' 89' ' ' ALA . 28.7 mt -98.78 139.03 21.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 121.339 0.59 . . . . 0.85 112.486 -174.226 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.419 ' HD1' ' CE2' ' A' ' 80' ' ' PHE . 68.8 t80 -105.59 111.76 24.58 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.31 -0.859 . . . . 0.71 108.976 174.538 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.42 HG13 HG22 ' A' ' 107' ' ' VAL . 5.3 t -99.29 139.34 21.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.068 0.461 . . . . 0.92 110.042 -178.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -140.53 138.11 8.76 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.268 -0.968 . . . . 0.84 113.396 -170.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 84.9 31.15 24.32 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 121.486 -0.388 . . . . 0.68 112.498 176.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.69 HD12 HG21 ' A' ' 46' ' ' THR . 3.3 mm? -67.24 129.15 93.86 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-O 120.564 0.221 . . . . 1.28 110.809 178.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.692 ' HA ' ' O6 ' ' B' ' 2' ' ' ' G' . 65.5 Cg_exo -54.97 159.73 9.0 Favored 'Trans proline' 0 CA--C 1.529 0.271 0 C-N-CA 123.448 2.765 . . . . 0.58 112.923 172.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.689 ' HA ' ' HB2' ' A' ' 75' ' ' SER . 6.8 m-30 -69.18 -9.67 54.04 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.738 -0.664 . . . . 1.05 112.486 -174.146 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . 0.414 ' HB3' ' OD2' ' A' ' 101' ' ' ASP . 44.5 t60 -104.23 -1.18 27.47 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.054 0.454 . . . . 2.01 110.368 178.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.69 HG21 HD12 ' A' ' 42' ' ' LEU . 85.3 m -73.3 116.4 13.8 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.639 0.733 . . . . 0.72 111.362 -177.631 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 6.1 p -110.74 -178.91 3.6 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.631 -1.168 . . . . 0.55 110.503 176.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -62.36 -35.94 80.71 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.334 0.588 . . . . 0.49 110.284 -175.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.667 ' O ' ' HG2' ' A' ' 53' ' ' GLU . 43.0 pttt -65.13 -35.13 80.14 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.336 -0.847 . . . . 2.76 110.821 179.498 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 6.4 m -67.51 -44.8 77.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.551 -0.295 . . . . 0.58 111.049 -178.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.675 HD21 HD11 ' A' ' 42' ' ' LEU . 22.1 mt -64.99 -33.99 77.36 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-O 120.855 0.36 . . . . 0.85 110.296 175.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.449 ' HA ' ' CD1' ' A' ' 61' ' ' ILE . 49.3 t-80 -64.95 -54.47 30.14 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 116.017 -0.538 . . . . 0.59 110.453 -179.214 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.667 ' HG2' ' O ' ' A' ' 49' ' ' LYS . 13.6 mm-40 -56.41 -51.1 69.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.252 -0.431 . . . . 1.52 111.777 -179.123 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.536 ' O ' ' HB2' ' A' ' 57' ' ' GLN . 2.1 t80 -70.44 -33.31 71.17 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 112.765 0.654 . . . . 1.12 112.765 -173.077 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.88 ' HB2' HD11 ' A' ' 61' ' ' ILE . 11.3 m-85 -85.44 -35.29 21.35 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 114.436 1.273 . . . . 0.56 114.436 -172.05 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.626 ' HB3' HG13 ' A' ' 61' ' ' ILE . 13.5 pt-20 -77.99 -6.56 54.87 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 119.747 1.158 . . . . 1.57 110.189 179.113 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.536 ' HB2' ' O ' ' A' ' 54' ' ' TYR . 11.7 mm100 -57.41 -9.83 1.19 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.454 -0.794 . . . . 2.16 112.028 162.369 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -104.3 -21.95 13.43 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.234 -0.439 . . . . 0.71 109.99 177.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.51 ' HA3' ' OG ' ' A' ' 88' ' ' SER . . . 169.91 -116.28 0.64 Allowed Glycine 0 C--O 1.226 -0.398 0 CA-C-N 115.856 -0.611 . . . . 0.75 112.061 -179.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -115.36 128.1 55.85 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.942 0.371 . . . . 1.02 110.617 179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.88 HD11 ' HB2' ' A' ' 55' ' ' PHE . 25.5 mt -97.13 124.27 49.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 109.776 -0.454 . . . . 0.47 109.776 170.236 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -88.8 -32.02 18.06 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.161 0.505 . . . . 2.07 110.257 178.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -161.06 126.67 3.77 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.965 -0.561 . . . . 2.48 110.483 179.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -117.53 124.66 49.25 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.834 0.35 . . . . 0.44 110.209 171.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.3 p -141.4 112.63 3.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 121.956 0.884 . . . . 1.38 111.991 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.525 HG22 HD12 ' A' ' 51' ' ' LEU . 23.0 t -79.37 129.06 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 CA-C-N 115.079 -0.964 . . . . 0.49 108.77 177.218 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.564 ' H ' ' HA2' ' A' ' 79' ' ' GLY . 44.5 mm -73.7 85.39 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 CA-C-O 121.699 0.761 . . . . 0.72 109.714 -178.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.656 HG22 ' HA ' ' A' ' 75' ' ' SER . 23.9 p -119.69 -179.12 3.79 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 114.652 -1.158 . . . . 1.52 110.438 178.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.996 ' H ' ' HA ' ' A' ' 73' ' ' GLN . 25.6 t70 -96.25 120.4 36.47 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.224 -0.444 . . . . 2.49 110.979 -173.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 6.3 mpt_? -57.89 -4.75 0.34 Allowed 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 113.909 1.078 . . . . 6.05 113.909 -177.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.415 ' HB2' ' OD2' ' A' ' 69' ' ' ASP . 37.4 m-80 -107.87 -40.65 5.2 Favored 'General case' 0 N--CA 1.464 0.272 0 O-C-N 121.82 -0.55 . . . . 4.05 111.577 177.534 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 11.3 p -132.07 -28.89 1.69 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.118 0.485 . . . . 3.08 111.951 -173.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.996 ' HA ' ' H ' ' A' ' 69' ' ' ASP . 28.9 mt-30 62.6 -92.16 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.999 -1.0 . . . . 3.3 111.625 -175.169 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp 55.16 78.26 0.19 Allowed 'General case' 0 C--N 1.333 -0.112 0 N-CA-C 108.114 -1.069 . . . . 3.49 108.114 -175.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.689 ' HB2' ' HA ' ' A' ' 44' ' ' TYR . 15.5 m -35.8 107.82 0.06 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 114.721 -1.127 . . . . 1.81 113.699 -164.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.507 ' HD2' ' O ' ' A' ' 67' ' ' ILE . 14.4 mtt180 -56.08 -25.59 46.1 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 114.249 -1.341 . . . . 2.56 111.903 177.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.476 ' HA2' ' O ' ' A' ' 42' ' ' LEU . . . 102.48 3.94 49.94 Favored Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.645 -0.788 . . . . 0.64 111.633 -174.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 24.3 m-85 -114.84 146.99 40.47 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.663 -0.495 . . . . 1.18 109.663 177.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.564 ' HA2' ' H ' ' A' ' 67' ' ' ILE . . . -170.08 140.85 6.25 Favored Glycine 0 C--O 1.224 -0.512 0 C-N-CA 120.525 -0.845 . . . . 0.59 112.091 171.305 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.419 ' CE2' ' HD1' ' A' ' 38' ' ' PHE . 59.4 m-85 -103.84 144.94 30.83 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 122.26 1.029 . . . . 0.63 113.279 175.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 55.7 t -123.65 130.52 74.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 113.739 -1.573 . . . . 0.41 109.216 176.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 19.2 m -110.59 106.23 15.43 Favored 'General case' 0 C--N 1.31 -1.128 0 N-CA-C 107.827 -1.175 . . . . 0.47 107.827 177.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.52 ' O ' ' HB ' ' A' ' 35' ' ' THR . 51.4 mtp -89.35 157.82 18.03 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 120.38 -0.528 . . . . 0.88 109.74 -175.121 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 23.1 tttm -84.01 -11.06 57.37 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.469 -0.332 . . . . 1.92 111.746 -171.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -147.81 147.55 29.95 Favored 'General case' 0 C--O 1.245 0.864 0 CA-C-O 121.585 0.707 . . . . 1.68 111.857 175.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 15.7 ptt180 -65.13 -28.05 69.15 Favored 'General case' 0 C--O 1.212 -0.908 0 CA-C-N 114.974 -1.012 . . . . 3.66 113.471 -174.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.46 -50.46 65.29 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 119.554 1.07 . . . . 0.66 111.629 -175.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.51 ' OG ' ' HA3' ' A' ' 59' ' ' GLY . 14.6 m -63.2 -39.69 95.35 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.474 0.654 . . . . 0.78 110.231 177.092 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.635 ' HA ' HD11 ' A' ' 37' ' ' ILE . . . -59.37 -50.37 74.23 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 114.529 -1.214 . . . . 0.46 110.49 178.172 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.688 ' O ' ' HG2' ' A' ' 94' ' ' LYS . 4.4 mm-40 -56.41 -50.73 70.79 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.034 -0.985 . . . . 2.11 112.258 176.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -58.93 -45.86 89.38 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 111.914 0.339 . . . . 3.82 111.914 -177.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -56.13 -35.15 66.8 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.006 0.431 . . . . 0.92 111.099 177.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 36.8 t -76.47 -26.79 55.73 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.326 -0.397 . . . . 1.16 112.0 176.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.688 ' HG2' ' O ' ' A' ' 90' ' ' GLU . 32.5 mmtm -72.97 -44.27 61.29 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 120.71 0.29 . . . . 4.2 111.155 -175.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -112.12 89.45 11.96 Favored Pre-proline 0 C--N 1.324 -0.508 0 N-CA-C 109.502 -0.555 . . . . 2.24 109.502 174.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.586 ' HB3' ' O ' ' A' ' 107' ' ' VAL . 73.5 Cg_endo -87.73 77.96 1.66 Allowed 'Trans proline' 0 N--CA 1.447 -1.221 0 C-N-CA 122.661 2.241 . . . . 2.38 111.909 -176.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 30.7 m-80 -154.66 39.98 0.13 Allowed Pre-proline 0 CA--C 1.54 0.573 0 CA-C-N 116.1 -0.5 . . . . 3.03 112.312 -175.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.696 ' HD2' ' O ' ' A' ' 105' ' ' ALA . 67.9 Cg_endo -72.36 121.4 7.44 Favored 'Trans proline' 0 C--N 1.352 0.762 0 CA-C-N 120.543 1.23 . . . . 1.29 112.646 -176.316 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 47.4 mm -71.85 91.49 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.966 0.889 . . . . 1.81 110.547 173.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 72.7 mt -106.89 131.98 55.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 114.717 -1.129 . . . . 0.99 110.309 -179.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.535 ' HB3' ' HG2' ' A' ' 43' ' ' PRO . 25.9 t70 45.07 30.0 0.55 Allowed 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 113.337 0.866 . . . . 1.37 113.337 178.248 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 86.88 21.66 49.33 Favored Glycine 0 CA--C 1.521 0.437 0 C-N-CA 120.497 -0.858 . . . . 1.56 113.034 177.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.546 ' HB2' ' HG3' ' A' ' 43' ' ' PRO . 83.0 mmt-85 -138.81 151.74 47.29 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.116 -0.698 . . . . 4.13 109.116 177.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -95.99 106.15 18.27 Favored 'General case' 0 C--N 1.32 -0.697 0 C-N-CA 119.298 -0.961 . . . . 2.73 109.284 172.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.696 ' O ' ' HD2' ' A' ' 98' ' ' PRO . . . -86.37 167.27 14.89 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.482 0.658 . . . . 1.04 112.432 174.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -114.15 128.92 56.59 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.02 -0.991 . . . . 2.04 110.147 -177.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.586 ' O ' ' HB3' ' A' ' 96' ' ' PRO . 57.5 t -119.61 147.99 22.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.418 -0.355 . . . . 1.06 110.542 -175.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -160.53 172.97 16.24 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.579 0.228 . . . . 2.49 110.593 177.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.552 HD11 ' O ' ' A' ' 34' ' ' PHE . 0.6 OUTLIER -79.68 130.19 35.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.617 0.246 . . . . 1.23 110.408 179.401 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -64.52 -33.67 76.45 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.716 0.636 . . . . 0.91 112.716 -174.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.419 ' HD1' HD12 ' A' ' 109' ' ' LEU . 7.1 p90 -68.89 -9.63 52.72 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.781 0.324 . . . . 1.4 111.737 -173.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 84.2 mt -79.83 -12.33 59.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.331 -0.395 . . . . 1.97 110.738 178.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.504 ' HA3' ' C4 ' ' B' ' 5' ' ' ' U' . . . -136.66 30.07 2.71 Favored Glycine 0 N--CA 1.45 -0.389 0 N-CA-C 111.118 -0.793 . . . . 2.14 111.118 177.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -92.68 118.77 31.4 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.188 -0.506 . . . . 2.66 110.124 -176.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -129.54 81.04 70.73 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-O 120.798 0.333 . . . . 4.16 110.318 178.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.401 ' HD2' ' H ' ' A' ' 117' ' ' ARG . 14.9 Cg_endo -91.86 -30.82 0.1 Allowed 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 123.111 2.541 . . . . 5.53 113.255 -176.241 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.401 ' H ' ' HD2' ' A' ' 116' ' ' PRO . 18.0 ptp180 -141.78 19.72 2.16 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.071 0.463 . . . . 8.6 111.13 -175.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 6.2 t -156.48 153.23 28.47 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.386 -0.598 . . . . 6.37 109.386 -179.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 47.6 t-20 -158.15 97.09 1.49 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.585 0.231 . . . . 7.85 110.641 -178.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 96.2 t 67.62 107.04 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-N 115.548 -0.751 . . . . 9.37 112.766 173.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 . . . . . 0 C--O 1.252 1.2 0 CA-C-O 118.063 -0.97 . . . . 12.28 109.782 173.693 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 1' ' ' ' G' . . . . . 0.584 ' N2 ' ' N7 ' ' B' ' 2' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.428 -0.738 0 C3'-C2'-C1' 100.56 -1.045 . 0.0 '__' . 4.94 . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 2' ' ' ' G' . . . . . 0.692 ' O6 ' ' HA ' ' A' ' 43' ' ' PRO . . . . . . . . 0 O5'--C5' 1.428 -0.724 0 C3'-C2'-C1' 99.339 -2.401 . 0.0 OUTLIER gamma 4.87 . . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 3' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.427 -0.808 0 C3'-C2'-C1' 100.673 -0.919 . 0.0 OUTLIER . 5.02 . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 4' ' ' ' G' . . . . . 0.48 " H3'" ' N3 ' ' B' ' 4' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.428 -0.725 0 O4'-C1'-C2' 108.276 1.34 . 0.0 OUTLIER gamma 2.69 . . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 5' ' ' ' U' . . . . . 0.504 ' C4 ' ' HA3' ' A' ' 113' ' ' GLY . . . . . . . . 0 O5'--C5' 1.425 -0.911 0 C3'-C2'-C1' 100.537 -1.07 . 0.0 OUTLIER gamma 1.93 . . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 6' ' ' ' G' . . . . . 0.797 ' O6 ' ' HE2' ' A' ' 36' ' ' LYS . . . . . . . . 0 O5'--C5' 1.427 -0.84 0 C3'-C2'-C1' 100.318 -1.313 . 0.149 0b . 2.38 . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.428 -0.765 0 C4'-C3'-C2' 103.895 1.195 . 0.0 OUTLIER . 4.19 . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.842 0 CA-C-O 120.101 -0.277 . . . . 13.03 112.812 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . 62.0 -160.16 0.31 Allowed 'General case' 0 C--O 1.233 0.207 0 C-N-CA 122.413 0.285 . . . . 11.06 110.461 -177.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 1.7 pmm? -142.26 163.61 32.38 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.771 0.32 . . . . 9.85 110.237 178.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -117.13 163.57 12.55 Favored Glycine 0 N--CA 1.443 -0.845 0 N-CA-C 111.366 -0.694 . . . . 6.69 111.366 176.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 23.2 t -88.49 14.73 9.15 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.989 0.395 . . . . 5.55 110.55 -179.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 35.4 mtp180 -116.25 148.36 40.55 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 110.116 -0.327 . . . . 3.87 110.116 177.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.35 114.81 4.06 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-O 121.25 0.548 . . . . 3.53 110.725 178.4 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.635 ' HA ' ' OG1' ' A' ' 35' ' ' THR . 10.7 p -118.32 15.09 13.93 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.739 -0.664 . . . . 1.69 111.485 -177.15 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 59.9 ttp -70.78 -40.89 72.31 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 120.885 -0.326 . . . . 1.49 111.648 177.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.601 ' HA ' HD11 ' A' ' 109' ' ' LEU . 50.2 m-85 -103.47 -21.06 13.84 Favored 'General case' 0 C--O 1.226 -0.17 0 O-C-N 122.043 -0.41 . . . . 1.5 110.79 -177.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.757 ' O ' ' HA ' ' A' ' 82' ' ' THR . 28.7 p -84.8 14.21 5.01 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.303 0.573 . . . . 0.53 110.631 -175.072 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.475 ' HD2' ' O6 ' ' B' ' 6' ' ' ' G' . 6.9 ttpt -121.21 102.45 8.31 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.355 -0.839 . . . . 2.75 109.227 -173.093 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.5 HG22 HG23 ' A' ' 39' ' ' VAL . 5.3 mp -109.42 126.85 66.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 116.119 -0.491 . . . . 0.85 111.042 -175.294 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.473 ' HD1' ' CZ ' ' A' ' 80' ' ' PHE . 80.3 t80 -85.76 115.83 23.65 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.487 -0.56 . . . . 0.71 109.487 175.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.708 HG13 HG22 ' A' ' 107' ' ' VAL . 91.6 t -133.05 97.32 2.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-O 118.405 -0.807 . . . . 0.92 110.282 -179.25 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.575 ' HA2' HD13 ' A' ' 42' ' ' LEU . . . -117.61 -156.24 10.34 Favored Glycine 0 C--O 1.215 -1.081 0 C-N-CA 115.838 -3.077 . . . . 0.84 113.721 162.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 88.67 12.0 65.09 Favored Glycine 0 N--CA 1.45 -0.4 0 N-CA-C 110.032 -1.227 . . . . 0.68 110.032 -171.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.575 HD13 ' HA2' ' A' ' 40' ' ' GLY . 7.7 mp -75.54 137.95 70.82 Favored Pre-proline 0 N--CA 1.447 -0.591 0 CA-C-N 114.626 -0.787 . . . . 1.28 110.716 -177.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.493 ' HG3' ' CG ' ' A' ' 103' ' ' ARG . 42.5 Cg_exo -55.33 159.89 9.65 Favored 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 123.029 2.486 . . . . 0.58 111.678 173.304 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 44.1 m-85 -65.1 -22.16 66.91 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.165 0.431 . . . . 1.05 112.165 -175.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 23.0 t60 -86.09 -25.49 25.8 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 120.917 0.389 . . . . 2.01 110.44 178.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.729 HG23 HG21 ' A' ' 50' ' ' THR . 19.1 m -66.91 130.08 41.98 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.704 -0.68 . . . . 0.72 110.302 -176.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 9.0 p -137.33 -176.65 4.47 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.033 -0.53 . . . . 0.55 111.871 -170.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -55.72 -35.4 66.07 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.559 -0.746 . . . . 0.49 110.126 -176.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.678 ' O ' ' HG2' ' A' ' 53' ' ' GLU . 9.5 ptpp? -66.54 -36.85 83.68 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.045 -0.98 . . . . 2.76 109.85 -177.053 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.729 HG21 HG23 ' A' ' 46' ' ' THR . 53.9 m -63.63 -45.56 89.72 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.797 -0.638 . . . . 0.58 110.89 179.055 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.415 HD23 ' HA ' ' A' ' 51' ' ' LEU . 63.1 mt -67.85 -39.16 83.86 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.75 -0.659 . . . . 0.85 111.237 -179.047 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 56.1 t-80 -55.31 -51.3 67.16 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.209 -0.451 . . . . 0.59 109.972 175.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.678 ' HG2' ' O ' ' A' ' 49' ' ' LYS . 10.9 mm-40 -64.9 -47.88 76.2 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.832 -0.622 . . . . 1.52 112.489 -176.454 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.404 ' O ' ' HB2' ' A' ' 57' ' ' GLN . 66.1 t80 -77.35 -36.85 53.41 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 121.054 0.454 . . . . 1.12 111.701 -170.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.578 ' CB ' HD11 ' A' ' 61' ' ' ILE . 14.3 m-85 -84.01 -25.81 29.64 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.655 0.613 . . . . 0.56 112.655 -174.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.635 ' HA ' ' O ' ' A' ' 59' ' ' GLY . 6.1 pt-20 -70.77 -9.72 57.98 Favored 'General case' 0 N--CA 1.461 0.101 0 CA-C-O 121.487 0.66 . . . . 1.57 109.872 178.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.404 ' HB2' ' O ' ' A' ' 54' ' ' TYR . 27.4 mm-40 -60.39 -25.84 66.2 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.091 -0.959 . . . . 2.16 110.967 170.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -88.08 -28.74 21.13 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.31 0.576 . . . . 0.71 110.036 178.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.635 ' O ' ' HA ' ' A' ' 56' ' ' GLU . . . 170.36 178.5 41.23 Favored Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 110.771 -0.932 . . . . 0.75 110.771 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -63.72 130.19 43.22 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 117.35 0.575 . . . . 1.02 109.65 -178.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.578 HD11 ' CB ' ' A' ' 55' ' ' PHE . 60.6 mt -97.72 125.74 50.82 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 110.376 -0.231 . . . . 0.47 110.376 177.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -66.56 -42.04 87.7 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 121.111 0.481 . . . . 2.07 110.721 177.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -161.97 142.28 10.3 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 115.457 -0.792 . . . . 2.48 111.061 -178.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -120.08 122.94 42.17 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.692 -0.685 . . . . 0.44 109.717 174.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.651 HG11 ' H22' ' B' ' 6' ' ' ' G' . 3.6 p -136.7 122.64 28.39 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-N 114.995 -1.002 . . . . 1.38 112.566 -174.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 54.6 t -101.43 134.14 42.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.697 -0.683 . . . . 0.49 109.423 173.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.482 ' O ' ' HB2' ' A' ' 76' ' ' ARG . 50.7 mm -86.08 100.43 9.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 121.192 0.52 . . . . 0.72 110.271 -174.012 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.4 HG22 ' HA ' ' A' ' 75' ' ' SER . 20.2 p -91.68 163.08 14.23 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.633 -0.712 . . . . 1.52 110.109 174.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.644 ' HA ' ' NE ' ' A' ' 76' ' ' ARG . 24.4 t70 -60.31 131.41 50.71 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.271 0.471 . . . . 2.49 112.271 -174.553 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 4.3 tmm_? -54.73 -40.96 69.8 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.973 -0.558 . . . . 6.05 111.067 178.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.437 ' HB2' ' OD2' ' A' ' 69' ' ' ASP . 29.9 m-80 -73.68 -60.33 2.3 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.075 0.398 . . . . 4.05 112.075 -176.382 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.434 ' OG1' ' HG3' ' A' ' 74' ' ' LYS . 22.2 p -115.53 -9.17 12.09 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.304 0.483 . . . . 3.08 112.304 -169.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 63.19 19.81 11.89 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 123.64 0.776 . . . . 3.3 112.894 -178.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.434 ' HG3' ' OG1' ' A' ' 72' ' ' THR . 54.0 mtmt -48.56 137.31 11.93 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 109.303 -0.629 . . . . 3.49 109.303 164.073 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.4 ' HA ' HG22 ' A' ' 68' ' ' THR . 13.7 m -64.68 96.87 0.19 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.358 -0.383 . . . . 1.81 111.331 -177.009 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.644 ' NE ' ' HA ' ' A' ' 69' ' ' ASP . 44.1 mtt180 -63.4 -18.99 64.29 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.912 -0.585 . . . . 2.56 111.313 175.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.477 ' HA3' ' H22' ' B' ' 2' ' ' ' G' . . . 79.73 24.44 60.28 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.81 -0.709 . . . . 0.64 113.389 173.16 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.475 ' HA ' ' CA ' ' A' ' 40' ' ' GLY . 14.0 m-85 -128.14 149.46 50.41 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 107.851 -1.166 . . . . 1.18 107.851 176.373 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -145.35 -173.55 16.72 Favored Glycine 0 N--CA 1.441 -0.99 0 C-N-CA 119.753 -1.213 . . . . 0.59 112.845 176.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.473 ' CZ ' ' HD1' ' A' ' 38' ' ' PHE . 59.1 m-85 -144.59 125.98 14.86 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 108.375 -0.972 . . . . 0.63 108.375 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 30.9 t -108.15 110.93 33.76 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 N-CA-C 109.464 -0.569 . . . . 0.41 109.464 177.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.757 ' HA ' ' O ' ' A' ' 35' ' ' THR . 28.4 m -105.52 103.72 13.3 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.47 -0.937 . . . . 0.47 108.47 177.459 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.44 ' HA ' ' HA ' ' A' ' 61' ' ' ILE . 48.6 mtp -89.16 173.8 8.22 Favored 'General case' 0 N--CA 1.448 -0.546 0 O-C-N 121.795 -0.565 . . . . 0.88 111.301 -170.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 23.2 tptt -69.52 -41.59 75.82 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.053 -0.522 . . . . 1.92 110.502 -175.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -131.99 153.71 50.07 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 121.087 0.47 . . . . 1.68 111.598 -178.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.495 ' CD ' ' H ' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -73.01 -20.76 60.94 Favored 'General case' 0 C--O 1.221 -0.399 0 CA-C-N 115.414 -0.812 . . . . 3.66 112.681 -172.762 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -64.64 -49.97 68.93 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 118.336 0.516 . . . . 0.66 111.403 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 15.3 m -70.45 -33.99 71.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.543 0.687 . . . . 0.78 109.739 177.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.515 ' CB ' ' HA ' ' A' ' 35' ' ' THR . . . -56.85 -45.6 82.32 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-N 114.472 -1.24 . . . . 0.46 109.658 174.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.602 ' O ' ' HG2' ' A' ' 94' ' ' LYS . 2.4 mm-40 -55.67 -45.59 77.69 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.618 -0.719 . . . . 2.11 110.78 173.021 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 8.3 mmm180 -57.86 -42.09 83.77 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.715 0.293 . . . . 3.82 111.007 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -58.03 -36.52 72.84 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.75 -0.659 . . . . 0.92 111.631 176.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 37.2 t -84.16 -22.95 30.81 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 112.016 0.376 . . . . 1.16 112.016 179.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.602 ' HG2' ' O ' ' A' ' 90' ' ' GLU . 67.8 mmtt -56.33 -48.32 76.98 Favored 'General case' 0 N--CA 1.469 0.511 0 N-CA-C 112.742 0.645 . . . . 4.2 112.742 -175.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.45 ' HA ' ' HD3' ' A' ' 96' ' ' PRO . 28.9 t0 -104.91 101.47 29.7 Favored Pre-proline 0 C--N 1.325 -0.462 0 C-N-CA 120.673 -0.411 . . . . 2.24 110.507 -178.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 95' ' ' ASP . 5.7 Cg_exo -80.08 172.74 13.52 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 123.211 2.607 . . . . 2.38 112.936 -175.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.474 ' N ' ' HD3' ' A' ' 98' ' ' PRO . 4.2 p30 31.91 62.45 1.24 Allowed Pre-proline 0 N--CA 1.473 0.707 0 CA-C-N 115.092 -0.958 . . . . 3.03 113.489 -172.431 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.474 ' HD3' ' N ' ' A' ' 97' ' ' ASN . 2.0 Cg_endo -81.15 167.32 17.91 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 123.356 2.704 . . . . 1.29 111.28 176.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 51.0 mm -99.07 135.56 33.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 108.072 -1.084 . . . . 1.81 108.072 178.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 71.6 mt -144.91 108.6 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 N-CA-C 109.453 -0.573 . . . . 0.99 109.453 -172.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 19.1 t0 60.2 52.67 4.85 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.782 0.801 . . . . 1.37 111.003 176.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 77.34 -6.99 40.83 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 115.653 1.021 . . . . 1.56 115.653 177.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.493 ' CG ' ' HG3' ' A' ' 43' ' ' PRO . 27.2 mmt180 -131.62 150.49 52.13 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 118.919 1.36 . . . . 4.13 111.106 -179.282 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -77.19 130.95 37.96 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.892 -0.594 . . . . 2.73 110.913 178.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -107.14 146.93 30.69 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.662 -0.699 . . . . 1.04 110.945 -175.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 39.3 m-20 -96.28 129.37 43.62 Favored 'General case' 0 C--O 1.251 1.163 0 CA-C-O 121.725 0.774 . . . . 2.04 110.011 173.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.708 HG22 HG13 ' A' ' 39' ' ' VAL . 73.3 t -142.26 131.28 22.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 112.942 -1.936 . . . . 1.06 110.462 -161.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 8.4 m-20 -166.6 158.58 13.42 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 123.709 0.63 . . . . 2.49 109.467 175.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.601 HD11 ' HA ' ' A' ' 34' ' ' PHE . 0.2 OUTLIER -58.16 150.16 22.06 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.19 -1.041 . . . . 1.23 108.19 172.35 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.51 -34.12 73.82 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.18 0.514 . . . . 0.91 110.311 -168.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 16.6 p90 -77.51 -8.68 58.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.583 -0.735 . . . . 1.4 110.678 -176.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 64.5 mt -85.06 -16.51 40.42 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.778 0.323 . . . . 1.97 111.712 179.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.758 ' HA3' ' C4 ' ' B' ' 5' ' ' ' U' . . . -125.41 13.81 7.37 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.515 -0.85 . . . . 2.14 111.408 -177.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -90.34 147.78 23.26 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.556 -0.535 . . . . 2.66 109.556 -177.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 22.9 mmtp -125.21 81.14 63.82 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-O 121.215 0.531 . . . . 4.16 109.855 174.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -97.18 -57.59 0.01 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 123.751 2.968 . . . . 5.53 113.214 -179.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 34.8 ptt180 -94.9 5.91 50.55 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.934 -0.575 . . . . 8.6 111.624 -173.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.7 t -159.5 139.26 11.59 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.144 -0.687 . . . . 6.37 109.144 176.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -136.68 170.68 15.68 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.864 0.364 . . . . 7.85 111.005 -175.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 42.9 t -106.94 139.27 29.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.146 -0.479 . . . . 9.37 110.616 -176.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 . . . . . 0 C--O 1.248 0.992 0 CA-C-O 118.847 -0.597 . . . . 12.28 110.022 178.047 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 1' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.434 -0.391 0 O5'-C5'-C4' 111.617 1.012 . 0.0 '__' . 4.94 . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 2' ' ' ' G' . . . . . 0.477 ' H22' ' HA3' ' A' ' 77' ' ' GLY . . . . . . . . 0 O5'--C5' 1.427 -0.833 0 C4'-C3'-C2' 103.948 1.248 . 0.0 OUTLIER . 4.87 . . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 3' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.427 -0.789 0 C3'-C2'-C1' 100.199 -1.445 . 0.0 OUTLIER . 5.02 . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 4' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.427 -0.809 0 O4'-C1'-C2' 108.457 1.469 . 0.152 0i . 2.69 . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 5' ' ' ' U' . . . . . 0.758 ' C4 ' ' HA3' ' A' ' 113' ' ' GLY . . . . . . . . 0 O5'--C5' 1.426 -0.859 0 C3'-C2'-C1' 100.514 -1.096 . 0.0 OUTLIER . 1.93 . . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 6' ' ' ' G' . . . . . 0.651 ' H22' HG11 ' A' ' 65' ' ' VAL . . . . . . . . 0 O5'--C5' 1.425 -0.96 0 C4'-C3'-C2' 103.852 1.152 . 0.321 0b . 2.38 . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.427 -0.829 0 C4'-C3'-C2' 104.472 1.772 . 0.0 OUTLIER . 4.19 . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.639 0 N-CA-C 112.337 -0.305 . . . . 13.03 112.337 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.36 -38.15 27.1 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.04 0.448 . . . . 11.06 109.904 179.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 96.0 mmm -111.43 107.42 16.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.93 -0.577 . . . . 9.85 110.453 -179.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -118.09 -105.07 2.26 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.861 -0.685 . . . . 6.69 112.642 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.7 p -135.21 139.04 44.18 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 110.536 -0.172 . . . . 5.55 110.536 -178.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 50.8 mtm180 -94.87 -73.52 0.58 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.832 0.348 . . . . 3.87 111.24 -176.035 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 68.67 164.17 0.23 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.236 -0.893 . . . . 3.53 111.094 -175.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.492 ' HA ' ' OG1' ' A' ' 35' ' ' THR . 10.8 p -121.86 -28.13 4.53 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.675 0.621 . . . . 1.69 112.675 -177.095 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 55.5 ttp -59.01 -43.66 91.56 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 111.983 0.364 . . . . 1.49 111.983 -173.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -96.36 -6.21 38.15 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 120.771 -0.371 . . . . 1.5 111.793 -177.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.679 ' O ' ' HA ' ' A' ' 82' ' ' THR . 34.2 p -102.78 -5.05 24.08 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.746 0.307 . . . . 0.53 111.371 -176.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.612 ' HG3' ' HB3' ' A' ' 110' ' ' ALA . 18.4 tptm -92.67 101.49 13.9 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.274 0.559 . . . . 2.75 110.461 -175.297 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.429 HG22 HG23 ' A' ' 39' ' ' VAL . 32.8 mt -107.85 132.92 54.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.724 -0.671 . . . . 0.85 110.449 -177.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.568 ' HD1' ' CE1' ' A' ' 80' ' ' PHE . 88.4 t80 -99.84 116.09 31.11 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.033 -0.728 . . . . 0.71 109.033 173.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.649 HG22 HG22 ' A' ' 107' ' ' VAL . 95.7 t -132.31 106.22 10.55 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.886 0 CA-C-O 118.803 -0.618 . . . . 0.92 110.067 -178.202 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.888 ' HA3' ' HD1' ' A' ' 78' ' ' TYR . . . -122.82 -154.74 9.14 Favored Glycine 0 N--CA 1.44 -1.073 0 C-N-CA 115.979 -3.01 . . . . 0.84 113.267 159.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 85.62 8.02 80.93 Favored Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 110.265 -1.134 . . . . 0.68 110.265 -174.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.739 ' HB3' ' HB ' ' A' ' 46' ' ' THR . 5.7 mp -69.55 135.57 88.37 Favored Pre-proline 0 N--CA 1.45 -0.448 0 CA-C-N 114.989 -0.605 . . . . 1.28 109.899 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 1.009 ' HG2' ' HB3' ' A' ' 101' ' ' ASP . 53.8 Cg_exo -49.88 158.85 1.89 Allowed 'Trans proline' 0 N--CA 1.463 -0.291 0 C-N-CA 123.146 2.564 . . . . 0.58 112.128 174.419 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.421 ' CE2' ' C5 ' ' B' ' 2' ' ' ' G' . 51.7 m-85 -66.72 -9.61 38.22 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 113.439 0.903 . . . . 1.05 113.439 -171.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 1.7 p80 -111.71 0.76 16.4 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.124 -0.631 . . . . 2.01 110.77 176.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.739 ' HB ' ' HB3' ' A' ' 42' ' ' LEU . 5.8 m -79.53 118.52 21.46 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.504 -0.554 . . . . 0.72 109.504 176.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.432 ' HA ' HG21 ' A' ' 66' ' ' VAL . 6.2 p -123.93 -177.95 3.91 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.116 -0.493 . . . . 0.55 112.303 -168.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -54.19 -30.84 51.07 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 115.628 -0.715 . . . . 0.49 110.79 -178.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.544 ' O ' ' HG2' ' A' ' 53' ' ' GLU . 23.2 pttm -74.92 -34.3 62.11 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.653 -0.703 . . . . 2.76 109.842 -178.114 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.601 HG21 HG23 ' A' ' 46' ' ' THR . 6.1 m -67.12 -45.18 77.95 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 116.535 -0.302 . . . . 0.58 110.514 -178.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.71 HD21 HD21 ' A' ' 42' ' ' LEU . 39.2 mt -62.07 -46.95 86.83 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-O 120.994 0.426 . . . . 0.85 109.974 175.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.534 ' HA ' HD12 ' A' ' 61' ' ' ILE . 55.1 t-80 -55.95 -51.28 68.24 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 115.687 -0.688 . . . . 0.59 110.574 179.388 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.544 ' HG2' ' O ' ' A' ' 49' ' ' LYS . 21.5 mm-40 -65.25 -36.54 84.45 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 112.311 0.486 . . . . 1.52 112.311 -176.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.7 ' O ' ' HB2' ' A' ' 57' ' ' GLN . 25.7 t80 -77.79 -34.87 52.04 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 118.128 0.422 . . . . 1.12 111.594 -178.383 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.482 ' CD2' HG11 ' A' ' 81' ' ' VAL . 25.9 m-85 -84.91 -28.88 25.63 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 112.892 0.701 . . . . 0.56 112.892 -175.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.583 ' HA ' ' O ' ' A' ' 59' ' ' GLY . 34.4 mm-40 -57.36 -24.72 57.04 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-O 122.563 1.173 . . . . 1.57 109.413 174.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.7 ' HB2' ' O ' ' A' ' 54' ' ' TYR . 69.1 mt-30 -60.27 -31.68 70.46 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 112.971 -1.922 . . . . 2.16 112.27 176.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.451 ' HD2' ' HA ' ' A' ' 55' ' ' PHE . 86.5 m-85 -89.12 -27.21 20.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.329 0.585 . . . . 0.71 109.463 177.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.583 ' O ' ' HA ' ' A' ' 56' ' ' GLU . . . 162.47 -172.28 38.51 Favored Glycine 0 N--CA 1.443 -0.864 0 CA-C-N 115.006 -0.997 . . . . 0.75 111.697 177.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -64.73 126.26 27.37 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.707 0.289 . . . . 1.02 110.801 -177.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.534 HD12 ' HA ' ' A' ' 52' ' ' HIS . 8.2 mt -99.98 124.31 53.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.101 -0.703 . . . . 0.47 109.101 177.295 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -78.97 -41.94 28.0 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.009 0.433 . . . . 2.07 111.608 179.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.574 ' HB3' ' HB ' ' A' ' 82' ' ' THR . 8.7 tp10 -139.89 126.6 20.55 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.974 -0.557 . . . . 2.48 111.013 -172.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -127.89 125.84 40.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.679 0.752 . . . . 0.44 110.883 174.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.649 HG21 ' N2 ' ' B' ' 6' ' ' ' G' . 7.1 p -145.62 136.17 18.92 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 CA-C-N 114.546 -1.206 . . . . 1.38 113.057 -178.098 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.432 HG21 ' HA ' ' A' ' 47' ' ' SER . 75.2 t -102.18 124.9 56.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.296 -0.865 . . . . 0.49 108.855 167.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.548 HG12 ' HA2' ' A' ' 79' ' ' GLY . 35.2 mm -81.1 103.05 7.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.785 -0.643 . . . . 0.72 110.672 -174.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 17.0 p -92.99 172.83 8.06 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.326 -0.852 . . . . 1.52 110.638 176.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.469 ' HA ' ' NE ' ' A' ' 76' ' ' ARG . 30.6 t70 -71.74 126.8 30.63 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.823 -0.626 . . . . 2.49 111.039 -176.461 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.436 ' HG3' ' OD1' ' A' ' 71' ' ' ASN . 33.1 ptt180 -55.9 -32.33 63.64 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 112.813 0.671 . . . . 6.05 112.813 -177.385 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.436 ' OD1' ' HG3' ' A' ' 70' ' ' ARG . 4.4 m-20 -83.94 -54.21 5.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.991 0.424 . . . . 4.05 111.971 -176.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 32.7 p -109.63 -21.94 12.19 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.226 -0.443 . . . . 3.08 111.93 -171.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 63.3 mt-30 57.62 76.39 0.33 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 122.442 1.115 . . . . 3.3 111.418 -171.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 54.0 mttm -108.25 153.01 23.84 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 105.953 -1.869 . . . . 3.49 105.953 171.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 35.2 t -71.55 93.07 1.18 Allowed 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 120.138 -0.625 . . . . 1.81 110.479 -177.012 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.469 ' NE ' ' HA ' ' A' ' 69' ' ' ASP . 64.3 mtt180 -61.48 -11.74 11.99 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.503 -0.772 . . . . 2.56 111.52 173.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.683 ' HA3' ' H22' ' B' ' 2' ' ' ' G' . . . 78.5 11.14 85.59 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.97 -0.633 . . . . 0.64 112.714 176.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.888 ' HD1' ' HA3' ' A' ' 40' ' ' GLY . 29.9 m-85 -114.78 161.66 17.9 Favored 'General case' 0 CA--C 1.504 -0.821 0 N-CA-C 109.807 -0.442 . . . . 1.18 109.807 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.548 ' HA2' HG12 ' A' ' 67' ' ' ILE . . . -161.67 -166.92 21.33 Favored Glycine 0 N--CA 1.438 -1.185 0 C-N-CA 119.855 -1.164 . . . . 0.59 112.432 168.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.568 ' CE1' ' HD1' ' A' ' 38' ' ' PHE . 62.9 m-85 -135.95 132.98 37.12 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.018 -0.734 . . . . 0.63 109.018 179.124 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.482 HG11 ' CD2' ' A' ' 55' ' ' PHE . 41.1 t -119.94 109.96 27.61 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-O 121.392 0.615 . . . . 0.41 110.012 175.334 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.679 ' HA ' ' O ' ' A' ' 35' ' ' THR . 11.2 m -107.96 112.01 24.38 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 107.663 -1.236 . . . . 0.47 107.663 174.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.438 ' HA ' ' HA ' ' A' ' 61' ' ' ILE . 55.6 mtp -90.23 166.99 13.04 Favored 'General case' 0 N--CA 1.447 -0.586 0 O-C-N 121.412 -0.805 . . . . 0.88 109.162 -173.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 24.6 ttmm -79.44 -17.27 54.61 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.816 0.341 . . . . 1.92 110.945 -173.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -145.01 146.75 32.04 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.281 -0.418 . . . . 1.68 110.235 -179.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.828 ' HD3' ' H ' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -72.77 -22.11 60.9 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.91 0.707 . . . . 3.66 112.91 -174.096 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.432 ' O ' ' HG3' ' A' ' 91' ' ' ARG . . . -72.16 -37.45 69.36 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.054 0.454 . . . . 0.66 111.07 -178.002 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.535 ' OG ' ' HA3' ' A' ' 59' ' ' GLY . 21.1 m -72.64 -37.94 67.85 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.712 0.768 . . . . 0.78 109.666 174.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -57.78 -41.96 83.14 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.061 -1.427 . . . . 0.46 109.333 175.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -54.69 -48.53 72.32 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.042 -0.981 . . . . 2.11 111.507 171.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.49 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 96.7 mtt180 -59.98 -38.84 83.73 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.258 -0.428 . . . . 3.82 110.951 -179.4 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -59.12 -46.37 88.51 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.028 -0.533 . . . . 0.92 111.658 174.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 51.7 t -76.58 -8.76 57.86 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 111.707 0.262 . . . . 1.16 111.707 -178.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.49 ' HB2' ' O ' ' A' ' 91' ' ' ARG . 39.7 mmtm -58.03 -41.63 83.61 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.661 -0.245 . . . . 4.2 110.951 177.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -103.44 104.67 42.86 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 109.56 -0.533 . . . . 2.24 109.56 174.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.564 ' O ' ' HB2' ' A' ' 97' ' ' ASN . 39.8 Cg_endo -84.94 102.6 0.81 Allowed 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 122.631 2.221 . . . . 2.38 113.427 -174.11 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.565 ' ND2' ' H ' ' A' ' 107' ' ' VAL . 10.8 m120 89.03 54.66 0.03 OUTLIER Pre-proline 0 N--CA 1.476 0.862 0 CA-C-N 114.39 -1.277 . . . . 3.03 110.266 174.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.551 ' O ' HG13 ' A' ' 100' ' ' ILE . 90.1 Cg_endo -82.75 116.85 2.58 Favored 'Trans proline' 0 N--CA 1.45 -1.037 0 C-N-CA 121.49 1.46 . . . . 1.29 112.767 -177.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.98 ' HA ' ' HA ' ' A' ' 104' ' ' LYS . 1.2 mt -25.47 131.39 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.49 -0.777 . . . . 1.81 112.866 151.364 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.551 HG13 ' O ' ' A' ' 98' ' ' PRO . 61.0 mt -148.46 126.99 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 N-CA-C 106.151 -1.796 . . . . 0.99 106.151 -178.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 1.009 ' HB3' ' HG2' ' A' ' 43' ' ' PRO . 10.3 t0 65.06 41.18 4.72 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 122.245 1.021 . . . . 1.37 109.164 -178.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 70.27 -8.14 4.13 Favored Glycine 0 CA--C 1.529 0.921 0 CA-C-N 114.708 -1.133 . . . . 1.56 115.529 -179.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.666 ' CG ' ' HG3' ' A' ' 43' ' ' PRO . 34.8 mmt180 -117.5 134.27 55.04 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 119.317 1.559 . . . . 4.13 110.629 178.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.98 ' HA ' ' HA ' ' A' ' 99' ' ' ILE . 4.7 ttpm? -63.98 128.46 35.9 Favored 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 121.382 -0.127 . . . . 2.73 111.267 -177.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -100.16 152.52 20.16 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-O 120.956 0.408 . . . . 1.04 111.109 -177.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.524 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 9.0 t30 -102.2 124.69 48.23 Favored 'General case' 0 C--O 1.243 0.726 0 CA-C-N 116.179 -0.464 . . . . 2.04 109.905 177.27 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.649 HG22 HG22 ' A' ' 39' ' ' VAL . 94.7 t -139.37 128.44 28.92 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.125 0 O-C-N 124.842 1.339 . . . . 1.06 110.505 -164.296 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 33.5 p30 -160.25 157.36 28.02 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.388 -0.369 . . . . 2.49 110.011 171.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.581 ' HB3' ' CE1' ' A' ' 111' ' ' TYR . 3.5 mm? -67.01 101.11 0.81 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.202 0.525 . . . . 1.23 110.901 175.154 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.612 ' HB3' ' HG3' ' A' ' 36' ' ' LYS . . . -46.97 -24.11 0.56 Allowed 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 115.518 1.673 . . . . 0.91 115.518 -174.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.581 ' CE1' ' HB3' ' A' ' 109' ' ' LEU . 14.9 p90 -66.21 -9.21 29.93 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 118.163 0.438 . . . . 1.4 111.515 -175.185 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.431 ' HG ' ' O ' ' A' ' 109' ' ' LEU . 91.4 mt -61.88 -47.39 85.23 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.739 -0.21 . . . . 1.97 111.421 -179.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -113.33 28.36 8.73 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.809 -0.71 . . . . 2.14 111.969 178.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -84.46 135.4 34.26 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.616 0.246 . . . . 2.66 111.156 -175.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -134.72 71.85 69.87 Favored Pre-proline 0 C--N 1.324 -0.537 0 N-CA-C 109.294 -0.632 . . . . 4.16 109.294 170.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -81.03 9.94 3.61 Favored 'Trans proline' 0 C--N 1.348 0.5 0 C-N-CA 123.058 2.505 . . . . 5.53 111.766 -178.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 33.2 ttm180 173.76 -39.36 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.272 -1.331 . . . . 8.6 108.387 -177.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 11.8 t -172.6 176.16 3.29 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 114.995 -1.002 . . . . 6.37 109.685 -178.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -178.37 -57.61 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 O-C-N 124.188 0.93 . . . . 7.85 108.788 173.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 34.2 t 55.69 87.43 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.251 0 CA-C-N 115.354 -0.839 . . . . 9.37 111.986 176.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.411 ' O ' ' HG3' ' A' ' 121' ' ' GLN . 3.9 pt20 . . . . . 0 C--O 1.251 1.174 0 CA-C-O 119.078 -0.486 . . . . 12.28 110.431 178.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 1' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.43 -0.62 0 C3'-C2'-C1' 100.448 -1.169 . 0.0 '__' . 4.94 . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 2' ' ' ' G' . . . . . 0.683 ' H22' ' HA3' ' A' ' 77' ' ' GLY . . . . . . . . 0 O5'--C5' 1.427 -0.803 0 C4'-C3'-C2' 103.746 1.046 . 0.0 OUTLIER gamma 4.87 . . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 3' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.429 -0.695 0 P-O3'-C3' 120.709 0.841 . 0.0 OUTLIER gamma 5.02 . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 4' ' ' ' G' . . . . . 0.517 ' C8 ' ' HE2' ' A' ' 38' ' ' PHE . . . . . . . . 0 O5'--C5' 1.425 -0.954 0 O4'-C1'-C2' 108.033 1.166 . 0.0 OUTLIER . 2.69 . . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 5' ' ' ' U' . . . . . 0.454 ' H6 ' " O5'" ' B' ' 5' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.429 -0.692 0 C3'-C2'-C1' 100.499 -1.113 . 0.0 OUTLIER gamma 1.93 . . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 6' ' ' ' G' . . . . . 0.649 ' N2 ' HG21 ' A' ' 65' ' ' VAL . . . . . . . . 0 O5'--C5' 1.428 -0.758 0 C4'-C3'-C2' 104.189 1.489 . 0.0 OUTLIER gamma 2.38 . . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 7' ' ' ' C' . . . . . 0.408 ' OP1' ' C6 ' ' B' ' 7' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.428 -0.762 0 C3'-C2'-C1' 103.293 1.992 . 0.0 OUTLIER . 4.19 . . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.796 0 N-CA-C 112.369 -0.292 . . . . 13.03 112.369 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . 67.89 -78.04 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 123.38 0.672 . . . . 11.06 112.24 178.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 68.2 mtm -88.11 99.83 12.49 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.039 0.447 . . . . 9.85 110.517 -175.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 172.21 113.35 0.3 Allowed Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 120.908 -0.663 . . . . 6.69 112.175 179.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.3 p -80.38 110.64 16.02 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.017 0.437 . . . . 5.55 110.357 175.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 78.9 mtm180 -110.65 132.31 54.3 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.999 -0.546 . . . . 3.87 111.307 -175.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -73.25 85.57 1.42 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.101 -0.5 . . . . 3.53 110.694 174.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.584 ' HA ' ' OG1' ' A' ' 35' ' ' THR . 12.2 p -85.05 -17.91 36.01 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.855 -0.338 . . . . 1.69 111.154 177.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 50.8 ttp -62.13 -44.66 96.15 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.035 -0.529 . . . . 1.49 111.438 -178.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -98.77 6.54 46.84 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 111.705 0.261 . . . . 1.5 111.705 -178.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.751 ' O ' ' HA ' ' A' ' 82' ' ' THR . 43.1 p -114.51 17.08 17.54 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.264 0.554 . . . . 0.53 109.922 177.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.886 ' HG3' ' HB3' ' A' ' 110' ' ' ALA . 0.1 OUTLIER -113.85 103.43 11.18 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.14 -0.937 . . . . 2.75 110.354 -176.737 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.5 mp -110.26 131.32 61.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.904 -0.589 . . . . 0.85 111.036 -176.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.514 ' O ' ' HA ' ' A' ' 107' ' ' VAL . 69.4 t80 -91.3 113.09 25.26 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.264 -0.88 . . . . 0.71 109.002 176.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.637 HG22 HG22 ' A' ' 107' ' ' VAL . 84.7 t -132.93 102.59 5.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 118.194 -0.907 . . . . 0.92 110.273 -176.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.591 ' HA2' ' CD1' ' A' ' 42' ' ' LEU . . . -122.83 -154.84 9.17 Favored Glycine 0 C--O 1.221 -0.705 0 C-N-CA 115.937 -3.03 . . . . 0.84 113.629 163.119 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 84.07 4.32 88.47 Favored Glycine 0 N--CA 1.452 -0.299 0 N-CA-C 111.098 -0.801 . . . . 0.68 111.098 -175.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.82 ' HB3' ' HB ' ' A' ' 46' ' ' THR . 5.4 mp -64.96 137.51 97.18 Favored Pre-proline 0 N--CA 1.453 -0.282 0 CA-C-N 115.409 -0.395 . . . . 1.28 110.38 -178.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.569 ' HG2' ' HB3' ' A' ' 101' ' ' ASP . 52.7 Cg_exo -51.73 159.75 3.29 Favored 'Trans proline' 0 N--CA 1.463 -0.305 0 C-N-CA 123.198 2.599 . . . . 0.58 111.955 173.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -66.43 -12.43 57.1 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 112.401 0.519 . . . . 1.05 112.401 -175.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 46.3 t60 -92.0 -24.92 19.06 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.15 0.5 . . . . 2.01 109.986 174.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.82 ' HB ' ' HB3' ' A' ' 42' ' ' LEU . 4.4 m -72.71 118.32 15.49 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.876 -0.602 . . . . 0.72 109.849 -176.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 6.0 p -134.46 -175.64 3.94 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.617 -0.719 . . . . 0.55 111.176 -168.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -49.93 -34.87 21.88 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-O 121.424 0.631 . . . . 0.49 110.594 -177.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.701 ' O ' ' HG2' ' A' ' 53' ' ' GLU . 8.5 ptpp? -67.65 -43.88 79.25 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 114.893 -1.049 . . . . 2.76 109.887 -178.089 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.606 HG21 HG23 ' A' ' 46' ' ' THR . 6.7 m -66.34 -40.51 89.91 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.629 -0.259 . . . . 0.58 111.24 -176.085 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.668 HD21 HD21 ' A' ' 42' ' ' LEU . 22.8 mt -61.78 -46.86 87.73 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 109.882 -0.414 . . . . 0.85 109.882 175.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.532 ' HA ' HD12 ' A' ' 61' ' ' ILE . 45.9 t-80 -52.69 -51.55 59.82 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.417 -0.811 . . . . 0.59 110.218 174.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.701 ' HG2' ' O ' ' A' ' 49' ' ' LYS . 23.4 mm-40 -59.48 -48.18 82.65 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.106 -0.497 . . . . 1.52 112.316 -176.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.435 ' O ' ' HB2' ' A' ' 57' ' ' GLN . 47.4 t80 -76.53 -41.44 46.7 Favored 'General case' 0 C--O 1.227 -0.109 0 CA-C-O 121.051 0.453 . . . . 1.12 111.495 -171.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.774 ' HB2' HD11 ' A' ' 61' ' ' ILE . 45.8 m-85 -84.16 -30.38 25.9 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 113.063 0.764 . . . . 0.56 113.063 -170.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.603 ' HA ' ' O ' ' A' ' 59' ' ' GLY . 16.6 pt-20 -67.45 -14.58 63.06 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 122.109 0.957 . . . . 1.57 110.113 -178.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.435 ' HB2' ' O ' ' A' ' 54' ' ' TYR . 13.6 mm100 -57.11 -26.3 60.23 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 114.082 -1.417 . . . . 2.16 112.063 172.167 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -93.12 -25.2 17.99 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.223 0.535 . . . . 0.71 110.055 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.603 ' O ' ' HA ' ' A' ' 56' ' ' GLU . . . 170.96 174.66 38.97 Favored Glycine 0 N--CA 1.447 -0.606 0 N-CA-C 110.386 -1.086 . . . . 0.75 110.386 -179.22 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 61.1 m-20 -67.9 125.14 25.36 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 117.492 0.646 . . . . 1.02 110.819 -173.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.774 HD11 ' HB2' ' A' ' 55' ' ' PHE . 29.8 mt -89.04 118.63 34.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.335 -0.393 . . . . 0.47 110.309 178.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.437 ' HB2' ' HG3' ' A' ' 84' ' ' LYS . 24.9 tt0 -75.7 -33.0 60.32 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.145 0.424 . . . . 2.07 112.145 -179.269 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -157.15 133.3 9.64 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.651 -0.42 . . . . 2.48 111.531 -178.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -125.3 130.08 51.28 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.643 -0.708 . . . . 0.44 110.928 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.834 HG21 ' H22' ' B' ' 6' ' ' ' G' . 20.6 t -135.54 136.19 50.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 114.527 -1.215 . . . . 1.38 111.927 -177.328 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 56.0 t -118.58 117.72 55.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 108.703 -0.851 . . . . 0.49 108.703 162.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 35.3 mm -77.06 111.81 14.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 115.293 -0.867 . . . . 0.72 111.111 -171.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 21.4 p -91.83 164.24 13.76 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.551 -0.75 . . . . 1.52 110.911 176.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.475 ' OD2' ' HB2' ' A' ' 71' ' ' ASN . 5.2 t70 -68.89 133.22 47.95 Favored 'General case' 0 C--O 1.217 -0.61 0 CA-C-N 116.151 -0.477 . . . . 2.49 111.59 -175.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.67 ' HD3' ' H ' ' A' ' 70' ' ' ARG . 0.8 OUTLIER -54.13 -41.6 68.57 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.063 -0.517 . . . . 6.05 111.286 179.548 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.475 ' HB2' ' OD2' ' A' ' 69' ' ' ASP . 35.2 m-80 -70.65 -59.63 2.72 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.76 0.652 . . . . 4.05 112.76 -176.218 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.485 ' OG1' ' HE2' ' A' ' 74' ' ' LYS . 41.4 p -115.73 -23.44 8.68 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.36 0.504 . . . . 3.08 112.36 -171.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.448 ' HA ' ' N ' ' A' ' 69' ' ' ASP . 42.2 mt-30 69.58 15.2 8.23 Favored 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 123.689 0.796 . . . . 3.3 112.606 -176.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.485 ' HE2' ' OG1' ' A' ' 72' ' ' THR . 46.9 mtmt -54.27 120.01 5.94 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 108.268 -1.012 . . . . 3.49 108.268 165.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 17.0 m -50.17 104.63 0.07 Allowed 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 112.806 0.669 . . . . 1.81 112.806 -168.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.446 ' HB3' ' CD2' ' A' ' 78' ' ' TYR . 21.7 mtp180 -61.19 -25.09 66.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.003 -0.999 . . . . 2.56 111.964 177.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.466 ' HA3' ' H22' ' B' ' 2' ' ' ' G' . . . 80.58 23.51 60.21 Favored Glycine 0 C--O 1.225 -0.467 0 C-N-CA 120.491 -0.861 . . . . 0.64 112.52 179.216 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.446 ' CD2' ' HB3' ' A' ' 76' ' ' ARG . 21.7 m-85 -120.07 138.91 53.26 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.113 -1.069 . . . . 1.18 108.113 176.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -141.88 -177.77 17.34 Favored Glycine 0 N--CA 1.441 -0.972 0 C-N-CA 119.076 -1.535 . . . . 0.59 113.508 178.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.45 ' CE1' ' HD1' ' A' ' 38' ' ' PHE . 61.3 m-85 -138.65 125.93 21.6 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 123.179 0.592 . . . . 0.63 109.445 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.474 HG23 HD13 ' A' ' 51' ' ' LEU . 42.8 t -113.33 114.51 47.09 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-O 121.03 0.443 . . . . 0.41 110.57 178.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.751 ' HA ' ' O ' ' A' ' 35' ' ' THR . 8.4 m -106.36 125.23 50.73 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.025 -1.102 . . . . 0.47 108.025 171.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 81.3 mtp -110.76 166.49 10.98 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 107.987 -1.116 . . . . 0.88 107.987 -172.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.437 ' HG3' ' HB2' ' A' ' 62' ' ' GLU . 3.4 mttm -83.53 -8.72 59.29 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 112.704 0.631 . . . . 1.92 112.704 -172.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.441 ' OD1' ' HD2' ' A' ' 86' ' ' ARG . 9.6 t70 -145.36 146.52 31.62 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 109.908 -0.404 . . . . 1.68 109.908 174.632 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.441 ' HD2' ' OD1' ' A' ' 85' ' ' ASP . 0.8 OUTLIER -73.84 -23.26 59.61 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 111.592 0.219 . . . . 3.66 111.592 -176.524 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -63.04 -50.3 71.19 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.03 0.443 . . . . 0.66 110.42 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 13.2 m -67.57 -35.89 79.88 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.953 -0.567 . . . . 0.78 109.933 176.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.41 ' HB3' ' HA ' ' A' ' 86' ' ' ARG . . . -57.15 -45.83 83.27 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 114.789 -1.096 . . . . 0.46 110.651 176.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -56.5 -42.49 78.43 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.198 -0.455 . . . . 2.11 111.521 172.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.738 ' O ' ' HG3' ' A' ' 94' ' ' LYS . 12.9 mmt180 -68.11 -31.81 71.66 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.969 -0.56 . . . . 3.82 110.83 -179.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -61.39 -38.33 86.67 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.603 -0.271 . . . . 0.92 111.651 171.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 37.0 t -86.58 -20.08 28.45 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 112.961 0.726 . . . . 1.16 112.961 -173.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.738 ' HG3' ' O ' ' A' ' 91' ' ' ARG . 0.0 OUTLIER -51.54 -19.44 1.47 Allowed 'General case' 0 N--CA 1.479 1.009 0 N-CA-C 112.959 0.726 . . . . 4.2 112.959 177.337 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.686 ' N ' ' HD3' ' A' ' 94' ' ' LYS . 24.5 t0 -112.03 103.96 55.66 Favored Pre-proline 0 C--N 1.325 -0.491 0 N-CA-C 108.788 -0.819 . . . . 2.24 108.788 168.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 95' ' ' ASP . 3.6 Cg_exo -80.42 -13.32 12.3 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 123.241 2.628 . . . . 2.38 113.503 -172.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 52.7 m-80 -148.75 53.55 1.44 Allowed Pre-proline 0 C--O 1.236 0.38 0 O-C-N 122.383 -0.198 . . . . 3.03 111.278 -176.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.54 ' O ' HG13 ' A' ' 100' ' ' ILE . 72.4 Cg_endo -82.81 113.14 2.17 Favored 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 120.739 0.959 . . . . 1.29 113.13 -175.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.441 HD13 ' CA ' ' A' ' 104' ' ' LYS . 12.7 mm -24.14 124.85 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-N 116.033 -0.53 . . . . 1.81 111.979 149.098 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.54 HG13 ' O ' ' A' ' 98' ' ' PRO . 75.2 mt -145.14 119.68 3.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 105.961 -1.866 . . . . 0.99 105.961 179.2 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.569 ' HB3' ' HG2' ' A' ' 43' ' ' PRO . 27.5 t0 55.21 50.64 14.69 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 122.637 1.208 . . . . 1.37 109.783 -174.443 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 71.42 -8.17 5.66 Favored Glycine 0 CA--C 1.53 1.006 0 N-CA-C 117.22 1.648 . . . . 1.56 117.22 176.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.497 ' HB2' ' HG3' ' A' ' 43' ' ' PRO . 2.0 mmm180 -116.22 142.07 47.31 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 120.59 2.195 . . . . 4.13 111.83 176.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.441 ' CA ' HD13 ' A' ' 99' ' ' ILE . 41.1 ttmt -64.64 124.08 20.96 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.896 -0.593 . . . . 2.73 110.57 176.432 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -102.0 162.17 13.12 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.431 -0.349 . . . . 1.04 110.5 178.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.587 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 39.7 t-20 -114.78 127.79 55.93 Favored 'General case' 0 C--O 1.248 0.986 0 N-CA-C 109.48 -0.563 . . . . 2.04 109.48 179.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.637 HG22 HG22 ' A' ' 39' ' ' VAL . 88.3 t -138.85 123.19 20.66 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 O-C-N 125.056 1.473 . . . . 1.06 111.065 -163.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -156.62 151.97 26.59 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.324 -0.621 . . . . 2.49 109.324 175.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.524 ' HB3' ' CE1' ' A' ' 111' ' ' TYR . 1.3 mm? -57.37 96.28 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.063 0.459 . . . . 1.23 111.238 176.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.886 ' HB3' ' HG3' ' A' ' 36' ' ' LYS . . . -45.19 -33.16 2.16 Favored 'General case' 0 C--O 1.224 -0.245 0 N-CA-C 115.654 1.724 . . . . 0.91 115.654 -176.378 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.524 ' CE1' ' HB3' ' A' ' 109' ' ' LEU . 9.1 p90 -55.96 -14.82 2.75 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 112.662 0.615 . . . . 1.4 112.662 -169.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 60.3 mt -62.28 -47.28 85.03 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-O 120.878 0.37 . . . . 1.97 110.444 175.179 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -102.34 -28.67 6.32 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 120.959 -0.638 . . . . 2.14 112.524 173.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -76.1 123.45 25.82 Favored 'General case' 0 CA--C 1.513 -0.469 0 N-CA-C 109.623 -0.51 . . . . 2.66 109.623 179.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -134.67 100.69 12.16 Favored Pre-proline 0 C--N 1.316 -0.866 0 CA-C-N 116.023 -0.535 . . . . 4.16 110.317 -172.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -77.15 15.25 1.19 Allowed 'Trans proline' 0 C--O 1.234 0.291 0 C-N-CA 123.16 2.573 . . . . 5.53 113.198 -176.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 16.6 tpt180 -176.78 -78.75 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.845 -0.616 . . . . 8.6 109.957 178.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 13.9 t -156.19 23.74 0.36 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 122.41 1.1 . . . . 6.37 108.275 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -70.83 104.18 2.83 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.375 -1.284 . . . . 7.85 112.362 -168.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 57.3 t -107.35 -50.2 7.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 107.691 -1.226 . . . . 9.37 107.691 165.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 19.8 tt0 . . . . . 0 C--O 1.245 0.834 0 CA-C-N 114.558 -1.201 . . . . 12.28 108.528 171.756 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 1' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.43 -0.629 0 C4'-C3'-C2' 104.046 1.346 . 0.0 '__' . 4.94 . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 2' ' ' ' G' . . . . . 0.466 ' H22' ' HA3' ' A' ' 77' ' ' GLY . . . . . . . . 0 O5'--C5' 1.424 -0.991 0 C3'-C2'-C1' 99.041 -2.732 . 0.0 OUTLIER . 4.87 . . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 3' ' ' ' U' . . . . . 0.445 ' P ' " O2'" ' B' ' 2' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.426 -0.85 0 O4'-C1'-N19 109.951 1.751 . 0.0 OUTLIER . 5.02 . . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 4' ' ' ' G' . . . . . 0.839 " H3'" ' N3 ' ' B' ' 4' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.427 -0.836 0 P-O3'-C3' 120.978 1.065 . 0.0 OUTLIER . 2.69 . . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 5' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.426 -0.869 0 C4'-C3'-C2' 104.544 1.844 . 0.0 OUTLIER gamma 1.93 . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 6' ' ' ' G' . . . . . 0.834 ' H22' HG21 ' A' ' 65' ' ' VAL . . . . . . . . 0 O5'--C5' 1.425 -0.931 0 C3'-C2'-C1' 100.836 -0.738 . 0.369 4b . 2.38 . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 C2'--C1' 1.536 0.759 0 O4'-C1'-C2' 108.031 1.165 . 0.0 OUTLIER . 4.19 . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.762 0 N-CA-C 111.625 -0.59 . . . . 13.03 111.625 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -86.23 132.62 33.96 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.815 0.341 . . . . 11.06 110.58 178.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 44.3 ttm -111.34 134.86 52.62 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.233 -0.439 . . . . 9.85 111.008 -177.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 167.48 155.2 9.04 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.952 -0.642 . . . . 6.69 112.468 177.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 8.6 m -87.37 -5.53 58.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.085 0.469 . . . . 5.55 110.55 177.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 64.2 mtm180 -94.92 139.46 31.29 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.769 -0.65 . . . . 3.87 110.695 -175.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.408 ' OD2' ' HB3' ' A' ' 33' ' ' MET . 29.0 t70 -88.84 108.68 19.65 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 110.116 -0.327 . . . . 3.53 110.116 176.105 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.663 ' O ' ' HB2' ' A' ' 36' ' ' LYS . 18.7 p -90.51 8.34 34.39 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.744 0.307 . . . . 1.69 111.685 -178.412 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . 0.408 ' HB3' ' OD2' ' A' ' 31' ' ' ASP . 49.3 ttp -73.9 -71.45 0.33 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.38 0.61 . . . . 1.49 110.418 171.385 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.409 ' C ' ' H ' ' A' ' 36' ' ' LYS . 21.4 m-85 -52.68 -71.62 0.07 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.716 -1.129 . . . . 1.5 111.575 176.492 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.617 ' HB ' ' O ' ' A' ' 83' ' ' MET . 34.5 p -53.26 18.17 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 116.542 2.053 . . . . 0.53 116.542 178.339 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.663 ' HB2' ' O ' ' A' ' 32' ' ' THR . 41.8 tptt -116.32 113.16 22.57 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 119.52 1.055 . . . . 2.75 111.205 -178.268 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.426 HD11 ' HA ' ' A' ' 89' ' ' ALA . 84.8 mt -103.06 131.15 52.0 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-N 115.147 -0.933 . . . . 0.85 110.681 -179.378 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.494 ' HB2' ' HA ' ' A' ' 110' ' ' ALA . 70.2 t80 -91.92 119.74 31.96 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 109.102 -0.703 . . . . 0.71 109.102 175.336 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.676 HG12 HD11 ' A' ' 42' ' ' LEU . 3.9 t -102.31 135.32 39.89 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 N-CA-C 108.315 -0.995 . . . . 0.92 108.315 -179.351 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -141.72 153.79 24.38 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.291 -0.957 . . . . 0.84 112.093 -169.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 70.21 34.96 69.86 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.705 -0.76 . . . . 0.68 112.518 176.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.676 HD11 HG12 ' A' ' 39' ' ' VAL . 7.2 mp -75.08 142.93 76.54 Favored Pre-proline 0 C--N 1.328 -0.35 0 N-CA-C 109.88 -0.415 . . . . 1.28 109.88 178.058 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.477 ' HG3' ' HB3' ' A' ' 103' ' ' ARG . 28.0 Cg_endo -68.63 158.61 57.03 Favored 'Trans proline' 0 N--CA 1.451 -1.016 0 C-N-CA 121.862 1.708 . . . . 0.58 110.736 173.659 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.517 ' HD1' ' OG ' ' A' ' 75' ' ' SER . 59.7 m-85 -64.96 0.15 1.33 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.771 0.656 . . . . 1.05 112.771 -173.256 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 84.3 t60 -110.37 -6.44 14.98 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.695 0.283 . . . . 2.01 111.441 -178.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.647 ' CG2' HD23 ' A' ' 42' ' ' LEU . 25.7 m -77.75 137.88 38.71 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.611 -0.436 . . . . 0.72 111.094 -179.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 10.4 p -131.73 -177.58 4.49 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.777 -0.647 . . . . 0.55 109.961 -179.005 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.404 ' OD2' ' HA ' ' A' ' 65' ' ' VAL . 1.8 m-20 -61.5 -49.4 76.92 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 122.165 0.983 . . . . 0.49 108.871 -175.503 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.726 ' O ' ' HG2' ' A' ' 53' ' ' GLU . 22.9 pttm -53.1 -33.78 53.73 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 113.229 -1.805 . . . . 2.76 111.13 175.333 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 5.0 m -68.11 -44.6 75.8 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.028 0.442 . . . . 0.58 110.193 178.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.534 HD21 HG11 ' A' ' 39' ' ' VAL . 33.3 mt -62.97 -44.48 95.93 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-N 115.985 -0.552 . . . . 0.85 110.48 176.492 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.662 ' O ' ' HB2' ' A' ' 56' ' ' GLU . 45.2 t-80 -56.29 -37.24 69.61 Favored 'General case' 0 C--O 1.216 -0.679 0 CA-C-N 116.096 -0.502 . . . . 0.59 110.641 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.726 ' HG2' ' O ' ' A' ' 49' ' ' LYS . 25.8 mm-40 -74.15 -40.44 62.59 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 116.311 -0.404 . . . . 1.52 111.781 -174.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.485 ' O ' ' HB2' ' A' ' 57' ' ' GLN . 2.9 t80 -77.66 -33.7 53.33 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.782 0.801 . . . . 1.12 110.293 -177.215 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.675 ' HB2' HD11 ' A' ' 61' ' ' ILE . 40.4 m-85 -85.89 -25.82 25.95 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.013 -0.994 . . . . 0.56 111.423 -174.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.662 ' HB2' ' O ' ' A' ' 52' ' ' HIS . 3.2 tp10 -62.09 -4.4 1.67 Allowed 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 122.266 1.031 . . . . 1.57 110.428 174.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.485 ' HB2' ' O ' ' A' ' 54' ' ' TYR . 82.5 mt-30 -88.51 -30.7 19.15 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 114.251 -1.34 . . . . 2.16 110.431 -177.248 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.583 ' CG ' ' HA ' ' A' ' 92' ' ' ALA . 68.4 m-85 -90.75 -8.91 48.49 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.997 -1.001 . . . . 0.71 110.662 -175.276 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 142.83 174.33 15.12 Favored Glycine 0 N--CA 1.441 -1.015 0 N-CA-C 111.139 -0.785 . . . . 0.75 111.139 -179.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.682 ' HB3' ' HD2' ' A' ' 84' ' ' LYS . 3.0 m-20 -49.23 121.82 5.33 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.319 0.581 . . . . 1.02 111.798 176.314 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.675 HD11 ' HB2' ' A' ' 55' ' ' PHE . 85.0 mt -91.59 144.7 8.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 107.059 -1.46 . . . . 0.47 107.059 171.609 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -94.71 -45.09 7.5 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 119.054 0.843 . . . . 2.07 108.872 179.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -154.01 123.91 6.79 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.358 -0.837 . . . . 2.48 109.866 176.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -112.47 127.9 56.18 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.789 0.328 . . . . 0.44 110.741 175.027 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.404 ' HA ' ' OD2' ' A' ' 48' ' ' ASP . 8.1 p -144.52 137.75 22.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.636 -0.711 . . . . 1.38 111.74 -175.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.532 HG12 HG23 ' A' ' 68' ' ' THR . 54.6 t -104.62 117.31 50.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 108.681 -0.859 . . . . 0.49 108.681 172.153 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.619 ' O ' ' HD3' ' A' ' 76' ' ' ARG . 47.7 mm -76.88 72.38 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 122.084 0.945 . . . . 0.72 111.235 -173.348 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.594 HG22 ' HA ' ' A' ' 75' ' ' SER . 38.5 p -101.78 160.22 14.66 Favored 'General case' 0 N--CA 1.433 -1.315 0 CA-C-N 114.627 -1.17 . . . . 1.52 109.757 164.33 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.486 ' N ' ' HA ' ' A' ' 73' ' ' GLN . 9.9 t70 -73.26 111.22 8.18 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.371 -0.377 . . . . 2.49 111.006 -176.5 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.444 ' HD3' HH11 ' A' ' 70' ' ' ARG . 2.1 ptp180 -52.09 -10.67 0.13 Allowed 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 114.632 1.345 . . . . 6.05 114.632 -179.273 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -93.07 -42.87 9.17 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 121.634 -0.666 . . . . 4.05 112.172 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 19.6 p -135.17 -24.59 1.42 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.864 0.84 . . . . 3.08 110.143 -175.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.486 ' HA ' ' N ' ' A' ' 69' ' ' ASP . 92.4 mt-30 69.45 -86.0 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 113.589 -1.641 . . . . 3.3 111.479 -173.045 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 32.3 mtmm 63.04 67.31 0.69 Allowed 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 105.317 -2.105 . . . . 3.49 105.317 -171.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.594 ' HA ' HG22 ' A' ' 68' ' ' THR . 5.6 p -42.99 121.99 2.28 Favored 'General case' 0 CA--C 1.52 -0.197 0 O-C-N 124.581 1.176 . . . . 1.81 112.218 -160.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.619 ' HD3' ' O ' ' A' ' 67' ' ' ILE . 41.1 mtp180 -87.3 1.35 53.49 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 113.937 -1.483 . . . . 2.56 111.064 -168.736 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 69.64 14.58 70.0 Favored Glycine 0 N--CA 1.447 -0.626 0 CA-C-N 115.785 -0.643 . . . . 0.64 113.084 177.078 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.485 ' O ' HG13 ' A' ' 66' ' ' VAL . 13.8 m-85 -118.68 156.1 29.87 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 116.879 0.339 . . . . 1.18 110.979 -177.185 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -148.2 179.16 25.28 Favored Glycine 0 N--CA 1.444 -0.808 0 CA-C-N 115.967 -0.56 . . . . 0.59 111.792 173.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.428 ' CE1' ' HD1' ' A' ' 38' ' ' PHE . 41.3 m-85 -156.04 123.71 5.56 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 123.604 0.762 . . . . 0.63 109.488 -179.444 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 70.4 t -120.95 127.04 75.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-O 120.811 0.339 . . . . 0.41 110.433 -178.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 13.4 m -104.06 114.85 29.38 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.883 -0.784 . . . . 0.47 108.883 177.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.617 ' O ' ' HB ' ' A' ' 35' ' ' THR . 93.0 mmm -90.68 133.1 35.39 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 120.9 -0.32 . . . . 0.88 110.719 -178.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.682 ' HD2' ' HB3' ' A' ' 60' ' ' ASP . 46.9 mttm -51.04 -6.24 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.592 0 N-CA-C 114.614 1.339 . . . . 1.92 114.614 174.136 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -160.46 155.49 24.49 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.774 -0.454 . . . . 1.68 109.774 174.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.618 ' HD3' ' H ' ' A' ' 86' ' ' ARG . 0.0 OUTLIER -75.41 -33.02 60.93 Favored 'General case' 0 C--O 1.224 -0.242 0 N-CA-C 108.279 -1.008 . . . . 3.66 108.279 179.49 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -47.71 -48.63 29.38 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.391 -1.277 . . . . 0.66 110.126 168.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 19.7 m -69.33 -27.97 65.83 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.166 -0.47 . . . . 0.78 111.326 179.161 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.426 ' HA ' HD11 ' A' ' 37' ' ' ILE . . . -70.19 -50.13 43.26 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.209 -0.451 . . . . 0.46 110.482 177.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -55.49 -32.48 62.87 Favored 'General case' 0 C--O 1.222 -0.384 0 CA-C-N 116.101 -0.499 . . . . 2.11 110.732 172.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.597 ' O ' ' HG3' ' A' ' 94' ' ' LYS . 13.4 mtp180 -70.33 -51.42 30.23 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.859 -1.064 . . . . 3.82 110.723 179.522 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.583 ' HA ' ' CG ' ' A' ' 58' ' ' PHE . . . -56.06 -46.72 78.85 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 113.992 1.108 . . . . 0.92 113.992 171.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 48.9 t -74.57 -42.47 58.69 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 120.974 -0.291 . . . . 1.16 111.531 -172.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.597 ' HG3' ' O ' ' A' ' 91' ' ' ARG . 1.2 pptp? -49.57 -9.77 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 113.105 0.78 . . . . 4.2 113.105 173.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -101.8 90.92 2.07 Favored Pre-proline 0 CA--C 1.534 0.343 0 N-CA-C 108.589 -0.893 . . . . 2.24 108.589 162.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.481 ' HD3' ' O ' ' A' ' 94' ' ' LYS . 2.9 Cg_exo -76.18 111.97 3.38 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.979 2.453 . . . . 2.38 113.016 -170.653 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.421 ' HB2' ' O ' ' A' ' 96' ' ' PRO . 92.7 m-20 79.23 69.65 0.17 Allowed Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 114.527 -1.215 . . . . 3.03 110.111 175.349 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.448 ' HB2' ' CE1' ' A' ' 54' ' ' TYR . 72.7 Cg_endo -76.23 146.42 28.39 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.534 2.156 . . . . 1.29 111.065 178.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.558 HG22 ' C ' ' A' ' 102' ' ' GLY . 14.6 mm -88.33 92.41 3.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 O-C-N 122.155 -0.341 . . . . 1.81 110.24 -172.7 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.488 ' C ' ' H ' ' A' ' 102' ' ' GLY . 15.9 mt -92.05 151.24 3.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-O 121.548 0.69 . . . . 0.99 112.279 -174.307 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 25.3 t0 35.02 17.83 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 CA-C-N 114.489 -1.232 . . . . 1.37 112.872 -152.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.558 ' C ' HG22 ' A' ' 99' ' ' ILE . . . 89.48 19.82 47.43 Favored Glycine 0 CA--C 1.529 0.929 0 CA-C-N 115.757 -0.656 . . . . 1.56 111.674 178.722 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.477 ' HB3' ' HG3' ' A' ' 43' ' ' PRO . 31.9 tpt180 -127.82 135.73 50.48 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.747 0.819 . . . . 4.13 108.989 174.033 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.421 ' HA ' ' HA ' ' A' ' 99' ' ' ILE . 33.9 ttpt -58.0 114.92 2.56 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 112.461 0.541 . . . . 2.73 112.461 -174.327 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -99.67 164.66 11.96 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.186 -0.915 . . . . 1.04 110.225 177.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 37.8 t30 -107.93 131.7 54.26 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.454 -0.339 . . . . 2.04 110.154 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 41.1 t -122.38 129.12 75.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.32 0.581 . . . . 1.06 112.003 -179.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -150.01 158.08 43.8 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.084 -0.962 . . . . 2.49 108.405 175.161 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.752 HD23 ' CE1' ' A' ' 111' ' ' TYR . 1.0 OUTLIER -73.24 124.67 26.11 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 121.594 -0.691 . . . . 1.23 111.461 -177.029 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.494 ' HA ' ' HB2' ' A' ' 38' ' ' PHE . . . -47.23 -47.3 24.61 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 114.375 -1.284 . . . . 0.91 113.026 -179.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.752 ' CE1' HD23 ' A' ' 109' ' ' LEU . 0.8 OUTLIER -74.55 -21.16 59.65 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.571 0.701 . . . . 1.4 110.055 -178.257 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -83.99 -45.06 13.53 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.035 -0.984 . . . . 1.97 109.607 -173.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.51 ' HA3' ' C4 ' ' B' ' 5' ' ' ' U' . . . -89.28 17.6 50.75 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.601 -0.809 . . . . 2.14 112.246 174.324 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.479 ' O ' ' HE3' ' A' ' 115' ' ' LYS . . . -64.34 162.05 15.66 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-O 120.553 0.216 . . . . 2.66 110.798 176.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.479 ' HE3' ' O ' ' A' ' 114' ' ' ALA . 0.0 OUTLIER 74.4 92.2 0.05 OUTLIER Pre-proline 0 N--CA 1.464 0.247 0 C-N-CA 123.508 0.723 . . . . 4.16 110.648 -179.222 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.656 ' HG3' " H3'" ' B' ' 5' ' ' ' U' . 1.9 Cg_endo -80.54 23.34 0.71 Allowed 'Trans proline' 0 C--O 1.235 0.34 0 C-N-CA 123.555 2.837 . . . . 5.53 111.889 -179.553 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 66.2 ttt180 -134.95 -46.6 0.72 Allowed 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.192 -0.913 . . . . 8.6 110.272 -178.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 2.4 t -134.57 92.41 2.9 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-O 121.739 0.78 . . . . 6.37 110.999 -178.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -108.51 137.7 46.02 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.327 -0.851 . . . . 7.85 108.857 176.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 4.1 t -100.48 14.56 5.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.207 0.527 . . . . 9.37 111.116 -171.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 27.8 mm-40 . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.478 -0.772 . . . . 12.28 110.757 -178.474 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 1' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.431 -0.564 0 C3'-C2'-C1' 100.403 -1.218 . 0.0 '__' . 4.94 . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 2' ' ' ' G' . . . . . 0.472 ' C5 ' ' CE1' ' A' ' 44' ' ' TYR . . . . . . . . 0 O5'--C5' 1.426 -0.877 0 C3'-C2'-C1' 100.092 -1.565 . 0.0 OUTLIER . 4.87 . . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 3' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.426 -0.855 0 C4'-C3'-C2' 104.069 1.369 . 0.0 OUTLIER . 5.02 . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 4' ' ' ' G' . . . . . 0.676 " H3'" ' N3 ' ' B' ' 4' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.425 -0.955 0 O4'-C1'-C2' 107.948 1.106 . 0.0 OUTLIER . 2.69 . . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 5' ' ' ' U' . . . . . 0.656 " H3'" ' HG3' ' A' ' 116' ' ' PRO . . . . . . . . 0 O5'--C5' 1.427 -0.812 0 C3'-C2'-C1' 100.28 -1.355 . 0.438 1b . 1.93 . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 6' ' ' ' G' . . . . . 0.882 " O2'" " H5'" ' B' ' 7' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.428 -0.751 0 C4'-C3'-C2' 103.483 0.783 . 0.011 0b . 2.38 . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 7' ' ' ' C' . . . . . 0.882 " H5'" " O2'" ' B' ' 6' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.431 -0.542 0 P-O5'-C5' 123.45 1.593 . 0.0 OUTLIER . 4.19 . . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.883 0 N-CA-C 112.603 -0.199 . . . . 13.03 112.603 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -90.32 114.31 26.35 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 122.568 -0.372 . . . . 11.06 111.11 -177.247 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 22.6 mmt 64.17 87.57 0.11 Allowed 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.305 -0.861 . . . . 9.85 111.557 176.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -82.45 117.75 4.48 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.811 -0.709 . . . . 6.69 111.669 177.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 23.6 m -113.42 127.98 56.3 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.868 0.366 . . . . 5.55 110.713 -177.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.486 ' HG3' HG23 ' A' ' 32' ' ' THR . 17.7 ptp180 -103.68 19.06 20.56 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.208 0.527 . . . . 3.87 110.073 178.312 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 58.81 48.88 10.66 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 114.736 -1.12 . . . . 3.53 111.86 178.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.625 ' O ' ' HB2' ' A' ' 36' ' ' LYS . 9.6 p -65.01 -13.79 58.74 Favored 'General case' 0 C--O 1.221 -0.439 0 CA-C-N 115.761 -0.654 . . . . 1.69 111.009 175.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 12.5 tmm? -62.18 -29.27 70.25 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.526 -0.307 . . . . 1.49 110.963 175.322 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -98.1 -46.43 5.87 Favored 'General case' 0 CA--C 1.527 0.077 0 O-C-N 122.225 -0.297 . . . . 1.5 111.312 177.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.609 ' OG1' ' HA ' ' A' ' 32' ' ' THR . 63.3 p -68.78 1.63 3.16 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 113.755 1.021 . . . . 0.53 113.755 -176.162 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.625 ' HB2' ' O ' ' A' ' 32' ' ' THR . 58.0 tttt -97.99 107.9 20.49 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.995 0.426 . . . . 2.75 110.117 -175.477 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.459 HD11 ' HA ' ' A' ' 89' ' ' ALA . 47.1 mt -109.38 136.3 45.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.781 -0.645 . . . . 0.85 111.148 -175.382 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 58.9 t80 -101.25 118.41 36.93 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.878 -0.601 . . . . 0.71 109.698 174.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.816 HG13 HG22 ' A' ' 107' ' ' VAL . 30.3 t -133.75 110.63 14.55 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.848 0 CA-C-O 117.85 -1.071 . . . . 0.92 110.977 -177.182 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.42 ' HA2' ' CD2' ' A' ' 42' ' ' LEU . . . -116.68 -156.76 10.73 Favored Glycine 0 CA--C 1.503 -0.706 1 C-N-CA 112.341 -4.742 . . . . 0.84 114.835 156.049 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.488 ' HA3' ' HA ' ' A' ' 105' ' ' ALA . . . 92.42 5.07 65.58 Favored Glycine 0 N--CA 1.442 -0.903 0 N-CA-C 110.211 -1.156 . . . . 0.68 110.211 -171.466 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.67 HD11 HD21 ' A' ' 51' ' ' LEU . 3.0 mm? -71.99 121.4 84.5 Favored Pre-proline 0 N--CA 1.45 -0.44 0 CA-C-N 115.06 -0.57 . . . . 1.28 109.931 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.79 ' HG3' ' HD3' ' A' ' 103' ' ' ARG . 88.8 Cg_exo -48.21 160.01 0.61 Allowed 'Trans proline' 0 CA--C 1.529 0.274 0 C-N-CA 124.198 3.266 . . . . 0.58 113.968 177.22 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.479 ' CE2' ' C5 ' ' B' ' 2' ' ' ' G' . 64.2 m-85 -71.26 -6.94 43.52 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.704 -0.68 . . . . 1.05 112.688 -174.105 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 7.6 p-80 -112.85 10.29 19.07 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 121.788 -0.57 . . . . 2.01 110.921 171.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.594 HG21 HD12 ' A' ' 42' ' ' LEU . 52.0 m -79.62 123.75 27.9 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.099 -0.5 . . . . 0.72 110.438 174.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 60.3 p -105.72 175.2 5.57 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.264 -0.425 . . . . 0.55 110.577 -178.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.511 ' HB3' ' O ' ' A' ' 64' ' ' ALA . 2.9 m-20 -57.44 -30.56 65.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.571 0.701 . . . . 0.49 110.124 176.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.679 ' O ' ' HG2' ' A' ' 53' ' ' GLU . 0.5 OUTLIER -78.71 -29.59 45.52 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.422 -0.808 . . . . 2.76 110.828 -179.389 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.583 ' HB ' HG23 ' A' ' 46' ' ' THR . 14.5 m -61.95 -41.98 98.6 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.98 0.419 . . . . 0.58 110.379 176.454 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.67 HD21 HD11 ' A' ' 42' ' ' LEU . 16.0 mt -67.65 -37.16 82.03 Favored 'General case' 0 CA--C 1.519 -0.213 0 CA-C-N 116.189 -0.46 . . . . 0.85 110.334 174.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.47 ' HA ' HD12 ' A' ' 61' ' ' ILE . 60.5 t-80 -57.05 -47.4 81.05 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.723 -0.672 . . . . 0.59 109.848 175.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.679 ' HG2' ' O ' ' A' ' 49' ' ' LYS . 23.6 mm-40 -57.54 -47.25 82.52 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.976 -0.556 . . . . 1.52 111.521 178.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.464 ' O ' ' HB2' ' A' ' 57' ' ' GLN . 20.9 t80 -76.75 -34.83 58.05 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.591 0.589 . . . . 1.12 112.591 -172.172 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.432 ' CZ ' HG21 ' A' ' 39' ' ' VAL . 22.5 m-85 -85.03 -25.17 27.83 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 114.391 1.256 . . . . 0.56 114.391 -173.339 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.587 ' N ' HD11 ' A' ' 61' ' ' ILE . 11.0 pt-20 -67.06 -12.52 60.16 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 122.351 1.072 . . . . 1.57 109.722 177.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.689 ' HA ' HE21 ' A' ' 57' ' ' GLN . 0.0 OUTLIER -56.15 -31.31 63.25 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 113.937 -1.483 . . . . 2.16 111.506 169.001 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -96.92 4.87 51.38 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.466 -0.334 . . . . 0.71 111.737 -176.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 142.2 -133.76 5.8 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.548 -0.834 . . . . 0.75 112.516 -176.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -114.29 124.38 51.86 Favored 'General case' 0 C--N 1.322 -0.599 0 O-C-N 122.567 -0.372 . . . . 1.02 110.475 -179.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.587 HD11 ' N ' ' A' ' 56' ' ' GLU . 7.5 mt -93.23 125.87 45.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 109.579 -0.526 . . . . 0.47 109.579 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.414 ' CD ' HH11 ' A' ' 30' ' ' ARG . 23.1 tt0 -78.48 -38.8 40.09 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.019 0.438 . . . . 2.07 110.753 176.217 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -157.22 136.37 11.87 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.149 -0.478 . . . . 2.48 111.34 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.511 ' O ' ' HB3' ' A' ' 48' ' ' ASP . . . -121.28 123.4 42.1 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 115.781 -0.645 . . . . 0.44 109.396 174.039 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 8.9 p -135.52 135.17 51.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 114.893 -1.048 . . . . 1.38 112.191 -176.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 98.1 t -102.83 131.76 50.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.356 -0.838 . . . . 0.49 109.386 173.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.471 HG12 ' HA2' ' A' ' 79' ' ' GLY . 44.6 mm -83.61 92.28 2.83 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.625 0 CA-C-O 121.478 0.656 . . . . 0.72 109.665 -179.284 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.456 ' HB ' ' HA ' ' A' ' 73' ' ' GLN . 31.7 p -92.44 172.82 8.14 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 115.023 -0.99 . . . . 1.52 110.757 -179.6 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.453 ' HB3' ' H ' ' A' ' 73' ' ' GLN . 29.3 t70 -61.56 124.0 19.44 Favored 'General case' 0 C--O 1.216 -0.709 0 CA-C-N 116.347 -0.388 . . . . 2.49 111.177 -174.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.476 ' HG3' ' OD1' ' A' ' 71' ' ' ASN . 11.3 ptt180 -54.92 -22.71 15.82 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 113.011 0.745 . . . . 6.05 113.011 -177.289 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.476 ' OD1' ' HG3' ' A' ' 70' ' ' ARG . 4.5 m-20 -100.9 -39.21 7.88 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 112.63 0.604 . . . . 4.05 112.63 -179.394 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 40.7 p -112.17 -27.95 8.15 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 112.148 0.425 . . . . 3.08 112.148 -175.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.456 ' HA ' ' HB ' ' A' ' 68' ' ' THR . 27.3 mt-30 63.16 12.91 6.42 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 123.775 0.83 . . . . 3.3 113.0 178.433 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.663 ' HE2' ' HA ' ' A' ' 74' ' ' LYS . 5.0 mmpt? -38.56 -76.32 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 113.565 0.95 . . . . 3.49 113.565 171.305 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.508 ' O ' ' HB2' ' A' ' 76' ' ' ARG . 8.4 m -155.99 -65.65 0.11 Allowed 'General case' 0 N--CA 1.468 0.451 0 N-CA-C 112.879 0.696 . . . . 1.81 112.879 -178.345 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.508 ' HB2' ' O ' ' A' ' 75' ' ' SER . 96.5 mtt180 74.57 -55.3 0.66 Allowed 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.329 0.652 . . . . 2.56 110.508 -169.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.652 ' HA3' ' N2 ' ' B' ' 2' ' ' ' G' . . . 103.97 19.24 12.07 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.841 -0.695 . . . . 0.64 113.142 175.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -123.85 157.28 34.53 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.215 -1.031 . . . . 1.18 108.215 177.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.471 ' HA2' HG12 ' A' ' 67' ' ' ILE . . . -159.23 -164.66 14.89 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 119.769 -1.205 . . . . 0.59 112.647 175.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -151.3 134.83 16.24 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.731 -0.84 . . . . 0.63 108.731 -177.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 53.7 t -122.36 120.07 60.06 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 N-CA-C 109.938 -0.393 . . . . 0.41 109.938 177.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.574 ' HA ' ' O ' ' A' ' 35' ' ' THR . 17.9 m -109.81 115.68 30.28 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 108.51 -0.922 . . . . 0.47 108.51 177.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 83.1 mmm -88.79 163.8 15.53 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 108.898 -0.778 . . . . 0.88 108.898 -176.163 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 20.7 ttmm -83.3 -10.94 58.21 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.099 0.476 . . . . 1.92 110.683 -178.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -145.67 146.64 31.38 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 116.232 -0.44 . . . . 1.68 110.616 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 4.3 tmm_? -71.39 -22.81 61.83 Favored 'General case' 0 C--O 1.223 -0.3 0 N-CA-C 112.845 0.683 . . . . 3.66 112.845 -177.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.26 -43.94 89.68 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 118.649 0.659 . . . . 0.66 110.392 177.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 8.7 m -64.55 -39.23 93.37 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.699 0.761 . . . . 0.78 109.881 175.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.459 ' HA ' HD11 ' A' ' 37' ' ' ILE . . . -59.41 -49.79 76.45 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.028 -1.442 . . . . 0.46 110.609 178.326 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -54.98 -49.16 72.13 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.55 -0.75 . . . . 2.11 111.826 175.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.62 ' O ' ' HB3' ' A' ' 94' ' ' LYS . 2.6 ttm-85 -61.85 -41.02 97.31 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.295 -0.412 . . . . 3.82 110.773 -177.25 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -63.56 -43.84 95.87 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.996 -0.547 . . . . 0.92 111.73 176.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 45.2 t -75.2 -6.9 52.14 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 121.337 0.589 . . . . 1.16 110.659 178.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.62 ' HB3' ' O ' ' A' ' 91' ' ' ARG . 2.9 tppp? -76.96 -37.94 54.26 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.285 -0.87 . . . . 4.2 110.016 177.402 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -108.33 91.58 8.47 Favored Pre-proline 0 C--N 1.326 -0.441 0 N-CA-C 109.358 -0.608 . . . . 2.24 109.358 172.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.594 ' HA ' ' HB ' ' A' ' 107' ' ' VAL . 59.4 Cg_endo -90.17 -6.54 4.62 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 123.1 2.533 . . . . 2.38 114.144 -169.18 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.456 ' N ' ' HD3' ' A' ' 98' ' ' PRO . 3.4 p-10 -132.76 60.86 53.02 Favored Pre-proline 0 C--N 1.328 -0.337 0 N-CA-C 112.306 0.484 . . . . 3.03 112.306 -177.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.456 ' HD3' ' N ' ' A' ' 97' ' ' ASN . 1.8 Cg_endo -81.38 151.73 17.72 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.795 2.33 . . . . 1.29 111.73 -179.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 35.9 mm -95.06 90.37 2.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.287 0.565 . . . . 1.81 110.302 179.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 57.6 mt -90.85 108.34 19.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.841 -0.618 . . . . 0.99 111.847 177.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.718 ' HB3' ' HG2' ' A' ' 43' ' ' PRO . 25.2 t70 65.31 44.17 3.3 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 122.813 1.292 . . . . 1.37 109.3 173.345 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 80.39 -9.03 51.15 Favored Glycine 0 N--CA 1.445 -0.712 0 CA-C-N 114.412 -1.267 . . . . 1.56 113.579 176.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.79 ' HD3' ' HG3' ' A' ' 43' ' ' PRO . 7.4 mpt_? -107.09 131.09 54.5 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 117.74 0.77 . . . . 4.13 111.623 176.524 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 26.3 ttpp -67.18 134.51 51.86 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.366 -0.834 . . . . 2.73 109.032 169.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.488 ' HA ' ' HA3' ' A' ' 41' ' ' GLY . . . -111.25 150.38 29.68 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 116.232 -0.44 . . . . 1.04 109.964 -175.582 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -108.15 106.18 16.26 Favored 'General case' 0 C--O 1.264 1.857 0 CA-C-O 121.556 0.694 . . . . 2.04 110.053 174.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.816 HG22 HG13 ' A' ' 39' ' ' VAL . 47.4 t -101.67 138.53 25.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 CA-C-N 112.876 -1.965 . . . . 1.06 111.451 174.317 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.462 ' HB3' HD12 ' A' ' 112' ' ' LEU . 32.8 m-80 -151.86 153.02 33.37 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.428 -0.953 . . . . 2.49 108.428 172.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.527 HD13 ' H ' ' A' ' 110' ' ' ALA . 0.2 OUTLIER -63.25 150.3 43.46 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 108.402 -0.962 . . . . 1.23 108.402 172.876 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.527 ' H ' HD13 ' A' ' 109' ' ' LEU . . . -74.67 -40.28 61.51 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.081 -0.647 . . . . 0.91 110.36 -167.361 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.409 ' CE1' ' HB3' ' A' ' 109' ' ' LEU . 0.1 OUTLIER -68.28 -2.3 8.0 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 114.97 -1.014 . . . . 1.4 112.654 -172.221 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.462 HD12 ' HB3' ' A' ' 108' ' ' ASN . 82.6 mt -66.42 -45.83 78.57 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.612 0.244 . . . . 1.97 110.714 179.045 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -126.67 40.51 1.78 Allowed Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 120.21 -0.995 . . . . 2.14 111.987 174.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -86.59 113.06 22.17 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.625 -0.509 . . . . 2.66 109.625 -178.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.41 ' HE3' ' HB2' ' A' ' 115' ' ' LYS . 41.0 mtmt -128.57 77.35 77.47 Favored Pre-proline 0 C--N 1.326 -0.442 0 C-N-CA 120.86 -0.336 . . . . 4.16 110.592 -175.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -83.89 -51.78 0.04 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 122.549 2.166 . . . . 5.53 110.553 174.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -157.55 1.97 0.12 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.109 -0.95 . . . . 8.6 108.703 177.399 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.13 96.77 5.18 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 114.792 -1.095 . . . . 6.37 111.1 -171.328 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 59.8 t30 -94.34 65.35 3.27 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.055 0.455 . . . . 7.85 111.222 -178.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 95.2 t 69.22 117.32 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 N-CA-C 113.64 0.978 . . . . 9.37 113.64 171.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.445 ' O ' ' HG3' ' A' ' 121' ' ' GLN . 6.8 pt20 . . . . . 0 C--O 1.245 0.866 0 CA-C-O 118.546 -0.74 . . . . 12.28 109.605 168.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 1' ' ' ' G' . . . . . 0.543 " H4'" " O5'" ' B' ' 2' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.431 -0.562 0 C3'-C2'-C1' 99.647 -2.059 . 0.0 '__' . 4.94 . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 2' ' ' ' G' . . . . . 0.681 ' O6 ' ' HA ' ' A' ' 43' ' ' PRO . . . . . . . . 0 O5'--C5' 1.427 -0.787 0 C4'-C3'-C2' 103.736 1.036 . 0.0 OUTLIER . 4.87 . . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 3' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.427 -0.832 0 C3'-C2'-C1' 100.876 -0.694 . 0.0 OUTLIER gamma 5.02 . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 4' ' ' ' G' . . . . . 0.561 " O2'" " H5'" ' B' ' 5' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.427 -0.786 0 O4'-C1'-C2' 108.171 1.265 . 0.0 OUTLIER '7D dist 2a' 2.69 . . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 5' ' ' ' U' . . . . . 0.561 " H5'" " O2'" ' B' ' 4' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.426 -0.863 0 C4'-C3'-C2' 103.95 1.25 . 0.418 1[ . 1.93 . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 6' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.427 -0.814 0 C4'-C3'-C2' 103.508 0.808 . 0.28 0b . 2.38 . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 7' ' ' ' C' . . . . . 0.658 ' H6 ' " O5'" ' B' ' 7' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.426 -0.855 0 C3'-C2'-C1' 100.52 -1.089 . 0.019 2[ . 4.19 . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.609 0 N-CA-C 112.059 -0.416 . . . . 13.03 112.059 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -115.98 94.92 4.87 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.09 0.471 . . . . 11.06 109.803 178.208 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 95.6 mmm -99.68 143.52 29.82 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.878 -0.601 . . . . 9.85 110.767 -175.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -137.58 49.63 0.85 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.795 -0.717 . . . . 6.69 112.63 -178.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 18.3 m 58.43 64.08 1.56 Allowed 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 121.014 0.435 . . . . 5.55 111.7 176.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -84.75 91.43 7.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.991 0.424 . . . . 3.87 110.21 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -82.46 109.97 17.16 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 109.173 -0.677 . . . . 3.53 109.173 -178.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.44 ' O ' ' HE2' ' A' ' 36' ' ' LYS . 14.5 p -90.5 53.92 2.58 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 114.094 1.146 . . . . 1.69 114.094 -165.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . 0.605 ' HG3' ' H ' ' A' ' 34' ' ' PHE . 22.5 ptm -73.23 -51.0 19.32 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 107.695 -1.224 . . . . 1.49 107.695 162.586 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.605 ' H ' ' HG3' ' A' ' 33' ' ' MET . 26.0 m-85 -88.17 -179.97 6.26 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-N 113.712 -1.586 . . . . 1.5 108.62 170.173 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.73 ' HB ' ' O ' ' A' ' 83' ' ' MET . 14.0 p 65.37 -0.46 1.16 Allowed 'General case' 0 N--CA 1.472 0.637 0 O-C-N 124.065 0.853 . . . . 0.53 112.642 174.588 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.591 ' HD2' ' O6 ' ' B' ' 6' ' ' ' G' . 33.0 ttpt -121.89 110.21 15.58 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.136 0.494 . . . . 2.75 110.248 -176.314 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.616 HD11 ' HA ' ' A' ' 89' ' ' ALA . 3.8 mp -96.3 130.02 45.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.972 -0.558 . . . . 0.85 110.575 -179.292 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -85.77 108.29 18.02 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 108.559 -0.904 . . . . 0.71 108.559 172.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.3 t -95.95 137.03 25.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 N-CA-C 108.074 -1.084 . . . . 0.92 108.074 179.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -140.42 138.09 8.78 Favored Glycine 0 N--CA 1.442 -0.94 0 C-N-CA 119.577 -1.297 . . . . 0.84 111.767 -170.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 96.43 16.36 37.53 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.582 -0.818 . . . . 0.68 112.84 177.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.553 HD12 HG21 ' A' ' 46' ' ' THR . 2.8 mm? -64.94 124.16 85.81 Favored Pre-proline 0 C--O 1.234 0.246 0 N-CA-C 109.304 -0.628 . . . . 1.28 109.304 177.006 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.578 ' HG2' ' HB3' ' A' ' 101' ' ' ASP . 52.9 Cg_exo -50.58 154.38 6.53 Favored 'Trans proline' 0 CA--C 1.529 0.252 0 C-N-CA 122.91 2.407 . . . . 0.58 111.88 173.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -65.76 -7.22 14.6 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.847 0.356 . . . . 1.05 111.61 -178.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 76.9 t60 -101.14 -6.43 24.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.188 0.518 . . . . 2.01 110.222 177.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.553 HG21 HD12 ' A' ' 42' ' ' LEU . 77.5 m -78.72 142.42 37.09 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 116.259 -0.428 . . . . 0.72 109.922 177.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 12.1 p -132.14 -178.77 5.05 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.028 0.442 . . . . 0.55 111.161 -175.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.587 ' OD2' ' HA ' ' A' ' 65' ' ' VAL . 2.4 m-20 -67.31 -48.18 68.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.862 0.839 . . . . 0.49 109.06 -176.423 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.598 ' O ' ' HG2' ' A' ' 53' ' ' GLU . 22.8 pttp -52.52 -35.38 53.14 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 113.908 -1.496 . . . . 2.76 111.149 175.38 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.47 HG21 HG23 ' A' ' 46' ' ' THR . 22.9 m -67.2 -45.76 75.9 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.854 0.359 . . . . 0.58 111.279 179.299 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.525 HD21 HD11 ' A' ' 42' ' ' LEU . 31.1 mt -67.33 -35.67 79.9 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.485 -0.325 . . . . 0.85 110.805 178.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.432 ' HA ' ' CD1' ' A' ' 61' ' ' ILE . 63.9 t-80 -57.3 -38.3 73.77 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.644 -0.502 . . . . 0.59 109.644 175.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.598 ' HG2' ' O ' ' A' ' 49' ' ' LYS . 82.3 mm-40 -68.18 -39.84 82.42 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.242 -0.89 . . . . 1.52 110.467 -177.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.634 ' O ' ' HB2' ' A' ' 57' ' ' GLN . 2.2 t80 -78.44 -34.33 47.87 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.566 0.698 . . . . 1.12 111.607 -177.282 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.46 ' HB2' HD11 ' A' ' 61' ' ' ILE . 28.7 m-85 -86.4 -25.63 25.19 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 113.086 0.772 . . . . 0.56 113.086 -172.124 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -71.98 -1.53 14.87 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 122.336 1.065 . . . . 1.57 109.619 174.102 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.634 ' HB2' ' O ' ' A' ' 54' ' ' TYR . 88.9 mt-30 -86.28 -10.6 54.22 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.092 -1.413 . . . . 2.16 109.96 176.223 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.431 ' HD2' ' HA ' ' A' ' 55' ' ' PHE . 78.8 m-85 -109.86 -51.2 2.9 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.395 -0.821 . . . . 0.71 111.118 -178.332 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -163.92 -135.75 1.87 Allowed Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.274 -0.965 . . . . 0.75 112.006 179.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.428 ' HB3' ' HE3' ' A' ' 84' ' ' LYS . 1.0 OUTLIER -98.22 132.88 43.35 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.803 0.335 . . . . 1.02 110.235 -179.902 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.46 HD11 ' HB2' ' A' ' 55' ' ' PHE . 66.0 mt -105.83 139.89 25.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 107.87 -1.159 . . . . 0.47 107.87 174.621 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -97.99 -41.21 8.09 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 107.933 -1.136 . . . . 2.07 107.933 177.099 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.402 ' HG2' HG13 ' A' ' 65' ' ' VAL . 43.0 tt0 -165.48 127.03 1.98 Allowed 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 115.458 -0.792 . . . . 2.48 110.267 177.014 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.419 ' O ' ' HB3' ' A' ' 48' ' ' ASP . . . -106.04 127.27 53.06 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.272 -0.64 . . . . 0.44 109.272 174.533 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.587 ' HA ' ' OD2' ' A' ' 48' ' ' ASP . 5.0 m -138.1 119.63 17.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.472 0.653 . . . . 1.38 112.649 -175.268 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 91.7 t -86.99 122.06 38.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.381 -0.827 . . . . 0.49 109.553 174.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 39.8 mm -71.69 139.34 19.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.34 0.59 . . . . 0.72 112.16 -176.021 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.478 ' HB ' ' C ' ' A' ' 73' ' ' GLN . 35.2 p -106.74 177.55 4.82 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 115.265 -0.88 . . . . 1.52 109.53 176.558 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.602 ' HB3' ' N ' ' A' ' 73' ' ' GLN . 31.4 t70 -70.61 160.39 32.64 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.737 0.779 . . . . 2.49 113.047 -171.467 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 77.3 ttt180 -72.27 -53.95 10.98 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.048 -1.433 . . . . 6.05 109.207 177.143 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 -79.76 -58.98 2.91 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.419 -0.81 . . . . 4.05 112.588 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 61.5 p -92.61 -16.05 26.11 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 112.615 0.598 . . . . 3.08 112.615 -171.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.602 ' N ' ' HB3' ' A' ' 69' ' ' ASP . 47.5 mt-30 57.12 31.99 20.93 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.507 0.67 . . . . 3.3 111.444 -175.056 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -94.6 142.71 27.13 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.24 -0.891 . . . . 3.49 109.054 171.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 1.8 m -45.8 132.15 8.99 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.712 0.634 . . . . 1.81 112.712 -169.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 60.2 mtp180 -98.15 -10.22 24.51 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.947 -0.57 . . . . 2.56 110.92 -175.29 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.445 ' HA3' ' N2 ' ' B' ' 2' ' ' ' G' . . . 86.89 13.77 66.13 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.596 -0.811 . . . . 0.64 112.462 -178.515 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -122.85 162.44 22.17 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.59 -0.893 . . . . 1.18 108.59 178.018 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -173.77 145.19 8.07 Favored Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 120.148 -1.025 . . . . 0.59 112.211 178.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -104.06 142.17 34.93 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.419 0.628 . . . . 0.63 111.258 176.064 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 49.8 t -117.99 106.02 19.01 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 CA-C-N 115.239 -0.891 . . . . 0.41 109.483 173.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 8.3 m -76.92 117.33 18.41 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.883 -0.598 . . . . 0.47 109.968 174.002 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.73 ' O ' ' HB ' ' A' ' 35' ' ' THR . 28.1 mtp -103.31 134.85 46.02 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.74 -0.467 . . . . 0.88 109.74 179.069 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.428 ' HE3' ' HB3' ' A' ' 60' ' ' ASP . 19.1 ttmt -51.73 -6.14 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.836 0 N-CA-C 114.87 1.433 . . . . 1.92 114.87 -179.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.481 ' C ' HG22 ' A' ' 35' ' ' THR . 7.2 t70 -162.53 156.68 21.21 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 118.871 0.76 . . . . 1.68 111.323 177.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.666 ' N ' HG22 ' A' ' 35' ' ' THR . 2.5 tmm_? -75.02 -34.8 61.94 Favored 'General case' 0 C--O 1.22 -0.48 0 N-CA-C 108.461 -0.94 . . . . 3.66 108.461 -177.279 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -52.71 -42.4 64.82 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.026 -0.988 . . . . 0.66 110.95 172.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 5.5 m -69.55 -31.95 70.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.072 0.463 . . . . 0.78 110.381 176.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.616 ' HA ' HD11 ' A' ' 37' ' ' ILE . . . -67.62 -50.43 58.11 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.599 -0.728 . . . . 0.46 110.819 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.573 ' O ' ' HG2' ' A' ' 94' ' ' LYS . 6.0 mt-10 -57.72 -32.77 67.74 Favored 'General case' 0 C--O 1.224 -0.283 0 CA-C-N 115.832 -0.622 . . . . 2.11 110.537 174.547 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.401 ' O ' ' HB2' ' A' ' 94' ' ' LYS . 13.3 tpp180 -64.15 -51.72 62.48 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.325 -0.852 . . . . 3.82 109.922 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -53.57 -32.1 49.45 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 113.461 0.912 . . . . 0.92 113.461 172.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 46.5 t -80.25 -34.57 36.99 Favored 'General case' 0 C--N 1.328 -0.363 0 O-C-N 121.894 -0.504 . . . . 1.16 110.609 178.173 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.573 ' HG2' ' O ' ' A' ' 90' ' ' GLU . 12.2 mmmm -48.23 -30.7 4.98 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 114.733 -1.121 . . . . 4.2 111.838 175.168 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -103.18 102.77 30.52 Favored Pre-proline 0 C--N 1.326 -0.438 0 N-CA-C 108.893 -0.78 . . . . 2.24 108.893 167.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -77.15 173.65 14.06 Favored 'Trans proline' 0 N--CA 1.463 -0.293 0 C-N-CA 122.608 2.205 . . . . 2.38 113.761 -169.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.51 ' ND2' ' HA ' ' A' ' 106' ' ' ASN . 12.4 m120 -15.98 91.13 0.04 OUTLIER Pre-proline 0 N--CA 1.481 1.092 0 C-N-CA 125.462 1.505 . . . . 3.03 114.126 -174.473 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -82.27 164.85 16.96 Favored 'Trans proline' 0 C--O 1.235 0.346 0 C-N-CA 123.408 2.739 . . . . 1.29 113.202 -179.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 41.1 mm -94.72 109.79 22.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.445 -0.798 . . . . 1.81 110.329 174.126 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 54.9 mt -114.22 115.65 50.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.017 -0.538 . . . . 0.99 110.251 178.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.578 ' HB3' ' HG2' ' A' ' 43' ' ' PRO . 28.0 t70 50.71 54.53 11.04 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 113.071 0.767 . . . . 1.37 113.071 169.281 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 74.75 21.72 78.17 Favored Glycine 0 N--CA 1.454 -0.12 0 C-N-CA 120.375 -0.917 . . . . 1.56 113.121 176.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.463 ' HB2' ' HG3' ' A' ' 43' ' ' PRO . 0.2 OUTLIER -145.66 160.11 42.17 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.9 -0.407 . . . . 4.13 109.9 179.207 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 2.1 ttmp? -101.79 149.23 24.39 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 107.751 -1.203 . . . . 2.73 107.751 169.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -116.85 141.48 48.17 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 120.674 -0.41 . . . . 1.04 110.103 -174.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.51 ' HA ' ' ND2' ' A' ' 97' ' ' ASN . 91.5 m-20 -94.23 123.8 37.85 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.268 -0.641 . . . . 2.04 109.268 175.453 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.517 HG13 HG21 ' A' ' 37' ' ' ILE . 97.9 t -119.72 114.92 45.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.247 -0.888 . . . . 1.06 110.219 179.353 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -156.48 171.32 20.49 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.506 -0.77 . . . . 2.49 110.254 -179.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.536 ' HB3' ' CD1' ' A' ' 111' ' ' TYR . 3.2 mm? -78.38 115.09 17.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.513 0.673 . . . . 1.23 111.415 -176.531 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -43.92 -35.83 2.17 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 113.949 -1.478 . . . . 0.91 113.987 -179.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.536 ' CD1' ' HB3' ' A' ' 109' ' ' LEU . 0.4 OUTLIER -72.97 -10.32 59.68 Favored 'General case' 0 N--CA 1.467 0.395 0 O-C-N 121.69 -0.631 . . . . 1.4 112.311 -174.712 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 96.6 mt -68.11 -38.71 82.58 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.906 0.384 . . . . 1.97 110.636 177.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -104.31 10.44 50.59 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.958 -0.639 . . . . 2.14 111.972 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -90.47 123.31 34.06 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 109.19 -0.67 . . . . 2.66 109.19 -178.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -132.5 94.08 23.43 Favored Pre-proline 0 C--N 1.322 -0.618 0 C-N-CA 120.199 -0.6 . . . . 4.16 111.498 -179.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.468 ' HD2' ' H ' ' A' ' 117' ' ' ARG . 34.3 Cg_endo -93.17 -37.98 0.04 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.092 0 C-N-CA 122.743 2.295 . . . . 5.53 111.559 171.18 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.468 ' H ' ' HD2' ' A' ' 116' ' ' PRO . 25.9 ptt180 -145.71 9.76 1.19 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.554 -0.748 . . . . 8.6 110.038 -178.214 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 5.7 p -101.87 50.79 0.84 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.639 -0.709 . . . . 6.37 110.831 -179.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -90.64 91.18 8.3 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.885 -0.598 . . . . 7.85 111.467 -175.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 56.4 t 69.81 103.55 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 115.334 -0.848 . . . . 9.37 112.825 172.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 . . . . . 0 C--O 1.247 0.956 0 CA-C-O 118.679 -0.677 . . . . 12.28 109.517 172.493 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 1' ' ' ' G' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.429 -0.714 0 C4'-C3'-C2' 103.827 1.127 . 0.0 '__' . 4.94 . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 2' ' ' ' G' . . . . . 0.445 ' N2 ' ' HA3' ' A' ' 77' ' ' GLY . . . . . . . . 0 O5'--C5' 1.425 -0.948 0 C4'-C3'-C2' 104.072 1.372 . 0.0 OUTLIER . 4.87 . . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 3' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.425 -0.919 0 C3'-C2'-C1' 100.823 -0.752 . 0.0 OUTLIER . 5.02 . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 4' ' ' ' G' . . . . . 0.539 " H3'" ' N3 ' ' B' ' 4' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.428 -0.727 0 O4'-C1'-C2' 108.248 1.32 . 0.0 OUTLIER . 2.69 . . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 5' ' ' ' U' . . . . . 0.507 ' H6 ' " O5'" ' B' ' 5' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.426 -0.902 0 C4'-C3'-C2' 104.113 1.413 . 0.091 1b . 1.93 . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 6' ' ' ' G' . . . . . 0.591 ' O6 ' ' HD2' ' A' ' 36' ' ' LYS . . . . . . . . 0 O5'--C5' 1.426 -0.858 0 C3'-C2'-C1' 100.335 -1.294 . 0.776 4b . 2.38 . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.426 -0.885 0 C3'-C2'-C1' 100.78 -0.8 . 0.0 OUTLIER . 4.19 . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.897 0 N-CA-C 112.73 -0.148 . . . . 13.03 112.73 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.61 -36.17 62.94 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.767 0.654 . . . . 11.06 112.767 -173.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . . . . . . . . . 24.3 ptm -131.77 172.88 11.76 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 121.137 -0.225 . . . . 9.85 110.776 -175.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -151.88 -113.79 0.58 Allowed Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.988 -0.625 . . . . 6.69 112.061 -177.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 51.1 m 69.01 103.33 0.06 Allowed 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 123.205 0.602 . . . . 5.55 111.055 -177.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 15.6 mmt180 66.55 178.44 0.22 Allowed 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.582 -0.735 . . . . 3.87 111.481 -178.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -151.47 130.44 12.55 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.813 -0.81 . . . . 3.53 108.813 177.574 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.578 ' HA ' ' OG1' ' A' ' 35' ' ' THR . 79.3 p -100.22 -26.13 14.03 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.926 0.393 . . . . 1.69 110.46 179.492 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 41.8 ttp -43.57 -54.52 4.87 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.808 -0.633 . . . . 1.49 111.987 178.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -93.71 23.8 4.51 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.924 0.712 . . . . 1.5 112.924 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.578 ' OG1' ' HA ' ' A' ' 32' ' ' THR . 70.5 p -149.49 19.45 0.93 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 118.726 0.693 . . . . 0.53 110.338 -171.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.447 ' HB2' ' O ' ' A' ' 32' ' ' THR . 5.8 ttpm? -121.97 103.88 9.13 Favored 'General case' 0 CA--C 1.509 -0.608 0 C-N-CA 119.925 -0.71 . . . . 2.75 109.733 -167.284 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.574 HG23 HG13 ' A' ' 107' ' ' VAL . 65.2 mt -90.35 111.91 24.08 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 CA-C-N 115.403 -0.817 . . . . 0.85 109.548 179.496 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.723 ' HB2' ' HB2' ' A' ' 110' ' ' ALA . 69.8 t80 -83.36 108.48 16.58 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 107.907 -1.146 . . . . 0.71 107.907 175.27 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.418 ' HB ' HD21 ' A' ' 42' ' ' LEU . 4.1 t -95.85 87.94 1.96 Allowed 'Isoleucine or valine' 0 C--O 1.209 -1.046 0 CA-C-O 122.105 0.955 . . . . 0.92 109.05 -177.048 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -68.3 147.28 47.17 Favored Glycine 0 C--N 1.305 -1.16 0 C-N-CA 119.359 -1.401 . . . . 0.84 112.151 168.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.526 ' HA2' ' O4 ' ' B' ' 3' ' ' ' U' . . . 81.91 38.58 13.31 Favored Glycine 0 CA--C 1.523 0.546 0 C-N-CA 120.74 -0.743 . . . . 0.68 114.773 170.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.815 HD11 HD21 ' A' ' 51' ' ' LEU . 2.8 mm? -72.49 143.63 85.47 Favored Pre-proline 0 CA--C 1.514 -0.438 0 CA-C-N 117.934 0.867 . . . . 1.28 110.802 172.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.558 ' HG2' ' HB3' ' A' ' 101' ' ' ASP . 75.4 Cg_exo -52.49 145.13 38.44 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 122.401 2.067 . . . . 0.58 110.867 166.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.439 ' CE1' ' C5 ' ' B' ' 2' ' ' ' G' . 46.8 m-85 -60.46 -16.26 34.81 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 113.795 1.035 . . . . 1.05 113.795 -171.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 3.0 p-80 -111.2 18.24 19.52 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 119.674 -0.811 . . . . 2.01 111.97 176.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.589 HG23 ' HB ' ' A' ' 50' ' ' THR . 91.7 m -78.22 107.13 10.59 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 118.971 -1.092 . . . . 0.72 110.445 178.229 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 6.6 p -87.02 171.62 10.6 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 113.767 -1.56 . . . . 0.55 113.849 170.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -55.16 -43.29 74.1 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 113.923 -1.49 . . . . 0.49 110.19 -174.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.639 ' O ' ' HG2' ' A' ' 53' ' ' GLU . 60.0 pttt -54.86 -41.84 71.29 Favored 'General case' 0 C--O 1.224 -0.268 0 CA-C-N 115.165 -0.925 . . . . 2.76 110.687 176.431 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.589 ' HB ' HG23 ' A' ' 46' ' ' THR . 11.2 m -61.8 -43.18 99.35 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.494 -0.321 . . . . 0.58 110.823 -176.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.815 HD21 HD11 ' A' ' 42' ' ' LEU . 18.3 mt -69.94 -46.96 64.17 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.736 -0.385 . . . . 0.85 111.318 178.442 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.446 ' HA ' HD12 ' A' ' 61' ' ' ILE . 57.9 t-80 -53.2 -55.52 23.63 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.899 0.381 . . . . 0.59 111.314 176.59 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.639 ' HG2' ' O ' ' A' ' 49' ' ' LYS . 9.6 mm-40 -56.02 -52.81 62.9 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.805 -0.634 . . . . 1.52 111.301 179.641 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -53.05 -49.09 67.04 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 115.385 1.624 . . . . 1.12 115.385 175.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.512 ' CE1' HD22 ' A' ' 51' ' ' LEU . 28.5 m-85 -81.62 -33.45 31.45 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 114.173 1.175 . . . . 0.56 114.173 -165.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.55 ' N ' HD11 ' A' ' 61' ' ' ILE . 9.8 pt-20 -53.53 0.17 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 114.126 1.158 . . . . 1.57 114.126 171.719 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.401 ' H ' ' C ' ' A' ' 55' ' ' PHE . 37.3 mt-30 -67.33 -34.98 78.47 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 116.105 -0.498 . . . . 2.16 110.499 167.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -68.71 -54.09 18.24 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.146 -0.479 . . . . 0.71 110.714 178.191 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -177.34 -82.06 0.06 OUTLIER Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 119.684 -1.246 . . . . 0.75 111.623 164.08 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.439 ' HB3' ' CB ' ' A' ' 84' ' ' LYS . 11.8 m-20 -115.36 106.91 14.56 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 111.536 0.199 . . . . 1.02 111.536 -178.075 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.55 HD11 ' N ' ' A' ' 56' ' ' GLU . 3.5 mt -84.07 146.95 6.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.099 -0.704 . . . . 0.47 109.099 166.515 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.617 ' HB2' ' HA ' ' A' ' 84' ' ' LYS . 8.2 tp10 -102.64 -45.49 5.01 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.405 -0.591 . . . . 2.07 109.405 177.349 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -157.49 123.87 4.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.634 -0.712 . . . . 2.48 109.802 179.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -115.7 141.13 48.49 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 120.929 0.395 . . . . 0.44 110.315 172.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.691 HG11 ' N2 ' ' B' ' 6' ' ' ' G' . 2.4 p -151.57 144.25 16.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.31 -0.859 . . . . 1.38 109.907 -174.629 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 57.5 t -114.3 128.56 71.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 O-C-N 122.3 -0.25 . . . . 0.49 110.558 176.315 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.524 HG22 ' HD3' ' A' ' 76' ' ' ARG . 31.7 mm -72.77 116.48 14.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.407 0.622 . . . . 0.72 110.436 -179.602 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.56 ' HB ' ' O ' ' A' ' 73' ' ' GLN . 73.3 p -104.78 149.81 25.32 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.247 -0.888 . . . . 1.52 111.399 -175.175 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.535 ' O ' ' HA ' ' A' ' 73' ' ' GLN . 16.7 t70 -44.96 154.92 0.12 Allowed 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 115.205 -0.907 . . . . 2.49 111.665 175.109 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 32.1 ttm180 -70.41 -47.9 58.64 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.489 -0.323 . . . . 6.05 111.245 -173.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -92.44 -50.37 5.66 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 111.792 0.293 . . . . 4.05 111.792 -171.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 82.4 p -90.8 -26.37 19.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.395 0.617 . . . . 3.08 110.735 -176.278 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.56 ' O ' ' HB ' ' A' ' 68' ' ' THR . 31.9 mt-30 65.47 21.1 11.81 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 114.741 -1.118 . . . . 3.3 112.933 178.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 50.3 mtmt -64.09 156.22 28.98 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.591 -0.522 . . . . 3.49 109.591 164.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 44.7 m -68.26 103.67 1.65 Allowed 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.211 0.529 . . . . 1.81 112.307 -174.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.635 ' HA ' " O5'" ' B' ' 1' ' ' ' G' . 66.4 mtp180 -48.92 -12.49 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 115.161 -0.927 . . . . 2.56 113.33 171.159 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 92.96 2.99 66.12 Favored Glycine 0 N--CA 1.441 -0.977 0 C-N-CA 120.378 -0.915 . . . . 0.64 112.426 178.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -114.56 136.91 52.51 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.504 -0.924 . . . . 1.18 108.504 178.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -134.55 179.11 17.91 Favored Glycine 0 N--CA 1.435 -1.405 0 C-N-CA 119.574 -1.298 . . . . 0.59 113.788 178.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.438 ' HB2' HG13 ' A' ' 65' ' ' VAL . 50.1 m-85 -144.71 124.04 13.04 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 113.787 -1.207 . . . . 0.63 110.124 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 53.0 t -127.79 106.98 15.69 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 CA-C-N 115.362 -0.835 . . . . 0.41 109.355 175.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.509 ' HA ' ' O ' ' A' ' 35' ' ' THR . 70.5 m -94.86 132.09 40.05 Favored 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 108.759 -0.83 . . . . 0.47 108.759 174.379 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . 0.425 ' HA ' ' HA ' ' A' ' 61' ' ' ILE . 26.5 mtp -99.96 156.26 17.25 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 109.132 -0.692 . . . . 0.88 109.132 -176.459 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.617 ' HA ' ' HB2' ' A' ' 62' ' ' GLU . 18.1 ttmt -60.22 -49.8 76.19 Favored 'General case' 0 C--N 1.327 -0.379 0 O-C-N 123.421 0.45 . . . . 1.92 110.554 -170.569 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -129.52 148.03 51.38 Favored 'General case' 0 C--O 1.245 0.864 0 CA-C-O 122.121 0.962 . . . . 1.68 111.926 166.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.575 ' O ' ' HG3' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -47.67 -24.61 0.96 Allowed 'General case' 0 C--O 1.214 -0.808 0 CA-C-N 113.708 -1.587 . . . . 3.66 114.096 176.685 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -58.0 -44.76 87.38 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 119.502 1.047 . . . . 0.66 111.483 175.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 49.9 m -71.96 -38.88 69.69 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.577 -0.449 . . . . 0.78 109.863 177.205 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.463 ' HB3' ' HA ' ' A' ' 86' ' ' ARG . . . -56.61 -28.89 61.41 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 115.916 -0.584 . . . . 0.46 111.789 173.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.575 ' HG3' ' O ' ' A' ' 86' ' ' ARG . 22.1 mt-10 -72.85 -43.97 61.96 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.471 0.653 . . . . 2.11 109.316 -179.686 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.434 ' O ' ' HG3' ' A' ' 94' ' ' LYS . 97.3 mtt180 -55.22 -41.93 72.71 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.983 -1.008 . . . . 3.82 111.254 176.036 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -69.36 -47.05 65.51 Favored 'General case' 0 C--O 1.219 -0.54 0 C-N-CA 120.971 -0.292 . . . . 0.92 111.533 174.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 48.4 t -48.5 -44.41 35.96 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 113.112 0.782 . . . . 1.16 113.112 177.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.54 ' HE2' ' HB2' ' A' ' 95' ' ' ASP . 0.0 OUTLIER -60.44 -22.89 63.95 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 118.314 0.506 . . . . 4.2 111.661 176.57 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.54 ' HB2' ' HE2' ' A' ' 94' ' ' LYS . 10.3 t70 -99.65 100.72 11.51 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 115.48 -0.782 . . . . 2.24 110.274 -177.529 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.425 ' HD3' ' O ' ' A' ' 94' ' ' LYS . 55.8 Cg_endo -90.72 113.78 0.44 Allowed 'Trans proline' 0 N--CA 1.451 -0.994 0 C-N-CA 123.113 2.542 . . . . 2.38 113.921 -171.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.543 ' HB3' ' HD2' ' A' ' 104' ' ' LYS . 1.0 OUTLIER 70.18 92.42 0.06 OUTLIER Pre-proline 0 N--CA 1.467 0.388 0 CA-C-N 114.495 -1.23 . . . . 3.03 111.464 175.978 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.626 ' O ' ' HA ' ' A' ' 104' ' ' LYS . 73.4 Cg_endo -82.3 168.75 14.71 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 123.843 3.029 . . . . 1.29 113.926 -175.303 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 48.6 mm -102.22 118.07 48.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 CA-C-N 114.1 -1.409 . . . . 1.81 108.737 178.057 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 70.9 mt -137.65 124.16 27.79 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.233 0 N-CA-C 110.462 -0.199 . . . . 0.99 110.462 -167.268 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.558 ' HB3' ' HG2' ' A' ' 43' ' ' PRO . 37.9 t70 44.51 48.15 8.38 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-O 121.288 0.566 . . . . 1.37 111.25 -179.219 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 77.0 2.3 77.15 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 115.478 0.951 . . . . 1.56 115.478 179.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 13.0 tpt180 -141.92 130.52 22.66 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 118.487 1.143 . . . . 4.13 112.01 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.626 ' HA ' ' O ' ' A' ' 98' ' ' PRO . 16.8 ttpp -60.1 141.93 55.0 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.388 -0.369 . . . . 2.73 111.527 172.376 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.461 ' O ' ' HD2' ' A' ' 98' ' ' PRO . . . -124.32 167.78 13.88 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 109.035 -0.728 . . . . 1.04 109.035 177.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -97.7 106.93 19.32 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 122.133 0.968 . . . . 2.04 111.838 -178.166 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.574 HG13 HG23 ' A' ' 37' ' ' ILE . 24.6 t -96.48 113.95 32.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 113.517 -1.674 . . . . 1.06 112.104 172.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -134.36 144.34 48.17 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 114.497 -1.228 . . . . 2.49 108.882 172.278 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.482 HD12 ' CD1' ' A' ' 111' ' ' TYR . 0.1 OUTLIER -68.86 93.3 0.54 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.878 0.371 . . . . 1.23 110.384 177.782 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . 0.723 ' HB2' ' HB2' ' A' ' 38' ' ' PHE . . . -36.42 -19.12 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 118.223 2.675 . . . . 0.91 118.223 177.296 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.482 ' CD1' HD12 ' A' ' 109' ' ' LEU . 0.3 OUTLIER -71.16 -9.57 58.31 Favored 'General case' 0 CA--C 1.545 0.759 0 CA-C-N 121.534 1.97 . . . . 1.4 109.99 175.29 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 60.5 mt -84.98 3.52 38.03 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.687 0.795 . . . . 1.97 110.222 172.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.517 ' HA3' ' N3 ' ' B' ' 5' ' ' ' U' . . . -138.14 -22.87 0.43 Allowed Glycine 0 N--CA 1.453 -0.168 0 CA-C-N 115.133 -0.94 . . . . 2.14 111.458 -172.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.511 ' O ' ' HD3' ' A' ' 116' ' ' PRO . . . -60.81 161.91 7.45 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 123.182 0.593 . . . . 2.66 110.247 172.419 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.444 ' N ' ' HD2' ' A' ' 115' ' ' LYS . 12.6 mptt -114.14 75.64 3.2 Favored Pre-proline 0 C--N 1.324 -0.533 0 N-CA-C 110.05 -0.352 . . . . 4.16 110.05 -179.606 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.511 ' HD3' ' O ' ' A' ' 114' ' ' ALA . 49.1 Cg_endo -90.03 -42.4 0.04 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.882 0 C-N-CA 122.572 2.181 . . . . 5.53 112.671 -178.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 28.2 ptt180 -124.87 6.45 8.05 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.082 -0.508 . . . . 8.6 110.239 -176.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 10.2 t -150.49 156.34 41.24 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.71 0.291 . . . . 6.37 111.294 -172.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -134.74 122.25 21.9 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.95 -0.759 . . . . 7.85 108.95 173.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 16.4 t -106.74 -10.08 10.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.22 0.533 . . . . 9.37 111.027 -173.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.238 -0.887 . . . . 12.28 111.243 -171.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 1' ' ' ' G' . . . . . 0.635 " O5'" ' HA ' ' A' ' 76' ' ' ARG . . . . . . . . 0 O5'--C5' 1.431 -0.586 0 C3'-C2'-C1' 99.518 -2.202 . 0.0 '__' . 4.94 . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 2' ' ' ' G' . . . . . 0.451 ' C4 ' ' C4 ' ' B' ' 3' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.429 -0.69 0 C3'-C2'-C1' 99.624 -2.084 . 0.0 OUTLIER gamma 4.87 . . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 3' ' ' ' U' . . . . . 0.526 ' O4 ' ' HA2' ' A' ' 41' ' ' GLY . . . . . . . . 0 O5'--C5' 1.427 -0.81 0 C3'-C2'-C1' 100.156 -1.493 . 0.0 OUTLIER . 5.02 . . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 4' ' ' ' G' . . . . . 0.47 " H3'" ' N3 ' ' B' ' 4' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.424 -1.029 0 O4'-C1'-C2' 108.107 1.219 . 0.0 OUTLIER . 2.69 . . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 5' ' ' ' U' . . . . . 0.517 ' N3 ' ' HA3' ' A' ' 113' ' ' GLY . . . . . . . . 0 O5'--C5' 1.427 -0.843 0 C3'-C2'-C1' 100.367 -1.259 . 0.0 OUTLIER '7D dist 1b' 1.93 . . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 6' ' ' ' G' . . . . . 0.691 ' N2 ' HG11 ' A' ' 65' ' ' VAL . . . . . . . . 0 O5'--C5' 1.425 -0.913 0 C3'-C2'-C1' 99.566 -2.149 . 0.0 OUTLIER gamma 2.38 . . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 7' ' ' ' C' . . . . . 0.519 " C5'" HH12 ' A' ' 76' ' ' ARG . . . . . . . . 0 O5'--C5' 1.424 -0.991 0 C4'-C3'-C2' 105.486 2.786 . 0.0 OUTLIER gamma 4.19 . . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.733 0 N-CA-C 111.8 -0.52 . . . . 13.03 111.8 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.928 ' HB3' ' HA ' ' A' ' 90' ' ' GLU . . . -111.59 136.74 50.38 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.603 0.716 . . . . 11.06 111.195 -178.629 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . 0.856 ' HB3' ' HA ' ' A' ' 34' ' ' PHE . 37.8 mtt -147.46 -130.38 0.06 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.812 -1.085 . . . . 9.85 108.902 -172.245 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.876 ' HA3' ' H ' ' A' ' 36' ' ' LYS . . . -173.92 -135.32 2.0 Favored Glycine 0 C--O 1.212 -1.278 0 C-N-CA 119.19 -1.481 . . . . 6.69 115.406 -178.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.97 ' H ' ' HB3' ' A' ' 36' ' ' LYS . 21.4 t 178.72 104.25 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 123.462 0.705 . . . . 5.55 111.48 175.379 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.487 ' HG2' ' HG3' ' A' ' 36' ' ' LYS . 0.0 OUTLIER 166.19 -154.04 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 124.959 1.304 . . . . 3.87 107.582 172.787 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -47.28 -51.75 18.16 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 108.48 -0.933 . . . . 3.53 108.48 168.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.725 ' HB ' ' OG1' ' A' ' 35' ' ' THR . 7.8 p -81.56 94.32 6.87 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 114.96 -1.018 . . . . 1.69 109.879 165.448 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 43.0 ttp -74.14 -50.96 17.09 Favored 'General case' 0 C--O 1.197 -1.699 0 CA-C-N 114.285 -1.325 . . . . 1.49 109.497 -175.424 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . 0.856 ' HA ' ' HB3' ' A' ' 27' ' ' MET . 15.4 m-30 -92.22 42.19 1.09 Allowed 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 115.43 1.641 . . . . 1.5 115.43 175.559 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.725 ' OG1' ' HB ' ' A' ' 32' ' ' THR . 16.2 p -147.89 20.06 1.13 Allowed 'General case' 0 N--CA 1.485 1.314 0 CA-C-N 122.219 2.282 . . . . 0.53 110.821 177.474 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.97 ' HB3' ' H ' ' A' ' 29' ' ' SER . 3.1 tmtm? -129.58 100.85 5.68 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-O 122.351 1.072 . . . . 2.75 110.753 -160.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 43.1 mt -88.48 142.35 13.03 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 O-C-N 121.677 -0.639 . . . . 0.85 111.894 -170.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.45 ' HB3' ' O ' ' A' ' 108' ' ' ASN . 49.3 t80 -102.17 128.12 48.81 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 108.348 -0.982 . . . . 0.71 108.348 169.39 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.7 t -120.98 89.09 1.35 Allowed 'Isoleucine or valine' 0 C--O 1.217 -0.652 0 C-N-CA 119.995 -0.682 . . . . 0.92 110.128 -176.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -59.14 154.67 28.65 Favored Glycine 0 C--O 1.221 -0.663 0 C-N-CA 118.113 -1.994 . . . . 0.84 114.513 165.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 96.15 39.16 4.35 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 121.105 -0.569 . . . . 0.68 114.189 170.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.675 HD12 HG21 ' A' ' 46' ' ' THR . 2.9 mm? -93.68 125.24 54.3 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 117.122 0.461 . . . . 1.28 109.96 173.381 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.601 ' HA ' ' H1 ' ' B' ' 2' ' ' ' G' . 50.0 Cg_exo -49.08 155.88 2.58 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.779 2.319 . . . . 0.58 111.953 171.406 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -69.42 -3.4 14.2 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.433 0.531 . . . . 1.05 112.433 -173.029 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -110.05 -8.95 14.75 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 120.545 0.212 . . . . 2.01 111.016 179.028 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.675 HG21 HD12 ' A' ' 42' ' ' LEU . 30.0 m -62.69 133.68 55.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.952 0.406 . . . . 0.72 111.156 -173.609 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 12.0 p -107.63 158.38 17.3 Favored 'General case' 0 C--O 1.251 1.183 0 CA-C-O 121.856 0.836 . . . . 0.55 112.06 -177.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.518 ' HA ' HG23 ' A' ' 66' ' ' VAL . 2.6 m-20 -49.99 -30.93 11.5 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 114.323 -1.308 . . . . 0.49 111.122 177.411 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.573 ' O ' ' HG2' ' A' ' 53' ' ' GLU . 60.6 pttt -78.77 -29.26 44.93 Favored 'General case' 0 C--O 1.215 -0.746 0 N-CA-C 108.799 -0.815 . . . . 2.76 108.799 -174.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.576 ' O ' ' HB2' ' A' ' 53' ' ' GLU . 7.0 m -64.91 -41.75 95.31 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 115.764 -0.653 . . . . 0.58 110.068 179.299 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.591 HD21 HD11 ' A' ' 42' ' ' LEU . 18.8 mt -62.05 -46.2 90.18 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 119.361 -0.935 . . . . 0.85 110.083 173.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . 0.535 ' HA ' ' CD1' ' A' ' 61' ' ' ILE . 59.6 t-80 -53.58 -32.39 50.77 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 116.27 -0.423 . . . . 0.59 110.911 172.474 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.576 ' HB2' ' O ' ' A' ' 50' ' ' THR . 45.2 mm-40 -68.05 -40.05 82.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.314 -0.857 . . . . 1.52 109.489 -175.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' TYR . . . . . 0.631 ' HA ' HE21 ' A' ' 57' ' ' GLN . 24.4 t80 -80.75 -40.82 24.55 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.421 -0.809 . . . . 1.12 111.499 -173.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.598 ' C ' ' H ' ' A' ' 57' ' ' GLN . 58.2 m-85 -85.56 -32.03 22.35 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 114.005 1.113 . . . . 0.56 114.005 -166.21 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.659 ' N ' HD11 ' A' ' 61' ' ' ILE . 15.7 pt-20 -63.28 4.13 0.24 Allowed 'General case' 0 N--CA 1.48 1.061 0 CA-C-O 122.168 0.985 . . . . 1.57 111.145 176.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.631 HE21 ' HA ' ' A' ' 54' ' ' TYR . 36.2 mt-30 -92.32 -18.11 23.79 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 113.753 -1.567 . . . . 2.16 110.73 -176.259 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -102.62 -29.43 11.55 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.506 0.67 . . . . 0.71 109.692 177.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.413 ' O ' ' HA ' ' A' ' 56' ' ' GLU . . . 178.46 -174.6 46.81 Favored Glycine 0 N--CA 1.443 -0.861 0 N-CA-C 110.255 -1.138 . . . . 0.75 110.255 -177.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -64.0 137.34 57.95 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 117.388 0.594 . . . . 1.02 110.492 175.409 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.659 HD11 ' N ' ' A' ' 56' ' ' GLU . 7.5 mt -101.91 142.42 16.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 105.692 -1.966 . . . . 0.47 105.692 172.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.475 ' OE1' ' HE3' ' A' ' 84' ' ' LYS . 7.7 tp10 -88.75 -37.13 15.71 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 119.61 1.096 . . . . 2.07 109.155 178.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -166.24 127.44 1.78 Allowed 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.063 -0.517 . . . . 2.48 110.792 177.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -115.01 134.33 55.28 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.1 0.476 . . . . 0.44 110.753 174.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.582 HG11 ' N2 ' ' B' ' 6' ' ' ' G' . 2.9 p -147.32 136.71 16.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.248 -0.887 . . . . 1.38 111.231 -174.61 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.518 HG23 ' HA ' ' A' ' 48' ' ' ASP . 78.4 t -107.36 131.37 57.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 109.043 -0.725 . . . . 0.49 109.043 176.317 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 49.0 mm -88.23 139.47 17.31 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-O 121.867 0.841 . . . . 0.72 112.625 -168.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.687 ' O ' ' HD2' ' A' ' 76' ' ' ARG . 34.4 p -118.34 -178.76 3.59 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 105.994 -1.854 . . . . 1.52 105.994 172.196 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.573 ' HB3' ' N ' ' A' ' 73' ' ' GLN . 37.6 t70 -95.47 158.75 15.32 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 105.874 -1.899 . . . . 2.49 105.874 -171.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 3.4 tpp180 -77.26 -55.62 5.26 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 120.224 1.375 . . . . 6.05 110.216 -179.443 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -71.25 -55.2 8.57 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 113.115 0.783 . . . . 4.05 113.115 178.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 60.3 p -91.22 -23.58 20.16 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.924 0.392 . . . . 3.08 111.803 -172.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.573 ' N ' ' HB3' ' A' ' 69' ' ' ASP . 50.0 mt-30 59.12 15.21 3.94 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 113.562 0.949 . . . . 3.3 113.562 179.047 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.432 ' HB3' ' N1 ' ' B' ' 1' ' ' ' G' . 67.4 mttm -53.93 145.86 15.5 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 110.099 -0.334 . . . . 3.49 110.099 166.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 2.8 m -59.8 107.82 0.66 Allowed 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.975 -0.75 . . . . 1.81 108.975 173.063 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.687 ' HD2' ' O ' ' A' ' 68' ' ' THR . 15.1 mtt180 -72.45 -10.62 60.02 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.188 -0.46 . . . . 2.56 112.042 -172.452 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 73.29 8.71 75.75 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.56 -0.828 . . . . 0.64 112.059 176.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.509 ' CD2' ' HB3' ' A' ' 76' ' ' ARG . 9.9 m-85 -111.18 141.62 44.46 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.44 -0.948 . . . . 1.18 108.44 178.401 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -126.96 164.76 20.43 Favored Glycine 0 N--CA 1.439 -1.157 0 C-N-CA 120.274 -0.965 . . . . 0.59 112.214 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.637 ' HD1' ' HE3' ' A' ' 36' ' ' LYS . 51.0 m-85 -139.44 123.12 17.46 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.25 0.547 . . . . 0.63 109.621 178.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.496 HG11 ' CD2' ' A' ' 55' ' ' PHE . 54.0 t -125.27 108.14 19.3 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 115.626 -0.715 . . . . 0.41 110.184 -178.483 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.451 ' HA ' ' HA ' ' A' ' 36' ' ' LYS . 18.5 m -92.83 118.03 30.67 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 109.128 -0.693 . . . . 0.47 109.128 178.022 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 80.3 mmm -85.91 -179.95 6.9 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.244 0.545 . . . . 0.88 110.326 178.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.475 ' HE3' ' OE1' ' A' ' 62' ' ' GLU . 6.4 tptm -93.99 -7.38 42.99 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.345 -0.843 . . . . 1.92 109.156 -171.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -167.28 154.17 8.48 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 114.672 -1.149 . . . . 1.68 110.12 -162.217 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.501 ' HB2' ' O ' ' A' ' 34' ' ' PHE . 0.0 OUTLIER -76.17 -49.49 17.11 Favored 'General case' 0 C--O 1.223 -0.341 0 N-CA-C 109.764 -0.458 . . . . 3.66 109.764 -174.258 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -51.69 -39.34 58.12 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.511 -0.768 . . . . 0.66 112.22 176.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.663 ' HA ' ' HE ' ' A' ' 91' ' ' ARG . 14.6 m -69.17 -40.54 78.06 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.838 0.351 . . . . 0.78 110.825 176.72 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -55.31 -46.08 76.29 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.049 -0.523 . . . . 0.46 110.525 170.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.928 ' HA ' ' HB3' ' A' ' 26' ' ' ALA . 4.1 mt-10 -60.34 -41.27 93.25 Favored 'General case' 0 C--O 1.222 -0.364 0 CA-C-O 121.268 0.556 . . . . 2.11 110.464 174.463 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.663 ' HE ' ' HA ' ' A' ' 88' ' ' SER . 16.4 mtm180 -56.72 -50.92 70.76 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 114.713 -1.13 . . . . 3.82 111.641 176.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -59.96 -27.31 66.7 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 113.837 1.051 . . . . 0.92 113.837 173.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 44.7 t -79.97 -36.1 36.58 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.943 0.878 . . . . 1.16 109.097 179.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.576 ' HB3' ' O ' ' A' ' 91' ' ' ARG . 59.8 tptt -50.4 -18.8 0.69 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 113.675 -1.602 . . . . 4.2 112.511 170.01 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -104.52 89.15 2.51 Favored Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 109.118 -0.697 . . . . 2.24 109.118 166.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.575 ' HD3' ' O ' ' A' ' 94' ' ' LYS . 5.6 Cg_exo -73.67 173.77 13.36 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.923 2.415 . . . . 2.38 111.138 -177.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 5.92 67.74 0.05 OUTLIER Pre-proline 0 N--CA 1.479 1.014 0 O-C-N 124.2 0.937 . . . . 3.03 113.417 -160.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -69.13 133.39 26.59 Favored 'Trans proline' 0 CA--C 1.511 -0.644 0 C-N-CA 121.723 1.615 . . . . 1.29 108.962 177.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.569 HG22 ' C ' ' A' ' 102' ' ' GLY . 17.2 mm -87.1 95.92 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.893 0 CA-C-N 119.307 0.958 . . . . 1.81 108.671 -172.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.441 ' C ' ' N ' ' A' ' 102' ' ' GLY . 11.2 mm -89.54 150.02 3.85 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.422 0 CA-C-O 121.461 0.648 . . . . 0.99 111.734 -170.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.545 ' HB3' ' HG2' ' A' ' 43' ' ' PRO . 30.5 t70 36.24 20.65 0.0 OUTLIER 'General case' 0 CA--C 1.559 1.306 0 CA-C-N 113.898 -1.501 . . . . 1.37 111.916 -156.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.569 ' C ' HG22 ' A' ' 99' ' ' ILE . . . 89.18 17.31 56.03 Favored Glycine 0 CA--C 1.535 1.31 0 C-N-CA 120.852 -0.69 . . . . 1.56 113.131 -179.546 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.487 ' N ' HG22 ' A' ' 99' ' ' ILE . 39.5 mmt180 -132.38 140.73 48.6 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.548 0.739 . . . . 4.13 110.035 176.18 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -58.58 112.68 1.69 Allowed 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 113.74 1.015 . . . . 2.73 113.74 -171.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -92.34 164.83 13.36 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 114.752 -1.113 . . . . 1.04 112.993 177.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -123.52 113.46 18.75 Favored 'General case' 0 C--O 1.253 1.27 0 CA-C-N 115.098 -0.956 . . . . 2.04 110.245 177.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 51.0 t -98.18 127.77 50.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 114.63 -1.168 . . . . 1.06 111.444 -173.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . 0.45 ' O ' ' HB3' ' A' ' 38' ' ' PHE . 66.5 t30 -157.39 152.75 26.23 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.517 -0.765 . . . . 2.49 109.909 178.532 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.823 HD13 ' HB2' ' A' ' 27' ' ' MET . 7.7 mt -65.97 125.93 26.98 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 113.539 0.94 . . . . 1.23 113.539 -177.627 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -45.92 -44.49 14.71 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 113.944 -1.48 . . . . 0.91 113.217 172.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.707 ' HB3' ' O ' ' A' ' 28' ' ' GLY . 0.1 OUTLIER -75.74 -6.42 50.51 Favored 'General case' 0 N--CA 1.473 0.692 0 O-C-N 121.866 -0.521 . . . . 1.4 111.418 -173.835 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 94.4 mt -86.1 -37.78 18.47 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.949 0.404 . . . . 1.97 110.715 174.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . -87.69 -15.59 61.36 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.852 -0.689 . . . . 2.14 112.786 -179.208 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.41 ' O ' ' HD3' ' A' ' 116' ' ' PRO . . . -67.11 154.61 40.82 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.992 -0.373 . . . . 2.66 109.992 -179.28 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.486 ' HD3' ' HA ' ' A' ' 119' ' ' ASN . 65.5 mttm -120.14 88.87 42.05 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-O 120.83 0.348 . . . . 4.16 111.158 -175.144 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.41 ' HD3' ' O ' ' A' ' 114' ' ' ALA . 1.2 Cg_endo -86.05 -39.66 0.08 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 122.822 2.348 . . . . 5.53 111.204 175.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 13.6 ptp180 -127.63 -21.7 3.73 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.93 -0.577 . . . . 8.6 111.626 -176.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 3.5 t -110.18 99.98 8.96 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.284 0.564 . . . . 6.37 110.633 -177.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.486 ' HA ' ' HD3' ' A' ' 115' ' ' LYS . 24.7 p-10 -99.61 -36.93 9.35 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.75 -0.659 . . . . 7.85 110.75 179.049 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 46.3 t 62.53 82.25 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-N 115.728 -0.669 . . . . 9.37 110.557 -176.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.424 ' HG2' ' OXT' ' A' ' 121' ' ' GLN . 19.1 pm0 . . . . . 0 C--O 1.247 0.959 0 CA-C-N 115.364 -0.835 . . . . 12.28 110.495 -179.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 1' ' ' ' G' . . . . . 0.432 ' N1 ' ' HB3' ' A' ' 74' ' ' LYS . . . . . . . . 0 O5'--C5' 1.434 -0.396 0 C3'-C2'-C1' 99.737 -1.959 . 0.0 '__' . 4.94 . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 2' ' ' ' G' . . . . . 0.601 ' H1 ' ' HA ' ' A' ' 43' ' ' PRO . . . . . . . . 0 O5'--C5' 1.426 -0.856 0 C3'-C2'-C1' 99.998 -1.669 . 0.0 OUTLIER . 4.87 . . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 3' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.426 -0.885 0 C4'-C3'-C2' 104.15 1.45 . 0.0 OUTLIER . 5.02 . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 4' ' ' ' G' . . . . . 0.618 " H3'" ' N3 ' ' B' ' 4' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.428 -0.762 0 O4'-C4'-C3' 103.844 -1.183 . 0.0 OUTLIER . 2.69 . . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 5' ' ' ' U' . . . . . 0.614 " H5'" " O2'" ' B' ' 4' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.425 -0.926 0 C4'-C3'-C2' 104.423 1.723 . 0.495 1b . 1.93 . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 6' ' ' ' G' . . . . . 0.582 ' N2 ' HG11 ' A' ' 65' ' ' VAL . . . . . . . . 0 O5'--C5' 1.424 -1.005 0 C4'-C3'-C2' 103.628 0.928 . 0.0 OUTLIER . 2.38 . . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 7' ' ' ' C' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.428 -0.729 0 O4'-C1'-C2' 107.996 1.14 . 0.0 OUTLIER . 4.19 . . . . . . . . . . 1 1 . 1 stop_ save_